data_2rug_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rug _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -76.52 137.49 39.63 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.002 0.921 . . . . 0.0 111.174 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.5 t -138.27 116.82 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.475 1.11 . . . . 0.0 109.77 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.2 141.75 49.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.536 0.734 . . . . 0.0 110.727 172.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.37 124.64 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.239 1.416 . . . . 0.0 109.509 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -119.57 144.88 17.78 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.789 1.185 . . . . 0.0 113.319 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 100.24 9.16 48.68 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.585 1.565 . . . . 0.0 114.502 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.05 141.77 75.66 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.38 1.472 . . . . 0.0 111.328 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -53.93 155.71 14.12 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.851 3.034 . . . . 0.0 114.084 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.45 3.75 7.22 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.956 3.104 . . . . 0.0 113.527 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -137.93 19.94 2.83 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.623 1.569 . . . . 0.0 112.159 -170.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -103.05 136.39 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.317 1.447 . . . . 0.0 110.547 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -109.03 171.79 7.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.177 0.991 . . . . 0.0 113.02 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -44.35 -46.25 9.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.863 1.665 . . . . 0.0 113.602 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -76.35 -26.96 56.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.449 0.699 . . . . 0.0 112.591 -173.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -78.7 -38.17 39.77 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.819 0.848 . . . . 0.0 111.425 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 34.6 mt -65.06 -39.89 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 121.601 -0.687 . . . . 0.0 109.415 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 90.2 m -61.29 -52.51 64.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.756 0.823 . . . . 0.0 110.345 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.3 69.88 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.453 1.024 . . . . 0.0 113.213 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.1 m -68.46 -23.99 64.66 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -120.42 -4.12 9.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.256 1.022 . . . . 0.0 113.435 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -60.39 -22.07 62.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.313 1.445 . . . . 0.0 113.439 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -54.87 -19.29 6.25 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.425 1.89 . . . . 0.0 114.888 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -98.85 -4.81 32.24 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.467 1.507 . . . . 0.0 113.688 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.66 170.65 13.63 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.996 1.76 . . . . 0.0 112.015 -170.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.37 150.49 76.01 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.598 2.865 . . . . 0.0 112.144 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.88 172.87 16.2 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.721 1.608 . . . . 0.0 112.275 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.17 159.69 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.523 1.529 . . . . 0.0 108.797 167.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.78 136.17 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.179 0.991 . . . . 0.0 110.421 -172.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.897 1.679 . . . . 0.0 111.667 -173.156 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.882 0 CA-C-O 118.997 -0.89 . . . . 0.0 114.491 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -148.06 150.2 33.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.402 1.601 . . . . 0.0 114.634 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -154.81 173.32 16.62 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.979 1.312 . . . . 0.0 112.171 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -118.33 122.01 41.81 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.226 1.811 . . . . 0.0 110.302 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.34 141.5 31.74 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.375 1.47 . . . . 0.0 108.511 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 64.4 mt -125.73 103.67 7.95 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.951 1.701 . . . . 0.0 108.191 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -83.47 157.51 22.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.339 0.656 . . . . 0.0 112.126 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -75.28 -25.33 57.89 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.463 0.705 . . . . 0.0 112.658 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -138.14 144.41 40.77 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.175 1.39 . . . . 0.0 111.032 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.32 -32.43 72.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.448 0.699 . . . . 0.0 111.222 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.3 m -57.12 -27.88 62.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.705 1.202 . . . . 0.0 112.996 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.4 m -72.33 -28.92 63.36 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.961 -1.087 . . . . 0.0 111.994 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.76 -39.13 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 121.697 -0.627 . . . . 0.0 109.781 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -66.24 -39.02 89.23 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.614 -0.679 . . . . 0.0 111.949 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.86 86.93 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.542 0.61 . . . . 0.0 112.306 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 26.8 tp -64.25 -48.63 75.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.478 0.711 . . . . 0.0 111.042 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.67 -41.44 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.022 0.929 . . . . 0.0 111.408 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.18 -17.71 63.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.725 1.21 . . . . 0.0 113.66 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.18 -13.46 18.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.071 1.348 . . . . 0.0 113.455 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.7 m -75.6 147.59 39.48 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.876 0.87 . . . . 0.0 113.266 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.43 173.08 12.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.529 1.532 . . . . 0.0 108.215 165.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.471 0.609 0 C-N-CA 123.217 0.607 . . . . 0.0 112.575 -170.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 89.6 mt . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -140.93 141.43 34.51 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -125.41 -169.75 2.05 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.183 1.793 . . . . 0.0 108.332 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.2 p -141.73 150.2 41.48 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.645 1.111 . . . . 0.0 113.607 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 27.6 m -151.95 177.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.567 1.947 . . . . 0.0 111.486 -171.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 79.7 p -160.55 170.49 20.79 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.031 1.332 . . . . 0.0 112.933 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.4 p -153.78 -179.35 1.04 Allowed Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.73 2.012 . . . . 0.0 110.425 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.65 -19.93 55.5 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.845 2.363 . . . . 0.0 114.337 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 52.7 p -114.97 -19.28 11.0 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.05 1.34 . . . . 0.0 114.285 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.81 137.03 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.43 1.492 . . . . 0.0 110.391 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -131.64 137.75 48.49 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.711 1.204 . . . . 0.0 112.092 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.1 t70 57.54 28.4 15.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.396 1.478 . . . . 0.0 113.283 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -72.11 127.13 90.85 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.837 -1.078 . . . . 0.0 111.466 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.6 142.91 18.6 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.317 2.678 . . . . 0.0 109.381 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.5 m -137.65 133.22 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.55 1.14 . . . . 0.0 110.627 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -81.52 131.23 35.27 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.654 1.182 . . . . 0.0 110.057 -172.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.1 mm -114.05 128.61 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 108.986 -171.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -136.22 89.15 20.16 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.909 1.283 . . . . 0.0 110.092 -175.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.95 134.8 64.7 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.658 2.905 . . . . 0.0 110.851 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 . . . . . 0 CA--C 1.537 0.442 0 CA-C-O 121.172 0.51 . . . . 0.0 112.024 -174.84 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -82.12 135.72 35.26 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.592 0.633 . . . . 0.0 110.601 171.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.82 117.77 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.195 0.998 . . . . 0.0 110.146 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -71.21 139.74 50.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.147 0.979 . . . . 0.0 110.715 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 64.1 t -133.64 118.16 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.399 1.48 . . . . 0.0 109.292 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.09 143.44 18.07 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 124.803 1.192 . . . . 0.0 113.478 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.49 15.49 32.04 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.109 1.338 . . . . 0.0 114.4 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.64 139.47 85.84 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.957 1.303 . . . . 0.0 110.933 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -55.12 156.46 16.18 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.578 2.852 . . . . 0.0 113.703 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.91 5.4 4.95 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.054 3.169 . . . . 0.0 113.715 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -140.3 29.54 2.0 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.393 1.477 . . . . 0.0 112.043 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -110.7 128.32 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.464 1.106 . . . . 0.0 111.179 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -97.73 167.49 10.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.667 1.187 . . . . 0.0 113.334 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -43.6 -46.53 7.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.261 1.825 . . . . 0.0 113.994 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -79.01 -25.44 43.31 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.846 0.858 . . . . 0.0 112.523 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -77.51 -36.41 52.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.589 0.756 . . . . 0.0 111.933 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 44.0 mt -65.54 -36.39 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.153 0.888 . . . . 0.0 109.569 170.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 60.4 m -64.23 -52.19 59.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.831 0.852 . . . . 0.0 110.54 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.16 -30.64 70.52 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.605 1.093 . . . . 0.0 112.992 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.1 m -66.86 -15.5 63.67 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -130.19 -2.78 4.48 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -61.12 -22.09 64.34 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.987 1.315 . . . . 0.0 113.096 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -56.91 -13.12 2.37 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.736 2.014 . . . . 0.0 114.956 169.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -104.56 -5.73 21.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.497 1.519 . . . . 0.0 113.961 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.8 170.97 13.66 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.878 1.704 . . . . 0.0 112.104 -170.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.56 151.35 70.18 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.793 2.995 . . . . 0.0 112.429 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.06 172.92 15.11 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.63 1.572 . . . . 0.0 112.486 -170.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.52 159.44 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.742 1.617 . . . . 0.0 109.33 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.98 136.36 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.489 1.115 . . . . 0.0 110.817 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.3 t70 . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 126.375 1.87 . . . . 0.0 111.659 -174.727 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.247 0 CA-C-O 119.618 -0.545 . . . . 0.0 114.13 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -151.44 158.0 43.1 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.622 1.211 . . . . 0.0 112.773 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -151.81 168.79 23.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.662 1.185 . . . . 0.0 111.904 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.57 118.69 33.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.51 1.924 . . . . 0.0 109.521 175.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 23.7 mt -82.34 142.33 32.11 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.306 1.442 . . . . 0.0 109.053 169.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 53.7 mt -125.97 106.79 9.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.018 1.727 . . . . 0.0 108.05 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.03 156.43 21.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.519 0.728 . . . . 0.0 112.161 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -69.01 -34.56 75.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.701 0.801 . . . . 0.0 112.41 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -140.57 141.62 35.21 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.991 1.716 . . . . 0.0 109.999 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -60.59 -32.41 71.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.052 0.941 . . . . 0.0 111.808 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 19.2 m -56.81 -27.05 59.3 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.616 1.166 . . . . 0.0 112.954 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 22.5 m -70.06 -28.73 65.69 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.089 -1.007 . . . . 0.0 112.283 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 57.9 t -77.18 -36.5 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.643 -0.66 . . . . 0.0 110.043 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -68.74 -37.15 79.22 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.515 -0.741 . . . . 0.0 111.871 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.43 -37.84 87.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.298 0.639 . . . . 0.0 112.294 172.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.0 tp -64.68 -48.55 74.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.435 0.694 . . . . 0.0 111.032 171.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.1 mt -55.89 -41.51 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.086 0.954 . . . . 0.0 111.261 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.45 -17.53 63.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.767 1.227 . . . . 0.0 113.636 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.83 -13.64 19.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.082 1.353 . . . . 0.0 113.27 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 56.8 m -71.93 141.17 49.47 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.029 0.919 . . . . 0.0 113.077 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 90.6 mt -80.94 176.28 9.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.541 1.536 . . . . 0.0 108.052 165.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 . . . . . 0 CA--C 1.536 0.421 0 C-N-CA 123.402 0.681 . . . . 0.0 110.956 178.773 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 120.713 0.292 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -141.22 152.13 44.33 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.873 1.269 . . . . 0.0 113.787 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.0 tp -140.17 161.62 37.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.767 1.627 . . . . 0.0 109.916 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 24.2 p -97.88 139.0 34.38 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.92 1.288 . . . . 0.0 112.769 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.1 m -148.21 175.61 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 126.627 1.971 . . . . 0.0 110.667 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 82.9 p -161.38 170.9 19.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.3 p -139.61 -177.82 0.74 Allowed Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 127.009 2.123 . . . . 0.0 110.885 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -65.6 -11.72 31.82 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.322 2.681 . . . . 0.0 114.273 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 43.7 p -122.7 -24.71 4.82 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.025 1.33 . . . . 0.0 113.857 -174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 31.0 mm -129.77 125.86 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.325 1.45 . . . . 0.0 109.648 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.06 143.74 48.91 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.576 1.15 . . . . 0.0 112.347 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 61.08 30.67 19.6 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.451 1.501 . . . . 0.0 112.701 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -69.18 127.95 92.76 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 121.128 -0.982 . . . . 0.0 111.529 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.25 131.8 5.05 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.397 2.732 . . . . 0.0 108.941 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.35 133.91 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.026 1.33 . . . . 0.0 110.915 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -77.34 127.98 33.5 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.411 1.085 . . . . 0.0 109.638 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.4 mm -109.21 132.77 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.91 1.284 . . . . 0.0 109.211 -174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -139.87 93.88 9.28 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.477 1.111 . . . . 0.0 110.295 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.04 135.56 69.38 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.252 2.635 . . . . 0.0 109.687 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -169.249 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.5 mtm-85 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -82.24 134.26 35.28 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.254 1.422 . . . . 0.0 111.128 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.6 t -141.0 121.05 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.297 1.039 . . . . 0.0 110.246 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -75.11 140.33 43.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.683 0.793 . . . . 0.0 110.49 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.73 120.6 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.24 1.416 . . . . 0.0 109.294 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.37 146.71 18.55 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 124.836 1.208 . . . . 0.0 113.917 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 91.32 23.75 28.38 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.958 1.266 . . . . 0.0 113.931 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.22 145.91 64.26 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.826 1.651 . . . . 0.0 111.717 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -52.34 155.56 9.38 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.13 3.22 . . . . 0.0 113.907 174.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.57 1.12 9.34 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.878 3.052 . . . . 0.0 113.576 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -140.4 45.79 1.83 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.672 1.589 . . . . 0.0 111.469 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.8 tt -127.57 147.67 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.437 1.495 . . . . 0.0 110.834 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -123.92 170.98 10.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.461 1.504 . . . . 0.0 113.08 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -50.28 -40.82 49.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.177 1.391 . . . . 0.0 113.994 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -81.1 -29.8 34.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.993 0.917 . . . . 0.0 112.361 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.22 -38.75 71.99 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.329 0.652 . . . . 0.0 111.882 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 46.8 mt -66.05 -38.23 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.52 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 88.8 m -61.26 -51.18 70.03 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.316 0.647 . . . . 0.0 110.634 172.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.84 -31.07 71.29 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.245 0.929 . . . . 0.0 112.866 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.5 m -69.09 -14.29 62.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -128.23 -3.08 5.65 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.34 0.973 . . . . 0.0 113.539 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -60.61 -22.1 63.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.905 1.282 . . . . 0.0 113.38 174.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -56.81 -14.17 3.19 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.663 1.985 . . . . 0.0 115.016 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -102.82 -4.4 24.95 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.36 1.464 . . . . 0.0 113.903 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 120.89 171.68 14.38 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.864 1.697 . . . . 0.0 111.981 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.18 151.87 72.35 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.589 2.859 . . . . 0.0 112.271 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.66 173.45 13.87 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.913 1.685 . . . . 0.0 112.312 -171.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.04 157.8 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.658 1.583 . . . . 0.0 108.707 166.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.18 136.25 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.514 1.126 . . . . 0.0 110.158 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 21.7 t0 . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.48 1.112 . . . . 0.0 112.751 -178.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.18 0 CA-C-O 119.369 -0.684 . . . . 0.0 114.354 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -148.16 160.76 42.58 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.775 1.288 . . . . 0.0 113.188 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.42 165.07 36.17 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.992 1.317 . . . . 0.0 111.879 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.28 121.52 45.48 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.832 1.653 . . . . 0.0 109.941 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 22.5 mt -84.85 139.91 31.56 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.433 1.493 . . . . 0.0 108.682 169.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 45.5 mt -127.06 103.13 7.28 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.922 1.689 . . . . 0.0 107.874 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -82.03 160.74 23.17 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.391 0.677 . . . . 0.0 111.813 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -82.84 -16.24 48.46 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -141.29 141.47 33.92 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.405 1.482 . . . . 0.0 110.51 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.77 -30.03 69.77 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.709 -0.62 . . . . 0.0 111.508 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.5 m -55.27 -28.46 53.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.666 1.187 . . . . 0.0 112.964 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.6 m -73.48 -28.74 62.09 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.01 -1.056 . . . . 0.0 112.213 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 86.1 t -75.21 -37.79 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.561 -0.712 . . . . 0.0 109.848 174.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -67.28 -38.2 84.69 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.552 -0.718 . . . . 0.0 111.967 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.83 -37.75 88.03 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.615 0.643 . . . . 0.0 112.322 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.1 tp -63.52 -49.12 74.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.386 0.675 . . . . 0.0 110.92 171.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.7 mt -55.85 -41.51 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.155 0.982 . . . . 0.0 111.351 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.4 -18.25 63.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.737 1.215 . . . . 0.0 113.672 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.48 -14.28 20.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.044 1.337 . . . . 0.0 113.433 174.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.0 m -75.03 146.72 41.34 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.064 0.935 . . . . 0.0 113.475 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -85.17 176.24 8.48 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.545 1.538 . . . . 0.0 107.844 165.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 123.375 0.67 . . . . 0.0 111.715 -175.863 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 120.82 0.343 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -144.98 150.55 37.13 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.504 1.122 . . . . 0.0 113.271 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.35 153.18 42.46 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.045 1.338 . . . . 0.0 110.617 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 21.5 p -83.72 136.45 34.17 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.627 1.171 . . . . 0.0 112.607 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.8 165.4 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 126.021 1.728 . . . . 0.0 111.264 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 50.4 m -146.59 168.06 22.19 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.262 1.025 . . . . 0.0 113.217 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.0 p -147.65 -173.79 0.38 Allowed Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 127.804 2.442 . . . . 0.0 109.942 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -64.63 -16.09 53.41 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.051 2.501 . . . . 0.0 114.341 171.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 57.4 p -126.99 -15.37 5.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.932 1.293 . . . . 0.0 114.312 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.0 mm -129.63 135.0 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.173 1.789 . . . . 0.0 109.27 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -133.14 132.4 41.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.039 0.936 . . . . 0.0 112.338 -169.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.7 t70 59.36 26.95 15.92 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.674 1.59 . . . . 0.0 113.032 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -75.15 129.86 81.81 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.401 1.48 . . . . 0.0 111.901 -169.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -76.35 117.75 4.71 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.407 2.738 . . . . 0.0 110.916 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.89 141.25 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.347 1.459 . . . . 0.0 110.436 173.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -79.03 129.47 34.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.045 0.938 . . . . 0.0 109.861 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.5 131.69 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.487 1.515 . . . . 0.0 108.77 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 29.2 mtp85 -139.25 86.86 14.21 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.681 1.193 . . . . 0.0 110.107 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.89 138.69 80.65 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.638 2.892 . . . . 0.0 111.372 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 123.478 0.711 . . . . 0.0 112.405 -173.202 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -71.19 138.63 49.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.928 0.891 . . . . 0.0 110.816 169.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.6 t -140.07 119.49 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.537 1.135 . . . . 0.0 109.717 175.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -71.77 139.53 49.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.867 0.867 . . . . 0.0 110.544 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.9 119.11 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.311 1.445 . . . . 0.0 109.407 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -117.03 147.67 18.88 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.113 1.339 . . . . 0.0 113.45 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 92.02 19.07 40.93 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 124.702 1.144 . . . . 0.0 114.142 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 98.3 mt -55.2 141.56 60.66 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.561 1.544 . . . . 0.0 111.189 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.94 148.86 28.17 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.625 2.884 . . . . 0.0 112.806 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.62 6.65 3.1 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.207 3.271 . . . . 0.0 114.461 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -140.05 16.57 2.45 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.48 1.512 . . . . 0.0 112.676 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.6 tt -93.39 137.73 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.039 0.936 . . . . 0.0 111.408 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -109.92 170.26 8.19 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.721 1.208 . . . . 0.0 113.161 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -47.66 -44.11 26.89 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.647 1.579 . . . . 0.0 113.746 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -79.65 -25.49 41.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.839 0.855 . . . . 0.0 112.316 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -77.99 -36.64 48.64 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.773 0.829 . . . . 0.0 111.496 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.0 mt -64.89 -38.64 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 118.932 0.787 . . . . 0.0 109.529 170.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 61.6 m -62.74 -52.01 64.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.533 0.733 . . . . 0.0 110.517 173.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.7 70.89 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.5 1.045 . . . . 0.0 112.998 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.6 m -67.66 -15.04 63.44 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -129.62 -2.97 4.8 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -60.98 -22.63 64.66 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.878 1.271 . . . . 0.0 113.142 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -56.42 -13.99 2.67 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.806 2.042 . . . . 0.0 115.009 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -103.67 -6.29 21.74 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.432 1.493 . . . . 0.0 113.946 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 123.44 172.33 13.77 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.961 1.743 . . . . 0.0 112.14 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.79 151.45 68.87 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.544 2.829 . . . . 0.0 112.358 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.27 172.88 15.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.746 1.618 . . . . 0.0 112.527 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -134.02 159.19 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.706 1.603 . . . . 0.0 109.28 167.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 56.1 t -129.26 135.11 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.308 1.043 . . . . 0.0 110.77 -171.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 CA--C 1.545 0.761 0 C-N-CA 126.257 1.823 . . . . 0.0 111.845 -172.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 CA-C-O 119.678 -0.512 . . . . 0.0 114.284 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -149.88 156.79 42.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.641 1.176 . . . . 0.0 112.651 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.58 169.67 22.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.905 1.282 . . . . 0.0 111.697 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -116.32 118.06 31.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.39 1.876 . . . . 0.0 109.531 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 25.4 mt -80.95 141.09 34.83 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.921 1.288 . . . . 0.0 108.682 169.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.8 mt -123.85 103.42 8.34 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.747 1.619 . . . . 0.0 107.871 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -81.02 156.52 25.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.116 0.566 . . . . 0.0 111.403 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -82.81 -15.75 50.45 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -141.87 141.85 33.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.4 1.48 . . . . 0.0 110.658 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.57 -31.86 70.97 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.228 0.611 . . . . 0.0 111.533 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -56.03 -28.04 55.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.65 1.18 . . . . 0.0 112.941 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.3 m -73.92 -29.64 62.15 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.955 -1.091 . . . . 0.0 112.168 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.95 -38.81 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.667 -0.646 . . . . 0.0 109.66 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -66.96 -38.51 86.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.636 -0.665 . . . . 0.0 111.985 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.92 88.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.627 0.649 . . . . 0.0 112.304 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.95 -48.85 74.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.45 0.7 . . . . 0.0 110.918 171.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 74.2 mt -55.67 -42.43 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.091 0.957 . . . . 0.0 111.345 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.98 -17.97 64.0 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.668 1.187 . . . . 0.0 113.671 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.09 -13.88 19.63 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.113 1.365 . . . . 0.0 113.431 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.9 m -77.51 150.46 34.86 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -86.83 176.23 7.81 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.79 1.636 . . . . 0.0 107.778 164.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.471 0.589 0 C-N-CA 123.463 0.705 . . . . 0.0 111.729 -174.783 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 120.68 0.276 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -144.18 148.97 35.7 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.224 1.01 . . . . 0.0 113.096 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -140.7 162.1 36.2 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.733 1.613 . . . . 0.0 110.017 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 24.8 p -97.79 141.17 31.11 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.082 1.353 . . . . 0.0 112.628 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.4 m -146.66 169.98 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 126.7 2.0 . . . . 0.0 110.644 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.7 m -148.9 169.05 21.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.553 1.141 . . . . 0.0 112.786 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.28 175.98 2.57 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 127.916 2.487 . . . . 0.0 109.493 -176.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -57.19 -31.97 92.13 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.162 2.575 . . . . 0.0 115.016 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 42.2 p -119.07 0.12 11.21 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.556 1.542 . . . . 0.0 114.03 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.6 mm -135.68 121.65 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.84 1.656 . . . . 0.0 109.061 -171.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -125.05 134.33 52.58 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.204 1.002 . . . . 0.0 111.984 -168.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.2 t70 60.3 30.81 20.14 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.298 1.439 . . . . 0.0 112.653 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -62.71 129.88 93.27 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.782 1.233 . . . . 0.0 110.962 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.87 137.61 11.19 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.214 2.61 . . . . 0.0 109.193 169.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.23 138.16 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.244 1.418 . . . . 0.0 110.201 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -79.05 127.74 32.38 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.012 1.325 . . . . 0.0 109.532 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.0 mm -112.22 132.8 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.581 1.552 . . . . 0.0 108.673 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -141.21 92.54 8.36 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.476 1.11 . . . . 0.0 110.074 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.79 133.37 55.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.53 2.82 . . . . 0.0 110.829 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 . . . . . 0 CA--C 1.54 0.559 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -169.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.26 133.86 35.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.686 1.195 . . . . 0.0 110.811 171.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.9 123.0 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.425 1.09 . . . . 0.0 110.524 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.37 143.44 44.85 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.313 1.045 . . . . 0.0 111.344 171.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.61 127.2 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.236 1.414 . . . . 0.0 109.586 172.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -127.78 146.44 16.62 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.938 1.256 . . . . 0.0 113.622 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 96.73 15.98 38.01 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.142 1.353 . . . . 0.0 114.451 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.31 141.99 86.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.238 1.415 . . . . 0.0 111.507 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.25 155.82 14.95 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.027 3.151 . . . . 0.0 114.283 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.75 2.71 7.58 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 124.117 3.212 . . . . 0.0 113.673 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -138.19 34.76 2.32 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.643 1.577 . . . . 0.0 111.815 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 10.4 tt -114.1 162.57 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.525 1.53 . . . . 0.0 110.234 172.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -146.22 170.36 16.9 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.049 1.34 . . . . 0.0 112.539 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -42.74 -47.66 5.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.132 1.773 . . . . 0.0 114.264 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.25 -29.2 42.53 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.388 -0.82 . . . . 0.0 112.34 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -74.15 -37.25 64.08 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.634 0.774 . . . . 0.0 111.45 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 64.6 mt -65.77 -39.52 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.454 -0.778 . . . . 0.0 109.569 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 62.0 m -60.63 -52.5 64.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.254 173.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.15 71.41 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.332 0.969 . . . . 0.0 112.942 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.2 m -69.42 -14.59 62.98 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -128.2 -4.1 5.59 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.347 0.976 . . . . 0.0 113.508 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -60.61 -22.44 63.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.952 1.301 . . . . 0.0 113.284 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -56.44 -13.7 2.47 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.716 2.006 . . . . 0.0 115.045 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -104.86 -4.38 22.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.236 1.414 . . . . 0.0 113.988 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.72 172.73 14.34 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.818 1.675 . . . . 0.0 112.228 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.68 151.59 69.55 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.722 2.948 . . . . 0.0 112.172 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.09 172.66 16.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.538 1.535 . . . . 0.0 112.553 -169.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.37 151.45 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.876 1.67 . . . . 0.0 109.389 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.98 134.77 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.338 1.455 . . . . 0.0 109.719 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 CA--C 1.544 0.724 0 C-N-CA 125.95 1.7 . . . . 0.0 112.05 -169.79 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 CA-C-O 118.813 -0.993 . . . . 0.0 114.315 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -137.15 158.05 45.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.495 1.648 . . . . 0.0 113.752 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.36 167.8 29.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.502 1.521 . . . . 0.0 111.763 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -118.71 135.07 54.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.023 1.729 . . . . 0.0 109.913 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.2 mt -103.41 139.26 39.03 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.064 1.746 . . . . 0.0 108.697 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 14.2 mt -121.27 113.0 19.31 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.86 156.19 19.08 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.761 0.824 . . . . 0.0 111.338 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -64.59 -35.64 81.64 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.746 -0.596 . . . . 0.0 112.359 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -141.0 144.99 35.35 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.641 1.576 . . . . 0.0 110.507 -171.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.02 -30.88 70.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.508 1.123 . . . . 0.0 112.203 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 24.0 p -61.25 -25.83 67.35 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.088 1.355 . . . . 0.0 113.147 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 25.9 m -70.36 -30.75 67.76 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.931 -1.105 . . . . 0.0 111.686 172.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.75 -34.53 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.539 -0.726 . . . . 0.0 110.249 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -66.44 -37.59 85.5 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.436 -0.79 . . . . 0.0 111.861 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.87 89.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.652 0.66 . . . . 0.0 112.408 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.7 tp -62.99 -48.83 77.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.252 0.621 . . . . 0.0 110.824 171.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 70.8 mt -55.82 -42.29 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.334 1.054 . . . . 0.0 111.289 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.27 -19.67 63.92 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.601 1.16 . . . . 0.0 113.63 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -96.63 -14.14 22.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.952 1.301 . . . . 0.0 113.312 174.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 29.7 m -75.55 146.69 40.27 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 88.7 mt -85.33 -179.06 6.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.998 1.719 . . . . 0.0 107.702 164.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 CA--C 1.537 0.469 0 O-C-N 121.465 -0.772 . . . . 0.0 111.843 -177.789 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 120.878 0.37 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -145.51 149.94 35.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.776 1.23 . . . . 0.0 112.711 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -144.27 153.17 41.76 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.891 1.276 . . . . 0.0 110.936 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 20.5 p -85.63 134.4 33.99 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.656 1.182 . . . . 0.0 112.804 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.87 167.48 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 126.335 1.854 . . . . 0.0 110.708 172.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.2 m -149.69 166.67 28.64 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.493 1.117 . . . . 0.0 112.814 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.5 p -138.51 -175.72 0.51 Allowed Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 127.209 2.204 . . . . 0.0 110.494 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.57 -15.39 49.7 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.064 2.509 . . . . 0.0 114.233 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 47.1 p -123.1 -23.7 4.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.898 1.279 . . . . 0.0 114.172 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.3 mm -126.23 132.28 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.601 1.56 . . . . 0.0 109.534 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -125.0 134.83 52.43 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.41 1.084 . . . . 0.0 111.773 -170.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 62.36 27.61 16.45 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.589 1.555 . . . . 0.0 112.928 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -60.32 127.27 86.11 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.607 1.163 . . . . 0.0 111.511 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.51 110.82 1.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.401 2.734 . . . . 0.0 108.287 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.27 136.22 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.115 0.966 . . . . 0.0 110.05 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -74.67 134.49 41.98 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.168 0.987 . . . . 0.0 109.486 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.73 133.92 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 126.14 1.776 . . . . 0.0 108.097 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 39.7 mtt180 -138.85 98.57 8.6 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.995 0.918 . . . . 0.0 110.343 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.31 134.4 61.29 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.434 2.756 . . . . 0.0 110.38 169.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 123.433 0.693 . . . . 0.0 112.455 -175.13 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -68.83 139.13 55.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.041 0.936 . . . . 0.0 111.222 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.5 t -139.04 118.53 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.595 1.158 . . . . 0.0 109.996 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -68.54 138.85 55.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.07 0.948 . . . . 0.0 110.838 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.5 t -132.55 116.91 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.255 1.422 . . . . 0.0 109.277 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.04 143.91 17.9 Favored Glycine 0 N--CA 1.47 0.913 0 C-N-CA 124.905 1.24 . . . . 0.0 113.637 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.1 23.71 21.68 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.669 1.128 . . . . 0.0 113.882 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.72 141.57 84.68 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.042 1.337 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.22 155.18 20.46 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.503 2.802 . . . . 0.0 113.538 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.23 3.29 6.36 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.803 3.002 . . . . 0.0 114.524 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -140.55 27.14 2.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.865 1.266 . . . . 0.0 112.819 -177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.2 tt -101.07 144.75 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.466 1.106 . . . . 0.0 110.817 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -122.38 170.93 9.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.609 1.163 . . . . 0.0 113.022 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -46.36 -43.71 16.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.109 1.764 . . . . 0.0 114.21 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -76.77 -27.86 55.47 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.447 -0.783 . . . . 0.0 112.401 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -78.67 -36.14 44.13 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.944 0.898 . . . . 0.0 111.499 172.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.0 mt -65.47 -36.77 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.968 0.803 . . . . 0.0 109.559 171.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 48.7 m -64.8 -52.39 57.11 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.461 0.704 . . . . 0.0 110.563 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.22 71.03 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.422 1.01 . . . . 0.0 113.019 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.2 m -67.84 -14.67 63.15 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.656 1.182 . . . . 0.0 114.094 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -129.65 -3.01 4.78 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.457 1.026 . . . . 0.0 113.651 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -60.5 -22.62 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.867 1.267 . . . . 0.0 113.143 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -56.81 -14.0 3.04 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.675 1.99 . . . . 0.0 115.001 170.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -103.78 -6.86 21.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.281 1.433 . . . . 0.0 113.97 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.98 172.18 13.44 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.072 1.796 . . . . 0.0 112.114 -171.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.09 151.21 72.9 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.512 2.808 . . . . 0.0 112.133 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.34 172.33 16.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.598 1.559 . . . . 0.0 112.367 -170.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.79 157.9 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.719 1.608 . . . . 0.0 109.411 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 80.4 t -126.74 135.0 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.61 1.164 . . . . 0.0 110.472 -171.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.0 t70 . . . . . 0 CA--C 1.544 0.72 0 C-N-CA 126.499 1.92 . . . . 0.0 111.689 -172.974 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.312 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.468 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -149.04 161.5 41.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.681 1.192 . . . . 0.0 112.871 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -148.69 164.66 33.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.177 1.391 . . . . 0.0 111.549 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -115.33 115.43 26.61 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.186 1.794 . . . . 0.0 109.155 171.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.4 mt -80.82 142.31 33.83 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.739 1.215 . . . . 0.0 108.911 169.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 48.8 mt -123.37 108.77 13.1 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.603 1.561 . . . . 0.0 107.544 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -85.43 156.4 20.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.245 0.618 . . . . 0.0 111.953 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -75.18 -27.22 59.58 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -142.42 146.6 35.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.238 1.415 . . . . 0.0 111.018 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -63.97 -28.96 70.17 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.047 0.939 . . . . 0.0 111.742 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 22.2 p -61.79 -26.26 67.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 112.948 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.4 m -73.93 -34.34 64.28 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.863 -1.148 . . . . 0.0 111.75 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.77 -40.26 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.773 -0.579 . . . . 0.0 109.871 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -67.66 -40.35 84.51 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.615 -0.678 . . . . 0.0 111.957 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.67 76.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.318 0.963 . . . . 0.0 112.553 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.3 tp -64.92 -48.2 75.0 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.171 0.589 . . . . 0.0 111.012 170.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 85.6 mt -56.38 -42.86 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 118.895 0.771 . . . . 0.0 111.335 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.0 -14.97 63.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.245 1.418 . . . . 0.0 114.154 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.7 -14.51 18.06 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.907 1.283 . . . . 0.0 113.417 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 56.2 m -73.46 145.25 45.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.156 0.979 . . . . 0.0 113.448 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.5 mt -82.36 175.05 10.56 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.591 1.556 . . . . 0.0 107.823 165.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.468 0.462 0 C-N-CA 123.537 0.735 . . . . 0.0 111.253 -177.435 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 120.747 0.308 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -142.24 152.36 42.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.291 1.037 . . . . 0.0 113.161 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.9 tp -139.52 168.36 20.0 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.797 1.639 . . . . 0.0 109.507 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 25.3 p -105.2 142.22 35.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.207 1.403 . . . . 0.0 112.518 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -144.83 171.59 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.628 1.971 . . . . 0.0 110.462 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 64.0 m -147.8 161.49 41.15 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.169 -0.957 . . . . 0.0 113.402 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 53.8 p -148.36 179.1 1.25 Allowed Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.764 2.025 . . . . 0.0 110.998 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -65.13 -13.83 41.91 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.295 2.663 . . . . 0.0 114.06 170.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 34.0 p -107.59 -31.38 8.13 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.01 1.324 . . . . 0.0 113.12 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 8.7 mm -134.69 126.62 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.515 1.126 . . . . 0.0 110.973 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -96.03 133.08 40.69 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.277 1.031 . . . . 0.0 111.535 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 61.8 34.64 17.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.132 1.373 . . . . 0.0 112.811 172.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -55.92 129.06 71.9 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.331 1.052 . . . . 0.0 110.817 171.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.37 137.62 11.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.273 2.648 . . . . 0.0 109.108 169.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.06 136.0 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.063 1.345 . . . . 0.0 110.433 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -73.77 131.22 41.34 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.143 0.977 . . . . 0.0 109.301 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.9 mm -113.35 129.57 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.97 1.308 . . . . 0.0 108.33 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 44.8 mtm105 -137.66 91.97 13.43 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.952 0.901 . . . . 0.0 110.725 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.57 145.66 98.4 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.774 2.983 . . . . 0.0 111.5 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 122.205 1.003 . . . . 0.0 111.878 -176.678 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -83.07 137.64 34.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.473 1.509 . . . . 0.0 110.801 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.1 t -142.98 120.34 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.555 1.142 . . . . 0.0 110.207 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -74.35 142.31 45.12 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.604 0.762 . . . . 0.0 110.851 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.65 125.35 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.487 1.515 . . . . 0.0 109.163 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -123.16 148.17 16.75 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.815 1.198 . . . . 0.0 113.33 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 93.57 19.52 34.73 Favored Glycine 0 N--CA 1.474 1.182 0 C-N-CA 124.797 1.189 . . . . 0.0 114.316 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.22 143.59 78.85 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 125.477 1.511 . . . . 0.0 111.514 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.61 154.07 26.84 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.628 2.885 . . . . 0.0 113.457 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.5 3.01 6.74 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.881 3.054 . . . . 0.0 114.422 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -140.46 25.1 2.24 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.759 1.224 . . . . 0.0 112.764 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 10.7 tt -92.82 162.43 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.169 0.988 . . . . 0.0 110.741 170.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -142.9 169.42 17.6 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.163 1.385 . . . . 0.0 112.437 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.87 -42.54 26.95 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.302 1.841 . . . . 0.0 114.106 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.38 -27.62 41.89 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.402 -0.811 . . . . 0.0 112.357 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -77.31 -35.17 55.15 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.794 0.837 . . . . 0.0 111.572 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 59.6 mt -65.9 -37.45 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.431 -0.793 . . . . 0.0 109.54 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 63.3 m -63.11 -52.18 63.63 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.342 0.657 . . . . 0.0 110.422 172.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -59.88 -31.67 70.01 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.166 0.894 . . . . 0.0 112.995 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 74.5 m -69.55 -14.16 62.71 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -131.64 -2.0 3.81 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.513 1.051 . . . . 0.0 113.743 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.16 -23.17 61.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.859 1.264 . . . . 0.0 112.993 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -57.55 -11.16 1.83 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.487 1.915 . . . . 0.0 115.17 170.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -107.75 -2.02 20.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.586 1.554 . . . . 0.0 113.945 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 119.34 176.53 16.24 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.194 1.854 . . . . 0.0 112.613 -174.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -63.31 148.54 92.81 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.582 2.854 . . . . 0.0 112.865 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.9 170.47 20.57 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.373 1.469 . . . . 0.0 112.639 -176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -131.44 157.9 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.911 1.685 . . . . 0.0 109.017 167.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 93.3 t -125.29 134.68 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.836 1.254 . . . . 0.0 109.93 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 125.975 1.71 . . . . 0.0 111.578 -170.776 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 CA-C-O 118.665 -1.075 . . . . 0.0 114.512 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -136.84 158.95 43.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.571 1.686 . . . . 0.0 114.051 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.31 165.82 35.45 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.388 1.475 . . . . 0.0 111.784 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.37 122.85 47.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.739 1.616 . . . . 0.0 110.01 170.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.0 mt -86.08 140.99 29.74 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.581 1.552 . . . . 0.0 108.917 169.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 52.2 mt -124.86 107.51 10.97 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.755 1.622 . . . . 0.0 107.811 171.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -85.54 159.47 19.89 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.622 0.769 . . . . 0.0 112.282 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -66.76 -36.08 81.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.941 0.896 . . . . 0.0 112.105 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -141.95 145.48 34.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.681 1.592 . . . . 0.0 110.109 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -63.77 -28.36 69.82 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.741 -0.6 . . . . 0.0 111.907 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 29.3 p -59.84 -24.53 64.27 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.912 -1.117 . . . . 0.0 113.181 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 27.5 m -70.7 -28.36 64.69 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.811 -1.181 . . . . 0.0 112.11 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.16 -37.14 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.696 -0.627 . . . . 0.0 109.929 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -64.13 -40.7 96.75 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.587 -0.696 . . . . 0.0 111.529 169.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.53 -37.93 85.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.763 0.711 . . . . 0.0 112.371 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.68 -47.85 76.88 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.432 0.693 . . . . 0.0 111.123 171.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.9 mt -56.02 -41.91 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.181 0.992 . . . . 0.0 111.421 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.24 -17.74 63.8 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.8 1.24 . . . . 0.0 113.485 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.04 -13.99 18.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.122 1.369 . . . . 0.0 113.518 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.4 m -74.3 146.57 43.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.001 0.905 . . . . 0.0 113.356 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.73 172.33 13.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.54 1.536 . . . . 0.0 108.097 165.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 N--CA 1.469 0.479 0 C-N-CA 123.532 0.733 . . . . 0.0 111.73 -175.529 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -143.34 147.26 34.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.225 1.01 . . . . 0.0 113.134 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.6 tp -130.68 -169.62 2.19 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.399 1.88 . . . . 0.0 108.5 170.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 29.3 p -141.3 149.96 41.93 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.069 0.947 . . . . 0.0 113.095 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -150.81 168.9 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 126.875 2.07 . . . . 0.0 110.478 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 56.4 m -144.24 161.85 37.85 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 54.0 p -147.81 179.05 1.25 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 126.926 2.09 . . . . 0.0 110.994 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -64.67 -13.76 40.84 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.389 2.726 . . . . 0.0 114.265 170.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 35.0 p -107.5 -32.36 7.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.924 1.29 . . . . 0.0 113.108 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 7.1 mm -134.4 126.88 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.451 1.1 . . . . 0.0 110.933 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -96.57 130.58 43.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 111.53 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 60.88 36.7 18.86 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.537 1.535 . . . . 0.0 112.691 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -56.53 125.64 67.42 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.431 1.092 . . . . 0.0 110.278 169.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.93 144.36 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.169 2.579 . . . . 0.0 109.4 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.65 135.39 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.973 1.309 . . . . 0.0 110.517 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -78.0 133.22 38.03 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.22 1.008 . . . . 0.0 109.717 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.5 mm -116.05 131.08 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.354 1.462 . . . . 0.0 108.538 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -137.42 90.31 15.17 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.665 1.186 . . . . 0.0 109.979 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.39 133.1 54.91 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.635 2.89 . . . . 0.0 110.881 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 121.568 0.699 . . . . 0.0 112.432 -173.403 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 56.5 mtm-85 . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -75.95 133.8 40.38 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.389 0.676 . . . . 0.0 110.783 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 52.7 t -138.22 117.27 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.424 1.09 . . . . 0.0 109.637 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -72.97 141.12 47.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.884 0.874 . . . . 0.0 110.468 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 81.2 t -133.05 119.37 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.477 1.511 . . . . 0.0 109.344 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -115.53 145.02 18.63 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 124.709 1.147 . . . . 0.0 113.718 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.32 17.75 28.31 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.123 1.344 . . . . 0.0 114.239 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.79 140.69 95.41 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.599 1.16 . . . . 0.0 111.121 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.24 156.37 13.62 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.958 3.106 . . . . 0.0 113.983 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.58 2.85 7.37 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.987 3.125 . . . . 0.0 113.448 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -140.29 41.92 1.92 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.8 1.64 . . . . 0.0 111.497 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -124.65 142.62 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.341 1.457 . . . . 0.0 110.529 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -119.65 172.62 7.54 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.098 1.359 . . . . 0.0 113.075 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -45.68 -46.67 14.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.713 1.605 . . . . 0.0 113.729 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.76 -26.04 49.55 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.542 0.737 . . . . 0.0 112.446 -173.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -79.06 -37.83 37.92 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.997 0.919 . . . . 0.0 111.524 172.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 48.3 mt -65.51 -36.32 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.403 -0.811 . . . . 0.0 109.589 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 71.4 m -64.62 -52.84 55.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.922 0.889 . . . . 0.0 110.414 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.16 70.23 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.579 1.081 . . . . 0.0 112.954 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.7 m -67.2 -15.57 63.78 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -130.7 -2.73 4.2 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -61.05 -22.29 64.45 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.165 1.386 . . . . 0.0 113.127 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -56.58 -13.71 2.6 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.809 2.044 . . . . 0.0 114.941 169.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -103.69 -7.19 20.86 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.47 1.508 . . . . 0.0 113.936 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.45 175.18 14.25 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.209 1.861 . . . . 0.0 112.269 -173.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.7 149.33 91.56 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.613 2.876 . . . . 0.0 112.796 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.15 171.88 17.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.216 1.406 . . . . 0.0 112.588 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -134.37 157.94 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.731 1.612 . . . . 0.0 109.431 167.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.94 137.74 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.643 1.177 . . . . 0.0 110.992 -171.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 CA--C 1.545 0.781 0 C-N-CA 126.603 1.961 . . . . 0.0 111.456 -176.874 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.233 0 CA-C-O 119.814 -0.437 . . . . 0.0 113.951 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -151.5 158.76 44.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.842 1.257 . . . . 0.0 112.654 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.14 167.48 26.72 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.671 1.188 . . . . 0.0 111.617 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.85 118.27 33.75 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.593 1.957 . . . . 0.0 109.599 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.5 mt -82.83 141.26 32.42 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.983 1.313 . . . . 0.0 108.688 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.5 mt -122.67 105.87 10.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.711 1.604 . . . . 0.0 107.768 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -81.14 156.61 25.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.218 0.607 . . . . 0.0 112.106 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -80.74 -24.62 38.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.152 0.981 . . . . 0.0 113.174 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.19 140.9 32.5 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.493 1.517 . . . . 0.0 110.357 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.77 -35.04 70.22 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.819 0.847 . . . . 0.0 111.96 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.9 m -56.95 -25.53 58.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.792 1.237 . . . . 0.0 113.212 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.3 m -69.23 -28.13 66.07 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.867 -1.146 . . . . 0.0 112.175 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.09 -37.42 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.602 -0.686 . . . . 0.0 109.775 175.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -70.26 -37.51 74.91 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.536 -0.728 . . . . 0.0 111.765 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.24 86.48 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.553 0.615 . . . . 0.0 112.079 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.6 tp -64.44 -49.81 70.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.463 0.705 . . . . 0.0 110.995 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.62 -41.66 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.094 0.958 . . . . 0.0 111.478 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.56 -18.24 63.63 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.799 1.24 . . . . 0.0 113.507 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.88 -13.64 19.96 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.21 1.404 . . . . 0.0 113.377 174.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.6 m -72.84 143.17 47.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.05 0.929 . . . . 0.0 113.37 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.27 175.9 9.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.779 1.632 . . . . 0.0 107.955 165.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 CA--C 1.537 0.45 0 C-N-CA 123.176 0.591 . . . . 0.0 111.712 -177.233 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.861 0.362 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -142.23 154.09 44.51 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.88 1.272 . . . . 0.0 113.097 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -141.8 158.29 43.98 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.627 1.571 . . . . 0.0 109.719 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 72.2 m -99.45 137.23 38.24 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.951 0.9 . . . . 0.0 112.105 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.9 m -144.78 177.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 126.762 2.025 . . . . 0.0 110.662 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 89.4 p -159.49 171.4 19.77 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.946 -1.096 . . . . 0.0 113.496 -175.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 91.6 p -155.16 179.91 1.23 Allowed Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 126.311 1.844 . . . . 0.0 110.586 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.51 -26.06 70.1 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.847 2.365 . . . . 0.0 113.933 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 40.3 p -116.35 -32.93 5.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.7 1.2 . . . . 0.0 113.793 -174.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 21.3 mm -112.18 127.78 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.932 1.293 . . . . 0.0 109.904 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -119.7 142.16 48.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.283 1.433 . . . . 0.0 112.075 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.46 32.92 19.89 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.042 1.337 . . . . 0.0 112.94 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -70.38 128.56 91.17 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.529 1.132 . . . . 0.0 111.428 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.48 131.31 5.53 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.279 2.653 . . . . 0.0 108.845 169.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.71 135.19 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.269 1.428 . . . . 0.0 110.294 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -79.15 131.25 36.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.095 0.958 . . . . 0.0 109.83 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.38 131.81 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.042 1.337 . . . . 0.0 109.319 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -137.78 90.25 14.53 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.953 1.301 . . . . 0.0 110.287 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -61.06 132.2 40.69 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.157 2.571 . . . . 0.0 110.695 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 123.448 0.699 . . . . 0.0 112.745 -174.062 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -86.47 139.8 30.55 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.009 0.924 . . . . 0.0 111.533 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.1 t -140.74 120.76 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.537 1.135 . . . . 0.0 110.378 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -71.65 140.2 49.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.195 0.998 . . . . 0.0 110.945 171.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.19 115.62 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.368 1.467 . . . . 0.0 109.217 173.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -114.91 144.27 18.37 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 124.942 1.258 . . . . 0.0 113.509 -177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.85 17.64 29.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.956 1.265 . . . . 0.0 114.163 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.21 141.48 93.97 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.713 1.205 . . . . 0.0 111.017 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.75 154.3 12.82 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.915 3.077 . . . . 0.0 113.746 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.43 3.78 6.5 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.93 3.087 . . . . 0.0 113.508 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -140.41 23.37 2.34 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.178 1.391 . . . . 0.0 112.227 -173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.4 tt -100.25 127.68 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.285 1.034 . . . . 0.0 111.029 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -92.99 165.71 12.73 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.497 1.119 . . . . 0.0 113.214 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -45.78 -45.51 14.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.918 1.687 . . . . 0.0 113.7 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.19 -29.24 54.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.777 0.831 . . . . 0.0 112.514 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -72.47 -38.71 68.15 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.416 0.686 . . . . 0.0 112.018 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.16 -39.6 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 119.193 0.906 . . . . 0.0 109.585 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 53.4 m -63.24 -51.62 65.46 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.438 0.695 . . . . 0.0 110.613 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.42 -29.08 70.25 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.38 0.991 . . . . 0.0 113.156 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.2 m -66.56 -22.83 66.15 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -123.46 -3.88 8.33 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.3 tpt85 -60.55 -22.36 63.57 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.275 1.43 . . . . 0.0 113.396 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -55.76 -18.71 8.96 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.384 1.874 . . . . 0.0 114.724 171.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.71 -3.4 35.96 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.508 1.523 . . . . 0.0 113.561 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.16 170.41 14.0 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.905 1.717 . . . . 0.0 111.982 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.9 151.0 78.62 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.667 2.912 . . . . 0.0 111.979 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.58 171.82 18.26 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.528 1.531 . . . . 0.0 112.498 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -132.66 157.34 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.494 1.518 . . . . 0.0 109.287 167.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.34 135.68 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.662 1.185 . . . . 0.0 110.351 -172.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 126.264 1.826 . . . . 0.0 111.699 -173.819 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.365 0 N-CA-C 114.316 0.486 . . . . 0.0 114.316 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -153.82 158.81 41.41 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.777 1.231 . . . . 0.0 112.591 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -151.03 167.45 27.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.735 1.214 . . . . 0.0 111.641 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.45 118.22 33.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.312 1.845 . . . . 0.0 109.365 173.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 34.8 mt -81.34 138.98 35.62 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.032 1.333 . . . . 0.0 108.778 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 55.2 mt -122.71 104.42 9.3 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.913 1.685 . . . . 0.0 107.863 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -81.6 157.52 24.69 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.59 0.756 . . . . 0.0 111.764 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -73.15 -27.4 61.64 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.647 -0.658 . . . . 0.0 112.485 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.85 145.29 39.83 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.851 1.261 . . . . 0.0 110.731 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -62.73 -32.11 73.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.255 0.622 . . . . 0.0 111.535 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.3 m -56.73 -27.13 58.69 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.65 1.18 . . . . 0.0 113.289 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.7 m -68.96 -25.89 64.77 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.863 -1.148 . . . . 0.0 112.29 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.68 -38.3 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.707 -0.621 . . . . 0.0 109.985 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -66.34 -39.36 89.15 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.645 -0.659 . . . . 0.0 111.463 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.75 83.51 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.62 0.646 . . . . 0.0 112.498 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 26.8 tp -65.4 -48.42 72.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.517 0.727 . . . . 0.0 111.213 171.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 71.8 mt -55.27 -40.13 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.968 0.907 . . . . 0.0 111.528 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.37 -17.77 63.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.874 1.27 . . . . 0.0 113.683 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.09 -13.56 18.95 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.956 1.302 . . . . 0.0 113.248 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.1 m -74.59 146.43 42.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.14 0.971 . . . . 0.0 113.499 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.74 173.93 12.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.686 1.594 . . . . 0.0 107.777 164.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 123.477 0.711 . . . . 0.0 111.062 -178.203 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.037 0.446 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.16 142.78 32.75 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.089 0.956 . . . . 0.0 113.054 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -127.02 -179.36 4.8 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.605 1.562 . . . . 0.0 108.91 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 71.7 m -128.38 142.3 51.16 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.274 1.03 . . . . 0.0 112.176 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 29.8 m -148.91 173.13 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 126.08 1.752 . . . . 0.0 111.761 -174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 79.9 p -160.42 171.41 19.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.103 1.361 . . . . 0.0 112.906 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.5 p -153.06 -176.18 0.57 Allowed Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.563 1.945 . . . . 0.0 110.565 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -63.91 -14.27 42.21 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.069 2.513 . . . . 0.0 114.38 170.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 60.7 p -122.3 -18.12 6.89 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.116 1.367 . . . . 0.0 114.114 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.4 mm -132.79 135.09 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.693 1.597 . . . . 0.0 110.363 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -128.38 136.18 50.56 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.849 1.26 . . . . 0.0 111.668 -171.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 58.76 28.68 17.66 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.305 1.442 . . . . 0.0 113.61 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -73.92 129.52 84.74 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.761 -1.212 . . . . 0.0 111.313 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.93 143.37 16.29 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.296 2.664 . . . . 0.0 109.758 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 2.4 m -129.43 135.72 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.309 1.444 . . . . 0.0 110.711 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -79.1 119.13 21.78 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.666 1.586 . . . . 0.0 109.565 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 31.3 mm -105.62 124.93 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.822 1.249 . . . . 0.0 108.477 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -133.11 92.22 25.94 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.243 1.017 . . . . 0.0 110.366 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.56 140.69 95.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.59 2.86 . . . . 0.0 111.569 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 . . . . . 0 CA--C 1.549 0.932 0 C-N-CA 123.872 0.869 . . . . 0.0 112.781 -178.825 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 76.3 mtm-85 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -77.4 134.32 38.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.529 1.132 . . . . 0.0 110.485 169.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.26 118.24 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.159 0.984 . . . . 0.0 110.039 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.47 139.23 45.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.618 0.767 . . . . 0.0 110.273 171.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 67.2 t -130.99 118.47 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.349 1.459 . . . . 0.0 109.156 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -115.29 151.27 18.51 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.789 1.185 . . . . 0.0 113.814 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 89.97 20.88 41.2 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.594 1.092 . . . . 0.0 113.802 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.61 144.61 72.31 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.885 1.274 . . . . 0.0 111.64 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.72 145.39 71.64 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.035 2.49 . . . . 0.0 112.02 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.07 0.52 7.12 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.921 3.081 . . . . 0.0 113.51 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -128.49 19.4 6.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.199 2.199 . . . . 0.0 112.291 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.5 tt -100.47 156.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.092 1.357 . . . . 0.0 111.96 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -135.25 170.57 15.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.186 1.395 . . . . 0.0 112.624 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -50.55 -42.27 55.09 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.386 1.475 . . . . 0.0 113.71 -172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.84 -27.65 44.27 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.561 0.744 . . . . 0.0 112.171 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -74.68 -39.15 62.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.811 0.845 . . . . 0.0 111.409 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.1 mt -64.43 -39.04 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.893 0.77 . . . . 0.0 109.564 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 59.1 m -63.1 -52.08 64.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.478 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.09 71.38 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.569 1.077 . . . . 0.0 112.944 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.4 m -68.51 -14.81 63.26 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -129.31 -3.16 4.97 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.312 0.96 . . . . 0.0 113.546 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -60.76 -22.45 64.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.98 1.312 . . . . 0.0 113.133 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -56.98 -12.01 1.79 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.794 2.037 . . . . 0.0 115.009 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -106.28 -4.15 20.43 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.527 1.531 . . . . 0.0 113.986 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.82 171.49 14.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.792 1.663 . . . . 0.0 112.204 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.37 150.2 58.04 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.659 2.906 . . . . 0.0 112.242 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.6 172.41 17.2 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.587 1.555 . . . . 0.0 112.632 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.85 159.43 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.747 1.619 . . . . 0.0 109.368 167.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.17 137.57 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.61 1.164 . . . . 0.0 110.729 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 CA--C 1.547 0.85 0 C-N-CA 126.407 1.883 . . . . 0.0 111.552 -174.333 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 CA-C-O 119.931 -0.372 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -152.95 160.85 43.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.314 1.445 . . . . 0.0 112.293 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.89 164.89 35.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.787 1.235 . . . . 0.0 111.808 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -110.84 117.79 34.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.158 1.783 . . . . 0.0 109.672 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.7 mt -82.59 140.94 32.95 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.99 1.316 . . . . 0.0 108.535 168.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 53.8 mt -125.1 104.85 8.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.622 1.569 . . . . 0.0 107.879 172.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -83.19 157.61 22.66 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.557 0.743 . . . . 0.0 111.505 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -83.26 -13.99 54.09 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.28 141.59 33.94 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.439 1.496 . . . . 0.0 110.617 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.68 -33.58 74.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.233 0.613 . . . . 0.0 111.359 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 12.4 m -59.51 -24.03 63.3 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.313 1.045 . . . . 0.0 113.057 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 22.9 m -70.67 -30.22 66.76 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.902 -1.124 . . . . 0.0 111.896 172.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.36 -34.91 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.502 -0.749 . . . . 0.0 109.902 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -69.64 -37.2 76.69 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.572 -0.705 . . . . 0.0 111.974 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.38 -37.39 85.53 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.961 0.8 . . . . 0.0 112.207 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.2 tp -63.66 -49.2 74.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.487 0.715 . . . . 0.0 110.894 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.23 -41.83 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.122 0.969 . . . . 0.0 111.557 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.51 -18.34 64.36 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.784 1.234 . . . . 0.0 113.63 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.99 -14.25 18.74 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.086 1.354 . . . . 0.0 113.487 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 53.3 m -72.55 144.56 47.89 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.019 0.914 . . . . 0.0 113.235 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.12 172.42 13.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.386 1.475 . . . . 0.0 107.782 165.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 123.384 0.674 . . . . 0.0 110.939 -179.281 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 120.99 0.424 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -141.84 148.81 39.42 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.565 1.146 . . . . 0.0 112.732 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.6 tp -131.9 171.06 14.03 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.03 1.732 . . . . 0.0 109.07 171.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 87.3 m -117.42 142.96 46.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.171 0.988 . . . . 0.0 112.351 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.21 172.94 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.848 2.059 . . . . 0.0 110.919 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 47.1 m -150.2 167.0 28.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.077 1.351 . . . . 0.0 112.344 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.9 m -161.54 167.44 13.05 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 127.755 2.422 . . . . 0.0 110.653 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.3 -22.03 14.78 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 124.407 3.405 . . . . 0.0 117.917 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 62.8 p -123.15 2.1 9.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.855 1.262 . . . . 0.0 113.908 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 30.3 mm -138.66 117.61 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.884 1.674 . . . . 0.0 110.536 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -118.35 137.73 52.9 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.375 1.07 . . . . 0.0 113.043 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 60.8 30.98 20.02 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.359 1.464 . . . . 0.0 112.423 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -63.89 126.25 89.56 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.739 1.216 . . . . 0.0 111.025 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.91 138.14 11.43 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.253 2.636 . . . . 0.0 109.067 171.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.7 m -130.98 132.26 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.061 1.344 . . . . 0.0 109.896 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -81.08 130.4 35.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.32 1.048 . . . . 0.0 109.876 -173.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 31.9 mm -111.01 132.03 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.905 1.282 . . . . 0.0 109.333 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -137.89 91.94 13.07 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.976 1.31 . . . . 0.0 110.192 -175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.66 132.62 49.14 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.406 2.737 . . . . 0.0 110.678 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -171.622 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.99 135.73 37.85 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.839 1.256 . . . . 0.0 110.654 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.52 121.63 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.274 1.03 . . . . 0.0 110.426 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.44 140.25 55.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.337 1.055 . . . . 0.0 111.385 172.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 56.9 t -133.53 123.18 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 109.422 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -122.11 149.37 17.08 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.452 1.501 . . . . 0.0 113.191 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.31 14.05 52.23 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.958 1.266 . . . . 0.0 114.366 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.96 141.59 85.93 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.031 1.332 . . . . 0.0 111.012 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.42 153.56 17.37 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.874 3.049 . . . . 0.0 113.638 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.73 6.1 4.77 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.002 3.135 . . . . 0.0 113.353 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -140.27 28.56 2.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.476 1.51 . . . . 0.0 111.9 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.8 tt -107.75 150.19 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.293 1.437 . . . . 0.0 110.075 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -124.77 170.29 11.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.81 1.244 . . . . 0.0 112.706 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -44.78 -46.23 10.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.409 1.884 . . . . 0.0 113.913 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -78.94 -26.31 43.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.65 0.78 . . . . 0.0 112.295 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -77.11 -36.53 55.49 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.684 0.794 . . . . 0.0 111.462 171.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.17 -38.73 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.322 0.965 . . . . 0.0 109.566 171.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 57.8 m -62.64 -52.03 64.92 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.367 0.667 . . . . 0.0 110.471 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.49 -30.95 70.94 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.401 1.001 . . . . 0.0 112.978 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.2 m -67.97 -14.67 63.15 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -129.82 -2.82 4.69 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.457 1.026 . . . . 0.0 113.604 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -60.31 -22.5 63.25 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.943 1.297 . . . . 0.0 113.104 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -56.83 -12.53 1.98 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.791 2.036 . . . . 0.0 115.103 170.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -105.65 -4.93 20.49 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.396 1.478 . . . . 0.0 113.974 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.48 172.96 14.14 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.801 1.667 . . . . 0.0 112.288 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.87 149.94 54.56 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.736 2.957 . . . . 0.0 112.29 -174.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.27 172.7 16.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.485 1.514 . . . . 0.0 112.668 -170.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.03 161.09 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.868 1.667 . . . . 0.0 108.728 167.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.49 135.25 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.273 1.029 . . . . 0.0 110.246 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 126.405 1.882 . . . . 0.0 111.538 -169.936 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.056 0 CA-C-O 118.917 -0.935 . . . . 0.0 114.315 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -140.33 157.95 44.78 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.469 1.635 . . . . 0.0 113.914 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.8 170.64 21.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.522 1.529 . . . . 0.0 111.625 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.53 120.49 36.9 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.952 1.701 . . . . 0.0 109.944 173.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.1 mt -80.99 140.83 34.97 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.848 1.259 . . . . 0.0 108.739 169.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 58.3 mt -124.34 101.98 7.45 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.696 1.598 . . . . 0.0 107.702 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -80.21 154.33 28.0 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.307 0.643 . . . . 0.0 110.978 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -76.89 -19.39 57.5 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.461 -0.774 . . . . 0.0 112.91 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.94 142.4 34.38 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.945 1.298 . . . . 0.0 110.799 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.71 -31.38 71.53 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.526 0.731 . . . . 0.0 111.649 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.4 m -56.39 -28.34 58.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.625 1.17 . . . . 0.0 112.899 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -28.4 62.45 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.964 -1.085 . . . . 0.0 112.118 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.3 t -76.32 -37.76 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.668 -0.645 . . . . 0.0 109.839 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -66.3 -38.14 87.03 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.578 -0.701 . . . . 0.0 111.85 172.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.5 91.21 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.557 0.617 . . . . 0.0 112.367 173.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.6 tp -63.53 -48.37 77.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.429 0.692 . . . . 0.0 110.926 171.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 69.9 mt -56.23 -43.25 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.249 1.02 . . . . 0.0 111.33 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.33 -18.88 64.6 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.682 1.193 . . . . 0.0 113.542 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.11 -13.65 19.72 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.185 1.394 . . . . 0.0 113.605 175.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.06 150.05 37.37 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.164 0.983 . . . . 0.0 113.617 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.3 mt -86.25 177.79 7.38 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.035 1.734 . . . . 0.0 107.843 165.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 N--CA 1.47 0.563 0 C-N-CA 123.437 0.695 . . . . 0.0 111.623 -175.099 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.615 0.245 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -141.04 145.47 35.92 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.977 0.911 . . . . 0.0 113.116 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.06 -173.95 3.19 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.142 1.777 . . . . 0.0 108.949 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.3 p -134.61 147.29 50.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.311 1.044 . . . . 0.0 113.276 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.2 m -152.05 -178.87 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 127.181 2.193 . . . . 0.0 110.753 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 80.5 p -161.7 170.56 19.45 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.503 1.121 . . . . 0.0 113.135 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 16.2 p -142.5 -177.01 0.61 Allowed Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 126.528 1.931 . . . . 0.0 110.682 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.17 -21.97 68.22 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.881 2.387 . . . . 0.0 114.145 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 46.3 p -123.09 -23.05 5.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.6 mm -115.24 127.63 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.075 1.35 . . . . 0.0 109.79 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -122.65 139.0 54.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.601 1.16 . . . . 0.0 111.974 -168.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.89 33.49 23.26 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.171 1.388 . . . . 0.0 112.963 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -69.45 126.56 92.72 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.201 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -80.48 142.9 14.96 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.286 2.657 . . . . 0.0 109.307 169.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.15 134.61 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.732 1.213 . . . . 0.0 110.585 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -79.14 126.41 30.71 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.902 1.681 . . . . 0.0 109.639 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 29.5 mm -114.87 132.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.545 1.538 . . . . 0.0 108.342 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -140.96 100.05 6.57 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.788 0.835 . . . . 0.0 110.678 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -55.88 134.95 67.16 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.472 2.781 . . . . 0.0 110.977 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -169.435 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -80.84 133.15 35.55 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.366 0.666 . . . . 0.0 110.765 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.2 115.44 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.383 1.073 . . . . 0.0 109.882 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -71.94 140.5 49.21 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.802 0.841 . . . . 0.0 110.384 171.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.73 118.59 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.08 1.352 . . . . 0.0 109.23 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.91 143.71 18.15 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.916 1.245 . . . . 0.0 113.381 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.88 11.0 47.95 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.451 1.501 . . . . 0.0 114.157 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.09 142.13 80.65 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.113 1.365 . . . . 0.0 111.482 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.41 154.79 18.22 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.769 2.98 . . . . 0.0 113.576 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -79.21 4.47 6.55 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.835 3.023 . . . . 0.0 113.421 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -135.97 20.24 3.25 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.691 1.597 . . . . 0.0 112.301 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 14.1 tt -104.02 123.38 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.696 1.199 . . . . 0.0 111.958 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.02 161.17 25.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.515 1.126 . . . . 0.0 112.806 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -48.1 -44.44 31.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.108 1.363 . . . . 0.0 112.543 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -74.74 -24.25 58.69 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.86 0.864 . . . . 0.0 112.891 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -78.21 -40.55 37.15 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.818 0.847 . . . . 0.0 111.118 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.2 mt -62.52 -41.84 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 170.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 60.7 m -61.0 -52.28 65.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.496 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.45 -29.36 70.46 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.552 1.069 . . . . 0.0 113.223 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 64.8 m -67.34 -23.26 65.6 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.58 -5.62 9.75 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.145 0.978 . . . . 0.0 113.552 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -61.52 -22.98 65.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.169 1.387 . . . . 0.0 113.139 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -53.04 -20.72 3.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.587 1.955 . . . . 0.0 114.73 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -97.74 -9.32 26.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.502 1.521 . . . . 0.0 113.915 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 126.12 170.55 13.0 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.976 1.75 . . . . 0.0 112.034 -169.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.88 150.82 56.0 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.682 2.922 . . . . 0.0 112.601 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.06 172.92 15.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.664 1.586 . . . . 0.0 112.664 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.62 158.69 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.851 1.66 . . . . 0.0 109.488 167.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 77.5 t -130.91 137.55 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.586 1.154 . . . . 0.0 110.89 -171.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 126.164 1.786 . . . . 0.0 111.628 -175.449 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 CA-C-O 119.504 -0.609 . . . . 0.0 114.259 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -152.45 158.1 42.12 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.797 1.298 . . . . 0.0 113.418 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.74 170.67 19.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.107 1.363 . . . . 0.0 111.645 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.29 121.65 41.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.32 1.848 . . . . 0.0 109.722 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.17 140.47 30.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.448 1.499 . . . . 0.0 108.916 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 55.0 mt -124.52 105.43 9.38 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.74 1.616 . . . . 0.0 107.96 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -83.41 159.12 21.87 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.523 0.729 . . . . 0.0 111.353 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.73 -22.04 24.83 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -130.12 144.53 51.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.125 1.77 . . . . 0.0 110.279 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 37.6 mp0 -66.01 -30.51 71.07 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.416 -0.803 . . . . 0.0 111.286 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.6 m -55.15 -27.76 47.85 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.832 1.253 . . . . 0.0 112.798 173.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.7 m -71.85 -29.56 64.51 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.109 -0.995 . . . . 0.0 112.048 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.99 -37.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.522 -0.736 . . . . 0.0 109.888 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -66.3 -38.16 87.09 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.533 -0.73 . . . . 0.0 111.86 172.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.81 -37.94 88.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.317 0.647 . . . . 0.0 112.38 173.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.2 tp -64.01 -48.78 75.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.333 0.653 . . . . 0.0 110.943 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 75.5 mt -55.54 -40.9 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.231 1.012 . . . . 0.0 111.35 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.45 -17.82 63.67 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.719 1.208 . . . . 0.0 113.818 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.02 -13.66 18.97 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.067 1.347 . . . . 0.0 113.351 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 54.6 m -75.89 149.29 37.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.052 0.941 . . . . 0.0 113.464 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.6 mt -83.84 173.28 11.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.431 1.492 . . . . 0.0 107.785 164.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.469 0.51 0 C-N-CA 123.528 0.731 . . . . 0.0 111.733 -174.521 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.662 0.268 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -144.81 145.87 31.84 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.993 0.917 . . . . 0.0 112.977 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.0 tp -131.62 -176.51 4.06 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.494 1.918 . . . . 0.0 108.614 172.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 89.6 m -129.63 146.12 51.45 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.508 1.049 . . . . 0.0 112.729 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 29.2 m -148.93 177.46 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 126.501 1.92 . . . . 0.0 111.531 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 80.2 p -161.13 170.79 19.71 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.096 1.358 . . . . 0.0 112.965 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.3 p -153.88 -179.78 1.13 Allowed Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 126.894 2.078 . . . . 0.0 110.567 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.61 -20.04 55.77 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.897 2.398 . . . . 0.0 114.403 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 57.6 p -113.88 -19.9 11.29 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.026 1.33 . . . . 0.0 114.325 -175.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.1 mm -132.31 135.99 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.489 1.516 . . . . 0.0 110.304 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -130.49 138.41 50.24 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.594 1.158 . . . . 0.0 112.179 -171.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.5 t70 57.54 29.88 17.83 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.336 1.454 . . . . 0.0 113.093 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -75.1 126.2 88.33 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-O 117.829 -1.081 . . . . 0.0 111.584 -172.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.32 141.78 18.41 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.297 2.665 . . . . 0.0 109.457 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.7 m -135.87 134.39 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.015 1.326 . . . . 0.0 110.453 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -75.37 129.67 37.74 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.555 1.142 . . . . 0.0 109.535 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.92 131.21 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.384 1.474 . . . . 0.0 108.373 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 16.7 mtp85 -137.11 89.72 16.33 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.491 1.116 . . . . 0.0 110.106 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -59.05 135.67 68.01 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.839 2.359 . . . . 0.0 109.102 169.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -171.057 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -80.41 137.86 36.56 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.694 1.198 . . . . 0.0 111.281 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.5 t -141.48 120.66 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.681 1.192 . . . . 0.0 109.763 175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -77.77 143.54 37.88 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.569 0.748 . . . . 0.0 110.79 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.02 124.62 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.58 1.552 . . . . 0.0 109.232 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -120.5 150.26 17.43 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.807 1.194 . . . . 0.0 113.409 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 90.49 20.1 42.46 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.543 1.068 . . . . 0.0 114.05 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.8 146.34 75.72 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.085 1.354 . . . . 0.0 111.562 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -54.04 152.79 22.88 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.586 2.858 . . . . 0.0 112.974 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.07 0.18 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.71 2.94 . . . . 0.0 114.667 -170.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -140.7 17.1 2.34 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.389 1.075 . . . . 0.0 113.128 -175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.1 tt -80.19 131.76 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.78 0.832 . . . . 0.0 111.527 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.22 170.48 9.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.92 -45.57 51.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.479 1.512 . . . . 0.0 113.044 176.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -74.88 -32.83 61.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.004 0.921 . . . . 0.0 112.609 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.2 -42.32 84.36 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.554 0.742 . . . . 0.0 112.201 170.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 51.3 mt -64.15 -38.36 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 119.197 0.908 . . . . 0.0 109.83 174.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 57.5 m -63.77 -52.31 60.94 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.357 0.663 . . . . 0.0 110.639 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.6 -31.18 71.23 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.348 0.976 . . . . 0.0 112.738 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.6 m -67.83 -15.08 63.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -129.16 -2.99 5.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.457 1.026 . . . . 0.0 113.507 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -60.48 -22.79 63.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.048 1.339 . . . . 0.0 113.268 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -57.48 -13.0 3.05 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.594 1.958 . . . . 0.0 114.99 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -104.11 -4.1 23.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.42 1.488 . . . . 0.0 113.823 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.69 170.26 13.82 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 126.07 1.795 . . . . 0.0 112.062 -170.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.09 153.03 75.9 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.495 2.796 . . . . 0.0 112.129 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.02 171.98 16.69 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.654 1.582 . . . . 0.0 112.424 -170.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.84 156.66 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.655 1.582 . . . . 0.0 109.248 167.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 65.9 t -128.64 137.42 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.705 1.202 . . . . 0.0 110.283 -171.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 27.5 t0 . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 126.025 1.73 . . . . 0.0 111.608 -175.345 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.269 0 N-CA-C 114.686 0.634 . . . . 0.0 114.686 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -151.25 155.27 38.44 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.513 1.156 . . . . 0.0 113.08 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.29 167.78 29.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.696 1.198 . . . . 0.0 112.362 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -112.65 127.16 56.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.632 1.973 . . . . 0.0 110.098 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.9 mt -92.95 139.24 30.73 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.184 1.794 . . . . 0.0 108.55 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 44.9 mt -123.93 107.56 11.48 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.458 1.503 . . . . 0.0 107.85 171.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -84.16 160.38 20.87 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.332 0.653 . . . . 0.0 112.292 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -75.65 -26.32 57.59 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.796 0.838 . . . . 0.0 112.856 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -140.09 144.79 36.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.29 1.436 . . . . 0.0 110.663 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.17 -30.88 69.62 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.711 -0.618 . . . . 0.0 111.564 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.4 m -55.55 -27.39 48.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.576 1.15 . . . . 0.0 113.139 172.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.1 m -73.84 -29.94 62.41 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.034 -1.041 . . . . 0.0 112.071 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.84 -38.54 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 121.744 -0.598 . . . . 0.0 109.584 173.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -68.63 -37.42 79.71 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.755 -0.591 . . . . 0.0 111.92 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.03 85.57 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.981 0.81 . . . . 0.0 112.287 173.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.71 -48.5 76.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.378 0.671 . . . . 0.0 110.87 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 80.8 mt -56.11 -43.04 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.986 0.914 . . . . 0.0 111.392 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.01 -18.62 64.76 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.738 1.215 . . . . 0.0 113.688 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.12 -13.42 18.98 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.06 1.344 . . . . 0.0 113.533 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 34.6 m -73.46 144.73 46.14 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.003 0.906 . . . . 0.0 113.33 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.2 172.69 13.34 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.311 1.444 . . . . 0.0 107.808 165.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 123.469 0.708 . . . . 0.0 111.363 -175.602 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -142.38 149.35 39.25 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.383 1.073 . . . . 0.0 113.144 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.3 tp -133.8 -170.44 2.5 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.475 1.91 . . . . 0.0 108.895 172.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 26.5 p -140.73 144.56 35.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.807 1.243 . . . . 0.0 112.593 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 25.3 m -147.99 171.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 126.255 1.822 . . . . 0.0 111.667 -169.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 40.1 m -147.65 153.66 39.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.601 1.16 . . . . 0.0 112.817 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.9 p -140.89 -173.9 0.38 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 126.383 1.873 . . . . 0.0 111.689 -174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -69.62 -10.89 29.81 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.34 2.693 . . . . 0.0 113.639 171.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 37.3 p -120.99 -32.27 3.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.076 1.35 . . . . 0.0 113.621 -171.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.0 mm -133.35 137.94 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.956 1.302 . . . . 0.0 110.005 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -119.75 135.16 54.96 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.98 1.312 . . . . 0.0 110.729 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 24.9 t70 64.53 27.3 13.41 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.344 1.457 . . . . 0.0 112.911 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -58.74 125.58 77.5 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.493 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.09 146.58 25.65 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.976 2.451 . . . . 0.0 109.776 171.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.8 m -139.3 140.56 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.16 1.384 . . . . 0.0 110.916 -174.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -83.03 132.33 35.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.912 1.285 . . . . 0.0 109.858 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.1 mm -114.95 131.23 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.831 1.252 . . . . 0.0 109.274 -174.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -135.76 90.2 19.93 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.401 1.481 . . . . 0.0 110.351 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.01 136.36 72.81 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.417 2.745 . . . . 0.0 111.041 172.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.189 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -64.31 136.54 57.25 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.08 0.952 . . . . 0.0 110.547 168.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 43.3 t -137.6 116.9 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.767 0.827 . . . . 0.0 109.375 169.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -73.37 137.17 44.53 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.587 0.755 . . . . 0.0 110.327 172.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 77.5 t -131.31 112.68 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.445 1.498 . . . . 0.0 108.991 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -110.45 151.29 17.58 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.117 1.342 . . . . 0.0 113.41 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 89.87 25.99 25.68 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.32 0.962 . . . . 0.0 113.891 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.77 143.21 91.33 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.787 1.235 . . . . 0.0 111.451 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.84 154.65 31.07 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.366 2.71 . . . . 0.0 113.052 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.04 3.15 6.88 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.901 3.068 . . . . 0.0 114.516 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -140.34 25.27 2.25 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.774 1.229 . . . . 0.0 112.835 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.2 tt -93.48 161.59 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.308 1.043 . . . . 0.0 110.85 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -140.79 169.29 17.92 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.212 1.405 . . . . 0.0 112.536 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.61 -43.07 25.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.581 1.952 . . . . 0.0 113.764 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.5 -27.25 41.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.632 0.773 . . . . 0.0 112.317 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -77.23 -35.94 55.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.834 0.854 . . . . 0.0 111.466 171.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.02 -37.0 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.425 -0.797 . . . . 0.0 109.562 171.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 61.4 m -64.0 -51.78 62.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.506 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.21 -31.28 70.01 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.252 0.933 . . . . 0.0 112.979 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 73.4 m -68.68 -14.59 63.11 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.85 -2.09 3.31 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.586 1.085 . . . . 0.0 113.797 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -60.73 -22.63 64.2 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.745 1.218 . . . . 0.0 112.868 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -56.93 -12.29 1.91 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.603 1.961 . . . . 0.0 114.976 170.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.05 -6.75 18.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.404 1.482 . . . . 0.0 113.924 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.56 179.81 15.87 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.258 1.885 . . . . 0.0 112.491 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.9 145.3 90.13 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.473 2.782 . . . . 0.0 112.54 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.75 170.76 20.83 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.262 1.425 . . . . 0.0 112.423 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -135.03 158.85 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.583 1.553 . . . . 0.0 109.148 167.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 72.6 t -125.05 136.56 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.706 1.202 . . . . 0.0 110.542 -170.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 126.182 1.793 . . . . 0.0 111.698 -173.471 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.275 0 CA-C-O 119.66 -0.522 . . . . 0.0 114.283 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -150.08 162.82 39.66 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.889 1.276 . . . . 0.0 113.05 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -149.24 161.91 41.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.058 1.343 . . . . 0.0 111.759 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -109.03 118.34 36.53 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.224 1.81 . . . . 0.0 109.211 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 38.5 mt -82.19 136.93 35.04 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.72 1.208 . . . . 0.0 108.579 169.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 63.7 mt -117.03 102.76 9.61 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.755 1.622 . . . . 0.0 107.74 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -81.79 156.05 25.12 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.206 0.526 . . . . 0.0 111.736 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -76.41 -26.26 55.35 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.753 0.821 . . . . 0.0 112.848 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -142.21 146.31 35.08 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.254 1.422 . . . . 0.0 110.99 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.85 -28.89 70.34 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.528 0.731 . . . . 0.0 111.995 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 25.1 p -60.53 -25.98 66.54 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.025 -1.047 . . . . 0.0 112.984 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.9 m -73.14 -30.9 63.93 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.852 -1.155 . . . . 0.0 111.942 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.47 -39.53 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 121.765 -0.584 . . . . 0.0 109.713 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -66.77 -38.13 85.98 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.61 -0.681 . . . . 0.0 112.16 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.7 87.54 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.703 0.683 . . . . 0.0 112.368 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.63 -49.19 74.24 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.289 0.636 . . . . 0.0 110.8 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 78.6 mt -55.76 -42.2 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.951 0.9 . . . . 0.0 111.335 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.53 -17.94 63.62 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.775 1.23 . . . . 0.0 113.625 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.97 -12.9 19.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.06 1.344 . . . . 0.0 113.419 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 35.6 m -75.13 147.29 40.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 122.114 0.959 . . . . 0.0 113.547 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.31 177.88 8.31 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.523 1.529 . . . . 0.0 107.73 164.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 CA--C 1.538 0.487 0 O-C-N 121.63 -0.669 . . . . 0.0 111.382 -177.316 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 120.774 0.321 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -140.72 148.22 40.4 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.984 0.914 . . . . 0.0 113.167 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.9 tp -134.87 173.13 12.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.786 1.634 . . . . 0.0 109.478 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 26.7 p -116.17 140.45 49.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.049 1.34 . . . . 0.0 112.58 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.38 178.48 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 126.761 2.024 . . . . 0.0 110.532 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 85.0 p -160.76 171.2 19.25 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 57.6 p -148.42 -179.34 0.94 Allowed Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 126.939 2.096 . . . . 0.0 110.957 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.67 -12.2 34.07 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.296 2.664 . . . . 0.0 114.124 170.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 37.2 p -109.86 -33.19 6.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.95 1.3 . . . . 0.0 113.255 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 6.7 mm -132.82 131.13 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.475 1.11 . . . . 0.0 110.948 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -111.73 141.2 45.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.227 1.411 . . . . 0.0 111.193 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 59.26 36.04 23.56 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.135 1.374 . . . . 0.0 112.906 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -67.41 127.7 93.5 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 120.943 -1.098 . . . . 0.0 110.899 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.35 140.91 12.39 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.34 2.693 . . . . 0.0 109.354 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.46 138.13 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.076 1.35 . . . . 0.0 110.697 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -85.13 120.59 26.8 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.171 1.788 . . . . 0.0 109.683 -172.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.27 129.49 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.998 1.319 . . . . 0.0 109.495 -171.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -135.6 94.03 15.53 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.282 1.433 . . . . 0.0 110.121 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.1 127.23 24.89 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.639 2.893 . . . . 0.0 109.522 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -168.117 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -81.54 140.0 34.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.76 0.824 . . . . 0.0 111.263 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.7 t -139.16 118.82 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.548 1.139 . . . . 0.0 109.758 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -73.78 140.05 45.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.314 0.646 . . . . 0.0 110.168 170.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.2 123.18 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.015 1.326 . . . . 0.0 109.175 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -117.67 146.17 18.64 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.724 1.154 . . . . 0.0 113.079 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 96.03 13.97 47.48 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.041 1.305 . . . . 0.0 114.241 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.4 mt -58.73 139.31 86.31 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.99 1.316 . . . . 0.0 110.632 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -55.1 152.42 30.44 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.433 2.755 . . . . 0.0 113.206 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.67 5.33 4.89 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.709 2.939 . . . . 0.0 114.189 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -133.78 18.07 3.87 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.765 1.626 . . . . 0.0 112.427 -174.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.7 tt -100.14 130.54 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 121.118 -0.988 . . . . 0.0 111.596 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -98.86 169.49 9.42 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 0.0 113.452 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -51.78 -41.55 61.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.096 1.359 . . . . 0.0 113.624 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.68 -25.3 44.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.677 0.791 . . . . 0.0 112.352 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -79.58 -36.23 38.47 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.6 0.76 . . . . 0.0 111.984 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 40.3 mt -65.53 -36.44 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.349 0.977 . . . . 0.0 109.418 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 89.3 m -63.53 -51.85 63.67 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.538 0.735 . . . . 0.0 110.636 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.39 -30.58 69.68 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.585 1.084 . . . . 0.0 112.944 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 69.9 m -67.51 -14.25 62.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -133.02 -2.01 3.25 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -60.37 -22.52 63.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.075 1.35 . . . . 0.0 112.899 173.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -57.2 -10.55 1.29 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.706 2.003 . . . . 0.0 115.133 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -108.67 -3.69 17.68 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.508 1.523 . . . . 0.0 114.127 175.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.76 178.55 15.78 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.164 1.84 . . . . 0.0 112.741 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -63.46 145.51 92.31 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.582 2.855 . . . . 0.0 112.996 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.41 170.41 21.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.634 1.574 . . . . 0.0 112.324 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.4 160.7 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.842 1.657 . . . . 0.0 108.635 166.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 93.5 t -135.7 138.52 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.158 0.983 . . . . 0.0 110.658 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 CA--C 1.544 0.743 0 C-N-CA 124.797 1.239 . . . . 0.0 112.232 179.845 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.129 0 CA-C-O 119.293 -0.726 . . . . 0.0 114.485 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -149.53 154.98 39.59 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.83 1.315 . . . . 0.0 113.512 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.32 170.5 21.73 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.835 1.254 . . . . 0.0 112.174 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -113.42 123.78 50.88 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.891 1.676 . . . . 0.0 110.67 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 22.5 mt -87.04 142.57 27.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.542 1.537 . . . . 0.0 108.74 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 65.7 mt -127.95 102.57 6.82 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.052 1.741 . . . . 0.0 108.175 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -85.1 154.99 21.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.361 0.664 . . . . 0.0 112.031 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -70.88 -27.58 63.92 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.655 0.782 . . . . 0.0 112.732 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -142.92 147.31 35.06 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.411 1.485 . . . . 0.0 110.635 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -63.58 -29.08 70.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.202 0.601 . . . . 0.0 111.952 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 23.0 p -60.24 -25.8 65.94 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.931 -1.105 . . . . 0.0 113.093 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 25.3 m -71.84 -30.8 65.84 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.815 -1.178 . . . . 0.0 111.996 171.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 49.8 t -74.84 -37.43 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.617 -0.677 . . . . 0.0 109.988 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -68.36 -35.31 77.54 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.576 -0.702 . . . . 0.0 111.742 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.17 86.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.074 0.852 . . . . 0.0 112.493 171.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.3 tp -63.4 -48.33 78.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.189 0.596 . . . . 0.0 110.741 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.81 -42.09 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.008 0.923 . . . . 0.0 111.267 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.28 -18.46 64.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.701 1.2 . . . . 0.0 113.887 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.11 -13.12 19.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.99 1.316 . . . . 0.0 113.362 175.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.4 m -72.23 143.07 48.94 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.902 0.858 . . . . 0.0 113.186 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.1 mt -78.87 170.04 17.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.061 1.344 . . . . 0.0 107.956 165.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 N--CA 1.468 0.45 0 C-N-CA 123.579 0.752 . . . . 0.0 111.3 -176.065 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -142.83 149.59 38.8 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.0 tp -135.0 -177.47 4.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.651 1.98 . . . . 0.0 108.734 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 97.3 m -131.49 145.6 51.84 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.599 1.09 . . . . 0.0 112.777 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 31.7 m -149.23 172.79 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 126.899 2.079 . . . . 0.0 111.598 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 58.6 m -149.38 161.58 41.8 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.833 1.253 . . . . 0.0 112.682 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 19.7 p -139.3 -172.37 0.31 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.611 1.964 . . . . 0.0 111.249 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.94 -13.79 37.39 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.112 2.541 . . . . 0.0 113.478 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 40.9 p -126.82 -25.43 3.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.046 1.339 . . . . 0.0 113.859 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 16.9 mm -127.08 134.47 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.512 1.525 . . . . 0.0 109.591 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -123.83 132.97 53.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.544 1.138 . . . . 0.0 111.26 -172.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.0 t70 62.27 30.89 17.63 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.236 1.414 . . . . 0.0 112.507 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -61.83 125.36 84.76 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.787 1.235 . . . . 0.0 110.871 176.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.75 143.98 24.27 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.206 2.604 . . . . 0.0 109.551 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.36 134.83 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.363 1.465 . . . . 0.0 110.417 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -78.37 131.6 37.04 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.652 0.781 . . . . 0.0 109.436 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.46 128.01 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.133 1.373 . . . . 0.0 108.618 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -135.97 84.99 29.86 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.654 1.182 . . . . 0.0 110.071 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.17 133.89 55.87 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.598 2.865 . . . . 0.0 110.984 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -172.509 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 70.8 mtm-85 . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -72.53 135.8 45.72 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.464 0.706 . . . . 0.0 110.506 169.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.41 117.75 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.384 1.074 . . . . 0.0 109.8 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -69.44 138.93 53.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.538 1.135 . . . . 0.0 110.885 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.62 115.38 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.428 1.491 . . . . 0.0 109.04 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.56 143.49 18.07 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 125.061 1.315 . . . . 0.0 113.8 -175.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.42 23.12 22.62 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.77 1.176 . . . . 0.0 114.196 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.77 141.91 88.67 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.957 1.303 . . . . 0.0 110.98 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.39 154.28 19.79 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.382 2.722 . . . . 0.0 113.106 172.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.49 3.76 6.09 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.733 2.955 . . . . 0.0 114.096 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -140.82 25.86 2.11 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.727 1.211 . . . . 0.0 112.599 -175.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.1 tt -99.27 137.3 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.311 1.045 . . . . 0.0 110.747 174.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -112.02 169.25 8.98 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.383 1.073 . . . . 0.0 113.437 -174.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -43.11 -46.54 5.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.146 1.779 . . . . 0.0 114.251 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -77.5 -26.47 51.26 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.647 -0.658 . . . . 0.0 112.414 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -79.38 -38.34 35.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.856 0.862 . . . . 0.0 111.533 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 46.2 mt -63.73 -35.84 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.794 0.724 . . . . 0.0 109.68 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 50.5 m -68.34 -53.32 24.92 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.644 0.778 . . . . 0.0 110.863 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.73 -29.69 70.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.515 1.052 . . . . 0.0 113.146 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.7 m -64.8 -25.39 67.89 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -120.49 -5.07 9.82 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.0 tpt85 -60.13 -22.49 62.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.05 1.34 . . . . 0.0 113.195 174.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -53.69 -21.41 6.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.732 2.013 . . . . 0.0 114.81 170.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -97.41 -7.56 31.44 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.311 1.444 . . . . 0.0 113.631 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 125.38 171.61 13.28 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.108 1.813 . . . . 0.0 112.102 -170.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.82 149.88 73.17 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.673 2.915 . . . . 0.0 112.292 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.08 171.69 18.84 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.622 1.569 . . . . 0.0 112.403 -171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.0 159.78 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.671 1.588 . . . . 0.0 109.223 167.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.84 135.88 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.224 1.009 . . . . 0.0 110.884 -170.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 126.169 1.788 . . . . 0.0 111.53 -175.647 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.326 0 CA-C-O 119.9 -0.389 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -154.52 159.4 40.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.248 1.419 . . . . 0.0 112.167 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.08 170.93 18.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.769 1.227 . . . . 0.0 111.792 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -119.48 117.37 28.24 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.312 1.845 . . . . 0.0 109.705 177.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.85 142.01 34.08 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.162 1.385 . . . . 0.0 108.757 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 64.4 mt -124.07 106.17 10.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.672 1.589 . . . . 0.0 107.928 171.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.99 156.1 22.46 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.37 0.668 . . . . 0.0 111.946 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -78.61 -24.65 45.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -143.16 141.95 31.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.308 1.443 . . . . 0.0 110.675 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.47 -33.0 69.28 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.032 0.933 . . . . 0.0 111.935 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -55.52 -28.24 53.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.771 1.228 . . . . 0.0 113.111 174.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.5 m -73.37 -28.85 62.26 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.941 -1.099 . . . . 0.0 112.283 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.88 -39.55 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.685 -0.634 . . . . 0.0 109.624 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -66.18 -38.39 87.91 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.708 -0.62 . . . . 0.0 111.951 173.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.39 86.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.379 0.671 . . . . 0.0 112.409 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.25 -48.1 74.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.206 0.602 . . . . 0.0 111.049 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 78.4 mt -55.54 -41.95 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.93 0.892 . . . . 0.0 111.221 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.28 -17.15 63.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.814 1.246 . . . . 0.0 113.72 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.0 -13.65 18.99 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.167 1.387 . . . . 0.0 113.404 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 57.8 m -76.3 149.06 37.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 93.2 mt -85.94 177.46 7.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.666 1.586 . . . . 0.0 107.934 165.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 123.518 0.727 . . . . 0.0 111.337 -178.325 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 120.307 0.099 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.55 144.43 32.91 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 3.7 tp -129.68 -167.05 1.74 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.673 1.989 . . . . 0.0 108.375 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.7 p -144.3 152.31 40.59 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.912 -1.118 . . . . 0.0 113.38 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.37 169.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.85 2.06 . . . . 0.0 110.761 -171.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 71.1 m -148.12 163.86 35.66 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.453 1.101 . . . . 0.0 113.018 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 52.4 p -145.32 -178.33 0.77 Allowed Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 126.905 2.082 . . . . 0.0 110.886 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.28 -10.96 30.43 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.298 2.665 . . . . 0.0 113.98 170.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 42.4 p -113.28 -31.33 6.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.016 1.326 . . . . 0.0 113.329 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.9 mm -133.62 134.23 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.159 1.384 . . . . 0.0 110.412 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -115.95 135.47 53.94 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.866 1.266 . . . . 0.0 111.119 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 61.84 32.95 17.91 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.468 1.507 . . . . 0.0 112.761 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -62.97 124.36 83.38 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.935 -1.103 . . . . 0.0 110.225 174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.48 145.88 27.0 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.983 2.455 . . . . 0.0 109.149 170.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.38 133.22 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.711 1.205 . . . . 0.0 110.719 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -76.41 130.59 38.25 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.497 1.119 . . . . 0.0 109.72 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.21 133.35 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.303 1.441 . . . . 0.0 108.54 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 51.8 mtp85 -138.65 98.19 8.92 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 124.306 1.042 . . . . 0.0 110.483 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.79 131.28 43.02 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.358 2.705 . . . . 0.0 110.01 169.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -169.472 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 82.9 mtm-85 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -79.61 136.78 36.93 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.884 1.274 . . . . 0.0 110.674 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.6 t -141.42 121.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.497 1.119 . . . . 0.0 110.104 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -74.54 142.17 44.77 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.72 0.808 . . . . 0.0 111.158 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.88 124.12 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.402 1.481 . . . . 0.0 109.251 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -122.49 149.64 16.95 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.011 1.291 . . . . 0.0 113.615 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 92.48 17.41 45.84 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.864 1.221 . . . . 0.0 114.366 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.92 141.74 89.39 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.295 1.438 . . . . 0.0 111.381 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.31 154.98 17.21 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.906 3.07 . . . . 0.0 113.818 175.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.43 2.6 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.984 3.122 . . . . 0.0 114.105 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -140.29 23.17 2.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.964 1.306 . . . . 0.0 112.413 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.1 tt -95.32 160.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.681 1.193 . . . . 0.0 109.744 169.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -142.33 171.15 14.45 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.294 1.037 . . . . 0.0 113.107 -173.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -41.67 -47.16 3.91 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.082 1.753 . . . . 0.0 114.241 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.4 -26.97 46.62 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.486 -0.759 . . . . 0.0 112.635 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -80.56 -35.23 34.65 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.016 0.927 . . . . 0.0 111.669 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 65.3 mt -64.7 -36.52 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.614 -0.679 . . . . 0.0 109.465 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 53.7 m -65.4 -53.5 42.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.559 171.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.26 -31.34 70.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.27 0.941 . . . . 0.0 113.275 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.1 m -67.68 -23.6 65.32 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -122.49 -4.3 8.81 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -59.5 -23.04 62.46 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.027 1.331 . . . . 0.0 112.909 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -53.54 -20.55 5.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.678 1.991 . . . . 0.0 114.921 170.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -99.51 -5.66 28.87 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.381 1.472 . . . . 0.0 113.718 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.89 177.47 15.2 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 126.294 1.902 . . . . 0.0 112.406 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.99 147.66 91.77 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.393 2.729 . . . . 0.0 112.65 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.5 169.82 23.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.359 1.464 . . . . 0.0 112.551 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.5 156.93 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.624 1.569 . . . . 0.0 109.158 167.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 94.3 t -119.67 136.38 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.904 1.282 . . . . 0.0 110.068 -173.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 126.288 1.835 . . . . 0.0 111.455 -171.227 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 CA-C-O 118.917 -0.935 . . . . 0.0 114.181 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -144.91 158.71 43.71 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.423 1.611 . . . . 0.0 114.741 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.99 170.04 23.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.607 1.563 . . . . 0.0 112.019 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -117.24 129.56 56.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.146 1.778 . . . . 0.0 110.243 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 35.8 mt -92.79 140.92 29.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.733 1.613 . . . . 0.0 108.699 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.8 mt -124.96 107.34 10.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.784 1.634 . . . . 0.0 108.077 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -88.21 161.55 17.16 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.822 0.849 . . . . 0.0 112.736 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -76.16 -27.2 56.88 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.294 1.038 . . . . 0.0 113.028 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.36 145.98 36.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.314 1.445 . . . . 0.0 110.515 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.98 -29.73 68.64 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.627 -0.67 . . . . 0.0 111.351 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.7 m -55.24 -28.15 51.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.358 1.063 . . . . 0.0 113.099 171.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 16.9 m -74.54 -28.59 61.03 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.928 -1.108 . . . . 0.0 112.046 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.59 -37.29 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.301 0.641 . . . . 0.0 109.83 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -63.33 -41.1 98.88 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.762 0.71 . . . . 0.0 111.552 170.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.21 84.61 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.655 0.661 . . . . 0.0 112.361 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.82 -48.22 75.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.413 0.685 . . . . 0.0 111.149 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 68.7 mt -55.56 -42.25 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.429 1.092 . . . . 0.0 111.16 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.2 -17.51 63.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.892 1.277 . . . . 0.0 113.589 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.11 -13.96 18.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.126 1.37 . . . . 0.0 113.317 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 59.0 m -74.75 146.8 41.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.944 0.878 . . . . 0.0 113.266 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.36 173.32 11.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.288 1.435 . . . . 0.0 108.001 165.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 N--CA 1.47 0.548 0 C-N-CA 123.646 0.778 . . . . 0.0 111.435 -175.236 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.36 0.124 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -143.19 149.1 37.52 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.1 tp -132.03 -179.67 5.55 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.614 1.966 . . . . 0.0 108.729 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 71.8 m -130.61 140.42 50.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.269 1.028 . . . . 0.0 112.04 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.9 m -148.43 171.39 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 126.159 1.783 . . . . 0.0 111.623 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 68.7 m -147.29 163.36 36.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.783 1.233 . . . . 0.0 112.516 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 28.4 p -140.19 -175.73 0.5 Allowed Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.84 2.056 . . . . 0.0 110.631 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -66.9 -13.07 38.54 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.0 2.467 . . . . 0.0 113.894 171.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 44.0 p -120.91 -28.18 4.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.906 1.282 . . . . 0.0 113.836 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 16.3 mm -126.5 135.28 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.206 1.402 . . . . 0.0 110.117 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -121.41 131.0 53.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.689 1.196 . . . . 0.0 111.158 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 24.5 t70 62.67 32.32 16.29 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.305 1.442 . . . . 0.0 112.666 176.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -60.55 128.33 88.1 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.348 1.059 . . . . 0.0 110.528 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.21 139.5 14.93 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.207 2.604 . . . . 0.0 109.095 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 5.2 m -131.38 132.17 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.271 1.428 . . . . 0.0 109.769 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.71 133.77 35.39 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.291 1.036 . . . . 0.0 109.815 -174.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.98 134.9 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.292 1.437 . . . . 0.0 108.901 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -141.11 95.5 7.48 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.53 1.132 . . . . 0.0 110.641 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.14 130.23 35.31 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.664 2.909 . . . . 0.0 111.241 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 123.74 0.816 . . . . 0.0 112.042 -175.606 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 46.7 mtm105 . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -79.92 136.99 36.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.146 0.978 . . . . 0.0 111.42 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.15 118.82 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.691 1.197 . . . . 0.0 109.709 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -75.23 142.31 43.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.394 0.678 . . . . 0.0 110.59 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.36 121.92 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.521 1.529 . . . . 0.0 109.189 176.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.78 148.23 18.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.796 1.189 . . . . 0.0 113.065 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 93.17 14.99 53.36 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.67 1.128 . . . . 0.0 114.268 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 92.9 mt -57.83 139.26 82.49 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.687 1.195 . . . . 0.0 110.375 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.32 150.56 19.8 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.602 2.868 . . . . 0.0 113.161 173.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.95 3.0 6.47 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.943 3.095 . . . . 0.0 113.579 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -137.57 16.07 2.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.728 2.011 . . . . 0.0 112.596 -169.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.4 tt -96.05 133.91 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.658 1.183 . . . . 0.0 111.781 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -94.8 162.16 13.87 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.472 1.109 . . . . 0.0 113.399 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -47.64 -44.49 26.96 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.107 1.763 . . . . 0.0 113.751 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.11 -27.91 57.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.825 0.85 . . . . 0.0 112.389 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -77.27 -34.47 55.68 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.528 0.731 . . . . 0.0 112.651 169.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.4 mt -64.99 -36.64 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.93 1.241 . . . . 0.0 109.609 169.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 54.0 m -64.99 -52.38 56.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.646 0.779 . . . . 0.0 110.54 172.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.49 -30.37 70.57 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.582 1.083 . . . . 0.0 112.924 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 75.6 m -65.61 -15.83 63.12 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -130.76 -3.24 4.14 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -61.03 -22.21 64.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.083 1.353 . . . . 0.0 113.009 173.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -57.58 -11.9 2.39 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.645 1.978 . . . . 0.0 114.931 169.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -105.92 -5.86 19.33 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.466 1.506 . . . . 0.0 114.047 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 123.91 173.98 14.04 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 126.073 1.797 . . . . 0.0 112.53 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.27 149.98 88.68 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.795 2.997 . . . . 0.0 113.016 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.75 171.98 16.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.255 1.422 . . . . 0.0 112.806 -176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.72 158.46 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.918 1.687 . . . . 0.0 109.298 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.37 135.63 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.578 1.151 . . . . 0.0 110.719 -170.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 125.893 1.677 . . . . 0.0 111.662 -175.277 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.186 0 N-CA-C 114.464 0.546 . . . . 0.0 114.464 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -152.22 157.53 41.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.463 1.131 . . . . 0.0 112.652 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.34 168.77 25.98 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.718 1.207 . . . . 0.0 112.257 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -113.37 121.14 43.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.307 1.843 . . . . 0.0 109.727 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.3 mt -86.02 140.73 30.03 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.422 1.489 . . . . 0.0 108.76 169.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.53 107.65 12.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.788 1.635 . . . . 0.0 107.734 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.97 154.17 22.32 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.417 0.687 . . . . 0.0 111.936 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -71.65 -26.29 62.48 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.76 0.824 . . . . 0.0 112.822 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -142.25 146.05 34.71 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.389 1.475 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.53 -31.44 71.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.308 0.643 . . . . 0.0 111.659 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -56.24 -28.41 58.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.75 1.22 . . . . 0.0 112.876 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.0 m -73.19 -29.13 62.61 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.964 -1.085 . . . . 0.0 112.147 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.04 -38.51 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.646 -0.659 . . . . 0.0 109.784 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -66.78 -38.35 86.39 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.547 -0.721 . . . . 0.0 111.897 172.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.84 88.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.579 0.627 . . . . 0.0 112.372 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.76 -49.13 74.18 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.306 0.642 . . . . 0.0 110.929 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.62 -42.18 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.1 0.96 . . . . 0.0 111.428 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.07 -17.84 63.92 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.76 1.224 . . . . 0.0 113.581 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.1 -13.59 18.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.165 1.386 . . . . 0.0 113.351 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 54.7 m -75.49 148.14 39.24 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.6 172.93 11.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.045 165.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.471 0.585 0 C-N-CA 123.487 0.715 . . . . 0.0 112.15 -175.08 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 110.83 -0.063 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -143.03 148.43 36.72 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.6 tp -135.75 177.93 7.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.474 1.91 . . . . 0.0 108.904 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 86.7 m -126.51 144.66 50.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.242 1.017 . . . . 0.0 112.761 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.0 m -149.85 170.06 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 126.855 2.062 . . . . 0.0 111.038 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 70.6 m -148.69 163.47 37.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.761 1.224 . . . . 0.0 112.406 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 25.7 p -140.89 -173.44 0.36 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 126.745 2.018 . . . . 0.0 111.278 -174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.79 -36.09 97.6 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.955 2.437 . . . . 0.0 113.863 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 44.8 p -119.29 -16.15 9.05 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 23.6 mm -113.69 128.79 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.693 1.133 . . . . 0.0 109.945 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -124.79 135.33 52.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.484 1.114 . . . . 0.0 111.69 -168.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 61.26 30.94 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.421 1.488 . . . . 0.0 112.631 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -66.85 128.32 93.82 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.52 1.128 . . . . 0.0 111.213 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.07 141.73 13.24 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.342 2.695 . . . . 0.0 109.119 169.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.18 135.08 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.396 1.479 . . . . 0.0 110.015 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -81.08 129.57 34.62 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.362 1.065 . . . . 0.0 109.561 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 35.7 mm -110.81 136.8 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.337 1.455 . . . . 0.0 109.08 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -142.14 87.01 9.89 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.904 1.282 . . . . 0.0 110.051 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.61 128.12 27.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.327 2.684 . . . . 0.0 109.763 172.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -169.417 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 86.3 mtm-85 . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -86.5 138.25 31.88 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.131 0.973 . . . . 0.0 111.132 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.0 t -140.6 120.63 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.293 1.037 . . . . 0.0 110.208 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -71.63 139.93 49.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.851 0.86 . . . . 0.0 110.644 171.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.4 t -132.6 119.35 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.32 1.448 . . . . 0.0 109.408 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.66 146.51 18.45 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.069 1.319 . . . . 0.0 113.435 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.13 17.87 30.75 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.883 1.23 . . . . 0.0 114.275 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.77 141.54 92.68 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.994 1.318 . . . . 0.0 111.441 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.11 156.77 15.22 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.877 3.052 . . . . 0.0 113.972 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.05 3.95 6.59 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.061 3.174 . . . . 0.0 113.815 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -137.45 23.22 2.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.377 1.471 . . . . 0.0 112.323 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.8 tt -104.81 142.66 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.556 1.142 . . . . 0.0 110.897 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -116.2 169.0 9.61 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.929 1.292 . . . . 0.0 113.068 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -48.64 -41.28 30.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.725 1.61 . . . . 0.0 113.921 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.13 -29.44 34.8 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.891 0.877 . . . . 0.0 112.388 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.93 -38.19 69.9 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.328 0.651 . . . . 0.0 111.822 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.1 mt -65.85 -38.71 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.301 -0.875 . . . . 0.0 109.449 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 85.2 m -60.93 -51.51 68.95 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.334 0.653 . . . . 0.0 110.539 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.93 -30.59 71.01 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.419 1.009 . . . . 0.0 112.914 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 65.9 m -68.93 -13.95 62.75 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -129.43 -2.89 4.91 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -60.96 -21.74 63.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.966 1.307 . . . . 0.0 113.228 174.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -56.74 -13.13 2.27 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.736 2.014 . . . . 0.0 114.976 169.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -104.47 -4.89 22.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.514 1.526 . . . . 0.0 113.999 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.07 175.1 15.08 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.983 1.754 . . . . 0.0 112.604 -174.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.26 145.54 98.38 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 123.923 3.082 . . . . 0.0 113.421 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.25 172.53 17.2 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.403 1.481 . . . . 0.0 112.698 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.58 159.85 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.835 1.654 . . . . 0.0 108.553 166.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 82.8 t -132.56 135.97 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.249 1.02 . . . . 0.0 110.421 -172.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 124.806 1.242 . . . . 0.0 112.437 -177.058 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.228 0 N-CA-C 114.724 0.649 . . . . 0.0 114.724 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -148.16 157.17 43.35 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.557 1.178 . . . . 0.0 112.973 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.91 167.54 27.25 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.051 1.341 . . . . 0.0 111.831 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -115.12 121.19 42.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.856 1.662 . . . . 0.0 109.845 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 21.0 mt -82.24 140.32 33.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.176 1.39 . . . . 0.0 108.731 169.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.9 mt -125.22 101.18 6.87 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.013 1.725 . . . . 0.0 108.11 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.34 159.13 27.3 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.165 0.586 . . . . 0.0 111.497 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -88.49 -13.51 40.09 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.68 142.23 34.92 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.695 1.598 . . . . 0.0 110.367 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.14 -29.78 71.07 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.556 -0.715 . . . . 0.0 112.04 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 26.7 p -59.58 -24.8 64.06 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.939 -1.1 . . . . 0.0 112.999 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.7 m -71.18 -28.79 64.48 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.888 -1.133 . . . . 0.0 112.314 172.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 70.4 t -73.88 -36.98 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.524 -0.735 . . . . 0.0 109.797 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -71.64 -35.74 70.49 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.736 -0.602 . . . . 0.0 112.137 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.37 85.87 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.673 0.67 . . . . 0.0 112.255 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.87 -49.17 73.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.543 0.737 . . . . 0.0 110.951 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.99 -41.64 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.094 0.958 . . . . 0.0 111.619 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.11 -18.48 63.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.844 1.258 . . . . 0.0 113.67 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.57 -13.5 20.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.049 1.339 . . . . 0.0 113.289 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 40.9 m -75.92 147.19 39.15 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.73 176.46 8.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.722 1.609 . . . . 0.0 107.798 165.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 CA--C 1.537 0.456 0 O-C-N 121.649 -0.657 . . . . 0.0 111.382 -179.381 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.94 0.4 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -143.65 148.84 36.38 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.513 1.125 . . . . 0.0 113.002 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.8 tp -140.39 157.91 44.82 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.365 1.466 . . . . 0.0 110.134 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 76.6 m -95.96 136.91 35.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.15 0.98 . . . . 0.0 112.424 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 31.5 m -146.11 177.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 126.846 2.058 . . . . 0.0 110.44 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 82.0 p -162.76 168.52 21.36 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.054 -1.029 . . . . 0.0 113.481 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 51.9 p -138.75 -175.54 0.49 Allowed Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.454 1.902 . . . . 0.0 110.617 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.55 -12.42 35.72 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.172 2.581 . . . . 0.0 114.154 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 46.9 p -119.11 -29.39 5.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.964 1.306 . . . . 0.0 113.689 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 27.2 mm -128.77 127.07 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.285 1.434 . . . . 0.0 109.592 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -117.26 141.79 47.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.661 1.184 . . . . 0.0 111.774 -169.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 57.69 31.92 21.12 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.123 1.369 . . . . 0.0 113.096 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -70.51 128.17 91.37 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.314 1.045 . . . . 0.0 111.712 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.62 128.38 4.62 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.309 2.673 . . . . 0.0 108.578 169.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.51 137.91 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.187 1.395 . . . . 0.0 110.47 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -76.71 125.95 30.13 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.104 1.362 . . . . 0.0 109.568 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.3 mm -110.96 128.78 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.54 1.536 . . . . 0.0 108.548 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -136.36 91.5 16.43 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.633 1.173 . . . . 0.0 109.85 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.9 132.48 51.95 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.765 2.977 . . . . 0.0 110.312 172.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -168.923 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 66.4 mtm-85 . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.48 136.0 49.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.566 1.147 . . . . 0.0 111.026 172.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 61.3 t -140.86 120.69 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.579 1.151 . . . . 0.0 110.111 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -68.64 141.25 55.44 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.221 1.008 . . . . 0.0 111.258 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.74 125.8 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.992 1.317 . . . . 0.0 109.161 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -127.28 148.6 17.51 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 125.218 1.39 . . . . 0.0 113.461 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 90.52 15.68 56.47 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.714 1.149 . . . . 0.0 114.009 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.68 142.5 62.25 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.485 1.514 . . . . 0.0 111.408 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.47 151.48 23.71 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.774 2.983 . . . . 0.0 113.145 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.96 0.62 8.66 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.776 2.984 . . . . 0.0 114.795 -169.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -140.71 16.92 2.34 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.38 1.072 . . . . 0.0 113.0 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.9 tt -79.75 131.61 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.632 0.773 . . . . 0.0 111.506 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -92.65 167.89 11.6 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.96 -39.99 69.53 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.491 1.117 . . . . 0.0 113.195 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.93 -30.24 58.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.969 0.907 . . . . 0.0 112.087 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.09 -42.54 80.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.948 0.899 . . . . 0.0 111.517 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 63.3 mt -63.15 -40.7 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.162 0.892 . . . . 0.0 109.795 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 56.9 m -62.21 -51.56 67.31 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.655 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.65 -31.08 71.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.275 0.943 . . . . 0.0 112.567 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.3 m -68.97 -13.14 62.27 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -129.02 -3.62 5.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.618 1.099 . . . . 0.0 113.572 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -61.02 -22.77 64.86 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.867 1.267 . . . . 0.0 113.165 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -57.11 -13.39 2.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.624 1.97 . . . . 0.0 114.951 170.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -103.34 -7.34 21.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.427 1.491 . . . . 0.0 113.901 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.07 172.14 13.61 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.1 1.81 . . . . 0.0 112.075 -170.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.1 150.8 60.69 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.501 2.801 . . . . 0.0 112.237 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.16 174.96 12.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.604 1.562 . . . . 0.0 112.603 -169.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.78 157.23 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.852 1.661 . . . . 0.0 109.144 167.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 59.3 t -124.04 134.02 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.856 1.262 . . . . 0.0 109.79 -174.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 CA--C 1.545 0.775 0 C-N-CA 125.851 1.66 . . . . 0.0 111.817 -170.819 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 CA-C-O 118.752 -1.027 . . . . 0.0 114.481 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -137.51 156.74 47.79 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.591 1.696 . . . . 0.0 114.175 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -154.44 168.57 26.22 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.665 1.586 . . . . 0.0 111.647 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -120.22 120.71 36.92 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.947 1.699 . . . . 0.0 109.987 172.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.7 mt -83.27 141.12 32.08 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.909 1.284 . . . . 0.0 108.571 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 43.6 mt -123.5 105.49 9.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.395 1.478 . . . . 0.0 107.54 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.92 157.75 26.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.011 0.524 . . . . 0.0 111.274 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -90.48 -12.78 36.27 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -142.21 137.2 30.59 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.562 1.545 . . . . 0.0 110.098 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.48 -34.11 70.53 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.797 0.839 . . . . 0.0 111.964 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.6 m -55.97 -26.42 48.17 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.742 1.217 . . . . 0.0 113.197 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.4 m -71.84 -27.83 63.15 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.947 -1.096 . . . . 0.0 112.384 174.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 57.0 t -73.87 -39.9 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.657 -0.652 . . . . 0.0 109.513 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -67.94 -37.75 82.0 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.694 -0.629 . . . . 0.0 111.941 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.28 -38.36 89.05 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.554 0.616 . . . . 0.0 112.342 173.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.2 tp -63.85 -48.83 75.2 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.288 0.635 . . . . 0.0 110.888 171.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 76.4 mt -56.0 -42.68 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.958 0.903 . . . . 0.0 111.42 176.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.21 -19.02 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.729 1.212 . . . . 0.0 113.514 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.33 -14.07 20.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.052 1.341 . . . . 0.0 113.5 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 42.3 m -75.46 147.94 39.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.079 0.942 . . . . 0.0 113.41 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.54 172.85 11.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.505 1.522 . . . . 0.0 107.803 165.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 123.402 0.681 . . . . 0.0 111.501 -176.441 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 120.619 0.247 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -140.17 146.75 39.17 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.005 0.922 . . . . 0.0 112.707 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.4 tp -129.87 -174.75 3.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.418 1.887 . . . . 0.0 108.561 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 30.0 p -133.94 149.49 51.27 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.058 0.943 . . . . 0.0 113.173 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 26.0 m -148.15 170.23 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 126.279 1.832 . . . . 0.0 111.588 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 50.8 m -145.33 154.23 42.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.536 1.134 . . . . 0.0 112.755 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 24.6 p -144.4 -175.04 0.44 Allowed Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 126.207 1.803 . . . . 0.0 111.502 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.31 -13.99 41.32 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.122 2.548 . . . . 0.0 113.659 171.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 29.3 p -117.51 -32.0 5.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.148 1.379 . . . . 0.0 113.77 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.5 mm -133.64 142.45 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.96 1.304 . . . . 0.0 110.137 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -120.94 133.63 55.28 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.081 1.352 . . . . 0.0 110.577 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.2 t70 63.08 28.34 16.08 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.152 1.381 . . . . 0.0 112.926 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -57.18 126.52 74.05 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-O 117.34 -1.314 . . . . 0.0 110.662 174.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.8 140.56 23.47 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.215 2.61 . . . . 0.0 109.652 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.05 134.78 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.829 1.252 . . . . 0.0 110.657 -174.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -73.14 134.73 44.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.001 1.321 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.8 mm -119.9 131.43 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.65 1.58 . . . . 0.0 108.105 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -139.99 95.36 8.59 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 123.848 0.859 . . . . 0.0 110.862 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.64 139.96 91.41 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.602 2.868 . . . . 0.0 111.889 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 124.185 0.994 . . . . 0.0 112.568 -179.724 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.477 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 53.1 m -147.87 153.87 39.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.1 1.36 . . . . 0.0 111.378 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 28.4 p -78.71 -18.25 54.6 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 61.54 -122.37 28.91 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.296 0.95 . . . . 0.0 112.548 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 57.6 p -91.27 -1.5 57.65 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.107 1.363 . . . . 0.0 114.224 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.6 m -69.57 138.78 53.48 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.681 -1.262 . . . . 0.0 113.294 -174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 131.0 -117.66 2.24 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.209 1.385 . . . . 0.0 110.775 -172.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 23.2 t -145.68 167.57 22.79 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.146 1.378 . . . . 0.0 111.959 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -75.11 -5.86 46.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.396 1.078 . . . . 0.0 113.506 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -76.52 137.49 39.63 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.002 0.921 . . . . 0.0 111.174 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.5 t -138.27 116.82 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.475 1.11 . . . . 0.0 109.77 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.2 141.75 49.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.536 0.734 . . . . 0.0 110.727 172.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.37 124.64 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.239 1.416 . . . . 0.0 109.509 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -119.57 144.88 17.78 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.789 1.185 . . . . 0.0 113.319 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 100.24 9.16 48.68 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.585 1.565 . . . . 0.0 114.502 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.05 141.77 75.66 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.38 1.472 . . . . 0.0 111.328 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -53.93 155.71 14.12 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.851 3.034 . . . . 0.0 114.084 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.45 3.75 7.22 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.956 3.104 . . . . 0.0 113.527 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -137.93 19.94 2.83 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.623 1.569 . . . . 0.0 112.159 -170.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -103.05 136.39 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.317 1.447 . . . . 0.0 110.547 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -109.03 171.79 7.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.177 0.991 . . . . 0.0 113.02 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -44.35 -46.25 9.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.863 1.665 . . . . 0.0 113.602 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -76.35 -26.96 56.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.449 0.699 . . . . 0.0 112.591 -173.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -78.7 -38.17 39.77 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.819 0.848 . . . . 0.0 111.425 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 34.6 mt -65.06 -39.89 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 121.601 -0.687 . . . . 0.0 109.415 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 90.2 m -61.29 -52.51 64.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.756 0.823 . . . . 0.0 110.345 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.3 69.88 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.453 1.024 . . . . 0.0 113.213 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.1 m -68.46 -23.99 64.66 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -120.42 -4.12 9.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.256 1.022 . . . . 0.0 113.435 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -60.39 -22.07 62.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.313 1.445 . . . . 0.0 113.439 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -54.87 -19.29 6.25 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.425 1.89 . . . . 0.0 114.888 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -98.85 -4.81 32.24 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.467 1.507 . . . . 0.0 113.688 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.66 170.65 13.63 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.996 1.76 . . . . 0.0 112.015 -170.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.37 150.49 76.01 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.598 2.865 . . . . 0.0 112.144 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.88 172.87 16.2 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.721 1.608 . . . . 0.0 112.275 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.17 159.69 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.523 1.529 . . . . 0.0 108.797 167.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.78 136.17 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.179 0.991 . . . . 0.0 110.421 -172.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.99 158.96 44.33 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.897 1.679 . . . . 0.0 111.667 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 32.0 p90 -158.03 159.72 30.15 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.454 1.101 . . . . 0.0 112.569 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -58.73 147.69 86.72 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 123.684 2.923 . . . . 0.0 113.167 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 66.76 5.71 4.11 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.506 1.523 . . . . 0.0 114.716 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -62.69 -33.51 75.23 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.542 -1.349 . . . . 0.0 112.105 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -62.34 -15.89 51.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.21 2.204 . . . . 0.0 115.018 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -128.47 7.44 5.83 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.583 1.553 . . . . 0.0 112.831 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 26.5 t -82.02 147.19 29.3 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.897 -1.127 . . . . 0.0 112.907 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -92.41 0.99 57.49 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.889 1.276 . . . . 0.0 113.171 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 62.2 m -141.4 148.19 39.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.977 1.311 . . . . 0.0 112.2 -173.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.24 14.96 6.85 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -170.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -107.49 153.44 41.31 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.572 1.549 . . . . 0.0 111.406 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.54 131.71 19.24 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.183 2.589 . . . . 0.0 110.958 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.9 140.86 32.46 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.345 2.696 . . . . 0.0 110.394 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt 61.3 9.81 2.74 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.408 1.483 . . . . 0.0 114.435 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 81.01 35.44 24.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.079 1.323 . . . . 0.0 114.491 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -148.06 150.2 33.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.402 1.601 . . . . 0.0 114.634 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -154.81 173.32 16.62 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.979 1.312 . . . . 0.0 112.171 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -118.33 122.01 41.81 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.226 1.811 . . . . 0.0 110.302 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.34 141.5 31.74 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.375 1.47 . . . . 0.0 108.511 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 64.4 mt -125.73 103.67 7.95 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.951 1.701 . . . . 0.0 108.191 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -83.47 157.51 22.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.339 0.656 . . . . 0.0 112.126 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -75.28 -25.33 57.89 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.463 0.705 . . . . 0.0 112.658 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -138.14 144.41 40.77 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.175 1.39 . . . . 0.0 111.032 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.32 -32.43 72.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.448 0.699 . . . . 0.0 111.222 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.3 m -57.12 -27.88 62.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.705 1.202 . . . . 0.0 112.996 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.4 m -72.33 -28.92 63.36 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.961 -1.087 . . . . 0.0 111.994 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.76 -39.13 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 121.697 -0.627 . . . . 0.0 109.781 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -66.24 -39.02 89.23 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.614 -0.679 . . . . 0.0 111.949 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.86 86.93 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.542 0.61 . . . . 0.0 112.306 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 26.8 tp -64.25 -48.63 75.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.478 0.711 . . . . 0.0 111.042 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.67 -41.44 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.022 0.929 . . . . 0.0 111.408 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.18 -17.71 63.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.725 1.21 . . . . 0.0 113.66 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.18 -13.46 18.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.071 1.348 . . . . 0.0 113.455 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.7 m -75.6 147.59 39.48 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.876 0.87 . . . . 0.0 113.266 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.43 173.08 12.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.529 1.532 . . . . 0.0 108.215 165.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -145.71 140.89 27.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.217 0.607 . . . . 0.0 112.575 -170.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -155.67 116.62 3.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.529 1.532 . . . . 0.0 110.019 176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 61.01 15.84 6.5 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.732 1.613 . . . . 0.0 114.632 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 98.23 -6.83 61.81 Favored Glycine 0 N--CA 1.473 1.123 0 C-N-CA 125.782 1.658 . . . . 0.0 114.068 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -78.3 147.25 34.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.653 1.181 . . . . 0.0 109.124 168.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.18 151.97 26.64 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.042 0.937 . . . . 0.0 110.013 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -140.93 141.43 34.51 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -125.41 -169.75 2.05 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.183 1.793 . . . . 0.0 108.332 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.2 p -141.73 150.2 41.48 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.645 1.111 . . . . 0.0 113.607 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 27.6 m -151.95 177.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.567 1.947 . . . . 0.0 111.486 -171.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 79.7 p -160.55 170.49 20.79 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.031 1.332 . . . . 0.0 112.933 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.4 p -153.78 -179.35 1.04 Allowed Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.73 2.012 . . . . 0.0 110.425 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.65 -19.93 55.5 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.845 2.363 . . . . 0.0 114.337 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 52.7 p -114.97 -19.28 11.0 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.05 1.34 . . . . 0.0 114.285 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.81 137.03 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.43 1.492 . . . . 0.0 110.391 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -131.64 137.75 48.49 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.711 1.204 . . . . 0.0 112.092 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.1 t70 57.54 28.4 15.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.396 1.478 . . . . 0.0 113.283 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -72.11 127.13 90.85 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.837 -1.078 . . . . 0.0 111.466 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.6 142.91 18.6 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.317 2.678 . . . . 0.0 109.381 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.5 m -137.65 133.22 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.55 1.14 . . . . 0.0 110.627 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -81.52 131.23 35.27 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.654 1.182 . . . . 0.0 110.057 -172.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.1 mm -114.05 128.61 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 108.986 -171.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -136.22 89.15 20.16 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.909 1.283 . . . . 0.0 110.092 -175.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.95 134.8 64.7 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.658 2.905 . . . . 0.0 110.851 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -73.75 122.69 22.79 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.172 0.51 . . . . 0.0 112.024 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -162.33 134.26 5.45 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.528 1.931 . . . . 0.0 109.087 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 80.2 mt -95.58 -2.51 48.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -170.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 70.0 m -76.39 147.43 38.03 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.147 -0.97 . . . . 0.0 113.027 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -76.16 152.29 36.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.854 1.262 . . . . 0.0 112.523 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 25.6 m -158.68 155.84 28.85 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.003 1.721 . . . . 0.0 111.581 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -80.17 1.14 29.39 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.103 1.361 . . . . 0.0 114.353 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -75.7 94.39 3.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.517 1.127 . . . . 0.0 111.436 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 12.2 p -154.87 138.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.852 1.661 . . . . 0.0 110.002 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -147.46 10.54 0.97 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.325 1.45 . . . . 0.0 113.803 -169.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.03 133.38 56.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.099 1.359 . . . . 0.0 112.268 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 42.4 m 67.94 -0.89 1.89 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 126.538 1.935 . . . . 0.0 114.7 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 77.71 178.9 49.08 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 125.233 1.397 . . . . 0.0 114.392 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.58 160.29 35.03 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.244 3.296 . . . . 0.0 111.763 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 55.9 p -161.12 140.91 10.7 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.85 1.26 . . . . 0.0 111.835 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 14.8 m -84.55 -7.26 59.32 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -174.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.359 1.457 . . . . 0.0 113.127 -178.093 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 57.6 p -169.09 -48.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.736 1.214 . . . . 0.0 112.106 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 24.1 m 70.09 4.28 4.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.928 2.091 . . . . 0.0 115.077 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -85.79 12.3 59.87 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.498 1.523 . . . . 0.0 115.054 -176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 31.6 p -87.24 5.12 39.8 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.569 1.548 . . . . 0.0 114.565 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 87.5 p -155.64 178.93 9.69 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.157 1.383 . . . . 0.0 112.854 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 104.93 -123.38 7.62 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 125.248 1.404 . . . . 0.0 111.258 -174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 22.2 t -146.62 152.06 38.28 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.969 1.308 . . . . 0.0 111.461 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -95.2 -5.2 44.43 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -82.12 135.72 35.26 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.592 0.633 . . . . 0.0 110.601 171.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.82 117.77 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.195 0.998 . . . . 0.0 110.146 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -71.21 139.74 50.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.147 0.979 . . . . 0.0 110.715 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 64.1 t -133.64 118.16 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.399 1.48 . . . . 0.0 109.292 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.09 143.44 18.07 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 124.803 1.192 . . . . 0.0 113.478 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.49 15.49 32.04 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.109 1.338 . . . . 0.0 114.4 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.64 139.47 85.84 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.957 1.303 . . . . 0.0 110.933 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -55.12 156.46 16.18 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.578 2.852 . . . . 0.0 113.703 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.91 5.4 4.95 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.054 3.169 . . . . 0.0 113.715 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -140.3 29.54 2.0 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.393 1.477 . . . . 0.0 112.043 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -110.7 128.32 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.464 1.106 . . . . 0.0 111.179 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -97.73 167.49 10.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.667 1.187 . . . . 0.0 113.334 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -43.6 -46.53 7.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.261 1.825 . . . . 0.0 113.994 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -79.01 -25.44 43.31 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.846 0.858 . . . . 0.0 112.523 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -77.51 -36.41 52.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.589 0.756 . . . . 0.0 111.933 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 44.0 mt -65.54 -36.39 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.153 0.888 . . . . 0.0 109.569 170.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 60.4 m -64.23 -52.19 59.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.831 0.852 . . . . 0.0 110.54 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.16 -30.64 70.52 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.605 1.093 . . . . 0.0 112.992 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.1 m -66.86 -15.5 63.67 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -130.19 -2.78 4.48 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -61.12 -22.09 64.34 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.987 1.315 . . . . 0.0 113.096 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -56.91 -13.12 2.37 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.736 2.014 . . . . 0.0 114.956 169.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -104.56 -5.73 21.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.497 1.519 . . . . 0.0 113.961 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.8 170.97 13.66 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.878 1.704 . . . . 0.0 112.104 -170.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.56 151.35 70.18 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.793 2.995 . . . . 0.0 112.429 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.06 172.92 15.11 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.63 1.572 . . . . 0.0 112.486 -170.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.52 159.44 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.742 1.617 . . . . 0.0 109.33 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.98 136.36 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.489 1.115 . . . . 0.0 110.817 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -146.2 163.21 36.13 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.375 1.87 . . . . 0.0 111.659 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -158.61 158.51 29.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.738 1.215 . . . . 0.0 112.277 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.24 147.8 93.57 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.03 2.486 . . . . 0.0 112.775 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 45.8 m170 65.78 14.95 9.83 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.572 1.549 . . . . 0.0 113.974 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -65.94 -19.01 65.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.305 1.442 . . . . 0.0 112.786 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -71.37 -22.66 61.86 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.394 1.878 . . . . 0.0 113.961 171.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -116.53 -31.18 5.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.011 1.324 . . . . 0.0 112.798 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 75.8 m -82.87 101.69 11.16 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.066 0.946 . . . . 0.0 109.228 169.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -78.79 55.65 1.75 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.107 1.363 . . . . 0.0 113.491 -169.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 84.9 p -155.78 159.24 39.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.635 1.174 . . . . 0.0 113.117 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -94.06 24.71 4.13 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.666 1.586 . . . . 0.0 113.926 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -116.72 141.98 28.98 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 126.434 1.893 . . . . 0.0 109.846 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.56 119.94 6.82 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.105 2.536 . . . . 0.0 109.883 174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.15 17.42 1.77 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.547 2.831 . . . . 0.0 113.382 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -136.58 -3.91 2.08 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.225 1.41 . . . . 0.0 114.366 -171.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.51 15.27 81.59 Favored Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.207 0.908 . . . . 0.0 114.13 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -151.44 158.0 43.1 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.622 1.211 . . . . 0.0 112.773 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -151.81 168.79 23.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.662 1.185 . . . . 0.0 111.904 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.57 118.69 33.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.51 1.924 . . . . 0.0 109.521 175.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 23.7 mt -82.34 142.33 32.11 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.306 1.442 . . . . 0.0 109.053 169.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 53.7 mt -125.97 106.79 9.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.018 1.727 . . . . 0.0 108.05 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.03 156.43 21.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.519 0.728 . . . . 0.0 112.161 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -69.01 -34.56 75.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.701 0.801 . . . . 0.0 112.41 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -140.57 141.62 35.21 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.991 1.716 . . . . 0.0 109.999 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -60.59 -32.41 71.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.052 0.941 . . . . 0.0 111.808 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 19.2 m -56.81 -27.05 59.3 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.616 1.166 . . . . 0.0 112.954 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 22.5 m -70.06 -28.73 65.69 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.089 -1.007 . . . . 0.0 112.283 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 57.9 t -77.18 -36.5 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.643 -0.66 . . . . 0.0 110.043 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -68.74 -37.15 79.22 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.515 -0.741 . . . . 0.0 111.871 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.43 -37.84 87.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.298 0.639 . . . . 0.0 112.294 172.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.0 tp -64.68 -48.55 74.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.435 0.694 . . . . 0.0 111.032 171.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.1 mt -55.89 -41.51 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.086 0.954 . . . . 0.0 111.261 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.45 -17.53 63.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.767 1.227 . . . . 0.0 113.636 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.83 -13.64 19.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.082 1.353 . . . . 0.0 113.27 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 56.8 m -71.93 141.17 49.47 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.029 0.919 . . . . 0.0 113.077 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 90.6 mt -80.94 176.28 9.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.541 1.536 . . . . 0.0 108.052 165.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -142.24 129.63 21.2 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.402 0.681 . . . . 0.0 110.956 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -144.2 122.02 11.96 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.033 1.733 . . . . 0.0 109.32 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 58.2 26.35 13.7 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.431 1.492 . . . . 0.0 113.721 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 89.65 -0.84 80.68 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.616 1.579 . . . . 0.0 114.363 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -109.67 143.27 39.68 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.979 1.711 . . . . 0.0 110.144 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 82.7 mt -84.06 148.33 26.89 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.707 -0.621 . . . . 0.0 111.568 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -141.22 152.13 44.33 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.873 1.269 . . . . 0.0 113.787 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.0 tp -140.17 161.62 37.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.767 1.627 . . . . 0.0 109.916 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 24.2 p -97.88 139.0 34.38 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.92 1.288 . . . . 0.0 112.769 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.1 m -148.21 175.61 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 126.627 1.971 . . . . 0.0 110.667 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 82.9 p -161.38 170.9 19.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.3 p -139.61 -177.82 0.74 Allowed Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 127.009 2.123 . . . . 0.0 110.885 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -65.6 -11.72 31.82 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.322 2.681 . . . . 0.0 114.273 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 43.7 p -122.7 -24.71 4.82 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.025 1.33 . . . . 0.0 113.857 -174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 31.0 mm -129.77 125.86 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.325 1.45 . . . . 0.0 109.648 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.06 143.74 48.91 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.576 1.15 . . . . 0.0 112.347 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 61.08 30.67 19.6 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.451 1.501 . . . . 0.0 112.701 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -69.18 127.95 92.76 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 121.128 -0.982 . . . . 0.0 111.529 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.25 131.8 5.05 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.397 2.732 . . . . 0.0 108.941 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.35 133.91 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.026 1.33 . . . . 0.0 110.915 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -77.34 127.98 33.5 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.411 1.085 . . . . 0.0 109.638 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.4 mm -109.21 132.77 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.91 1.284 . . . . 0.0 109.211 -174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -139.87 93.88 9.28 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.477 1.111 . . . . 0.0 110.295 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.04 135.56 69.38 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.252 2.635 . . . . 0.0 109.687 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -66.91 -14.76 63.11 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -169.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -83.79 -13.66 53.3 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.263 1.025 . . . . 0.0 113.384 172.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -124.38 -1.6 8.09 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.795 2.038 . . . . 0.0 113.337 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 65.3 p -72.49 -14.79 61.75 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -168.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -106.16 -0.96 24.2 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.037 1.735 . . . . 0.0 115.45 -168.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 7.2 t -159.99 165.42 32.03 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.127 0.876 . . . . 0.0 113.05 -176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 21.1 t70 69.51 -4.09 1.46 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.091 2.556 . . . . 0.0 115.311 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -79.26 12.18 2.49 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.561 1.545 . . . . 0.0 114.9 -174.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 6.8 p -160.16 143.08 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 126.174 1.79 . . . . 0.0 110.323 -169.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.34 10.4 1.12 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.51 1.524 . . . . 0.0 113.785 -170.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.41 -3.15 28.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.592 1.557 . . . . 0.0 114.36 -170.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 13.2 m -67.64 -9.04 39.63 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.626 1.57 . . . . 0.0 114.865 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -169.24 168.77 41.49 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.932 1.253 . . . . 0.0 114.135 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.05 159.2 37.73 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.141 3.227 . . . . 0.0 111.67 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.3 m -74.58 -6.71 50.07 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 9.3 t -165.16 164.02 20.26 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.412 1.885 . . . . 0.0 111.003 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.218 0 C-N-CA 125.229 1.395 . . . . 0.0 112.863 -178.422 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.442 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 49.2 p -159.96 -60.46 0.06 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.053 0.941 . . . . 0.0 112.476 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 53.4 p -90.73 -11.45 39.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 86.43 155.34 26.55 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.652 1.596 . . . . 0.0 113.716 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.3 p -166.98 -66.97 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.971 1.308 . . . . 0.0 111.49 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 47.2 p -167.57 153.61 7.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.843 1.657 . . . . 0.0 112.042 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -155.76 -90.05 0.07 OUTLIER Glycine 0 N--CA 1.468 0.807 0 C-N-CA 125.737 1.636 . . . . 0.0 110.798 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 12.5 t -155.55 160.12 40.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.287 1.435 . . . . 0.0 111.748 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.5 mtm-85 -88.08 -3.76 58.85 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.333 1.053 . . . . 0.0 112.794 170.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -82.24 134.26 35.28 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.254 1.422 . . . . 0.0 111.128 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.6 t -141.0 121.05 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.297 1.039 . . . . 0.0 110.246 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -75.11 140.33 43.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.683 0.793 . . . . 0.0 110.49 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.73 120.6 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.24 1.416 . . . . 0.0 109.294 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.37 146.71 18.55 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 124.836 1.208 . . . . 0.0 113.917 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 91.32 23.75 28.38 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.958 1.266 . . . . 0.0 113.931 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.22 145.91 64.26 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.826 1.651 . . . . 0.0 111.717 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -52.34 155.56 9.38 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.13 3.22 . . . . 0.0 113.907 174.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.57 1.12 9.34 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.878 3.052 . . . . 0.0 113.576 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -140.4 45.79 1.83 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.672 1.589 . . . . 0.0 111.469 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.8 tt -127.57 147.67 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.437 1.495 . . . . 0.0 110.834 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -123.92 170.98 10.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.461 1.504 . . . . 0.0 113.08 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -50.28 -40.82 49.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.177 1.391 . . . . 0.0 113.994 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -81.1 -29.8 34.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.993 0.917 . . . . 0.0 112.361 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.22 -38.75 71.99 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.329 0.652 . . . . 0.0 111.882 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 46.8 mt -66.05 -38.23 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.52 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 88.8 m -61.26 -51.18 70.03 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.316 0.647 . . . . 0.0 110.634 172.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.84 -31.07 71.29 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.245 0.929 . . . . 0.0 112.866 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.5 m -69.09 -14.29 62.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -128.23 -3.08 5.65 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.34 0.973 . . . . 0.0 113.539 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -60.61 -22.1 63.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.905 1.282 . . . . 0.0 113.38 174.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -56.81 -14.17 3.19 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.663 1.985 . . . . 0.0 115.016 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -102.82 -4.4 24.95 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.36 1.464 . . . . 0.0 113.903 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 120.89 171.68 14.38 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.864 1.697 . . . . 0.0 111.981 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.18 151.87 72.35 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.589 2.859 . . . . 0.0 112.271 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.66 173.45 13.87 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.913 1.685 . . . . 0.0 112.312 -171.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.04 157.8 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.658 1.583 . . . . 0.0 108.707 166.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.18 136.25 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.514 1.126 . . . . 0.0 110.158 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -154.41 169.39 23.85 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.48 1.112 . . . . 0.0 112.751 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -156.88 157.21 30.65 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.827 1.251 . . . . 0.0 112.654 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.13 149.71 83.35 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.727 2.951 . . . . 0.0 113.963 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 32.5 m170 70.65 3.54 4.59 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.318 1.847 . . . . 0.0 115.067 170.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -58.42 -28.47 65.26 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.731 -1.231 . . . . 0.0 111.979 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -59.31 -24.52 63.37 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.027 2.131 . . . . 0.0 114.666 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.09 -38.52 2.16 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.594 1.157 . . . . 0.0 112.304 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 74.9 m -89.65 79.53 6.79 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.465 1.106 . . . . 0.0 109.077 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -59.34 115.77 3.47 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.423 1.089 . . . . 0.0 111.509 -174.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 14.7 t -166.74 147.51 5.97 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.014 0.925 . . . . 0.0 112.215 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -101.72 6.62 41.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.416 1.487 . . . . 0.0 112.98 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -112.45 142.91 27.87 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.746 2.019 . . . . 0.0 109.134 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.89 117.78 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.955 2.437 . . . . 0.0 110.254 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.46 16.86 1.88 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.458 2.772 . . . . 0.0 113.14 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -135.33 -5.59 2.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.493 1.517 . . . . 0.0 114.144 -172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.87 13.11 83.77 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.45 1.024 . . . . 0.0 114.354 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -148.16 160.76 42.58 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.775 1.288 . . . . 0.0 113.188 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.42 165.07 36.17 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.992 1.317 . . . . 0.0 111.879 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.28 121.52 45.48 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.832 1.653 . . . . 0.0 109.941 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 22.5 mt -84.85 139.91 31.56 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.433 1.493 . . . . 0.0 108.682 169.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 45.5 mt -127.06 103.13 7.28 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.922 1.689 . . . . 0.0 107.874 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -82.03 160.74 23.17 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.391 0.677 . . . . 0.0 111.813 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -82.84 -16.24 48.46 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -141.29 141.47 33.92 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.405 1.482 . . . . 0.0 110.51 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.77 -30.03 69.77 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.709 -0.62 . . . . 0.0 111.508 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.5 m -55.27 -28.46 53.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.666 1.187 . . . . 0.0 112.964 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.6 m -73.48 -28.74 62.09 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.01 -1.056 . . . . 0.0 112.213 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 86.1 t -75.21 -37.79 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.561 -0.712 . . . . 0.0 109.848 174.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -67.28 -38.2 84.69 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.552 -0.718 . . . . 0.0 111.967 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.83 -37.75 88.03 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.615 0.643 . . . . 0.0 112.322 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.1 tp -63.52 -49.12 74.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.386 0.675 . . . . 0.0 110.92 171.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.7 mt -55.85 -41.51 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.155 0.982 . . . . 0.0 111.351 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.4 -18.25 63.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.737 1.215 . . . . 0.0 113.672 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.48 -14.28 20.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.044 1.337 . . . . 0.0 113.433 174.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.0 m -75.03 146.72 41.34 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.064 0.935 . . . . 0.0 113.475 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -85.17 176.24 8.48 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.545 1.538 . . . . 0.0 107.844 165.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -146.04 138.23 25.28 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.375 0.67 . . . . 0.0 111.715 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -154.75 121.16 5.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.983 1.313 . . . . 0.0 110.233 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 65.42 6.19 3.57 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.339 2.256 . . . . 0.0 113.932 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 97.98 -8.52 63.24 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.835 1.683 . . . . 0.0 113.636 -170.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -79.33 142.82 35.73 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.495 1.147 . . . . 0.0 109.762 170.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.4 mt -93.41 156.04 17.01 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.35 0.66 . . . . 0.0 111.342 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -144.98 150.55 37.13 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.504 1.122 . . . . 0.0 113.271 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.35 153.18 42.46 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.045 1.338 . . . . 0.0 110.617 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 21.5 p -83.72 136.45 34.17 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.627 1.171 . . . . 0.0 112.607 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.8 165.4 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 126.021 1.728 . . . . 0.0 111.264 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 50.4 m -146.59 168.06 22.19 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.262 1.025 . . . . 0.0 113.217 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.0 p -147.65 -173.79 0.38 Allowed Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 127.804 2.442 . . . . 0.0 109.942 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -64.63 -16.09 53.41 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.051 2.501 . . . . 0.0 114.341 171.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 57.4 p -126.99 -15.37 5.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.932 1.293 . . . . 0.0 114.312 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.0 mm -129.63 135.0 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.173 1.789 . . . . 0.0 109.27 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -133.14 132.4 41.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.039 0.936 . . . . 0.0 112.338 -169.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.7 t70 59.36 26.95 15.92 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.674 1.59 . . . . 0.0 113.032 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -75.15 129.86 81.81 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.401 1.48 . . . . 0.0 111.901 -169.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -76.35 117.75 4.71 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.407 2.738 . . . . 0.0 110.916 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.89 141.25 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.347 1.459 . . . . 0.0 110.436 173.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -79.03 129.47 34.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.045 0.938 . . . . 0.0 109.861 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.5 131.69 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.487 1.515 . . . . 0.0 108.77 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 29.2 mtp85 -139.25 86.86 14.21 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.681 1.193 . . . . 0.0 110.107 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.89 138.69 80.65 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.638 2.892 . . . . 0.0 111.372 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -81.52 120.28 24.83 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.478 0.711 . . . . 0.0 112.405 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -162.63 156.1 20.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.529 1.532 . . . . 0.0 111.347 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.24 148.65 25.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.572 1.149 . . . . 0.0 111.738 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 14.7 m -70.83 -5.11 27.93 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -71.63 -14.11 61.96 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.679 1.191 . . . . 0.0 112.264 169.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 70.2 m -122.67 -3.23 8.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.271 1.428 . . . . 0.0 114.457 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -159.5 139.26 11.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.58 1.952 . . . . 0.0 110.651 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -68.37 161.69 26.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.557 0.743 . . . . 0.0 111.912 172.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 13.7 p -154.34 141.8 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.527 1.131 . . . . 0.0 111.242 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.17 7.77 10.84 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.976 2.11 . . . . 0.0 113.554 -170.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -148.54 123.68 10.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.991 1.716 . . . . 0.0 110.447 -169.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 48.3 m 67.62 -6.42 0.67 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.055 2.142 . . . . 0.0 114.994 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 82.21 169.72 43.84 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 125.903 1.716 . . . . 0.0 114.43 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.34 145.74 97.99 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.201 3.267 . . . . 0.0 113.848 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 94.7 p -71.33 -9.0 57.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.055 0.942 . . . . 0.0 113.202 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 8.9 m -76.44 -9.27 58.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.107 1.763 . . . . 0.0 114.604 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.197 -179.342 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 8.4 t -164.64 -177.97 5.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.782 1.633 . . . . 0.0 110.998 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 73.9 m -139.83 130.5 25.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.917 1.687 . . . . 0.0 110.781 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -89.61 161.09 29.48 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.628 1.109 . . . . 0.0 113.672 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 45.2 p -85.91 2.89 44.27 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.459 1.504 . . . . 0.0 113.496 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 7.8 p -81.47 2.24 29.66 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.873 2.069 . . . . 0.0 114.934 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -68.88 169.44 42.33 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.56 1.076 . . . . 0.0 113.611 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 39.5 t -145.01 160.09 41.92 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.445 1.098 . . . . 0.0 112.794 -173.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -76.14 -7.1 54.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.25 1.02 . . . . 0.0 113.08 170.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -71.19 138.63 49.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.928 0.891 . . . . 0.0 110.816 169.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.6 t -140.07 119.49 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.537 1.135 . . . . 0.0 109.717 175.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -71.77 139.53 49.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.867 0.867 . . . . 0.0 110.544 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.9 119.11 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.311 1.445 . . . . 0.0 109.407 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -117.03 147.67 18.88 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.113 1.339 . . . . 0.0 113.45 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 92.02 19.07 40.93 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 124.702 1.144 . . . . 0.0 114.142 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 98.3 mt -55.2 141.56 60.66 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.561 1.544 . . . . 0.0 111.189 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.94 148.86 28.17 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.625 2.884 . . . . 0.0 112.806 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.62 6.65 3.1 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.207 3.271 . . . . 0.0 114.461 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -140.05 16.57 2.45 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.48 1.512 . . . . 0.0 112.676 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.6 tt -93.39 137.73 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.039 0.936 . . . . 0.0 111.408 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -109.92 170.26 8.19 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.721 1.208 . . . . 0.0 113.161 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -47.66 -44.11 26.89 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.647 1.579 . . . . 0.0 113.746 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -79.65 -25.49 41.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.839 0.855 . . . . 0.0 112.316 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -77.99 -36.64 48.64 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.773 0.829 . . . . 0.0 111.496 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.0 mt -64.89 -38.64 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 118.932 0.787 . . . . 0.0 109.529 170.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 61.6 m -62.74 -52.01 64.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.533 0.733 . . . . 0.0 110.517 173.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.7 70.89 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.5 1.045 . . . . 0.0 112.998 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.6 m -67.66 -15.04 63.44 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -129.62 -2.97 4.8 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -60.98 -22.63 64.66 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.878 1.271 . . . . 0.0 113.142 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -56.42 -13.99 2.67 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.806 2.042 . . . . 0.0 115.009 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -103.67 -6.29 21.74 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.432 1.493 . . . . 0.0 113.946 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 123.44 172.33 13.77 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.961 1.743 . . . . 0.0 112.14 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.79 151.45 68.87 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.544 2.829 . . . . 0.0 112.358 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.27 172.88 15.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.746 1.618 . . . . 0.0 112.527 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -134.02 159.19 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.706 1.603 . . . . 0.0 109.28 167.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 56.1 t -129.26 135.11 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.308 1.043 . . . . 0.0 110.77 -171.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -145.11 164.15 32.14 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.257 1.823 . . . . 0.0 111.845 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -157.36 158.93 31.1 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.874 1.27 . . . . 0.0 112.083 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.98 150.79 87.57 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.139 2.559 . . . . 0.0 112.849 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 48.3 m170 64.85 12.64 7.92 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.435 1.494 . . . . 0.0 114.044 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -67.52 -15.32 63.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.551 1.541 . . . . 0.0 112.867 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -63.33 -22.93 67.18 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.612 1.965 . . . . 0.0 113.944 169.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.85 -40.68 2.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.138 1.375 . . . . 0.0 111.561 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 68.7 m -83.83 62.4 6.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.792 1.237 . . . . 0.0 109.931 169.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -74.77 -0.66 18.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.787 1.635 . . . . 0.0 114.53 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.6 m -56.79 159.95 3.7 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.797 1.639 . . . . 0.0 113.35 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.32 5.38 7.15 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -171.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -128.83 139.73 36.5 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.28 1.832 . . . . 0.0 110.008 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.95 121.79 8.84 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.977 2.451 . . . . 0.0 110.173 173.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -85.58 16.97 1.85 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.322 2.681 . . . . 0.0 113.726 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -136.04 -3.04 2.27 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.83 15.44 81.23 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.121 0.867 . . . . 0.0 114.284 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -149.88 156.79 42.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.641 1.176 . . . . 0.0 112.651 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.58 169.67 22.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.905 1.282 . . . . 0.0 111.697 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -116.32 118.06 31.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.39 1.876 . . . . 0.0 109.531 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 25.4 mt -80.95 141.09 34.83 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.921 1.288 . . . . 0.0 108.682 169.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.8 mt -123.85 103.42 8.34 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.747 1.619 . . . . 0.0 107.871 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -81.02 156.52 25.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.116 0.566 . . . . 0.0 111.403 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -82.81 -15.75 50.45 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -141.87 141.85 33.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.4 1.48 . . . . 0.0 110.658 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.57 -31.86 70.97 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.228 0.611 . . . . 0.0 111.533 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -56.03 -28.04 55.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.65 1.18 . . . . 0.0 112.941 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.3 m -73.92 -29.64 62.15 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.955 -1.091 . . . . 0.0 112.168 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.95 -38.81 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.667 -0.646 . . . . 0.0 109.66 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -66.96 -38.51 86.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.636 -0.665 . . . . 0.0 111.985 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.92 88.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.627 0.649 . . . . 0.0 112.304 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.95 -48.85 74.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.45 0.7 . . . . 0.0 110.918 171.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 74.2 mt -55.67 -42.43 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.091 0.957 . . . . 0.0 111.345 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.98 -17.97 64.0 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.668 1.187 . . . . 0.0 113.671 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.09 -13.88 19.63 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.113 1.365 . . . . 0.0 113.431 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.9 m -77.51 150.46 34.86 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -86.83 176.23 7.81 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.79 1.636 . . . . 0.0 107.778 164.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -147.07 137.44 23.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.463 0.705 . . . . 0.0 111.729 -174.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -157.47 126.1 5.67 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.244 1.418 . . . . 0.0 110.202 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 58.77 24.3 12.14 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.22 1.808 . . . . 0.0 113.79 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 85.99 -4.52 85.81 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.711 1.625 . . . . 0.0 114.424 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -94.87 147.57 23.23 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.95 1.3 . . . . 0.0 110.341 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 95.8 mt -94.8 158.21 15.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.77 0.828 . . . . 0.0 111.163 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -144.18 148.97 35.7 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.224 1.01 . . . . 0.0 113.096 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -140.7 162.1 36.2 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.733 1.613 . . . . 0.0 110.017 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 24.8 p -97.79 141.17 31.11 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.082 1.353 . . . . 0.0 112.628 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.4 m -146.66 169.98 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 126.7 2.0 . . . . 0.0 110.644 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.7 m -148.9 169.05 21.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.553 1.141 . . . . 0.0 112.786 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.28 175.98 2.57 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 127.916 2.487 . . . . 0.0 109.493 -176.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -57.19 -31.97 92.13 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.162 2.575 . . . . 0.0 115.016 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 42.2 p -119.07 0.12 11.21 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.556 1.542 . . . . 0.0 114.03 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.6 mm -135.68 121.65 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.84 1.656 . . . . 0.0 109.061 -171.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -125.05 134.33 52.58 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.204 1.002 . . . . 0.0 111.984 -168.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.2 t70 60.3 30.81 20.14 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.298 1.439 . . . . 0.0 112.653 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -62.71 129.88 93.27 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.782 1.233 . . . . 0.0 110.962 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.87 137.61 11.19 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.214 2.61 . . . . 0.0 109.193 169.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.23 138.16 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.244 1.418 . . . . 0.0 110.201 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -79.05 127.74 32.38 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.012 1.325 . . . . 0.0 109.532 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.0 mm -112.22 132.8 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.581 1.552 . . . . 0.0 108.673 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -141.21 92.54 8.36 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.476 1.11 . . . . 0.0 110.074 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.79 133.37 55.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.53 2.82 . . . . 0.0 110.829 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -84.26 157.79 21.45 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -169.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -150.08 134.64 17.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.569 1.548 . . . . 0.0 110.821 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 73.3 mt -85.35 101.18 12.36 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.408 1.483 . . . . 0.0 110.094 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 10.6 t -163.87 -178.81 5.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.359 1.464 . . . . 0.0 110.996 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -75.61 -3.8 36.48 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.652 1.581 . . . . 0.0 113.802 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 25.3 t -158.09 140.75 14.65 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.707 1.603 . . . . 0.0 111.278 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -97.55 0.6 47.72 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.707 2.003 . . . . 0.0 113.704 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -61.6 149.34 39.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.764 1.626 . . . . 0.0 113.098 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 3.4 p -162.94 120.11 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.688 1.595 . . . . 0.0 110.462 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 70.6 mtp -159.0 157.55 31.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.986 2.514 . . . . 0.0 110.668 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -146.63 136.54 23.34 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.148 1.779 . . . . 0.0 110.58 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 9.5 t -165.54 166.55 18.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.289 1.436 . . . . 0.0 111.34 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 86.59 175.28 49.51 Favored Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.268 1.413 . . . . 0.0 113.961 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.5 152.76 34.25 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.059 3.173 . . . . 0.0 111.725 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.5 m -71.35 -5.71 34.56 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 17.5 m -77.22 -8.33 57.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.436 1.494 . . . . 0.0 114.346 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.194 0 CA-C-O 118.224 -1.32 . . . . 0.0 113.183 179.59 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 19.8 m -90.54 -1.54 57.89 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 87.3 p -163.5 172.73 14.03 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.507 1.523 . . . . 0.0 112.153 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 94.75 -25.8 21.54 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.499 1.524 . . . . 0.0 114.449 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 90.8 p -166.65 163.89 16.78 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.622 1.569 . . . . 0.0 112.011 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 17.0 p -97.34 11.13 37.66 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.806 1.643 . . . . 0.0 113.37 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 84.2 -59.98 4.88 Favored Glycine 0 N--CA 1.472 1.044 0 C-N-CA 125.761 1.648 . . . . 0.0 112.772 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 19.8 t -159.17 160.25 35.27 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.216 1.407 . . . . 0.0 112.263 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 -79.0 -13.28 59.89 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.2 1.0 . . . . 0.0 112.942 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.26 133.86 35.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.686 1.195 . . . . 0.0 110.811 171.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.9 123.0 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.425 1.09 . . . . 0.0 110.524 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.37 143.44 44.85 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.313 1.045 . . . . 0.0 111.344 171.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.61 127.2 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.236 1.414 . . . . 0.0 109.586 172.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -127.78 146.44 16.62 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.938 1.256 . . . . 0.0 113.622 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 96.73 15.98 38.01 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.142 1.353 . . . . 0.0 114.451 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.31 141.99 86.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.238 1.415 . . . . 0.0 111.507 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.25 155.82 14.95 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.027 3.151 . . . . 0.0 114.283 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.75 2.71 7.58 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 124.117 3.212 . . . . 0.0 113.673 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -138.19 34.76 2.32 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.643 1.577 . . . . 0.0 111.815 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 10.4 tt -114.1 162.57 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.525 1.53 . . . . 0.0 110.234 172.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -146.22 170.36 16.9 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.049 1.34 . . . . 0.0 112.539 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -42.74 -47.66 5.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.132 1.773 . . . . 0.0 114.264 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.25 -29.2 42.53 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.388 -0.82 . . . . 0.0 112.34 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -74.15 -37.25 64.08 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.634 0.774 . . . . 0.0 111.45 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 64.6 mt -65.77 -39.52 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.454 -0.778 . . . . 0.0 109.569 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 62.0 m -60.63 -52.5 64.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.254 173.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.15 71.41 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.332 0.969 . . . . 0.0 112.942 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.2 m -69.42 -14.59 62.98 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -128.2 -4.1 5.59 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.347 0.976 . . . . 0.0 113.508 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -60.61 -22.44 63.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.952 1.301 . . . . 0.0 113.284 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -56.44 -13.7 2.47 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.716 2.006 . . . . 0.0 115.045 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -104.86 -4.38 22.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.236 1.414 . . . . 0.0 113.988 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.72 172.73 14.34 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.818 1.675 . . . . 0.0 112.228 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.68 151.59 69.55 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.722 2.948 . . . . 0.0 112.172 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.09 172.66 16.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.538 1.535 . . . . 0.0 112.553 -169.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.37 151.45 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.876 1.67 . . . . 0.0 109.389 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.98 134.77 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.338 1.455 . . . . 0.0 109.719 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.88 161.71 40.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.95 1.7 . . . . 0.0 112.05 -169.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.5 p90 -165.23 163.57 13.32 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.657 1.583 . . . . 0.0 111.846 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -55.7 143.0 81.75 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.656 2.904 . . . . 0.0 112.9 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 69.99 3.65 4.44 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.098 1.759 . . . . 0.0 114.742 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -68.49 -21.13 64.62 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.31 -1.494 . . . . 0.0 112.639 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -78.47 -8.54 58.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.806 2.042 . . . . 0.0 114.142 172.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -135.9 13.04 3.38 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.62 1.568 . . . . 0.0 112.943 -170.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 42.6 t -153.25 147.94 26.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.695 1.598 . . . . 0.0 111.644 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -83.53 -4.08 58.22 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.52 1.128 . . . . 0.0 113.616 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 68.2 m -65.28 116.63 6.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.068 0.947 . . . . 0.0 112.97 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -98.08 13.7 30.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.919 1.688 . . . . 0.0 113.414 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -106.94 147.52 35.23 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 127.332 2.253 . . . . 0.0 110.224 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.52 126.46 14.18 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.108 2.538 . . . . 0.0 110.593 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.6 129.62 18.1 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.293 2.662 . . . . 0.0 110.238 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 58.32 13.07 2.22 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.562 1.545 . . . . 0.0 114.565 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 85.41 27.87 31.75 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.97 1.272 . . . . 0.0 114.315 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -137.15 158.05 45.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.495 1.648 . . . . 0.0 113.752 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.36 167.8 29.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.502 1.521 . . . . 0.0 111.763 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -118.71 135.07 54.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.023 1.729 . . . . 0.0 109.913 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.2 mt -103.41 139.26 39.03 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.064 1.746 . . . . 0.0 108.697 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 14.2 mt -121.27 113.0 19.31 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.86 156.19 19.08 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.761 0.824 . . . . 0.0 111.338 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -64.59 -35.64 81.64 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.746 -0.596 . . . . 0.0 112.359 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -141.0 144.99 35.35 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.641 1.576 . . . . 0.0 110.507 -171.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.02 -30.88 70.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.508 1.123 . . . . 0.0 112.203 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 24.0 p -61.25 -25.83 67.35 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.088 1.355 . . . . 0.0 113.147 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 25.9 m -70.36 -30.75 67.76 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.931 -1.105 . . . . 0.0 111.686 172.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.75 -34.53 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.539 -0.726 . . . . 0.0 110.249 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -66.44 -37.59 85.5 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.436 -0.79 . . . . 0.0 111.861 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.87 89.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.652 0.66 . . . . 0.0 112.408 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.7 tp -62.99 -48.83 77.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.252 0.621 . . . . 0.0 110.824 171.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 70.8 mt -55.82 -42.29 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.334 1.054 . . . . 0.0 111.289 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.27 -19.67 63.92 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.601 1.16 . . . . 0.0 113.63 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -96.63 -14.14 22.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.952 1.301 . . . . 0.0 113.312 174.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 29.7 m -75.55 146.69 40.27 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 88.7 mt -85.33 -179.06 6.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.998 1.719 . . . . 0.0 107.702 164.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -147.0 138.24 24.02 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.465 -0.772 . . . . 0.0 111.843 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.56 130.14 8.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.802 1.641 . . . . 0.0 109.442 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 59.09 17.43 5.54 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.728 1.611 . . . . 0.0 113.408 -171.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 83.1 -5.25 77.45 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.077 1.323 . . . . 0.0 113.85 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -89.27 147.28 24.21 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.759 1.623 . . . . 0.0 109.807 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.3 mt -86.41 157.49 19.82 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.848 -0.532 . . . . 0.0 111.431 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -145.51 149.94 35.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.776 1.23 . . . . 0.0 112.711 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -144.27 153.17 41.76 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.891 1.276 . . . . 0.0 110.936 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 20.5 p -85.63 134.4 33.99 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.656 1.182 . . . . 0.0 112.804 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.87 167.48 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 126.335 1.854 . . . . 0.0 110.708 172.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.2 m -149.69 166.67 28.64 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.493 1.117 . . . . 0.0 112.814 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.5 p -138.51 -175.72 0.51 Allowed Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 127.209 2.204 . . . . 0.0 110.494 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.57 -15.39 49.7 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.064 2.509 . . . . 0.0 114.233 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 47.1 p -123.1 -23.7 4.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.898 1.279 . . . . 0.0 114.172 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.3 mm -126.23 132.28 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.601 1.56 . . . . 0.0 109.534 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -125.0 134.83 52.43 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.41 1.084 . . . . 0.0 111.773 -170.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 62.36 27.61 16.45 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.589 1.555 . . . . 0.0 112.928 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -60.32 127.27 86.11 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.607 1.163 . . . . 0.0 111.511 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.51 110.82 1.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.401 2.734 . . . . 0.0 108.287 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.27 136.22 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.115 0.966 . . . . 0.0 110.05 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -74.67 134.49 41.98 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.168 0.987 . . . . 0.0 109.486 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.73 133.92 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 126.14 1.776 . . . . 0.0 108.097 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 39.7 mtt180 -138.85 98.57 8.6 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.995 0.918 . . . . 0.0 110.343 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.31 134.4 61.29 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.434 2.756 . . . . 0.0 110.38 169.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -74.51 149.24 40.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.433 0.693 . . . . 0.0 112.455 -175.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -78.89 -80.08 0.12 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.421 0.688 . . . . 0.0 111.832 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 68.5 mt -151.24 171.1 17.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.691 1.996 . . . . 0.0 110.82 -176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 29.9 p -69.52 -13.74 62.5 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 170.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -161.04 128.38 4.18 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.404 2.282 . . . . 0.0 109.575 173.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 17.8 p -165.63 154.42 11.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.615 1.166 . . . . 0.0 112.54 -173.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -84.94 -1.53 56.8 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.771 1.228 . . . . 0.0 113.907 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -152.78 155.74 37.75 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.606 1.562 . . . . 0.0 111.925 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.31 136.09 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.557 2.343 . . . . 0.0 107.687 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.14 125.65 28.82 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.209 0.604 . . . . 0.0 111.193 -172.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -161.51 -33.8 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.691 1.596 . . . . 0.0 113.313 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 12.0 m -71.84 -3.13 20.53 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 89.68 -159.48 28.18 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 124.604 1.097 . . . . 0.0 113.26 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.76 151.82 25.03 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.531 2.821 . . . . 0.0 111.646 -171.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 8.6 t -164.87 170.09 15.79 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.399 1.48 . . . . 0.0 111.36 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 10.1 t -164.33 159.96 20.38 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.92 1.688 . . . . 0.0 111.357 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.226 0 C-N-CA 125.298 1.428 . . . . 0.0 112.972 -178.209 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.443 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 58.8 m -147.31 152.55 38.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.02 1.328 . . . . 0.0 111.455 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 17.4 m -81.68 -3.5 53.75 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -80.66 165.03 47.48 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.979 1.276 . . . . 0.0 113.733 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 78.1 p -164.73 165.87 20.4 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.522 1.529 . . . . 0.0 111.868 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.8 m -108.06 137.06 46.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.321 1.449 . . . . 0.0 111.294 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 153.83 -162.36 30.38 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.61 1.1 . . . . 0.0 113.766 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 23.2 t -148.78 164.41 34.49 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.425 1.49 . . . . 0.0 111.967 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -76.53 1.55 16.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.692 1.197 . . . . 0.0 113.96 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -68.83 139.13 55.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.041 0.936 . . . . 0.0 111.222 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.5 t -139.04 118.53 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.595 1.158 . . . . 0.0 109.996 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -68.54 138.85 55.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.07 0.948 . . . . 0.0 110.838 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.5 t -132.55 116.91 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.255 1.422 . . . . 0.0 109.277 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.04 143.91 17.9 Favored Glycine 0 N--CA 1.47 0.913 0 C-N-CA 124.905 1.24 . . . . 0.0 113.637 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.1 23.71 21.68 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.669 1.128 . . . . 0.0 113.882 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.72 141.57 84.68 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.042 1.337 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.22 155.18 20.46 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.503 2.802 . . . . 0.0 113.538 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.23 3.29 6.36 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.803 3.002 . . . . 0.0 114.524 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -140.55 27.14 2.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.865 1.266 . . . . 0.0 112.819 -177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.2 tt -101.07 144.75 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.466 1.106 . . . . 0.0 110.817 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -122.38 170.93 9.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.609 1.163 . . . . 0.0 113.022 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -46.36 -43.71 16.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.109 1.764 . . . . 0.0 114.21 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -76.77 -27.86 55.47 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.447 -0.783 . . . . 0.0 112.401 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -78.67 -36.14 44.13 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.944 0.898 . . . . 0.0 111.499 172.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.0 mt -65.47 -36.77 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.968 0.803 . . . . 0.0 109.559 171.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 48.7 m -64.8 -52.39 57.11 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.461 0.704 . . . . 0.0 110.563 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.22 71.03 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.422 1.01 . . . . 0.0 113.019 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.2 m -67.84 -14.67 63.15 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.656 1.182 . . . . 0.0 114.094 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -129.65 -3.01 4.78 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.457 1.026 . . . . 0.0 113.651 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -60.5 -22.62 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.867 1.267 . . . . 0.0 113.143 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -56.81 -14.0 3.04 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.675 1.99 . . . . 0.0 115.001 170.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -103.78 -6.86 21.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.281 1.433 . . . . 0.0 113.97 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.98 172.18 13.44 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.072 1.796 . . . . 0.0 112.114 -171.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.09 151.21 72.9 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.512 2.808 . . . . 0.0 112.133 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.34 172.33 16.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.598 1.559 . . . . 0.0 112.367 -170.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.79 157.9 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.719 1.608 . . . . 0.0 109.411 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 80.4 t -126.74 135.0 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.61 1.164 . . . . 0.0 110.472 -171.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -141.36 162.23 35.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.499 1.92 . . . . 0.0 111.689 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -161.19 156.79 21.28 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.105 1.362 . . . . 0.0 111.785 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.85 132.1 49.99 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.384 2.723 . . . . 0.0 112.328 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 22.9 m170 81.08 4.35 1.51 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 127.578 2.351 . . . . 0.0 114.279 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.55 -27.69 69.34 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.275 -1.516 . . . . 0.0 111.896 171.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -68.38 -8.67 42.35 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.362 1.865 . . . . 0.0 114.747 171.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.75 11.72 3.41 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.681 1.592 . . . . 0.0 113.145 -170.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 43.4 t -152.1 146.0 25.18 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.95 1.3 . . . . 0.0 112.518 -173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -81.75 -9.86 59.52 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.871 1.268 . . . . 0.0 113.223 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 71.2 m -66.25 118.15 9.54 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.948 -1.095 . . . . 0.0 112.886 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -94.77 15.4 18.49 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.251 1.42 . . . . 0.0 113.343 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -112.57 139.98 23.32 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.566 2.346 . . . . 0.0 107.865 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.6 117.51 5.04 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.387 2.725 . . . . 0.0 110.229 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -85.17 16.04 2.07 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.468 2.779 . . . . 0.0 113.533 -172.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -137.34 -3.12 1.95 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.675 1.59 . . . . 0.0 114.279 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.1 84.58 Favored Glycine 0 N--CA 1.476 1.312 0 C-N-CA 124.579 1.085 . . . . 0.0 114.468 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -149.04 161.5 41.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.681 1.192 . . . . 0.0 112.871 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -148.69 164.66 33.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.177 1.391 . . . . 0.0 111.549 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -115.33 115.43 26.61 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.186 1.794 . . . . 0.0 109.155 171.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.4 mt -80.82 142.31 33.83 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.739 1.215 . . . . 0.0 108.911 169.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 48.8 mt -123.37 108.77 13.1 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.603 1.561 . . . . 0.0 107.544 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -85.43 156.4 20.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.245 0.618 . . . . 0.0 111.953 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -75.18 -27.22 59.58 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -142.42 146.6 35.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.238 1.415 . . . . 0.0 111.018 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -63.97 -28.96 70.17 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.047 0.939 . . . . 0.0 111.742 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 22.2 p -61.79 -26.26 67.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 112.948 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.4 m -73.93 -34.34 64.28 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.863 -1.148 . . . . 0.0 111.75 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.77 -40.26 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.773 -0.579 . . . . 0.0 109.871 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -67.66 -40.35 84.51 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.615 -0.678 . . . . 0.0 111.957 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.67 76.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.318 0.963 . . . . 0.0 112.553 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.3 tp -64.92 -48.2 75.0 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.171 0.589 . . . . 0.0 111.012 170.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 85.6 mt -56.38 -42.86 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 118.895 0.771 . . . . 0.0 111.335 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.0 -14.97 63.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.245 1.418 . . . . 0.0 114.154 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.7 -14.51 18.06 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.907 1.283 . . . . 0.0 113.417 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 56.2 m -73.46 145.25 45.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.156 0.979 . . . . 0.0 113.448 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.5 mt -82.36 175.05 10.56 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.591 1.556 . . . . 0.0 107.823 165.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -144.05 139.81 29.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.537 0.735 . . . . 0.0 111.253 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -156.65 123.74 5.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.988 1.315 . . . . 0.0 110.074 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.42 21.46 12.59 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.072 1.749 . . . . 0.0 113.642 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 90.62 -2.61 80.59 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.485 1.516 . . . . 0.0 114.329 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -99.15 149.94 22.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.893 1.347 . . . . 0.0 111.167 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 93.5 mt -95.3 152.66 18.19 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.192 0.997 . . . . 0.0 111.374 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -142.24 152.36 42.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.291 1.037 . . . . 0.0 113.161 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.9 tp -139.52 168.36 20.0 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.797 1.639 . . . . 0.0 109.507 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 25.3 p -105.2 142.22 35.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.207 1.403 . . . . 0.0 112.518 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -144.83 171.59 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.628 1.971 . . . . 0.0 110.462 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 64.0 m -147.8 161.49 41.15 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.169 -0.957 . . . . 0.0 113.402 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 53.8 p -148.36 179.1 1.25 Allowed Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.764 2.025 . . . . 0.0 110.998 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -65.13 -13.83 41.91 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.295 2.663 . . . . 0.0 114.06 170.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 34.0 p -107.59 -31.38 8.13 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.01 1.324 . . . . 0.0 113.12 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 8.7 mm -134.69 126.62 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.515 1.126 . . . . 0.0 110.973 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -96.03 133.08 40.69 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.277 1.031 . . . . 0.0 111.535 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 61.8 34.64 17.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.132 1.373 . . . . 0.0 112.811 172.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -55.92 129.06 71.9 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.331 1.052 . . . . 0.0 110.817 171.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.37 137.62 11.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.273 2.648 . . . . 0.0 109.108 169.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.06 136.0 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.063 1.345 . . . . 0.0 110.433 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -73.77 131.22 41.34 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.143 0.977 . . . . 0.0 109.301 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.9 mm -113.35 129.57 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.97 1.308 . . . . 0.0 108.33 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 44.8 mtm105 -137.66 91.97 13.43 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.952 0.901 . . . . 0.0 110.725 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.57 145.66 98.4 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.774 2.983 . . . . 0.0 111.5 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -83.29 53.67 2.56 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.205 1.003 . . . . 0.0 111.878 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -76.85 136.5 38.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.083 1.353 . . . . 0.0 110.352 172.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 95.0 mt -124.08 17.83 9.22 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.058 1.743 . . . . 0.0 112.144 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.1 m -87.52 165.06 15.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.155 1.382 . . . . 0.0 112.356 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -156.98 113.89 3.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.123 1.369 . . . . 0.0 110.748 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 70.0 m -153.26 -54.3 0.11 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.828 1.251 . . . . 0.0 112.149 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -168.31 140.82 2.96 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.293 1.837 . . . . 0.0 110.198 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -141.42 155.68 45.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.543 1.537 . . . . 0.0 111.817 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 13.3 p -160.42 155.29 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.12 1.768 . . . . 0.0 110.105 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 22.1 ptm -147.23 140.89 25.63 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.482 1.513 . . . . 0.0 111.287 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.97 -28.42 29.76 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -171.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 80.6 p -165.27 147.87 7.95 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.502 1.121 . . . . 0.0 113.258 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -108.54 -142.75 10.12 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.998 1.761 . . . . 0.0 111.785 172.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -70.76 157.64 57.86 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.258 2.638 . . . . 0.0 111.409 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 14.1 m -74.13 -3.77 31.62 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 9.1 t -163.64 163.01 24.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.208 1.803 . . . . 0.0 111.276 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.208 0 C-N-CA 125.385 1.469 . . . . 0.0 112.855 -178.192 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.415 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 37.1 m -60.5 113.8 2.62 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.149 0.98 . . . . 0.0 111.788 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 72.9 p -168.01 167.15 12.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.86 1.264 . . . . 0.0 112.131 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 179.23 174.24 45.16 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.048 1.309 . . . . 0.0 113.234 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 6.1 t 70.48 -160.3 0.15 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.397 1.879 . . . . 0.0 111.792 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.7 m -159.25 141.23 13.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.962 1.705 . . . . 0.0 110.905 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -81.88 -15.71 74.48 Favored Glycine 0 N--CA 1.475 1.299 0 C-N-CA 123.856 0.741 . . . . 0.0 114.461 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 12.3 t -168.68 172.77 7.74 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.301 1.84 . . . . 0.0 111.611 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -90.6 -9.26 47.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.061 1.344 . . . . 0.0 111.856 167.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -83.07 137.64 34.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.473 1.509 . . . . 0.0 110.801 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.1 t -142.98 120.34 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.555 1.142 . . . . 0.0 110.207 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -74.35 142.31 45.12 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.604 0.762 . . . . 0.0 110.851 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.65 125.35 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.487 1.515 . . . . 0.0 109.163 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -123.16 148.17 16.75 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.815 1.198 . . . . 0.0 113.33 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 93.57 19.52 34.73 Favored Glycine 0 N--CA 1.474 1.182 0 C-N-CA 124.797 1.189 . . . . 0.0 114.316 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.22 143.59 78.85 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 125.477 1.511 . . . . 0.0 111.514 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.61 154.07 26.84 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.628 2.885 . . . . 0.0 113.457 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.5 3.01 6.74 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.881 3.054 . . . . 0.0 114.422 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -140.46 25.1 2.24 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.759 1.224 . . . . 0.0 112.764 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 10.7 tt -92.82 162.43 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.169 0.988 . . . . 0.0 110.741 170.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -142.9 169.42 17.6 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.163 1.385 . . . . 0.0 112.437 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.87 -42.54 26.95 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.302 1.841 . . . . 0.0 114.106 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.38 -27.62 41.89 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.402 -0.811 . . . . 0.0 112.357 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -77.31 -35.17 55.15 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.794 0.837 . . . . 0.0 111.572 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 59.6 mt -65.9 -37.45 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.431 -0.793 . . . . 0.0 109.54 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 63.3 m -63.11 -52.18 63.63 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.342 0.657 . . . . 0.0 110.422 172.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -59.88 -31.67 70.01 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.166 0.894 . . . . 0.0 112.995 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 74.5 m -69.55 -14.16 62.71 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -131.64 -2.0 3.81 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.513 1.051 . . . . 0.0 113.743 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.16 -23.17 61.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.859 1.264 . . . . 0.0 112.993 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -57.55 -11.16 1.83 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.487 1.915 . . . . 0.0 115.17 170.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -107.75 -2.02 20.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.586 1.554 . . . . 0.0 113.945 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 119.34 176.53 16.24 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.194 1.854 . . . . 0.0 112.613 -174.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -63.31 148.54 92.81 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.582 2.854 . . . . 0.0 112.865 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.9 170.47 20.57 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.373 1.469 . . . . 0.0 112.639 -176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -131.44 157.9 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.911 1.685 . . . . 0.0 109.017 167.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 93.3 t -125.29 134.68 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.836 1.254 . . . . 0.0 109.93 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -151.38 165.45 34.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.975 1.71 . . . . 0.0 111.578 -170.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . 0.467 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 6.9 p90 -165.09 162.87 14.06 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.377 1.471 . . . . 0.0 112.185 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -57.88 149.38 70.11 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.745 2.963 . . . . 0.0 112.987 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 8.2 m170 73.07 -5.37 1.95 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 126.13 1.772 . . . . 0.0 114.338 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.467 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 41.4 tttm -67.64 -22.29 65.33 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.325 1.45 . . . . 0.0 112.361 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -86.82 -11.38 51.07 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.3 2.24 . . . . 0.0 113.964 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.62 -19.02 12.65 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.553 1.541 . . . . 0.0 112.479 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 22.9 t -149.73 125.1 10.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.801 1.64 . . . . 0.0 109.459 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.85 127.34 32.47 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.373 0.669 . . . . 0.0 111.782 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 22.9 t -162.01 157.89 24.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.916 1.286 . . . . 0.0 111.203 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -134.94 17.19 3.51 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.45 1.9 . . . . 0.0 112.258 176.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.27 138.67 23.1 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.212 1.805 . . . . 0.0 110.25 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.38 129.82 18.69 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.381 2.72 . . . . 0.0 111.419 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.48 131.05 16.91 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.502 2.801 . . . . 0.0 110.165 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 37.3 tttp 58.76 13.23 2.58 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 125.304 1.442 . . . . 0.0 114.428 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.2 35.88 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.053 1.311 . . . . 0.0 114.512 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -136.84 158.95 43.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.571 1.686 . . . . 0.0 114.051 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.31 165.82 35.45 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.388 1.475 . . . . 0.0 111.784 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.37 122.85 47.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.739 1.616 . . . . 0.0 110.01 170.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.0 mt -86.08 140.99 29.74 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.581 1.552 . . . . 0.0 108.917 169.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 52.2 mt -124.86 107.51 10.97 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.755 1.622 . . . . 0.0 107.811 171.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -85.54 159.47 19.89 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.622 0.769 . . . . 0.0 112.282 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -66.76 -36.08 81.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.941 0.896 . . . . 0.0 112.105 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -141.95 145.48 34.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.681 1.592 . . . . 0.0 110.109 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -63.77 -28.36 69.82 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.741 -0.6 . . . . 0.0 111.907 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 29.3 p -59.84 -24.53 64.27 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.912 -1.117 . . . . 0.0 113.181 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 27.5 m -70.7 -28.36 64.69 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.811 -1.181 . . . . 0.0 112.11 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.16 -37.14 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.696 -0.627 . . . . 0.0 109.929 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -64.13 -40.7 96.75 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.587 -0.696 . . . . 0.0 111.529 169.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.53 -37.93 85.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.763 0.711 . . . . 0.0 112.371 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.68 -47.85 76.88 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.432 0.693 . . . . 0.0 111.123 171.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.9 mt -56.02 -41.91 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.181 0.992 . . . . 0.0 111.421 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.24 -17.74 63.8 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.8 1.24 . . . . 0.0 113.485 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.04 -13.99 18.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.122 1.369 . . . . 0.0 113.518 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.4 m -74.3 146.57 43.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.001 0.905 . . . . 0.0 113.356 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.73 172.33 13.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.54 1.536 . . . . 0.0 108.097 165.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.55 132.35 22.64 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.532 0.733 . . . . 0.0 111.73 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -146.04 118.69 8.58 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.894 1.678 . . . . 0.0 109.313 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 64.37 11.46 6.48 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.628 1.971 . . . . 0.0 113.859 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 93.49 -8.52 74.69 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.577 1.56 . . . . 0.0 113.795 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -79.74 143.15 34.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.514 1.126 . . . . 0.0 109.847 170.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 91.4 mt -97.8 152.37 19.23 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.537 0.735 . . . . 0.0 111.915 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -143.34 147.26 34.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.225 1.01 . . . . 0.0 113.134 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.6 tp -130.68 -169.62 2.19 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.399 1.88 . . . . 0.0 108.5 170.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 29.3 p -141.3 149.96 41.93 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.069 0.947 . . . . 0.0 113.095 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -150.81 168.9 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 126.875 2.07 . . . . 0.0 110.478 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 56.4 m -144.24 161.85 37.85 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 54.0 p -147.81 179.05 1.25 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 126.926 2.09 . . . . 0.0 110.994 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -64.67 -13.76 40.84 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.389 2.726 . . . . 0.0 114.265 170.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 35.0 p -107.5 -32.36 7.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.924 1.29 . . . . 0.0 113.108 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 7.1 mm -134.4 126.88 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.451 1.1 . . . . 0.0 110.933 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -96.57 130.58 43.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 111.53 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 60.88 36.7 18.86 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.537 1.535 . . . . 0.0 112.691 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -56.53 125.64 67.42 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.431 1.092 . . . . 0.0 110.278 169.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.93 144.36 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.169 2.579 . . . . 0.0 109.4 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.65 135.39 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.973 1.309 . . . . 0.0 110.517 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -78.0 133.22 38.03 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.22 1.008 . . . . 0.0 109.717 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.5 mm -116.05 131.08 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.354 1.462 . . . . 0.0 108.538 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -137.42 90.31 15.17 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.665 1.186 . . . . 0.0 109.979 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.39 133.1 54.91 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.635 2.89 . . . . 0.0 110.881 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -73.62 135.34 43.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.568 0.699 . . . . 0.0 112.432 -173.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -164.65 148.95 9.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.397 1.879 . . . . 0.0 110.015 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.29 134.58 44.07 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.415 1.486 . . . . 0.0 110.129 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 9.3 t -165.4 173.94 10.57 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.251 1.421 . . . . 0.0 111.326 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.94 -3.45 57.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.714 1.606 . . . . 0.0 113.433 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 81.1 p -158.32 165.49 34.63 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.612 1.565 . . . . 0.0 112.521 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -163.08 149.37 12.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.948 2.099 . . . . 0.0 109.499 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -65.17 147.88 52.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.236 1.014 . . . . 0.0 112.986 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.4 p -164.1 145.17 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.051 1.74 . . . . 0.0 109.996 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -160.08 157.4 28.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.501 1.52 . . . . 0.0 111.836 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -161.79 -38.69 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.133 1.373 . . . . 0.0 112.637 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 14.9 m -74.53 -3.83 33.22 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 89.58 -174.66 41.58 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.166 1.365 . . . . 0.0 113.494 -176.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.41 -10.64 12.13 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.985 3.123 . . . . 0.0 114.154 -173.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 85.0 p -163.5 164.98 24.18 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.123 1.369 . . . . 0.0 111.969 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 19.1 m -163.99 155.06 15.89 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.343 1.857 . . . . 0.0 110.912 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 CA-C-O 118.342 -1.254 . . . . 0.0 112.959 -179.423 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 14.9 m -81.0 -9.56 59.83 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 8.1 t -163.63 169.55 18.43 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.084 1.753 . . . . 0.0 111.008 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -97.46 -163.13 31.67 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.486 1.517 . . . . 0.0 113.449 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 3.4 p -72.98 140.79 47.6 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.012 1.325 . . . . 0.0 112.153 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.3 p -125.15 -2.99 7.58 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -92.52 -158.85 34.72 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.227 1.394 . . . . 0.0 113.262 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 45.3 t -80.97 161.79 24.14 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.628 1.171 . . . . 0.0 112.12 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 56.5 mtm-85 -75.0 -6.73 50.97 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 169.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -75.95 133.8 40.38 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.389 0.676 . . . . 0.0 110.783 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 52.7 t -138.22 117.27 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.424 1.09 . . . . 0.0 109.637 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -72.97 141.12 47.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.884 0.874 . . . . 0.0 110.468 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 81.2 t -133.05 119.37 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.477 1.511 . . . . 0.0 109.344 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -115.53 145.02 18.63 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 124.709 1.147 . . . . 0.0 113.718 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.32 17.75 28.31 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.123 1.344 . . . . 0.0 114.239 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.79 140.69 95.41 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.599 1.16 . . . . 0.0 111.121 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.24 156.37 13.62 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.958 3.106 . . . . 0.0 113.983 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.58 2.85 7.37 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.987 3.125 . . . . 0.0 113.448 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -140.29 41.92 1.92 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.8 1.64 . . . . 0.0 111.497 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -124.65 142.62 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.341 1.457 . . . . 0.0 110.529 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -119.65 172.62 7.54 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.098 1.359 . . . . 0.0 113.075 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -45.68 -46.67 14.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.713 1.605 . . . . 0.0 113.729 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.76 -26.04 49.55 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.542 0.737 . . . . 0.0 112.446 -173.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -79.06 -37.83 37.92 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.997 0.919 . . . . 0.0 111.524 172.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 48.3 mt -65.51 -36.32 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.403 -0.811 . . . . 0.0 109.589 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 71.4 m -64.62 -52.84 55.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.922 0.889 . . . . 0.0 110.414 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.16 70.23 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.579 1.081 . . . . 0.0 112.954 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.7 m -67.2 -15.57 63.78 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -130.7 -2.73 4.2 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -61.05 -22.29 64.45 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.165 1.386 . . . . 0.0 113.127 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -56.58 -13.71 2.6 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.809 2.044 . . . . 0.0 114.941 169.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -103.69 -7.19 20.86 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.47 1.508 . . . . 0.0 113.936 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.45 175.18 14.25 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.209 1.861 . . . . 0.0 112.269 -173.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.7 149.33 91.56 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.613 2.876 . . . . 0.0 112.796 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.15 171.88 17.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.216 1.406 . . . . 0.0 112.588 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -134.37 157.94 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.731 1.612 . . . . 0.0 109.431 167.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.94 137.74 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.643 1.177 . . . . 0.0 110.992 -171.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.57 159.08 43.09 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.603 1.961 . . . . 0.0 111.456 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -160.13 163.99 20.9 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.847 1.259 . . . . 0.0 112.304 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -59.1 136.51 73.46 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.459 2.772 . . . . 0.0 112.765 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 67.44 12.66 9.02 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.547 1.539 . . . . 0.0 114.46 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -62.66 -24.1 67.44 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.326 -1.484 . . . . 0.0 112.741 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -85.96 -8.37 58.04 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.929 2.092 . . . . 0.0 114.538 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -138.39 -21.19 1.05 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.5 t -85.31 140.87 30.47 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.748 -1.22 . . . . 0.0 112.008 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -81.01 56.94 2.93 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.995 1.318 . . . . 0.0 112.453 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 92.7 p -159.9 175.72 12.72 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.424 1.49 . . . . 0.0 112.569 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -135.13 27.97 3.48 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.413 1.485 . . . . 0.0 112.773 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -126.66 150.83 72.15 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 127.23 2.212 . . . . 0.0 109.471 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.66 117.86 5.18 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.05 2.5 . . . . 0.0 110.406 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -86.18 10.77 3.53 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.256 2.637 . . . . 0.0 113.863 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -124.09 -5.33 7.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.85 1.66 . . . . 0.0 113.867 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.73 13.1 83.82 Favored Glycine 0 N--CA 1.474 1.233 0 C-N-CA 124.581 1.086 . . . . 0.0 113.951 -172.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -151.5 158.76 44.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.842 1.257 . . . . 0.0 112.654 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.14 167.48 26.72 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.671 1.188 . . . . 0.0 111.617 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.85 118.27 33.75 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.593 1.957 . . . . 0.0 109.599 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.5 mt -82.83 141.26 32.42 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.983 1.313 . . . . 0.0 108.688 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.5 mt -122.67 105.87 10.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.711 1.604 . . . . 0.0 107.768 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -81.14 156.61 25.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.218 0.607 . . . . 0.0 112.106 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -80.74 -24.62 38.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.152 0.981 . . . . 0.0 113.174 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.19 140.9 32.5 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.493 1.517 . . . . 0.0 110.357 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.77 -35.04 70.22 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.819 0.847 . . . . 0.0 111.96 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.9 m -56.95 -25.53 58.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.792 1.237 . . . . 0.0 113.212 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.3 m -69.23 -28.13 66.07 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.867 -1.146 . . . . 0.0 112.175 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.09 -37.42 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.602 -0.686 . . . . 0.0 109.775 175.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -70.26 -37.51 74.91 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.536 -0.728 . . . . 0.0 111.765 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.24 86.48 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.553 0.615 . . . . 0.0 112.079 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.6 tp -64.44 -49.81 70.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.463 0.705 . . . . 0.0 110.995 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.62 -41.66 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.094 0.958 . . . . 0.0 111.478 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.56 -18.24 63.63 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.799 1.24 . . . . 0.0 113.507 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.88 -13.64 19.96 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.21 1.404 . . . . 0.0 113.377 174.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.6 m -72.84 143.17 47.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.05 0.929 . . . . 0.0 113.37 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.27 175.9 9.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.779 1.632 . . . . 0.0 107.955 165.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -145.92 133.91 21.41 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.176 0.591 . . . . 0.0 111.712 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -142.01 112.18 6.96 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.995 1.718 . . . . 0.0 109.774 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 64.77 10.73 6.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.047 2.139 . . . . 0.0 113.833 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 99.79 -6.56 58.77 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.802 1.668 . . . . 0.0 113.834 -171.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -84.91 136.58 33.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.83 1.252 . . . . 0.0 109.671 173.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.9 mt -87.02 151.53 23.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.859 0.754 . . . . 0.0 111.904 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -142.23 154.09 44.51 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.88 1.272 . . . . 0.0 113.097 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -141.8 158.29 43.98 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.627 1.571 . . . . 0.0 109.719 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 72.2 m -99.45 137.23 38.24 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.951 0.9 . . . . 0.0 112.105 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.9 m -144.78 177.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 126.762 2.025 . . . . 0.0 110.662 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 89.4 p -159.49 171.4 19.77 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.946 -1.096 . . . . 0.0 113.496 -175.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 91.6 p -155.16 179.91 1.23 Allowed Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 126.311 1.844 . . . . 0.0 110.586 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.51 -26.06 70.1 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.847 2.365 . . . . 0.0 113.933 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 40.3 p -116.35 -32.93 5.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.7 1.2 . . . . 0.0 113.793 -174.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 21.3 mm -112.18 127.78 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.932 1.293 . . . . 0.0 109.904 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -119.7 142.16 48.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.283 1.433 . . . . 0.0 112.075 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.46 32.92 19.89 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.042 1.337 . . . . 0.0 112.94 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -70.38 128.56 91.17 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.529 1.132 . . . . 0.0 111.428 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.48 131.31 5.53 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.279 2.653 . . . . 0.0 108.845 169.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.71 135.19 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.269 1.428 . . . . 0.0 110.294 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -79.15 131.25 36.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.095 0.958 . . . . 0.0 109.83 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.38 131.81 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.042 1.337 . . . . 0.0 109.319 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -137.78 90.25 14.53 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.953 1.301 . . . . 0.0 110.287 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -61.06 132.2 40.69 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.157 2.571 . . . . 0.0 110.695 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -82.06 148.57 28.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.448 0.699 . . . . 0.0 112.745 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -157.06 157.4 34.53 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.989 1.316 . . . . 0.0 111.749 175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 78.6 mt -71.69 172.32 9.95 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.666 1.186 . . . . 0.0 111.666 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 14.7 m -67.37 1.59 2.15 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -175.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -73.85 -19.2 60.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.473 1.509 . . . . 0.0 113.639 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 11.1 t -163.11 138.93 6.9 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.746 1.218 . . . . 0.0 112.024 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -165.27 168.4 17.0 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.402 2.281 . . . . 0.0 110.182 -173.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.26 145.52 51.02 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.948 1.699 . . . . 0.0 111.526 -175.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 7.7 p -161.02 137.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.789 1.635 . . . . 0.0 109.947 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -111.34 -0.23 16.43 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.061 1.344 . . . . 0.0 113.358 -174.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.25 -9.88 59.05 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.585 1.554 . . . . 0.0 113.624 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 32.8 p -74.08 -10.09 59.28 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.385 1.474 . . . . 0.0 114.193 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 78.84 -158.33 44.6 Favored Glycine 0 CA--C 1.543 1.805 0 C-N-CA 124.46 1.029 . . . . 0.0 113.912 174.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.86 161.23 39.46 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.916 3.077 . . . . 0.0 111.97 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 48.1 p -80.22 1.25 29.14 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.914 1.286 . . . . 0.0 114.46 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 19.1 m -163.55 152.1 13.8 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.08 2.152 . . . . 0.0 110.883 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.344 -1.253 . . . . 0.0 112.841 179.742 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 7.9 t -163.35 -179.6 6.67 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.423 1.489 . . . . 0.0 111.295 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 49.5 m -67.75 146.33 53.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.25 1.42 . . . . 0.0 113.156 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -80.57 56.29 4.72 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.864 1.697 . . . . 0.0 111.564 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 22.7 m -73.04 -6.16 43.68 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.225 1.41 . . . . 0.0 114.594 -171.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 80.2 p -158.54 157.75 32.66 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.841 1.257 . . . . 0.0 113.027 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 154.14 -68.5 0.3 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.505 2.002 . . . . 0.0 110.55 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 18.4 t -153.04 162.6 41.13 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.702 1.601 . . . . 0.0 112.23 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -100.01 -3.72 31.52 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.355 1.462 . . . . 0.0 112.683 171.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -86.47 139.8 30.55 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.009 0.924 . . . . 0.0 111.533 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.1 t -140.74 120.76 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.537 1.135 . . . . 0.0 110.378 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -71.65 140.2 49.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.195 0.998 . . . . 0.0 110.945 171.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.19 115.62 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.368 1.467 . . . . 0.0 109.217 173.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -114.91 144.27 18.37 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 124.942 1.258 . . . . 0.0 113.509 -177.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.85 17.64 29.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.956 1.265 . . . . 0.0 114.163 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.21 141.48 93.97 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.713 1.205 . . . . 0.0 111.017 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.75 154.3 12.82 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.915 3.077 . . . . 0.0 113.746 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.43 3.78 6.5 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.93 3.087 . . . . 0.0 113.508 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -140.41 23.37 2.34 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.178 1.391 . . . . 0.0 112.227 -173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.4 tt -100.25 127.68 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.285 1.034 . . . . 0.0 111.029 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -92.99 165.71 12.73 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.497 1.119 . . . . 0.0 113.214 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -45.78 -45.51 14.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.918 1.687 . . . . 0.0 113.7 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.19 -29.24 54.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.777 0.831 . . . . 0.0 112.514 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -72.47 -38.71 68.15 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.416 0.686 . . . . 0.0 112.018 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.16 -39.6 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 119.193 0.906 . . . . 0.0 109.585 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 53.4 m -63.24 -51.62 65.46 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.438 0.695 . . . . 0.0 110.613 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.42 -29.08 70.25 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.38 0.991 . . . . 0.0 113.156 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.2 m -66.56 -22.83 66.15 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -123.46 -3.88 8.33 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.3 tpt85 -60.55 -22.36 63.57 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.275 1.43 . . . . 0.0 113.396 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -55.76 -18.71 8.96 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.384 1.874 . . . . 0.0 114.724 171.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.71 -3.4 35.96 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.508 1.523 . . . . 0.0 113.561 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.16 170.41 14.0 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.905 1.717 . . . . 0.0 111.982 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.9 151.0 78.62 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.667 2.912 . . . . 0.0 111.979 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.58 171.82 18.26 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.528 1.531 . . . . 0.0 112.498 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -132.66 157.34 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.494 1.518 . . . . 0.0 109.287 167.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.34 135.68 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.662 1.185 . . . . 0.0 110.351 -172.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -143.22 161.54 37.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.264 1.826 . . . . 0.0 111.699 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -156.85 158.46 31.28 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.92 1.288 . . . . 0.0 111.929 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -59.08 137.44 79.43 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.184 2.589 . . . . 0.0 113.219 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 66.75 16.41 10.37 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 126.098 1.759 . . . . 0.0 114.433 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.34 -20.16 66.28 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.632 -1.293 . . . . 0.0 112.678 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -64.98 -33.69 76.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.745 1.618 . . . . 0.0 112.824 169.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -95.46 -51.7 4.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.961 1.304 . . . . 0.0 111.212 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.6 m -80.9 114.18 19.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.495 1.118 . . . . 0.0 111.336 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 1.55 16.8 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.2 p -68.14 131.98 46.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.097 1.359 . . . . 0.0 112.358 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -89.24 24.01 2.31 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.142 1.377 . . . . 0.0 113.422 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -126.74 141.09 39.32 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 128.43 2.692 . . . . 0.0 108.11 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.43 118.08 5.4 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.962 2.442 . . . . 0.0 110.064 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.12 18.62 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.511 2.807 . . . . 0.0 113.097 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -132.78 -4.7 3.21 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.601 1.56 . . . . 0.0 114.27 -171.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.61 13.9 82.68 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 124.5 1.047 . . . . 0.0 114.316 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -153.82 158.81 41.41 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.777 1.231 . . . . 0.0 112.591 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -151.03 167.45 27.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.735 1.214 . . . . 0.0 111.641 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.45 118.22 33.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.312 1.845 . . . . 0.0 109.365 173.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 34.8 mt -81.34 138.98 35.62 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.032 1.333 . . . . 0.0 108.778 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 55.2 mt -122.71 104.42 9.3 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.913 1.685 . . . . 0.0 107.863 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -81.6 157.52 24.69 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.59 0.756 . . . . 0.0 111.764 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -73.15 -27.4 61.64 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.647 -0.658 . . . . 0.0 112.485 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.85 145.29 39.83 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.851 1.261 . . . . 0.0 110.731 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -62.73 -32.11 73.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.255 0.622 . . . . 0.0 111.535 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.3 m -56.73 -27.13 58.69 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.65 1.18 . . . . 0.0 113.289 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.7 m -68.96 -25.89 64.77 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.863 -1.148 . . . . 0.0 112.29 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.68 -38.3 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.707 -0.621 . . . . 0.0 109.985 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -66.34 -39.36 89.15 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.645 -0.659 . . . . 0.0 111.463 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.75 83.51 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.62 0.646 . . . . 0.0 112.498 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 26.8 tp -65.4 -48.42 72.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.517 0.727 . . . . 0.0 111.213 171.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 71.8 mt -55.27 -40.13 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.968 0.907 . . . . 0.0 111.528 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.37 -17.77 63.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.874 1.27 . . . . 0.0 113.683 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.09 -13.56 18.95 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.956 1.302 . . . . 0.0 113.248 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.1 m -74.59 146.43 42.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.14 0.971 . . . . 0.0 113.499 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.74 173.93 12.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.686 1.594 . . . . 0.0 107.777 164.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -141.44 130.81 23.68 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.477 0.711 . . . . 0.0 111.062 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -146.15 122.35 10.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.724 1.609 . . . . 0.0 109.652 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 62.78 9.63 3.74 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.663 1.985 . . . . 0.0 114.61 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 105.17 -11.75 48.26 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 126.336 1.922 . . . . 0.0 114.051 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -91.64 155.6 18.22 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.916 1.286 . . . . 0.0 112.311 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.12 151.04 20.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.705 1.202 . . . . 0.0 111.633 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.16 142.78 32.75 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.089 0.956 . . . . 0.0 113.054 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -127.02 -179.36 4.8 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.605 1.562 . . . . 0.0 108.91 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 71.7 m -128.38 142.3 51.16 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.274 1.03 . . . . 0.0 112.176 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 29.8 m -148.91 173.13 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 126.08 1.752 . . . . 0.0 111.761 -174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 79.9 p -160.42 171.41 19.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.103 1.361 . . . . 0.0 112.906 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.5 p -153.06 -176.18 0.57 Allowed Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.563 1.945 . . . . 0.0 110.565 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -63.91 -14.27 42.21 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.069 2.513 . . . . 0.0 114.38 170.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 60.7 p -122.3 -18.12 6.89 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.116 1.367 . . . . 0.0 114.114 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.4 mm -132.79 135.09 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.693 1.597 . . . . 0.0 110.363 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -128.38 136.18 50.56 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.849 1.26 . . . . 0.0 111.668 -171.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 58.76 28.68 17.66 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.305 1.442 . . . . 0.0 113.61 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -73.92 129.52 84.74 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.761 -1.212 . . . . 0.0 111.313 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.93 143.37 16.29 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.296 2.664 . . . . 0.0 109.758 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 2.4 m -129.43 135.72 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.309 1.444 . . . . 0.0 110.711 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -79.1 119.13 21.78 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.666 1.586 . . . . 0.0 109.565 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 31.3 mm -105.62 124.93 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.822 1.249 . . . . 0.0 108.477 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -133.11 92.22 25.94 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.243 1.017 . . . . 0.0 110.366 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.56 140.69 95.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.59 2.86 . . . . 0.0 111.569 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -80.9 20.77 0.74 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.872 0.869 . . . . 0.0 112.781 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -68.17 -18.33 64.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.839 1.255 . . . . 0.0 112.836 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.06 123.11 32.41 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.569 1.548 . . . . 0.0 109.353 170.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 34.5 m -128.52 4.31 5.61 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -141.01 8.64 2.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.184 1.394 . . . . 0.0 114.166 -169.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 10.3 t -164.91 174.39 10.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.536 1.535 . . . . 0.0 111.408 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -126.35 -2.92 6.85 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.258 1.823 . . . . 0.0 112.408 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -85.98 123.43 31.3 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.566 1.146 . . . . 0.0 110.322 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.98 36.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.384 1.473 . . . . 0.0 110.979 -171.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 99.1 mtp -141.05 140.3 34.22 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.628 1.571 . . . . 0.0 110.89 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -166.36 152.5 8.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.807 1.643 . . . . 0.0 111.839 -175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 67.5 m -141.57 4.01 1.72 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.148 1.779 . . . . 0.0 113.441 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -78.34 152.36 37.76 Favored Glycine 0 CA--C 1.542 1.719 0 O-C-N 120.916 -1.115 . . . . 0.0 113.575 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.6 160.25 31.65 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.955 3.103 . . . . 0.0 111.668 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.8 m -75.42 -5.8 46.79 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 16.4 m -167.58 155.3 8.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.617 2.367 . . . . 0.0 110.78 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.891 179.268 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 35.8 p -165.58 158.89 16.07 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.112 1.365 . . . . 0.0 111.81 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 28.3 m -69.61 142.41 53.51 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.094 0.958 . . . . 0.0 113.086 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 173.66 -169.09 42.14 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.068 1.318 . . . . 0.0 113.202 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 72.7 m -134.79 125.8 27.64 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.637 1.175 . . . . 0.0 110.861 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 71.7 m -94.04 139.47 30.92 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.3 1.04 . . . . 0.0 112.948 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 84.02 165.55 39.09 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.851 1.215 . . . . 0.0 113.71 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 23.8 t -72.8 168.12 19.49 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.833 0.853 . . . . 0.0 111.84 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 76.3 mtm-85 -67.72 -14.96 63.39 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -77.4 134.32 38.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.529 1.132 . . . . 0.0 110.485 169.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.26 118.24 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.159 0.984 . . . . 0.0 110.039 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.47 139.23 45.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.618 0.767 . . . . 0.0 110.273 171.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 67.2 t -130.99 118.47 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.349 1.459 . . . . 0.0 109.156 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -115.29 151.27 18.51 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.789 1.185 . . . . 0.0 113.814 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 89.97 20.88 41.2 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.594 1.092 . . . . 0.0 113.802 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.61 144.61 72.31 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.885 1.274 . . . . 0.0 111.64 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.72 145.39 71.64 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.035 2.49 . . . . 0.0 112.02 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.07 0.52 7.12 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.921 3.081 . . . . 0.0 113.51 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -128.49 19.4 6.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.199 2.199 . . . . 0.0 112.291 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.5 tt -100.47 156.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.092 1.357 . . . . 0.0 111.96 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -135.25 170.57 15.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.186 1.395 . . . . 0.0 112.624 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -50.55 -42.27 55.09 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.386 1.475 . . . . 0.0 113.71 -172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.84 -27.65 44.27 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.561 0.744 . . . . 0.0 112.171 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -74.68 -39.15 62.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.811 0.845 . . . . 0.0 111.409 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.1 mt -64.43 -39.04 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.893 0.77 . . . . 0.0 109.564 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 59.1 m -63.1 -52.08 64.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.478 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.09 71.38 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.569 1.077 . . . . 0.0 112.944 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.4 m -68.51 -14.81 63.26 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -129.31 -3.16 4.97 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.312 0.96 . . . . 0.0 113.546 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -60.76 -22.45 64.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.98 1.312 . . . . 0.0 113.133 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -56.98 -12.01 1.79 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.794 2.037 . . . . 0.0 115.009 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -106.28 -4.15 20.43 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.527 1.531 . . . . 0.0 113.986 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.82 171.49 14.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.792 1.663 . . . . 0.0 112.204 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.37 150.2 58.04 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.659 2.906 . . . . 0.0 112.242 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.6 172.41 17.2 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.587 1.555 . . . . 0.0 112.632 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.85 159.43 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.747 1.619 . . . . 0.0 109.368 167.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.17 137.57 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.61 1.164 . . . . 0.0 110.729 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -147.52 163.53 36.27 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.407 1.883 . . . . 0.0 111.552 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . 0.413 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 14.1 p90 -160.59 162.97 22.34 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.027 1.331 . . . . 0.0 112.373 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -58.15 146.65 87.35 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.566 2.844 . . . . 0.0 113.428 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 68.6 4.31 4.28 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.903 1.681 . . . . 0.0 114.623 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.413 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 59.9 tttm -66.21 -21.48 66.31 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.166 1.387 . . . . 0.0 113.005 -173.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -76.78 -14.36 59.93 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.261 2.224 . . . . 0.0 114.384 175.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -124.87 -54.15 1.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.157 1.383 . . . . 0.0 110.577 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.2 m -77.81 54.23 1.23 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.64 1.976 . . . . 0.0 110.667 169.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -58.12 113.94 2.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.629 1.972 . . . . 0.0 111.836 -172.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 29.9 t -167.89 158.33 10.61 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.109 1.364 . . . . 0.0 110.996 -171.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.69 -4.56 58.71 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.003 1.321 . . . . 0.0 113.83 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -119.64 139.82 28.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.644 1.577 . . . . 0.0 110.158 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.57 121.36 7.63 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.385 2.724 . . . . 0.0 110.988 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -88.2 19.31 1.35 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.001 3.134 . . . . 0.0 113.006 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.03 -9.42 2.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.138 1.375 . . . . 0.0 114.633 -169.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 75.53 12.1 83.93 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 124.206 0.907 . . . . 0.0 113.988 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -152.95 160.85 43.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.314 1.445 . . . . 0.0 112.293 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.89 164.89 35.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.787 1.235 . . . . 0.0 111.808 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -110.84 117.79 34.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.158 1.783 . . . . 0.0 109.672 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.7 mt -82.59 140.94 32.95 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.99 1.316 . . . . 0.0 108.535 168.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 53.8 mt -125.1 104.85 8.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.622 1.569 . . . . 0.0 107.879 172.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -83.19 157.61 22.66 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.557 0.743 . . . . 0.0 111.505 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -83.26 -13.99 54.09 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.28 141.59 33.94 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.439 1.496 . . . . 0.0 110.617 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.68 -33.58 74.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.233 0.613 . . . . 0.0 111.359 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 12.4 m -59.51 -24.03 63.3 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.313 1.045 . . . . 0.0 113.057 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 22.9 m -70.67 -30.22 66.76 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.902 -1.124 . . . . 0.0 111.896 172.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.36 -34.91 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.502 -0.749 . . . . 0.0 109.902 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -69.64 -37.2 76.69 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.572 -0.705 . . . . 0.0 111.974 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.38 -37.39 85.53 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.961 0.8 . . . . 0.0 112.207 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.2 tp -63.66 -49.2 74.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.487 0.715 . . . . 0.0 110.894 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.23 -41.83 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.122 0.969 . . . . 0.0 111.557 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.51 -18.34 64.36 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.784 1.234 . . . . 0.0 113.63 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.99 -14.25 18.74 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.086 1.354 . . . . 0.0 113.487 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 53.3 m -72.55 144.56 47.89 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.019 0.914 . . . . 0.0 113.235 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.12 172.42 13.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.386 1.475 . . . . 0.0 107.782 165.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.19 127.14 18.31 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.384 0.674 . . . . 0.0 110.939 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -148.91 129.03 13.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.97 1.708 . . . . 0.0 109.646 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 55.82 31.53 17.81 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.556 1.543 . . . . 0.0 113.767 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 85.25 5.1 85.79 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.517 1.532 . . . . 0.0 114.347 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -123.74 147.7 47.26 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.745 1.618 . . . . 0.0 110.917 -170.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.64 150.83 23.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.324 0.65 . . . . 0.0 111.766 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -141.84 148.81 39.42 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.565 1.146 . . . . 0.0 112.732 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.6 tp -131.9 171.06 14.03 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.03 1.732 . . . . 0.0 109.07 171.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 87.3 m -117.42 142.96 46.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.171 0.988 . . . . 0.0 112.351 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.21 172.94 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.848 2.059 . . . . 0.0 110.919 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 47.1 m -150.2 167.0 28.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.077 1.351 . . . . 0.0 112.344 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.9 m -161.54 167.44 13.05 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 127.755 2.422 . . . . 0.0 110.653 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.3 -22.03 14.78 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 124.407 3.405 . . . . 0.0 117.917 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 62.8 p -123.15 2.1 9.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.855 1.262 . . . . 0.0 113.908 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 30.3 mm -138.66 117.61 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.884 1.674 . . . . 0.0 110.536 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -118.35 137.73 52.9 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.375 1.07 . . . . 0.0 113.043 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 60.8 30.98 20.02 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.359 1.464 . . . . 0.0 112.423 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -63.89 126.25 89.56 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.739 1.216 . . . . 0.0 111.025 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.91 138.14 11.43 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.253 2.636 . . . . 0.0 109.067 171.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.7 m -130.98 132.26 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.061 1.344 . . . . 0.0 109.896 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -81.08 130.4 35.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.32 1.048 . . . . 0.0 109.876 -173.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 31.9 mm -111.01 132.03 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.905 1.282 . . . . 0.0 109.333 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -137.89 91.94 13.07 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.976 1.31 . . . . 0.0 110.192 -175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.66 132.62 49.14 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.406 2.737 . . . . 0.0 110.678 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -76.52 146.01 38.73 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -171.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -156.02 125.71 6.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.87 1.668 . . . . 0.0 109.659 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 31.3 tp -100.74 -11.74 19.68 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.365 1.466 . . . . 0.0 112.935 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 30.8 m -101.48 -11.51 19.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.906 1.282 . . . . 0.0 113.632 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -160.09 155.22 24.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.48 1.912 . . . . 0.0 111.03 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 79.9 p -156.83 10.44 0.22 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.057 1.743 . . . . 0.0 113.564 -172.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.39 105.94 3.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.204 1.401 . . . . 0.0 111.886 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.87 165.28 23.59 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.419 1.888 . . . . 0.0 113.184 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.9 p -154.61 142.57 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.724 1.61 . . . . 0.0 110.791 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 11.5 tpt -159.29 144.41 15.76 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.41 1.884 . . . . 0.0 110.297 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -77.15 140.05 40.1 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.221 1.408 . . . . 0.0 112.525 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.0 t -164.74 148.74 9.07 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.392 1.477 . . . . 0.0 111.115 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 81.15 -177.73 54.21 Favored Glycine 0 CA--C 1.542 1.736 0 C-N-CA 124.687 1.137 . . . . 0.0 114.317 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.61 162.08 33.33 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.233 3.289 . . . . 0.0 111.956 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 23.9 t -161.65 154.79 20.89 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.186 1.394 . . . . 0.0 111.403 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 56.2 p -89.71 -6.31 56.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.07 1.348 . . . . 0.0 113.914 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.084 1.326 . . . . 0.0 113.244 179.535 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 8.6 t -162.53 177.29 9.59 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.497 1.519 . . . . 0.0 110.996 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 10.0 t -153.71 156.84 38.57 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.808 1.243 . . . . 0.0 112.433 -170.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 169.53 -149.34 13.19 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.174 1.845 . . . . 0.0 111.672 -169.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 8.7 t -160.49 174.73 13.65 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.251 1.024 . . . . 0.0 113.452 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 78.4 p -151.65 11.39 0.59 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.732 2.013 . . . . 0.0 112.912 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -75.35 159.27 51.37 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.661 1.124 . . . . 0.0 114.129 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 17.0 t -76.93 178.53 6.84 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.274 1.43 . . . . 0.0 113.076 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -67.37 -15.51 63.72 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.821 1.249 . . . . 0.0 113.191 170.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.99 135.73 37.85 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.839 1.256 . . . . 0.0 110.654 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.52 121.63 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.274 1.03 . . . . 0.0 110.426 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.44 140.25 55.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.337 1.055 . . . . 0.0 111.385 172.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 56.9 t -133.53 123.18 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 109.422 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -122.11 149.37 17.08 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.452 1.501 . . . . 0.0 113.191 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.31 14.05 52.23 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.958 1.266 . . . . 0.0 114.366 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.96 141.59 85.93 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.031 1.332 . . . . 0.0 111.012 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.42 153.56 17.37 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.874 3.049 . . . . 0.0 113.638 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.73 6.1 4.77 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.002 3.135 . . . . 0.0 113.353 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -140.27 28.56 2.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.476 1.51 . . . . 0.0 111.9 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.8 tt -107.75 150.19 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.293 1.437 . . . . 0.0 110.075 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -124.77 170.29 11.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.81 1.244 . . . . 0.0 112.706 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -44.78 -46.23 10.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.409 1.884 . . . . 0.0 113.913 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -78.94 -26.31 43.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.65 0.78 . . . . 0.0 112.295 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -77.11 -36.53 55.49 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.684 0.794 . . . . 0.0 111.462 171.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.17 -38.73 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.322 0.965 . . . . 0.0 109.566 171.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 57.8 m -62.64 -52.03 64.92 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.367 0.667 . . . . 0.0 110.471 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.49 -30.95 70.94 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.401 1.001 . . . . 0.0 112.978 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.2 m -67.97 -14.67 63.15 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -129.82 -2.82 4.69 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.457 1.026 . . . . 0.0 113.604 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -60.31 -22.5 63.25 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.943 1.297 . . . . 0.0 113.104 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -56.83 -12.53 1.98 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.791 2.036 . . . . 0.0 115.103 170.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -105.65 -4.93 20.49 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.396 1.478 . . . . 0.0 113.974 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.48 172.96 14.14 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.801 1.667 . . . . 0.0 112.288 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.87 149.94 54.56 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.736 2.957 . . . . 0.0 112.29 -174.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.27 172.7 16.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.485 1.514 . . . . 0.0 112.668 -170.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.03 161.09 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.868 1.667 . . . . 0.0 108.728 167.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.49 135.25 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.273 1.029 . . . . 0.0 110.246 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -145.09 164.16 32.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.405 1.882 . . . . 0.0 111.538 -169.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -162.69 160.97 19.83 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.168 1.387 . . . . 0.0 112.015 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -57.5 148.88 69.92 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.49 2.793 . . . . 0.0 112.672 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 8.0 m170 72.98 -4.85 2.06 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 126.072 1.749 . . . . 0.0 114.098 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.34 -22.48 65.59 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.899 1.28 . . . . 0.0 112.471 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -82.89 -8.81 59.54 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.174 2.19 . . . . 0.0 114.19 173.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -120.71 -23.02 6.11 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.411 1.484 . . . . 0.0 112.838 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.7 m -143.25 126.86 16.95 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.13 1.772 . . . . 0.0 109.816 172.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.72 132.78 52.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.598 0.759 . . . . 0.0 111.662 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 35.6 p -160.35 153.91 22.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.718 1.207 . . . . 0.0 111.605 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -138.83 20.15 2.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.092 1.357 . . . . 0.0 112.787 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -126.61 146.47 57.0 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 127.233 2.213 . . . . 0.0 109.682 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.71 124.46 9.77 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.199 2.6 . . . . 0.0 110.632 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.62 130.52 19.67 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.089 2.526 . . . . 0.0 110.067 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 58.68 12.84 2.35 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.49 1.516 . . . . 0.0 114.548 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 85.64 28.81 28.47 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.903 1.24 . . . . 0.0 114.315 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -140.33 157.95 44.78 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.469 1.635 . . . . 0.0 113.914 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.8 170.64 21.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.522 1.529 . . . . 0.0 111.625 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.53 120.49 36.9 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.952 1.701 . . . . 0.0 109.944 173.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.1 mt -80.99 140.83 34.97 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.848 1.259 . . . . 0.0 108.739 169.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 58.3 mt -124.34 101.98 7.45 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.696 1.598 . . . . 0.0 107.702 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -80.21 154.33 28.0 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.307 0.643 . . . . 0.0 110.978 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -76.89 -19.39 57.5 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.461 -0.774 . . . . 0.0 112.91 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.94 142.4 34.38 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.945 1.298 . . . . 0.0 110.799 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.71 -31.38 71.53 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.526 0.731 . . . . 0.0 111.649 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.4 m -56.39 -28.34 58.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.625 1.17 . . . . 0.0 112.899 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -28.4 62.45 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.964 -1.085 . . . . 0.0 112.118 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.3 t -76.32 -37.76 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.668 -0.645 . . . . 0.0 109.839 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -66.3 -38.14 87.03 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.578 -0.701 . . . . 0.0 111.85 172.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.5 91.21 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.557 0.617 . . . . 0.0 112.367 173.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.6 tp -63.53 -48.37 77.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.429 0.692 . . . . 0.0 110.926 171.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 69.9 mt -56.23 -43.25 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.249 1.02 . . . . 0.0 111.33 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.33 -18.88 64.6 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.682 1.193 . . . . 0.0 113.542 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.11 -13.65 19.72 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.185 1.394 . . . . 0.0 113.605 175.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.06 150.05 37.37 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.164 0.983 . . . . 0.0 113.617 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.3 mt -86.25 177.79 7.38 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.035 1.734 . . . . 0.0 107.843 165.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -145.66 133.64 21.39 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.437 0.695 . . . . 0.0 111.623 -175.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -164.51 139.97 5.8 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.66 1.584 . . . . 0.0 110.219 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 27.1 t70 60.28 28.62 18.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.813 1.245 . . . . 0.0 113.517 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 82.74 3.5 90.47 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.117 1.341 . . . . 0.0 114.175 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -123.52 162.44 22.9 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.719 2.008 . . . . 0.0 111.343 -170.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.8 mt -98.38 157.02 16.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.025 0.93 . . . . 0.0 111.103 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -141.04 145.47 35.92 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.977 0.911 . . . . 0.0 113.116 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.06 -173.95 3.19 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.142 1.777 . . . . 0.0 108.949 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.3 p -134.61 147.29 50.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.311 1.044 . . . . 0.0 113.276 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.2 m -152.05 -178.87 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 127.181 2.193 . . . . 0.0 110.753 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 80.5 p -161.7 170.56 19.45 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.503 1.121 . . . . 0.0 113.135 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 16.2 p -142.5 -177.01 0.61 Allowed Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 126.528 1.931 . . . . 0.0 110.682 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.17 -21.97 68.22 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.881 2.387 . . . . 0.0 114.145 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 46.3 p -123.09 -23.05 5.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.6 mm -115.24 127.63 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.075 1.35 . . . . 0.0 109.79 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -122.65 139.0 54.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.601 1.16 . . . . 0.0 111.974 -168.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.89 33.49 23.26 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.171 1.388 . . . . 0.0 112.963 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -69.45 126.56 92.72 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.201 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -80.48 142.9 14.96 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.286 2.657 . . . . 0.0 109.307 169.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.15 134.61 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.732 1.213 . . . . 0.0 110.585 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -79.14 126.41 30.71 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.902 1.681 . . . . 0.0 109.639 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 29.5 mm -114.87 132.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.545 1.538 . . . . 0.0 108.342 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -140.96 100.05 6.57 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.788 0.835 . . . . 0.0 110.678 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -55.88 134.95 67.16 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.472 2.781 . . . . 0.0 110.977 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -74.37 124.37 26.37 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -169.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -76.87 114.03 15.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.605 0.762 . . . . 0.0 110.637 170.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 25.7 tp -85.0 59.75 5.82 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.753 1.221 . . . . 0.0 110.93 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 8.5 t -165.59 176.79 7.82 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.048 1.739 . . . . 0.0 110.889 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -80.77 51.7 1.57 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.146 1.778 . . . . 0.0 112.745 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 11.6 t -162.11 162.56 28.62 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.673 1.589 . . . . 0.0 111.764 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -154.2 39.12 0.46 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.182 1.793 . . . . 0.0 111.121 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -72.23 176.27 5.36 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.67 1.588 . . . . 0.0 113.936 -172.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.8 p -163.11 156.6 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.046 2.138 . . . . 0.0 109.626 -170.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 24.8 tpp 76.24 21.34 1.46 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.057 1.743 . . . . 0.0 113.082 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -154.12 143.11 21.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.991 1.716 . . . . 0.0 110.964 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 88.7 p -165.02 167.94 17.91 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.138 1.375 . . . . 0.0 112.494 -172.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -164.81 -177.67 37.56 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.253 1.406 . . . . 0.0 112.981 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.84 157.7 60.8 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.971 3.114 . . . . 0.0 112.392 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 13.4 m -72.49 -6.45 43.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 80.3 p -166.13 165.35 17.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.504 1.922 . . . . 0.0 111.702 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.176 0 CA-C-O 118.434 -1.203 . . . . 0.0 113.014 179.43 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.479 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 57.6 m -147.73 154.72 40.91 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.091 1.357 . . . . 0.0 111.411 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 19.3 m -161.97 150.24 14.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.884 1.674 . . . . 0.0 111.129 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -93.14 172.49 33.57 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.926 1.25 . . . . 0.0 113.515 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 67.8 m 68.79 14.04 8.92 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.929 1.691 . . . . 0.0 115.27 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 23.2 m -76.8 -13.99 59.96 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.79 174.44 29.14 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 125.397 1.475 . . . . 0.0 113.937 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 34.4 t -85.52 153.29 22.54 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.649 0.78 . . . . 0.0 111.999 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -95.49 -3.27 47.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.453 1.101 . . . . 0.0 113.792 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -80.84 133.15 35.55 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.366 0.666 . . . . 0.0 110.765 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.2 115.44 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.383 1.073 . . . . 0.0 109.882 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -71.94 140.5 49.21 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.802 0.841 . . . . 0.0 110.384 171.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.73 118.59 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.08 1.352 . . . . 0.0 109.23 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.91 143.71 18.15 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.916 1.245 . . . . 0.0 113.381 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.88 11.0 47.95 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.451 1.501 . . . . 0.0 114.157 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.09 142.13 80.65 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.113 1.365 . . . . 0.0 111.482 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.41 154.79 18.22 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.769 2.98 . . . . 0.0 113.576 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -79.21 4.47 6.55 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.835 3.023 . . . . 0.0 113.421 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -135.97 20.24 3.25 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.691 1.597 . . . . 0.0 112.301 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 14.1 tt -104.02 123.38 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.696 1.199 . . . . 0.0 111.958 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.02 161.17 25.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.515 1.126 . . . . 0.0 112.806 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -48.1 -44.44 31.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.108 1.363 . . . . 0.0 112.543 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -74.74 -24.25 58.69 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.86 0.864 . . . . 0.0 112.891 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -78.21 -40.55 37.15 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.818 0.847 . . . . 0.0 111.118 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.2 mt -62.52 -41.84 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 170.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 60.7 m -61.0 -52.28 65.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.496 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.45 -29.36 70.46 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.552 1.069 . . . . 0.0 113.223 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 64.8 m -67.34 -23.26 65.6 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.58 -5.62 9.75 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.145 0.978 . . . . 0.0 113.552 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -61.52 -22.98 65.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.169 1.387 . . . . 0.0 113.139 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -53.04 -20.72 3.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.587 1.955 . . . . 0.0 114.73 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -97.74 -9.32 26.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.502 1.521 . . . . 0.0 113.915 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 126.12 170.55 13.0 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.976 1.75 . . . . 0.0 112.034 -169.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.88 150.82 56.0 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.682 2.922 . . . . 0.0 112.601 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.06 172.92 15.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.664 1.586 . . . . 0.0 112.664 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.62 158.69 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.851 1.66 . . . . 0.0 109.488 167.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 77.5 t -130.91 137.55 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.586 1.154 . . . . 0.0 110.89 -171.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -148.1 157.54 43.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.164 1.786 . . . . 0.0 111.628 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -157.02 162.39 27.73 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.621 1.168 . . . . 0.0 112.428 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -59.24 139.52 90.52 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.465 2.777 . . . . 0.0 113.01 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 65.91 11.26 7.56 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.497 1.519 . . . . 0.0 114.56 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -63.35 -23.69 67.52 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 120.417 -1.427 . . . . 0.0 112.54 176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -101.23 0.39 37.38 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.648 2.379 . . . . 0.0 113.863 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -136.07 2.52 2.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.952 1.301 . . . . 0.0 113.741 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 14.0 t -151.37 147.51 27.0 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.364 1.466 . . . . 0.0 111.164 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -79.93 54.16 1.82 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.408 1.483 . . . . 0.0 112.789 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 70.5 m -132.55 111.66 11.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.805 1.242 . . . . 0.0 111.731 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -87.37 6.64 32.67 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.022 1.329 . . . . 0.0 113.388 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -112.0 152.98 44.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.115 2.166 . . . . 0.0 109.106 168.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -64.64 116.61 3.89 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.948 2.432 . . . . 0.0 110.069 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -84.32 12.01 3.16 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.719 2.946 . . . . 0.0 114.213 -169.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -135.74 1.17 2.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.029 1.732 . . . . 0.0 113.524 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.08 17.87 77.57 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.424 1.012 . . . . 0.0 114.259 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -152.45 158.1 42.12 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.797 1.298 . . . . 0.0 113.418 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.74 170.67 19.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.107 1.363 . . . . 0.0 111.645 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.29 121.65 41.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.32 1.848 . . . . 0.0 109.722 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.17 140.47 30.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.448 1.499 . . . . 0.0 108.916 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 55.0 mt -124.52 105.43 9.38 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.74 1.616 . . . . 0.0 107.96 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -83.41 159.12 21.87 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.523 0.729 . . . . 0.0 111.353 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.73 -22.04 24.83 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -130.12 144.53 51.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.125 1.77 . . . . 0.0 110.279 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 37.6 mp0 -66.01 -30.51 71.07 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.416 -0.803 . . . . 0.0 111.286 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.6 m -55.15 -27.76 47.85 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.832 1.253 . . . . 0.0 112.798 173.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.7 m -71.85 -29.56 64.51 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.109 -0.995 . . . . 0.0 112.048 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.99 -37.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.522 -0.736 . . . . 0.0 109.888 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -66.3 -38.16 87.09 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.533 -0.73 . . . . 0.0 111.86 172.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.81 -37.94 88.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.317 0.647 . . . . 0.0 112.38 173.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.2 tp -64.01 -48.78 75.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.333 0.653 . . . . 0.0 110.943 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 75.5 mt -55.54 -40.9 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.231 1.012 . . . . 0.0 111.35 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.45 -17.82 63.67 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.719 1.208 . . . . 0.0 113.818 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.02 -13.66 18.97 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.067 1.347 . . . . 0.0 113.351 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 54.6 m -75.89 149.29 37.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.052 0.941 . . . . 0.0 113.464 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.6 mt -83.84 173.28 11.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.431 1.492 . . . . 0.0 107.785 164.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -145.36 138.24 26.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.528 0.731 . . . . 0.0 111.733 -174.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.1 121.51 5.79 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.893 1.277 . . . . 0.0 109.928 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 63.33 9.28 3.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.847 2.059 . . . . 0.0 113.945 -172.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 95.1 -13.19 67.43 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.842 1.687 . . . . 0.0 113.6 -170.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -72.17 141.88 49.07 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.393 1.096 . . . . 0.0 109.494 169.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.24 156.48 16.95 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.458 0.703 . . . . 0.0 111.525 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -144.81 145.87 31.84 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.993 0.917 . . . . 0.0 112.977 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.0 tp -131.62 -176.51 4.06 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.494 1.918 . . . . 0.0 108.614 172.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 89.6 m -129.63 146.12 51.45 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.508 1.049 . . . . 0.0 112.729 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 29.2 m -148.93 177.46 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 126.501 1.92 . . . . 0.0 111.531 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 80.2 p -161.13 170.79 19.71 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.096 1.358 . . . . 0.0 112.965 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.3 p -153.88 -179.78 1.13 Allowed Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 126.894 2.078 . . . . 0.0 110.567 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.61 -20.04 55.77 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.897 2.398 . . . . 0.0 114.403 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 57.6 p -113.88 -19.9 11.29 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.026 1.33 . . . . 0.0 114.325 -175.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.1 mm -132.31 135.99 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.489 1.516 . . . . 0.0 110.304 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -130.49 138.41 50.24 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.594 1.158 . . . . 0.0 112.179 -171.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.5 t70 57.54 29.88 17.83 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.336 1.454 . . . . 0.0 113.093 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -75.1 126.2 88.33 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-O 117.829 -1.081 . . . . 0.0 111.584 -172.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.32 141.78 18.41 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.297 2.665 . . . . 0.0 109.457 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.7 m -135.87 134.39 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.015 1.326 . . . . 0.0 110.453 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -75.37 129.67 37.74 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.555 1.142 . . . . 0.0 109.535 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.92 131.21 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.384 1.474 . . . . 0.0 108.373 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 16.7 mtp85 -137.11 89.72 16.33 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.491 1.116 . . . . 0.0 110.106 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -59.05 135.67 68.01 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.839 2.359 . . . . 0.0 109.102 169.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -65.27 138.04 57.95 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -171.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -132.36 160.99 34.7 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.898 1.679 . . . . 0.0 112.28 -174.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.8 163.95 26.31 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.521 1.128 . . . . 0.0 111.583 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 14.8 m -69.34 -8.07 43.03 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -169.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.98 -17.61 39.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 20.6 t -169.63 124.04 0.79 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.295 1.438 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -159.03 130.53 6.33 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.442 1.097 . . . . 0.0 111.511 -172.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.29 89.54 6.56 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.435 1.094 . . . . 0.0 112.058 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.59 139.92 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.466 1.906 . . . . 0.0 109.162 175.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 59.3 mtt -145.64 167.55 22.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.168 1.387 . . . . 0.0 111.946 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -153.11 163.34 40.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.105 1.762 . . . . 0.0 110.999 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 22.7 m -71.15 -4.71 26.86 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -171.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -155.23 165.06 32.19 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.312 1.435 . . . . 0.0 113.551 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.83 163.93 30.68 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.087 3.191 . . . . 0.0 111.698 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 50.7 p -80.42 -4.96 55.67 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 15.5 m -167.01 153.62 8.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.463 2.305 . . . . 0.0 110.847 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.894 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.515 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 55.6 m -148.11 155.1 41.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.898 1.279 . . . . 0.0 111.602 -173.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 16.3 m -80.07 -0.48 35.82 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -80.69 144.23 25.15 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.961 1.267 . . . . 0.0 112.902 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 10.7 t -141.85 140.56 32.96 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.719 1.208 . . . . 0.0 111.929 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 52.0 m -152.89 160.48 43.06 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.874 1.67 . . . . 0.0 111.287 -169.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 127.05 -16.66 6.38 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.807 1.67 . . . . 0.0 114.598 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 10.2 t -161.15 154.48 21.56 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.278 1.431 . . . . 0.0 112.755 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -100.37 0.24 39.55 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.215 1.406 . . . . 0.0 112.886 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -80.41 137.86 36.56 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.694 1.198 . . . . 0.0 111.281 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.5 t -141.48 120.66 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.681 1.192 . . . . 0.0 109.763 175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -77.77 143.54 37.88 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.569 0.748 . . . . 0.0 110.79 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.02 124.62 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.58 1.552 . . . . 0.0 109.232 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -120.5 150.26 17.43 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.807 1.194 . . . . 0.0 113.409 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 90.49 20.1 42.46 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.543 1.068 . . . . 0.0 114.05 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.8 146.34 75.72 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.085 1.354 . . . . 0.0 111.562 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -54.04 152.79 22.88 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.586 2.858 . . . . 0.0 112.974 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.07 0.18 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.71 2.94 . . . . 0.0 114.667 -170.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -140.7 17.1 2.34 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.389 1.075 . . . . 0.0 113.128 -175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.1 tt -80.19 131.76 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.78 0.832 . . . . 0.0 111.527 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.22 170.48 9.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.92 -45.57 51.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.479 1.512 . . . . 0.0 113.044 176.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -74.88 -32.83 61.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.004 0.921 . . . . 0.0 112.609 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.2 -42.32 84.36 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.554 0.742 . . . . 0.0 112.201 170.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 51.3 mt -64.15 -38.36 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 119.197 0.908 . . . . 0.0 109.83 174.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 57.5 m -63.77 -52.31 60.94 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.357 0.663 . . . . 0.0 110.639 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.6 -31.18 71.23 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.348 0.976 . . . . 0.0 112.738 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.6 m -67.83 -15.08 63.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -129.16 -2.99 5.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.457 1.026 . . . . 0.0 113.507 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -60.48 -22.79 63.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.048 1.339 . . . . 0.0 113.268 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -57.48 -13.0 3.05 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.594 1.958 . . . . 0.0 114.99 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -104.11 -4.1 23.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.42 1.488 . . . . 0.0 113.823 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.69 170.26 13.82 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 126.07 1.795 . . . . 0.0 112.062 -170.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.09 153.03 75.9 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.495 2.796 . . . . 0.0 112.129 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.02 171.98 16.69 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.654 1.582 . . . . 0.0 112.424 -170.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.84 156.66 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.655 1.582 . . . . 0.0 109.248 167.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 65.9 t -128.64 137.42 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.705 1.202 . . . . 0.0 110.283 -171.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -149.91 165.96 31.01 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.025 1.73 . . . . 0.0 111.608 -175.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . 0.434 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 26.7 p90 -157.08 155.51 28.22 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.419 1.088 . . . . 0.0 112.024 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -65.32 12.61 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 125.063 3.842 . . . . 0.0 118.102 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -132.71 -4.82 3.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.92 1.688 . . . . 0.0 112.794 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.434 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 37.7 ttmt -70.64 -20.45 62.72 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.557 1.143 . . . . 0.0 112.397 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -76.3 -9.76 58.89 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.054 1.741 . . . . 0.0 114.193 171.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -133.78 11.47 4.01 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.305 1.442 . . . . 0.0 113.251 -172.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 46.3 t -153.22 143.39 22.32 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.248 1.419 . . . . 0.0 111.825 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -7.46 55.55 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 66.8 m -82.76 126.38 32.33 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.173 -0.955 . . . . 0.0 112.382 -169.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -84.24 34.68 0.52 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.464 1.506 . . . . 0.0 112.936 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -136.12 135.29 21.02 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 128.143 2.577 . . . . 0.0 107.949 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.55 120.13 7.15 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.86 2.373 . . . . 0.0 109.92 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.28 11.33 3.32 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.126 2.55 . . . . 0.0 114.771 -169.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -136.79 0.57 2.45 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.616 1.566 . . . . 0.0 114.421 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 80.94 22.34 61.52 Favored Glycine 0 N--CA 1.475 1.269 0 O-C-N 121.381 -0.825 . . . . 0.0 114.686 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -151.25 155.27 38.44 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.513 1.156 . . . . 0.0 113.08 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.29 167.78 29.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.696 1.198 . . . . 0.0 112.362 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -112.65 127.16 56.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.632 1.973 . . . . 0.0 110.098 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.9 mt -92.95 139.24 30.73 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.184 1.794 . . . . 0.0 108.55 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 44.9 mt -123.93 107.56 11.48 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.458 1.503 . . . . 0.0 107.85 171.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -84.16 160.38 20.87 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.332 0.653 . . . . 0.0 112.292 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -75.65 -26.32 57.59 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.796 0.838 . . . . 0.0 112.856 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -140.09 144.79 36.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.29 1.436 . . . . 0.0 110.663 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.17 -30.88 69.62 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.711 -0.618 . . . . 0.0 111.564 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.4 m -55.55 -27.39 48.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.576 1.15 . . . . 0.0 113.139 172.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.1 m -73.84 -29.94 62.41 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.034 -1.041 . . . . 0.0 112.071 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.84 -38.54 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 121.744 -0.598 . . . . 0.0 109.584 173.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -68.63 -37.42 79.71 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.755 -0.591 . . . . 0.0 111.92 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.03 85.57 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.981 0.81 . . . . 0.0 112.287 173.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.71 -48.5 76.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.378 0.671 . . . . 0.0 110.87 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 80.8 mt -56.11 -43.04 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.986 0.914 . . . . 0.0 111.392 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.01 -18.62 64.76 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.738 1.215 . . . . 0.0 113.688 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.12 -13.42 18.98 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.06 1.344 . . . . 0.0 113.533 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 34.6 m -73.46 144.73 46.14 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.003 0.906 . . . . 0.0 113.33 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.2 172.69 13.34 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.311 1.444 . . . . 0.0 107.808 165.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -142.95 135.03 27.12 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.469 0.708 . . . . 0.0 111.363 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -159.36 135.62 9.01 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.075 1.35 . . . . 0.0 110.922 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 16.1 t70 55.82 22.02 5.24 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.78 2.032 . . . . 0.0 114.643 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 92.34 0.78 69.93 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.548 1.547 . . . . 0.0 114.525 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -114.73 161.7 17.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.704 1.602 . . . . 0.0 112.76 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.7 mt -101.2 152.32 20.79 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.708 1.203 . . . . 0.0 112.075 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -142.38 149.35 39.25 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.383 1.073 . . . . 0.0 113.144 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.3 tp -133.8 -170.44 2.5 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.475 1.91 . . . . 0.0 108.895 172.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 26.5 p -140.73 144.56 35.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.807 1.243 . . . . 0.0 112.593 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 25.3 m -147.99 171.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 126.255 1.822 . . . . 0.0 111.667 -169.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 40.1 m -147.65 153.66 39.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.601 1.16 . . . . 0.0 112.817 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.9 p -140.89 -173.9 0.38 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 126.383 1.873 . . . . 0.0 111.689 -174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -69.62 -10.89 29.81 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.34 2.693 . . . . 0.0 113.639 171.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 37.3 p -120.99 -32.27 3.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.076 1.35 . . . . 0.0 113.621 -171.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.0 mm -133.35 137.94 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.956 1.302 . . . . 0.0 110.005 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -119.75 135.16 54.96 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.98 1.312 . . . . 0.0 110.729 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 24.9 t70 64.53 27.3 13.41 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.344 1.457 . . . . 0.0 112.911 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -58.74 125.58 77.5 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.493 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.09 146.58 25.65 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.976 2.451 . . . . 0.0 109.776 171.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.8 m -139.3 140.56 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.16 1.384 . . . . 0.0 110.916 -174.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -83.03 132.33 35.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.912 1.285 . . . . 0.0 109.858 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.1 mm -114.95 131.23 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.831 1.252 . . . . 0.0 109.274 -174.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -135.76 90.2 19.93 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.401 1.481 . . . . 0.0 110.351 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.01 136.36 72.81 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.417 2.745 . . . . 0.0 111.041 172.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -69.93 134.88 48.86 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -147.23 150.52 35.02 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.017 1.727 . . . . 0.0 110.82 -175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 95.6 mt -136.03 156.19 49.1 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.268 1.827 . . . . 0.0 110.391 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 3.5 t 68.06 16.54 9.5 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.379 1.472 . . . . 0.0 113.271 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -157.59 162.32 38.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.996 2.119 . . . . 0.0 110.818 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 6.1 t -98.62 -178.51 4.02 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 125.208 1.403 . . . . 0.0 113.221 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -158.49 136.84 10.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.658 1.983 . . . . 0.0 110.738 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -63.08 151.87 38.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.989 1.315 . . . . 0.0 113.034 -173.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 10.9 p -157.01 138.84 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.883 1.273 . . . . 0.0 110.711 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -93.41 17.64 11.07 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.693 1.597 . . . . 0.0 113.639 -173.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -150.2 152.16 34.19 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.89 1.676 . . . . 0.0 111.824 -173.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 6.9 t -110.76 11.67 22.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.989 1.316 . . . . 0.0 113.661 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -78.23 -177.98 48.8 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.778 1.18 . . . . 0.0 114.1 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.36 133.26 57.09 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.462 3.442 . . . . 0.0 112.776 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 57.1 m -131.24 12.15 5.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.65 1.18 . . . . 0.0 113.108 -174.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 70.6 m -145.59 150.57 36.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.883 1.673 . . . . 0.0 111.435 -173.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.341 -1.255 . . . . 0.0 112.955 -179.82 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 24.7 m -66.58 144.9 56.15 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.458 1.103 . . . . 0.0 112.919 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 7.7 t -163.01 170.83 17.42 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.997 1.319 . . . . 0.0 111.683 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -78.1 83.05 1.2 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.07 1.319 . . . . 0.0 111.106 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 29.9 m -130.91 17.83 5.11 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.682 1.193 . . . . 0.0 113.531 -169.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 81.6 p -158.07 163.4 37.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.83 1.252 . . . . 0.0 113.072 -177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 94.38 -148.22 18.91 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.28 1.419 . . . . 0.0 112.659 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 33.4 t -152.66 164.04 38.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.438 1.095 . . . . 0.0 113.253 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -76.54 -5.23 46.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.337 1.055 . . . . 0.0 112.921 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -64.31 136.54 57.25 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.08 0.952 . . . . 0.0 110.547 168.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 43.3 t -137.6 116.9 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.767 0.827 . . . . 0.0 109.375 169.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -73.37 137.17 44.53 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.587 0.755 . . . . 0.0 110.327 172.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 77.5 t -131.31 112.68 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.445 1.498 . . . . 0.0 108.991 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -110.45 151.29 17.58 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.117 1.342 . . . . 0.0 113.41 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 89.87 25.99 25.68 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.32 0.962 . . . . 0.0 113.891 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.77 143.21 91.33 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.787 1.235 . . . . 0.0 111.451 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.84 154.65 31.07 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.366 2.71 . . . . 0.0 113.052 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.04 3.15 6.88 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.901 3.068 . . . . 0.0 114.516 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -140.34 25.27 2.25 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.774 1.229 . . . . 0.0 112.835 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.2 tt -93.48 161.59 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.308 1.043 . . . . 0.0 110.85 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -140.79 169.29 17.92 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.212 1.405 . . . . 0.0 112.536 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.61 -43.07 25.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.581 1.952 . . . . 0.0 113.764 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.5 -27.25 41.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.632 0.773 . . . . 0.0 112.317 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -77.23 -35.94 55.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.834 0.854 . . . . 0.0 111.466 171.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.02 -37.0 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.425 -0.797 . . . . 0.0 109.562 171.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 61.4 m -64.0 -51.78 62.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.506 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.21 -31.28 70.01 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.252 0.933 . . . . 0.0 112.979 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 73.4 m -68.68 -14.59 63.11 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.85 -2.09 3.31 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.586 1.085 . . . . 0.0 113.797 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -60.73 -22.63 64.2 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.745 1.218 . . . . 0.0 112.868 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -56.93 -12.29 1.91 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.603 1.961 . . . . 0.0 114.976 170.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.05 -6.75 18.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.404 1.482 . . . . 0.0 113.924 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.56 179.81 15.87 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.258 1.885 . . . . 0.0 112.491 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.9 145.3 90.13 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.473 2.782 . . . . 0.0 112.54 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.75 170.76 20.83 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.262 1.425 . . . . 0.0 112.423 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -135.03 158.85 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.583 1.553 . . . . 0.0 109.148 167.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 72.6 t -125.05 136.56 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.706 1.202 . . . . 0.0 110.542 -170.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -148.07 165.9 29.41 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.182 1.793 . . . . 0.0 111.698 -173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . 0.506 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 13.7 p90 -161.02 160.56 24.75 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.357 1.463 . . . . 0.0 111.906 176.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -57.68 138.11 84.5 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.345 2.696 . . . . 0.0 112.902 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 11.9 m170 76.17 0.01 3.19 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 127.289 2.236 . . . . 0.0 114.407 177.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.506 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 48.4 tttm -64.08 -24.67 67.79 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.6 -1.313 . . . . 0.0 112.427 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -86.5 -11.71 50.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.379 2.272 . . . . 0.0 114.246 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -112.03 -21.66 11.42 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.547 1.539 . . . . 0.0 112.37 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 22.8 t -141.35 110.41 6.22 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.959 1.704 . . . . 0.0 108.312 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.75 129.49 39.24 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.41 0.684 . . . . 0.0 112.123 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 23.0 t -164.76 161.38 20.51 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.462 1.505 . . . . 0.0 110.72 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -124.63 14.54 8.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.727 1.611 . . . . 0.0 112.566 172.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -114.5 132.96 22.58 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.88 1.672 . . . . 0.0 109.161 169.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.76 116.94 4.88 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.39 2.727 . . . . 0.0 110.512 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -89.48 15.84 1.89 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.371 2.714 . . . . 0.0 113.472 -172.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.9 mttp -137.19 -3.81 1.94 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.357 1.463 . . . . 0.0 114.42 -171.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.72 13.28 83.63 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 124.284 0.945 . . . . 0.0 114.283 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -150.08 162.82 39.66 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.889 1.276 . . . . 0.0 113.05 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -149.24 161.91 41.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.058 1.343 . . . . 0.0 111.759 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -109.03 118.34 36.53 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.224 1.81 . . . . 0.0 109.211 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 38.5 mt -82.19 136.93 35.04 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.72 1.208 . . . . 0.0 108.579 169.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 63.7 mt -117.03 102.76 9.61 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.755 1.622 . . . . 0.0 107.74 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -81.79 156.05 25.12 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.206 0.526 . . . . 0.0 111.736 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -76.41 -26.26 55.35 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.753 0.821 . . . . 0.0 112.848 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -142.21 146.31 35.08 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.254 1.422 . . . . 0.0 110.99 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.85 -28.89 70.34 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.528 0.731 . . . . 0.0 111.995 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 25.1 p -60.53 -25.98 66.54 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.025 -1.047 . . . . 0.0 112.984 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.9 m -73.14 -30.9 63.93 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.852 -1.155 . . . . 0.0 111.942 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.47 -39.53 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 121.765 -0.584 . . . . 0.0 109.713 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -66.77 -38.13 85.98 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.61 -0.681 . . . . 0.0 112.16 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.7 87.54 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.703 0.683 . . . . 0.0 112.368 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.63 -49.19 74.24 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.289 0.636 . . . . 0.0 110.8 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 78.6 mt -55.76 -42.2 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.951 0.9 . . . . 0.0 111.335 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.53 -17.94 63.62 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.775 1.23 . . . . 0.0 113.625 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.97 -12.9 19.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.06 1.344 . . . . 0.0 113.419 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 35.6 m -75.13 147.29 40.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 122.114 0.959 . . . . 0.0 113.547 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.31 177.88 8.31 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.523 1.529 . . . . 0.0 107.73 164.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -145.43 134.7 22.94 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.63 -0.669 . . . . 0.0 111.382 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -160.32 132.28 6.1 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.231 1.412 . . . . 0.0 110.485 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 52.68 37.41 23.52 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.482 1.513 . . . . 0.0 113.437 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 81.22 3.27 90.69 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.738 1.161 . . . . 0.0 114.736 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -119.88 158.1 27.36 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.387 1.475 . . . . 0.0 112.175 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 88.2 mt -92.35 153.55 19.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.256 1.022 . . . . 0.0 110.971 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -140.72 148.22 40.4 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.984 0.914 . . . . 0.0 113.167 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.9 tp -134.87 173.13 12.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.786 1.634 . . . . 0.0 109.478 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 26.7 p -116.17 140.45 49.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.049 1.34 . . . . 0.0 112.58 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.38 178.48 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 126.761 2.024 . . . . 0.0 110.532 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 85.0 p -160.76 171.2 19.25 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 57.6 p -148.42 -179.34 0.94 Allowed Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 126.939 2.096 . . . . 0.0 110.957 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.67 -12.2 34.07 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.296 2.664 . . . . 0.0 114.124 170.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 37.2 p -109.86 -33.19 6.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.95 1.3 . . . . 0.0 113.255 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 6.7 mm -132.82 131.13 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.475 1.11 . . . . 0.0 110.948 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -111.73 141.2 45.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.227 1.411 . . . . 0.0 111.193 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 59.26 36.04 23.56 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.135 1.374 . . . . 0.0 112.906 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -67.41 127.7 93.5 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 120.943 -1.098 . . . . 0.0 110.899 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.35 140.91 12.39 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.34 2.693 . . . . 0.0 109.354 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.46 138.13 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.076 1.35 . . . . 0.0 110.697 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -85.13 120.59 26.8 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.171 1.788 . . . . 0.0 109.683 -172.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.27 129.49 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.998 1.319 . . . . 0.0 109.495 -171.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -135.6 94.03 15.53 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.282 1.433 . . . . 0.0 110.121 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.1 127.23 24.89 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.639 2.893 . . . . 0.0 109.522 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -75.74 148.66 38.39 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -168.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -144.06 137.8 27.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.818 1.647 . . . . 0.0 111.01 -171.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.22 -165.23 1.12 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.79 2.036 . . . . 0.0 109.714 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 15.8 m -64.61 -6.14 7.06 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.09 -2.95 56.34 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.663 1.985 . . . . 0.0 113.525 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 6.2 p -151.31 -173.67 4.58 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.096 1.759 . . . . 0.0 111.802 -168.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -163.1 143.95 9.45 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.474 -1.391 . . . . 0.0 112.163 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -147.41 143.19 27.76 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.841 2.056 . . . . 0.0 109.006 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 8.3 p -164.29 149.02 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.251 1.42 . . . . 0.0 110.613 -169.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 13.4 tpt -158.11 158.62 35.06 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.181 1.793 . . . . 0.0 110.72 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 20.0 t70 82.24 -3.1 1.46 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.87 2.868 . . . . 0.0 114.394 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 22.8 m -71.07 -11.48 60.98 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.506 1.122 . . . . 0.0 113.949 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 161.21 166.94 20.93 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 126.136 1.827 . . . . 0.0 113.279 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.4 153.33 35.21 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.803 3.002 . . . . 0.0 111.419 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.2 m -67.68 -9.0 39.61 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 54.1 p -92.05 -4.74 54.04 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.052 1.741 . . . . 0.0 114.084 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.255 -1.303 . . . . 0.0 113.641 179.959 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 33.7 p -89.79 -7.59 54.06 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 83.8 p -162.8 159.88 24.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.676 1.59 . . . . 0.0 112.006 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -116.91 143.37 18.02 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 125.401 1.477 . . . . 0.0 112.193 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 70.8 m -150.67 153.69 36.07 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.941 1.296 . . . . 0.0 112.009 -175.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 16.2 p -77.81 153.6 32.65 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.799 1.24 . . . . 0.0 113.687 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -96.35 -3.64 59.93 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.641 1.115 . . . . 0.0 114.642 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 22.9 t -162.93 165.06 25.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.866 1.666 . . . . 0.0 112.23 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -79.93 -9.14 59.65 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.709 1.204 . . . . 0.0 113.108 169.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -81.54 140.0 34.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.76 0.824 . . . . 0.0 111.263 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.7 t -139.16 118.82 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.548 1.139 . . . . 0.0 109.758 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -73.78 140.05 45.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.314 0.646 . . . . 0.0 110.168 170.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.2 123.18 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.015 1.326 . . . . 0.0 109.175 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -117.67 146.17 18.64 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.724 1.154 . . . . 0.0 113.079 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 96.03 13.97 47.48 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.041 1.305 . . . . 0.0 114.241 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.4 mt -58.73 139.31 86.31 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.99 1.316 . . . . 0.0 110.632 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -55.1 152.42 30.44 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.433 2.755 . . . . 0.0 113.206 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.67 5.33 4.89 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.709 2.939 . . . . 0.0 114.189 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -133.78 18.07 3.87 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.765 1.626 . . . . 0.0 112.427 -174.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.7 tt -100.14 130.54 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 121.118 -0.988 . . . . 0.0 111.596 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -98.86 169.49 9.42 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 0.0 113.452 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -51.78 -41.55 61.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.096 1.359 . . . . 0.0 113.624 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.68 -25.3 44.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.677 0.791 . . . . 0.0 112.352 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -79.58 -36.23 38.47 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.6 0.76 . . . . 0.0 111.984 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 40.3 mt -65.53 -36.44 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.349 0.977 . . . . 0.0 109.418 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 89.3 m -63.53 -51.85 63.67 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.538 0.735 . . . . 0.0 110.636 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.39 -30.58 69.68 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.585 1.084 . . . . 0.0 112.944 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 69.9 m -67.51 -14.25 62.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -133.02 -2.01 3.25 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -60.37 -22.52 63.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.075 1.35 . . . . 0.0 112.899 173.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -57.2 -10.55 1.29 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.706 2.003 . . . . 0.0 115.133 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -108.67 -3.69 17.68 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.508 1.523 . . . . 0.0 114.127 175.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.76 178.55 15.78 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.164 1.84 . . . . 0.0 112.741 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -63.46 145.51 92.31 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.582 2.855 . . . . 0.0 112.996 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.41 170.41 21.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.634 1.574 . . . . 0.0 112.324 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.4 160.7 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.842 1.657 . . . . 0.0 108.635 166.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 93.5 t -135.7 138.52 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.158 0.983 . . . . 0.0 110.658 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -155.16 165.98 34.98 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.797 1.239 . . . . 0.0 112.232 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -155.75 155.24 29.26 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.95 157.61 47.69 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 123.812 3.008 . . . . 0.0 113.254 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 11.8 m170 68.66 3.63 3.97 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.438 1.495 . . . . 0.0 113.84 173.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -67.96 -22.2 65.04 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.391 1.876 . . . . 0.0 112.595 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -74.88 -15.59 60.71 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.904 2.081 . . . . 0.0 114.386 173.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.45 -15.31 6.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.042 1.337 . . . . 0.0 113.534 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 39.7 t -66.49 147.37 53.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.169 1.388 . . . . 0.0 112.823 172.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -95.88 6.41 48.95 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.116 1.366 . . . . 0.0 112.131 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 67.4 m -133.28 148.72 51.95 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.484 1.513 . . . . 0.0 111.927 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -88.85 26.23 1.59 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.51 1.524 . . . . 0.0 113.573 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -117.04 159.92 39.14 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 127.72 2.408 . . . . 0.0 110.035 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.26 118.63 5.57 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.7 2.267 . . . . 0.0 109.298 170.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.79 5.52 5.86 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.481 2.787 . . . . 0.0 115.157 -168.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -141.22 6.88 1.96 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.517 1.927 . . . . 0.0 113.376 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.66 24.28 62.92 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.229 0.918 . . . . 0.0 114.485 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -149.53 154.98 39.59 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.83 1.315 . . . . 0.0 113.512 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.32 170.5 21.73 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.835 1.254 . . . . 0.0 112.174 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -113.42 123.78 50.88 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.891 1.676 . . . . 0.0 110.67 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 22.5 mt -87.04 142.57 27.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.542 1.537 . . . . 0.0 108.74 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 65.7 mt -127.95 102.57 6.82 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.052 1.741 . . . . 0.0 108.175 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -85.1 154.99 21.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.361 0.664 . . . . 0.0 112.031 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -70.88 -27.58 63.92 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.655 0.782 . . . . 0.0 112.732 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -142.92 147.31 35.06 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.411 1.485 . . . . 0.0 110.635 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -63.58 -29.08 70.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.202 0.601 . . . . 0.0 111.952 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 23.0 p -60.24 -25.8 65.94 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.931 -1.105 . . . . 0.0 113.093 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 25.3 m -71.84 -30.8 65.84 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.815 -1.178 . . . . 0.0 111.996 171.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 49.8 t -74.84 -37.43 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.617 -0.677 . . . . 0.0 109.988 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -68.36 -35.31 77.54 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.576 -0.702 . . . . 0.0 111.742 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.17 86.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.074 0.852 . . . . 0.0 112.493 171.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.3 tp -63.4 -48.33 78.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.189 0.596 . . . . 0.0 110.741 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.81 -42.09 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.008 0.923 . . . . 0.0 111.267 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.28 -18.46 64.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.701 1.2 . . . . 0.0 113.887 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.11 -13.12 19.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.99 1.316 . . . . 0.0 113.362 175.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.4 m -72.23 143.07 48.94 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.902 0.858 . . . . 0.0 113.186 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.1 mt -78.87 170.04 17.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.061 1.344 . . . . 0.0 107.956 165.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -141.88 133.01 26.2 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.579 0.752 . . . . 0.0 111.3 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -160.81 133.11 6.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.509 1.524 . . . . 0.0 109.928 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 27.1 t70 58.22 31.97 21.45 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.793 1.237 . . . . 0.0 113.105 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 78.77 3.69 87.53 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.056 1.312 . . . . 0.0 114.421 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -117.36 151.69 36.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.381 1.872 . . . . 0.0 110.956 -172.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.5 mt -99.04 151.12 21.29 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.056 0.942 . . . . 0.0 111.616 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -142.83 149.59 38.8 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.0 tp -135.0 -177.47 4.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.651 1.98 . . . . 0.0 108.734 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 97.3 m -131.49 145.6 51.84 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.599 1.09 . . . . 0.0 112.777 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 31.7 m -149.23 172.79 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 126.899 2.079 . . . . 0.0 111.598 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 58.6 m -149.38 161.58 41.8 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.833 1.253 . . . . 0.0 112.682 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 19.7 p -139.3 -172.37 0.31 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.611 1.964 . . . . 0.0 111.249 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.94 -13.79 37.39 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.112 2.541 . . . . 0.0 113.478 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 40.9 p -126.82 -25.43 3.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.046 1.339 . . . . 0.0 113.859 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 16.9 mm -127.08 134.47 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.512 1.525 . . . . 0.0 109.591 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -123.83 132.97 53.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.544 1.138 . . . . 0.0 111.26 -172.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.0 t70 62.27 30.89 17.63 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.236 1.414 . . . . 0.0 112.507 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -61.83 125.36 84.76 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.787 1.235 . . . . 0.0 110.871 176.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.75 143.98 24.27 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.206 2.604 . . . . 0.0 109.551 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.36 134.83 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.363 1.465 . . . . 0.0 110.417 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -78.37 131.6 37.04 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.652 0.781 . . . . 0.0 109.436 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.46 128.01 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.133 1.373 . . . . 0.0 108.618 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -135.97 84.99 29.86 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.654 1.182 . . . . 0.0 110.071 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.17 133.89 55.87 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.598 2.865 . . . . 0.0 110.984 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -78.98 153.8 30.04 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -172.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -165.44 174.19 10.27 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.99 2.116 . . . . 0.0 111.244 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 61.1 tp -145.5 121.08 10.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.269 1.427 . . . . 0.0 109.391 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 6.7 t -169.88 -165.34 0.48 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.967 1.707 . . . . 0.0 110.456 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -150.91 135.61 17.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.454 1.902 . . . . 0.0 110.648 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 45.6 p -166.56 158.93 13.82 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.772 1.229 . . . . 0.0 112.62 -170.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.41 -2.29 58.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.56 1.544 . . . . 0.0 114.785 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -63.65 139.39 58.76 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.774 1.229 . . . . 0.0 112.177 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 12.5 p -161.3 145.09 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.638 1.575 . . . . 0.0 110.479 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 91.3 mtp -136.22 114.0 11.14 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.272 1.429 . . . . 0.0 109.397 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -167.15 156.16 10.25 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.347 1.859 . . . . 0.0 110.458 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 57.2 p -77.58 -10.05 59.28 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -72.17 -62.48 3.3 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.448 1.499 . . . . 0.0 113.532 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.01 124.75 10.34 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.156 2.571 . . . . 0.0 110.871 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 69.5 p -96.88 -9.23 28.98 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 27.6 m 65.64 6.74 4.01 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.86 2.064 . . . . 0.0 114.906 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.037 1.304 . . . . 0.0 113.316 179.632 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.554 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 25.1 m -128.08 9.61 6.28 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -170.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 25.0 m 68.67 8.93 7.04 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.349 1.86 . . . . 0.0 115.267 172.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 85.25 -128.8 8.92 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.798 1.19 . . . . 0.0 112.64 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 41.8 m -148.74 165.93 29.93 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.527 1.531 . . . . 0.0 111.669 -172.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.2 m -157.83 160.76 38.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.015 1.726 . . . . 0.0 111.089 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 113.18 -147.65 18.55 Favored Glycine 0 N--CA 1.47 0.961 0 C-N-CA 125.212 1.387 . . . . 0.0 112.561 -175.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 35.5 t -148.55 164.54 33.91 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.038 1.335 . . . . 0.0 112.375 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 70.8 mtm-85 -75.48 -3.8 36.05 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.09 0.956 . . . . 0.0 113.45 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -72.53 135.8 45.72 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.464 0.706 . . . . 0.0 110.506 169.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.41 117.75 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.384 1.074 . . . . 0.0 109.8 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -69.44 138.93 53.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.538 1.135 . . . . 0.0 110.885 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.62 115.38 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.428 1.491 . . . . 0.0 109.04 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.56 143.49 18.07 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 125.061 1.315 . . . . 0.0 113.8 -175.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.42 23.12 22.62 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.77 1.176 . . . . 0.0 114.196 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.77 141.91 88.67 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.957 1.303 . . . . 0.0 110.98 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.39 154.28 19.79 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.382 2.722 . . . . 0.0 113.106 172.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.49 3.76 6.09 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.733 2.955 . . . . 0.0 114.096 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -140.82 25.86 2.11 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.727 1.211 . . . . 0.0 112.599 -175.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.1 tt -99.27 137.3 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.311 1.045 . . . . 0.0 110.747 174.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -112.02 169.25 8.98 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.383 1.073 . . . . 0.0 113.437 -174.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -43.11 -46.54 5.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.146 1.779 . . . . 0.0 114.251 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -77.5 -26.47 51.26 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.647 -0.658 . . . . 0.0 112.414 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -79.38 -38.34 35.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.856 0.862 . . . . 0.0 111.533 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 46.2 mt -63.73 -35.84 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.794 0.724 . . . . 0.0 109.68 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 50.5 m -68.34 -53.32 24.92 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.644 0.778 . . . . 0.0 110.863 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.73 -29.69 70.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.515 1.052 . . . . 0.0 113.146 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.7 m -64.8 -25.39 67.89 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -120.49 -5.07 9.82 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.0 tpt85 -60.13 -22.49 62.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.05 1.34 . . . . 0.0 113.195 174.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -53.69 -21.41 6.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.732 2.013 . . . . 0.0 114.81 170.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -97.41 -7.56 31.44 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.311 1.444 . . . . 0.0 113.631 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 125.38 171.61 13.28 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.108 1.813 . . . . 0.0 112.102 -170.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.82 149.88 73.17 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.673 2.915 . . . . 0.0 112.292 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.08 171.69 18.84 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.622 1.569 . . . . 0.0 112.403 -171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.0 159.78 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.671 1.588 . . . . 0.0 109.223 167.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.84 135.88 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.224 1.009 . . . . 0.0 110.884 -170.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -148.12 162.76 38.76 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.169 1.788 . . . . 0.0 111.53 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 21.4 p90 -159.54 159.15 28.18 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.617 1.167 . . . . 0.0 112.601 -177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.01 146.02 98.32 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.388 2.725 . . . . 0.0 112.752 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 63.59 18.39 11.06 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.93 1.292 . . . . 0.0 114.083 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -64.14 -33.73 76.45 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.286 -1.509 . . . . 0.0 112.082 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -76.92 -22.12 53.84 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.824 2.049 . . . . 0.0 114.08 174.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -94.14 -43.46 8.46 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.81 1.244 . . . . 0.0 111.608 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 67.6 m -83.2 -13.89 54.48 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.459 1.104 . . . . 0.0 113.089 174.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 50.1 mttp 55.91 49.38 16.05 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.321 1.448 . . . . 0.0 112.081 169.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 25.1 t -143.47 151.26 40.1 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.372 1.069 . . . . 0.0 112.737 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -93.93 16.1 15.15 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.372 1.869 . . . . 0.0 113.174 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -117.23 142.46 30.17 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 127.26 2.224 . . . . 0.0 109.213 169.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.95 121.22 7.13 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.402 2.735 . . . . 0.0 110.832 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.49 13.9 2.63 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.729 2.952 . . . . 0.0 113.41 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -124.59 -10.23 7.36 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.599 1.56 . . . . 0.0 114.198 -171.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 75.56 13.27 83.11 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 124.348 0.975 . . . . 0.0 113.826 -172.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -154.52 159.4 40.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.248 1.419 . . . . 0.0 112.167 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.08 170.93 18.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.769 1.227 . . . . 0.0 111.792 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -119.48 117.37 28.24 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.312 1.845 . . . . 0.0 109.705 177.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.85 142.01 34.08 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.162 1.385 . . . . 0.0 108.757 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 64.4 mt -124.07 106.17 10.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.672 1.589 . . . . 0.0 107.928 171.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.99 156.1 22.46 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.37 0.668 . . . . 0.0 111.946 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -78.61 -24.65 45.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -143.16 141.95 31.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.308 1.443 . . . . 0.0 110.675 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.47 -33.0 69.28 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.032 0.933 . . . . 0.0 111.935 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -55.52 -28.24 53.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.771 1.228 . . . . 0.0 113.111 174.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.5 m -73.37 -28.85 62.26 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.941 -1.099 . . . . 0.0 112.283 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.88 -39.55 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.685 -0.634 . . . . 0.0 109.624 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -66.18 -38.39 87.91 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.708 -0.62 . . . . 0.0 111.951 173.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.39 86.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.379 0.671 . . . . 0.0 112.409 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.25 -48.1 74.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.206 0.602 . . . . 0.0 111.049 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 78.4 mt -55.54 -41.95 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.93 0.892 . . . . 0.0 111.221 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.28 -17.15 63.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.814 1.246 . . . . 0.0 113.72 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.0 -13.65 18.99 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.167 1.387 . . . . 0.0 113.404 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 57.8 m -76.3 149.06 37.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 93.2 mt -85.94 177.46 7.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.666 1.586 . . . . 0.0 107.934 165.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.37 130.16 18.14 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.518 0.727 . . . . 0.0 111.337 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -150.6 128.48 11.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.044 1.737 . . . . 0.0 110.385 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 22.2 t70 59.42 22.74 11.23 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.772 1.629 . . . . 0.0 113.96 175.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 92.27 -1.46 73.25 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.662 1.601 . . . . 0.0 114.602 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -110.39 151.75 27.09 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.242 1.817 . . . . 0.0 111.466 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.4 mt -90.85 155.76 18.53 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.846 0.859 . . . . 0.0 111.137 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.55 144.43 32.91 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 3.7 tp -129.68 -167.05 1.74 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.673 1.989 . . . . 0.0 108.375 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.7 p -144.3 152.31 40.59 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.912 -1.118 . . . . 0.0 113.38 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.37 169.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.85 2.06 . . . . 0.0 110.761 -171.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 71.1 m -148.12 163.86 35.66 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.453 1.101 . . . . 0.0 113.018 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 52.4 p -145.32 -178.33 0.77 Allowed Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 126.905 2.082 . . . . 0.0 110.886 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.28 -10.96 30.43 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.298 2.665 . . . . 0.0 113.98 170.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 42.4 p -113.28 -31.33 6.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.016 1.326 . . . . 0.0 113.329 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.9 mm -133.62 134.23 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.159 1.384 . . . . 0.0 110.412 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -115.95 135.47 53.94 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.866 1.266 . . . . 0.0 111.119 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 61.84 32.95 17.91 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.468 1.507 . . . . 0.0 112.761 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -62.97 124.36 83.38 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.935 -1.103 . . . . 0.0 110.225 174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.48 145.88 27.0 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.983 2.455 . . . . 0.0 109.149 170.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.38 133.22 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.711 1.205 . . . . 0.0 110.719 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -76.41 130.59 38.25 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.497 1.119 . . . . 0.0 109.72 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.21 133.35 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.303 1.441 . . . . 0.0 108.54 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 51.8 mtp85 -138.65 98.19 8.92 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 124.306 1.042 . . . . 0.0 110.483 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.79 131.28 43.02 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.358 2.705 . . . . 0.0 110.01 169.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -76.84 141.64 40.57 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -169.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -160.24 152.16 20.18 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.422 2.289 . . . . 0.0 109.227 172.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.22 64.16 4.95 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.427 1.091 . . . . 0.0 110.372 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.1 m -84.24 -0.98 54.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.341 1.457 . . . . 0.0 114.215 -173.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 20.3 t70 71.87 9.74 6.18 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.769 2.427 . . . . 0.0 114.007 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 89.1 p -157.53 154.18 28.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.982 1.713 . . . . 0.0 112.066 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.1 137.58 7.37 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.755 1.622 . . . . 0.0 110.523 -174.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -142.68 155.02 44.85 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.602 1.161 . . . . 0.0 112.818 -168.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.2 125.68 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.77 1.228 . . . . 0.0 110.513 171.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 16.0 ttt -90.78 -13.08 34.62 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.472 1.509 . . . . 0.0 113.577 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.07 141.24 36.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.335 1.454 . . . . 0.0 111.566 176.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 18.3 m -69.33 -14.79 63.12 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 79.73 -169.19 53.15 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.893 1.235 . . . . 0.0 114.038 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -62.2 156.33 51.19 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 124.533 3.488 . . . . 0.0 113.319 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 11.1 t -162.12 169.91 20.07 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.231 1.412 . . . . 0.0 111.325 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 79.6 p -147.55 5.13 0.8 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.196 1.398 . . . . 0.0 114.364 -172.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.125 0 CA-C-O 118.34 -1.255 . . . . 0.0 113.077 -179.695 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 30.9 m -59.52 123.37 16.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.431 1.093 . . . . 0.0 112.255 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 51.7 p -166.86 164.48 16.33 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.868 1.267 . . . . 0.0 111.826 -171.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 79.95 -58.46 4.55 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.382 1.468 . . . . 0.0 111.571 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 50.8 m -65.57 133.72 51.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.315 1.046 . . . . 0.0 110.627 169.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 57.5 m -133.24 15.59 4.14 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.817 1.247 . . . . 0.0 113.065 -169.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 82.65 -41.48 2.85 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 125.758 1.647 . . . . 0.0 112.724 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 13.3 t -162.89 166.89 23.46 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.606 1.962 . . . . 0.0 111.56 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 82.9 mtm-85 -86.68 -7.82 57.97 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.136 0.974 . . . . 0.0 112.275 168.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -79.61 136.78 36.93 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.884 1.274 . . . . 0.0 110.674 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.6 t -141.42 121.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.497 1.119 . . . . 0.0 110.104 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -74.54 142.17 44.77 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.72 0.808 . . . . 0.0 111.158 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.88 124.12 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.402 1.481 . . . . 0.0 109.251 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -122.49 149.64 16.95 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.011 1.291 . . . . 0.0 113.615 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 92.48 17.41 45.84 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.864 1.221 . . . . 0.0 114.366 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.92 141.74 89.39 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.295 1.438 . . . . 0.0 111.381 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.31 154.98 17.21 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.906 3.07 . . . . 0.0 113.818 175.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.43 2.6 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.984 3.122 . . . . 0.0 114.105 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -140.29 23.17 2.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.964 1.306 . . . . 0.0 112.413 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.1 tt -95.32 160.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.681 1.193 . . . . 0.0 109.744 169.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -142.33 171.15 14.45 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.294 1.037 . . . . 0.0 113.107 -173.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -41.67 -47.16 3.91 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.082 1.753 . . . . 0.0 114.241 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.4 -26.97 46.62 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.486 -0.759 . . . . 0.0 112.635 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -80.56 -35.23 34.65 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.016 0.927 . . . . 0.0 111.669 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 65.3 mt -64.7 -36.52 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.614 -0.679 . . . . 0.0 109.465 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 53.7 m -65.4 -53.5 42.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.559 171.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.26 -31.34 70.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.27 0.941 . . . . 0.0 113.275 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.1 m -67.68 -23.6 65.32 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -122.49 -4.3 8.81 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -59.5 -23.04 62.46 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.027 1.331 . . . . 0.0 112.909 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -53.54 -20.55 5.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.678 1.991 . . . . 0.0 114.921 170.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -99.51 -5.66 28.87 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.381 1.472 . . . . 0.0 113.718 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.89 177.47 15.2 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 126.294 1.902 . . . . 0.0 112.406 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.99 147.66 91.77 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.393 2.729 . . . . 0.0 112.65 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.5 169.82 23.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.359 1.464 . . . . 0.0 112.551 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.5 156.93 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.624 1.569 . . . . 0.0 109.158 167.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 94.3 t -119.67 136.38 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.904 1.282 . . . . 0.0 110.068 -173.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -146.34 162.45 38.13 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.288 1.835 . . . . 0.0 111.455 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -164.25 164.1 14.47 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.094 1.358 . . . . 0.0 112.315 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -57.39 139.96 91.67 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.36 2.707 . . . . 0.0 112.341 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 66.14 15.14 9.97 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.064 1.346 . . . . 0.0 114.421 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -64.41 -20.49 66.18 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.056 -1.653 . . . . 0.0 113.043 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -72.69 -18.2 61.57 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.057 2.143 . . . . 0.0 114.789 173.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -136.44 -11.58 1.86 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 17.5 t -66.93 152.73 45.17 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.813 1.245 . . . . 0.0 112.954 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -93.09 9.48 35.68 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -169.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 98.7 p -153.84 170.0 22.03 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.795 1.238 . . . . 0.0 113.029 -175.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -109.85 23.41 14.41 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.218 1.807 . . . . 0.0 112.771 -174.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -104.03 152.9 39.17 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 127.273 2.229 . . . . 0.0 110.901 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.01 126.55 13.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.179 2.586 . . . . 0.0 110.549 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.37 135.4 26.64 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.411 2.741 . . . . 0.0 110.46 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 60.2 11.35 2.74 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.18 1.392 . . . . 0.0 114.291 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 85.65 25.69 37.91 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.222 1.391 . . . . 0.0 114.181 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -144.91 158.71 43.71 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.423 1.611 . . . . 0.0 114.741 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.99 170.04 23.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.607 1.563 . . . . 0.0 112.019 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -117.24 129.56 56.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.146 1.778 . . . . 0.0 110.243 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 35.8 mt -92.79 140.92 29.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.733 1.613 . . . . 0.0 108.699 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.8 mt -124.96 107.34 10.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.784 1.634 . . . . 0.0 108.077 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -88.21 161.55 17.16 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.822 0.849 . . . . 0.0 112.736 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -76.16 -27.2 56.88 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.294 1.038 . . . . 0.0 113.028 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.36 145.98 36.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.314 1.445 . . . . 0.0 110.515 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.98 -29.73 68.64 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.627 -0.67 . . . . 0.0 111.351 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.7 m -55.24 -28.15 51.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.358 1.063 . . . . 0.0 113.099 171.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 16.9 m -74.54 -28.59 61.03 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.928 -1.108 . . . . 0.0 112.046 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.59 -37.29 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.301 0.641 . . . . 0.0 109.83 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -63.33 -41.1 98.88 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.762 0.71 . . . . 0.0 111.552 170.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.21 84.61 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.655 0.661 . . . . 0.0 112.361 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.82 -48.22 75.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.413 0.685 . . . . 0.0 111.149 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 68.7 mt -55.56 -42.25 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.429 1.092 . . . . 0.0 111.16 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.2 -17.51 63.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.892 1.277 . . . . 0.0 113.589 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.11 -13.96 18.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.126 1.37 . . . . 0.0 113.317 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 59.0 m -74.75 146.8 41.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.944 0.878 . . . . 0.0 113.266 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.36 173.32 11.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.288 1.435 . . . . 0.0 108.001 165.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -145.81 135.38 23.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.646 0.778 . . . . 0.0 111.435 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -158.06 122.25 4.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.574 1.15 . . . . 0.0 111.185 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 66.45 5.88 4.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.819 2.448 . . . . 0.0 114.903 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 103.02 -2.32 47.84 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.892 1.71 . . . . 0.0 113.908 -170.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -93.82 144.79 25.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.537 1.535 . . . . 0.0 110.473 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.3 mt -97.22 154.33 17.46 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.929 0.891 . . . . 0.0 111.054 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -143.19 149.1 37.52 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.1 tp -132.03 -179.67 5.55 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.614 1.966 . . . . 0.0 108.729 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 71.8 m -130.61 140.42 50.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.269 1.028 . . . . 0.0 112.04 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.9 m -148.43 171.39 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 126.159 1.783 . . . . 0.0 111.623 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 68.7 m -147.29 163.36 36.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.783 1.233 . . . . 0.0 112.516 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 28.4 p -140.19 -175.73 0.5 Allowed Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.84 2.056 . . . . 0.0 110.631 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -66.9 -13.07 38.54 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.0 2.467 . . . . 0.0 113.894 171.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 44.0 p -120.91 -28.18 4.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.906 1.282 . . . . 0.0 113.836 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 16.3 mm -126.5 135.28 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.206 1.402 . . . . 0.0 110.117 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -121.41 131.0 53.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.689 1.196 . . . . 0.0 111.158 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 24.5 t70 62.67 32.32 16.29 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.305 1.442 . . . . 0.0 112.666 176.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -60.55 128.33 88.1 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.348 1.059 . . . . 0.0 110.528 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.21 139.5 14.93 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.207 2.604 . . . . 0.0 109.095 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 5.2 m -131.38 132.17 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.271 1.428 . . . . 0.0 109.769 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.71 133.77 35.39 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.291 1.036 . . . . 0.0 109.815 -174.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.98 134.9 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.292 1.437 . . . . 0.0 108.901 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -141.11 95.5 7.48 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.53 1.132 . . . . 0.0 110.641 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.14 130.23 35.31 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.664 2.909 . . . . 0.0 111.241 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -74.23 143.31 45.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.74 0.816 . . . . 0.0 112.042 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -161.83 157.65 24.39 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.985 1.314 . . . . 0.0 111.897 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.89 154.34 48.37 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.58 1.552 . . . . 0.0 110.763 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 25.8 m 65.96 17.96 10.94 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.452 1.501 . . . . 0.0 114.427 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -158.18 163.17 37.8 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.664 1.986 . . . . 0.0 110.846 -174.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 8.3 t -161.29 162.33 30.94 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.728 1.211 . . . . 0.0 112.395 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -160.77 142.19 12.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.309 2.244 . . . . 0.0 109.511 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -63.98 145.64 55.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 3.7 p -166.96 131.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 128.022 2.529 . . . . 0.0 106.955 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -16.24 63.64 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -169.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.34 -2.24 56.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.328 1.451 . . . . 0.0 113.444 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 3.1 t -70.28 3.57 2.8 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.252 1.421 . . . . 0.0 114.578 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -78.61 -147.49 3.58 Favored Glycine 0 CA--C 1.544 1.848 0 C-N-CA 125.651 1.596 . . . . 0.0 112.688 171.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -53.8 -26.48 39.2 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.113 3.209 . . . . 0.0 115.28 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 24.2 m -66.27 -14.37 61.88 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 67.7 m -119.96 5.27 10.89 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.592 1.557 . . . . 0.0 113.353 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.25 -1.306 . . . . 0.0 113.773 -179.113 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 36.1 p -73.49 -12.83 60.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.084 0.953 . . . . 0.0 113.166 171.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 9.3 t -153.62 -175.76 5.51 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.57 2.348 . . . . 0.0 109.473 170.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 92.87 0.43 68.74 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.27 1.415 . . . . 0.0 115.022 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 66.9 m -145.57 132.78 20.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.743 1.617 . . . . 0.0 110.174 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.7 p -154.41 4.91 0.26 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -169.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.11 -143.7 22.21 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.324 0.964 . . . . 0.0 113.104 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 24.0 t -158.76 166.09 32.78 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.309 1.443 . . . . 0.0 112.222 -170.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 46.7 mtm105 -75.25 -9.35 58.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.324 1.05 . . . . 0.0 112.931 169.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -79.92 136.99 36.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.146 0.978 . . . . 0.0 111.42 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.15 118.82 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.691 1.197 . . . . 0.0 109.709 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -75.23 142.31 43.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.394 0.678 . . . . 0.0 110.59 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.36 121.92 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.521 1.529 . . . . 0.0 109.189 176.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.78 148.23 18.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.796 1.189 . . . . 0.0 113.065 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 93.17 14.99 53.36 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.67 1.128 . . . . 0.0 114.268 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 92.9 mt -57.83 139.26 82.49 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.687 1.195 . . . . 0.0 110.375 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.32 150.56 19.8 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.602 2.868 . . . . 0.0 113.161 173.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.95 3.0 6.47 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.943 3.095 . . . . 0.0 113.579 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -137.57 16.07 2.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.728 2.011 . . . . 0.0 112.596 -169.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.4 tt -96.05 133.91 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.658 1.183 . . . . 0.0 111.781 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -94.8 162.16 13.87 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.472 1.109 . . . . 0.0 113.399 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -47.64 -44.49 26.96 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.107 1.763 . . . . 0.0 113.751 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.11 -27.91 57.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.825 0.85 . . . . 0.0 112.389 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -77.27 -34.47 55.68 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.528 0.731 . . . . 0.0 112.651 169.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.4 mt -64.99 -36.64 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.93 1.241 . . . . 0.0 109.609 169.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 54.0 m -64.99 -52.38 56.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.646 0.779 . . . . 0.0 110.54 172.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.49 -30.37 70.57 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.582 1.083 . . . . 0.0 112.924 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 75.6 m -65.61 -15.83 63.12 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -130.76 -3.24 4.14 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -61.03 -22.21 64.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.083 1.353 . . . . 0.0 113.009 173.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -57.58 -11.9 2.39 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.645 1.978 . . . . 0.0 114.931 169.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -105.92 -5.86 19.33 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.466 1.506 . . . . 0.0 114.047 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 123.91 173.98 14.04 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 126.073 1.797 . . . . 0.0 112.53 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.27 149.98 88.68 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.795 2.997 . . . . 0.0 113.016 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.75 171.98 16.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.255 1.422 . . . . 0.0 112.806 -176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.72 158.46 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.918 1.687 . . . . 0.0 109.298 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.37 135.63 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.578 1.151 . . . . 0.0 110.719 -170.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -149.56 162.42 40.21 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.893 1.677 . . . . 0.0 111.662 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -157.79 157.03 29.41 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.369 1.067 . . . . 0.0 112.722 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -59.89 156.3 39.21 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.951 3.101 . . . . 0.0 113.847 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 69.02 -6.46 0.9 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 126.842 2.057 . . . . 0.0 114.183 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -66.56 -23.74 66.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.299 1.44 . . . . 0.0 112.385 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -82.71 -14.3 54.83 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.183 2.193 . . . . 0.0 114.162 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.4 -21.19 11.49 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.459 1.503 . . . . 0.0 112.562 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 23.0 t -145.33 111.65 5.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.787 1.635 . . . . 0.0 108.806 170.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -74.04 132.64 42.54 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.421 0.688 . . . . 0.0 111.946 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 26.1 t -164.71 155.37 14.52 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.376 1.471 . . . . 0.0 110.51 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -108.59 15.9 23.38 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.362 1.465 . . . . 0.0 112.782 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.69 141.52 32.5 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.81 2.044 . . . . 0.0 109.594 169.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.64 120.22 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.226 2.617 . . . . 0.0 109.803 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -83.58 9.57 4.05 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.51 2.807 . . . . 0.0 114.611 -169.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -140.79 1.98 1.74 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.817 1.647 . . . . 0.0 114.239 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.82 21.63 68.15 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.115 0.864 . . . . 0.0 114.464 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -152.22 157.53 41.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.463 1.131 . . . . 0.0 112.652 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.34 168.77 25.98 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.718 1.207 . . . . 0.0 112.257 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -113.37 121.14 43.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.307 1.843 . . . . 0.0 109.727 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.3 mt -86.02 140.73 30.03 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.422 1.489 . . . . 0.0 108.76 169.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.53 107.65 12.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.788 1.635 . . . . 0.0 107.734 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.97 154.17 22.32 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.417 0.687 . . . . 0.0 111.936 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -71.65 -26.29 62.48 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.76 0.824 . . . . 0.0 112.822 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -142.25 146.05 34.71 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.389 1.475 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.53 -31.44 71.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.308 0.643 . . . . 0.0 111.659 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -56.24 -28.41 58.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.75 1.22 . . . . 0.0 112.876 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.0 m -73.19 -29.13 62.61 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.964 -1.085 . . . . 0.0 112.147 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.04 -38.51 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.646 -0.659 . . . . 0.0 109.784 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -66.78 -38.35 86.39 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.547 -0.721 . . . . 0.0 111.897 172.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.84 88.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.579 0.627 . . . . 0.0 112.372 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.76 -49.13 74.18 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.306 0.642 . . . . 0.0 110.929 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.62 -42.18 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.1 0.96 . . . . 0.0 111.428 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.07 -17.84 63.92 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.76 1.224 . . . . 0.0 113.581 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.1 -13.59 18.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.165 1.386 . . . . 0.0 113.351 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 54.7 m -75.49 148.14 39.24 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.6 172.93 11.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.045 165.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -146.91 139.06 24.62 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.487 0.715 . . . . 0.0 112.15 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -155.18 118.09 4.34 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.324 1.45 . . . . 0.0 109.275 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 18.6 t70 65.51 5.75 3.39 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.891 2.076 . . . . 0.0 114.973 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 103.09 -6.3 50.9 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.768 1.651 . . . . 0.0 113.575 -171.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -82.27 138.16 34.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.881 1.273 . . . . 0.0 109.348 169.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.8 mt -97.61 155.91 16.76 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.674 0.79 . . . . 0.0 110.83 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -143.03 148.43 36.72 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.6 tp -135.75 177.93 7.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.474 1.91 . . . . 0.0 108.904 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 86.7 m -126.51 144.66 50.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.242 1.017 . . . . 0.0 112.761 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.0 m -149.85 170.06 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 126.855 2.062 . . . . 0.0 111.038 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 70.6 m -148.69 163.47 37.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.761 1.224 . . . . 0.0 112.406 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 25.7 p -140.89 -173.44 0.36 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 126.745 2.018 . . . . 0.0 111.278 -174.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.79 -36.09 97.6 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.955 2.437 . . . . 0.0 113.863 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 44.8 p -119.29 -16.15 9.05 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 23.6 mm -113.69 128.79 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.693 1.133 . . . . 0.0 109.945 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -124.79 135.33 52.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.484 1.114 . . . . 0.0 111.69 -168.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 61.26 30.94 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.421 1.488 . . . . 0.0 112.631 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -66.85 128.32 93.82 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.52 1.128 . . . . 0.0 111.213 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.07 141.73 13.24 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.342 2.695 . . . . 0.0 109.119 169.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.18 135.08 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.396 1.479 . . . . 0.0 110.015 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -81.08 129.57 34.62 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.362 1.065 . . . . 0.0 109.561 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 35.7 mm -110.81 136.8 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.337 1.455 . . . . 0.0 109.08 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -142.14 87.01 9.89 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.904 1.282 . . . . 0.0 110.051 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.61 128.12 27.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.327 2.684 . . . . 0.0 109.763 172.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -74.66 121.19 21.27 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -169.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -154.4 19.86 0.48 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.032 1.733 . . . . 0.0 111.764 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 54.0 tp -73.14 125.35 27.5 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.012 1.325 . . . . 0.0 111.533 -171.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 67.6 m -134.13 57.81 1.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.455 1.502 . . . . 0.0 109.394 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . 0.285 2.6 p30 56.6 16.07 2.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.558 2.343 . . . . 0.0 114.431 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 4.7 p -84.67 8.59 16.43 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.865 2.866 . . . . 0.0 114.547 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -63.39 -6.37 4.73 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -81.21 3.7 22.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.488 1.515 . . . . 0.0 114.708 172.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.91 132.97 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.011 1.724 . . . . 0.0 110.955 -171.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 65.0 ttp -168.78 141.22 2.75 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.924 2.09 . . . . 0.0 109.868 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -163.43 169.62 18.62 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.113 1.365 . . . . 0.0 112.897 -175.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 89.1 p -155.02 166.49 33.43 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.889 1.676 . . . . 0.0 111.984 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -167.71 172.48 42.54 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.571 1.081 . . . . 0.0 113.973 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.68 153.85 49.02 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.074 3.183 . . . . 0.0 111.823 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 33.6 p -84.29 -3.56 58.31 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.754 1.222 . . . . 0.0 114.159 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 3.3 t 70.7 -175.29 0.19 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.03 2.132 . . . . 0.0 113.854 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 C-N-CA 125.7 1.619 . . . . 0.0 112.831 -178.009 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 92.0 p -163.87 178.41 7.82 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.547 1.539 . . . . 0.0 111.496 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 37.5 p -80.94 -3.67 52.31 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -97.51 173.13 28.21 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.558 1.552 . . . . 0.0 114.024 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 8.2 t -163.0 157.36 20.82 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.361 1.465 . . . . 0.0 111.442 173.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 48.7 m -153.45 155.23 35.92 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.06 1.744 . . . . 0.0 111.274 -171.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 151.76 -32.21 0.9 Allowed Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.048 1.309 . . . . 0.0 114.469 172.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 8.2 t -165.9 156.21 12.82 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.555 1.542 . . . . 0.0 112.32 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 86.3 mtm-85 -100.33 -2.52 33.38 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.486 1.114 . . . . 0.0 112.457 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -86.5 138.25 31.88 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.131 0.973 . . . . 0.0 111.132 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.0 t -140.6 120.63 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.293 1.037 . . . . 0.0 110.208 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -71.63 139.93 49.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.851 0.86 . . . . 0.0 110.644 171.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.4 t -132.6 119.35 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.32 1.448 . . . . 0.0 109.408 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.66 146.51 18.45 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.069 1.319 . . . . 0.0 113.435 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.13 17.87 30.75 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.883 1.23 . . . . 0.0 114.275 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.77 141.54 92.68 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.994 1.318 . . . . 0.0 111.441 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.11 156.77 15.22 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.877 3.052 . . . . 0.0 113.972 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.05 3.95 6.59 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.061 3.174 . . . . 0.0 113.815 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -137.45 23.22 2.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.377 1.471 . . . . 0.0 112.323 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.8 tt -104.81 142.66 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.556 1.142 . . . . 0.0 110.897 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -116.2 169.0 9.61 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.929 1.292 . . . . 0.0 113.068 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -48.64 -41.28 30.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.725 1.61 . . . . 0.0 113.921 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.13 -29.44 34.8 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.891 0.877 . . . . 0.0 112.388 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.93 -38.19 69.9 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.328 0.651 . . . . 0.0 111.822 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.1 mt -65.85 -38.71 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.301 -0.875 . . . . 0.0 109.449 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 85.2 m -60.93 -51.51 68.95 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.334 0.653 . . . . 0.0 110.539 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.93 -30.59 71.01 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.419 1.009 . . . . 0.0 112.914 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 65.9 m -68.93 -13.95 62.75 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -129.43 -2.89 4.91 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -60.96 -21.74 63.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.966 1.307 . . . . 0.0 113.228 174.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -56.74 -13.13 2.27 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.736 2.014 . . . . 0.0 114.976 169.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -104.47 -4.89 22.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.514 1.526 . . . . 0.0 113.999 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.07 175.1 15.08 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.983 1.754 . . . . 0.0 112.604 -174.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.26 145.54 98.38 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 123.923 3.082 . . . . 0.0 113.421 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.25 172.53 17.2 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.403 1.481 . . . . 0.0 112.698 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.58 159.85 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.835 1.654 . . . . 0.0 108.553 166.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 82.8 t -132.56 135.97 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.249 1.02 . . . . 0.0 110.421 -172.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -153.84 172.1 17.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.806 1.242 . . . . 0.0 112.437 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -152.6 150.88 25.83 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.928 0.891 . . . . 0.0 113.08 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -70.45 16.52 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 125.083 3.855 . . . . 0.0 117.666 -168.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -147.87 7.38 0.83 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.585 1.554 . . . . 0.0 113.674 -169.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -66.31 -21.33 66.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.237 1.015 . . . . 0.0 112.438 172.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -72.03 -33.17 67.82 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.612 1.565 . . . . 0.0 113.164 172.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.97 -21.54 17.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.659 1.184 . . . . 0.0 113.091 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.6 t -137.38 114.25 10.56 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.226 1.41 . . . . 0.0 108.587 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -72.36 0.95 8.74 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -167.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 49.0 m -60.96 139.06 58.12 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.157 1.383 . . . . 0.0 113.461 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -86.82 15.69 5.57 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.833 1.253 . . . . 0.0 113.44 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -118.22 133.92 23.42 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 128.515 2.726 . . . . 0.0 106.723 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.03 117.36 5.05 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.654 2.236 . . . . 0.0 110.638 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.04 13.58 2.32 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.562 2.841 . . . . 0.0 114.427 -172.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -132.56 -0.28 3.57 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.851 1.66 . . . . 0.0 113.998 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.61 18.35 77.68 Favored Glycine 0 N--CA 1.474 1.228 0 C-N-CA 124.276 0.941 . . . . 0.0 114.724 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -148.16 157.17 43.35 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.557 1.178 . . . . 0.0 112.973 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.91 167.54 27.25 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.051 1.341 . . . . 0.0 111.831 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -115.12 121.19 42.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.856 1.662 . . . . 0.0 109.845 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 21.0 mt -82.24 140.32 33.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.176 1.39 . . . . 0.0 108.731 169.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.9 mt -125.22 101.18 6.87 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.013 1.725 . . . . 0.0 108.11 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.34 159.13 27.3 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.165 0.586 . . . . 0.0 111.497 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -88.49 -13.51 40.09 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.68 142.23 34.92 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.695 1.598 . . . . 0.0 110.367 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.14 -29.78 71.07 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.556 -0.715 . . . . 0.0 112.04 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 26.7 p -59.58 -24.8 64.06 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.939 -1.1 . . . . 0.0 112.999 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.7 m -71.18 -28.79 64.48 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.888 -1.133 . . . . 0.0 112.314 172.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 70.4 t -73.88 -36.98 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.524 -0.735 . . . . 0.0 109.797 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -71.64 -35.74 70.49 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.736 -0.602 . . . . 0.0 112.137 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.37 85.87 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.673 0.67 . . . . 0.0 112.255 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.87 -49.17 73.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.543 0.737 . . . . 0.0 110.951 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.99 -41.64 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.094 0.958 . . . . 0.0 111.619 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.11 -18.48 63.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.844 1.258 . . . . 0.0 113.67 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.57 -13.5 20.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.049 1.339 . . . . 0.0 113.289 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 40.9 m -75.92 147.19 39.15 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.73 176.46 8.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.722 1.609 . . . . 0.0 107.798 165.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -144.74 128.96 17.74 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.649 -0.657 . . . . 0.0 111.382 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -149.43 132.6 16.36 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.965 2.106 . . . . 0.0 108.981 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 57.3 31.8 20.72 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.867 1.267 . . . . 0.0 113.246 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 78.42 7.36 87.95 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.811 1.196 . . . . 0.0 114.419 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -123.71 152.32 42.21 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.17 1.788 . . . . 0.0 111.354 -175.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 89.5 mt -89.21 154.07 20.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.68 0.792 . . . . 0.0 111.671 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -143.65 148.84 36.38 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.513 1.125 . . . . 0.0 113.002 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.8 tp -140.39 157.91 44.82 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.365 1.466 . . . . 0.0 110.134 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 76.6 m -95.96 136.91 35.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.15 0.98 . . . . 0.0 112.424 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 31.5 m -146.11 177.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 126.846 2.058 . . . . 0.0 110.44 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 82.0 p -162.76 168.52 21.36 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.054 -1.029 . . . . 0.0 113.481 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 51.9 p -138.75 -175.54 0.49 Allowed Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.454 1.902 . . . . 0.0 110.617 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.55 -12.42 35.72 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.172 2.581 . . . . 0.0 114.154 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 46.9 p -119.11 -29.39 5.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.964 1.306 . . . . 0.0 113.689 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 27.2 mm -128.77 127.07 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.285 1.434 . . . . 0.0 109.592 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -117.26 141.79 47.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.661 1.184 . . . . 0.0 111.774 -169.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 57.69 31.92 21.12 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.123 1.369 . . . . 0.0 113.096 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -70.51 128.17 91.37 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.314 1.045 . . . . 0.0 111.712 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.62 128.38 4.62 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.309 2.673 . . . . 0.0 108.578 169.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.51 137.91 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.187 1.395 . . . . 0.0 110.47 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -76.71 125.95 30.13 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.104 1.362 . . . . 0.0 109.568 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.3 mm -110.96 128.78 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.54 1.536 . . . . 0.0 108.548 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -136.36 91.5 16.43 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.633 1.173 . . . . 0.0 109.85 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.9 132.48 51.95 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.765 2.977 . . . . 0.0 110.312 172.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -88.3 170.94 10.55 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -168.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -157.83 149.48 21.76 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.728 1.611 . . . . 0.0 111.414 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -100.3 -14.87 18.24 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 79.9 p -97.17 -5.87 36.12 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -161.99 150.43 15.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.293 1.837 . . . . 0.0 111.406 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 78.3 p -156.5 15.56 0.31 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.631 1.973 . . . . 0.0 112.712 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.23 58.88 5.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.337 1.455 . . . . 0.0 112.623 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -63.1 115.93 4.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.306 1.442 . . . . 0.0 110.322 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 9.6 p -161.02 150.25 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.545 1.538 . . . . 0.0 110.883 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 27.0 ttt -157.44 146.38 19.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.503 1.521 . . . . 0.0 110.961 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -154.24 145.48 22.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.941 1.696 . . . . 0.0 110.777 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.3 m -80.92 96.2 6.99 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.168 0.987 . . . . 0.0 112.282 -174.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -83.43 168.33 46.05 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 124.602 1.096 . . . . 0.0 113.409 174.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.12 158.63 45.29 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.964 3.109 . . . . 0.0 111.609 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 51.5 p -82.63 -2.98 55.46 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 16.0 m -166.01 155.32 11.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.292 2.237 . . . . 0.0 110.944 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 118.278 -1.29 . . . . 0.0 112.889 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.554 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 7.9 t -155.53 -168.11 2.72 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.035 1.334 . . . . 0.0 111.907 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 72.3 p -121.57 14.52 11.04 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.405 1.882 . . . . 0.0 113.828 -171.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -77.55 176.57 53.53 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.283 1.421 . . . . 0.0 114.127 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 4.8 m -170.71 157.25 5.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.223 2.209 . . . . 0.0 110.127 -173.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 84.1 p -81.52 -20.02 40.94 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.008 -1.058 . . . . 0.0 112.769 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 82.55 3.64 90.44 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.305 1.431 . . . . 0.0 113.983 -175.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 22.6 t -68.41 135.31 51.53 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.01 1.405 . . . . 0.0 112.739 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 66.4 mtm-85 -100.37 3.66 43.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.375 1.47 . . . . 0.0 113.599 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.48 136.0 49.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.566 1.147 . . . . 0.0 111.026 172.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 61.3 t -140.86 120.69 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.579 1.151 . . . . 0.0 110.111 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -68.64 141.25 55.44 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.221 1.008 . . . . 0.0 111.258 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.74 125.8 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.992 1.317 . . . . 0.0 109.161 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -127.28 148.6 17.51 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 125.218 1.39 . . . . 0.0 113.461 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 90.52 15.68 56.47 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.714 1.149 . . . . 0.0 114.009 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.68 142.5 62.25 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.485 1.514 . . . . 0.0 111.408 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.47 151.48 23.71 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.774 2.983 . . . . 0.0 113.145 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.96 0.62 8.66 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.776 2.984 . . . . 0.0 114.795 -169.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -140.71 16.92 2.34 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.38 1.072 . . . . 0.0 113.0 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.9 tt -79.75 131.61 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.632 0.773 . . . . 0.0 111.506 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -92.65 167.89 11.6 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.96 -39.99 69.53 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.491 1.117 . . . . 0.0 113.195 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.93 -30.24 58.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.969 0.907 . . . . 0.0 112.087 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.09 -42.54 80.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.948 0.899 . . . . 0.0 111.517 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 63.3 mt -63.15 -40.7 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.162 0.892 . . . . 0.0 109.795 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 56.9 m -62.21 -51.56 67.31 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.655 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.65 -31.08 71.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.275 0.943 . . . . 0.0 112.567 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.3 m -68.97 -13.14 62.27 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -129.02 -3.62 5.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.618 1.099 . . . . 0.0 113.572 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -61.02 -22.77 64.86 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.867 1.267 . . . . 0.0 113.165 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -57.11 -13.39 2.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.624 1.97 . . . . 0.0 114.951 170.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -103.34 -7.34 21.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.427 1.491 . . . . 0.0 113.901 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.07 172.14 13.61 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.1 1.81 . . . . 0.0 112.075 -170.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.1 150.8 60.69 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.501 2.801 . . . . 0.0 112.237 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.16 174.96 12.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.604 1.562 . . . . 0.0 112.603 -169.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.78 157.23 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.852 1.661 . . . . 0.0 109.144 167.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 59.3 t -124.04 134.02 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.856 1.262 . . . . 0.0 109.79 -174.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -147.4 164.28 33.81 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.851 1.66 . . . . 0.0 111.817 -170.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . 0.5 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 10.2 p90 -163.19 162.68 17.67 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.553 1.541 . . . . 0.0 111.724 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -55.03 140.85 80.17 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.645 2.897 . . . . 0.0 113.006 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 69.64 3.35 4.2 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.106 1.762 . . . . 0.0 114.901 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.5 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 42.8 tttm -65.35 -29.79 70.55 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 120.551 -1.343 . . . . 0.0 112.165 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -67.29 -29.47 69.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.257 1.823 . . . . 0.0 113.628 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -101.53 -36.1 8.92 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.759 1.223 . . . . 0.0 112.558 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 66.7 m -91.68 -11.0 38.18 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 55.41 33.11 20.21 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 125.389 1.476 . . . . 0.0 112.206 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 27.6 p -81.29 164.5 22.17 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -168.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -134.51 3.51 3.32 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -168.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.25 144.96 54.72 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.61 1.964 . . . . 0.0 109.104 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.85 126.98 13.13 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.393 2.729 . . . . 0.0 111.242 -170.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.28 130.1 19.3 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.351 2.701 . . . . 0.0 109.964 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 58.53 12.66 2.19 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.399 1.48 . . . . 0.0 114.461 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 85.46 27.87 31.62 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.974 1.273 . . . . 0.0 114.481 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -137.51 156.74 47.79 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.591 1.696 . . . . 0.0 114.175 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -154.44 168.57 26.22 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.665 1.586 . . . . 0.0 111.647 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -120.22 120.71 36.92 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.947 1.699 . . . . 0.0 109.987 172.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.7 mt -83.27 141.12 32.08 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.909 1.284 . . . . 0.0 108.571 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 43.6 mt -123.5 105.49 9.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.395 1.478 . . . . 0.0 107.54 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.92 157.75 26.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.011 0.524 . . . . 0.0 111.274 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -90.48 -12.78 36.27 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -142.21 137.2 30.59 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.562 1.545 . . . . 0.0 110.098 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.48 -34.11 70.53 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.797 0.839 . . . . 0.0 111.964 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.6 m -55.97 -26.42 48.17 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.742 1.217 . . . . 0.0 113.197 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.4 m -71.84 -27.83 63.15 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.947 -1.096 . . . . 0.0 112.384 174.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 57.0 t -73.87 -39.9 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.657 -0.652 . . . . 0.0 109.513 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -67.94 -37.75 82.0 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.694 -0.629 . . . . 0.0 111.941 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.28 -38.36 89.05 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.554 0.616 . . . . 0.0 112.342 173.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.2 tp -63.85 -48.83 75.2 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.288 0.635 . . . . 0.0 110.888 171.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 76.4 mt -56.0 -42.68 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.958 0.903 . . . . 0.0 111.42 176.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.21 -19.02 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.729 1.212 . . . . 0.0 113.514 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.33 -14.07 20.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.052 1.341 . . . . 0.0 113.5 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 42.3 m -75.46 147.94 39.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.079 0.942 . . . . 0.0 113.41 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.54 172.85 11.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.505 1.522 . . . . 0.0 107.803 165.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.8 132.48 23.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.402 0.681 . . . . 0.0 111.501 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -147.12 121.49 9.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.818 1.647 . . . . 0.0 109.499 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 63.71 6.16 2.54 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.71 2.004 . . . . 0.0 114.42 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 101.6 -10.56 57.68 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.938 1.733 . . . . 0.0 113.589 -172.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -79.27 147.95 32.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.511 1.155 . . . . 0.0 109.7 169.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.1 mt -95.92 153.57 17.69 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.181 0.592 . . . . 0.0 111.014 173.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -140.17 146.75 39.17 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.005 0.922 . . . . 0.0 112.707 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.4 tp -129.87 -174.75 3.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.418 1.887 . . . . 0.0 108.561 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 30.0 p -133.94 149.49 51.27 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.058 0.943 . . . . 0.0 113.173 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 26.0 m -148.15 170.23 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 126.279 1.832 . . . . 0.0 111.588 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 50.8 m -145.33 154.23 42.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.536 1.134 . . . . 0.0 112.755 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 24.6 p -144.4 -175.04 0.44 Allowed Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 126.207 1.803 . . . . 0.0 111.502 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.31 -13.99 41.32 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.122 2.548 . . . . 0.0 113.659 171.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 29.3 p -117.51 -32.0 5.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.148 1.379 . . . . 0.0 113.77 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.5 mm -133.64 142.45 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.96 1.304 . . . . 0.0 110.137 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -120.94 133.63 55.28 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.081 1.352 . . . . 0.0 110.577 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.2 t70 63.08 28.34 16.08 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.152 1.381 . . . . 0.0 112.926 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -57.18 126.52 74.05 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-O 117.34 -1.314 . . . . 0.0 110.662 174.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.8 140.56 23.47 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.215 2.61 . . . . 0.0 109.652 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.05 134.78 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.829 1.252 . . . . 0.0 110.657 -174.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -73.14 134.73 44.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.001 1.321 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.8 mm -119.9 131.43 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.65 1.58 . . . . 0.0 108.105 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -139.99 95.36 8.59 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 123.848 0.859 . . . . 0.0 110.862 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.64 139.96 91.41 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.602 2.868 . . . . 0.0 111.889 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -82.26 -3.45 55.2 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.185 0.994 . . . . 0.0 112.568 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -77.79 95.8 4.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.788 1.235 . . . . 0.0 111.707 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -119.73 157.91 27.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.112 1.765 . . . . 0.0 110.522 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 81.1 p -163.91 180.0 6.66 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.428 1.491 . . . . 0.0 111.441 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.45 8.02 4.74 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.101 1.36 . . . . 0.0 113.245 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 31.0 m -75.95 -0.07 20.22 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -174.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 25.2 t0 81.29 150.19 0.1 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 129.118 2.967 . . . . 0.0 113.799 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -72.74 169.64 16.27 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.253 1.821 . . . . 0.0 113.045 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.6 p -152.92 139.28 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.806 1.642 . . . . 0.0 110.402 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 28.2 ttt -164.77 143.62 6.85 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.427 1.891 . . . . 0.0 110.036 -174.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 25.5 t70 63.44 18.14 10.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.651 1.98 . . . . 0.0 113.814 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 70.0 m -98.96 11.37 39.15 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.294 1.437 . . . . 0.0 113.86 -170.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -75.35 170.21 54.51 Favored Glycine 0 CA--C 1.543 1.782 0 C-N-CA 124.765 1.174 . . . . 0.0 113.812 177.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.67 152.72 53.7 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.047 3.165 . . . . 0.0 111.858 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.5 m -77.08 -3.41 39.11 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 80.5 p -164.49 165.37 21.41 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.025 1.73 . . . . 0.0 112.138 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.255 -1.303 . . . . 0.0 112.863 179.513 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -76.52 137.49 39.63 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.002 0.921 . . . . 0.0 111.174 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.5 t -138.27 116.82 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.475 1.11 . . . . 0.0 109.77 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.2 141.75 49.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.536 0.734 . . . . 0.0 110.727 172.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.37 124.64 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.239 1.416 . . . . 0.0 109.509 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -119.57 144.88 17.78 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.789 1.185 . . . . 0.0 113.319 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 100.24 9.16 48.68 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.585 1.565 . . . . 0.0 114.502 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.05 141.77 75.66 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.38 1.472 . . . . 0.0 111.328 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -53.93 155.71 14.12 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.851 3.034 . . . . 0.0 114.084 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.45 3.75 7.22 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.956 3.104 . . . . 0.0 113.527 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -137.93 19.94 2.83 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.623 1.569 . . . . 0.0 112.159 -170.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -103.05 136.39 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.317 1.447 . . . . 0.0 110.547 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -109.03 171.79 7.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.177 0.991 . . . . 0.0 113.02 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -44.35 -46.25 9.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.863 1.665 . . . . 0.0 113.602 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -76.35 -26.96 56.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.449 0.699 . . . . 0.0 112.591 -173.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -78.7 -38.17 39.77 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.819 0.848 . . . . 0.0 111.425 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 34.6 mt -65.06 -39.89 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 121.601 -0.687 . . . . 0.0 109.415 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 90.2 m -61.29 -52.51 64.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.756 0.823 . . . . 0.0 110.345 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.3 69.88 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.453 1.024 . . . . 0.0 113.213 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.1 m -68.46 -23.99 64.66 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -120.42 -4.12 9.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.256 1.022 . . . . 0.0 113.435 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -60.39 -22.07 62.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.313 1.445 . . . . 0.0 113.439 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -54.87 -19.29 6.25 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.425 1.89 . . . . 0.0 114.888 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -98.85 -4.81 32.24 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.467 1.507 . . . . 0.0 113.688 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.66 170.65 13.63 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.996 1.76 . . . . 0.0 112.015 -170.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.37 150.49 76.01 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.598 2.865 . . . . 0.0 112.144 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.88 172.87 16.2 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.721 1.608 . . . . 0.0 112.275 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.17 159.69 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.523 1.529 . . . . 0.0 108.797 167.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.78 136.17 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.179 0.991 . . . . 0.0 110.421 -172.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.897 1.679 . . . . 0.0 111.667 -173.156 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.882 0 CA-C-O 118.997 -0.89 . . . . 0.0 114.491 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -148.06 150.2 33.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.402 1.601 . . . . 0.0 114.634 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -154.81 173.32 16.62 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.979 1.312 . . . . 0.0 112.171 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -118.33 122.01 41.81 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.226 1.811 . . . . 0.0 110.302 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.34 141.5 31.74 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.375 1.47 . . . . 0.0 108.511 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 64.4 mt -125.73 103.67 7.95 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.951 1.701 . . . . 0.0 108.191 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -83.47 157.51 22.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.339 0.656 . . . . 0.0 112.126 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -75.28 -25.33 57.89 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.463 0.705 . . . . 0.0 112.658 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -138.14 144.41 40.77 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.175 1.39 . . . . 0.0 111.032 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.32 -32.43 72.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.448 0.699 . . . . 0.0 111.222 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.3 m -57.12 -27.88 62.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.705 1.202 . . . . 0.0 112.996 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.4 m -72.33 -28.92 63.36 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.961 -1.087 . . . . 0.0 111.994 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.76 -39.13 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 121.697 -0.627 . . . . 0.0 109.781 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -66.24 -39.02 89.23 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.614 -0.679 . . . . 0.0 111.949 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.86 86.93 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.542 0.61 . . . . 0.0 112.306 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 26.8 tp -64.25 -48.63 75.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.478 0.711 . . . . 0.0 111.042 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.67 -41.44 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.022 0.929 . . . . 0.0 111.408 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.18 -17.71 63.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.725 1.21 . . . . 0.0 113.66 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.18 -13.46 18.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.071 1.348 . . . . 0.0 113.455 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.7 m -75.6 147.59 39.48 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.876 0.87 . . . . 0.0 113.266 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.43 173.08 12.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.529 1.532 . . . . 0.0 108.215 165.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.471 0.609 0 C-N-CA 123.217 0.607 . . . . 0.0 112.575 -170.936 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 89.6 mt . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -140.93 141.43 34.51 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -125.41 -169.75 2.05 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.183 1.793 . . . . 0.0 108.332 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.2 p -141.73 150.2 41.48 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.645 1.111 . . . . 0.0 113.607 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 27.6 m -151.95 177.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.567 1.947 . . . . 0.0 111.486 -171.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 79.7 p -160.55 170.49 20.79 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.031 1.332 . . . . 0.0 112.933 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.4 p -153.78 -179.35 1.04 Allowed Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.73 2.012 . . . . 0.0 110.425 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.65 -19.93 55.5 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.845 2.363 . . . . 0.0 114.337 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 52.7 p -114.97 -19.28 11.0 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.05 1.34 . . . . 0.0 114.285 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.81 137.03 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.43 1.492 . . . . 0.0 110.391 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -131.64 137.75 48.49 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.711 1.204 . . . . 0.0 112.092 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.1 t70 57.54 28.4 15.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.396 1.478 . . . . 0.0 113.283 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -72.11 127.13 90.85 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.837 -1.078 . . . . 0.0 111.466 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.6 142.91 18.6 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.317 2.678 . . . . 0.0 109.381 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.5 m -137.65 133.22 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.55 1.14 . . . . 0.0 110.627 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -81.52 131.23 35.27 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.654 1.182 . . . . 0.0 110.057 -172.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.1 mm -114.05 128.61 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 108.986 -171.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -136.22 89.15 20.16 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.909 1.283 . . . . 0.0 110.092 -175.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.95 134.8 64.7 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.658 2.905 . . . . 0.0 110.851 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 . . . . . 0 CA--C 1.537 0.442 0 CA-C-O 121.172 0.51 . . . . 0.0 112.024 -174.84 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -82.12 135.72 35.26 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.592 0.633 . . . . 0.0 110.601 171.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.82 117.77 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.195 0.998 . . . . 0.0 110.146 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -71.21 139.74 50.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.147 0.979 . . . . 0.0 110.715 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 64.1 t -133.64 118.16 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.399 1.48 . . . . 0.0 109.292 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.09 143.44 18.07 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 124.803 1.192 . . . . 0.0 113.478 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.49 15.49 32.04 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.109 1.338 . . . . 0.0 114.4 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.64 139.47 85.84 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.957 1.303 . . . . 0.0 110.933 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -55.12 156.46 16.18 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.578 2.852 . . . . 0.0 113.703 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.91 5.4 4.95 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.054 3.169 . . . . 0.0 113.715 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -140.3 29.54 2.0 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.393 1.477 . . . . 0.0 112.043 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -110.7 128.32 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.464 1.106 . . . . 0.0 111.179 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -97.73 167.49 10.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.667 1.187 . . . . 0.0 113.334 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -43.6 -46.53 7.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.261 1.825 . . . . 0.0 113.994 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -79.01 -25.44 43.31 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.846 0.858 . . . . 0.0 112.523 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -77.51 -36.41 52.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.589 0.756 . . . . 0.0 111.933 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 44.0 mt -65.54 -36.39 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.153 0.888 . . . . 0.0 109.569 170.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 60.4 m -64.23 -52.19 59.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.831 0.852 . . . . 0.0 110.54 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.16 -30.64 70.52 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.605 1.093 . . . . 0.0 112.992 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.1 m -66.86 -15.5 63.67 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -130.19 -2.78 4.48 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -61.12 -22.09 64.34 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.987 1.315 . . . . 0.0 113.096 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -56.91 -13.12 2.37 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.736 2.014 . . . . 0.0 114.956 169.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -104.56 -5.73 21.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.497 1.519 . . . . 0.0 113.961 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.8 170.97 13.66 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.878 1.704 . . . . 0.0 112.104 -170.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.56 151.35 70.18 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.793 2.995 . . . . 0.0 112.429 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.06 172.92 15.11 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.63 1.572 . . . . 0.0 112.486 -170.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.52 159.44 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.742 1.617 . . . . 0.0 109.33 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.98 136.36 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.489 1.115 . . . . 0.0 110.817 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.3 t70 . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 126.375 1.87 . . . . 0.0 111.659 -174.727 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.247 0 CA-C-O 119.618 -0.545 . . . . 0.0 114.13 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -151.44 158.0 43.1 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.622 1.211 . . . . 0.0 112.773 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -151.81 168.79 23.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.662 1.185 . . . . 0.0 111.904 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.57 118.69 33.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.51 1.924 . . . . 0.0 109.521 175.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 23.7 mt -82.34 142.33 32.11 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.306 1.442 . . . . 0.0 109.053 169.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 53.7 mt -125.97 106.79 9.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.018 1.727 . . . . 0.0 108.05 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.03 156.43 21.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.519 0.728 . . . . 0.0 112.161 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -69.01 -34.56 75.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.701 0.801 . . . . 0.0 112.41 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -140.57 141.62 35.21 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.991 1.716 . . . . 0.0 109.999 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -60.59 -32.41 71.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.052 0.941 . . . . 0.0 111.808 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 19.2 m -56.81 -27.05 59.3 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.616 1.166 . . . . 0.0 112.954 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 22.5 m -70.06 -28.73 65.69 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.089 -1.007 . . . . 0.0 112.283 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 57.9 t -77.18 -36.5 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.643 -0.66 . . . . 0.0 110.043 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -68.74 -37.15 79.22 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.515 -0.741 . . . . 0.0 111.871 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.43 -37.84 87.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.298 0.639 . . . . 0.0 112.294 172.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.0 tp -64.68 -48.55 74.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.435 0.694 . . . . 0.0 111.032 171.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.1 mt -55.89 -41.51 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.086 0.954 . . . . 0.0 111.261 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.45 -17.53 63.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.767 1.227 . . . . 0.0 113.636 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.83 -13.64 19.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.082 1.353 . . . . 0.0 113.27 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 56.8 m -71.93 141.17 49.47 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.029 0.919 . . . . 0.0 113.077 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 90.6 mt -80.94 176.28 9.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.541 1.536 . . . . 0.0 108.052 165.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 . . . . . 0 CA--C 1.536 0.421 0 C-N-CA 123.402 0.681 . . . . 0.0 110.956 178.773 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 120.713 0.292 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -141.22 152.13 44.33 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.873 1.269 . . . . 0.0 113.787 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.0 tp -140.17 161.62 37.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.767 1.627 . . . . 0.0 109.916 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 24.2 p -97.88 139.0 34.38 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.92 1.288 . . . . 0.0 112.769 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.1 m -148.21 175.61 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 126.627 1.971 . . . . 0.0 110.667 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 82.9 p -161.38 170.9 19.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.3 p -139.61 -177.82 0.74 Allowed Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 127.009 2.123 . . . . 0.0 110.885 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -65.6 -11.72 31.82 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.322 2.681 . . . . 0.0 114.273 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 43.7 p -122.7 -24.71 4.82 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.025 1.33 . . . . 0.0 113.857 -174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 31.0 mm -129.77 125.86 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.325 1.45 . . . . 0.0 109.648 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.06 143.74 48.91 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.576 1.15 . . . . 0.0 112.347 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 61.08 30.67 19.6 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.451 1.501 . . . . 0.0 112.701 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -69.18 127.95 92.76 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 121.128 -0.982 . . . . 0.0 111.529 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.25 131.8 5.05 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.397 2.732 . . . . 0.0 108.941 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.35 133.91 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.026 1.33 . . . . 0.0 110.915 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -77.34 127.98 33.5 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.411 1.085 . . . . 0.0 109.638 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.4 mm -109.21 132.77 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.91 1.284 . . . . 0.0 109.211 -174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -139.87 93.88 9.28 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.477 1.111 . . . . 0.0 110.295 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.04 135.56 69.38 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.252 2.635 . . . . 0.0 109.687 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -169.249 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.5 mtm-85 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -82.24 134.26 35.28 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.254 1.422 . . . . 0.0 111.128 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.6 t -141.0 121.05 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.297 1.039 . . . . 0.0 110.246 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -75.11 140.33 43.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.683 0.793 . . . . 0.0 110.49 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.73 120.6 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.24 1.416 . . . . 0.0 109.294 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.37 146.71 18.55 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 124.836 1.208 . . . . 0.0 113.917 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 91.32 23.75 28.38 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.958 1.266 . . . . 0.0 113.931 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.22 145.91 64.26 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.826 1.651 . . . . 0.0 111.717 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -52.34 155.56 9.38 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.13 3.22 . . . . 0.0 113.907 174.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.57 1.12 9.34 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.878 3.052 . . . . 0.0 113.576 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -140.4 45.79 1.83 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.672 1.589 . . . . 0.0 111.469 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.8 tt -127.57 147.67 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.437 1.495 . . . . 0.0 110.834 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -123.92 170.98 10.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.461 1.504 . . . . 0.0 113.08 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -50.28 -40.82 49.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.177 1.391 . . . . 0.0 113.994 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -81.1 -29.8 34.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.993 0.917 . . . . 0.0 112.361 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.22 -38.75 71.99 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.329 0.652 . . . . 0.0 111.882 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 46.8 mt -66.05 -38.23 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.52 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 88.8 m -61.26 -51.18 70.03 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.316 0.647 . . . . 0.0 110.634 172.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.84 -31.07 71.29 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.245 0.929 . . . . 0.0 112.866 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.5 m -69.09 -14.29 62.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -128.23 -3.08 5.65 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.34 0.973 . . . . 0.0 113.539 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -60.61 -22.1 63.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.905 1.282 . . . . 0.0 113.38 174.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -56.81 -14.17 3.19 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.663 1.985 . . . . 0.0 115.016 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -102.82 -4.4 24.95 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.36 1.464 . . . . 0.0 113.903 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 120.89 171.68 14.38 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.864 1.697 . . . . 0.0 111.981 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.18 151.87 72.35 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.589 2.859 . . . . 0.0 112.271 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.66 173.45 13.87 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.913 1.685 . . . . 0.0 112.312 -171.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.04 157.8 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.658 1.583 . . . . 0.0 108.707 166.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.18 136.25 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.514 1.126 . . . . 0.0 110.158 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 21.7 t0 . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.48 1.112 . . . . 0.0 112.751 -178.94 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.18 0 CA-C-O 119.369 -0.684 . . . . 0.0 114.354 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -148.16 160.76 42.58 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.775 1.288 . . . . 0.0 113.188 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.42 165.07 36.17 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.992 1.317 . . . . 0.0 111.879 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.28 121.52 45.48 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.832 1.653 . . . . 0.0 109.941 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 22.5 mt -84.85 139.91 31.56 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.433 1.493 . . . . 0.0 108.682 169.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 45.5 mt -127.06 103.13 7.28 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.922 1.689 . . . . 0.0 107.874 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -82.03 160.74 23.17 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.391 0.677 . . . . 0.0 111.813 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -82.84 -16.24 48.46 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -141.29 141.47 33.92 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.405 1.482 . . . . 0.0 110.51 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.77 -30.03 69.77 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.709 -0.62 . . . . 0.0 111.508 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.5 m -55.27 -28.46 53.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.666 1.187 . . . . 0.0 112.964 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.6 m -73.48 -28.74 62.09 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.01 -1.056 . . . . 0.0 112.213 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 86.1 t -75.21 -37.79 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.561 -0.712 . . . . 0.0 109.848 174.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -67.28 -38.2 84.69 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.552 -0.718 . . . . 0.0 111.967 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.83 -37.75 88.03 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.615 0.643 . . . . 0.0 112.322 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.1 tp -63.52 -49.12 74.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.386 0.675 . . . . 0.0 110.92 171.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.7 mt -55.85 -41.51 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.155 0.982 . . . . 0.0 111.351 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.4 -18.25 63.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.737 1.215 . . . . 0.0 113.672 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.48 -14.28 20.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.044 1.337 . . . . 0.0 113.433 174.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.0 m -75.03 146.72 41.34 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.064 0.935 . . . . 0.0 113.475 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -85.17 176.24 8.48 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.545 1.538 . . . . 0.0 107.844 165.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 123.375 0.67 . . . . 0.0 111.715 -175.863 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 120.82 0.343 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -144.98 150.55 37.13 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.504 1.122 . . . . 0.0 113.271 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.35 153.18 42.46 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.045 1.338 . . . . 0.0 110.617 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 21.5 p -83.72 136.45 34.17 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.627 1.171 . . . . 0.0 112.607 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.8 165.4 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 126.021 1.728 . . . . 0.0 111.264 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 50.4 m -146.59 168.06 22.19 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.262 1.025 . . . . 0.0 113.217 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.0 p -147.65 -173.79 0.38 Allowed Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 127.804 2.442 . . . . 0.0 109.942 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -64.63 -16.09 53.41 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.051 2.501 . . . . 0.0 114.341 171.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 57.4 p -126.99 -15.37 5.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.932 1.293 . . . . 0.0 114.312 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.0 mm -129.63 135.0 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.173 1.789 . . . . 0.0 109.27 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -133.14 132.4 41.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.039 0.936 . . . . 0.0 112.338 -169.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.7 t70 59.36 26.95 15.92 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.674 1.59 . . . . 0.0 113.032 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -75.15 129.86 81.81 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.401 1.48 . . . . 0.0 111.901 -169.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -76.35 117.75 4.71 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.407 2.738 . . . . 0.0 110.916 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.89 141.25 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.347 1.459 . . . . 0.0 110.436 173.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -79.03 129.47 34.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.045 0.938 . . . . 0.0 109.861 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.5 131.69 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.487 1.515 . . . . 0.0 108.77 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 29.2 mtp85 -139.25 86.86 14.21 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.681 1.193 . . . . 0.0 110.107 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.89 138.69 80.65 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.638 2.892 . . . . 0.0 111.372 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 123.478 0.711 . . . . 0.0 112.405 -173.202 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -71.19 138.63 49.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.928 0.891 . . . . 0.0 110.816 169.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.6 t -140.07 119.49 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.537 1.135 . . . . 0.0 109.717 175.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -71.77 139.53 49.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.867 0.867 . . . . 0.0 110.544 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.9 119.11 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.311 1.445 . . . . 0.0 109.407 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -117.03 147.67 18.88 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.113 1.339 . . . . 0.0 113.45 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 92.02 19.07 40.93 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 124.702 1.144 . . . . 0.0 114.142 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 98.3 mt -55.2 141.56 60.66 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.561 1.544 . . . . 0.0 111.189 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.94 148.86 28.17 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.625 2.884 . . . . 0.0 112.806 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.62 6.65 3.1 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.207 3.271 . . . . 0.0 114.461 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -140.05 16.57 2.45 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.48 1.512 . . . . 0.0 112.676 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.6 tt -93.39 137.73 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.039 0.936 . . . . 0.0 111.408 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -109.92 170.26 8.19 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.721 1.208 . . . . 0.0 113.161 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -47.66 -44.11 26.89 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.647 1.579 . . . . 0.0 113.746 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -79.65 -25.49 41.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.839 0.855 . . . . 0.0 112.316 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -77.99 -36.64 48.64 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.773 0.829 . . . . 0.0 111.496 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.0 mt -64.89 -38.64 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 118.932 0.787 . . . . 0.0 109.529 170.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 61.6 m -62.74 -52.01 64.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.533 0.733 . . . . 0.0 110.517 173.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.7 70.89 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.5 1.045 . . . . 0.0 112.998 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.6 m -67.66 -15.04 63.44 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -129.62 -2.97 4.8 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -60.98 -22.63 64.66 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.878 1.271 . . . . 0.0 113.142 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -56.42 -13.99 2.67 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.806 2.042 . . . . 0.0 115.009 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -103.67 -6.29 21.74 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.432 1.493 . . . . 0.0 113.946 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 123.44 172.33 13.77 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.961 1.743 . . . . 0.0 112.14 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.79 151.45 68.87 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.544 2.829 . . . . 0.0 112.358 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.27 172.88 15.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.746 1.618 . . . . 0.0 112.527 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -134.02 159.19 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.706 1.603 . . . . 0.0 109.28 167.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 56.1 t -129.26 135.11 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.308 1.043 . . . . 0.0 110.77 -171.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 CA--C 1.545 0.761 0 C-N-CA 126.257 1.823 . . . . 0.0 111.845 -172.969 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 CA-C-O 119.678 -0.512 . . . . 0.0 114.284 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -149.88 156.79 42.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.641 1.176 . . . . 0.0 112.651 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.58 169.67 22.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.905 1.282 . . . . 0.0 111.697 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -116.32 118.06 31.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.39 1.876 . . . . 0.0 109.531 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 25.4 mt -80.95 141.09 34.83 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.921 1.288 . . . . 0.0 108.682 169.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.8 mt -123.85 103.42 8.34 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.747 1.619 . . . . 0.0 107.871 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -81.02 156.52 25.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.116 0.566 . . . . 0.0 111.403 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -82.81 -15.75 50.45 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -141.87 141.85 33.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.4 1.48 . . . . 0.0 110.658 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.57 -31.86 70.97 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.228 0.611 . . . . 0.0 111.533 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -56.03 -28.04 55.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.65 1.18 . . . . 0.0 112.941 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.3 m -73.92 -29.64 62.15 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.955 -1.091 . . . . 0.0 112.168 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.95 -38.81 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.667 -0.646 . . . . 0.0 109.66 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -66.96 -38.51 86.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.636 -0.665 . . . . 0.0 111.985 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.92 88.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.627 0.649 . . . . 0.0 112.304 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.95 -48.85 74.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.45 0.7 . . . . 0.0 110.918 171.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 74.2 mt -55.67 -42.43 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.091 0.957 . . . . 0.0 111.345 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.98 -17.97 64.0 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.668 1.187 . . . . 0.0 113.671 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.09 -13.88 19.63 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.113 1.365 . . . . 0.0 113.431 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.9 m -77.51 150.46 34.86 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -86.83 176.23 7.81 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.79 1.636 . . . . 0.0 107.778 164.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.471 0.589 0 C-N-CA 123.463 0.705 . . . . 0.0 111.729 -174.783 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 120.68 0.276 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -144.18 148.97 35.7 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.224 1.01 . . . . 0.0 113.096 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -140.7 162.1 36.2 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.733 1.613 . . . . 0.0 110.017 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 24.8 p -97.79 141.17 31.11 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.082 1.353 . . . . 0.0 112.628 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.4 m -146.66 169.98 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 126.7 2.0 . . . . 0.0 110.644 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.7 m -148.9 169.05 21.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.553 1.141 . . . . 0.0 112.786 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.28 175.98 2.57 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 127.916 2.487 . . . . 0.0 109.493 -176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -57.19 -31.97 92.13 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.162 2.575 . . . . 0.0 115.016 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 42.2 p -119.07 0.12 11.21 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.556 1.542 . . . . 0.0 114.03 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.6 mm -135.68 121.65 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.84 1.656 . . . . 0.0 109.061 -171.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -125.05 134.33 52.58 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.204 1.002 . . . . 0.0 111.984 -168.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.2 t70 60.3 30.81 20.14 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.298 1.439 . . . . 0.0 112.653 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -62.71 129.88 93.27 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.782 1.233 . . . . 0.0 110.962 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.87 137.61 11.19 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.214 2.61 . . . . 0.0 109.193 169.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.23 138.16 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.244 1.418 . . . . 0.0 110.201 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -79.05 127.74 32.38 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.012 1.325 . . . . 0.0 109.532 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.0 mm -112.22 132.8 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.581 1.552 . . . . 0.0 108.673 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -141.21 92.54 8.36 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.476 1.11 . . . . 0.0 110.074 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.79 133.37 55.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.53 2.82 . . . . 0.0 110.829 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 . . . . . 0 CA--C 1.54 0.559 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -169.875 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.26 133.86 35.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.686 1.195 . . . . 0.0 110.811 171.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.9 123.0 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.425 1.09 . . . . 0.0 110.524 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.37 143.44 44.85 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.313 1.045 . . . . 0.0 111.344 171.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.61 127.2 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.236 1.414 . . . . 0.0 109.586 172.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -127.78 146.44 16.62 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.938 1.256 . . . . 0.0 113.622 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 96.73 15.98 38.01 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.142 1.353 . . . . 0.0 114.451 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.31 141.99 86.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.238 1.415 . . . . 0.0 111.507 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.25 155.82 14.95 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.027 3.151 . . . . 0.0 114.283 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.75 2.71 7.58 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 124.117 3.212 . . . . 0.0 113.673 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -138.19 34.76 2.32 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.643 1.577 . . . . 0.0 111.815 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 10.4 tt -114.1 162.57 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.525 1.53 . . . . 0.0 110.234 172.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -146.22 170.36 16.9 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.049 1.34 . . . . 0.0 112.539 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -42.74 -47.66 5.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.132 1.773 . . . . 0.0 114.264 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.25 -29.2 42.53 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.388 -0.82 . . . . 0.0 112.34 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -74.15 -37.25 64.08 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.634 0.774 . . . . 0.0 111.45 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 64.6 mt -65.77 -39.52 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.454 -0.778 . . . . 0.0 109.569 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 62.0 m -60.63 -52.5 64.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.254 173.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.15 71.41 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.332 0.969 . . . . 0.0 112.942 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.2 m -69.42 -14.59 62.98 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -128.2 -4.1 5.59 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.347 0.976 . . . . 0.0 113.508 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -60.61 -22.44 63.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.952 1.301 . . . . 0.0 113.284 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -56.44 -13.7 2.47 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.716 2.006 . . . . 0.0 115.045 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -104.86 -4.38 22.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.236 1.414 . . . . 0.0 113.988 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.72 172.73 14.34 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.818 1.675 . . . . 0.0 112.228 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.68 151.59 69.55 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.722 2.948 . . . . 0.0 112.172 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.09 172.66 16.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.538 1.535 . . . . 0.0 112.553 -169.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.37 151.45 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.876 1.67 . . . . 0.0 109.389 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.98 134.77 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.338 1.455 . . . . 0.0 109.719 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 CA--C 1.544 0.724 0 C-N-CA 125.95 1.7 . . . . 0.0 112.05 -169.79 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 CA-C-O 118.813 -0.993 . . . . 0.0 114.315 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -137.15 158.05 45.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.495 1.648 . . . . 0.0 113.752 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.36 167.8 29.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.502 1.521 . . . . 0.0 111.763 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -118.71 135.07 54.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.023 1.729 . . . . 0.0 109.913 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.2 mt -103.41 139.26 39.03 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.064 1.746 . . . . 0.0 108.697 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 14.2 mt -121.27 113.0 19.31 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.86 156.19 19.08 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.761 0.824 . . . . 0.0 111.338 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -64.59 -35.64 81.64 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.746 -0.596 . . . . 0.0 112.359 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -141.0 144.99 35.35 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.641 1.576 . . . . 0.0 110.507 -171.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.02 -30.88 70.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.508 1.123 . . . . 0.0 112.203 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 24.0 p -61.25 -25.83 67.35 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.088 1.355 . . . . 0.0 113.147 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 25.9 m -70.36 -30.75 67.76 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.931 -1.105 . . . . 0.0 111.686 172.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.75 -34.53 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.539 -0.726 . . . . 0.0 110.249 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -66.44 -37.59 85.5 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.436 -0.79 . . . . 0.0 111.861 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.87 89.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.652 0.66 . . . . 0.0 112.408 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.7 tp -62.99 -48.83 77.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.252 0.621 . . . . 0.0 110.824 171.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 70.8 mt -55.82 -42.29 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.334 1.054 . . . . 0.0 111.289 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.27 -19.67 63.92 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.601 1.16 . . . . 0.0 113.63 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -96.63 -14.14 22.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.952 1.301 . . . . 0.0 113.312 174.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 29.7 m -75.55 146.69 40.27 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 88.7 mt -85.33 -179.06 6.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.998 1.719 . . . . 0.0 107.702 164.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 CA--C 1.537 0.469 0 O-C-N 121.465 -0.772 . . . . 0.0 111.843 -177.789 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 120.878 0.37 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -145.51 149.94 35.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.776 1.23 . . . . 0.0 112.711 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -144.27 153.17 41.76 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.891 1.276 . . . . 0.0 110.936 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 20.5 p -85.63 134.4 33.99 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.656 1.182 . . . . 0.0 112.804 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.87 167.48 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 126.335 1.854 . . . . 0.0 110.708 172.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.2 m -149.69 166.67 28.64 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.493 1.117 . . . . 0.0 112.814 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.5 p -138.51 -175.72 0.51 Allowed Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 127.209 2.204 . . . . 0.0 110.494 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.57 -15.39 49.7 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.064 2.509 . . . . 0.0 114.233 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 47.1 p -123.1 -23.7 4.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.898 1.279 . . . . 0.0 114.172 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.3 mm -126.23 132.28 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.601 1.56 . . . . 0.0 109.534 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -125.0 134.83 52.43 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.41 1.084 . . . . 0.0 111.773 -170.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 62.36 27.61 16.45 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.589 1.555 . . . . 0.0 112.928 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -60.32 127.27 86.11 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.607 1.163 . . . . 0.0 111.511 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.51 110.82 1.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.401 2.734 . . . . 0.0 108.287 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.27 136.22 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.115 0.966 . . . . 0.0 110.05 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -74.67 134.49 41.98 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.168 0.987 . . . . 0.0 109.486 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.73 133.92 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 126.14 1.776 . . . . 0.0 108.097 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 39.7 mtt180 -138.85 98.57 8.6 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.995 0.918 . . . . 0.0 110.343 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.31 134.4 61.29 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.434 2.756 . . . . 0.0 110.38 169.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 123.433 0.693 . . . . 0.0 112.455 -175.13 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -68.83 139.13 55.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.041 0.936 . . . . 0.0 111.222 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.5 t -139.04 118.53 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.595 1.158 . . . . 0.0 109.996 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -68.54 138.85 55.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.07 0.948 . . . . 0.0 110.838 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.5 t -132.55 116.91 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.255 1.422 . . . . 0.0 109.277 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.04 143.91 17.9 Favored Glycine 0 N--CA 1.47 0.913 0 C-N-CA 124.905 1.24 . . . . 0.0 113.637 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.1 23.71 21.68 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.669 1.128 . . . . 0.0 113.882 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.72 141.57 84.68 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.042 1.337 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.22 155.18 20.46 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.503 2.802 . . . . 0.0 113.538 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.23 3.29 6.36 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.803 3.002 . . . . 0.0 114.524 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -140.55 27.14 2.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.865 1.266 . . . . 0.0 112.819 -177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.2 tt -101.07 144.75 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.466 1.106 . . . . 0.0 110.817 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -122.38 170.93 9.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.609 1.163 . . . . 0.0 113.022 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -46.36 -43.71 16.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.109 1.764 . . . . 0.0 114.21 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -76.77 -27.86 55.47 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.447 -0.783 . . . . 0.0 112.401 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -78.67 -36.14 44.13 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.944 0.898 . . . . 0.0 111.499 172.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.0 mt -65.47 -36.77 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.968 0.803 . . . . 0.0 109.559 171.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 48.7 m -64.8 -52.39 57.11 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.461 0.704 . . . . 0.0 110.563 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.22 71.03 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.422 1.01 . . . . 0.0 113.019 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.2 m -67.84 -14.67 63.15 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.656 1.182 . . . . 0.0 114.094 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -129.65 -3.01 4.78 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.457 1.026 . . . . 0.0 113.651 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -60.5 -22.62 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.867 1.267 . . . . 0.0 113.143 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -56.81 -14.0 3.04 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.675 1.99 . . . . 0.0 115.001 170.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -103.78 -6.86 21.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.281 1.433 . . . . 0.0 113.97 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.98 172.18 13.44 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.072 1.796 . . . . 0.0 112.114 -171.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.09 151.21 72.9 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.512 2.808 . . . . 0.0 112.133 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.34 172.33 16.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.598 1.559 . . . . 0.0 112.367 -170.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.79 157.9 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.719 1.608 . . . . 0.0 109.411 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 80.4 t -126.74 135.0 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.61 1.164 . . . . 0.0 110.472 -171.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.0 t70 . . . . . 0 CA--C 1.544 0.72 0 C-N-CA 126.499 1.92 . . . . 0.0 111.689 -172.974 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.312 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.468 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -149.04 161.5 41.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.681 1.192 . . . . 0.0 112.871 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -148.69 164.66 33.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.177 1.391 . . . . 0.0 111.549 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -115.33 115.43 26.61 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.186 1.794 . . . . 0.0 109.155 171.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.4 mt -80.82 142.31 33.83 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.739 1.215 . . . . 0.0 108.911 169.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 48.8 mt -123.37 108.77 13.1 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.603 1.561 . . . . 0.0 107.544 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -85.43 156.4 20.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.245 0.618 . . . . 0.0 111.953 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -75.18 -27.22 59.58 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -142.42 146.6 35.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.238 1.415 . . . . 0.0 111.018 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -63.97 -28.96 70.17 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.047 0.939 . . . . 0.0 111.742 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 22.2 p -61.79 -26.26 67.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 112.948 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.4 m -73.93 -34.34 64.28 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.863 -1.148 . . . . 0.0 111.75 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.77 -40.26 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.773 -0.579 . . . . 0.0 109.871 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -67.66 -40.35 84.51 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.615 -0.678 . . . . 0.0 111.957 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.67 76.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.318 0.963 . . . . 0.0 112.553 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.3 tp -64.92 -48.2 75.0 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.171 0.589 . . . . 0.0 111.012 170.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 85.6 mt -56.38 -42.86 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 118.895 0.771 . . . . 0.0 111.335 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.0 -14.97 63.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.245 1.418 . . . . 0.0 114.154 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.7 -14.51 18.06 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.907 1.283 . . . . 0.0 113.417 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 56.2 m -73.46 145.25 45.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.156 0.979 . . . . 0.0 113.448 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.5 mt -82.36 175.05 10.56 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.591 1.556 . . . . 0.0 107.823 165.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.468 0.462 0 C-N-CA 123.537 0.735 . . . . 0.0 111.253 -177.435 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 120.747 0.308 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -142.24 152.36 42.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.291 1.037 . . . . 0.0 113.161 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.9 tp -139.52 168.36 20.0 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.797 1.639 . . . . 0.0 109.507 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 25.3 p -105.2 142.22 35.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.207 1.403 . . . . 0.0 112.518 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -144.83 171.59 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.628 1.971 . . . . 0.0 110.462 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 64.0 m -147.8 161.49 41.15 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.169 -0.957 . . . . 0.0 113.402 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 53.8 p -148.36 179.1 1.25 Allowed Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.764 2.025 . . . . 0.0 110.998 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -65.13 -13.83 41.91 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.295 2.663 . . . . 0.0 114.06 170.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 34.0 p -107.59 -31.38 8.13 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.01 1.324 . . . . 0.0 113.12 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 8.7 mm -134.69 126.62 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.515 1.126 . . . . 0.0 110.973 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -96.03 133.08 40.69 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.277 1.031 . . . . 0.0 111.535 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 61.8 34.64 17.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.132 1.373 . . . . 0.0 112.811 172.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -55.92 129.06 71.9 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.331 1.052 . . . . 0.0 110.817 171.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.37 137.62 11.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.273 2.648 . . . . 0.0 109.108 169.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.06 136.0 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.063 1.345 . . . . 0.0 110.433 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -73.77 131.22 41.34 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.143 0.977 . . . . 0.0 109.301 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.9 mm -113.35 129.57 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.97 1.308 . . . . 0.0 108.33 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 44.8 mtm105 -137.66 91.97 13.43 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.952 0.901 . . . . 0.0 110.725 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.57 145.66 98.4 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.774 2.983 . . . . 0.0 111.5 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 122.205 1.003 . . . . 0.0 111.878 -176.678 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -83.07 137.64 34.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.473 1.509 . . . . 0.0 110.801 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.1 t -142.98 120.34 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.555 1.142 . . . . 0.0 110.207 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -74.35 142.31 45.12 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.604 0.762 . . . . 0.0 110.851 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.65 125.35 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.487 1.515 . . . . 0.0 109.163 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -123.16 148.17 16.75 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.815 1.198 . . . . 0.0 113.33 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 93.57 19.52 34.73 Favored Glycine 0 N--CA 1.474 1.182 0 C-N-CA 124.797 1.189 . . . . 0.0 114.316 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.22 143.59 78.85 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 125.477 1.511 . . . . 0.0 111.514 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.61 154.07 26.84 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.628 2.885 . . . . 0.0 113.457 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.5 3.01 6.74 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.881 3.054 . . . . 0.0 114.422 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -140.46 25.1 2.24 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.759 1.224 . . . . 0.0 112.764 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 10.7 tt -92.82 162.43 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.169 0.988 . . . . 0.0 110.741 170.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -142.9 169.42 17.6 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.163 1.385 . . . . 0.0 112.437 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.87 -42.54 26.95 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.302 1.841 . . . . 0.0 114.106 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.38 -27.62 41.89 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.402 -0.811 . . . . 0.0 112.357 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -77.31 -35.17 55.15 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.794 0.837 . . . . 0.0 111.572 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 59.6 mt -65.9 -37.45 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.431 -0.793 . . . . 0.0 109.54 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 63.3 m -63.11 -52.18 63.63 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.342 0.657 . . . . 0.0 110.422 172.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -59.88 -31.67 70.01 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.166 0.894 . . . . 0.0 112.995 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 74.5 m -69.55 -14.16 62.71 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -131.64 -2.0 3.81 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.513 1.051 . . . . 0.0 113.743 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.16 -23.17 61.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.859 1.264 . . . . 0.0 112.993 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -57.55 -11.16 1.83 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.487 1.915 . . . . 0.0 115.17 170.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -107.75 -2.02 20.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.586 1.554 . . . . 0.0 113.945 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 119.34 176.53 16.24 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.194 1.854 . . . . 0.0 112.613 -174.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -63.31 148.54 92.81 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.582 2.854 . . . . 0.0 112.865 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.9 170.47 20.57 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.373 1.469 . . . . 0.0 112.639 -176.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -131.44 157.9 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.911 1.685 . . . . 0.0 109.017 167.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 93.3 t -125.29 134.68 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.836 1.254 . . . . 0.0 109.93 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 125.975 1.71 . . . . 0.0 111.578 -170.776 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 CA-C-O 118.665 -1.075 . . . . 0.0 114.512 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -136.84 158.95 43.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.571 1.686 . . . . 0.0 114.051 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.31 165.82 35.45 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.388 1.475 . . . . 0.0 111.784 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.37 122.85 47.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.739 1.616 . . . . 0.0 110.01 170.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.0 mt -86.08 140.99 29.74 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.581 1.552 . . . . 0.0 108.917 169.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 52.2 mt -124.86 107.51 10.97 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.755 1.622 . . . . 0.0 107.811 171.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -85.54 159.47 19.89 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.622 0.769 . . . . 0.0 112.282 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -66.76 -36.08 81.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.941 0.896 . . . . 0.0 112.105 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -141.95 145.48 34.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.681 1.592 . . . . 0.0 110.109 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -63.77 -28.36 69.82 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.741 -0.6 . . . . 0.0 111.907 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 29.3 p -59.84 -24.53 64.27 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.912 -1.117 . . . . 0.0 113.181 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 27.5 m -70.7 -28.36 64.69 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.811 -1.181 . . . . 0.0 112.11 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.16 -37.14 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.696 -0.627 . . . . 0.0 109.929 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -64.13 -40.7 96.75 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.587 -0.696 . . . . 0.0 111.529 169.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.53 -37.93 85.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.763 0.711 . . . . 0.0 112.371 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.68 -47.85 76.88 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.432 0.693 . . . . 0.0 111.123 171.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.9 mt -56.02 -41.91 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.181 0.992 . . . . 0.0 111.421 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.24 -17.74 63.8 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.8 1.24 . . . . 0.0 113.485 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.04 -13.99 18.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.122 1.369 . . . . 0.0 113.518 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.4 m -74.3 146.57 43.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.001 0.905 . . . . 0.0 113.356 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.73 172.33 13.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.54 1.536 . . . . 0.0 108.097 165.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 N--CA 1.469 0.479 0 C-N-CA 123.532 0.733 . . . . 0.0 111.73 -175.529 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -143.34 147.26 34.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.225 1.01 . . . . 0.0 113.134 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.6 tp -130.68 -169.62 2.19 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.399 1.88 . . . . 0.0 108.5 170.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 29.3 p -141.3 149.96 41.93 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.069 0.947 . . . . 0.0 113.095 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -150.81 168.9 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 126.875 2.07 . . . . 0.0 110.478 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 56.4 m -144.24 161.85 37.85 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 54.0 p -147.81 179.05 1.25 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 126.926 2.09 . . . . 0.0 110.994 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -64.67 -13.76 40.84 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.389 2.726 . . . . 0.0 114.265 170.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 35.0 p -107.5 -32.36 7.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.924 1.29 . . . . 0.0 113.108 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 7.1 mm -134.4 126.88 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.451 1.1 . . . . 0.0 110.933 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -96.57 130.58 43.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 111.53 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 60.88 36.7 18.86 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.537 1.535 . . . . 0.0 112.691 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -56.53 125.64 67.42 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.431 1.092 . . . . 0.0 110.278 169.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.93 144.36 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.169 2.579 . . . . 0.0 109.4 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.65 135.39 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.973 1.309 . . . . 0.0 110.517 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -78.0 133.22 38.03 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.22 1.008 . . . . 0.0 109.717 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.5 mm -116.05 131.08 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.354 1.462 . . . . 0.0 108.538 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -137.42 90.31 15.17 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.665 1.186 . . . . 0.0 109.979 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.39 133.1 54.91 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.635 2.89 . . . . 0.0 110.881 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 121.568 0.699 . . . . 0.0 112.432 -173.403 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 56.5 mtm-85 . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -75.95 133.8 40.38 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.389 0.676 . . . . 0.0 110.783 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 52.7 t -138.22 117.27 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.424 1.09 . . . . 0.0 109.637 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -72.97 141.12 47.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.884 0.874 . . . . 0.0 110.468 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 81.2 t -133.05 119.37 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.477 1.511 . . . . 0.0 109.344 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -115.53 145.02 18.63 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 124.709 1.147 . . . . 0.0 113.718 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.32 17.75 28.31 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.123 1.344 . . . . 0.0 114.239 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.79 140.69 95.41 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.599 1.16 . . . . 0.0 111.121 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.24 156.37 13.62 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.958 3.106 . . . . 0.0 113.983 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.58 2.85 7.37 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.987 3.125 . . . . 0.0 113.448 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -140.29 41.92 1.92 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.8 1.64 . . . . 0.0 111.497 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -124.65 142.62 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.341 1.457 . . . . 0.0 110.529 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -119.65 172.62 7.54 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.098 1.359 . . . . 0.0 113.075 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -45.68 -46.67 14.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.713 1.605 . . . . 0.0 113.729 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.76 -26.04 49.55 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.542 0.737 . . . . 0.0 112.446 -173.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -79.06 -37.83 37.92 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.997 0.919 . . . . 0.0 111.524 172.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 48.3 mt -65.51 -36.32 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.403 -0.811 . . . . 0.0 109.589 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 71.4 m -64.62 -52.84 55.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.922 0.889 . . . . 0.0 110.414 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.16 70.23 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.579 1.081 . . . . 0.0 112.954 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.7 m -67.2 -15.57 63.78 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -130.7 -2.73 4.2 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -61.05 -22.29 64.45 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.165 1.386 . . . . 0.0 113.127 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -56.58 -13.71 2.6 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.809 2.044 . . . . 0.0 114.941 169.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -103.69 -7.19 20.86 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.47 1.508 . . . . 0.0 113.936 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.45 175.18 14.25 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.209 1.861 . . . . 0.0 112.269 -173.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.7 149.33 91.56 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.613 2.876 . . . . 0.0 112.796 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.15 171.88 17.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.216 1.406 . . . . 0.0 112.588 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -134.37 157.94 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.731 1.612 . . . . 0.0 109.431 167.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.94 137.74 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.643 1.177 . . . . 0.0 110.992 -171.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 CA--C 1.545 0.781 0 C-N-CA 126.603 1.961 . . . . 0.0 111.456 -176.874 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.233 0 CA-C-O 119.814 -0.437 . . . . 0.0 113.951 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -151.5 158.76 44.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.842 1.257 . . . . 0.0 112.654 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.14 167.48 26.72 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.671 1.188 . . . . 0.0 111.617 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.85 118.27 33.75 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.593 1.957 . . . . 0.0 109.599 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.5 mt -82.83 141.26 32.42 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.983 1.313 . . . . 0.0 108.688 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.5 mt -122.67 105.87 10.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.711 1.604 . . . . 0.0 107.768 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -81.14 156.61 25.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.218 0.607 . . . . 0.0 112.106 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -80.74 -24.62 38.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.152 0.981 . . . . 0.0 113.174 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.19 140.9 32.5 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.493 1.517 . . . . 0.0 110.357 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.77 -35.04 70.22 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.819 0.847 . . . . 0.0 111.96 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.9 m -56.95 -25.53 58.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.792 1.237 . . . . 0.0 113.212 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.3 m -69.23 -28.13 66.07 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.867 -1.146 . . . . 0.0 112.175 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.09 -37.42 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.602 -0.686 . . . . 0.0 109.775 175.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -70.26 -37.51 74.91 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.536 -0.728 . . . . 0.0 111.765 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.24 86.48 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.553 0.615 . . . . 0.0 112.079 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.6 tp -64.44 -49.81 70.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.463 0.705 . . . . 0.0 110.995 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.62 -41.66 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.094 0.958 . . . . 0.0 111.478 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.56 -18.24 63.63 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.799 1.24 . . . . 0.0 113.507 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.88 -13.64 19.96 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.21 1.404 . . . . 0.0 113.377 174.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.6 m -72.84 143.17 47.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.05 0.929 . . . . 0.0 113.37 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.27 175.9 9.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.779 1.632 . . . . 0.0 107.955 165.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 CA--C 1.537 0.45 0 C-N-CA 123.176 0.591 . . . . 0.0 111.712 -177.233 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.861 0.362 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -142.23 154.09 44.51 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.88 1.272 . . . . 0.0 113.097 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -141.8 158.29 43.98 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.627 1.571 . . . . 0.0 109.719 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 72.2 m -99.45 137.23 38.24 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.951 0.9 . . . . 0.0 112.105 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.9 m -144.78 177.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 126.762 2.025 . . . . 0.0 110.662 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 89.4 p -159.49 171.4 19.77 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.946 -1.096 . . . . 0.0 113.496 -175.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 91.6 p -155.16 179.91 1.23 Allowed Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 126.311 1.844 . . . . 0.0 110.586 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.51 -26.06 70.1 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.847 2.365 . . . . 0.0 113.933 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 40.3 p -116.35 -32.93 5.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.7 1.2 . . . . 0.0 113.793 -174.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 21.3 mm -112.18 127.78 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.932 1.293 . . . . 0.0 109.904 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -119.7 142.16 48.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.283 1.433 . . . . 0.0 112.075 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.46 32.92 19.89 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.042 1.337 . . . . 0.0 112.94 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -70.38 128.56 91.17 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.529 1.132 . . . . 0.0 111.428 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.48 131.31 5.53 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.279 2.653 . . . . 0.0 108.845 169.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.71 135.19 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.269 1.428 . . . . 0.0 110.294 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -79.15 131.25 36.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.095 0.958 . . . . 0.0 109.83 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.38 131.81 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.042 1.337 . . . . 0.0 109.319 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -137.78 90.25 14.53 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.953 1.301 . . . . 0.0 110.287 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -61.06 132.2 40.69 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.157 2.571 . . . . 0.0 110.695 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 123.448 0.699 . . . . 0.0 112.745 -174.062 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -86.47 139.8 30.55 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.009 0.924 . . . . 0.0 111.533 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.1 t -140.74 120.76 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.537 1.135 . . . . 0.0 110.378 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -71.65 140.2 49.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.195 0.998 . . . . 0.0 110.945 171.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.19 115.62 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.368 1.467 . . . . 0.0 109.217 173.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -114.91 144.27 18.37 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 124.942 1.258 . . . . 0.0 113.509 -177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.85 17.64 29.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.956 1.265 . . . . 0.0 114.163 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.21 141.48 93.97 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.713 1.205 . . . . 0.0 111.017 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.75 154.3 12.82 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.915 3.077 . . . . 0.0 113.746 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.43 3.78 6.5 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.93 3.087 . . . . 0.0 113.508 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -140.41 23.37 2.34 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.178 1.391 . . . . 0.0 112.227 -173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.4 tt -100.25 127.68 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.285 1.034 . . . . 0.0 111.029 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -92.99 165.71 12.73 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.497 1.119 . . . . 0.0 113.214 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -45.78 -45.51 14.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.918 1.687 . . . . 0.0 113.7 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.19 -29.24 54.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.777 0.831 . . . . 0.0 112.514 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -72.47 -38.71 68.15 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.416 0.686 . . . . 0.0 112.018 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.16 -39.6 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 119.193 0.906 . . . . 0.0 109.585 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 53.4 m -63.24 -51.62 65.46 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.438 0.695 . . . . 0.0 110.613 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.42 -29.08 70.25 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.38 0.991 . . . . 0.0 113.156 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.2 m -66.56 -22.83 66.15 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -123.46 -3.88 8.33 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.3 tpt85 -60.55 -22.36 63.57 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.275 1.43 . . . . 0.0 113.396 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -55.76 -18.71 8.96 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.384 1.874 . . . . 0.0 114.724 171.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.71 -3.4 35.96 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.508 1.523 . . . . 0.0 113.561 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.16 170.41 14.0 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.905 1.717 . . . . 0.0 111.982 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.9 151.0 78.62 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.667 2.912 . . . . 0.0 111.979 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.58 171.82 18.26 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.528 1.531 . . . . 0.0 112.498 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -132.66 157.34 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.494 1.518 . . . . 0.0 109.287 167.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.34 135.68 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.662 1.185 . . . . 0.0 110.351 -172.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 126.264 1.826 . . . . 0.0 111.699 -173.819 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.365 0 N-CA-C 114.316 0.486 . . . . 0.0 114.316 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -153.82 158.81 41.41 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.777 1.231 . . . . 0.0 112.591 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -151.03 167.45 27.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.735 1.214 . . . . 0.0 111.641 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.45 118.22 33.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.312 1.845 . . . . 0.0 109.365 173.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 34.8 mt -81.34 138.98 35.62 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.032 1.333 . . . . 0.0 108.778 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 55.2 mt -122.71 104.42 9.3 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.913 1.685 . . . . 0.0 107.863 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -81.6 157.52 24.69 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.59 0.756 . . . . 0.0 111.764 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -73.15 -27.4 61.64 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.647 -0.658 . . . . 0.0 112.485 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.85 145.29 39.83 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.851 1.261 . . . . 0.0 110.731 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -62.73 -32.11 73.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.255 0.622 . . . . 0.0 111.535 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.3 m -56.73 -27.13 58.69 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.65 1.18 . . . . 0.0 113.289 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.7 m -68.96 -25.89 64.77 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.863 -1.148 . . . . 0.0 112.29 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.68 -38.3 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.707 -0.621 . . . . 0.0 109.985 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -66.34 -39.36 89.15 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.645 -0.659 . . . . 0.0 111.463 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.75 83.51 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.62 0.646 . . . . 0.0 112.498 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 26.8 tp -65.4 -48.42 72.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.517 0.727 . . . . 0.0 111.213 171.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 71.8 mt -55.27 -40.13 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.968 0.907 . . . . 0.0 111.528 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.37 -17.77 63.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.874 1.27 . . . . 0.0 113.683 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.09 -13.56 18.95 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.956 1.302 . . . . 0.0 113.248 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.1 m -74.59 146.43 42.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.14 0.971 . . . . 0.0 113.499 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.74 173.93 12.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.686 1.594 . . . . 0.0 107.777 164.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 123.477 0.711 . . . . 0.0 111.062 -178.203 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.037 0.446 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.16 142.78 32.75 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.089 0.956 . . . . 0.0 113.054 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -127.02 -179.36 4.8 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.605 1.562 . . . . 0.0 108.91 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 71.7 m -128.38 142.3 51.16 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.274 1.03 . . . . 0.0 112.176 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 29.8 m -148.91 173.13 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 126.08 1.752 . . . . 0.0 111.761 -174.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 79.9 p -160.42 171.41 19.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.103 1.361 . . . . 0.0 112.906 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.5 p -153.06 -176.18 0.57 Allowed Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.563 1.945 . . . . 0.0 110.565 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -63.91 -14.27 42.21 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.069 2.513 . . . . 0.0 114.38 170.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 60.7 p -122.3 -18.12 6.89 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.116 1.367 . . . . 0.0 114.114 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.4 mm -132.79 135.09 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.693 1.597 . . . . 0.0 110.363 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -128.38 136.18 50.56 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.849 1.26 . . . . 0.0 111.668 -171.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 58.76 28.68 17.66 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.305 1.442 . . . . 0.0 113.61 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -73.92 129.52 84.74 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.761 -1.212 . . . . 0.0 111.313 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.93 143.37 16.29 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.296 2.664 . . . . 0.0 109.758 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 2.4 m -129.43 135.72 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.309 1.444 . . . . 0.0 110.711 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -79.1 119.13 21.78 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.666 1.586 . . . . 0.0 109.565 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 31.3 mm -105.62 124.93 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.822 1.249 . . . . 0.0 108.477 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -133.11 92.22 25.94 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.243 1.017 . . . . 0.0 110.366 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.56 140.69 95.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.59 2.86 . . . . 0.0 111.569 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 . . . . . 0 CA--C 1.549 0.932 0 C-N-CA 123.872 0.869 . . . . 0.0 112.781 -178.825 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 76.3 mtm-85 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -77.4 134.32 38.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.529 1.132 . . . . 0.0 110.485 169.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.26 118.24 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.159 0.984 . . . . 0.0 110.039 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.47 139.23 45.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.618 0.767 . . . . 0.0 110.273 171.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 67.2 t -130.99 118.47 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.349 1.459 . . . . 0.0 109.156 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -115.29 151.27 18.51 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.789 1.185 . . . . 0.0 113.814 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 89.97 20.88 41.2 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.594 1.092 . . . . 0.0 113.802 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.61 144.61 72.31 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.885 1.274 . . . . 0.0 111.64 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.72 145.39 71.64 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.035 2.49 . . . . 0.0 112.02 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.07 0.52 7.12 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.921 3.081 . . . . 0.0 113.51 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -128.49 19.4 6.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.199 2.199 . . . . 0.0 112.291 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.5 tt -100.47 156.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.092 1.357 . . . . 0.0 111.96 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -135.25 170.57 15.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.186 1.395 . . . . 0.0 112.624 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -50.55 -42.27 55.09 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.386 1.475 . . . . 0.0 113.71 -172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.84 -27.65 44.27 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.561 0.744 . . . . 0.0 112.171 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -74.68 -39.15 62.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.811 0.845 . . . . 0.0 111.409 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.1 mt -64.43 -39.04 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.893 0.77 . . . . 0.0 109.564 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 59.1 m -63.1 -52.08 64.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.478 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.09 71.38 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.569 1.077 . . . . 0.0 112.944 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.4 m -68.51 -14.81 63.26 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -129.31 -3.16 4.97 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.312 0.96 . . . . 0.0 113.546 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -60.76 -22.45 64.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.98 1.312 . . . . 0.0 113.133 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -56.98 -12.01 1.79 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.794 2.037 . . . . 0.0 115.009 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -106.28 -4.15 20.43 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.527 1.531 . . . . 0.0 113.986 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.82 171.49 14.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.792 1.663 . . . . 0.0 112.204 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.37 150.2 58.04 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.659 2.906 . . . . 0.0 112.242 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.6 172.41 17.2 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.587 1.555 . . . . 0.0 112.632 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.85 159.43 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.747 1.619 . . . . 0.0 109.368 167.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.17 137.57 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.61 1.164 . . . . 0.0 110.729 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 CA--C 1.547 0.85 0 C-N-CA 126.407 1.883 . . . . 0.0 111.552 -174.333 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 CA-C-O 119.931 -0.372 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -152.95 160.85 43.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.314 1.445 . . . . 0.0 112.293 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.89 164.89 35.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.787 1.235 . . . . 0.0 111.808 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -110.84 117.79 34.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.158 1.783 . . . . 0.0 109.672 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.7 mt -82.59 140.94 32.95 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.99 1.316 . . . . 0.0 108.535 168.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 53.8 mt -125.1 104.85 8.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.622 1.569 . . . . 0.0 107.879 172.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -83.19 157.61 22.66 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.557 0.743 . . . . 0.0 111.505 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -83.26 -13.99 54.09 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.28 141.59 33.94 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.439 1.496 . . . . 0.0 110.617 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.68 -33.58 74.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.233 0.613 . . . . 0.0 111.359 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 12.4 m -59.51 -24.03 63.3 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.313 1.045 . . . . 0.0 113.057 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 22.9 m -70.67 -30.22 66.76 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.902 -1.124 . . . . 0.0 111.896 172.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.36 -34.91 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.502 -0.749 . . . . 0.0 109.902 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -69.64 -37.2 76.69 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.572 -0.705 . . . . 0.0 111.974 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.38 -37.39 85.53 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.961 0.8 . . . . 0.0 112.207 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.2 tp -63.66 -49.2 74.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.487 0.715 . . . . 0.0 110.894 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.23 -41.83 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.122 0.969 . . . . 0.0 111.557 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.51 -18.34 64.36 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.784 1.234 . . . . 0.0 113.63 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.99 -14.25 18.74 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.086 1.354 . . . . 0.0 113.487 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 53.3 m -72.55 144.56 47.89 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.019 0.914 . . . . 0.0 113.235 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.12 172.42 13.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.386 1.475 . . . . 0.0 107.782 165.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 123.384 0.674 . . . . 0.0 110.939 -179.281 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 120.99 0.424 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -141.84 148.81 39.42 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.565 1.146 . . . . 0.0 112.732 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.6 tp -131.9 171.06 14.03 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.03 1.732 . . . . 0.0 109.07 171.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 87.3 m -117.42 142.96 46.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.171 0.988 . . . . 0.0 112.351 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.21 172.94 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.848 2.059 . . . . 0.0 110.919 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 47.1 m -150.2 167.0 28.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.077 1.351 . . . . 0.0 112.344 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.9 m -161.54 167.44 13.05 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 127.755 2.422 . . . . 0.0 110.653 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.3 -22.03 14.78 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 124.407 3.405 . . . . 0.0 117.917 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 62.8 p -123.15 2.1 9.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.855 1.262 . . . . 0.0 113.908 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 30.3 mm -138.66 117.61 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.884 1.674 . . . . 0.0 110.536 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -118.35 137.73 52.9 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.375 1.07 . . . . 0.0 113.043 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 60.8 30.98 20.02 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.359 1.464 . . . . 0.0 112.423 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -63.89 126.25 89.56 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.739 1.216 . . . . 0.0 111.025 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.91 138.14 11.43 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.253 2.636 . . . . 0.0 109.067 171.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.7 m -130.98 132.26 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.061 1.344 . . . . 0.0 109.896 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -81.08 130.4 35.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.32 1.048 . . . . 0.0 109.876 -173.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 31.9 mm -111.01 132.03 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.905 1.282 . . . . 0.0 109.333 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -137.89 91.94 13.07 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.976 1.31 . . . . 0.0 110.192 -175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.66 132.62 49.14 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.406 2.737 . . . . 0.0 110.678 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -171.622 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.99 135.73 37.85 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.839 1.256 . . . . 0.0 110.654 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.52 121.63 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.274 1.03 . . . . 0.0 110.426 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.44 140.25 55.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.337 1.055 . . . . 0.0 111.385 172.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 56.9 t -133.53 123.18 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 109.422 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -122.11 149.37 17.08 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.452 1.501 . . . . 0.0 113.191 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.31 14.05 52.23 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.958 1.266 . . . . 0.0 114.366 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.96 141.59 85.93 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.031 1.332 . . . . 0.0 111.012 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.42 153.56 17.37 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.874 3.049 . . . . 0.0 113.638 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.73 6.1 4.77 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.002 3.135 . . . . 0.0 113.353 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -140.27 28.56 2.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.476 1.51 . . . . 0.0 111.9 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.8 tt -107.75 150.19 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.293 1.437 . . . . 0.0 110.075 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -124.77 170.29 11.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.81 1.244 . . . . 0.0 112.706 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -44.78 -46.23 10.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.409 1.884 . . . . 0.0 113.913 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -78.94 -26.31 43.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.65 0.78 . . . . 0.0 112.295 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -77.11 -36.53 55.49 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.684 0.794 . . . . 0.0 111.462 171.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.17 -38.73 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.322 0.965 . . . . 0.0 109.566 171.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 57.8 m -62.64 -52.03 64.92 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.367 0.667 . . . . 0.0 110.471 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.49 -30.95 70.94 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.401 1.001 . . . . 0.0 112.978 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.2 m -67.97 -14.67 63.15 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -129.82 -2.82 4.69 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.457 1.026 . . . . 0.0 113.604 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -60.31 -22.5 63.25 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.943 1.297 . . . . 0.0 113.104 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -56.83 -12.53 1.98 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.791 2.036 . . . . 0.0 115.103 170.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -105.65 -4.93 20.49 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.396 1.478 . . . . 0.0 113.974 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.48 172.96 14.14 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.801 1.667 . . . . 0.0 112.288 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.87 149.94 54.56 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.736 2.957 . . . . 0.0 112.29 -174.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.27 172.7 16.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.485 1.514 . . . . 0.0 112.668 -170.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.03 161.09 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.868 1.667 . . . . 0.0 108.728 167.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.49 135.25 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.273 1.029 . . . . 0.0 110.246 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 126.405 1.882 . . . . 0.0 111.538 -169.936 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.056 0 CA-C-O 118.917 -0.935 . . . . 0.0 114.315 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -140.33 157.95 44.78 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.469 1.635 . . . . 0.0 113.914 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.8 170.64 21.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.522 1.529 . . . . 0.0 111.625 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.53 120.49 36.9 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.952 1.701 . . . . 0.0 109.944 173.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.1 mt -80.99 140.83 34.97 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.848 1.259 . . . . 0.0 108.739 169.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 58.3 mt -124.34 101.98 7.45 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.696 1.598 . . . . 0.0 107.702 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -80.21 154.33 28.0 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.307 0.643 . . . . 0.0 110.978 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -76.89 -19.39 57.5 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.461 -0.774 . . . . 0.0 112.91 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.94 142.4 34.38 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.945 1.298 . . . . 0.0 110.799 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.71 -31.38 71.53 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.526 0.731 . . . . 0.0 111.649 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.4 m -56.39 -28.34 58.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.625 1.17 . . . . 0.0 112.899 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -28.4 62.45 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.964 -1.085 . . . . 0.0 112.118 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.3 t -76.32 -37.76 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.668 -0.645 . . . . 0.0 109.839 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -66.3 -38.14 87.03 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.578 -0.701 . . . . 0.0 111.85 172.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.5 91.21 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.557 0.617 . . . . 0.0 112.367 173.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.6 tp -63.53 -48.37 77.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.429 0.692 . . . . 0.0 110.926 171.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 69.9 mt -56.23 -43.25 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.249 1.02 . . . . 0.0 111.33 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.33 -18.88 64.6 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.682 1.193 . . . . 0.0 113.542 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.11 -13.65 19.72 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.185 1.394 . . . . 0.0 113.605 175.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.06 150.05 37.37 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.164 0.983 . . . . 0.0 113.617 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.3 mt -86.25 177.79 7.38 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.035 1.734 . . . . 0.0 107.843 165.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 N--CA 1.47 0.563 0 C-N-CA 123.437 0.695 . . . . 0.0 111.623 -175.099 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.615 0.245 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -141.04 145.47 35.92 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.977 0.911 . . . . 0.0 113.116 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.06 -173.95 3.19 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.142 1.777 . . . . 0.0 108.949 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.3 p -134.61 147.29 50.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.311 1.044 . . . . 0.0 113.276 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.2 m -152.05 -178.87 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 127.181 2.193 . . . . 0.0 110.753 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 80.5 p -161.7 170.56 19.45 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.503 1.121 . . . . 0.0 113.135 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 16.2 p -142.5 -177.01 0.61 Allowed Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 126.528 1.931 . . . . 0.0 110.682 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.17 -21.97 68.22 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.881 2.387 . . . . 0.0 114.145 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 46.3 p -123.09 -23.05 5.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.6 mm -115.24 127.63 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.075 1.35 . . . . 0.0 109.79 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -122.65 139.0 54.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.601 1.16 . . . . 0.0 111.974 -168.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.89 33.49 23.26 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.171 1.388 . . . . 0.0 112.963 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -69.45 126.56 92.72 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.201 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -80.48 142.9 14.96 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.286 2.657 . . . . 0.0 109.307 169.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.15 134.61 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.732 1.213 . . . . 0.0 110.585 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -79.14 126.41 30.71 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.902 1.681 . . . . 0.0 109.639 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 29.5 mm -114.87 132.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.545 1.538 . . . . 0.0 108.342 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -140.96 100.05 6.57 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.788 0.835 . . . . 0.0 110.678 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -55.88 134.95 67.16 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.472 2.781 . . . . 0.0 110.977 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -169.435 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -80.84 133.15 35.55 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.366 0.666 . . . . 0.0 110.765 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.2 115.44 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.383 1.073 . . . . 0.0 109.882 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -71.94 140.5 49.21 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.802 0.841 . . . . 0.0 110.384 171.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.73 118.59 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.08 1.352 . . . . 0.0 109.23 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.91 143.71 18.15 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.916 1.245 . . . . 0.0 113.381 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.88 11.0 47.95 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.451 1.501 . . . . 0.0 114.157 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.09 142.13 80.65 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.113 1.365 . . . . 0.0 111.482 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.41 154.79 18.22 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.769 2.98 . . . . 0.0 113.576 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -79.21 4.47 6.55 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.835 3.023 . . . . 0.0 113.421 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -135.97 20.24 3.25 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.691 1.597 . . . . 0.0 112.301 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 14.1 tt -104.02 123.38 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.696 1.199 . . . . 0.0 111.958 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.02 161.17 25.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.515 1.126 . . . . 0.0 112.806 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -48.1 -44.44 31.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.108 1.363 . . . . 0.0 112.543 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -74.74 -24.25 58.69 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.86 0.864 . . . . 0.0 112.891 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -78.21 -40.55 37.15 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.818 0.847 . . . . 0.0 111.118 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.2 mt -62.52 -41.84 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 170.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 60.7 m -61.0 -52.28 65.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.496 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.45 -29.36 70.46 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.552 1.069 . . . . 0.0 113.223 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 64.8 m -67.34 -23.26 65.6 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.58 -5.62 9.75 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.145 0.978 . . . . 0.0 113.552 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -61.52 -22.98 65.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.169 1.387 . . . . 0.0 113.139 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -53.04 -20.72 3.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.587 1.955 . . . . 0.0 114.73 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -97.74 -9.32 26.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.502 1.521 . . . . 0.0 113.915 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 126.12 170.55 13.0 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.976 1.75 . . . . 0.0 112.034 -169.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.88 150.82 56.0 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.682 2.922 . . . . 0.0 112.601 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.06 172.92 15.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.664 1.586 . . . . 0.0 112.664 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.62 158.69 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.851 1.66 . . . . 0.0 109.488 167.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 77.5 t -130.91 137.55 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.586 1.154 . . . . 0.0 110.89 -171.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 126.164 1.786 . . . . 0.0 111.628 -175.449 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 CA-C-O 119.504 -0.609 . . . . 0.0 114.259 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -152.45 158.1 42.12 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.797 1.298 . . . . 0.0 113.418 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.74 170.67 19.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.107 1.363 . . . . 0.0 111.645 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.29 121.65 41.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.32 1.848 . . . . 0.0 109.722 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.17 140.47 30.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.448 1.499 . . . . 0.0 108.916 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 55.0 mt -124.52 105.43 9.38 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.74 1.616 . . . . 0.0 107.96 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -83.41 159.12 21.87 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.523 0.729 . . . . 0.0 111.353 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.73 -22.04 24.83 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -130.12 144.53 51.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.125 1.77 . . . . 0.0 110.279 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 37.6 mp0 -66.01 -30.51 71.07 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.416 -0.803 . . . . 0.0 111.286 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.6 m -55.15 -27.76 47.85 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.832 1.253 . . . . 0.0 112.798 173.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.7 m -71.85 -29.56 64.51 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.109 -0.995 . . . . 0.0 112.048 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.99 -37.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.522 -0.736 . . . . 0.0 109.888 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -66.3 -38.16 87.09 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.533 -0.73 . . . . 0.0 111.86 172.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.81 -37.94 88.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.317 0.647 . . . . 0.0 112.38 173.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.2 tp -64.01 -48.78 75.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.333 0.653 . . . . 0.0 110.943 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 75.5 mt -55.54 -40.9 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.231 1.012 . . . . 0.0 111.35 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.45 -17.82 63.67 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.719 1.208 . . . . 0.0 113.818 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.02 -13.66 18.97 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.067 1.347 . . . . 0.0 113.351 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 54.6 m -75.89 149.29 37.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.052 0.941 . . . . 0.0 113.464 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.6 mt -83.84 173.28 11.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.431 1.492 . . . . 0.0 107.785 164.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.469 0.51 0 C-N-CA 123.528 0.731 . . . . 0.0 111.733 -174.521 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.662 0.268 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -144.81 145.87 31.84 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.993 0.917 . . . . 0.0 112.977 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.0 tp -131.62 -176.51 4.06 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.494 1.918 . . . . 0.0 108.614 172.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 89.6 m -129.63 146.12 51.45 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.508 1.049 . . . . 0.0 112.729 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 29.2 m -148.93 177.46 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 126.501 1.92 . . . . 0.0 111.531 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 80.2 p -161.13 170.79 19.71 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.096 1.358 . . . . 0.0 112.965 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.3 p -153.88 -179.78 1.13 Allowed Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 126.894 2.078 . . . . 0.0 110.567 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.61 -20.04 55.77 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.897 2.398 . . . . 0.0 114.403 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 57.6 p -113.88 -19.9 11.29 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.026 1.33 . . . . 0.0 114.325 -175.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.1 mm -132.31 135.99 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.489 1.516 . . . . 0.0 110.304 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -130.49 138.41 50.24 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.594 1.158 . . . . 0.0 112.179 -171.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.5 t70 57.54 29.88 17.83 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.336 1.454 . . . . 0.0 113.093 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -75.1 126.2 88.33 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-O 117.829 -1.081 . . . . 0.0 111.584 -172.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.32 141.78 18.41 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.297 2.665 . . . . 0.0 109.457 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.7 m -135.87 134.39 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.015 1.326 . . . . 0.0 110.453 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -75.37 129.67 37.74 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.555 1.142 . . . . 0.0 109.535 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.92 131.21 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.384 1.474 . . . . 0.0 108.373 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 16.7 mtp85 -137.11 89.72 16.33 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.491 1.116 . . . . 0.0 110.106 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -59.05 135.67 68.01 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.839 2.359 . . . . 0.0 109.102 169.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -171.057 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -80.41 137.86 36.56 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.694 1.198 . . . . 0.0 111.281 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.5 t -141.48 120.66 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.681 1.192 . . . . 0.0 109.763 175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -77.77 143.54 37.88 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.569 0.748 . . . . 0.0 110.79 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.02 124.62 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.58 1.552 . . . . 0.0 109.232 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -120.5 150.26 17.43 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.807 1.194 . . . . 0.0 113.409 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 90.49 20.1 42.46 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.543 1.068 . . . . 0.0 114.05 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.8 146.34 75.72 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.085 1.354 . . . . 0.0 111.562 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -54.04 152.79 22.88 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.586 2.858 . . . . 0.0 112.974 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.07 0.18 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.71 2.94 . . . . 0.0 114.667 -170.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -140.7 17.1 2.34 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.389 1.075 . . . . 0.0 113.128 -175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.1 tt -80.19 131.76 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.78 0.832 . . . . 0.0 111.527 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.22 170.48 9.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.92 -45.57 51.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.479 1.512 . . . . 0.0 113.044 176.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -74.88 -32.83 61.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.004 0.921 . . . . 0.0 112.609 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.2 -42.32 84.36 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.554 0.742 . . . . 0.0 112.201 170.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 51.3 mt -64.15 -38.36 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 119.197 0.908 . . . . 0.0 109.83 174.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 57.5 m -63.77 -52.31 60.94 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.357 0.663 . . . . 0.0 110.639 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.6 -31.18 71.23 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.348 0.976 . . . . 0.0 112.738 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.6 m -67.83 -15.08 63.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -129.16 -2.99 5.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.457 1.026 . . . . 0.0 113.507 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -60.48 -22.79 63.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.048 1.339 . . . . 0.0 113.268 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -57.48 -13.0 3.05 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.594 1.958 . . . . 0.0 114.99 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -104.11 -4.1 23.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.42 1.488 . . . . 0.0 113.823 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.69 170.26 13.82 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 126.07 1.795 . . . . 0.0 112.062 -170.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.09 153.03 75.9 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.495 2.796 . . . . 0.0 112.129 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.02 171.98 16.69 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.654 1.582 . . . . 0.0 112.424 -170.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.84 156.66 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.655 1.582 . . . . 0.0 109.248 167.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 65.9 t -128.64 137.42 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.705 1.202 . . . . 0.0 110.283 -171.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 27.5 t0 . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 126.025 1.73 . . . . 0.0 111.608 -175.345 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.269 0 N-CA-C 114.686 0.634 . . . . 0.0 114.686 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -151.25 155.27 38.44 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.513 1.156 . . . . 0.0 113.08 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.29 167.78 29.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.696 1.198 . . . . 0.0 112.362 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -112.65 127.16 56.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.632 1.973 . . . . 0.0 110.098 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.9 mt -92.95 139.24 30.73 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.184 1.794 . . . . 0.0 108.55 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 44.9 mt -123.93 107.56 11.48 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.458 1.503 . . . . 0.0 107.85 171.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -84.16 160.38 20.87 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.332 0.653 . . . . 0.0 112.292 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -75.65 -26.32 57.59 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.796 0.838 . . . . 0.0 112.856 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -140.09 144.79 36.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.29 1.436 . . . . 0.0 110.663 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.17 -30.88 69.62 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.711 -0.618 . . . . 0.0 111.564 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.4 m -55.55 -27.39 48.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.576 1.15 . . . . 0.0 113.139 172.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.1 m -73.84 -29.94 62.41 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.034 -1.041 . . . . 0.0 112.071 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.84 -38.54 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 121.744 -0.598 . . . . 0.0 109.584 173.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -68.63 -37.42 79.71 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.755 -0.591 . . . . 0.0 111.92 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.03 85.57 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.981 0.81 . . . . 0.0 112.287 173.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.71 -48.5 76.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.378 0.671 . . . . 0.0 110.87 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 80.8 mt -56.11 -43.04 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.986 0.914 . . . . 0.0 111.392 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.01 -18.62 64.76 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.738 1.215 . . . . 0.0 113.688 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.12 -13.42 18.98 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.06 1.344 . . . . 0.0 113.533 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 34.6 m -73.46 144.73 46.14 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.003 0.906 . . . . 0.0 113.33 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.2 172.69 13.34 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.311 1.444 . . . . 0.0 107.808 165.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 123.469 0.708 . . . . 0.0 111.363 -175.602 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -142.38 149.35 39.25 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.383 1.073 . . . . 0.0 113.144 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.3 tp -133.8 -170.44 2.5 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.475 1.91 . . . . 0.0 108.895 172.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 26.5 p -140.73 144.56 35.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.807 1.243 . . . . 0.0 112.593 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 25.3 m -147.99 171.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 126.255 1.822 . . . . 0.0 111.667 -169.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 40.1 m -147.65 153.66 39.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.601 1.16 . . . . 0.0 112.817 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.9 p -140.89 -173.9 0.38 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 126.383 1.873 . . . . 0.0 111.689 -174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -69.62 -10.89 29.81 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.34 2.693 . . . . 0.0 113.639 171.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 37.3 p -120.99 -32.27 3.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.076 1.35 . . . . 0.0 113.621 -171.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.0 mm -133.35 137.94 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.956 1.302 . . . . 0.0 110.005 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -119.75 135.16 54.96 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.98 1.312 . . . . 0.0 110.729 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 24.9 t70 64.53 27.3 13.41 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.344 1.457 . . . . 0.0 112.911 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -58.74 125.58 77.5 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.493 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.09 146.58 25.65 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.976 2.451 . . . . 0.0 109.776 171.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.8 m -139.3 140.56 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.16 1.384 . . . . 0.0 110.916 -174.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -83.03 132.33 35.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.912 1.285 . . . . 0.0 109.858 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.1 mm -114.95 131.23 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.831 1.252 . . . . 0.0 109.274 -174.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -135.76 90.2 19.93 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.401 1.481 . . . . 0.0 110.351 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.01 136.36 72.81 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.417 2.745 . . . . 0.0 111.041 172.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.189 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -64.31 136.54 57.25 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.08 0.952 . . . . 0.0 110.547 168.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 43.3 t -137.6 116.9 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.767 0.827 . . . . 0.0 109.375 169.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -73.37 137.17 44.53 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.587 0.755 . . . . 0.0 110.327 172.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 77.5 t -131.31 112.68 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.445 1.498 . . . . 0.0 108.991 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -110.45 151.29 17.58 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.117 1.342 . . . . 0.0 113.41 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 89.87 25.99 25.68 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.32 0.962 . . . . 0.0 113.891 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.77 143.21 91.33 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.787 1.235 . . . . 0.0 111.451 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.84 154.65 31.07 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.366 2.71 . . . . 0.0 113.052 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.04 3.15 6.88 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.901 3.068 . . . . 0.0 114.516 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -140.34 25.27 2.25 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.774 1.229 . . . . 0.0 112.835 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.2 tt -93.48 161.59 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.308 1.043 . . . . 0.0 110.85 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -140.79 169.29 17.92 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.212 1.405 . . . . 0.0 112.536 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.61 -43.07 25.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.581 1.952 . . . . 0.0 113.764 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.5 -27.25 41.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.632 0.773 . . . . 0.0 112.317 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -77.23 -35.94 55.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.834 0.854 . . . . 0.0 111.466 171.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.02 -37.0 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.425 -0.797 . . . . 0.0 109.562 171.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 61.4 m -64.0 -51.78 62.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.506 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.21 -31.28 70.01 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.252 0.933 . . . . 0.0 112.979 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 73.4 m -68.68 -14.59 63.11 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.85 -2.09 3.31 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.586 1.085 . . . . 0.0 113.797 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -60.73 -22.63 64.2 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.745 1.218 . . . . 0.0 112.868 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -56.93 -12.29 1.91 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.603 1.961 . . . . 0.0 114.976 170.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.05 -6.75 18.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.404 1.482 . . . . 0.0 113.924 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.56 179.81 15.87 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.258 1.885 . . . . 0.0 112.491 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.9 145.3 90.13 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.473 2.782 . . . . 0.0 112.54 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.75 170.76 20.83 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.262 1.425 . . . . 0.0 112.423 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -135.03 158.85 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.583 1.553 . . . . 0.0 109.148 167.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 72.6 t -125.05 136.56 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.706 1.202 . . . . 0.0 110.542 -170.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 126.182 1.793 . . . . 0.0 111.698 -173.471 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.275 0 CA-C-O 119.66 -0.522 . . . . 0.0 114.283 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -150.08 162.82 39.66 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.889 1.276 . . . . 0.0 113.05 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -149.24 161.91 41.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.058 1.343 . . . . 0.0 111.759 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -109.03 118.34 36.53 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.224 1.81 . . . . 0.0 109.211 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 38.5 mt -82.19 136.93 35.04 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.72 1.208 . . . . 0.0 108.579 169.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 63.7 mt -117.03 102.76 9.61 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.755 1.622 . . . . 0.0 107.74 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -81.79 156.05 25.12 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.206 0.526 . . . . 0.0 111.736 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -76.41 -26.26 55.35 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.753 0.821 . . . . 0.0 112.848 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -142.21 146.31 35.08 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.254 1.422 . . . . 0.0 110.99 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.85 -28.89 70.34 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.528 0.731 . . . . 0.0 111.995 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 25.1 p -60.53 -25.98 66.54 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.025 -1.047 . . . . 0.0 112.984 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.9 m -73.14 -30.9 63.93 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.852 -1.155 . . . . 0.0 111.942 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.47 -39.53 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 121.765 -0.584 . . . . 0.0 109.713 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -66.77 -38.13 85.98 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.61 -0.681 . . . . 0.0 112.16 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.7 87.54 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.703 0.683 . . . . 0.0 112.368 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.63 -49.19 74.24 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.289 0.636 . . . . 0.0 110.8 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 78.6 mt -55.76 -42.2 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.951 0.9 . . . . 0.0 111.335 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.53 -17.94 63.62 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.775 1.23 . . . . 0.0 113.625 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.97 -12.9 19.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.06 1.344 . . . . 0.0 113.419 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 35.6 m -75.13 147.29 40.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 122.114 0.959 . . . . 0.0 113.547 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.31 177.88 8.31 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.523 1.529 . . . . 0.0 107.73 164.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 CA--C 1.538 0.487 0 O-C-N 121.63 -0.669 . . . . 0.0 111.382 -177.316 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 120.774 0.321 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -140.72 148.22 40.4 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.984 0.914 . . . . 0.0 113.167 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.9 tp -134.87 173.13 12.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.786 1.634 . . . . 0.0 109.478 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 26.7 p -116.17 140.45 49.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.049 1.34 . . . . 0.0 112.58 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.38 178.48 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 126.761 2.024 . . . . 0.0 110.532 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 85.0 p -160.76 171.2 19.25 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 57.6 p -148.42 -179.34 0.94 Allowed Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 126.939 2.096 . . . . 0.0 110.957 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.67 -12.2 34.07 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.296 2.664 . . . . 0.0 114.124 170.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 37.2 p -109.86 -33.19 6.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.95 1.3 . . . . 0.0 113.255 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 6.7 mm -132.82 131.13 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.475 1.11 . . . . 0.0 110.948 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -111.73 141.2 45.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.227 1.411 . . . . 0.0 111.193 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 59.26 36.04 23.56 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.135 1.374 . . . . 0.0 112.906 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -67.41 127.7 93.5 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 120.943 -1.098 . . . . 0.0 110.899 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.35 140.91 12.39 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.34 2.693 . . . . 0.0 109.354 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.46 138.13 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.076 1.35 . . . . 0.0 110.697 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -85.13 120.59 26.8 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.171 1.788 . . . . 0.0 109.683 -172.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.27 129.49 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.998 1.319 . . . . 0.0 109.495 -171.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -135.6 94.03 15.53 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.282 1.433 . . . . 0.0 110.121 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.1 127.23 24.89 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.639 2.893 . . . . 0.0 109.522 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -168.117 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -81.54 140.0 34.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.76 0.824 . . . . 0.0 111.263 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.7 t -139.16 118.82 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.548 1.139 . . . . 0.0 109.758 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -73.78 140.05 45.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.314 0.646 . . . . 0.0 110.168 170.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.2 123.18 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.015 1.326 . . . . 0.0 109.175 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -117.67 146.17 18.64 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.724 1.154 . . . . 0.0 113.079 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 96.03 13.97 47.48 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.041 1.305 . . . . 0.0 114.241 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.4 mt -58.73 139.31 86.31 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.99 1.316 . . . . 0.0 110.632 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -55.1 152.42 30.44 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.433 2.755 . . . . 0.0 113.206 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.67 5.33 4.89 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.709 2.939 . . . . 0.0 114.189 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -133.78 18.07 3.87 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.765 1.626 . . . . 0.0 112.427 -174.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.7 tt -100.14 130.54 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 121.118 -0.988 . . . . 0.0 111.596 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -98.86 169.49 9.42 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 0.0 113.452 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -51.78 -41.55 61.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.096 1.359 . . . . 0.0 113.624 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.68 -25.3 44.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.677 0.791 . . . . 0.0 112.352 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -79.58 -36.23 38.47 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.6 0.76 . . . . 0.0 111.984 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 40.3 mt -65.53 -36.44 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.349 0.977 . . . . 0.0 109.418 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 89.3 m -63.53 -51.85 63.67 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.538 0.735 . . . . 0.0 110.636 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.39 -30.58 69.68 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.585 1.084 . . . . 0.0 112.944 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 69.9 m -67.51 -14.25 62.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -133.02 -2.01 3.25 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -60.37 -22.52 63.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.075 1.35 . . . . 0.0 112.899 173.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -57.2 -10.55 1.29 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.706 2.003 . . . . 0.0 115.133 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -108.67 -3.69 17.68 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.508 1.523 . . . . 0.0 114.127 175.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.76 178.55 15.78 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.164 1.84 . . . . 0.0 112.741 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -63.46 145.51 92.31 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.582 2.855 . . . . 0.0 112.996 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.41 170.41 21.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.634 1.574 . . . . 0.0 112.324 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.4 160.7 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.842 1.657 . . . . 0.0 108.635 166.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 93.5 t -135.7 138.52 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.158 0.983 . . . . 0.0 110.658 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 CA--C 1.544 0.743 0 C-N-CA 124.797 1.239 . . . . 0.0 112.232 179.845 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.129 0 CA-C-O 119.293 -0.726 . . . . 0.0 114.485 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -149.53 154.98 39.59 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.83 1.315 . . . . 0.0 113.512 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.32 170.5 21.73 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.835 1.254 . . . . 0.0 112.174 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -113.42 123.78 50.88 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.891 1.676 . . . . 0.0 110.67 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 22.5 mt -87.04 142.57 27.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.542 1.537 . . . . 0.0 108.74 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 65.7 mt -127.95 102.57 6.82 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.052 1.741 . . . . 0.0 108.175 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -85.1 154.99 21.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.361 0.664 . . . . 0.0 112.031 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -70.88 -27.58 63.92 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.655 0.782 . . . . 0.0 112.732 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -142.92 147.31 35.06 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.411 1.485 . . . . 0.0 110.635 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -63.58 -29.08 70.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.202 0.601 . . . . 0.0 111.952 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 23.0 p -60.24 -25.8 65.94 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.931 -1.105 . . . . 0.0 113.093 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 25.3 m -71.84 -30.8 65.84 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.815 -1.178 . . . . 0.0 111.996 171.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 49.8 t -74.84 -37.43 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.617 -0.677 . . . . 0.0 109.988 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -68.36 -35.31 77.54 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.576 -0.702 . . . . 0.0 111.742 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.17 86.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.074 0.852 . . . . 0.0 112.493 171.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.3 tp -63.4 -48.33 78.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.189 0.596 . . . . 0.0 110.741 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.81 -42.09 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.008 0.923 . . . . 0.0 111.267 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.28 -18.46 64.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.701 1.2 . . . . 0.0 113.887 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.11 -13.12 19.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.99 1.316 . . . . 0.0 113.362 175.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.4 m -72.23 143.07 48.94 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.902 0.858 . . . . 0.0 113.186 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.1 mt -78.87 170.04 17.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.061 1.344 . . . . 0.0 107.956 165.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 N--CA 1.468 0.45 0 C-N-CA 123.579 0.752 . . . . 0.0 111.3 -176.065 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -142.83 149.59 38.8 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.0 tp -135.0 -177.47 4.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.651 1.98 . . . . 0.0 108.734 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 97.3 m -131.49 145.6 51.84 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.599 1.09 . . . . 0.0 112.777 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 31.7 m -149.23 172.79 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 126.899 2.079 . . . . 0.0 111.598 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 58.6 m -149.38 161.58 41.8 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.833 1.253 . . . . 0.0 112.682 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 19.7 p -139.3 -172.37 0.31 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.611 1.964 . . . . 0.0 111.249 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.94 -13.79 37.39 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.112 2.541 . . . . 0.0 113.478 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 40.9 p -126.82 -25.43 3.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.046 1.339 . . . . 0.0 113.859 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 16.9 mm -127.08 134.47 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.512 1.525 . . . . 0.0 109.591 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -123.83 132.97 53.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.544 1.138 . . . . 0.0 111.26 -172.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.0 t70 62.27 30.89 17.63 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.236 1.414 . . . . 0.0 112.507 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -61.83 125.36 84.76 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.787 1.235 . . . . 0.0 110.871 176.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.75 143.98 24.27 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.206 2.604 . . . . 0.0 109.551 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.36 134.83 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.363 1.465 . . . . 0.0 110.417 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -78.37 131.6 37.04 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.652 0.781 . . . . 0.0 109.436 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.46 128.01 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.133 1.373 . . . . 0.0 108.618 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -135.97 84.99 29.86 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.654 1.182 . . . . 0.0 110.071 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.17 133.89 55.87 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.598 2.865 . . . . 0.0 110.984 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -172.509 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 70.8 mtm-85 . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -72.53 135.8 45.72 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.464 0.706 . . . . 0.0 110.506 169.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.41 117.75 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.384 1.074 . . . . 0.0 109.8 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -69.44 138.93 53.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.538 1.135 . . . . 0.0 110.885 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.62 115.38 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.428 1.491 . . . . 0.0 109.04 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.56 143.49 18.07 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 125.061 1.315 . . . . 0.0 113.8 -175.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.42 23.12 22.62 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.77 1.176 . . . . 0.0 114.196 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.77 141.91 88.67 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.957 1.303 . . . . 0.0 110.98 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.39 154.28 19.79 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.382 2.722 . . . . 0.0 113.106 172.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.49 3.76 6.09 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.733 2.955 . . . . 0.0 114.096 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -140.82 25.86 2.11 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.727 1.211 . . . . 0.0 112.599 -175.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.1 tt -99.27 137.3 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.311 1.045 . . . . 0.0 110.747 174.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -112.02 169.25 8.98 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.383 1.073 . . . . 0.0 113.437 -174.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -43.11 -46.54 5.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.146 1.779 . . . . 0.0 114.251 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -77.5 -26.47 51.26 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.647 -0.658 . . . . 0.0 112.414 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -79.38 -38.34 35.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.856 0.862 . . . . 0.0 111.533 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 46.2 mt -63.73 -35.84 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.794 0.724 . . . . 0.0 109.68 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 50.5 m -68.34 -53.32 24.92 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.644 0.778 . . . . 0.0 110.863 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.73 -29.69 70.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.515 1.052 . . . . 0.0 113.146 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.7 m -64.8 -25.39 67.89 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -120.49 -5.07 9.82 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.0 tpt85 -60.13 -22.49 62.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.05 1.34 . . . . 0.0 113.195 174.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -53.69 -21.41 6.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.732 2.013 . . . . 0.0 114.81 170.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -97.41 -7.56 31.44 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.311 1.444 . . . . 0.0 113.631 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 125.38 171.61 13.28 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.108 1.813 . . . . 0.0 112.102 -170.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.82 149.88 73.17 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.673 2.915 . . . . 0.0 112.292 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.08 171.69 18.84 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.622 1.569 . . . . 0.0 112.403 -171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.0 159.78 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.671 1.588 . . . . 0.0 109.223 167.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.84 135.88 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.224 1.009 . . . . 0.0 110.884 -170.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 126.169 1.788 . . . . 0.0 111.53 -175.647 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.326 0 CA-C-O 119.9 -0.389 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -154.52 159.4 40.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.248 1.419 . . . . 0.0 112.167 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.08 170.93 18.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.769 1.227 . . . . 0.0 111.792 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -119.48 117.37 28.24 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.312 1.845 . . . . 0.0 109.705 177.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.85 142.01 34.08 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.162 1.385 . . . . 0.0 108.757 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 64.4 mt -124.07 106.17 10.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.672 1.589 . . . . 0.0 107.928 171.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.99 156.1 22.46 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.37 0.668 . . . . 0.0 111.946 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -78.61 -24.65 45.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -143.16 141.95 31.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.308 1.443 . . . . 0.0 110.675 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.47 -33.0 69.28 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.032 0.933 . . . . 0.0 111.935 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -55.52 -28.24 53.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.771 1.228 . . . . 0.0 113.111 174.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.5 m -73.37 -28.85 62.26 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.941 -1.099 . . . . 0.0 112.283 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.88 -39.55 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.685 -0.634 . . . . 0.0 109.624 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -66.18 -38.39 87.91 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.708 -0.62 . . . . 0.0 111.951 173.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.39 86.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.379 0.671 . . . . 0.0 112.409 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.25 -48.1 74.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.206 0.602 . . . . 0.0 111.049 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 78.4 mt -55.54 -41.95 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.93 0.892 . . . . 0.0 111.221 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.28 -17.15 63.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.814 1.246 . . . . 0.0 113.72 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.0 -13.65 18.99 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.167 1.387 . . . . 0.0 113.404 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 57.8 m -76.3 149.06 37.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 93.2 mt -85.94 177.46 7.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.666 1.586 . . . . 0.0 107.934 165.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 123.518 0.727 . . . . 0.0 111.337 -178.325 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 120.307 0.099 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.55 144.43 32.91 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 3.7 tp -129.68 -167.05 1.74 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.673 1.989 . . . . 0.0 108.375 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.7 p -144.3 152.31 40.59 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.912 -1.118 . . . . 0.0 113.38 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.37 169.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.85 2.06 . . . . 0.0 110.761 -171.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 71.1 m -148.12 163.86 35.66 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.453 1.101 . . . . 0.0 113.018 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 52.4 p -145.32 -178.33 0.77 Allowed Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 126.905 2.082 . . . . 0.0 110.886 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.28 -10.96 30.43 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.298 2.665 . . . . 0.0 113.98 170.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 42.4 p -113.28 -31.33 6.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.016 1.326 . . . . 0.0 113.329 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.9 mm -133.62 134.23 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.159 1.384 . . . . 0.0 110.412 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -115.95 135.47 53.94 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.866 1.266 . . . . 0.0 111.119 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 61.84 32.95 17.91 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.468 1.507 . . . . 0.0 112.761 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -62.97 124.36 83.38 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.935 -1.103 . . . . 0.0 110.225 174.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.48 145.88 27.0 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.983 2.455 . . . . 0.0 109.149 170.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.38 133.22 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.711 1.205 . . . . 0.0 110.719 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -76.41 130.59 38.25 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.497 1.119 . . . . 0.0 109.72 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.21 133.35 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.303 1.441 . . . . 0.0 108.54 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 51.8 mtp85 -138.65 98.19 8.92 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 124.306 1.042 . . . . 0.0 110.483 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.79 131.28 43.02 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.358 2.705 . . . . 0.0 110.01 169.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -169.472 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 82.9 mtm-85 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -79.61 136.78 36.93 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.884 1.274 . . . . 0.0 110.674 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.6 t -141.42 121.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.497 1.119 . . . . 0.0 110.104 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -74.54 142.17 44.77 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.72 0.808 . . . . 0.0 111.158 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.88 124.12 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.402 1.481 . . . . 0.0 109.251 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -122.49 149.64 16.95 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.011 1.291 . . . . 0.0 113.615 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 92.48 17.41 45.84 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.864 1.221 . . . . 0.0 114.366 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.92 141.74 89.39 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.295 1.438 . . . . 0.0 111.381 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.31 154.98 17.21 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.906 3.07 . . . . 0.0 113.818 175.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.43 2.6 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.984 3.122 . . . . 0.0 114.105 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -140.29 23.17 2.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.964 1.306 . . . . 0.0 112.413 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.1 tt -95.32 160.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.681 1.193 . . . . 0.0 109.744 169.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -142.33 171.15 14.45 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.294 1.037 . . . . 0.0 113.107 -173.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -41.67 -47.16 3.91 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.082 1.753 . . . . 0.0 114.241 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.4 -26.97 46.62 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.486 -0.759 . . . . 0.0 112.635 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -80.56 -35.23 34.65 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.016 0.927 . . . . 0.0 111.669 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 65.3 mt -64.7 -36.52 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.614 -0.679 . . . . 0.0 109.465 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 53.7 m -65.4 -53.5 42.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.559 171.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.26 -31.34 70.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.27 0.941 . . . . 0.0 113.275 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.1 m -67.68 -23.6 65.32 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -122.49 -4.3 8.81 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -59.5 -23.04 62.46 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.027 1.331 . . . . 0.0 112.909 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -53.54 -20.55 5.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.678 1.991 . . . . 0.0 114.921 170.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -99.51 -5.66 28.87 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.381 1.472 . . . . 0.0 113.718 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.89 177.47 15.2 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 126.294 1.902 . . . . 0.0 112.406 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.99 147.66 91.77 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.393 2.729 . . . . 0.0 112.65 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.5 169.82 23.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.359 1.464 . . . . 0.0 112.551 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.5 156.93 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.624 1.569 . . . . 0.0 109.158 167.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 94.3 t -119.67 136.38 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.904 1.282 . . . . 0.0 110.068 -173.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 126.288 1.835 . . . . 0.0 111.455 -171.227 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 CA-C-O 118.917 -0.935 . . . . 0.0 114.181 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -144.91 158.71 43.71 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.423 1.611 . . . . 0.0 114.741 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.99 170.04 23.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.607 1.563 . . . . 0.0 112.019 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -117.24 129.56 56.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.146 1.778 . . . . 0.0 110.243 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 35.8 mt -92.79 140.92 29.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.733 1.613 . . . . 0.0 108.699 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.8 mt -124.96 107.34 10.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.784 1.634 . . . . 0.0 108.077 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -88.21 161.55 17.16 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.822 0.849 . . . . 0.0 112.736 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -76.16 -27.2 56.88 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.294 1.038 . . . . 0.0 113.028 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.36 145.98 36.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.314 1.445 . . . . 0.0 110.515 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.98 -29.73 68.64 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.627 -0.67 . . . . 0.0 111.351 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.7 m -55.24 -28.15 51.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.358 1.063 . . . . 0.0 113.099 171.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 16.9 m -74.54 -28.59 61.03 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.928 -1.108 . . . . 0.0 112.046 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.59 -37.29 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.301 0.641 . . . . 0.0 109.83 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -63.33 -41.1 98.88 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.762 0.71 . . . . 0.0 111.552 170.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.21 84.61 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.655 0.661 . . . . 0.0 112.361 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.82 -48.22 75.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.413 0.685 . . . . 0.0 111.149 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 68.7 mt -55.56 -42.25 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.429 1.092 . . . . 0.0 111.16 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.2 -17.51 63.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.892 1.277 . . . . 0.0 113.589 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.11 -13.96 18.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.126 1.37 . . . . 0.0 113.317 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 59.0 m -74.75 146.8 41.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.944 0.878 . . . . 0.0 113.266 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.36 173.32 11.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.288 1.435 . . . . 0.0 108.001 165.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 N--CA 1.47 0.548 0 C-N-CA 123.646 0.778 . . . . 0.0 111.435 -175.236 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.36 0.124 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -143.19 149.1 37.52 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.1 tp -132.03 -179.67 5.55 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.614 1.966 . . . . 0.0 108.729 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 71.8 m -130.61 140.42 50.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.269 1.028 . . . . 0.0 112.04 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.9 m -148.43 171.39 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 126.159 1.783 . . . . 0.0 111.623 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 68.7 m -147.29 163.36 36.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.783 1.233 . . . . 0.0 112.516 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 28.4 p -140.19 -175.73 0.5 Allowed Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.84 2.056 . . . . 0.0 110.631 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -66.9 -13.07 38.54 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.0 2.467 . . . . 0.0 113.894 171.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 44.0 p -120.91 -28.18 4.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.906 1.282 . . . . 0.0 113.836 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 16.3 mm -126.5 135.28 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.206 1.402 . . . . 0.0 110.117 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -121.41 131.0 53.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.689 1.196 . . . . 0.0 111.158 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 24.5 t70 62.67 32.32 16.29 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.305 1.442 . . . . 0.0 112.666 176.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -60.55 128.33 88.1 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.348 1.059 . . . . 0.0 110.528 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.21 139.5 14.93 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.207 2.604 . . . . 0.0 109.095 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 5.2 m -131.38 132.17 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.271 1.428 . . . . 0.0 109.769 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.71 133.77 35.39 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.291 1.036 . . . . 0.0 109.815 -174.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.98 134.9 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.292 1.437 . . . . 0.0 108.901 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -141.11 95.5 7.48 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.53 1.132 . . . . 0.0 110.641 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.14 130.23 35.31 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.664 2.909 . . . . 0.0 111.241 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 123.74 0.816 . . . . 0.0 112.042 -175.606 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 46.7 mtm105 . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -79.92 136.99 36.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.146 0.978 . . . . 0.0 111.42 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.15 118.82 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.691 1.197 . . . . 0.0 109.709 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -75.23 142.31 43.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.394 0.678 . . . . 0.0 110.59 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.36 121.92 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.521 1.529 . . . . 0.0 109.189 176.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.78 148.23 18.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.796 1.189 . . . . 0.0 113.065 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 93.17 14.99 53.36 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.67 1.128 . . . . 0.0 114.268 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 92.9 mt -57.83 139.26 82.49 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.687 1.195 . . . . 0.0 110.375 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.32 150.56 19.8 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.602 2.868 . . . . 0.0 113.161 173.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.95 3.0 6.47 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.943 3.095 . . . . 0.0 113.579 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -137.57 16.07 2.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.728 2.011 . . . . 0.0 112.596 -169.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.4 tt -96.05 133.91 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.658 1.183 . . . . 0.0 111.781 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -94.8 162.16 13.87 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.472 1.109 . . . . 0.0 113.399 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -47.64 -44.49 26.96 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.107 1.763 . . . . 0.0 113.751 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.11 -27.91 57.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.825 0.85 . . . . 0.0 112.389 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -77.27 -34.47 55.68 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.528 0.731 . . . . 0.0 112.651 169.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.4 mt -64.99 -36.64 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.93 1.241 . . . . 0.0 109.609 169.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 54.0 m -64.99 -52.38 56.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.646 0.779 . . . . 0.0 110.54 172.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.49 -30.37 70.57 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.582 1.083 . . . . 0.0 112.924 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 75.6 m -65.61 -15.83 63.12 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -130.76 -3.24 4.14 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -61.03 -22.21 64.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.083 1.353 . . . . 0.0 113.009 173.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -57.58 -11.9 2.39 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.645 1.978 . . . . 0.0 114.931 169.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -105.92 -5.86 19.33 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.466 1.506 . . . . 0.0 114.047 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 123.91 173.98 14.04 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 126.073 1.797 . . . . 0.0 112.53 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.27 149.98 88.68 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.795 2.997 . . . . 0.0 113.016 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.75 171.98 16.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.255 1.422 . . . . 0.0 112.806 -176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.72 158.46 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.918 1.687 . . . . 0.0 109.298 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.37 135.63 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.578 1.151 . . . . 0.0 110.719 -170.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 125.893 1.677 . . . . 0.0 111.662 -175.277 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.186 0 N-CA-C 114.464 0.546 . . . . 0.0 114.464 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -152.22 157.53 41.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.463 1.131 . . . . 0.0 112.652 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.34 168.77 25.98 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.718 1.207 . . . . 0.0 112.257 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -113.37 121.14 43.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.307 1.843 . . . . 0.0 109.727 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.3 mt -86.02 140.73 30.03 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.422 1.489 . . . . 0.0 108.76 169.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.53 107.65 12.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.788 1.635 . . . . 0.0 107.734 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.97 154.17 22.32 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.417 0.687 . . . . 0.0 111.936 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -71.65 -26.29 62.48 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.76 0.824 . . . . 0.0 112.822 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -142.25 146.05 34.71 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.389 1.475 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.53 -31.44 71.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.308 0.643 . . . . 0.0 111.659 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -56.24 -28.41 58.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.75 1.22 . . . . 0.0 112.876 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.0 m -73.19 -29.13 62.61 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.964 -1.085 . . . . 0.0 112.147 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.04 -38.51 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.646 -0.659 . . . . 0.0 109.784 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -66.78 -38.35 86.39 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.547 -0.721 . . . . 0.0 111.897 172.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.84 88.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.579 0.627 . . . . 0.0 112.372 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.76 -49.13 74.18 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.306 0.642 . . . . 0.0 110.929 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.62 -42.18 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.1 0.96 . . . . 0.0 111.428 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.07 -17.84 63.92 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.76 1.224 . . . . 0.0 113.581 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.1 -13.59 18.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.165 1.386 . . . . 0.0 113.351 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 54.7 m -75.49 148.14 39.24 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.6 172.93 11.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.045 165.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.471 0.585 0 C-N-CA 123.487 0.715 . . . . 0.0 112.15 -175.08 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 110.83 -0.063 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -143.03 148.43 36.72 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.6 tp -135.75 177.93 7.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.474 1.91 . . . . 0.0 108.904 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 86.7 m -126.51 144.66 50.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.242 1.017 . . . . 0.0 112.761 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.0 m -149.85 170.06 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 126.855 2.062 . . . . 0.0 111.038 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 70.6 m -148.69 163.47 37.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.761 1.224 . . . . 0.0 112.406 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 25.7 p -140.89 -173.44 0.36 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 126.745 2.018 . . . . 0.0 111.278 -174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.79 -36.09 97.6 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.955 2.437 . . . . 0.0 113.863 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 44.8 p -119.29 -16.15 9.05 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 23.6 mm -113.69 128.79 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.693 1.133 . . . . 0.0 109.945 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -124.79 135.33 52.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.484 1.114 . . . . 0.0 111.69 -168.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 61.26 30.94 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.421 1.488 . . . . 0.0 112.631 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -66.85 128.32 93.82 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.52 1.128 . . . . 0.0 111.213 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.07 141.73 13.24 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.342 2.695 . . . . 0.0 109.119 169.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.18 135.08 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.396 1.479 . . . . 0.0 110.015 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -81.08 129.57 34.62 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.362 1.065 . . . . 0.0 109.561 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 35.7 mm -110.81 136.8 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.337 1.455 . . . . 0.0 109.08 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -142.14 87.01 9.89 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.904 1.282 . . . . 0.0 110.051 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.61 128.12 27.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.327 2.684 . . . . 0.0 109.763 172.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -169.417 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 86.3 mtm-85 . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -86.5 138.25 31.88 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.131 0.973 . . . . 0.0 111.132 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.0 t -140.6 120.63 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.293 1.037 . . . . 0.0 110.208 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -71.63 139.93 49.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.851 0.86 . . . . 0.0 110.644 171.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.4 t -132.6 119.35 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.32 1.448 . . . . 0.0 109.408 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.66 146.51 18.45 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.069 1.319 . . . . 0.0 113.435 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.13 17.87 30.75 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.883 1.23 . . . . 0.0 114.275 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.77 141.54 92.68 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.994 1.318 . . . . 0.0 111.441 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.11 156.77 15.22 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.877 3.052 . . . . 0.0 113.972 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.05 3.95 6.59 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.061 3.174 . . . . 0.0 113.815 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -137.45 23.22 2.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.377 1.471 . . . . 0.0 112.323 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.8 tt -104.81 142.66 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.556 1.142 . . . . 0.0 110.897 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -116.2 169.0 9.61 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.929 1.292 . . . . 0.0 113.068 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -48.64 -41.28 30.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.725 1.61 . . . . 0.0 113.921 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.13 -29.44 34.8 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.891 0.877 . . . . 0.0 112.388 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.93 -38.19 69.9 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.328 0.651 . . . . 0.0 111.822 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.1 mt -65.85 -38.71 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.301 -0.875 . . . . 0.0 109.449 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 85.2 m -60.93 -51.51 68.95 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.334 0.653 . . . . 0.0 110.539 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.93 -30.59 71.01 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.419 1.009 . . . . 0.0 112.914 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 65.9 m -68.93 -13.95 62.75 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -129.43 -2.89 4.91 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -60.96 -21.74 63.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.966 1.307 . . . . 0.0 113.228 174.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -56.74 -13.13 2.27 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.736 2.014 . . . . 0.0 114.976 169.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -104.47 -4.89 22.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.514 1.526 . . . . 0.0 113.999 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.07 175.1 15.08 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.983 1.754 . . . . 0.0 112.604 -174.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.26 145.54 98.38 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 123.923 3.082 . . . . 0.0 113.421 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.25 172.53 17.2 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.403 1.481 . . . . 0.0 112.698 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.58 159.85 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.835 1.654 . . . . 0.0 108.553 166.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 82.8 t -132.56 135.97 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.249 1.02 . . . . 0.0 110.421 -172.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 124.806 1.242 . . . . 0.0 112.437 -177.058 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.228 0 N-CA-C 114.724 0.649 . . . . 0.0 114.724 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -148.16 157.17 43.35 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.557 1.178 . . . . 0.0 112.973 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.91 167.54 27.25 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.051 1.341 . . . . 0.0 111.831 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -115.12 121.19 42.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.856 1.662 . . . . 0.0 109.845 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 21.0 mt -82.24 140.32 33.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.176 1.39 . . . . 0.0 108.731 169.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.9 mt -125.22 101.18 6.87 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.013 1.725 . . . . 0.0 108.11 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.34 159.13 27.3 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.165 0.586 . . . . 0.0 111.497 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -88.49 -13.51 40.09 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.68 142.23 34.92 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.695 1.598 . . . . 0.0 110.367 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.14 -29.78 71.07 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.556 -0.715 . . . . 0.0 112.04 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 26.7 p -59.58 -24.8 64.06 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.939 -1.1 . . . . 0.0 112.999 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.7 m -71.18 -28.79 64.48 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.888 -1.133 . . . . 0.0 112.314 172.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 70.4 t -73.88 -36.98 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.524 -0.735 . . . . 0.0 109.797 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -71.64 -35.74 70.49 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.736 -0.602 . . . . 0.0 112.137 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.37 85.87 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.673 0.67 . . . . 0.0 112.255 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.87 -49.17 73.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.543 0.737 . . . . 0.0 110.951 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.99 -41.64 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.094 0.958 . . . . 0.0 111.619 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.11 -18.48 63.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.844 1.258 . . . . 0.0 113.67 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.57 -13.5 20.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.049 1.339 . . . . 0.0 113.289 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 40.9 m -75.92 147.19 39.15 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.73 176.46 8.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.722 1.609 . . . . 0.0 107.798 165.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 CA--C 1.537 0.456 0 O-C-N 121.649 -0.657 . . . . 0.0 111.382 -179.381 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.94 0.4 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -143.65 148.84 36.38 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.513 1.125 . . . . 0.0 113.002 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.8 tp -140.39 157.91 44.82 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.365 1.466 . . . . 0.0 110.134 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 76.6 m -95.96 136.91 35.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.15 0.98 . . . . 0.0 112.424 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 31.5 m -146.11 177.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 126.846 2.058 . . . . 0.0 110.44 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 82.0 p -162.76 168.52 21.36 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.054 -1.029 . . . . 0.0 113.481 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 51.9 p -138.75 -175.54 0.49 Allowed Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.454 1.902 . . . . 0.0 110.617 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.55 -12.42 35.72 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.172 2.581 . . . . 0.0 114.154 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 46.9 p -119.11 -29.39 5.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.964 1.306 . . . . 0.0 113.689 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 27.2 mm -128.77 127.07 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.285 1.434 . . . . 0.0 109.592 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -117.26 141.79 47.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.661 1.184 . . . . 0.0 111.774 -169.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 57.69 31.92 21.12 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.123 1.369 . . . . 0.0 113.096 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -70.51 128.17 91.37 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.314 1.045 . . . . 0.0 111.712 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.62 128.38 4.62 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.309 2.673 . . . . 0.0 108.578 169.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.51 137.91 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.187 1.395 . . . . 0.0 110.47 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -76.71 125.95 30.13 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.104 1.362 . . . . 0.0 109.568 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.3 mm -110.96 128.78 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.54 1.536 . . . . 0.0 108.548 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -136.36 91.5 16.43 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.633 1.173 . . . . 0.0 109.85 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.9 132.48 51.95 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.765 2.977 . . . . 0.0 110.312 172.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -168.923 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 66.4 mtm-85 . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.48 136.0 49.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.566 1.147 . . . . 0.0 111.026 172.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 61.3 t -140.86 120.69 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.579 1.151 . . . . 0.0 110.111 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -68.64 141.25 55.44 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.221 1.008 . . . . 0.0 111.258 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.74 125.8 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.992 1.317 . . . . 0.0 109.161 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -127.28 148.6 17.51 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 125.218 1.39 . . . . 0.0 113.461 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 90.52 15.68 56.47 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.714 1.149 . . . . 0.0 114.009 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.68 142.5 62.25 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.485 1.514 . . . . 0.0 111.408 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.47 151.48 23.71 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.774 2.983 . . . . 0.0 113.145 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.96 0.62 8.66 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.776 2.984 . . . . 0.0 114.795 -169.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -140.71 16.92 2.34 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.38 1.072 . . . . 0.0 113.0 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.9 tt -79.75 131.61 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.632 0.773 . . . . 0.0 111.506 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -92.65 167.89 11.6 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.96 -39.99 69.53 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.491 1.117 . . . . 0.0 113.195 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.93 -30.24 58.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.969 0.907 . . . . 0.0 112.087 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.09 -42.54 80.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.948 0.899 . . . . 0.0 111.517 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 63.3 mt -63.15 -40.7 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.162 0.892 . . . . 0.0 109.795 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 56.9 m -62.21 -51.56 67.31 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.655 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.65 -31.08 71.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.275 0.943 . . . . 0.0 112.567 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.3 m -68.97 -13.14 62.27 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -129.02 -3.62 5.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.618 1.099 . . . . 0.0 113.572 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -61.02 -22.77 64.86 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.867 1.267 . . . . 0.0 113.165 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -57.11 -13.39 2.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.624 1.97 . . . . 0.0 114.951 170.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -103.34 -7.34 21.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.427 1.491 . . . . 0.0 113.901 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.07 172.14 13.61 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.1 1.81 . . . . 0.0 112.075 -170.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.1 150.8 60.69 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.501 2.801 . . . . 0.0 112.237 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.16 174.96 12.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.604 1.562 . . . . 0.0 112.603 -169.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.78 157.23 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.852 1.661 . . . . 0.0 109.144 167.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 59.3 t -124.04 134.02 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.856 1.262 . . . . 0.0 109.79 -174.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 CA--C 1.545 0.775 0 C-N-CA 125.851 1.66 . . . . 0.0 111.817 -170.819 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 CA-C-O 118.752 -1.027 . . . . 0.0 114.481 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -137.51 156.74 47.79 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.591 1.696 . . . . 0.0 114.175 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -154.44 168.57 26.22 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.665 1.586 . . . . 0.0 111.647 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -120.22 120.71 36.92 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.947 1.699 . . . . 0.0 109.987 172.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.7 mt -83.27 141.12 32.08 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.909 1.284 . . . . 0.0 108.571 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 43.6 mt -123.5 105.49 9.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.395 1.478 . . . . 0.0 107.54 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.92 157.75 26.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.011 0.524 . . . . 0.0 111.274 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -90.48 -12.78 36.27 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -142.21 137.2 30.59 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.562 1.545 . . . . 0.0 110.098 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.48 -34.11 70.53 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.797 0.839 . . . . 0.0 111.964 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.6 m -55.97 -26.42 48.17 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.742 1.217 . . . . 0.0 113.197 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.4 m -71.84 -27.83 63.15 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.947 -1.096 . . . . 0.0 112.384 174.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 57.0 t -73.87 -39.9 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.657 -0.652 . . . . 0.0 109.513 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -67.94 -37.75 82.0 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.694 -0.629 . . . . 0.0 111.941 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.28 -38.36 89.05 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.554 0.616 . . . . 0.0 112.342 173.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.2 tp -63.85 -48.83 75.2 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.288 0.635 . . . . 0.0 110.888 171.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 76.4 mt -56.0 -42.68 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.958 0.903 . . . . 0.0 111.42 176.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.21 -19.02 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.729 1.212 . . . . 0.0 113.514 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.33 -14.07 20.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.052 1.341 . . . . 0.0 113.5 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 42.3 m -75.46 147.94 39.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.079 0.942 . . . . 0.0 113.41 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.54 172.85 11.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.505 1.522 . . . . 0.0 107.803 165.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 123.402 0.681 . . . . 0.0 111.501 -176.441 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 120.619 0.247 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -140.17 146.75 39.17 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.005 0.922 . . . . 0.0 112.707 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.4 tp -129.87 -174.75 3.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.418 1.887 . . . . 0.0 108.561 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 30.0 p -133.94 149.49 51.27 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.058 0.943 . . . . 0.0 113.173 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 26.0 m -148.15 170.23 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 126.279 1.832 . . . . 0.0 111.588 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 50.8 m -145.33 154.23 42.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.536 1.134 . . . . 0.0 112.755 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 24.6 p -144.4 -175.04 0.44 Allowed Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 126.207 1.803 . . . . 0.0 111.502 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.31 -13.99 41.32 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.122 2.548 . . . . 0.0 113.659 171.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 29.3 p -117.51 -32.0 5.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.148 1.379 . . . . 0.0 113.77 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.5 mm -133.64 142.45 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.96 1.304 . . . . 0.0 110.137 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -120.94 133.63 55.28 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.081 1.352 . . . . 0.0 110.577 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.2 t70 63.08 28.34 16.08 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.152 1.381 . . . . 0.0 112.926 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -57.18 126.52 74.05 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-O 117.34 -1.314 . . . . 0.0 110.662 174.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.8 140.56 23.47 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.215 2.61 . . . . 0.0 109.652 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.05 134.78 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.829 1.252 . . . . 0.0 110.657 -174.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -73.14 134.73 44.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.001 1.321 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.8 mm -119.9 131.43 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.65 1.58 . . . . 0.0 108.105 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -139.99 95.36 8.59 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 123.848 0.859 . . . . 0.0 110.862 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.64 139.96 91.41 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.602 2.868 . . . . 0.0 111.889 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 124.185 0.994 . . . . 0.0 112.568 -179.724 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.477 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 53.1 m -147.87 153.87 39.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.1 1.36 . . . . 0.0 111.378 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 28.4 p -78.71 -18.25 54.6 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 61.54 -122.37 28.91 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.296 0.95 . . . . 0.0 112.548 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 57.6 p -91.27 -1.5 57.65 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.107 1.363 . . . . 0.0 114.224 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.6 m -69.57 138.78 53.48 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.681 -1.262 . . . . 0.0 113.294 -174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 131.0 -117.66 2.24 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.209 1.385 . . . . 0.0 110.775 -172.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 23.2 t -145.68 167.57 22.79 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.146 1.378 . . . . 0.0 111.959 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -75.11 -5.86 46.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.396 1.078 . . . . 0.0 113.506 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -76.52 137.49 39.63 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.002 0.921 . . . . 0.0 111.174 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.5 t -138.27 116.82 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.475 1.11 . . . . 0.0 109.77 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.2 141.75 49.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.536 0.734 . . . . 0.0 110.727 172.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.37 124.64 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.239 1.416 . . . . 0.0 109.509 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -119.57 144.88 17.78 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.789 1.185 . . . . 0.0 113.319 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 100.24 9.16 48.68 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.585 1.565 . . . . 0.0 114.502 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.05 141.77 75.66 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.38 1.472 . . . . 0.0 111.328 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -53.93 155.71 14.12 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.851 3.034 . . . . 0.0 114.084 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.45 3.75 7.22 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.956 3.104 . . . . 0.0 113.527 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -137.93 19.94 2.83 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.623 1.569 . . . . 0.0 112.159 -170.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -103.05 136.39 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.317 1.447 . . . . 0.0 110.547 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -109.03 171.79 7.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.177 0.991 . . . . 0.0 113.02 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -44.35 -46.25 9.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.863 1.665 . . . . 0.0 113.602 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -76.35 -26.96 56.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.449 0.699 . . . . 0.0 112.591 -173.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -78.7 -38.17 39.77 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.819 0.848 . . . . 0.0 111.425 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 34.6 mt -65.06 -39.89 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 121.601 -0.687 . . . . 0.0 109.415 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 90.2 m -61.29 -52.51 64.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.756 0.823 . . . . 0.0 110.345 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.3 69.88 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.453 1.024 . . . . 0.0 113.213 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.1 m -68.46 -23.99 64.66 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -120.42 -4.12 9.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.256 1.022 . . . . 0.0 113.435 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -60.39 -22.07 62.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.313 1.445 . . . . 0.0 113.439 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -54.87 -19.29 6.25 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.425 1.89 . . . . 0.0 114.888 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -98.85 -4.81 32.24 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.467 1.507 . . . . 0.0 113.688 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.66 170.65 13.63 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.996 1.76 . . . . 0.0 112.015 -170.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.37 150.49 76.01 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.598 2.865 . . . . 0.0 112.144 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.88 172.87 16.2 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.721 1.608 . . . . 0.0 112.275 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.17 159.69 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.523 1.529 . . . . 0.0 108.797 167.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.78 136.17 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.179 0.991 . . . . 0.0 110.421 -172.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.99 158.96 44.33 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.897 1.679 . . . . 0.0 111.667 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 32.0 p90 -158.03 159.72 30.15 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.454 1.101 . . . . 0.0 112.569 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -58.73 147.69 86.72 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 123.684 2.923 . . . . 0.0 113.167 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 66.76 5.71 4.11 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.506 1.523 . . . . 0.0 114.716 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -62.69 -33.51 75.23 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.542 -1.349 . . . . 0.0 112.105 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -62.34 -15.89 51.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.21 2.204 . . . . 0.0 115.018 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -128.47 7.44 5.83 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.583 1.553 . . . . 0.0 112.831 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 26.5 t -82.02 147.19 29.3 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.897 -1.127 . . . . 0.0 112.907 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -92.41 0.99 57.49 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.889 1.276 . . . . 0.0 113.171 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 62.2 m -141.4 148.19 39.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.977 1.311 . . . . 0.0 112.2 -173.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.24 14.96 6.85 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -170.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -107.49 153.44 41.31 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.572 1.549 . . . . 0.0 111.406 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.54 131.71 19.24 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.183 2.589 . . . . 0.0 110.958 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.9 140.86 32.46 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.345 2.696 . . . . 0.0 110.394 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt 61.3 9.81 2.74 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.408 1.483 . . . . 0.0 114.435 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 81.01 35.44 24.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.079 1.323 . . . . 0.0 114.491 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -148.06 150.2 33.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.402 1.601 . . . . 0.0 114.634 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -154.81 173.32 16.62 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.979 1.312 . . . . 0.0 112.171 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -118.33 122.01 41.81 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.226 1.811 . . . . 0.0 110.302 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.34 141.5 31.74 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.375 1.47 . . . . 0.0 108.511 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 64.4 mt -125.73 103.67 7.95 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.951 1.701 . . . . 0.0 108.191 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -83.47 157.51 22.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.339 0.656 . . . . 0.0 112.126 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -75.28 -25.33 57.89 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.463 0.705 . . . . 0.0 112.658 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -138.14 144.41 40.77 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.175 1.39 . . . . 0.0 111.032 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.32 -32.43 72.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.448 0.699 . . . . 0.0 111.222 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.3 m -57.12 -27.88 62.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.705 1.202 . . . . 0.0 112.996 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.4 m -72.33 -28.92 63.36 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.961 -1.087 . . . . 0.0 111.994 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.76 -39.13 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 121.697 -0.627 . . . . 0.0 109.781 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -66.24 -39.02 89.23 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.614 -0.679 . . . . 0.0 111.949 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.86 86.93 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.542 0.61 . . . . 0.0 112.306 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 26.8 tp -64.25 -48.63 75.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.478 0.711 . . . . 0.0 111.042 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.67 -41.44 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.022 0.929 . . . . 0.0 111.408 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.18 -17.71 63.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.725 1.21 . . . . 0.0 113.66 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.18 -13.46 18.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.071 1.348 . . . . 0.0 113.455 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.7 m -75.6 147.59 39.48 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.876 0.87 . . . . 0.0 113.266 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.43 173.08 12.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.529 1.532 . . . . 0.0 108.215 165.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -145.71 140.89 27.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.217 0.607 . . . . 0.0 112.575 -170.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -155.67 116.62 3.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.529 1.532 . . . . 0.0 110.019 176.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 61.01 15.84 6.5 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.732 1.613 . . . . 0.0 114.632 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 98.23 -6.83 61.81 Favored Glycine 0 N--CA 1.473 1.123 0 C-N-CA 125.782 1.658 . . . . 0.0 114.068 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -78.3 147.25 34.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.653 1.181 . . . . 0.0 109.124 168.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.18 151.97 26.64 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.042 0.937 . . . . 0.0 110.013 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -140.93 141.43 34.51 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -125.41 -169.75 2.05 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.183 1.793 . . . . 0.0 108.332 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.2 p -141.73 150.2 41.48 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.645 1.111 . . . . 0.0 113.607 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 27.6 m -151.95 177.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.567 1.947 . . . . 0.0 111.486 -171.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 79.7 p -160.55 170.49 20.79 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.031 1.332 . . . . 0.0 112.933 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.4 p -153.78 -179.35 1.04 Allowed Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.73 2.012 . . . . 0.0 110.425 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.65 -19.93 55.5 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.845 2.363 . . . . 0.0 114.337 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 52.7 p -114.97 -19.28 11.0 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.05 1.34 . . . . 0.0 114.285 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.81 137.03 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.43 1.492 . . . . 0.0 110.391 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -131.64 137.75 48.49 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.711 1.204 . . . . 0.0 112.092 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.1 t70 57.54 28.4 15.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.396 1.478 . . . . 0.0 113.283 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -72.11 127.13 90.85 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.837 -1.078 . . . . 0.0 111.466 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.6 142.91 18.6 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.317 2.678 . . . . 0.0 109.381 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.5 m -137.65 133.22 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.55 1.14 . . . . 0.0 110.627 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -81.52 131.23 35.27 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.654 1.182 . . . . 0.0 110.057 -172.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.1 mm -114.05 128.61 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 108.986 -171.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -136.22 89.15 20.16 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.909 1.283 . . . . 0.0 110.092 -175.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.95 134.8 64.7 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.658 2.905 . . . . 0.0 110.851 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -73.75 122.69 22.79 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.172 0.51 . . . . 0.0 112.024 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -162.33 134.26 5.45 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.528 1.931 . . . . 0.0 109.087 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 80.2 mt -95.58 -2.51 48.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -170.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 70.0 m -76.39 147.43 38.03 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.147 -0.97 . . . . 0.0 113.027 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -76.16 152.29 36.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.854 1.262 . . . . 0.0 112.523 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 25.6 m -158.68 155.84 28.85 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.003 1.721 . . . . 0.0 111.581 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -80.17 1.14 29.39 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.103 1.361 . . . . 0.0 114.353 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -75.7 94.39 3.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.517 1.127 . . . . 0.0 111.436 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 12.2 p -154.87 138.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.852 1.661 . . . . 0.0 110.002 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -147.46 10.54 0.97 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.325 1.45 . . . . 0.0 113.803 -169.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.03 133.38 56.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.099 1.359 . . . . 0.0 112.268 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 42.4 m 67.94 -0.89 1.89 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 126.538 1.935 . . . . 0.0 114.7 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 77.71 178.9 49.08 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 125.233 1.397 . . . . 0.0 114.392 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.58 160.29 35.03 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.244 3.296 . . . . 0.0 111.763 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 55.9 p -161.12 140.91 10.7 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.85 1.26 . . . . 0.0 111.835 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 14.8 m -84.55 -7.26 59.32 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -174.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.359 1.457 . . . . 0.0 113.127 -178.093 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 57.6 p -169.09 -48.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.736 1.214 . . . . 0.0 112.106 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 24.1 m 70.09 4.28 4.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.928 2.091 . . . . 0.0 115.077 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -85.79 12.3 59.87 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.498 1.523 . . . . 0.0 115.054 -176.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 31.6 p -87.24 5.12 39.8 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.569 1.548 . . . . 0.0 114.565 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 87.5 p -155.64 178.93 9.69 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.157 1.383 . . . . 0.0 112.854 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 104.93 -123.38 7.62 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 125.248 1.404 . . . . 0.0 111.258 -174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 22.2 t -146.62 152.06 38.28 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.969 1.308 . . . . 0.0 111.461 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -95.2 -5.2 44.43 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -82.12 135.72 35.26 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.592 0.633 . . . . 0.0 110.601 171.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.82 117.77 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.195 0.998 . . . . 0.0 110.146 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -71.21 139.74 50.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.147 0.979 . . . . 0.0 110.715 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 64.1 t -133.64 118.16 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.399 1.48 . . . . 0.0 109.292 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.09 143.44 18.07 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 124.803 1.192 . . . . 0.0 113.478 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.49 15.49 32.04 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.109 1.338 . . . . 0.0 114.4 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.64 139.47 85.84 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.957 1.303 . . . . 0.0 110.933 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -55.12 156.46 16.18 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.578 2.852 . . . . 0.0 113.703 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.91 5.4 4.95 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.054 3.169 . . . . 0.0 113.715 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -140.3 29.54 2.0 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.393 1.477 . . . . 0.0 112.043 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -110.7 128.32 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.464 1.106 . . . . 0.0 111.179 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -97.73 167.49 10.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.667 1.187 . . . . 0.0 113.334 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -43.6 -46.53 7.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.261 1.825 . . . . 0.0 113.994 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -79.01 -25.44 43.31 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.846 0.858 . . . . 0.0 112.523 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -77.51 -36.41 52.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.589 0.756 . . . . 0.0 111.933 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 44.0 mt -65.54 -36.39 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.153 0.888 . . . . 0.0 109.569 170.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 60.4 m -64.23 -52.19 59.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.831 0.852 . . . . 0.0 110.54 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.16 -30.64 70.52 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.605 1.093 . . . . 0.0 112.992 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.1 m -66.86 -15.5 63.67 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -130.19 -2.78 4.48 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -61.12 -22.09 64.34 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.987 1.315 . . . . 0.0 113.096 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -56.91 -13.12 2.37 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.736 2.014 . . . . 0.0 114.956 169.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -104.56 -5.73 21.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.497 1.519 . . . . 0.0 113.961 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.8 170.97 13.66 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.878 1.704 . . . . 0.0 112.104 -170.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.56 151.35 70.18 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.793 2.995 . . . . 0.0 112.429 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.06 172.92 15.11 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.63 1.572 . . . . 0.0 112.486 -170.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.52 159.44 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.742 1.617 . . . . 0.0 109.33 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.98 136.36 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.489 1.115 . . . . 0.0 110.817 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -146.2 163.21 36.13 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.375 1.87 . . . . 0.0 111.659 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -158.61 158.51 29.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.738 1.215 . . . . 0.0 112.277 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.24 147.8 93.57 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.03 2.486 . . . . 0.0 112.775 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 45.8 m170 65.78 14.95 9.83 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.572 1.549 . . . . 0.0 113.974 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -65.94 -19.01 65.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.305 1.442 . . . . 0.0 112.786 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -71.37 -22.66 61.86 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.394 1.878 . . . . 0.0 113.961 171.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -116.53 -31.18 5.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.011 1.324 . . . . 0.0 112.798 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 75.8 m -82.87 101.69 11.16 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.066 0.946 . . . . 0.0 109.228 169.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -78.79 55.65 1.75 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.107 1.363 . . . . 0.0 113.491 -169.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 84.9 p -155.78 159.24 39.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.635 1.174 . . . . 0.0 113.117 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -94.06 24.71 4.13 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.666 1.586 . . . . 0.0 113.926 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -116.72 141.98 28.98 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 126.434 1.893 . . . . 0.0 109.846 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.56 119.94 6.82 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.105 2.536 . . . . 0.0 109.883 174.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.15 17.42 1.77 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.547 2.831 . . . . 0.0 113.382 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -136.58 -3.91 2.08 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.225 1.41 . . . . 0.0 114.366 -171.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.51 15.27 81.59 Favored Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.207 0.908 . . . . 0.0 114.13 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -151.44 158.0 43.1 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.622 1.211 . . . . 0.0 112.773 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -151.81 168.79 23.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.662 1.185 . . . . 0.0 111.904 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.57 118.69 33.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.51 1.924 . . . . 0.0 109.521 175.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 23.7 mt -82.34 142.33 32.11 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.306 1.442 . . . . 0.0 109.053 169.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 53.7 mt -125.97 106.79 9.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.018 1.727 . . . . 0.0 108.05 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.03 156.43 21.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.519 0.728 . . . . 0.0 112.161 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -69.01 -34.56 75.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.701 0.801 . . . . 0.0 112.41 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -140.57 141.62 35.21 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.991 1.716 . . . . 0.0 109.999 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -60.59 -32.41 71.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.052 0.941 . . . . 0.0 111.808 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 19.2 m -56.81 -27.05 59.3 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.616 1.166 . . . . 0.0 112.954 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 22.5 m -70.06 -28.73 65.69 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.089 -1.007 . . . . 0.0 112.283 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 57.9 t -77.18 -36.5 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.643 -0.66 . . . . 0.0 110.043 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -68.74 -37.15 79.22 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.515 -0.741 . . . . 0.0 111.871 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.43 -37.84 87.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.298 0.639 . . . . 0.0 112.294 172.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.0 tp -64.68 -48.55 74.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.435 0.694 . . . . 0.0 111.032 171.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.1 mt -55.89 -41.51 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.086 0.954 . . . . 0.0 111.261 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.45 -17.53 63.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.767 1.227 . . . . 0.0 113.636 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.83 -13.64 19.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.082 1.353 . . . . 0.0 113.27 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 56.8 m -71.93 141.17 49.47 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.029 0.919 . . . . 0.0 113.077 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 90.6 mt -80.94 176.28 9.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.541 1.536 . . . . 0.0 108.052 165.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -142.24 129.63 21.2 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.402 0.681 . . . . 0.0 110.956 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -144.2 122.02 11.96 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.033 1.733 . . . . 0.0 109.32 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 58.2 26.35 13.7 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.431 1.492 . . . . 0.0 113.721 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 89.65 -0.84 80.68 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.616 1.579 . . . . 0.0 114.363 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -109.67 143.27 39.68 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.979 1.711 . . . . 0.0 110.144 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 82.7 mt -84.06 148.33 26.89 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.707 -0.621 . . . . 0.0 111.568 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -141.22 152.13 44.33 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.873 1.269 . . . . 0.0 113.787 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.0 tp -140.17 161.62 37.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.767 1.627 . . . . 0.0 109.916 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 24.2 p -97.88 139.0 34.38 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.92 1.288 . . . . 0.0 112.769 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.1 m -148.21 175.61 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 126.627 1.971 . . . . 0.0 110.667 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 82.9 p -161.38 170.9 19.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.3 p -139.61 -177.82 0.74 Allowed Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 127.009 2.123 . . . . 0.0 110.885 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -65.6 -11.72 31.82 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.322 2.681 . . . . 0.0 114.273 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 43.7 p -122.7 -24.71 4.82 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.025 1.33 . . . . 0.0 113.857 -174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 31.0 mm -129.77 125.86 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.325 1.45 . . . . 0.0 109.648 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.06 143.74 48.91 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.576 1.15 . . . . 0.0 112.347 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 61.08 30.67 19.6 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.451 1.501 . . . . 0.0 112.701 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -69.18 127.95 92.76 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 121.128 -0.982 . . . . 0.0 111.529 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.25 131.8 5.05 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.397 2.732 . . . . 0.0 108.941 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.35 133.91 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.026 1.33 . . . . 0.0 110.915 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -77.34 127.98 33.5 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.411 1.085 . . . . 0.0 109.638 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.4 mm -109.21 132.77 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.91 1.284 . . . . 0.0 109.211 -174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -139.87 93.88 9.28 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.477 1.111 . . . . 0.0 110.295 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.04 135.56 69.38 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.252 2.635 . . . . 0.0 109.687 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -66.91 -14.76 63.11 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -169.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -83.79 -13.66 53.3 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.263 1.025 . . . . 0.0 113.384 172.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -124.38 -1.6 8.09 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.795 2.038 . . . . 0.0 113.337 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 65.3 p -72.49 -14.79 61.75 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -168.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -106.16 -0.96 24.2 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.037 1.735 . . . . 0.0 115.45 -168.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 7.2 t -159.99 165.42 32.03 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.127 0.876 . . . . 0.0 113.05 -176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 21.1 t70 69.51 -4.09 1.46 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.091 2.556 . . . . 0.0 115.311 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -79.26 12.18 2.49 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.561 1.545 . . . . 0.0 114.9 -174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 6.8 p -160.16 143.08 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 126.174 1.79 . . . . 0.0 110.323 -169.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.34 10.4 1.12 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.51 1.524 . . . . 0.0 113.785 -170.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.41 -3.15 28.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.592 1.557 . . . . 0.0 114.36 -170.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 13.2 m -67.64 -9.04 39.63 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.626 1.57 . . . . 0.0 114.865 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -169.24 168.77 41.49 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.932 1.253 . . . . 0.0 114.135 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.05 159.2 37.73 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.141 3.227 . . . . 0.0 111.67 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.3 m -74.58 -6.71 50.07 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 9.3 t -165.16 164.02 20.26 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.412 1.885 . . . . 0.0 111.003 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.218 0 C-N-CA 125.229 1.395 . . . . 0.0 112.863 -178.422 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.442 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 49.2 p -159.96 -60.46 0.06 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.053 0.941 . . . . 0.0 112.476 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 53.4 p -90.73 -11.45 39.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 86.43 155.34 26.55 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.652 1.596 . . . . 0.0 113.716 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.3 p -166.98 -66.97 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.971 1.308 . . . . 0.0 111.49 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 47.2 p -167.57 153.61 7.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.843 1.657 . . . . 0.0 112.042 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -155.76 -90.05 0.07 OUTLIER Glycine 0 N--CA 1.468 0.807 0 C-N-CA 125.737 1.636 . . . . 0.0 110.798 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 12.5 t -155.55 160.12 40.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.287 1.435 . . . . 0.0 111.748 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.5 mtm-85 -88.08 -3.76 58.85 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.333 1.053 . . . . 0.0 112.794 170.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -82.24 134.26 35.28 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.254 1.422 . . . . 0.0 111.128 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.6 t -141.0 121.05 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.297 1.039 . . . . 0.0 110.246 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -75.11 140.33 43.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.683 0.793 . . . . 0.0 110.49 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.73 120.6 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.24 1.416 . . . . 0.0 109.294 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.37 146.71 18.55 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 124.836 1.208 . . . . 0.0 113.917 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 91.32 23.75 28.38 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.958 1.266 . . . . 0.0 113.931 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.22 145.91 64.26 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.826 1.651 . . . . 0.0 111.717 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -52.34 155.56 9.38 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.13 3.22 . . . . 0.0 113.907 174.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.57 1.12 9.34 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.878 3.052 . . . . 0.0 113.576 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -140.4 45.79 1.83 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.672 1.589 . . . . 0.0 111.469 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.8 tt -127.57 147.67 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.437 1.495 . . . . 0.0 110.834 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -123.92 170.98 10.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.461 1.504 . . . . 0.0 113.08 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -50.28 -40.82 49.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.177 1.391 . . . . 0.0 113.994 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -81.1 -29.8 34.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.993 0.917 . . . . 0.0 112.361 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.22 -38.75 71.99 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.329 0.652 . . . . 0.0 111.882 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 46.8 mt -66.05 -38.23 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.52 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 88.8 m -61.26 -51.18 70.03 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.316 0.647 . . . . 0.0 110.634 172.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.84 -31.07 71.29 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.245 0.929 . . . . 0.0 112.866 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.5 m -69.09 -14.29 62.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -128.23 -3.08 5.65 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.34 0.973 . . . . 0.0 113.539 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -60.61 -22.1 63.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.905 1.282 . . . . 0.0 113.38 174.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -56.81 -14.17 3.19 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.663 1.985 . . . . 0.0 115.016 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -102.82 -4.4 24.95 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.36 1.464 . . . . 0.0 113.903 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 120.89 171.68 14.38 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.864 1.697 . . . . 0.0 111.981 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.18 151.87 72.35 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.589 2.859 . . . . 0.0 112.271 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.66 173.45 13.87 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.913 1.685 . . . . 0.0 112.312 -171.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.04 157.8 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.658 1.583 . . . . 0.0 108.707 166.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.18 136.25 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.514 1.126 . . . . 0.0 110.158 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -154.41 169.39 23.85 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.48 1.112 . . . . 0.0 112.751 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -156.88 157.21 30.65 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.827 1.251 . . . . 0.0 112.654 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.13 149.71 83.35 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.727 2.951 . . . . 0.0 113.963 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 32.5 m170 70.65 3.54 4.59 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.318 1.847 . . . . 0.0 115.067 170.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -58.42 -28.47 65.26 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.731 -1.231 . . . . 0.0 111.979 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -59.31 -24.52 63.37 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.027 2.131 . . . . 0.0 114.666 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.09 -38.52 2.16 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.594 1.157 . . . . 0.0 112.304 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 74.9 m -89.65 79.53 6.79 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.465 1.106 . . . . 0.0 109.077 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -59.34 115.77 3.47 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.423 1.089 . . . . 0.0 111.509 -174.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 14.7 t -166.74 147.51 5.97 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.014 0.925 . . . . 0.0 112.215 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -101.72 6.62 41.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.416 1.487 . . . . 0.0 112.98 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -112.45 142.91 27.87 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.746 2.019 . . . . 0.0 109.134 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.89 117.78 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.955 2.437 . . . . 0.0 110.254 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.46 16.86 1.88 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.458 2.772 . . . . 0.0 113.14 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -135.33 -5.59 2.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.493 1.517 . . . . 0.0 114.144 -172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.87 13.11 83.77 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.45 1.024 . . . . 0.0 114.354 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -148.16 160.76 42.58 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.775 1.288 . . . . 0.0 113.188 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.42 165.07 36.17 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.992 1.317 . . . . 0.0 111.879 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.28 121.52 45.48 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.832 1.653 . . . . 0.0 109.941 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 22.5 mt -84.85 139.91 31.56 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.433 1.493 . . . . 0.0 108.682 169.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 45.5 mt -127.06 103.13 7.28 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.922 1.689 . . . . 0.0 107.874 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -82.03 160.74 23.17 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.391 0.677 . . . . 0.0 111.813 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -82.84 -16.24 48.46 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -141.29 141.47 33.92 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.405 1.482 . . . . 0.0 110.51 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.77 -30.03 69.77 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.709 -0.62 . . . . 0.0 111.508 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.5 m -55.27 -28.46 53.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.666 1.187 . . . . 0.0 112.964 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.6 m -73.48 -28.74 62.09 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.01 -1.056 . . . . 0.0 112.213 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 86.1 t -75.21 -37.79 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.561 -0.712 . . . . 0.0 109.848 174.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -67.28 -38.2 84.69 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.552 -0.718 . . . . 0.0 111.967 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.83 -37.75 88.03 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.615 0.643 . . . . 0.0 112.322 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.1 tp -63.52 -49.12 74.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.386 0.675 . . . . 0.0 110.92 171.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.7 mt -55.85 -41.51 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.155 0.982 . . . . 0.0 111.351 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.4 -18.25 63.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.737 1.215 . . . . 0.0 113.672 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.48 -14.28 20.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.044 1.337 . . . . 0.0 113.433 174.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.0 m -75.03 146.72 41.34 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.064 0.935 . . . . 0.0 113.475 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -85.17 176.24 8.48 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.545 1.538 . . . . 0.0 107.844 165.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -146.04 138.23 25.28 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.375 0.67 . . . . 0.0 111.715 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -154.75 121.16 5.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.983 1.313 . . . . 0.0 110.233 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 65.42 6.19 3.57 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.339 2.256 . . . . 0.0 113.932 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 97.98 -8.52 63.24 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.835 1.683 . . . . 0.0 113.636 -170.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -79.33 142.82 35.73 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.495 1.147 . . . . 0.0 109.762 170.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.4 mt -93.41 156.04 17.01 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.35 0.66 . . . . 0.0 111.342 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -144.98 150.55 37.13 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.504 1.122 . . . . 0.0 113.271 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.35 153.18 42.46 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.045 1.338 . . . . 0.0 110.617 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 21.5 p -83.72 136.45 34.17 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.627 1.171 . . . . 0.0 112.607 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.8 165.4 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 126.021 1.728 . . . . 0.0 111.264 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 50.4 m -146.59 168.06 22.19 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.262 1.025 . . . . 0.0 113.217 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.0 p -147.65 -173.79 0.38 Allowed Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 127.804 2.442 . . . . 0.0 109.942 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -64.63 -16.09 53.41 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.051 2.501 . . . . 0.0 114.341 171.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 57.4 p -126.99 -15.37 5.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.932 1.293 . . . . 0.0 114.312 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.0 mm -129.63 135.0 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.173 1.789 . . . . 0.0 109.27 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -133.14 132.4 41.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.039 0.936 . . . . 0.0 112.338 -169.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.7 t70 59.36 26.95 15.92 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.674 1.59 . . . . 0.0 113.032 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -75.15 129.86 81.81 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.401 1.48 . . . . 0.0 111.901 -169.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -76.35 117.75 4.71 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.407 2.738 . . . . 0.0 110.916 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.89 141.25 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.347 1.459 . . . . 0.0 110.436 173.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -79.03 129.47 34.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.045 0.938 . . . . 0.0 109.861 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.5 131.69 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.487 1.515 . . . . 0.0 108.77 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 29.2 mtp85 -139.25 86.86 14.21 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.681 1.193 . . . . 0.0 110.107 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.89 138.69 80.65 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.638 2.892 . . . . 0.0 111.372 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -81.52 120.28 24.83 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.478 0.711 . . . . 0.0 112.405 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -162.63 156.1 20.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.529 1.532 . . . . 0.0 111.347 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.24 148.65 25.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.572 1.149 . . . . 0.0 111.738 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 14.7 m -70.83 -5.11 27.93 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -71.63 -14.11 61.96 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.679 1.191 . . . . 0.0 112.264 169.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 70.2 m -122.67 -3.23 8.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.271 1.428 . . . . 0.0 114.457 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -159.5 139.26 11.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.58 1.952 . . . . 0.0 110.651 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -68.37 161.69 26.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.557 0.743 . . . . 0.0 111.912 172.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 13.7 p -154.34 141.8 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.527 1.131 . . . . 0.0 111.242 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.17 7.77 10.84 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.976 2.11 . . . . 0.0 113.554 -170.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -148.54 123.68 10.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.991 1.716 . . . . 0.0 110.447 -169.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 48.3 m 67.62 -6.42 0.67 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.055 2.142 . . . . 0.0 114.994 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 82.21 169.72 43.84 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 125.903 1.716 . . . . 0.0 114.43 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.34 145.74 97.99 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.201 3.267 . . . . 0.0 113.848 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 94.7 p -71.33 -9.0 57.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.055 0.942 . . . . 0.0 113.202 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 8.9 m -76.44 -9.27 58.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.107 1.763 . . . . 0.0 114.604 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.197 -179.342 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 8.4 t -164.64 -177.97 5.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.782 1.633 . . . . 0.0 110.998 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 73.9 m -139.83 130.5 25.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.917 1.687 . . . . 0.0 110.781 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -89.61 161.09 29.48 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.628 1.109 . . . . 0.0 113.672 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 45.2 p -85.91 2.89 44.27 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.459 1.504 . . . . 0.0 113.496 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 7.8 p -81.47 2.24 29.66 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.873 2.069 . . . . 0.0 114.934 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -68.88 169.44 42.33 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.56 1.076 . . . . 0.0 113.611 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 39.5 t -145.01 160.09 41.92 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.445 1.098 . . . . 0.0 112.794 -173.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -76.14 -7.1 54.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.25 1.02 . . . . 0.0 113.08 170.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -71.19 138.63 49.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.928 0.891 . . . . 0.0 110.816 169.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.6 t -140.07 119.49 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.537 1.135 . . . . 0.0 109.717 175.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -71.77 139.53 49.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.867 0.867 . . . . 0.0 110.544 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.9 119.11 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.311 1.445 . . . . 0.0 109.407 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -117.03 147.67 18.88 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.113 1.339 . . . . 0.0 113.45 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 92.02 19.07 40.93 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 124.702 1.144 . . . . 0.0 114.142 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 98.3 mt -55.2 141.56 60.66 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.561 1.544 . . . . 0.0 111.189 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.94 148.86 28.17 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.625 2.884 . . . . 0.0 112.806 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.62 6.65 3.1 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.207 3.271 . . . . 0.0 114.461 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -140.05 16.57 2.45 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.48 1.512 . . . . 0.0 112.676 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.6 tt -93.39 137.73 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.039 0.936 . . . . 0.0 111.408 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -109.92 170.26 8.19 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.721 1.208 . . . . 0.0 113.161 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -47.66 -44.11 26.89 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.647 1.579 . . . . 0.0 113.746 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -79.65 -25.49 41.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.839 0.855 . . . . 0.0 112.316 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -77.99 -36.64 48.64 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.773 0.829 . . . . 0.0 111.496 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.0 mt -64.89 -38.64 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 118.932 0.787 . . . . 0.0 109.529 170.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 61.6 m -62.74 -52.01 64.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.533 0.733 . . . . 0.0 110.517 173.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.7 70.89 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.5 1.045 . . . . 0.0 112.998 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.6 m -67.66 -15.04 63.44 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -129.62 -2.97 4.8 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -60.98 -22.63 64.66 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.878 1.271 . . . . 0.0 113.142 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -56.42 -13.99 2.67 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.806 2.042 . . . . 0.0 115.009 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -103.67 -6.29 21.74 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.432 1.493 . . . . 0.0 113.946 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 123.44 172.33 13.77 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.961 1.743 . . . . 0.0 112.14 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.79 151.45 68.87 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.544 2.829 . . . . 0.0 112.358 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.27 172.88 15.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.746 1.618 . . . . 0.0 112.527 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -134.02 159.19 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.706 1.603 . . . . 0.0 109.28 167.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 56.1 t -129.26 135.11 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.308 1.043 . . . . 0.0 110.77 -171.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -145.11 164.15 32.14 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.257 1.823 . . . . 0.0 111.845 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -157.36 158.93 31.1 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.874 1.27 . . . . 0.0 112.083 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.98 150.79 87.57 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.139 2.559 . . . . 0.0 112.849 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 48.3 m170 64.85 12.64 7.92 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.435 1.494 . . . . 0.0 114.044 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -67.52 -15.32 63.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.551 1.541 . . . . 0.0 112.867 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -63.33 -22.93 67.18 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.612 1.965 . . . . 0.0 113.944 169.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.85 -40.68 2.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.138 1.375 . . . . 0.0 111.561 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 68.7 m -83.83 62.4 6.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.792 1.237 . . . . 0.0 109.931 169.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -74.77 -0.66 18.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.787 1.635 . . . . 0.0 114.53 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.6 m -56.79 159.95 3.7 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.797 1.639 . . . . 0.0 113.35 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.32 5.38 7.15 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -171.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -128.83 139.73 36.5 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.28 1.832 . . . . 0.0 110.008 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.95 121.79 8.84 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.977 2.451 . . . . 0.0 110.173 173.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -85.58 16.97 1.85 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.322 2.681 . . . . 0.0 113.726 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -136.04 -3.04 2.27 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.83 15.44 81.23 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.121 0.867 . . . . 0.0 114.284 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -149.88 156.79 42.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.641 1.176 . . . . 0.0 112.651 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.58 169.67 22.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.905 1.282 . . . . 0.0 111.697 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -116.32 118.06 31.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.39 1.876 . . . . 0.0 109.531 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 25.4 mt -80.95 141.09 34.83 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.921 1.288 . . . . 0.0 108.682 169.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.8 mt -123.85 103.42 8.34 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.747 1.619 . . . . 0.0 107.871 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -81.02 156.52 25.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.116 0.566 . . . . 0.0 111.403 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -82.81 -15.75 50.45 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -141.87 141.85 33.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.4 1.48 . . . . 0.0 110.658 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.57 -31.86 70.97 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.228 0.611 . . . . 0.0 111.533 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -56.03 -28.04 55.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.65 1.18 . . . . 0.0 112.941 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.3 m -73.92 -29.64 62.15 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.955 -1.091 . . . . 0.0 112.168 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.95 -38.81 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.667 -0.646 . . . . 0.0 109.66 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -66.96 -38.51 86.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.636 -0.665 . . . . 0.0 111.985 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.92 88.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.627 0.649 . . . . 0.0 112.304 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.95 -48.85 74.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.45 0.7 . . . . 0.0 110.918 171.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 74.2 mt -55.67 -42.43 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.091 0.957 . . . . 0.0 111.345 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.98 -17.97 64.0 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.668 1.187 . . . . 0.0 113.671 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.09 -13.88 19.63 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.113 1.365 . . . . 0.0 113.431 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.9 m -77.51 150.46 34.86 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -86.83 176.23 7.81 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.79 1.636 . . . . 0.0 107.778 164.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -147.07 137.44 23.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.463 0.705 . . . . 0.0 111.729 -174.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -157.47 126.1 5.67 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.244 1.418 . . . . 0.0 110.202 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 58.77 24.3 12.14 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.22 1.808 . . . . 0.0 113.79 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 85.99 -4.52 85.81 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.711 1.625 . . . . 0.0 114.424 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -94.87 147.57 23.23 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.95 1.3 . . . . 0.0 110.341 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 95.8 mt -94.8 158.21 15.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.77 0.828 . . . . 0.0 111.163 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -144.18 148.97 35.7 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.224 1.01 . . . . 0.0 113.096 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -140.7 162.1 36.2 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.733 1.613 . . . . 0.0 110.017 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 24.8 p -97.79 141.17 31.11 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.082 1.353 . . . . 0.0 112.628 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.4 m -146.66 169.98 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 126.7 2.0 . . . . 0.0 110.644 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.7 m -148.9 169.05 21.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.553 1.141 . . . . 0.0 112.786 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.28 175.98 2.57 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 127.916 2.487 . . . . 0.0 109.493 -176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -57.19 -31.97 92.13 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.162 2.575 . . . . 0.0 115.016 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 42.2 p -119.07 0.12 11.21 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.556 1.542 . . . . 0.0 114.03 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.6 mm -135.68 121.65 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.84 1.656 . . . . 0.0 109.061 -171.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -125.05 134.33 52.58 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.204 1.002 . . . . 0.0 111.984 -168.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.2 t70 60.3 30.81 20.14 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.298 1.439 . . . . 0.0 112.653 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -62.71 129.88 93.27 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.782 1.233 . . . . 0.0 110.962 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.87 137.61 11.19 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.214 2.61 . . . . 0.0 109.193 169.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.23 138.16 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.244 1.418 . . . . 0.0 110.201 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -79.05 127.74 32.38 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.012 1.325 . . . . 0.0 109.532 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.0 mm -112.22 132.8 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.581 1.552 . . . . 0.0 108.673 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -141.21 92.54 8.36 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.476 1.11 . . . . 0.0 110.074 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.79 133.37 55.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.53 2.82 . . . . 0.0 110.829 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -84.26 157.79 21.45 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -169.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -150.08 134.64 17.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.569 1.548 . . . . 0.0 110.821 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 73.3 mt -85.35 101.18 12.36 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.408 1.483 . . . . 0.0 110.094 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 10.6 t -163.87 -178.81 5.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.359 1.464 . . . . 0.0 110.996 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -75.61 -3.8 36.48 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.652 1.581 . . . . 0.0 113.802 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 25.3 t -158.09 140.75 14.65 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.707 1.603 . . . . 0.0 111.278 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -97.55 0.6 47.72 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.707 2.003 . . . . 0.0 113.704 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -61.6 149.34 39.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.764 1.626 . . . . 0.0 113.098 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 3.4 p -162.94 120.11 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.688 1.595 . . . . 0.0 110.462 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 70.6 mtp -159.0 157.55 31.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.986 2.514 . . . . 0.0 110.668 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -146.63 136.54 23.34 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.148 1.779 . . . . 0.0 110.58 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 9.5 t -165.54 166.55 18.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.289 1.436 . . . . 0.0 111.34 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 86.59 175.28 49.51 Favored Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.268 1.413 . . . . 0.0 113.961 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.5 152.76 34.25 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.059 3.173 . . . . 0.0 111.725 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.5 m -71.35 -5.71 34.56 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 17.5 m -77.22 -8.33 57.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.436 1.494 . . . . 0.0 114.346 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.194 0 CA-C-O 118.224 -1.32 . . . . 0.0 113.183 179.59 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 19.8 m -90.54 -1.54 57.89 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 87.3 p -163.5 172.73 14.03 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.507 1.523 . . . . 0.0 112.153 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 94.75 -25.8 21.54 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.499 1.524 . . . . 0.0 114.449 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 90.8 p -166.65 163.89 16.78 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.622 1.569 . . . . 0.0 112.011 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 17.0 p -97.34 11.13 37.66 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.806 1.643 . . . . 0.0 113.37 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 84.2 -59.98 4.88 Favored Glycine 0 N--CA 1.472 1.044 0 C-N-CA 125.761 1.648 . . . . 0.0 112.772 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 19.8 t -159.17 160.25 35.27 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.216 1.407 . . . . 0.0 112.263 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 -79.0 -13.28 59.89 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.2 1.0 . . . . 0.0 112.942 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.26 133.86 35.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.686 1.195 . . . . 0.0 110.811 171.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.9 123.0 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.425 1.09 . . . . 0.0 110.524 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.37 143.44 44.85 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.313 1.045 . . . . 0.0 111.344 171.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.61 127.2 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.236 1.414 . . . . 0.0 109.586 172.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -127.78 146.44 16.62 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.938 1.256 . . . . 0.0 113.622 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 96.73 15.98 38.01 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.142 1.353 . . . . 0.0 114.451 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.31 141.99 86.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.238 1.415 . . . . 0.0 111.507 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.25 155.82 14.95 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.027 3.151 . . . . 0.0 114.283 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.75 2.71 7.58 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 124.117 3.212 . . . . 0.0 113.673 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -138.19 34.76 2.32 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.643 1.577 . . . . 0.0 111.815 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 10.4 tt -114.1 162.57 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.525 1.53 . . . . 0.0 110.234 172.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -146.22 170.36 16.9 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.049 1.34 . . . . 0.0 112.539 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -42.74 -47.66 5.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.132 1.773 . . . . 0.0 114.264 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.25 -29.2 42.53 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.388 -0.82 . . . . 0.0 112.34 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -74.15 -37.25 64.08 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.634 0.774 . . . . 0.0 111.45 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 64.6 mt -65.77 -39.52 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.454 -0.778 . . . . 0.0 109.569 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 62.0 m -60.63 -52.5 64.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.254 173.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.15 71.41 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.332 0.969 . . . . 0.0 112.942 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.2 m -69.42 -14.59 62.98 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -128.2 -4.1 5.59 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.347 0.976 . . . . 0.0 113.508 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -60.61 -22.44 63.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.952 1.301 . . . . 0.0 113.284 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -56.44 -13.7 2.47 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.716 2.006 . . . . 0.0 115.045 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -104.86 -4.38 22.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.236 1.414 . . . . 0.0 113.988 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.72 172.73 14.34 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.818 1.675 . . . . 0.0 112.228 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.68 151.59 69.55 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.722 2.948 . . . . 0.0 112.172 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.09 172.66 16.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.538 1.535 . . . . 0.0 112.553 -169.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.37 151.45 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.876 1.67 . . . . 0.0 109.389 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.98 134.77 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.338 1.455 . . . . 0.0 109.719 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.88 161.71 40.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.95 1.7 . . . . 0.0 112.05 -169.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.5 p90 -165.23 163.57 13.32 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.657 1.583 . . . . 0.0 111.846 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -55.7 143.0 81.75 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.656 2.904 . . . . 0.0 112.9 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 69.99 3.65 4.44 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.098 1.759 . . . . 0.0 114.742 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -68.49 -21.13 64.62 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.31 -1.494 . . . . 0.0 112.639 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -78.47 -8.54 58.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.806 2.042 . . . . 0.0 114.142 172.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -135.9 13.04 3.38 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.62 1.568 . . . . 0.0 112.943 -170.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 42.6 t -153.25 147.94 26.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.695 1.598 . . . . 0.0 111.644 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -83.53 -4.08 58.22 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.52 1.128 . . . . 0.0 113.616 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 68.2 m -65.28 116.63 6.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.068 0.947 . . . . 0.0 112.97 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -98.08 13.7 30.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.919 1.688 . . . . 0.0 113.414 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -106.94 147.52 35.23 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 127.332 2.253 . . . . 0.0 110.224 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.52 126.46 14.18 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.108 2.538 . . . . 0.0 110.593 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.6 129.62 18.1 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.293 2.662 . . . . 0.0 110.238 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 58.32 13.07 2.22 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.562 1.545 . . . . 0.0 114.565 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 85.41 27.87 31.75 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.97 1.272 . . . . 0.0 114.315 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -137.15 158.05 45.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.495 1.648 . . . . 0.0 113.752 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.36 167.8 29.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.502 1.521 . . . . 0.0 111.763 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -118.71 135.07 54.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.023 1.729 . . . . 0.0 109.913 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.2 mt -103.41 139.26 39.03 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.064 1.746 . . . . 0.0 108.697 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 14.2 mt -121.27 113.0 19.31 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.86 156.19 19.08 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.761 0.824 . . . . 0.0 111.338 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -64.59 -35.64 81.64 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.746 -0.596 . . . . 0.0 112.359 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -141.0 144.99 35.35 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.641 1.576 . . . . 0.0 110.507 -171.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.02 -30.88 70.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.508 1.123 . . . . 0.0 112.203 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 24.0 p -61.25 -25.83 67.35 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.088 1.355 . . . . 0.0 113.147 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 25.9 m -70.36 -30.75 67.76 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.931 -1.105 . . . . 0.0 111.686 172.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.75 -34.53 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.539 -0.726 . . . . 0.0 110.249 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -66.44 -37.59 85.5 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.436 -0.79 . . . . 0.0 111.861 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.87 89.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.652 0.66 . . . . 0.0 112.408 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.7 tp -62.99 -48.83 77.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.252 0.621 . . . . 0.0 110.824 171.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 70.8 mt -55.82 -42.29 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.334 1.054 . . . . 0.0 111.289 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.27 -19.67 63.92 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.601 1.16 . . . . 0.0 113.63 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -96.63 -14.14 22.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.952 1.301 . . . . 0.0 113.312 174.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 29.7 m -75.55 146.69 40.27 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 88.7 mt -85.33 -179.06 6.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.998 1.719 . . . . 0.0 107.702 164.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -147.0 138.24 24.02 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.465 -0.772 . . . . 0.0 111.843 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.56 130.14 8.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.802 1.641 . . . . 0.0 109.442 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 59.09 17.43 5.54 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.728 1.611 . . . . 0.0 113.408 -171.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 83.1 -5.25 77.45 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.077 1.323 . . . . 0.0 113.85 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -89.27 147.28 24.21 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.759 1.623 . . . . 0.0 109.807 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.3 mt -86.41 157.49 19.82 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.848 -0.532 . . . . 0.0 111.431 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -145.51 149.94 35.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.776 1.23 . . . . 0.0 112.711 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -144.27 153.17 41.76 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.891 1.276 . . . . 0.0 110.936 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 20.5 p -85.63 134.4 33.99 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.656 1.182 . . . . 0.0 112.804 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.87 167.48 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 126.335 1.854 . . . . 0.0 110.708 172.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.2 m -149.69 166.67 28.64 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.493 1.117 . . . . 0.0 112.814 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.5 p -138.51 -175.72 0.51 Allowed Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 127.209 2.204 . . . . 0.0 110.494 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.57 -15.39 49.7 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.064 2.509 . . . . 0.0 114.233 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 47.1 p -123.1 -23.7 4.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.898 1.279 . . . . 0.0 114.172 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.3 mm -126.23 132.28 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.601 1.56 . . . . 0.0 109.534 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -125.0 134.83 52.43 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.41 1.084 . . . . 0.0 111.773 -170.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 62.36 27.61 16.45 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.589 1.555 . . . . 0.0 112.928 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -60.32 127.27 86.11 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.607 1.163 . . . . 0.0 111.511 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.51 110.82 1.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.401 2.734 . . . . 0.0 108.287 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.27 136.22 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.115 0.966 . . . . 0.0 110.05 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -74.67 134.49 41.98 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.168 0.987 . . . . 0.0 109.486 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.73 133.92 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 126.14 1.776 . . . . 0.0 108.097 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 39.7 mtt180 -138.85 98.57 8.6 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.995 0.918 . . . . 0.0 110.343 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.31 134.4 61.29 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.434 2.756 . . . . 0.0 110.38 169.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -74.51 149.24 40.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.433 0.693 . . . . 0.0 112.455 -175.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -78.89 -80.08 0.12 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.421 0.688 . . . . 0.0 111.832 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 68.5 mt -151.24 171.1 17.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.691 1.996 . . . . 0.0 110.82 -176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 29.9 p -69.52 -13.74 62.5 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 170.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -161.04 128.38 4.18 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.404 2.282 . . . . 0.0 109.575 173.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 17.8 p -165.63 154.42 11.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.615 1.166 . . . . 0.0 112.54 -173.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -84.94 -1.53 56.8 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.771 1.228 . . . . 0.0 113.907 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -152.78 155.74 37.75 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.606 1.562 . . . . 0.0 111.925 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.31 136.09 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.557 2.343 . . . . 0.0 107.687 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.14 125.65 28.82 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.209 0.604 . . . . 0.0 111.193 -172.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -161.51 -33.8 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.691 1.596 . . . . 0.0 113.313 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 12.0 m -71.84 -3.13 20.53 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 89.68 -159.48 28.18 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 124.604 1.097 . . . . 0.0 113.26 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.76 151.82 25.03 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.531 2.821 . . . . 0.0 111.646 -171.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 8.6 t -164.87 170.09 15.79 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.399 1.48 . . . . 0.0 111.36 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 10.1 t -164.33 159.96 20.38 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.92 1.688 . . . . 0.0 111.357 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.226 0 C-N-CA 125.298 1.428 . . . . 0.0 112.972 -178.209 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.443 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 58.8 m -147.31 152.55 38.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.02 1.328 . . . . 0.0 111.455 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 17.4 m -81.68 -3.5 53.75 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -80.66 165.03 47.48 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.979 1.276 . . . . 0.0 113.733 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 78.1 p -164.73 165.87 20.4 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.522 1.529 . . . . 0.0 111.868 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.8 m -108.06 137.06 46.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.321 1.449 . . . . 0.0 111.294 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 153.83 -162.36 30.38 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.61 1.1 . . . . 0.0 113.766 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 23.2 t -148.78 164.41 34.49 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.425 1.49 . . . . 0.0 111.967 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -76.53 1.55 16.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.692 1.197 . . . . 0.0 113.96 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -68.83 139.13 55.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.041 0.936 . . . . 0.0 111.222 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.5 t -139.04 118.53 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.595 1.158 . . . . 0.0 109.996 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -68.54 138.85 55.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.07 0.948 . . . . 0.0 110.838 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.5 t -132.55 116.91 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.255 1.422 . . . . 0.0 109.277 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.04 143.91 17.9 Favored Glycine 0 N--CA 1.47 0.913 0 C-N-CA 124.905 1.24 . . . . 0.0 113.637 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.1 23.71 21.68 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.669 1.128 . . . . 0.0 113.882 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.72 141.57 84.68 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.042 1.337 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.22 155.18 20.46 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.503 2.802 . . . . 0.0 113.538 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.23 3.29 6.36 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.803 3.002 . . . . 0.0 114.524 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -140.55 27.14 2.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.865 1.266 . . . . 0.0 112.819 -177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.2 tt -101.07 144.75 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.466 1.106 . . . . 0.0 110.817 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -122.38 170.93 9.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.609 1.163 . . . . 0.0 113.022 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -46.36 -43.71 16.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.109 1.764 . . . . 0.0 114.21 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -76.77 -27.86 55.47 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.447 -0.783 . . . . 0.0 112.401 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -78.67 -36.14 44.13 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.944 0.898 . . . . 0.0 111.499 172.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.0 mt -65.47 -36.77 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.968 0.803 . . . . 0.0 109.559 171.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 48.7 m -64.8 -52.39 57.11 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.461 0.704 . . . . 0.0 110.563 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.22 71.03 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.422 1.01 . . . . 0.0 113.019 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.2 m -67.84 -14.67 63.15 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.656 1.182 . . . . 0.0 114.094 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -129.65 -3.01 4.78 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.457 1.026 . . . . 0.0 113.651 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -60.5 -22.62 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.867 1.267 . . . . 0.0 113.143 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -56.81 -14.0 3.04 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.675 1.99 . . . . 0.0 115.001 170.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -103.78 -6.86 21.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.281 1.433 . . . . 0.0 113.97 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.98 172.18 13.44 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.072 1.796 . . . . 0.0 112.114 -171.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.09 151.21 72.9 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.512 2.808 . . . . 0.0 112.133 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.34 172.33 16.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.598 1.559 . . . . 0.0 112.367 -170.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.79 157.9 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.719 1.608 . . . . 0.0 109.411 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 80.4 t -126.74 135.0 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.61 1.164 . . . . 0.0 110.472 -171.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -141.36 162.23 35.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.499 1.92 . . . . 0.0 111.689 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -161.19 156.79 21.28 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.105 1.362 . . . . 0.0 111.785 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.85 132.1 49.99 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.384 2.723 . . . . 0.0 112.328 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 22.9 m170 81.08 4.35 1.51 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 127.578 2.351 . . . . 0.0 114.279 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.55 -27.69 69.34 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.275 -1.516 . . . . 0.0 111.896 171.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -68.38 -8.67 42.35 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.362 1.865 . . . . 0.0 114.747 171.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.75 11.72 3.41 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.681 1.592 . . . . 0.0 113.145 -170.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 43.4 t -152.1 146.0 25.18 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.95 1.3 . . . . 0.0 112.518 -173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -81.75 -9.86 59.52 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.871 1.268 . . . . 0.0 113.223 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 71.2 m -66.25 118.15 9.54 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.948 -1.095 . . . . 0.0 112.886 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -94.77 15.4 18.49 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.251 1.42 . . . . 0.0 113.343 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -112.57 139.98 23.32 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.566 2.346 . . . . 0.0 107.865 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.6 117.51 5.04 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.387 2.725 . . . . 0.0 110.229 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -85.17 16.04 2.07 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.468 2.779 . . . . 0.0 113.533 -172.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -137.34 -3.12 1.95 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.675 1.59 . . . . 0.0 114.279 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.1 84.58 Favored Glycine 0 N--CA 1.476 1.312 0 C-N-CA 124.579 1.085 . . . . 0.0 114.468 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -149.04 161.5 41.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.681 1.192 . . . . 0.0 112.871 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -148.69 164.66 33.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.177 1.391 . . . . 0.0 111.549 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -115.33 115.43 26.61 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.186 1.794 . . . . 0.0 109.155 171.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.4 mt -80.82 142.31 33.83 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.739 1.215 . . . . 0.0 108.911 169.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 48.8 mt -123.37 108.77 13.1 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.603 1.561 . . . . 0.0 107.544 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -85.43 156.4 20.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.245 0.618 . . . . 0.0 111.953 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -75.18 -27.22 59.58 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -142.42 146.6 35.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.238 1.415 . . . . 0.0 111.018 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -63.97 -28.96 70.17 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.047 0.939 . . . . 0.0 111.742 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 22.2 p -61.79 -26.26 67.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 112.948 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.4 m -73.93 -34.34 64.28 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.863 -1.148 . . . . 0.0 111.75 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.77 -40.26 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.773 -0.579 . . . . 0.0 109.871 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -67.66 -40.35 84.51 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.615 -0.678 . . . . 0.0 111.957 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.67 76.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.318 0.963 . . . . 0.0 112.553 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.3 tp -64.92 -48.2 75.0 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.171 0.589 . . . . 0.0 111.012 170.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 85.6 mt -56.38 -42.86 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 118.895 0.771 . . . . 0.0 111.335 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.0 -14.97 63.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.245 1.418 . . . . 0.0 114.154 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.7 -14.51 18.06 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.907 1.283 . . . . 0.0 113.417 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 56.2 m -73.46 145.25 45.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.156 0.979 . . . . 0.0 113.448 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.5 mt -82.36 175.05 10.56 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.591 1.556 . . . . 0.0 107.823 165.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -144.05 139.81 29.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.537 0.735 . . . . 0.0 111.253 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -156.65 123.74 5.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.988 1.315 . . . . 0.0 110.074 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.42 21.46 12.59 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.072 1.749 . . . . 0.0 113.642 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 90.62 -2.61 80.59 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.485 1.516 . . . . 0.0 114.329 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -99.15 149.94 22.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.893 1.347 . . . . 0.0 111.167 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 93.5 mt -95.3 152.66 18.19 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.192 0.997 . . . . 0.0 111.374 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -142.24 152.36 42.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.291 1.037 . . . . 0.0 113.161 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.9 tp -139.52 168.36 20.0 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.797 1.639 . . . . 0.0 109.507 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 25.3 p -105.2 142.22 35.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.207 1.403 . . . . 0.0 112.518 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -144.83 171.59 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.628 1.971 . . . . 0.0 110.462 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 64.0 m -147.8 161.49 41.15 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.169 -0.957 . . . . 0.0 113.402 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 53.8 p -148.36 179.1 1.25 Allowed Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.764 2.025 . . . . 0.0 110.998 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -65.13 -13.83 41.91 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.295 2.663 . . . . 0.0 114.06 170.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 34.0 p -107.59 -31.38 8.13 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.01 1.324 . . . . 0.0 113.12 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 8.7 mm -134.69 126.62 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.515 1.126 . . . . 0.0 110.973 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -96.03 133.08 40.69 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.277 1.031 . . . . 0.0 111.535 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 61.8 34.64 17.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.132 1.373 . . . . 0.0 112.811 172.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -55.92 129.06 71.9 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.331 1.052 . . . . 0.0 110.817 171.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.37 137.62 11.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.273 2.648 . . . . 0.0 109.108 169.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.06 136.0 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.063 1.345 . . . . 0.0 110.433 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -73.77 131.22 41.34 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.143 0.977 . . . . 0.0 109.301 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.9 mm -113.35 129.57 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.97 1.308 . . . . 0.0 108.33 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 44.8 mtm105 -137.66 91.97 13.43 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.952 0.901 . . . . 0.0 110.725 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.57 145.66 98.4 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.774 2.983 . . . . 0.0 111.5 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -83.29 53.67 2.56 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.205 1.003 . . . . 0.0 111.878 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -76.85 136.5 38.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.083 1.353 . . . . 0.0 110.352 172.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 95.0 mt -124.08 17.83 9.22 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.058 1.743 . . . . 0.0 112.144 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.1 m -87.52 165.06 15.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.155 1.382 . . . . 0.0 112.356 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -156.98 113.89 3.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.123 1.369 . . . . 0.0 110.748 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 70.0 m -153.26 -54.3 0.11 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.828 1.251 . . . . 0.0 112.149 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -168.31 140.82 2.96 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.293 1.837 . . . . 0.0 110.198 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -141.42 155.68 45.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.543 1.537 . . . . 0.0 111.817 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 13.3 p -160.42 155.29 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.12 1.768 . . . . 0.0 110.105 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 22.1 ptm -147.23 140.89 25.63 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.482 1.513 . . . . 0.0 111.287 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.97 -28.42 29.76 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -171.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 80.6 p -165.27 147.87 7.95 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.502 1.121 . . . . 0.0 113.258 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -108.54 -142.75 10.12 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.998 1.761 . . . . 0.0 111.785 172.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -70.76 157.64 57.86 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.258 2.638 . . . . 0.0 111.409 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 14.1 m -74.13 -3.77 31.62 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 9.1 t -163.64 163.01 24.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.208 1.803 . . . . 0.0 111.276 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.208 0 C-N-CA 125.385 1.469 . . . . 0.0 112.855 -178.192 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.415 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 37.1 m -60.5 113.8 2.62 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.149 0.98 . . . . 0.0 111.788 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 72.9 p -168.01 167.15 12.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.86 1.264 . . . . 0.0 112.131 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 179.23 174.24 45.16 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.048 1.309 . . . . 0.0 113.234 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 6.1 t 70.48 -160.3 0.15 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.397 1.879 . . . . 0.0 111.792 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.7 m -159.25 141.23 13.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.962 1.705 . . . . 0.0 110.905 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -81.88 -15.71 74.48 Favored Glycine 0 N--CA 1.475 1.299 0 C-N-CA 123.856 0.741 . . . . 0.0 114.461 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 12.3 t -168.68 172.77 7.74 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.301 1.84 . . . . 0.0 111.611 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -90.6 -9.26 47.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.061 1.344 . . . . 0.0 111.856 167.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -83.07 137.64 34.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.473 1.509 . . . . 0.0 110.801 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.1 t -142.98 120.34 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.555 1.142 . . . . 0.0 110.207 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -74.35 142.31 45.12 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.604 0.762 . . . . 0.0 110.851 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.65 125.35 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.487 1.515 . . . . 0.0 109.163 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -123.16 148.17 16.75 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.815 1.198 . . . . 0.0 113.33 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 93.57 19.52 34.73 Favored Glycine 0 N--CA 1.474 1.182 0 C-N-CA 124.797 1.189 . . . . 0.0 114.316 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.22 143.59 78.85 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 125.477 1.511 . . . . 0.0 111.514 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.61 154.07 26.84 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.628 2.885 . . . . 0.0 113.457 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.5 3.01 6.74 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.881 3.054 . . . . 0.0 114.422 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -140.46 25.1 2.24 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.759 1.224 . . . . 0.0 112.764 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 10.7 tt -92.82 162.43 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.169 0.988 . . . . 0.0 110.741 170.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -142.9 169.42 17.6 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.163 1.385 . . . . 0.0 112.437 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.87 -42.54 26.95 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.302 1.841 . . . . 0.0 114.106 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.38 -27.62 41.89 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.402 -0.811 . . . . 0.0 112.357 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -77.31 -35.17 55.15 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.794 0.837 . . . . 0.0 111.572 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 59.6 mt -65.9 -37.45 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.431 -0.793 . . . . 0.0 109.54 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 63.3 m -63.11 -52.18 63.63 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.342 0.657 . . . . 0.0 110.422 172.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -59.88 -31.67 70.01 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.166 0.894 . . . . 0.0 112.995 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 74.5 m -69.55 -14.16 62.71 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -131.64 -2.0 3.81 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.513 1.051 . . . . 0.0 113.743 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.16 -23.17 61.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.859 1.264 . . . . 0.0 112.993 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -57.55 -11.16 1.83 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.487 1.915 . . . . 0.0 115.17 170.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -107.75 -2.02 20.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.586 1.554 . . . . 0.0 113.945 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 119.34 176.53 16.24 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.194 1.854 . . . . 0.0 112.613 -174.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -63.31 148.54 92.81 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.582 2.854 . . . . 0.0 112.865 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.9 170.47 20.57 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.373 1.469 . . . . 0.0 112.639 -176.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -131.44 157.9 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.911 1.685 . . . . 0.0 109.017 167.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 93.3 t -125.29 134.68 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.836 1.254 . . . . 0.0 109.93 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -151.38 165.45 34.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.975 1.71 . . . . 0.0 111.578 -170.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' TRP . . . . . 0.464 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 6.9 p90 -165.09 162.87 14.06 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.377 1.471 . . . . 0.0 112.185 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -57.88 149.38 70.11 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.745 2.963 . . . . 0.0 112.987 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 8.2 m170 73.07 -5.37 1.95 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 126.13 1.772 . . . . 0.0 114.338 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.464 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 41.4 tttm -67.64 -22.29 65.33 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.325 1.45 . . . . 0.0 112.361 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -86.82 -11.38 51.07 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.3 2.24 . . . . 0.0 113.964 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.62 -19.02 12.65 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.553 1.541 . . . . 0.0 112.479 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 22.9 t -149.73 125.1 10.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.801 1.64 . . . . 0.0 109.459 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.85 127.34 32.47 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.373 0.669 . . . . 0.0 111.782 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 22.9 t -162.01 157.89 24.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.916 1.286 . . . . 0.0 111.203 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -134.94 17.19 3.51 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.45 1.9 . . . . 0.0 112.258 176.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.27 138.67 23.1 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.212 1.805 . . . . 0.0 110.25 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.38 129.82 18.69 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.381 2.72 . . . . 0.0 111.419 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.48 131.05 16.91 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.502 2.801 . . . . 0.0 110.165 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 37.3 tttp 58.76 13.23 2.58 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 125.304 1.442 . . . . 0.0 114.428 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.2 35.88 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.053 1.311 . . . . 0.0 114.512 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -136.84 158.95 43.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.571 1.686 . . . . 0.0 114.051 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.31 165.82 35.45 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.388 1.475 . . . . 0.0 111.784 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.37 122.85 47.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.739 1.616 . . . . 0.0 110.01 170.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.0 mt -86.08 140.99 29.74 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.581 1.552 . . . . 0.0 108.917 169.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 52.2 mt -124.86 107.51 10.97 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.755 1.622 . . . . 0.0 107.811 171.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -85.54 159.47 19.89 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.622 0.769 . . . . 0.0 112.282 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -66.76 -36.08 81.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.941 0.896 . . . . 0.0 112.105 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -141.95 145.48 34.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.681 1.592 . . . . 0.0 110.109 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -63.77 -28.36 69.82 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.741 -0.6 . . . . 0.0 111.907 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 29.3 p -59.84 -24.53 64.27 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.912 -1.117 . . . . 0.0 113.181 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 27.5 m -70.7 -28.36 64.69 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.811 -1.181 . . . . 0.0 112.11 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.16 -37.14 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.696 -0.627 . . . . 0.0 109.929 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -64.13 -40.7 96.75 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.587 -0.696 . . . . 0.0 111.529 169.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.53 -37.93 85.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.763 0.711 . . . . 0.0 112.371 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.68 -47.85 76.88 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.432 0.693 . . . . 0.0 111.123 171.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.9 mt -56.02 -41.91 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.181 0.992 . . . . 0.0 111.421 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.24 -17.74 63.8 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.8 1.24 . . . . 0.0 113.485 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.04 -13.99 18.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.122 1.369 . . . . 0.0 113.518 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.4 m -74.3 146.57 43.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.001 0.905 . . . . 0.0 113.356 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.73 172.33 13.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.54 1.536 . . . . 0.0 108.097 165.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.55 132.35 22.64 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.532 0.733 . . . . 0.0 111.73 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -146.04 118.69 8.58 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.894 1.678 . . . . 0.0 109.313 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 64.37 11.46 6.48 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.628 1.971 . . . . 0.0 113.859 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 93.49 -8.52 74.69 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.577 1.56 . . . . 0.0 113.795 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -79.74 143.15 34.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.514 1.126 . . . . 0.0 109.847 170.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 91.4 mt -97.8 152.37 19.23 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.537 0.735 . . . . 0.0 111.915 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -143.34 147.26 34.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.225 1.01 . . . . 0.0 113.134 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.6 tp -130.68 -169.62 2.19 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.399 1.88 . . . . 0.0 108.5 170.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 29.3 p -141.3 149.96 41.93 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.069 0.947 . . . . 0.0 113.095 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -150.81 168.9 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 126.875 2.07 . . . . 0.0 110.478 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 56.4 m -144.24 161.85 37.85 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 54.0 p -147.81 179.05 1.25 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 126.926 2.09 . . . . 0.0 110.994 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -64.67 -13.76 40.84 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.389 2.726 . . . . 0.0 114.265 170.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 35.0 p -107.5 -32.36 7.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.924 1.29 . . . . 0.0 113.108 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 7.1 mm -134.4 126.88 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.451 1.1 . . . . 0.0 110.933 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -96.57 130.58 43.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 111.53 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 60.88 36.7 18.86 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.537 1.535 . . . . 0.0 112.691 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -56.53 125.64 67.42 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.431 1.092 . . . . 0.0 110.278 169.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.93 144.36 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.169 2.579 . . . . 0.0 109.4 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.65 135.39 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.973 1.309 . . . . 0.0 110.517 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -78.0 133.22 38.03 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.22 1.008 . . . . 0.0 109.717 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.5 mm -116.05 131.08 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.354 1.462 . . . . 0.0 108.538 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -137.42 90.31 15.17 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.665 1.186 . . . . 0.0 109.979 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.39 133.1 54.91 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.635 2.89 . . . . 0.0 110.881 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -73.62 135.34 43.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.568 0.699 . . . . 0.0 112.432 -173.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -164.65 148.95 9.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.397 1.879 . . . . 0.0 110.015 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.29 134.58 44.07 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.415 1.486 . . . . 0.0 110.129 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 9.3 t -165.4 173.94 10.57 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.251 1.421 . . . . 0.0 111.326 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.94 -3.45 57.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.714 1.606 . . . . 0.0 113.433 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 81.1 p -158.32 165.49 34.63 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.612 1.565 . . . . 0.0 112.521 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -163.08 149.37 12.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.948 2.099 . . . . 0.0 109.499 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -65.17 147.88 52.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.236 1.014 . . . . 0.0 112.986 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.4 p -164.1 145.17 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.051 1.74 . . . . 0.0 109.996 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -160.08 157.4 28.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.501 1.52 . . . . 0.0 111.836 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -161.79 -38.69 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.133 1.373 . . . . 0.0 112.637 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 14.9 m -74.53 -3.83 33.22 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 89.58 -174.66 41.58 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.166 1.365 . . . . 0.0 113.494 -176.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.41 -10.64 12.13 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.985 3.123 . . . . 0.0 114.154 -173.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 85.0 p -163.5 164.98 24.18 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.123 1.369 . . . . 0.0 111.969 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 19.1 m -163.99 155.06 15.89 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.343 1.857 . . . . 0.0 110.912 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 CA-C-O 118.342 -1.254 . . . . 0.0 112.959 -179.423 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 14.9 m -81.0 -9.56 59.83 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 8.1 t -163.63 169.55 18.43 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.084 1.753 . . . . 0.0 111.008 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -97.46 -163.13 31.67 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.486 1.517 . . . . 0.0 113.449 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 3.4 p -72.98 140.79 47.6 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.012 1.325 . . . . 0.0 112.153 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.3 p -125.15 -2.99 7.58 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -92.52 -158.85 34.72 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.227 1.394 . . . . 0.0 113.262 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 45.3 t -80.97 161.79 24.14 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.628 1.171 . . . . 0.0 112.12 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 56.5 mtm-85 -75.0 -6.73 50.97 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 169.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -75.95 133.8 40.38 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.389 0.676 . . . . 0.0 110.783 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 52.7 t -138.22 117.27 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.424 1.09 . . . . 0.0 109.637 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -72.97 141.12 47.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.884 0.874 . . . . 0.0 110.468 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 81.2 t -133.05 119.37 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.477 1.511 . . . . 0.0 109.344 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -115.53 145.02 18.63 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 124.709 1.147 . . . . 0.0 113.718 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.32 17.75 28.31 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.123 1.344 . . . . 0.0 114.239 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.79 140.69 95.41 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.599 1.16 . . . . 0.0 111.121 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.24 156.37 13.62 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.958 3.106 . . . . 0.0 113.983 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.58 2.85 7.37 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.987 3.125 . . . . 0.0 113.448 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -140.29 41.92 1.92 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.8 1.64 . . . . 0.0 111.497 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -124.65 142.62 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.341 1.457 . . . . 0.0 110.529 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -119.65 172.62 7.54 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.098 1.359 . . . . 0.0 113.075 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -45.68 -46.67 14.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.713 1.605 . . . . 0.0 113.729 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.76 -26.04 49.55 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.542 0.737 . . . . 0.0 112.446 -173.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -79.06 -37.83 37.92 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.997 0.919 . . . . 0.0 111.524 172.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 48.3 mt -65.51 -36.32 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.403 -0.811 . . . . 0.0 109.589 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 71.4 m -64.62 -52.84 55.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.922 0.889 . . . . 0.0 110.414 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.16 70.23 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.579 1.081 . . . . 0.0 112.954 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.7 m -67.2 -15.57 63.78 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -130.7 -2.73 4.2 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -61.05 -22.29 64.45 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.165 1.386 . . . . 0.0 113.127 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -56.58 -13.71 2.6 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.809 2.044 . . . . 0.0 114.941 169.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -103.69 -7.19 20.86 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.47 1.508 . . . . 0.0 113.936 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.45 175.18 14.25 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.209 1.861 . . . . 0.0 112.269 -173.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.7 149.33 91.56 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.613 2.876 . . . . 0.0 112.796 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.15 171.88 17.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.216 1.406 . . . . 0.0 112.588 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -134.37 157.94 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.731 1.612 . . . . 0.0 109.431 167.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.94 137.74 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.643 1.177 . . . . 0.0 110.992 -171.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.57 159.08 43.09 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.603 1.961 . . . . 0.0 111.456 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -160.13 163.99 20.9 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.847 1.259 . . . . 0.0 112.304 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -59.1 136.51 73.46 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.459 2.772 . . . . 0.0 112.765 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 67.44 12.66 9.02 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.547 1.539 . . . . 0.0 114.46 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -62.66 -24.1 67.44 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.326 -1.484 . . . . 0.0 112.741 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -85.96 -8.37 58.04 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.929 2.092 . . . . 0.0 114.538 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -138.39 -21.19 1.05 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.5 t -85.31 140.87 30.47 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.748 -1.22 . . . . 0.0 112.008 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -81.01 56.94 2.93 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.995 1.318 . . . . 0.0 112.453 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 92.7 p -159.9 175.72 12.72 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.424 1.49 . . . . 0.0 112.569 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -135.13 27.97 3.48 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.413 1.485 . . . . 0.0 112.773 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -126.66 150.83 72.15 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 127.23 2.212 . . . . 0.0 109.471 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.66 117.86 5.18 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.05 2.5 . . . . 0.0 110.406 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -86.18 10.77 3.53 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.256 2.637 . . . . 0.0 113.863 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -124.09 -5.33 7.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.85 1.66 . . . . 0.0 113.867 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.73 13.1 83.82 Favored Glycine 0 N--CA 1.474 1.233 0 C-N-CA 124.581 1.086 . . . . 0.0 113.951 -172.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -151.5 158.76 44.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.842 1.257 . . . . 0.0 112.654 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.14 167.48 26.72 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.671 1.188 . . . . 0.0 111.617 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.85 118.27 33.75 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.593 1.957 . . . . 0.0 109.599 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.5 mt -82.83 141.26 32.42 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.983 1.313 . . . . 0.0 108.688 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.5 mt -122.67 105.87 10.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.711 1.604 . . . . 0.0 107.768 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -81.14 156.61 25.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.218 0.607 . . . . 0.0 112.106 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -80.74 -24.62 38.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.152 0.981 . . . . 0.0 113.174 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.19 140.9 32.5 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.493 1.517 . . . . 0.0 110.357 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.77 -35.04 70.22 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.819 0.847 . . . . 0.0 111.96 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.9 m -56.95 -25.53 58.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.792 1.237 . . . . 0.0 113.212 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.3 m -69.23 -28.13 66.07 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.867 -1.146 . . . . 0.0 112.175 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.09 -37.42 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.602 -0.686 . . . . 0.0 109.775 175.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -70.26 -37.51 74.91 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.536 -0.728 . . . . 0.0 111.765 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.24 86.48 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.553 0.615 . . . . 0.0 112.079 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.6 tp -64.44 -49.81 70.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.463 0.705 . . . . 0.0 110.995 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.62 -41.66 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.094 0.958 . . . . 0.0 111.478 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.56 -18.24 63.63 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.799 1.24 . . . . 0.0 113.507 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.88 -13.64 19.96 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.21 1.404 . . . . 0.0 113.377 174.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.6 m -72.84 143.17 47.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.05 0.929 . . . . 0.0 113.37 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.27 175.9 9.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.779 1.632 . . . . 0.0 107.955 165.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -145.92 133.91 21.41 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.176 0.591 . . . . 0.0 111.712 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -142.01 112.18 6.96 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.995 1.718 . . . . 0.0 109.774 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 64.77 10.73 6.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.047 2.139 . . . . 0.0 113.833 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 99.79 -6.56 58.77 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.802 1.668 . . . . 0.0 113.834 -171.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -84.91 136.58 33.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.83 1.252 . . . . 0.0 109.671 173.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.9 mt -87.02 151.53 23.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.859 0.754 . . . . 0.0 111.904 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -142.23 154.09 44.51 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.88 1.272 . . . . 0.0 113.097 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -141.8 158.29 43.98 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.627 1.571 . . . . 0.0 109.719 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 72.2 m -99.45 137.23 38.24 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.951 0.9 . . . . 0.0 112.105 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.9 m -144.78 177.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 126.762 2.025 . . . . 0.0 110.662 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 89.4 p -159.49 171.4 19.77 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.946 -1.096 . . . . 0.0 113.496 -175.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 91.6 p -155.16 179.91 1.23 Allowed Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 126.311 1.844 . . . . 0.0 110.586 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.51 -26.06 70.1 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.847 2.365 . . . . 0.0 113.933 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 40.3 p -116.35 -32.93 5.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.7 1.2 . . . . 0.0 113.793 -174.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 21.3 mm -112.18 127.78 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.932 1.293 . . . . 0.0 109.904 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -119.7 142.16 48.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.283 1.433 . . . . 0.0 112.075 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.46 32.92 19.89 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.042 1.337 . . . . 0.0 112.94 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -70.38 128.56 91.17 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.529 1.132 . . . . 0.0 111.428 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.48 131.31 5.53 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.279 2.653 . . . . 0.0 108.845 169.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.71 135.19 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.269 1.428 . . . . 0.0 110.294 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -79.15 131.25 36.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.095 0.958 . . . . 0.0 109.83 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.38 131.81 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.042 1.337 . . . . 0.0 109.319 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -137.78 90.25 14.53 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.953 1.301 . . . . 0.0 110.287 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -61.06 132.2 40.69 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.157 2.571 . . . . 0.0 110.695 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -82.06 148.57 28.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.448 0.699 . . . . 0.0 112.745 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -157.06 157.4 34.53 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.989 1.316 . . . . 0.0 111.749 175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 78.6 mt -71.69 172.32 9.95 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.666 1.186 . . . . 0.0 111.666 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 14.7 m -67.37 1.59 2.15 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -175.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -73.85 -19.2 60.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.473 1.509 . . . . 0.0 113.639 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 11.1 t -163.11 138.93 6.9 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.746 1.218 . . . . 0.0 112.024 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -165.27 168.4 17.0 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.402 2.281 . . . . 0.0 110.182 -173.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.26 145.52 51.02 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.948 1.699 . . . . 0.0 111.526 -175.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 7.7 p -161.02 137.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.789 1.635 . . . . 0.0 109.947 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -111.34 -0.23 16.43 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.061 1.344 . . . . 0.0 113.358 -174.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.25 -9.88 59.05 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.585 1.554 . . . . 0.0 113.624 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 32.8 p -74.08 -10.09 59.28 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.385 1.474 . . . . 0.0 114.193 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 78.84 -158.33 44.6 Favored Glycine 0 CA--C 1.543 1.805 0 C-N-CA 124.46 1.029 . . . . 0.0 113.912 174.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.86 161.23 39.46 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.916 3.077 . . . . 0.0 111.97 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 48.1 p -80.22 1.25 29.14 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.914 1.286 . . . . 0.0 114.46 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 19.1 m -163.55 152.1 13.8 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.08 2.152 . . . . 0.0 110.883 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.344 -1.253 . . . . 0.0 112.841 179.742 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 7.9 t -163.35 -179.6 6.67 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.423 1.489 . . . . 0.0 111.295 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 49.5 m -67.75 146.33 53.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.25 1.42 . . . . 0.0 113.156 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -80.57 56.29 4.72 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.864 1.697 . . . . 0.0 111.564 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 22.7 m -73.04 -6.16 43.68 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.225 1.41 . . . . 0.0 114.594 -171.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 80.2 p -158.54 157.75 32.66 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.841 1.257 . . . . 0.0 113.027 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 154.14 -68.5 0.3 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.505 2.002 . . . . 0.0 110.55 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 18.4 t -153.04 162.6 41.13 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.702 1.601 . . . . 0.0 112.23 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -100.01 -3.72 31.52 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.355 1.462 . . . . 0.0 112.683 171.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -86.47 139.8 30.55 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.009 0.924 . . . . 0.0 111.533 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.1 t -140.74 120.76 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.537 1.135 . . . . 0.0 110.378 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -71.65 140.2 49.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.195 0.998 . . . . 0.0 110.945 171.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.19 115.62 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.368 1.467 . . . . 0.0 109.217 173.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -114.91 144.27 18.37 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 124.942 1.258 . . . . 0.0 113.509 -177.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.85 17.64 29.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.956 1.265 . . . . 0.0 114.163 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.21 141.48 93.97 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.713 1.205 . . . . 0.0 111.017 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.75 154.3 12.82 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.915 3.077 . . . . 0.0 113.746 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.43 3.78 6.5 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.93 3.087 . . . . 0.0 113.508 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -140.41 23.37 2.34 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.178 1.391 . . . . 0.0 112.227 -173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.4 tt -100.25 127.68 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.285 1.034 . . . . 0.0 111.029 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -92.99 165.71 12.73 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.497 1.119 . . . . 0.0 113.214 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -45.78 -45.51 14.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.918 1.687 . . . . 0.0 113.7 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.19 -29.24 54.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.777 0.831 . . . . 0.0 112.514 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -72.47 -38.71 68.15 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.416 0.686 . . . . 0.0 112.018 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.16 -39.6 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 119.193 0.906 . . . . 0.0 109.585 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 53.4 m -63.24 -51.62 65.46 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.438 0.695 . . . . 0.0 110.613 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.42 -29.08 70.25 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.38 0.991 . . . . 0.0 113.156 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.2 m -66.56 -22.83 66.15 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -123.46 -3.88 8.33 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.3 tpt85 -60.55 -22.36 63.57 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.275 1.43 . . . . 0.0 113.396 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -55.76 -18.71 8.96 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.384 1.874 . . . . 0.0 114.724 171.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.71 -3.4 35.96 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.508 1.523 . . . . 0.0 113.561 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.16 170.41 14.0 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.905 1.717 . . . . 0.0 111.982 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.9 151.0 78.62 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.667 2.912 . . . . 0.0 111.979 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.58 171.82 18.26 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.528 1.531 . . . . 0.0 112.498 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -132.66 157.34 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.494 1.518 . . . . 0.0 109.287 167.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.34 135.68 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.662 1.185 . . . . 0.0 110.351 -172.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -143.22 161.54 37.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.264 1.826 . . . . 0.0 111.699 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -156.85 158.46 31.28 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.92 1.288 . . . . 0.0 111.929 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -59.08 137.44 79.43 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.184 2.589 . . . . 0.0 113.219 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 66.75 16.41 10.37 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 126.098 1.759 . . . . 0.0 114.433 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.34 -20.16 66.28 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.632 -1.293 . . . . 0.0 112.678 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -64.98 -33.69 76.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.745 1.618 . . . . 0.0 112.824 169.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -95.46 -51.7 4.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.961 1.304 . . . . 0.0 111.212 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.6 m -80.9 114.18 19.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.495 1.118 . . . . 0.0 111.336 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 1.55 16.8 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.2 p -68.14 131.98 46.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.097 1.359 . . . . 0.0 112.358 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -89.24 24.01 2.31 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.142 1.377 . . . . 0.0 113.422 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -126.74 141.09 39.32 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 128.43 2.692 . . . . 0.0 108.11 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.43 118.08 5.4 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.962 2.442 . . . . 0.0 110.064 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.12 18.62 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.511 2.807 . . . . 0.0 113.097 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -132.78 -4.7 3.21 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.601 1.56 . . . . 0.0 114.27 -171.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.61 13.9 82.68 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 124.5 1.047 . . . . 0.0 114.316 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -153.82 158.81 41.41 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.777 1.231 . . . . 0.0 112.591 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -151.03 167.45 27.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.735 1.214 . . . . 0.0 111.641 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.45 118.22 33.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.312 1.845 . . . . 0.0 109.365 173.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 34.8 mt -81.34 138.98 35.62 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.032 1.333 . . . . 0.0 108.778 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 55.2 mt -122.71 104.42 9.3 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.913 1.685 . . . . 0.0 107.863 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -81.6 157.52 24.69 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.59 0.756 . . . . 0.0 111.764 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -73.15 -27.4 61.64 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.647 -0.658 . . . . 0.0 112.485 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.85 145.29 39.83 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.851 1.261 . . . . 0.0 110.731 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -62.73 -32.11 73.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.255 0.622 . . . . 0.0 111.535 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.3 m -56.73 -27.13 58.69 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.65 1.18 . . . . 0.0 113.289 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.7 m -68.96 -25.89 64.77 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.863 -1.148 . . . . 0.0 112.29 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.68 -38.3 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.707 -0.621 . . . . 0.0 109.985 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -66.34 -39.36 89.15 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.645 -0.659 . . . . 0.0 111.463 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.75 83.51 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.62 0.646 . . . . 0.0 112.498 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 26.8 tp -65.4 -48.42 72.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.517 0.727 . . . . 0.0 111.213 171.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 71.8 mt -55.27 -40.13 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.968 0.907 . . . . 0.0 111.528 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.37 -17.77 63.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.874 1.27 . . . . 0.0 113.683 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.09 -13.56 18.95 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.956 1.302 . . . . 0.0 113.248 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.1 m -74.59 146.43 42.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.14 0.971 . . . . 0.0 113.499 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.74 173.93 12.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.686 1.594 . . . . 0.0 107.777 164.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -141.44 130.81 23.68 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.477 0.711 . . . . 0.0 111.062 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -146.15 122.35 10.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.724 1.609 . . . . 0.0 109.652 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 62.78 9.63 3.74 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.663 1.985 . . . . 0.0 114.61 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 105.17 -11.75 48.26 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 126.336 1.922 . . . . 0.0 114.051 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -91.64 155.6 18.22 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.916 1.286 . . . . 0.0 112.311 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.12 151.04 20.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.705 1.202 . . . . 0.0 111.633 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.16 142.78 32.75 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.089 0.956 . . . . 0.0 113.054 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -127.02 -179.36 4.8 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.605 1.562 . . . . 0.0 108.91 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 71.7 m -128.38 142.3 51.16 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.274 1.03 . . . . 0.0 112.176 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 29.8 m -148.91 173.13 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 126.08 1.752 . . . . 0.0 111.761 -174.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 79.9 p -160.42 171.41 19.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.103 1.361 . . . . 0.0 112.906 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.5 p -153.06 -176.18 0.57 Allowed Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.563 1.945 . . . . 0.0 110.565 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -63.91 -14.27 42.21 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.069 2.513 . . . . 0.0 114.38 170.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 60.7 p -122.3 -18.12 6.89 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.116 1.367 . . . . 0.0 114.114 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.4 mm -132.79 135.09 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.693 1.597 . . . . 0.0 110.363 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -128.38 136.18 50.56 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.849 1.26 . . . . 0.0 111.668 -171.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 58.76 28.68 17.66 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.305 1.442 . . . . 0.0 113.61 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -73.92 129.52 84.74 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.761 -1.212 . . . . 0.0 111.313 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.93 143.37 16.29 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.296 2.664 . . . . 0.0 109.758 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 2.4 m -129.43 135.72 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.309 1.444 . . . . 0.0 110.711 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -79.1 119.13 21.78 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.666 1.586 . . . . 0.0 109.565 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 31.3 mm -105.62 124.93 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.822 1.249 . . . . 0.0 108.477 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -133.11 92.22 25.94 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.243 1.017 . . . . 0.0 110.366 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.56 140.69 95.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.59 2.86 . . . . 0.0 111.569 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -80.9 20.77 0.74 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.872 0.869 . . . . 0.0 112.781 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -68.17 -18.33 64.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.839 1.255 . . . . 0.0 112.836 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.06 123.11 32.41 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.569 1.548 . . . . 0.0 109.353 170.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 34.5 m -128.52 4.31 5.61 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -141.01 8.64 2.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.184 1.394 . . . . 0.0 114.166 -169.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 10.3 t -164.91 174.39 10.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.536 1.535 . . . . 0.0 111.408 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -126.35 -2.92 6.85 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.258 1.823 . . . . 0.0 112.408 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -85.98 123.43 31.3 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.566 1.146 . . . . 0.0 110.322 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.98 36.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.384 1.473 . . . . 0.0 110.979 -171.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 99.1 mtp -141.05 140.3 34.22 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.628 1.571 . . . . 0.0 110.89 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -166.36 152.5 8.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.807 1.643 . . . . 0.0 111.839 -175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 67.5 m -141.57 4.01 1.72 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.148 1.779 . . . . 0.0 113.441 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -78.34 152.36 37.76 Favored Glycine 0 CA--C 1.542 1.719 0 O-C-N 120.916 -1.115 . . . . 0.0 113.575 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.6 160.25 31.65 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.955 3.103 . . . . 0.0 111.668 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.8 m -75.42 -5.8 46.79 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 16.4 m -167.58 155.3 8.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.617 2.367 . . . . 0.0 110.78 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.891 179.268 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 35.8 p -165.58 158.89 16.07 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.112 1.365 . . . . 0.0 111.81 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 28.3 m -69.61 142.41 53.51 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.094 0.958 . . . . 0.0 113.086 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 173.66 -169.09 42.14 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.068 1.318 . . . . 0.0 113.202 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 72.7 m -134.79 125.8 27.64 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.637 1.175 . . . . 0.0 110.861 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 71.7 m -94.04 139.47 30.92 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.3 1.04 . . . . 0.0 112.948 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 84.02 165.55 39.09 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.851 1.215 . . . . 0.0 113.71 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 23.8 t -72.8 168.12 19.49 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.833 0.853 . . . . 0.0 111.84 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 76.3 mtm-85 -67.72 -14.96 63.39 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -77.4 134.32 38.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.529 1.132 . . . . 0.0 110.485 169.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.26 118.24 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.159 0.984 . . . . 0.0 110.039 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.47 139.23 45.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.618 0.767 . . . . 0.0 110.273 171.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 67.2 t -130.99 118.47 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.349 1.459 . . . . 0.0 109.156 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -115.29 151.27 18.51 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.789 1.185 . . . . 0.0 113.814 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 89.97 20.88 41.2 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.594 1.092 . . . . 0.0 113.802 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.61 144.61 72.31 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.885 1.274 . . . . 0.0 111.64 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.72 145.39 71.64 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.035 2.49 . . . . 0.0 112.02 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.07 0.52 7.12 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.921 3.081 . . . . 0.0 113.51 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -128.49 19.4 6.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.199 2.199 . . . . 0.0 112.291 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.5 tt -100.47 156.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.092 1.357 . . . . 0.0 111.96 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -135.25 170.57 15.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.186 1.395 . . . . 0.0 112.624 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -50.55 -42.27 55.09 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.386 1.475 . . . . 0.0 113.71 -172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.84 -27.65 44.27 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.561 0.744 . . . . 0.0 112.171 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -74.68 -39.15 62.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.811 0.845 . . . . 0.0 111.409 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.1 mt -64.43 -39.04 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.893 0.77 . . . . 0.0 109.564 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 59.1 m -63.1 -52.08 64.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.478 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.09 71.38 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.569 1.077 . . . . 0.0 112.944 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.4 m -68.51 -14.81 63.26 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -129.31 -3.16 4.97 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.312 0.96 . . . . 0.0 113.546 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -60.76 -22.45 64.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.98 1.312 . . . . 0.0 113.133 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -56.98 -12.01 1.79 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.794 2.037 . . . . 0.0 115.009 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -106.28 -4.15 20.43 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.527 1.531 . . . . 0.0 113.986 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.82 171.49 14.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.792 1.663 . . . . 0.0 112.204 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.37 150.2 58.04 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.659 2.906 . . . . 0.0 112.242 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.6 172.41 17.2 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.587 1.555 . . . . 0.0 112.632 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.85 159.43 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.747 1.619 . . . . 0.0 109.368 167.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.17 137.57 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.61 1.164 . . . . 0.0 110.729 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -147.52 163.53 36.27 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.407 1.883 . . . . 0.0 111.552 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' TRP . . . . . 0.401 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 14.1 p90 -160.59 162.97 22.34 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.027 1.331 . . . . 0.0 112.373 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -58.15 146.65 87.35 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.566 2.844 . . . . 0.0 113.428 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 68.6 4.31 4.28 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.903 1.681 . . . . 0.0 114.623 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.401 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 59.9 tttm -66.21 -21.48 66.31 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.166 1.387 . . . . 0.0 113.005 -173.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -76.78 -14.36 59.93 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.261 2.224 . . . . 0.0 114.384 175.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -124.87 -54.15 1.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.157 1.383 . . . . 0.0 110.577 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.2 m -77.81 54.23 1.23 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.64 1.976 . . . . 0.0 110.667 169.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -58.12 113.94 2.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.629 1.972 . . . . 0.0 111.836 -172.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 29.9 t -167.89 158.33 10.61 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.109 1.364 . . . . 0.0 110.996 -171.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.69 -4.56 58.71 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.003 1.321 . . . . 0.0 113.83 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -119.64 139.82 28.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.644 1.577 . . . . 0.0 110.158 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.57 121.36 7.63 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.385 2.724 . . . . 0.0 110.988 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -88.2 19.31 1.35 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.001 3.134 . . . . 0.0 113.006 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.03 -9.42 2.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.138 1.375 . . . . 0.0 114.633 -169.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 75.53 12.1 83.93 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 124.206 0.907 . . . . 0.0 113.988 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -152.95 160.85 43.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.314 1.445 . . . . 0.0 112.293 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.89 164.89 35.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.787 1.235 . . . . 0.0 111.808 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -110.84 117.79 34.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.158 1.783 . . . . 0.0 109.672 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.7 mt -82.59 140.94 32.95 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.99 1.316 . . . . 0.0 108.535 168.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 53.8 mt -125.1 104.85 8.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.622 1.569 . . . . 0.0 107.879 172.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -83.19 157.61 22.66 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.557 0.743 . . . . 0.0 111.505 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -83.26 -13.99 54.09 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.28 141.59 33.94 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.439 1.496 . . . . 0.0 110.617 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.68 -33.58 74.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.233 0.613 . . . . 0.0 111.359 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 12.4 m -59.51 -24.03 63.3 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.313 1.045 . . . . 0.0 113.057 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 22.9 m -70.67 -30.22 66.76 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.902 -1.124 . . . . 0.0 111.896 172.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.36 -34.91 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.502 -0.749 . . . . 0.0 109.902 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -69.64 -37.2 76.69 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.572 -0.705 . . . . 0.0 111.974 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.38 -37.39 85.53 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.961 0.8 . . . . 0.0 112.207 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.2 tp -63.66 -49.2 74.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.487 0.715 . . . . 0.0 110.894 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.23 -41.83 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.122 0.969 . . . . 0.0 111.557 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.51 -18.34 64.36 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.784 1.234 . . . . 0.0 113.63 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.99 -14.25 18.74 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.086 1.354 . . . . 0.0 113.487 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 53.3 m -72.55 144.56 47.89 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.019 0.914 . . . . 0.0 113.235 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.12 172.42 13.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.386 1.475 . . . . 0.0 107.782 165.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.19 127.14 18.31 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.384 0.674 . . . . 0.0 110.939 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -148.91 129.03 13.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.97 1.708 . . . . 0.0 109.646 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 55.82 31.53 17.81 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.556 1.543 . . . . 0.0 113.767 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 85.25 5.1 85.79 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.517 1.532 . . . . 0.0 114.347 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -123.74 147.7 47.26 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.745 1.618 . . . . 0.0 110.917 -170.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.64 150.83 23.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.324 0.65 . . . . 0.0 111.766 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -141.84 148.81 39.42 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.565 1.146 . . . . 0.0 112.732 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.6 tp -131.9 171.06 14.03 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.03 1.732 . . . . 0.0 109.07 171.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 87.3 m -117.42 142.96 46.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.171 0.988 . . . . 0.0 112.351 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.21 172.94 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.848 2.059 . . . . 0.0 110.919 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 47.1 m -150.2 167.0 28.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.077 1.351 . . . . 0.0 112.344 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.9 m -161.54 167.44 13.05 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 127.755 2.422 . . . . 0.0 110.653 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.3 -22.03 14.78 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 124.407 3.405 . . . . 0.0 117.917 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 62.8 p -123.15 2.1 9.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.855 1.262 . . . . 0.0 113.908 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 30.3 mm -138.66 117.61 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.884 1.674 . . . . 0.0 110.536 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -118.35 137.73 52.9 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.375 1.07 . . . . 0.0 113.043 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 60.8 30.98 20.02 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.359 1.464 . . . . 0.0 112.423 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -63.89 126.25 89.56 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.739 1.216 . . . . 0.0 111.025 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.91 138.14 11.43 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.253 2.636 . . . . 0.0 109.067 171.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.7 m -130.98 132.26 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.061 1.344 . . . . 0.0 109.896 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -81.08 130.4 35.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.32 1.048 . . . . 0.0 109.876 -173.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 31.9 mm -111.01 132.03 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.905 1.282 . . . . 0.0 109.333 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -137.89 91.94 13.07 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.976 1.31 . . . . 0.0 110.192 -175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.66 132.62 49.14 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.406 2.737 . . . . 0.0 110.678 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -76.52 146.01 38.73 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -171.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -156.02 125.71 6.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.87 1.668 . . . . 0.0 109.659 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 31.3 tp -100.74 -11.74 19.68 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.365 1.466 . . . . 0.0 112.935 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 30.8 m -101.48 -11.51 19.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.906 1.282 . . . . 0.0 113.632 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -160.09 155.22 24.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.48 1.912 . . . . 0.0 111.03 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 79.9 p -156.83 10.44 0.22 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.057 1.743 . . . . 0.0 113.564 -172.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.39 105.94 3.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.204 1.401 . . . . 0.0 111.886 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.87 165.28 23.59 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.419 1.888 . . . . 0.0 113.184 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.9 p -154.61 142.57 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.724 1.61 . . . . 0.0 110.791 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 11.5 tpt -159.29 144.41 15.76 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.41 1.884 . . . . 0.0 110.297 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -77.15 140.05 40.1 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.221 1.408 . . . . 0.0 112.525 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.0 t -164.74 148.74 9.07 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.392 1.477 . . . . 0.0 111.115 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 81.15 -177.73 54.21 Favored Glycine 0 CA--C 1.542 1.736 0 C-N-CA 124.687 1.137 . . . . 0.0 114.317 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.61 162.08 33.33 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.233 3.289 . . . . 0.0 111.956 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 23.9 t -161.65 154.79 20.89 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.186 1.394 . . . . 0.0 111.403 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 56.2 p -89.71 -6.31 56.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.07 1.348 . . . . 0.0 113.914 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.084 1.326 . . . . 0.0 113.244 179.535 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 8.6 t -162.53 177.29 9.59 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.497 1.519 . . . . 0.0 110.996 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 10.0 t -153.71 156.84 38.57 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.808 1.243 . . . . 0.0 112.433 -170.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 169.53 -149.34 13.19 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.174 1.845 . . . . 0.0 111.672 -169.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 8.7 t -160.49 174.73 13.65 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.251 1.024 . . . . 0.0 113.452 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 78.4 p -151.65 11.39 0.59 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.732 2.013 . . . . 0.0 112.912 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -75.35 159.27 51.37 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.661 1.124 . . . . 0.0 114.129 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 17.0 t -76.93 178.53 6.84 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.274 1.43 . . . . 0.0 113.076 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -67.37 -15.51 63.72 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.821 1.249 . . . . 0.0 113.191 170.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.99 135.73 37.85 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.839 1.256 . . . . 0.0 110.654 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.52 121.63 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.274 1.03 . . . . 0.0 110.426 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.44 140.25 55.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.337 1.055 . . . . 0.0 111.385 172.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 56.9 t -133.53 123.18 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 109.422 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -122.11 149.37 17.08 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.452 1.501 . . . . 0.0 113.191 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.31 14.05 52.23 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.958 1.266 . . . . 0.0 114.366 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.96 141.59 85.93 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.031 1.332 . . . . 0.0 111.012 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.42 153.56 17.37 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.874 3.049 . . . . 0.0 113.638 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.73 6.1 4.77 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.002 3.135 . . . . 0.0 113.353 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -140.27 28.56 2.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.476 1.51 . . . . 0.0 111.9 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.8 tt -107.75 150.19 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.293 1.437 . . . . 0.0 110.075 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -124.77 170.29 11.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.81 1.244 . . . . 0.0 112.706 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -44.78 -46.23 10.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.409 1.884 . . . . 0.0 113.913 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -78.94 -26.31 43.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.65 0.78 . . . . 0.0 112.295 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -77.11 -36.53 55.49 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.684 0.794 . . . . 0.0 111.462 171.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.17 -38.73 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.322 0.965 . . . . 0.0 109.566 171.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 57.8 m -62.64 -52.03 64.92 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.367 0.667 . . . . 0.0 110.471 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.49 -30.95 70.94 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.401 1.001 . . . . 0.0 112.978 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.2 m -67.97 -14.67 63.15 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -129.82 -2.82 4.69 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.457 1.026 . . . . 0.0 113.604 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -60.31 -22.5 63.25 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.943 1.297 . . . . 0.0 113.104 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -56.83 -12.53 1.98 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.791 2.036 . . . . 0.0 115.103 170.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -105.65 -4.93 20.49 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.396 1.478 . . . . 0.0 113.974 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.48 172.96 14.14 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.801 1.667 . . . . 0.0 112.288 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.87 149.94 54.56 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.736 2.957 . . . . 0.0 112.29 -174.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.27 172.7 16.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.485 1.514 . . . . 0.0 112.668 -170.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.03 161.09 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.868 1.667 . . . . 0.0 108.728 167.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.49 135.25 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.273 1.029 . . . . 0.0 110.246 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -145.09 164.16 32.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.405 1.882 . . . . 0.0 111.538 -169.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -162.69 160.97 19.83 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.168 1.387 . . . . 0.0 112.015 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -57.5 148.88 69.92 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.49 2.793 . . . . 0.0 112.672 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 8.0 m170 72.98 -4.85 2.06 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 126.072 1.749 . . . . 0.0 114.098 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.34 -22.48 65.59 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.899 1.28 . . . . 0.0 112.471 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -82.89 -8.81 59.54 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.174 2.19 . . . . 0.0 114.19 173.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -120.71 -23.02 6.11 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.411 1.484 . . . . 0.0 112.838 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.7 m -143.25 126.86 16.95 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.13 1.772 . . . . 0.0 109.816 172.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.72 132.78 52.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.598 0.759 . . . . 0.0 111.662 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 35.6 p -160.35 153.91 22.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.718 1.207 . . . . 0.0 111.605 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -138.83 20.15 2.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.092 1.357 . . . . 0.0 112.787 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -126.61 146.47 57.0 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 127.233 2.213 . . . . 0.0 109.682 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.71 124.46 9.77 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.199 2.6 . . . . 0.0 110.632 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.62 130.52 19.67 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.089 2.526 . . . . 0.0 110.067 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 58.68 12.84 2.35 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.49 1.516 . . . . 0.0 114.548 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 85.64 28.81 28.47 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.903 1.24 . . . . 0.0 114.315 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -140.33 157.95 44.78 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.469 1.635 . . . . 0.0 113.914 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.8 170.64 21.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.522 1.529 . . . . 0.0 111.625 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.53 120.49 36.9 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.952 1.701 . . . . 0.0 109.944 173.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.1 mt -80.99 140.83 34.97 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.848 1.259 . . . . 0.0 108.739 169.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 58.3 mt -124.34 101.98 7.45 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.696 1.598 . . . . 0.0 107.702 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -80.21 154.33 28.0 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.307 0.643 . . . . 0.0 110.978 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -76.89 -19.39 57.5 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.461 -0.774 . . . . 0.0 112.91 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.94 142.4 34.38 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.945 1.298 . . . . 0.0 110.799 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.71 -31.38 71.53 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.526 0.731 . . . . 0.0 111.649 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.4 m -56.39 -28.34 58.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.625 1.17 . . . . 0.0 112.899 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -28.4 62.45 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.964 -1.085 . . . . 0.0 112.118 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.3 t -76.32 -37.76 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.668 -0.645 . . . . 0.0 109.839 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -66.3 -38.14 87.03 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.578 -0.701 . . . . 0.0 111.85 172.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.5 91.21 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.557 0.617 . . . . 0.0 112.367 173.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.6 tp -63.53 -48.37 77.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.429 0.692 . . . . 0.0 110.926 171.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 69.9 mt -56.23 -43.25 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.249 1.02 . . . . 0.0 111.33 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.33 -18.88 64.6 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.682 1.193 . . . . 0.0 113.542 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.11 -13.65 19.72 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.185 1.394 . . . . 0.0 113.605 175.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.06 150.05 37.37 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.164 0.983 . . . . 0.0 113.617 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.3 mt -86.25 177.79 7.38 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.035 1.734 . . . . 0.0 107.843 165.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -145.66 133.64 21.39 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.437 0.695 . . . . 0.0 111.623 -175.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -164.51 139.97 5.8 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.66 1.584 . . . . 0.0 110.219 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 27.1 t70 60.28 28.62 18.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.813 1.245 . . . . 0.0 113.517 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 82.74 3.5 90.47 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.117 1.341 . . . . 0.0 114.175 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -123.52 162.44 22.9 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.719 2.008 . . . . 0.0 111.343 -170.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.8 mt -98.38 157.02 16.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.025 0.93 . . . . 0.0 111.103 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -141.04 145.47 35.92 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.977 0.911 . . . . 0.0 113.116 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.06 -173.95 3.19 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.142 1.777 . . . . 0.0 108.949 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.3 p -134.61 147.29 50.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.311 1.044 . . . . 0.0 113.276 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.2 m -152.05 -178.87 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 127.181 2.193 . . . . 0.0 110.753 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 80.5 p -161.7 170.56 19.45 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.503 1.121 . . . . 0.0 113.135 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 16.2 p -142.5 -177.01 0.61 Allowed Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 126.528 1.931 . . . . 0.0 110.682 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.17 -21.97 68.22 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.881 2.387 . . . . 0.0 114.145 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 46.3 p -123.09 -23.05 5.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.6 mm -115.24 127.63 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.075 1.35 . . . . 0.0 109.79 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -122.65 139.0 54.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.601 1.16 . . . . 0.0 111.974 -168.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.89 33.49 23.26 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.171 1.388 . . . . 0.0 112.963 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -69.45 126.56 92.72 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.201 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -80.48 142.9 14.96 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.286 2.657 . . . . 0.0 109.307 169.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.15 134.61 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.732 1.213 . . . . 0.0 110.585 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -79.14 126.41 30.71 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.902 1.681 . . . . 0.0 109.639 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 29.5 mm -114.87 132.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.545 1.538 . . . . 0.0 108.342 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -140.96 100.05 6.57 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.788 0.835 . . . . 0.0 110.678 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -55.88 134.95 67.16 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.472 2.781 . . . . 0.0 110.977 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -74.37 124.37 26.37 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -169.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -76.87 114.03 15.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.605 0.762 . . . . 0.0 110.637 170.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 25.7 tp -85.0 59.75 5.82 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.753 1.221 . . . . 0.0 110.93 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 8.5 t -165.59 176.79 7.82 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.048 1.739 . . . . 0.0 110.889 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -80.77 51.7 1.57 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.146 1.778 . . . . 0.0 112.745 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 11.6 t -162.11 162.56 28.62 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.673 1.589 . . . . 0.0 111.764 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -154.2 39.12 0.46 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.182 1.793 . . . . 0.0 111.121 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -72.23 176.27 5.36 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.67 1.588 . . . . 0.0 113.936 -172.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.8 p -163.11 156.6 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.046 2.138 . . . . 0.0 109.626 -170.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 24.8 tpp 76.24 21.34 1.46 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.057 1.743 . . . . 0.0 113.082 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -154.12 143.11 21.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.991 1.716 . . . . 0.0 110.964 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 88.7 p -165.02 167.94 17.91 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.138 1.375 . . . . 0.0 112.494 -172.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -164.81 -177.67 37.56 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.253 1.406 . . . . 0.0 112.981 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.84 157.7 60.8 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.971 3.114 . . . . 0.0 112.392 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 13.4 m -72.49 -6.45 43.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 80.3 p -166.13 165.35 17.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.504 1.922 . . . . 0.0 111.702 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.176 0 CA-C-O 118.434 -1.203 . . . . 0.0 113.014 179.43 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.479 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 57.6 m -147.73 154.72 40.91 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.091 1.357 . . . . 0.0 111.411 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 19.3 m -161.97 150.24 14.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.884 1.674 . . . . 0.0 111.129 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -93.14 172.49 33.57 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.926 1.25 . . . . 0.0 113.515 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 67.8 m 68.79 14.04 8.92 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.929 1.691 . . . . 0.0 115.27 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 23.2 m -76.8 -13.99 59.96 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.79 174.44 29.14 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 125.397 1.475 . . . . 0.0 113.937 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 34.4 t -85.52 153.29 22.54 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.649 0.78 . . . . 0.0 111.999 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -95.49 -3.27 47.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.453 1.101 . . . . 0.0 113.792 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -80.84 133.15 35.55 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.366 0.666 . . . . 0.0 110.765 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.2 115.44 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.383 1.073 . . . . 0.0 109.882 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -71.94 140.5 49.21 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.802 0.841 . . . . 0.0 110.384 171.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.73 118.59 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.08 1.352 . . . . 0.0 109.23 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.91 143.71 18.15 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.916 1.245 . . . . 0.0 113.381 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.88 11.0 47.95 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.451 1.501 . . . . 0.0 114.157 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.09 142.13 80.65 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.113 1.365 . . . . 0.0 111.482 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.41 154.79 18.22 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.769 2.98 . . . . 0.0 113.576 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -79.21 4.47 6.55 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.835 3.023 . . . . 0.0 113.421 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -135.97 20.24 3.25 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.691 1.597 . . . . 0.0 112.301 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 14.1 tt -104.02 123.38 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.696 1.199 . . . . 0.0 111.958 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.02 161.17 25.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.515 1.126 . . . . 0.0 112.806 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -48.1 -44.44 31.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.108 1.363 . . . . 0.0 112.543 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -74.74 -24.25 58.69 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.86 0.864 . . . . 0.0 112.891 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -78.21 -40.55 37.15 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.818 0.847 . . . . 0.0 111.118 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.2 mt -62.52 -41.84 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 170.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 60.7 m -61.0 -52.28 65.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.496 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.45 -29.36 70.46 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.552 1.069 . . . . 0.0 113.223 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 64.8 m -67.34 -23.26 65.6 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.58 -5.62 9.75 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.145 0.978 . . . . 0.0 113.552 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -61.52 -22.98 65.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.169 1.387 . . . . 0.0 113.139 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -53.04 -20.72 3.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.587 1.955 . . . . 0.0 114.73 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -97.74 -9.32 26.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.502 1.521 . . . . 0.0 113.915 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 126.12 170.55 13.0 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.976 1.75 . . . . 0.0 112.034 -169.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.88 150.82 56.0 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.682 2.922 . . . . 0.0 112.601 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.06 172.92 15.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.664 1.586 . . . . 0.0 112.664 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.62 158.69 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.851 1.66 . . . . 0.0 109.488 167.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 77.5 t -130.91 137.55 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.586 1.154 . . . . 0.0 110.89 -171.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -148.1 157.54 43.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.164 1.786 . . . . 0.0 111.628 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -157.02 162.39 27.73 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.621 1.168 . . . . 0.0 112.428 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -59.24 139.52 90.52 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.465 2.777 . . . . 0.0 113.01 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 65.91 11.26 7.56 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.497 1.519 . . . . 0.0 114.56 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -63.35 -23.69 67.52 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 120.417 -1.427 . . . . 0.0 112.54 176.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -101.23 0.39 37.38 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.648 2.379 . . . . 0.0 113.863 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -136.07 2.52 2.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.952 1.301 . . . . 0.0 113.741 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 14.0 t -151.37 147.51 27.0 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.364 1.466 . . . . 0.0 111.164 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -79.93 54.16 1.82 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.408 1.483 . . . . 0.0 112.789 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 70.5 m -132.55 111.66 11.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.805 1.242 . . . . 0.0 111.731 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -87.37 6.64 32.67 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.022 1.329 . . . . 0.0 113.388 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -112.0 152.98 44.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.115 2.166 . . . . 0.0 109.106 168.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -64.64 116.61 3.89 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.948 2.432 . . . . 0.0 110.069 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -84.32 12.01 3.16 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.719 2.946 . . . . 0.0 114.213 -169.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -135.74 1.17 2.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.029 1.732 . . . . 0.0 113.524 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.08 17.87 77.57 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.424 1.012 . . . . 0.0 114.259 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -152.45 158.1 42.12 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.797 1.298 . . . . 0.0 113.418 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.74 170.67 19.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.107 1.363 . . . . 0.0 111.645 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.29 121.65 41.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.32 1.848 . . . . 0.0 109.722 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.17 140.47 30.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.448 1.499 . . . . 0.0 108.916 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 55.0 mt -124.52 105.43 9.38 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.74 1.616 . . . . 0.0 107.96 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -83.41 159.12 21.87 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.523 0.729 . . . . 0.0 111.353 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.73 -22.04 24.83 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -130.12 144.53 51.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.125 1.77 . . . . 0.0 110.279 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 37.6 mp0 -66.01 -30.51 71.07 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.416 -0.803 . . . . 0.0 111.286 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.6 m -55.15 -27.76 47.85 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.832 1.253 . . . . 0.0 112.798 173.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.7 m -71.85 -29.56 64.51 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.109 -0.995 . . . . 0.0 112.048 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.99 -37.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.522 -0.736 . . . . 0.0 109.888 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -66.3 -38.16 87.09 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.533 -0.73 . . . . 0.0 111.86 172.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.81 -37.94 88.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.317 0.647 . . . . 0.0 112.38 173.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.2 tp -64.01 -48.78 75.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.333 0.653 . . . . 0.0 110.943 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 75.5 mt -55.54 -40.9 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.231 1.012 . . . . 0.0 111.35 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.45 -17.82 63.67 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.719 1.208 . . . . 0.0 113.818 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.02 -13.66 18.97 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.067 1.347 . . . . 0.0 113.351 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 54.6 m -75.89 149.29 37.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.052 0.941 . . . . 0.0 113.464 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.6 mt -83.84 173.28 11.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.431 1.492 . . . . 0.0 107.785 164.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -145.36 138.24 26.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.528 0.731 . . . . 0.0 111.733 -174.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.1 121.51 5.79 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.893 1.277 . . . . 0.0 109.928 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 63.33 9.28 3.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.847 2.059 . . . . 0.0 113.945 -172.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 95.1 -13.19 67.43 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.842 1.687 . . . . 0.0 113.6 -170.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -72.17 141.88 49.07 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.393 1.096 . . . . 0.0 109.494 169.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.24 156.48 16.95 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.458 0.703 . . . . 0.0 111.525 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -144.81 145.87 31.84 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.993 0.917 . . . . 0.0 112.977 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.0 tp -131.62 -176.51 4.06 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.494 1.918 . . . . 0.0 108.614 172.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 89.6 m -129.63 146.12 51.45 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.508 1.049 . . . . 0.0 112.729 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 29.2 m -148.93 177.46 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 126.501 1.92 . . . . 0.0 111.531 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 80.2 p -161.13 170.79 19.71 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.096 1.358 . . . . 0.0 112.965 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.3 p -153.88 -179.78 1.13 Allowed Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 126.894 2.078 . . . . 0.0 110.567 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.61 -20.04 55.77 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.897 2.398 . . . . 0.0 114.403 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 57.6 p -113.88 -19.9 11.29 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.026 1.33 . . . . 0.0 114.325 -175.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.1 mm -132.31 135.99 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.489 1.516 . . . . 0.0 110.304 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -130.49 138.41 50.24 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.594 1.158 . . . . 0.0 112.179 -171.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.5 t70 57.54 29.88 17.83 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.336 1.454 . . . . 0.0 113.093 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -75.1 126.2 88.33 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-O 117.829 -1.081 . . . . 0.0 111.584 -172.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.32 141.78 18.41 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.297 2.665 . . . . 0.0 109.457 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.7 m -135.87 134.39 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.015 1.326 . . . . 0.0 110.453 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -75.37 129.67 37.74 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.555 1.142 . . . . 0.0 109.535 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.92 131.21 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.384 1.474 . . . . 0.0 108.373 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 16.7 mtp85 -137.11 89.72 16.33 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.491 1.116 . . . . 0.0 110.106 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -59.05 135.67 68.01 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.839 2.359 . . . . 0.0 109.102 169.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -65.27 138.04 57.95 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -171.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -132.36 160.99 34.7 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.898 1.679 . . . . 0.0 112.28 -174.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.8 163.95 26.31 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.521 1.128 . . . . 0.0 111.583 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 14.8 m -69.34 -8.07 43.03 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -169.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.98 -17.61 39.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 20.6 t -169.63 124.04 0.79 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.295 1.438 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -159.03 130.53 6.33 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.442 1.097 . . . . 0.0 111.511 -172.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.29 89.54 6.56 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.435 1.094 . . . . 0.0 112.058 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.59 139.92 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.466 1.906 . . . . 0.0 109.162 175.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 59.3 mtt -145.64 167.55 22.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.168 1.387 . . . . 0.0 111.946 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -153.11 163.34 40.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.105 1.762 . . . . 0.0 110.999 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 22.7 m -71.15 -4.71 26.86 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -171.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -155.23 165.06 32.19 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.312 1.435 . . . . 0.0 113.551 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.83 163.93 30.68 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.087 3.191 . . . . 0.0 111.698 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 50.7 p -80.42 -4.96 55.67 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 15.5 m -167.01 153.62 8.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.463 2.305 . . . . 0.0 110.847 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.894 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.515 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 55.6 m -148.11 155.1 41.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.898 1.279 . . . . 0.0 111.602 -173.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 16.3 m -80.07 -0.48 35.82 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -80.69 144.23 25.15 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.961 1.267 . . . . 0.0 112.902 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 10.7 t -141.85 140.56 32.96 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.719 1.208 . . . . 0.0 111.929 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 52.0 m -152.89 160.48 43.06 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.874 1.67 . . . . 0.0 111.287 -169.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 127.05 -16.66 6.38 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.807 1.67 . . . . 0.0 114.598 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 10.2 t -161.15 154.48 21.56 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.278 1.431 . . . . 0.0 112.755 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -100.37 0.24 39.55 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.215 1.406 . . . . 0.0 112.886 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -80.41 137.86 36.56 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.694 1.198 . . . . 0.0 111.281 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.5 t -141.48 120.66 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.681 1.192 . . . . 0.0 109.763 175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -77.77 143.54 37.88 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.569 0.748 . . . . 0.0 110.79 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.02 124.62 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.58 1.552 . . . . 0.0 109.232 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -120.5 150.26 17.43 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.807 1.194 . . . . 0.0 113.409 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 90.49 20.1 42.46 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.543 1.068 . . . . 0.0 114.05 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.8 146.34 75.72 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.085 1.354 . . . . 0.0 111.562 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -54.04 152.79 22.88 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.586 2.858 . . . . 0.0 112.974 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.07 0.18 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.71 2.94 . . . . 0.0 114.667 -170.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -140.7 17.1 2.34 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.389 1.075 . . . . 0.0 113.128 -175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.1 tt -80.19 131.76 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.78 0.832 . . . . 0.0 111.527 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.22 170.48 9.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.92 -45.57 51.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.479 1.512 . . . . 0.0 113.044 176.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -74.88 -32.83 61.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.004 0.921 . . . . 0.0 112.609 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.2 -42.32 84.36 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.554 0.742 . . . . 0.0 112.201 170.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 51.3 mt -64.15 -38.36 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 119.197 0.908 . . . . 0.0 109.83 174.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 57.5 m -63.77 -52.31 60.94 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.357 0.663 . . . . 0.0 110.639 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.6 -31.18 71.23 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.348 0.976 . . . . 0.0 112.738 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.6 m -67.83 -15.08 63.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -129.16 -2.99 5.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.457 1.026 . . . . 0.0 113.507 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -60.48 -22.79 63.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.048 1.339 . . . . 0.0 113.268 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -57.48 -13.0 3.05 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.594 1.958 . . . . 0.0 114.99 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -104.11 -4.1 23.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.42 1.488 . . . . 0.0 113.823 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.69 170.26 13.82 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 126.07 1.795 . . . . 0.0 112.062 -170.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.09 153.03 75.9 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.495 2.796 . . . . 0.0 112.129 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.02 171.98 16.69 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.654 1.582 . . . . 0.0 112.424 -170.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.84 156.66 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.655 1.582 . . . . 0.0 109.248 167.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 65.9 t -128.64 137.42 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.705 1.202 . . . . 0.0 110.283 -171.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -149.91 165.96 31.01 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.025 1.73 . . . . 0.0 111.608 -175.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' TRP . . . . . 0.449 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 26.7 p90 -157.08 155.51 28.22 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.419 1.088 . . . . 0.0 112.024 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -65.32 12.61 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 125.063 3.842 . . . . 0.0 118.102 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -132.71 -4.82 3.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.92 1.688 . . . . 0.0 112.794 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.449 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 37.7 ttmt -70.64 -20.45 62.72 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.557 1.143 . . . . 0.0 112.397 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -76.3 -9.76 58.89 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.054 1.741 . . . . 0.0 114.193 171.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -133.78 11.47 4.01 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.305 1.442 . . . . 0.0 113.251 -172.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 46.3 t -153.22 143.39 22.32 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.248 1.419 . . . . 0.0 111.825 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -7.46 55.55 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 66.8 m -82.76 126.38 32.33 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.173 -0.955 . . . . 0.0 112.382 -169.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -84.24 34.68 0.52 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.464 1.506 . . . . 0.0 112.936 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -136.12 135.29 21.02 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 128.143 2.577 . . . . 0.0 107.949 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.55 120.13 7.15 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.86 2.373 . . . . 0.0 109.92 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.28 11.33 3.32 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.126 2.55 . . . . 0.0 114.771 -169.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -136.79 0.57 2.45 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.616 1.566 . . . . 0.0 114.421 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 80.94 22.34 61.52 Favored Glycine 0 N--CA 1.475 1.269 0 O-C-N 121.381 -0.825 . . . . 0.0 114.686 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -151.25 155.27 38.44 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.513 1.156 . . . . 0.0 113.08 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.29 167.78 29.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.696 1.198 . . . . 0.0 112.362 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -112.65 127.16 56.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.632 1.973 . . . . 0.0 110.098 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.9 mt -92.95 139.24 30.73 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.184 1.794 . . . . 0.0 108.55 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 44.9 mt -123.93 107.56 11.48 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.458 1.503 . . . . 0.0 107.85 171.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -84.16 160.38 20.87 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.332 0.653 . . . . 0.0 112.292 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -75.65 -26.32 57.59 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.796 0.838 . . . . 0.0 112.856 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -140.09 144.79 36.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.29 1.436 . . . . 0.0 110.663 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.17 -30.88 69.62 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.711 -0.618 . . . . 0.0 111.564 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.4 m -55.55 -27.39 48.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.576 1.15 . . . . 0.0 113.139 172.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.1 m -73.84 -29.94 62.41 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.034 -1.041 . . . . 0.0 112.071 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.84 -38.54 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 121.744 -0.598 . . . . 0.0 109.584 173.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -68.63 -37.42 79.71 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.755 -0.591 . . . . 0.0 111.92 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.03 85.57 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.981 0.81 . . . . 0.0 112.287 173.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.71 -48.5 76.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.378 0.671 . . . . 0.0 110.87 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 80.8 mt -56.11 -43.04 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.986 0.914 . . . . 0.0 111.392 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.01 -18.62 64.76 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.738 1.215 . . . . 0.0 113.688 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.12 -13.42 18.98 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.06 1.344 . . . . 0.0 113.533 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 34.6 m -73.46 144.73 46.14 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.003 0.906 . . . . 0.0 113.33 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.2 172.69 13.34 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.311 1.444 . . . . 0.0 107.808 165.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -142.95 135.03 27.12 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.469 0.708 . . . . 0.0 111.363 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -159.36 135.62 9.01 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.075 1.35 . . . . 0.0 110.922 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 16.1 t70 55.82 22.02 5.24 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.78 2.032 . . . . 0.0 114.643 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 92.34 0.78 69.93 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.548 1.547 . . . . 0.0 114.525 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -114.73 161.7 17.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.704 1.602 . . . . 0.0 112.76 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.7 mt -101.2 152.32 20.79 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.708 1.203 . . . . 0.0 112.075 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -142.38 149.35 39.25 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.383 1.073 . . . . 0.0 113.144 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.3 tp -133.8 -170.44 2.5 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.475 1.91 . . . . 0.0 108.895 172.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 26.5 p -140.73 144.56 35.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.807 1.243 . . . . 0.0 112.593 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 25.3 m -147.99 171.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 126.255 1.822 . . . . 0.0 111.667 -169.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 40.1 m -147.65 153.66 39.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.601 1.16 . . . . 0.0 112.817 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.9 p -140.89 -173.9 0.38 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 126.383 1.873 . . . . 0.0 111.689 -174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -69.62 -10.89 29.81 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.34 2.693 . . . . 0.0 113.639 171.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 37.3 p -120.99 -32.27 3.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.076 1.35 . . . . 0.0 113.621 -171.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.0 mm -133.35 137.94 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.956 1.302 . . . . 0.0 110.005 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -119.75 135.16 54.96 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.98 1.312 . . . . 0.0 110.729 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 24.9 t70 64.53 27.3 13.41 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.344 1.457 . . . . 0.0 112.911 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -58.74 125.58 77.5 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.493 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.09 146.58 25.65 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.976 2.451 . . . . 0.0 109.776 171.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.8 m -139.3 140.56 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.16 1.384 . . . . 0.0 110.916 -174.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -83.03 132.33 35.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.912 1.285 . . . . 0.0 109.858 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.1 mm -114.95 131.23 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.831 1.252 . . . . 0.0 109.274 -174.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -135.76 90.2 19.93 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.401 1.481 . . . . 0.0 110.351 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.01 136.36 72.81 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.417 2.745 . . . . 0.0 111.041 172.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -69.93 134.88 48.86 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -147.23 150.52 35.02 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.017 1.727 . . . . 0.0 110.82 -175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 95.6 mt -136.03 156.19 49.1 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.268 1.827 . . . . 0.0 110.391 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 3.5 t 68.06 16.54 9.5 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.379 1.472 . . . . 0.0 113.271 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -157.59 162.32 38.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.996 2.119 . . . . 0.0 110.818 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 6.1 t -98.62 -178.51 4.02 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 125.208 1.403 . . . . 0.0 113.221 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -158.49 136.84 10.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.658 1.983 . . . . 0.0 110.738 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -63.08 151.87 38.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.989 1.315 . . . . 0.0 113.034 -173.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 10.9 p -157.01 138.84 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.883 1.273 . . . . 0.0 110.711 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -93.41 17.64 11.07 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.693 1.597 . . . . 0.0 113.639 -173.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -150.2 152.16 34.19 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.89 1.676 . . . . 0.0 111.824 -173.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 6.9 t -110.76 11.67 22.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.989 1.316 . . . . 0.0 113.661 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -78.23 -177.98 48.8 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.778 1.18 . . . . 0.0 114.1 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.36 133.26 57.09 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.462 3.442 . . . . 0.0 112.776 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 57.1 m -131.24 12.15 5.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.65 1.18 . . . . 0.0 113.108 -174.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 70.6 m -145.59 150.57 36.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.883 1.673 . . . . 0.0 111.435 -173.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.341 -1.255 . . . . 0.0 112.955 -179.82 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 24.7 m -66.58 144.9 56.15 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.458 1.103 . . . . 0.0 112.919 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 7.7 t -163.01 170.83 17.42 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.997 1.319 . . . . 0.0 111.683 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -78.1 83.05 1.2 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.07 1.319 . . . . 0.0 111.106 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 29.9 m -130.91 17.83 5.11 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.682 1.193 . . . . 0.0 113.531 -169.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 81.6 p -158.07 163.4 37.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.83 1.252 . . . . 0.0 113.072 -177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 94.38 -148.22 18.91 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.28 1.419 . . . . 0.0 112.659 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 33.4 t -152.66 164.04 38.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.438 1.095 . . . . 0.0 113.253 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -76.54 -5.23 46.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.337 1.055 . . . . 0.0 112.921 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -64.31 136.54 57.25 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.08 0.952 . . . . 0.0 110.547 168.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 43.3 t -137.6 116.9 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.767 0.827 . . . . 0.0 109.375 169.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -73.37 137.17 44.53 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.587 0.755 . . . . 0.0 110.327 172.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 77.5 t -131.31 112.68 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.445 1.498 . . . . 0.0 108.991 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -110.45 151.29 17.58 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.117 1.342 . . . . 0.0 113.41 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 89.87 25.99 25.68 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.32 0.962 . . . . 0.0 113.891 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.77 143.21 91.33 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.787 1.235 . . . . 0.0 111.451 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.84 154.65 31.07 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.366 2.71 . . . . 0.0 113.052 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.04 3.15 6.88 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.901 3.068 . . . . 0.0 114.516 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -140.34 25.27 2.25 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.774 1.229 . . . . 0.0 112.835 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.2 tt -93.48 161.59 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.308 1.043 . . . . 0.0 110.85 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -140.79 169.29 17.92 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.212 1.405 . . . . 0.0 112.536 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.61 -43.07 25.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.581 1.952 . . . . 0.0 113.764 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.5 -27.25 41.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.632 0.773 . . . . 0.0 112.317 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -77.23 -35.94 55.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.834 0.854 . . . . 0.0 111.466 171.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.02 -37.0 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.425 -0.797 . . . . 0.0 109.562 171.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 61.4 m -64.0 -51.78 62.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.506 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.21 -31.28 70.01 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.252 0.933 . . . . 0.0 112.979 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 73.4 m -68.68 -14.59 63.11 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.85 -2.09 3.31 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.586 1.085 . . . . 0.0 113.797 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -60.73 -22.63 64.2 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.745 1.218 . . . . 0.0 112.868 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -56.93 -12.29 1.91 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.603 1.961 . . . . 0.0 114.976 170.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.05 -6.75 18.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.404 1.482 . . . . 0.0 113.924 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.56 179.81 15.87 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.258 1.885 . . . . 0.0 112.491 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.9 145.3 90.13 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.473 2.782 . . . . 0.0 112.54 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.75 170.76 20.83 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.262 1.425 . . . . 0.0 112.423 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -135.03 158.85 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.583 1.553 . . . . 0.0 109.148 167.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 72.6 t -125.05 136.56 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.706 1.202 . . . . 0.0 110.542 -170.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -148.07 165.9 29.41 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.182 1.793 . . . . 0.0 111.698 -173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' TRP . . . . . 0.505 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 13.7 p90 -161.02 160.56 24.75 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.357 1.463 . . . . 0.0 111.906 176.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -57.68 138.11 84.5 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.345 2.696 . . . . 0.0 112.902 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 11.9 m170 76.17 0.01 3.19 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 127.289 2.236 . . . . 0.0 114.407 177.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.505 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 48.4 tttm -64.08 -24.67 67.79 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.6 -1.313 . . . . 0.0 112.427 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -86.5 -11.71 50.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.379 2.272 . . . . 0.0 114.246 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -112.03 -21.66 11.42 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.547 1.539 . . . . 0.0 112.37 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 22.8 t -141.35 110.41 6.22 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.959 1.704 . . . . 0.0 108.312 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.75 129.49 39.24 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.41 0.684 . . . . 0.0 112.123 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 23.0 t -164.76 161.38 20.51 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.462 1.505 . . . . 0.0 110.72 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -124.63 14.54 8.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.727 1.611 . . . . 0.0 112.566 172.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -114.5 132.96 22.58 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.88 1.672 . . . . 0.0 109.161 169.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.76 116.94 4.88 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.39 2.727 . . . . 0.0 110.512 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -89.48 15.84 1.89 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.371 2.714 . . . . 0.0 113.472 -172.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.9 mttp -137.19 -3.81 1.94 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.357 1.463 . . . . 0.0 114.42 -171.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.72 13.28 83.63 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 124.284 0.945 . . . . 0.0 114.283 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -150.08 162.82 39.66 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.889 1.276 . . . . 0.0 113.05 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -149.24 161.91 41.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.058 1.343 . . . . 0.0 111.759 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -109.03 118.34 36.53 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.224 1.81 . . . . 0.0 109.211 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 38.5 mt -82.19 136.93 35.04 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.72 1.208 . . . . 0.0 108.579 169.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 63.7 mt -117.03 102.76 9.61 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.755 1.622 . . . . 0.0 107.74 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -81.79 156.05 25.12 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.206 0.526 . . . . 0.0 111.736 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -76.41 -26.26 55.35 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.753 0.821 . . . . 0.0 112.848 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -142.21 146.31 35.08 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.254 1.422 . . . . 0.0 110.99 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.85 -28.89 70.34 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.528 0.731 . . . . 0.0 111.995 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 25.1 p -60.53 -25.98 66.54 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.025 -1.047 . . . . 0.0 112.984 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.9 m -73.14 -30.9 63.93 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.852 -1.155 . . . . 0.0 111.942 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.47 -39.53 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 121.765 -0.584 . . . . 0.0 109.713 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -66.77 -38.13 85.98 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.61 -0.681 . . . . 0.0 112.16 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.7 87.54 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.703 0.683 . . . . 0.0 112.368 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.63 -49.19 74.24 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.289 0.636 . . . . 0.0 110.8 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 78.6 mt -55.76 -42.2 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.951 0.9 . . . . 0.0 111.335 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.53 -17.94 63.62 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.775 1.23 . . . . 0.0 113.625 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.97 -12.9 19.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.06 1.344 . . . . 0.0 113.419 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 35.6 m -75.13 147.29 40.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 122.114 0.959 . . . . 0.0 113.547 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.31 177.88 8.31 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.523 1.529 . . . . 0.0 107.73 164.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -145.43 134.7 22.94 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.63 -0.669 . . . . 0.0 111.382 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -160.32 132.28 6.1 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.231 1.412 . . . . 0.0 110.485 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 52.68 37.41 23.52 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.482 1.513 . . . . 0.0 113.437 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 81.22 3.27 90.69 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.738 1.161 . . . . 0.0 114.736 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -119.88 158.1 27.36 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.387 1.475 . . . . 0.0 112.175 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 88.2 mt -92.35 153.55 19.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.256 1.022 . . . . 0.0 110.971 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -140.72 148.22 40.4 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.984 0.914 . . . . 0.0 113.167 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.9 tp -134.87 173.13 12.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.786 1.634 . . . . 0.0 109.478 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 26.7 p -116.17 140.45 49.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.049 1.34 . . . . 0.0 112.58 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.38 178.48 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 126.761 2.024 . . . . 0.0 110.532 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 85.0 p -160.76 171.2 19.25 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 57.6 p -148.42 -179.34 0.94 Allowed Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 126.939 2.096 . . . . 0.0 110.957 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.67 -12.2 34.07 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.296 2.664 . . . . 0.0 114.124 170.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 37.2 p -109.86 -33.19 6.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.95 1.3 . . . . 0.0 113.255 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 6.7 mm -132.82 131.13 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.475 1.11 . . . . 0.0 110.948 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -111.73 141.2 45.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.227 1.411 . . . . 0.0 111.193 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 59.26 36.04 23.56 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.135 1.374 . . . . 0.0 112.906 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -67.41 127.7 93.5 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 120.943 -1.098 . . . . 0.0 110.899 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.35 140.91 12.39 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.34 2.693 . . . . 0.0 109.354 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.46 138.13 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.076 1.35 . . . . 0.0 110.697 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -85.13 120.59 26.8 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.171 1.788 . . . . 0.0 109.683 -172.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.27 129.49 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.998 1.319 . . . . 0.0 109.495 -171.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -135.6 94.03 15.53 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.282 1.433 . . . . 0.0 110.121 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.1 127.23 24.89 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.639 2.893 . . . . 0.0 109.522 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -75.74 148.66 38.39 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -168.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -144.06 137.8 27.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.818 1.647 . . . . 0.0 111.01 -171.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.22 -165.23 1.12 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.79 2.036 . . . . 0.0 109.714 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 15.8 m -64.61 -6.14 7.06 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.09 -2.95 56.34 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.663 1.985 . . . . 0.0 113.525 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 6.2 p -151.31 -173.67 4.58 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.096 1.759 . . . . 0.0 111.802 -168.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -163.1 143.95 9.45 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.474 -1.391 . . . . 0.0 112.163 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -147.41 143.19 27.76 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.841 2.056 . . . . 0.0 109.006 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 8.3 p -164.29 149.02 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.251 1.42 . . . . 0.0 110.613 -169.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 13.4 tpt -158.11 158.62 35.06 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.181 1.793 . . . . 0.0 110.72 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 20.0 t70 82.24 -3.1 1.46 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.87 2.868 . . . . 0.0 114.394 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 22.8 m -71.07 -11.48 60.98 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.506 1.122 . . . . 0.0 113.949 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 161.21 166.94 20.93 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 126.136 1.827 . . . . 0.0 113.279 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.4 153.33 35.21 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.803 3.002 . . . . 0.0 111.419 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.2 m -67.68 -9.0 39.61 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 54.1 p -92.05 -4.74 54.04 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.052 1.741 . . . . 0.0 114.084 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.255 -1.303 . . . . 0.0 113.641 179.959 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 33.7 p -89.79 -7.59 54.06 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 83.8 p -162.8 159.88 24.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.676 1.59 . . . . 0.0 112.006 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -116.91 143.37 18.02 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 125.401 1.477 . . . . 0.0 112.193 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 70.8 m -150.67 153.69 36.07 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.941 1.296 . . . . 0.0 112.009 -175.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 16.2 p -77.81 153.6 32.65 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.799 1.24 . . . . 0.0 113.687 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -96.35 -3.64 59.93 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.641 1.115 . . . . 0.0 114.642 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 22.9 t -162.93 165.06 25.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.866 1.666 . . . . 0.0 112.23 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -79.93 -9.14 59.65 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.709 1.204 . . . . 0.0 113.108 169.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -81.54 140.0 34.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.76 0.824 . . . . 0.0 111.263 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.7 t -139.16 118.82 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.548 1.139 . . . . 0.0 109.758 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -73.78 140.05 45.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.314 0.646 . . . . 0.0 110.168 170.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.2 123.18 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.015 1.326 . . . . 0.0 109.175 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -117.67 146.17 18.64 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.724 1.154 . . . . 0.0 113.079 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 96.03 13.97 47.48 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.041 1.305 . . . . 0.0 114.241 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.4 mt -58.73 139.31 86.31 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.99 1.316 . . . . 0.0 110.632 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -55.1 152.42 30.44 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.433 2.755 . . . . 0.0 113.206 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.67 5.33 4.89 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.709 2.939 . . . . 0.0 114.189 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -133.78 18.07 3.87 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.765 1.626 . . . . 0.0 112.427 -174.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.7 tt -100.14 130.54 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 121.118 -0.988 . . . . 0.0 111.596 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -98.86 169.49 9.42 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 0.0 113.452 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -51.78 -41.55 61.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.096 1.359 . . . . 0.0 113.624 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.68 -25.3 44.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.677 0.791 . . . . 0.0 112.352 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -79.58 -36.23 38.47 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.6 0.76 . . . . 0.0 111.984 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 40.3 mt -65.53 -36.44 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.349 0.977 . . . . 0.0 109.418 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 89.3 m -63.53 -51.85 63.67 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.538 0.735 . . . . 0.0 110.636 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.39 -30.58 69.68 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.585 1.084 . . . . 0.0 112.944 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 69.9 m -67.51 -14.25 62.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -133.02 -2.01 3.25 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -60.37 -22.52 63.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.075 1.35 . . . . 0.0 112.899 173.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -57.2 -10.55 1.29 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.706 2.003 . . . . 0.0 115.133 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -108.67 -3.69 17.68 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.508 1.523 . . . . 0.0 114.127 175.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.76 178.55 15.78 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.164 1.84 . . . . 0.0 112.741 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -63.46 145.51 92.31 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.582 2.855 . . . . 0.0 112.996 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.41 170.41 21.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.634 1.574 . . . . 0.0 112.324 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.4 160.7 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.842 1.657 . . . . 0.0 108.635 166.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 93.5 t -135.7 138.52 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.158 0.983 . . . . 0.0 110.658 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -155.16 165.98 34.98 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.797 1.239 . . . . 0.0 112.232 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -155.75 155.24 29.26 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.95 157.61 47.69 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 123.812 3.008 . . . . 0.0 113.254 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 11.8 m170 68.66 3.63 3.97 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.438 1.495 . . . . 0.0 113.84 173.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -67.96 -22.2 65.04 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.391 1.876 . . . . 0.0 112.595 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -74.88 -15.59 60.71 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.904 2.081 . . . . 0.0 114.386 173.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.45 -15.31 6.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.042 1.337 . . . . 0.0 113.534 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 39.7 t -66.49 147.37 53.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.169 1.388 . . . . 0.0 112.823 172.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -95.88 6.41 48.95 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.116 1.366 . . . . 0.0 112.131 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 67.4 m -133.28 148.72 51.95 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.484 1.513 . . . . 0.0 111.927 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -88.85 26.23 1.59 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.51 1.524 . . . . 0.0 113.573 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -117.04 159.92 39.14 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 127.72 2.408 . . . . 0.0 110.035 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.26 118.63 5.57 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.7 2.267 . . . . 0.0 109.298 170.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.79 5.52 5.86 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.481 2.787 . . . . 0.0 115.157 -168.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -141.22 6.88 1.96 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.517 1.927 . . . . 0.0 113.376 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.66 24.28 62.92 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.229 0.918 . . . . 0.0 114.485 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -149.53 154.98 39.59 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.83 1.315 . . . . 0.0 113.512 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.32 170.5 21.73 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.835 1.254 . . . . 0.0 112.174 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -113.42 123.78 50.88 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.891 1.676 . . . . 0.0 110.67 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 22.5 mt -87.04 142.57 27.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.542 1.537 . . . . 0.0 108.74 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 65.7 mt -127.95 102.57 6.82 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.052 1.741 . . . . 0.0 108.175 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -85.1 154.99 21.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.361 0.664 . . . . 0.0 112.031 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -70.88 -27.58 63.92 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.655 0.782 . . . . 0.0 112.732 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -142.92 147.31 35.06 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.411 1.485 . . . . 0.0 110.635 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -63.58 -29.08 70.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.202 0.601 . . . . 0.0 111.952 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 23.0 p -60.24 -25.8 65.94 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.931 -1.105 . . . . 0.0 113.093 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 25.3 m -71.84 -30.8 65.84 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.815 -1.178 . . . . 0.0 111.996 171.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 49.8 t -74.84 -37.43 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.617 -0.677 . . . . 0.0 109.988 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -68.36 -35.31 77.54 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.576 -0.702 . . . . 0.0 111.742 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.17 86.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.074 0.852 . . . . 0.0 112.493 171.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.3 tp -63.4 -48.33 78.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.189 0.596 . . . . 0.0 110.741 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.81 -42.09 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.008 0.923 . . . . 0.0 111.267 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.28 -18.46 64.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.701 1.2 . . . . 0.0 113.887 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.11 -13.12 19.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.99 1.316 . . . . 0.0 113.362 175.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.4 m -72.23 143.07 48.94 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.902 0.858 . . . . 0.0 113.186 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.1 mt -78.87 170.04 17.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.061 1.344 . . . . 0.0 107.956 165.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -141.88 133.01 26.2 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.579 0.752 . . . . 0.0 111.3 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -160.81 133.11 6.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.509 1.524 . . . . 0.0 109.928 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 27.1 t70 58.22 31.97 21.45 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.793 1.237 . . . . 0.0 113.105 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 78.77 3.69 87.53 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.056 1.312 . . . . 0.0 114.421 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -117.36 151.69 36.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.381 1.872 . . . . 0.0 110.956 -172.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.5 mt -99.04 151.12 21.29 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.056 0.942 . . . . 0.0 111.616 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -142.83 149.59 38.8 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.0 tp -135.0 -177.47 4.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.651 1.98 . . . . 0.0 108.734 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 97.3 m -131.49 145.6 51.84 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.599 1.09 . . . . 0.0 112.777 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 31.7 m -149.23 172.79 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 126.899 2.079 . . . . 0.0 111.598 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 58.6 m -149.38 161.58 41.8 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.833 1.253 . . . . 0.0 112.682 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 19.7 p -139.3 -172.37 0.31 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.611 1.964 . . . . 0.0 111.249 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.94 -13.79 37.39 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.112 2.541 . . . . 0.0 113.478 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 40.9 p -126.82 -25.43 3.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.046 1.339 . . . . 0.0 113.859 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 16.9 mm -127.08 134.47 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.512 1.525 . . . . 0.0 109.591 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -123.83 132.97 53.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.544 1.138 . . . . 0.0 111.26 -172.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.0 t70 62.27 30.89 17.63 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.236 1.414 . . . . 0.0 112.507 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -61.83 125.36 84.76 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.787 1.235 . . . . 0.0 110.871 176.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.75 143.98 24.27 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.206 2.604 . . . . 0.0 109.551 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.36 134.83 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.363 1.465 . . . . 0.0 110.417 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -78.37 131.6 37.04 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.652 0.781 . . . . 0.0 109.436 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.46 128.01 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.133 1.373 . . . . 0.0 108.618 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -135.97 84.99 29.86 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.654 1.182 . . . . 0.0 110.071 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.17 133.89 55.87 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.598 2.865 . . . . 0.0 110.984 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -78.98 153.8 30.04 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -172.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -165.44 174.19 10.27 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.99 2.116 . . . . 0.0 111.244 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 61.1 tp -145.5 121.08 10.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.269 1.427 . . . . 0.0 109.391 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 6.7 t -169.88 -165.34 0.48 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.967 1.707 . . . . 0.0 110.456 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -150.91 135.61 17.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.454 1.902 . . . . 0.0 110.648 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 45.6 p -166.56 158.93 13.82 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.772 1.229 . . . . 0.0 112.62 -170.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.41 -2.29 58.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.56 1.544 . . . . 0.0 114.785 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -63.65 139.39 58.76 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.774 1.229 . . . . 0.0 112.177 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 12.5 p -161.3 145.09 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.638 1.575 . . . . 0.0 110.479 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 91.3 mtp -136.22 114.0 11.14 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.272 1.429 . . . . 0.0 109.397 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -167.15 156.16 10.25 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.347 1.859 . . . . 0.0 110.458 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 57.2 p -77.58 -10.05 59.28 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -72.17 -62.48 3.3 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.448 1.499 . . . . 0.0 113.532 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.01 124.75 10.34 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.156 2.571 . . . . 0.0 110.871 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 69.5 p -96.88 -9.23 28.98 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 27.6 m 65.64 6.74 4.01 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.86 2.064 . . . . 0.0 114.906 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.037 1.304 . . . . 0.0 113.316 179.632 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.554 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 25.1 m -128.08 9.61 6.28 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -170.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 25.0 m 68.67 8.93 7.04 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.349 1.86 . . . . 0.0 115.267 172.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 85.25 -128.8 8.92 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.798 1.19 . . . . 0.0 112.64 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 41.8 m -148.74 165.93 29.93 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.527 1.531 . . . . 0.0 111.669 -172.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.2 m -157.83 160.76 38.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.015 1.726 . . . . 0.0 111.089 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 113.18 -147.65 18.55 Favored Glycine 0 N--CA 1.47 0.961 0 C-N-CA 125.212 1.387 . . . . 0.0 112.561 -175.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 35.5 t -148.55 164.54 33.91 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.038 1.335 . . . . 0.0 112.375 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 70.8 mtm-85 -75.48 -3.8 36.05 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.09 0.956 . . . . 0.0 113.45 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -72.53 135.8 45.72 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.464 0.706 . . . . 0.0 110.506 169.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.41 117.75 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.384 1.074 . . . . 0.0 109.8 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -69.44 138.93 53.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.538 1.135 . . . . 0.0 110.885 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.62 115.38 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.428 1.491 . . . . 0.0 109.04 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.56 143.49 18.07 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 125.061 1.315 . . . . 0.0 113.8 -175.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.42 23.12 22.62 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.77 1.176 . . . . 0.0 114.196 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.77 141.91 88.67 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.957 1.303 . . . . 0.0 110.98 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.39 154.28 19.79 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.382 2.722 . . . . 0.0 113.106 172.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.49 3.76 6.09 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.733 2.955 . . . . 0.0 114.096 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -140.82 25.86 2.11 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.727 1.211 . . . . 0.0 112.599 -175.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.1 tt -99.27 137.3 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.311 1.045 . . . . 0.0 110.747 174.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -112.02 169.25 8.98 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.383 1.073 . . . . 0.0 113.437 -174.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -43.11 -46.54 5.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.146 1.779 . . . . 0.0 114.251 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -77.5 -26.47 51.26 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.647 -0.658 . . . . 0.0 112.414 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -79.38 -38.34 35.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.856 0.862 . . . . 0.0 111.533 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 46.2 mt -63.73 -35.84 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.794 0.724 . . . . 0.0 109.68 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 50.5 m -68.34 -53.32 24.92 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.644 0.778 . . . . 0.0 110.863 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.73 -29.69 70.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.515 1.052 . . . . 0.0 113.146 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.7 m -64.8 -25.39 67.89 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -120.49 -5.07 9.82 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.0 tpt85 -60.13 -22.49 62.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.05 1.34 . . . . 0.0 113.195 174.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -53.69 -21.41 6.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.732 2.013 . . . . 0.0 114.81 170.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -97.41 -7.56 31.44 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.311 1.444 . . . . 0.0 113.631 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 125.38 171.61 13.28 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.108 1.813 . . . . 0.0 112.102 -170.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.82 149.88 73.17 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.673 2.915 . . . . 0.0 112.292 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.08 171.69 18.84 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.622 1.569 . . . . 0.0 112.403 -171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.0 159.78 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.671 1.588 . . . . 0.0 109.223 167.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.84 135.88 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.224 1.009 . . . . 0.0 110.884 -170.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -148.12 162.76 38.76 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.169 1.788 . . . . 0.0 111.53 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 21.4 p90 -159.54 159.15 28.18 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.617 1.167 . . . . 0.0 112.601 -177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.01 146.02 98.32 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.388 2.725 . . . . 0.0 112.752 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 63.59 18.39 11.06 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.93 1.292 . . . . 0.0 114.083 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -64.14 -33.73 76.45 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.286 -1.509 . . . . 0.0 112.082 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -76.92 -22.12 53.84 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.824 2.049 . . . . 0.0 114.08 174.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -94.14 -43.46 8.46 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.81 1.244 . . . . 0.0 111.608 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 67.6 m -83.2 -13.89 54.48 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.459 1.104 . . . . 0.0 113.089 174.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 50.1 mttp 55.91 49.38 16.05 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.321 1.448 . . . . 0.0 112.081 169.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 25.1 t -143.47 151.26 40.1 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.372 1.069 . . . . 0.0 112.737 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -93.93 16.1 15.15 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.372 1.869 . . . . 0.0 113.174 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -117.23 142.46 30.17 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 127.26 2.224 . . . . 0.0 109.213 169.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.95 121.22 7.13 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.402 2.735 . . . . 0.0 110.832 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.49 13.9 2.63 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.729 2.952 . . . . 0.0 113.41 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -124.59 -10.23 7.36 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.599 1.56 . . . . 0.0 114.198 -171.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 75.56 13.27 83.11 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 124.348 0.975 . . . . 0.0 113.826 -172.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -154.52 159.4 40.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.248 1.419 . . . . 0.0 112.167 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.08 170.93 18.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.769 1.227 . . . . 0.0 111.792 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -119.48 117.37 28.24 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.312 1.845 . . . . 0.0 109.705 177.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.85 142.01 34.08 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.162 1.385 . . . . 0.0 108.757 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 64.4 mt -124.07 106.17 10.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.672 1.589 . . . . 0.0 107.928 171.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.99 156.1 22.46 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.37 0.668 . . . . 0.0 111.946 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -78.61 -24.65 45.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -143.16 141.95 31.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.308 1.443 . . . . 0.0 110.675 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.47 -33.0 69.28 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.032 0.933 . . . . 0.0 111.935 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -55.52 -28.24 53.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.771 1.228 . . . . 0.0 113.111 174.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.5 m -73.37 -28.85 62.26 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.941 -1.099 . . . . 0.0 112.283 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.88 -39.55 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.685 -0.634 . . . . 0.0 109.624 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -66.18 -38.39 87.91 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.708 -0.62 . . . . 0.0 111.951 173.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.39 86.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.379 0.671 . . . . 0.0 112.409 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.25 -48.1 74.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.206 0.602 . . . . 0.0 111.049 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 78.4 mt -55.54 -41.95 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.93 0.892 . . . . 0.0 111.221 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.28 -17.15 63.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.814 1.246 . . . . 0.0 113.72 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.0 -13.65 18.99 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.167 1.387 . . . . 0.0 113.404 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 57.8 m -76.3 149.06 37.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 93.2 mt -85.94 177.46 7.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.666 1.586 . . . . 0.0 107.934 165.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.37 130.16 18.14 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.518 0.727 . . . . 0.0 111.337 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -150.6 128.48 11.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.044 1.737 . . . . 0.0 110.385 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 22.2 t70 59.42 22.74 11.23 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.772 1.629 . . . . 0.0 113.96 175.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 92.27 -1.46 73.25 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.662 1.601 . . . . 0.0 114.602 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -110.39 151.75 27.09 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.242 1.817 . . . . 0.0 111.466 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.4 mt -90.85 155.76 18.53 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.846 0.859 . . . . 0.0 111.137 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.55 144.43 32.91 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 3.7 tp -129.68 -167.05 1.74 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.673 1.989 . . . . 0.0 108.375 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.7 p -144.3 152.31 40.59 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.912 -1.118 . . . . 0.0 113.38 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.37 169.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.85 2.06 . . . . 0.0 110.761 -171.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 71.1 m -148.12 163.86 35.66 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.453 1.101 . . . . 0.0 113.018 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 52.4 p -145.32 -178.33 0.77 Allowed Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 126.905 2.082 . . . . 0.0 110.886 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.28 -10.96 30.43 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.298 2.665 . . . . 0.0 113.98 170.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 42.4 p -113.28 -31.33 6.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.016 1.326 . . . . 0.0 113.329 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.9 mm -133.62 134.23 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.159 1.384 . . . . 0.0 110.412 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -115.95 135.47 53.94 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.866 1.266 . . . . 0.0 111.119 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 61.84 32.95 17.91 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.468 1.507 . . . . 0.0 112.761 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -62.97 124.36 83.38 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.935 -1.103 . . . . 0.0 110.225 174.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.48 145.88 27.0 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.983 2.455 . . . . 0.0 109.149 170.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.38 133.22 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.711 1.205 . . . . 0.0 110.719 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -76.41 130.59 38.25 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.497 1.119 . . . . 0.0 109.72 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.21 133.35 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.303 1.441 . . . . 0.0 108.54 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 51.8 mtp85 -138.65 98.19 8.92 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 124.306 1.042 . . . . 0.0 110.483 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.79 131.28 43.02 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.358 2.705 . . . . 0.0 110.01 169.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -76.84 141.64 40.57 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -169.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -160.24 152.16 20.18 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.422 2.289 . . . . 0.0 109.227 172.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.22 64.16 4.95 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.427 1.091 . . . . 0.0 110.372 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.1 m -84.24 -0.98 54.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.341 1.457 . . . . 0.0 114.215 -173.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 20.3 t70 71.87 9.74 6.18 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.769 2.427 . . . . 0.0 114.007 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 89.1 p -157.53 154.18 28.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.982 1.713 . . . . 0.0 112.066 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.1 137.58 7.37 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.755 1.622 . . . . 0.0 110.523 -174.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -142.68 155.02 44.85 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.602 1.161 . . . . 0.0 112.818 -168.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.2 125.68 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.77 1.228 . . . . 0.0 110.513 171.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 16.0 ttt -90.78 -13.08 34.62 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.472 1.509 . . . . 0.0 113.577 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.07 141.24 36.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.335 1.454 . . . . 0.0 111.566 176.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 18.3 m -69.33 -14.79 63.12 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 79.73 -169.19 53.15 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.893 1.235 . . . . 0.0 114.038 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -62.2 156.33 51.19 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 124.533 3.488 . . . . 0.0 113.319 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 11.1 t -162.12 169.91 20.07 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.231 1.412 . . . . 0.0 111.325 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 79.6 p -147.55 5.13 0.8 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.196 1.398 . . . . 0.0 114.364 -172.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.125 0 CA-C-O 118.34 -1.255 . . . . 0.0 113.077 -179.695 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 30.9 m -59.52 123.37 16.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.431 1.093 . . . . 0.0 112.255 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 51.7 p -166.86 164.48 16.33 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.868 1.267 . . . . 0.0 111.826 -171.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 79.95 -58.46 4.55 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.382 1.468 . . . . 0.0 111.571 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 50.8 m -65.57 133.72 51.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.315 1.046 . . . . 0.0 110.627 169.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 57.5 m -133.24 15.59 4.14 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.817 1.247 . . . . 0.0 113.065 -169.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 82.65 -41.48 2.85 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 125.758 1.647 . . . . 0.0 112.724 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 13.3 t -162.89 166.89 23.46 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.606 1.962 . . . . 0.0 111.56 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 82.9 mtm-85 -86.68 -7.82 57.97 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.136 0.974 . . . . 0.0 112.275 168.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -79.61 136.78 36.93 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.884 1.274 . . . . 0.0 110.674 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.6 t -141.42 121.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.497 1.119 . . . . 0.0 110.104 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -74.54 142.17 44.77 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.72 0.808 . . . . 0.0 111.158 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.88 124.12 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.402 1.481 . . . . 0.0 109.251 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -122.49 149.64 16.95 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.011 1.291 . . . . 0.0 113.615 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 92.48 17.41 45.84 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.864 1.221 . . . . 0.0 114.366 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.92 141.74 89.39 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.295 1.438 . . . . 0.0 111.381 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.31 154.98 17.21 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.906 3.07 . . . . 0.0 113.818 175.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.43 2.6 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.984 3.122 . . . . 0.0 114.105 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -140.29 23.17 2.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.964 1.306 . . . . 0.0 112.413 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.1 tt -95.32 160.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.681 1.193 . . . . 0.0 109.744 169.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -142.33 171.15 14.45 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.294 1.037 . . . . 0.0 113.107 -173.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -41.67 -47.16 3.91 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.082 1.753 . . . . 0.0 114.241 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.4 -26.97 46.62 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.486 -0.759 . . . . 0.0 112.635 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -80.56 -35.23 34.65 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.016 0.927 . . . . 0.0 111.669 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 65.3 mt -64.7 -36.52 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.614 -0.679 . . . . 0.0 109.465 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 53.7 m -65.4 -53.5 42.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.559 171.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.26 -31.34 70.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.27 0.941 . . . . 0.0 113.275 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.1 m -67.68 -23.6 65.32 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -122.49 -4.3 8.81 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -59.5 -23.04 62.46 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.027 1.331 . . . . 0.0 112.909 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -53.54 -20.55 5.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.678 1.991 . . . . 0.0 114.921 170.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -99.51 -5.66 28.87 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.381 1.472 . . . . 0.0 113.718 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.89 177.47 15.2 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 126.294 1.902 . . . . 0.0 112.406 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.99 147.66 91.77 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.393 2.729 . . . . 0.0 112.65 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.5 169.82 23.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.359 1.464 . . . . 0.0 112.551 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.5 156.93 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.624 1.569 . . . . 0.0 109.158 167.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 94.3 t -119.67 136.38 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.904 1.282 . . . . 0.0 110.068 -173.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -146.34 162.45 38.13 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.288 1.835 . . . . 0.0 111.455 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -164.25 164.1 14.47 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.094 1.358 . . . . 0.0 112.315 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -57.39 139.96 91.67 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.36 2.707 . . . . 0.0 112.341 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 66.14 15.14 9.97 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.064 1.346 . . . . 0.0 114.421 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -64.41 -20.49 66.18 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.056 -1.653 . . . . 0.0 113.043 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -72.69 -18.2 61.57 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.057 2.143 . . . . 0.0 114.789 173.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -136.44 -11.58 1.86 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 17.5 t -66.93 152.73 45.17 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.813 1.245 . . . . 0.0 112.954 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -93.09 9.48 35.68 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -169.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 98.7 p -153.84 170.0 22.03 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.795 1.238 . . . . 0.0 113.029 -175.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -109.85 23.41 14.41 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.218 1.807 . . . . 0.0 112.771 -174.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -104.03 152.9 39.17 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 127.273 2.229 . . . . 0.0 110.901 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.01 126.55 13.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.179 2.586 . . . . 0.0 110.549 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.37 135.4 26.64 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.411 2.741 . . . . 0.0 110.46 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 60.2 11.35 2.74 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.18 1.392 . . . . 0.0 114.291 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 85.65 25.69 37.91 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.222 1.391 . . . . 0.0 114.181 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -144.91 158.71 43.71 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.423 1.611 . . . . 0.0 114.741 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.99 170.04 23.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.607 1.563 . . . . 0.0 112.019 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -117.24 129.56 56.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.146 1.778 . . . . 0.0 110.243 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 35.8 mt -92.79 140.92 29.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.733 1.613 . . . . 0.0 108.699 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.8 mt -124.96 107.34 10.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.784 1.634 . . . . 0.0 108.077 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -88.21 161.55 17.16 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.822 0.849 . . . . 0.0 112.736 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -76.16 -27.2 56.88 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.294 1.038 . . . . 0.0 113.028 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.36 145.98 36.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.314 1.445 . . . . 0.0 110.515 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.98 -29.73 68.64 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.627 -0.67 . . . . 0.0 111.351 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.7 m -55.24 -28.15 51.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.358 1.063 . . . . 0.0 113.099 171.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 16.9 m -74.54 -28.59 61.03 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.928 -1.108 . . . . 0.0 112.046 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.59 -37.29 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.301 0.641 . . . . 0.0 109.83 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -63.33 -41.1 98.88 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.762 0.71 . . . . 0.0 111.552 170.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.21 84.61 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.655 0.661 . . . . 0.0 112.361 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.82 -48.22 75.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.413 0.685 . . . . 0.0 111.149 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 68.7 mt -55.56 -42.25 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.429 1.092 . . . . 0.0 111.16 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.2 -17.51 63.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.892 1.277 . . . . 0.0 113.589 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.11 -13.96 18.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.126 1.37 . . . . 0.0 113.317 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 59.0 m -74.75 146.8 41.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.944 0.878 . . . . 0.0 113.266 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.36 173.32 11.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.288 1.435 . . . . 0.0 108.001 165.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -145.81 135.38 23.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.646 0.778 . . . . 0.0 111.435 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -158.06 122.25 4.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.574 1.15 . . . . 0.0 111.185 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 66.45 5.88 4.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.819 2.448 . . . . 0.0 114.903 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 103.02 -2.32 47.84 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.892 1.71 . . . . 0.0 113.908 -170.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -93.82 144.79 25.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.537 1.535 . . . . 0.0 110.473 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.3 mt -97.22 154.33 17.46 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.929 0.891 . . . . 0.0 111.054 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -143.19 149.1 37.52 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.1 tp -132.03 -179.67 5.55 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.614 1.966 . . . . 0.0 108.729 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 71.8 m -130.61 140.42 50.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.269 1.028 . . . . 0.0 112.04 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.9 m -148.43 171.39 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 126.159 1.783 . . . . 0.0 111.623 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 68.7 m -147.29 163.36 36.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.783 1.233 . . . . 0.0 112.516 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 28.4 p -140.19 -175.73 0.5 Allowed Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.84 2.056 . . . . 0.0 110.631 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -66.9 -13.07 38.54 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.0 2.467 . . . . 0.0 113.894 171.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 44.0 p -120.91 -28.18 4.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.906 1.282 . . . . 0.0 113.836 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 16.3 mm -126.5 135.28 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.206 1.402 . . . . 0.0 110.117 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -121.41 131.0 53.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.689 1.196 . . . . 0.0 111.158 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 24.5 t70 62.67 32.32 16.29 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.305 1.442 . . . . 0.0 112.666 176.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -60.55 128.33 88.1 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.348 1.059 . . . . 0.0 110.528 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.21 139.5 14.93 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.207 2.604 . . . . 0.0 109.095 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 5.2 m -131.38 132.17 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.271 1.428 . . . . 0.0 109.769 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.71 133.77 35.39 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.291 1.036 . . . . 0.0 109.815 -174.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.98 134.9 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.292 1.437 . . . . 0.0 108.901 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -141.11 95.5 7.48 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.53 1.132 . . . . 0.0 110.641 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.14 130.23 35.31 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.664 2.909 . . . . 0.0 111.241 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -74.23 143.31 45.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.74 0.816 . . . . 0.0 112.042 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -161.83 157.65 24.39 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.985 1.314 . . . . 0.0 111.897 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.89 154.34 48.37 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.58 1.552 . . . . 0.0 110.763 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 25.8 m 65.96 17.96 10.94 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.452 1.501 . . . . 0.0 114.427 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -158.18 163.17 37.8 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.664 1.986 . . . . 0.0 110.846 -174.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 8.3 t -161.29 162.33 30.94 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.728 1.211 . . . . 0.0 112.395 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -160.77 142.19 12.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.309 2.244 . . . . 0.0 109.511 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -63.98 145.64 55.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 3.7 p -166.96 131.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 128.022 2.529 . . . . 0.0 106.955 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -16.24 63.64 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -169.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.34 -2.24 56.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.328 1.451 . . . . 0.0 113.444 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 3.1 t -70.28 3.57 2.8 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.252 1.421 . . . . 0.0 114.578 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -78.61 -147.49 3.58 Favored Glycine 0 CA--C 1.544 1.848 0 C-N-CA 125.651 1.596 . . . . 0.0 112.688 171.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -53.8 -26.48 39.2 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.113 3.209 . . . . 0.0 115.28 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 24.2 m -66.27 -14.37 61.88 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 67.7 m -119.96 5.27 10.89 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.592 1.557 . . . . 0.0 113.353 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.25 -1.306 . . . . 0.0 113.773 -179.113 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 36.1 p -73.49 -12.83 60.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.084 0.953 . . . . 0.0 113.166 171.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 9.3 t -153.62 -175.76 5.51 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.57 2.348 . . . . 0.0 109.473 170.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 92.87 0.43 68.74 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.27 1.415 . . . . 0.0 115.022 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 66.9 m -145.57 132.78 20.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.743 1.617 . . . . 0.0 110.174 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.7 p -154.41 4.91 0.26 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -169.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.11 -143.7 22.21 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.324 0.964 . . . . 0.0 113.104 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 24.0 t -158.76 166.09 32.78 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.309 1.443 . . . . 0.0 112.222 -170.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 46.7 mtm105 -75.25 -9.35 58.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.324 1.05 . . . . 0.0 112.931 169.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -79.92 136.99 36.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.146 0.978 . . . . 0.0 111.42 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.15 118.82 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.691 1.197 . . . . 0.0 109.709 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -75.23 142.31 43.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.394 0.678 . . . . 0.0 110.59 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.36 121.92 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.521 1.529 . . . . 0.0 109.189 176.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.78 148.23 18.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.796 1.189 . . . . 0.0 113.065 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 93.17 14.99 53.36 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.67 1.128 . . . . 0.0 114.268 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 92.9 mt -57.83 139.26 82.49 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.687 1.195 . . . . 0.0 110.375 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.32 150.56 19.8 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.602 2.868 . . . . 0.0 113.161 173.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.95 3.0 6.47 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.943 3.095 . . . . 0.0 113.579 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -137.57 16.07 2.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.728 2.011 . . . . 0.0 112.596 -169.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.4 tt -96.05 133.91 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.658 1.183 . . . . 0.0 111.781 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -94.8 162.16 13.87 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.472 1.109 . . . . 0.0 113.399 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -47.64 -44.49 26.96 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.107 1.763 . . . . 0.0 113.751 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.11 -27.91 57.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.825 0.85 . . . . 0.0 112.389 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -77.27 -34.47 55.68 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.528 0.731 . . . . 0.0 112.651 169.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.4 mt -64.99 -36.64 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.93 1.241 . . . . 0.0 109.609 169.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 54.0 m -64.99 -52.38 56.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.646 0.779 . . . . 0.0 110.54 172.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.49 -30.37 70.57 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.582 1.083 . . . . 0.0 112.924 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 75.6 m -65.61 -15.83 63.12 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -130.76 -3.24 4.14 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -61.03 -22.21 64.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.083 1.353 . . . . 0.0 113.009 173.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -57.58 -11.9 2.39 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.645 1.978 . . . . 0.0 114.931 169.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -105.92 -5.86 19.33 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.466 1.506 . . . . 0.0 114.047 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 123.91 173.98 14.04 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 126.073 1.797 . . . . 0.0 112.53 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.27 149.98 88.68 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.795 2.997 . . . . 0.0 113.016 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.75 171.98 16.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.255 1.422 . . . . 0.0 112.806 -176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.72 158.46 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.918 1.687 . . . . 0.0 109.298 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.37 135.63 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.578 1.151 . . . . 0.0 110.719 -170.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -149.56 162.42 40.21 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.893 1.677 . . . . 0.0 111.662 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -157.79 157.03 29.41 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.369 1.067 . . . . 0.0 112.722 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -59.89 156.3 39.21 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.951 3.101 . . . . 0.0 113.847 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 69.02 -6.46 0.9 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 126.842 2.057 . . . . 0.0 114.183 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -66.56 -23.74 66.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.299 1.44 . . . . 0.0 112.385 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -82.71 -14.3 54.83 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.183 2.193 . . . . 0.0 114.162 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.4 -21.19 11.49 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.459 1.503 . . . . 0.0 112.562 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 23.0 t -145.33 111.65 5.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.787 1.635 . . . . 0.0 108.806 170.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -74.04 132.64 42.54 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.421 0.688 . . . . 0.0 111.946 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 26.1 t -164.71 155.37 14.52 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.376 1.471 . . . . 0.0 110.51 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -108.59 15.9 23.38 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.362 1.465 . . . . 0.0 112.782 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.69 141.52 32.5 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.81 2.044 . . . . 0.0 109.594 169.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.64 120.22 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.226 2.617 . . . . 0.0 109.803 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -83.58 9.57 4.05 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.51 2.807 . . . . 0.0 114.611 -169.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -140.79 1.98 1.74 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.817 1.647 . . . . 0.0 114.239 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.82 21.63 68.15 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.115 0.864 . . . . 0.0 114.464 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -152.22 157.53 41.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.463 1.131 . . . . 0.0 112.652 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.34 168.77 25.98 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.718 1.207 . . . . 0.0 112.257 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -113.37 121.14 43.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.307 1.843 . . . . 0.0 109.727 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.3 mt -86.02 140.73 30.03 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.422 1.489 . . . . 0.0 108.76 169.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.53 107.65 12.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.788 1.635 . . . . 0.0 107.734 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.97 154.17 22.32 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.417 0.687 . . . . 0.0 111.936 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -71.65 -26.29 62.48 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.76 0.824 . . . . 0.0 112.822 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -142.25 146.05 34.71 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.389 1.475 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.53 -31.44 71.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.308 0.643 . . . . 0.0 111.659 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -56.24 -28.41 58.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.75 1.22 . . . . 0.0 112.876 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.0 m -73.19 -29.13 62.61 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.964 -1.085 . . . . 0.0 112.147 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.04 -38.51 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.646 -0.659 . . . . 0.0 109.784 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -66.78 -38.35 86.39 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.547 -0.721 . . . . 0.0 111.897 172.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.84 88.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.579 0.627 . . . . 0.0 112.372 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.76 -49.13 74.18 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.306 0.642 . . . . 0.0 110.929 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.62 -42.18 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.1 0.96 . . . . 0.0 111.428 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.07 -17.84 63.92 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.76 1.224 . . . . 0.0 113.581 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.1 -13.59 18.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.165 1.386 . . . . 0.0 113.351 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 54.7 m -75.49 148.14 39.24 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.6 172.93 11.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.045 165.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -146.91 139.06 24.62 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.487 0.715 . . . . 0.0 112.15 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -155.18 118.09 4.34 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.324 1.45 . . . . 0.0 109.275 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 18.6 t70 65.51 5.75 3.39 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.891 2.076 . . . . 0.0 114.973 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 103.09 -6.3 50.9 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.768 1.651 . . . . 0.0 113.575 -171.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -82.27 138.16 34.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.881 1.273 . . . . 0.0 109.348 169.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.8 mt -97.61 155.91 16.76 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.674 0.79 . . . . 0.0 110.83 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -143.03 148.43 36.72 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.6 tp -135.75 177.93 7.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.474 1.91 . . . . 0.0 108.904 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 86.7 m -126.51 144.66 50.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.242 1.017 . . . . 0.0 112.761 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.0 m -149.85 170.06 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 126.855 2.062 . . . . 0.0 111.038 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 70.6 m -148.69 163.47 37.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.761 1.224 . . . . 0.0 112.406 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 25.7 p -140.89 -173.44 0.36 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 126.745 2.018 . . . . 0.0 111.278 -174.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.79 -36.09 97.6 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.955 2.437 . . . . 0.0 113.863 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 44.8 p -119.29 -16.15 9.05 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 23.6 mm -113.69 128.79 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.693 1.133 . . . . 0.0 109.945 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -124.79 135.33 52.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.484 1.114 . . . . 0.0 111.69 -168.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 61.26 30.94 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.421 1.488 . . . . 0.0 112.631 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -66.85 128.32 93.82 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.52 1.128 . . . . 0.0 111.213 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.07 141.73 13.24 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.342 2.695 . . . . 0.0 109.119 169.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.18 135.08 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.396 1.479 . . . . 0.0 110.015 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -81.08 129.57 34.62 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.362 1.065 . . . . 0.0 109.561 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 35.7 mm -110.81 136.8 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.337 1.455 . . . . 0.0 109.08 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -142.14 87.01 9.89 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.904 1.282 . . . . 0.0 110.051 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.61 128.12 27.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.327 2.684 . . . . 0.0 109.763 172.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -74.66 121.19 21.27 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -169.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -154.4 19.86 0.48 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.032 1.733 . . . . 0.0 111.764 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 54.0 tp -73.14 125.35 27.5 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.012 1.325 . . . . 0.0 111.533 -171.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 67.6 m -134.13 57.81 1.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.455 1.502 . . . . 0.0 109.394 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . 0.285 2.6 p30 56.6 16.07 2.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.558 2.343 . . . . 0.0 114.431 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 4.7 p -84.67 8.59 16.43 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.865 2.866 . . . . 0.0 114.547 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -63.39 -6.37 4.73 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -81.21 3.7 22.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.488 1.515 . . . . 0.0 114.708 172.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.91 132.97 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.011 1.724 . . . . 0.0 110.955 -171.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 65.0 ttp -168.78 141.22 2.75 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.924 2.09 . . . . 0.0 109.868 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -163.43 169.62 18.62 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.113 1.365 . . . . 0.0 112.897 -175.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 89.1 p -155.02 166.49 33.43 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.889 1.676 . . . . 0.0 111.984 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -167.71 172.48 42.54 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.571 1.081 . . . . 0.0 113.973 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.68 153.85 49.02 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.074 3.183 . . . . 0.0 111.823 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 33.6 p -84.29 -3.56 58.31 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.754 1.222 . . . . 0.0 114.159 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 3.3 t 70.7 -175.29 0.19 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.03 2.132 . . . . 0.0 113.854 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 C-N-CA 125.7 1.619 . . . . 0.0 112.831 -178.009 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 92.0 p -163.87 178.41 7.82 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.547 1.539 . . . . 0.0 111.496 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 37.5 p -80.94 -3.67 52.31 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -97.51 173.13 28.21 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.558 1.552 . . . . 0.0 114.024 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 8.2 t -163.0 157.36 20.82 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.361 1.465 . . . . 0.0 111.442 173.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 48.7 m -153.45 155.23 35.92 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.06 1.744 . . . . 0.0 111.274 -171.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 151.76 -32.21 0.9 Allowed Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.048 1.309 . . . . 0.0 114.469 172.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 8.2 t -165.9 156.21 12.82 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.555 1.542 . . . . 0.0 112.32 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 86.3 mtm-85 -100.33 -2.52 33.38 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.486 1.114 . . . . 0.0 112.457 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -86.5 138.25 31.88 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.131 0.973 . . . . 0.0 111.132 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.0 t -140.6 120.63 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.293 1.037 . . . . 0.0 110.208 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -71.63 139.93 49.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.851 0.86 . . . . 0.0 110.644 171.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.4 t -132.6 119.35 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.32 1.448 . . . . 0.0 109.408 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.66 146.51 18.45 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.069 1.319 . . . . 0.0 113.435 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.13 17.87 30.75 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.883 1.23 . . . . 0.0 114.275 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.77 141.54 92.68 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.994 1.318 . . . . 0.0 111.441 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.11 156.77 15.22 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.877 3.052 . . . . 0.0 113.972 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.05 3.95 6.59 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.061 3.174 . . . . 0.0 113.815 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -137.45 23.22 2.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.377 1.471 . . . . 0.0 112.323 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.8 tt -104.81 142.66 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.556 1.142 . . . . 0.0 110.897 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -116.2 169.0 9.61 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.929 1.292 . . . . 0.0 113.068 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -48.64 -41.28 30.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.725 1.61 . . . . 0.0 113.921 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.13 -29.44 34.8 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.891 0.877 . . . . 0.0 112.388 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.93 -38.19 69.9 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.328 0.651 . . . . 0.0 111.822 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.1 mt -65.85 -38.71 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.301 -0.875 . . . . 0.0 109.449 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 85.2 m -60.93 -51.51 68.95 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.334 0.653 . . . . 0.0 110.539 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.93 -30.59 71.01 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.419 1.009 . . . . 0.0 112.914 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 65.9 m -68.93 -13.95 62.75 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -129.43 -2.89 4.91 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -60.96 -21.74 63.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.966 1.307 . . . . 0.0 113.228 174.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -56.74 -13.13 2.27 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.736 2.014 . . . . 0.0 114.976 169.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -104.47 -4.89 22.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.514 1.526 . . . . 0.0 113.999 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.07 175.1 15.08 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.983 1.754 . . . . 0.0 112.604 -174.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.26 145.54 98.38 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 123.923 3.082 . . . . 0.0 113.421 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.25 172.53 17.2 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.403 1.481 . . . . 0.0 112.698 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.58 159.85 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.835 1.654 . . . . 0.0 108.553 166.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 82.8 t -132.56 135.97 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.249 1.02 . . . . 0.0 110.421 -172.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -153.84 172.1 17.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.806 1.242 . . . . 0.0 112.437 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -152.6 150.88 25.83 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.928 0.891 . . . . 0.0 113.08 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -70.45 16.52 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 125.083 3.855 . . . . 0.0 117.666 -168.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -147.87 7.38 0.83 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.585 1.554 . . . . 0.0 113.674 -169.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -66.31 -21.33 66.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.237 1.015 . . . . 0.0 112.438 172.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -72.03 -33.17 67.82 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.612 1.565 . . . . 0.0 113.164 172.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.97 -21.54 17.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.659 1.184 . . . . 0.0 113.091 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.6 t -137.38 114.25 10.56 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.226 1.41 . . . . 0.0 108.587 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -72.36 0.95 8.74 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -167.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 49.0 m -60.96 139.06 58.12 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.157 1.383 . . . . 0.0 113.461 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -86.82 15.69 5.57 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.833 1.253 . . . . 0.0 113.44 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -118.22 133.92 23.42 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 128.515 2.726 . . . . 0.0 106.723 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.03 117.36 5.05 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.654 2.236 . . . . 0.0 110.638 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.04 13.58 2.32 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.562 2.841 . . . . 0.0 114.427 -172.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -132.56 -0.28 3.57 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.851 1.66 . . . . 0.0 113.998 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.61 18.35 77.68 Favored Glycine 0 N--CA 1.474 1.228 0 C-N-CA 124.276 0.941 . . . . 0.0 114.724 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -148.16 157.17 43.35 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.557 1.178 . . . . 0.0 112.973 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.91 167.54 27.25 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.051 1.341 . . . . 0.0 111.831 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -115.12 121.19 42.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.856 1.662 . . . . 0.0 109.845 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 21.0 mt -82.24 140.32 33.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.176 1.39 . . . . 0.0 108.731 169.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.9 mt -125.22 101.18 6.87 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.013 1.725 . . . . 0.0 108.11 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.34 159.13 27.3 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.165 0.586 . . . . 0.0 111.497 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -88.49 -13.51 40.09 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.68 142.23 34.92 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.695 1.598 . . . . 0.0 110.367 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.14 -29.78 71.07 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.556 -0.715 . . . . 0.0 112.04 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 26.7 p -59.58 -24.8 64.06 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.939 -1.1 . . . . 0.0 112.999 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.7 m -71.18 -28.79 64.48 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.888 -1.133 . . . . 0.0 112.314 172.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 70.4 t -73.88 -36.98 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.524 -0.735 . . . . 0.0 109.797 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -71.64 -35.74 70.49 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.736 -0.602 . . . . 0.0 112.137 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.37 85.87 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.673 0.67 . . . . 0.0 112.255 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.87 -49.17 73.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.543 0.737 . . . . 0.0 110.951 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.99 -41.64 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.094 0.958 . . . . 0.0 111.619 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.11 -18.48 63.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.844 1.258 . . . . 0.0 113.67 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.57 -13.5 20.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.049 1.339 . . . . 0.0 113.289 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 40.9 m -75.92 147.19 39.15 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.73 176.46 8.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.722 1.609 . . . . 0.0 107.798 165.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -144.74 128.96 17.74 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.649 -0.657 . . . . 0.0 111.382 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -149.43 132.6 16.36 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.965 2.106 . . . . 0.0 108.981 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 57.3 31.8 20.72 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.867 1.267 . . . . 0.0 113.246 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 78.42 7.36 87.95 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.811 1.196 . . . . 0.0 114.419 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -123.71 152.32 42.21 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.17 1.788 . . . . 0.0 111.354 -175.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 89.5 mt -89.21 154.07 20.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.68 0.792 . . . . 0.0 111.671 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -143.65 148.84 36.38 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.513 1.125 . . . . 0.0 113.002 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.8 tp -140.39 157.91 44.82 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.365 1.466 . . . . 0.0 110.134 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 76.6 m -95.96 136.91 35.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.15 0.98 . . . . 0.0 112.424 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 31.5 m -146.11 177.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 126.846 2.058 . . . . 0.0 110.44 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 82.0 p -162.76 168.52 21.36 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.054 -1.029 . . . . 0.0 113.481 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 51.9 p -138.75 -175.54 0.49 Allowed Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.454 1.902 . . . . 0.0 110.617 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.55 -12.42 35.72 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.172 2.581 . . . . 0.0 114.154 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 46.9 p -119.11 -29.39 5.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.964 1.306 . . . . 0.0 113.689 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 27.2 mm -128.77 127.07 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.285 1.434 . . . . 0.0 109.592 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -117.26 141.79 47.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.661 1.184 . . . . 0.0 111.774 -169.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 57.69 31.92 21.12 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.123 1.369 . . . . 0.0 113.096 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -70.51 128.17 91.37 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.314 1.045 . . . . 0.0 111.712 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.62 128.38 4.62 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.309 2.673 . . . . 0.0 108.578 169.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.51 137.91 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.187 1.395 . . . . 0.0 110.47 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -76.71 125.95 30.13 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.104 1.362 . . . . 0.0 109.568 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.3 mm -110.96 128.78 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.54 1.536 . . . . 0.0 108.548 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -136.36 91.5 16.43 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.633 1.173 . . . . 0.0 109.85 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.9 132.48 51.95 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.765 2.977 . . . . 0.0 110.312 172.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -88.3 170.94 10.55 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -168.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -157.83 149.48 21.76 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.728 1.611 . . . . 0.0 111.414 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 532' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 532' ' ' LEU . 1.8 pt? -100.3 -14.87 18.24 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 79.9 p -97.17 -5.87 36.12 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -161.99 150.43 15.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.293 1.837 . . . . 0.0 111.406 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 78.3 p -156.5 15.56 0.31 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.631 1.973 . . . . 0.0 112.712 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.23 58.88 5.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.337 1.455 . . . . 0.0 112.623 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -63.1 115.93 4.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.306 1.442 . . . . 0.0 110.322 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 9.6 p -161.02 150.25 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.545 1.538 . . . . 0.0 110.883 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 27.0 ttt -157.44 146.38 19.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.503 1.521 . . . . 0.0 110.961 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -154.24 145.48 22.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.941 1.696 . . . . 0.0 110.777 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.3 m -80.92 96.2 6.99 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.168 0.987 . . . . 0.0 112.282 -174.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -83.43 168.33 46.05 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 124.602 1.096 . . . . 0.0 113.409 174.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.12 158.63 45.29 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.964 3.109 . . . . 0.0 111.609 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 51.5 p -82.63 -2.98 55.46 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 16.0 m -166.01 155.32 11.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.292 2.237 . . . . 0.0 110.944 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 118.278 -1.29 . . . . 0.0 112.889 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.554 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 7.9 t -155.53 -168.11 2.72 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.035 1.334 . . . . 0.0 111.907 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 72.3 p -121.57 14.52 11.04 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.405 1.882 . . . . 0.0 113.828 -171.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -77.55 176.57 53.53 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.283 1.421 . . . . 0.0 114.127 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 4.8 m -170.71 157.25 5.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.223 2.209 . . . . 0.0 110.127 -173.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 84.1 p -81.52 -20.02 40.94 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.008 -1.058 . . . . 0.0 112.769 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 82.55 3.64 90.44 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.305 1.431 . . . . 0.0 113.983 -175.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 22.6 t -68.41 135.31 51.53 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.01 1.405 . . . . 0.0 112.739 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 66.4 mtm-85 -100.37 3.66 43.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.375 1.47 . . . . 0.0 113.599 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.48 136.0 49.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.566 1.147 . . . . 0.0 111.026 172.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 61.3 t -140.86 120.69 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.579 1.151 . . . . 0.0 110.111 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -68.64 141.25 55.44 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.221 1.008 . . . . 0.0 111.258 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.74 125.8 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.992 1.317 . . . . 0.0 109.161 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -127.28 148.6 17.51 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 125.218 1.39 . . . . 0.0 113.461 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 90.52 15.68 56.47 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.714 1.149 . . . . 0.0 114.009 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.68 142.5 62.25 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.485 1.514 . . . . 0.0 111.408 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.47 151.48 23.71 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.774 2.983 . . . . 0.0 113.145 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.96 0.62 8.66 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.776 2.984 . . . . 0.0 114.795 -169.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -140.71 16.92 2.34 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.38 1.072 . . . . 0.0 113.0 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.9 tt -79.75 131.61 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.632 0.773 . . . . 0.0 111.506 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -92.65 167.89 11.6 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.96 -39.99 69.53 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.491 1.117 . . . . 0.0 113.195 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.93 -30.24 58.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.969 0.907 . . . . 0.0 112.087 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.09 -42.54 80.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.948 0.899 . . . . 0.0 111.517 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 63.3 mt -63.15 -40.7 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.162 0.892 . . . . 0.0 109.795 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 56.9 m -62.21 -51.56 67.31 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.655 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.65 -31.08 71.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.275 0.943 . . . . 0.0 112.567 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.3 m -68.97 -13.14 62.27 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -129.02 -3.62 5.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.618 1.099 . . . . 0.0 113.572 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -61.02 -22.77 64.86 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.867 1.267 . . . . 0.0 113.165 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -57.11 -13.39 2.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.624 1.97 . . . . 0.0 114.951 170.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -103.34 -7.34 21.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.427 1.491 . . . . 0.0 113.901 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.07 172.14 13.61 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.1 1.81 . . . . 0.0 112.075 -170.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.1 150.8 60.69 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.501 2.801 . . . . 0.0 112.237 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.16 174.96 12.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.604 1.562 . . . . 0.0 112.603 -169.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.78 157.23 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.852 1.661 . . . . 0.0 109.144 167.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 59.3 t -124.04 134.02 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.856 1.262 . . . . 0.0 109.79 -174.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -147.4 164.28 33.81 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.851 1.66 . . . . 0.0 111.817 -170.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' TRP . . . . . 0.498 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 10.2 p90 -163.19 162.68 17.67 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.553 1.541 . . . . 0.0 111.724 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -55.03 140.85 80.17 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.645 2.897 . . . . 0.0 113.006 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 69.64 3.35 4.2 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.106 1.762 . . . . 0.0 114.901 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.498 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 42.8 tttm -65.35 -29.79 70.55 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 120.551 -1.343 . . . . 0.0 112.165 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -67.29 -29.47 69.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.257 1.823 . . . . 0.0 113.628 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -101.53 -36.1 8.92 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.759 1.223 . . . . 0.0 112.558 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 66.7 m -91.68 -11.0 38.18 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 55.41 33.11 20.21 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 125.389 1.476 . . . . 0.0 112.206 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 27.6 p -81.29 164.5 22.17 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -168.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -134.51 3.51 3.32 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -168.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.25 144.96 54.72 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.61 1.964 . . . . 0.0 109.104 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.85 126.98 13.13 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.393 2.729 . . . . 0.0 111.242 -170.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.28 130.1 19.3 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.351 2.701 . . . . 0.0 109.964 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 58.53 12.66 2.19 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.399 1.48 . . . . 0.0 114.461 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 85.46 27.87 31.62 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.974 1.273 . . . . 0.0 114.481 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -137.51 156.74 47.79 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.591 1.696 . . . . 0.0 114.175 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -154.44 168.57 26.22 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.665 1.586 . . . . 0.0 111.647 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -120.22 120.71 36.92 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.947 1.699 . . . . 0.0 109.987 172.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.7 mt -83.27 141.12 32.08 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.909 1.284 . . . . 0.0 108.571 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 43.6 mt -123.5 105.49 9.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.395 1.478 . . . . 0.0 107.54 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.92 157.75 26.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.011 0.524 . . . . 0.0 111.274 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -90.48 -12.78 36.27 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -142.21 137.2 30.59 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.562 1.545 . . . . 0.0 110.098 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.48 -34.11 70.53 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.797 0.839 . . . . 0.0 111.964 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.6 m -55.97 -26.42 48.17 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.742 1.217 . . . . 0.0 113.197 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.4 m -71.84 -27.83 63.15 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.947 -1.096 . . . . 0.0 112.384 174.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 57.0 t -73.87 -39.9 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.657 -0.652 . . . . 0.0 109.513 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -67.94 -37.75 82.0 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.694 -0.629 . . . . 0.0 111.941 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.28 -38.36 89.05 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.554 0.616 . . . . 0.0 112.342 173.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.2 tp -63.85 -48.83 75.2 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.288 0.635 . . . . 0.0 110.888 171.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 76.4 mt -56.0 -42.68 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.958 0.903 . . . . 0.0 111.42 176.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.21 -19.02 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.729 1.212 . . . . 0.0 113.514 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.33 -14.07 20.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.052 1.341 . . . . 0.0 113.5 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 42.3 m -75.46 147.94 39.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.079 0.942 . . . . 0.0 113.41 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.54 172.85 11.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.505 1.522 . . . . 0.0 107.803 165.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.8 132.48 23.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.402 0.681 . . . . 0.0 111.501 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -147.12 121.49 9.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.818 1.647 . . . . 0.0 109.499 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 63.71 6.16 2.54 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.71 2.004 . . . . 0.0 114.42 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 101.6 -10.56 57.68 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.938 1.733 . . . . 0.0 113.589 -172.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -79.27 147.95 32.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.511 1.155 . . . . 0.0 109.7 169.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.1 mt -95.92 153.57 17.69 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.181 0.592 . . . . 0.0 111.014 173.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -140.17 146.75 39.17 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.005 0.922 . . . . 0.0 112.707 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.4 tp -129.87 -174.75 3.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.418 1.887 . . . . 0.0 108.561 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 30.0 p -133.94 149.49 51.27 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.058 0.943 . . . . 0.0 113.173 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 26.0 m -148.15 170.23 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 126.279 1.832 . . . . 0.0 111.588 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 50.8 m -145.33 154.23 42.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.536 1.134 . . . . 0.0 112.755 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 24.6 p -144.4 -175.04 0.44 Allowed Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 126.207 1.803 . . . . 0.0 111.502 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.31 -13.99 41.32 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.122 2.548 . . . . 0.0 113.659 171.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 29.3 p -117.51 -32.0 5.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.148 1.379 . . . . 0.0 113.77 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.5 mm -133.64 142.45 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.96 1.304 . . . . 0.0 110.137 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -120.94 133.63 55.28 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.081 1.352 . . . . 0.0 110.577 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.2 t70 63.08 28.34 16.08 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.152 1.381 . . . . 0.0 112.926 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -57.18 126.52 74.05 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-O 117.34 -1.314 . . . . 0.0 110.662 174.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.8 140.56 23.47 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.215 2.61 . . . . 0.0 109.652 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.05 134.78 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.829 1.252 . . . . 0.0 110.657 -174.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -73.14 134.73 44.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.001 1.321 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.8 mm -119.9 131.43 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.65 1.58 . . . . 0.0 108.105 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -139.99 95.36 8.59 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 123.848 0.859 . . . . 0.0 110.862 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.64 139.96 91.41 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.602 2.868 . . . . 0.0 111.889 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -82.26 -3.45 55.2 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.185 0.994 . . . . 0.0 112.568 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -77.79 95.8 4.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.788 1.235 . . . . 0.0 111.707 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -119.73 157.91 27.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.112 1.765 . . . . 0.0 110.522 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 81.1 p -163.91 180.0 6.66 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.428 1.491 . . . . 0.0 111.441 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.45 8.02 4.74 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.101 1.36 . . . . 0.0 113.245 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 31.0 m -75.95 -0.07 20.22 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -174.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 25.2 t0 81.29 150.19 0.1 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 129.118 2.967 . . . . 0.0 113.799 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -72.74 169.64 16.27 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.253 1.821 . . . . 0.0 113.045 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.6 p -152.92 139.28 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.806 1.642 . . . . 0.0 110.402 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 28.2 ttt -164.77 143.62 6.85 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.427 1.891 . . . . 0.0 110.036 -174.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 25.5 t70 63.44 18.14 10.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.651 1.98 . . . . 0.0 113.814 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 70.0 m -98.96 11.37 39.15 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.294 1.437 . . . . 0.0 113.86 -170.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -75.35 170.21 54.51 Favored Glycine 0 CA--C 1.543 1.782 0 C-N-CA 124.765 1.174 . . . . 0.0 113.812 177.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.67 152.72 53.7 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.047 3.165 . . . . 0.0 111.858 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.5 m -77.08 -3.41 39.11 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 80.5 p -164.49 165.37 21.41 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.025 1.73 . . . . 0.0 112.138 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.255 -1.303 . . . . 0.0 112.863 179.513 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -76.52 137.49 39.63 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.002 0.921 . . . . 0.0 111.174 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.5 t -138.27 116.82 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.475 1.11 . . . . 0.0 109.77 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.2 141.75 49.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.536 0.734 . . . . 0.0 110.727 172.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.37 124.64 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.239 1.416 . . . . 0.0 109.509 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -119.57 144.88 17.78 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.789 1.185 . . . . 0.0 113.319 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 100.24 9.16 48.68 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.585 1.565 . . . . 0.0 114.502 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.05 141.77 75.66 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.38 1.472 . . . . 0.0 111.328 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -53.93 155.71 14.12 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.851 3.034 . . . . 0.0 114.084 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.45 3.75 7.22 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.956 3.104 . . . . 0.0 113.527 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -137.93 19.94 2.83 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.623 1.569 . . . . 0.0 112.159 -170.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -103.05 136.39 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.317 1.447 . . . . 0.0 110.547 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -109.03 171.79 7.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.177 0.991 . . . . 0.0 113.02 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -44.35 -46.25 9.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.863 1.665 . . . . 0.0 113.602 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -76.35 -26.96 56.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.449 0.699 . . . . 0.0 112.591 -173.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -78.7 -38.17 39.77 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.819 0.848 . . . . 0.0 111.425 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 34.6 mt -65.06 -39.89 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 121.601 -0.687 . . . . 0.0 109.415 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 90.2 m -61.29 -52.51 64.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.756 0.823 . . . . 0.0 110.345 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.3 69.88 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.453 1.024 . . . . 0.0 113.213 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.1 m -68.46 -23.99 64.66 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -120.42 -4.12 9.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.256 1.022 . . . . 0.0 113.435 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -60.39 -22.07 62.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.313 1.445 . . . . 0.0 113.439 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -54.87 -19.29 6.25 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.425 1.89 . . . . 0.0 114.888 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -98.85 -4.81 32.24 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.467 1.507 . . . . 0.0 113.688 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.66 170.65 13.63 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.996 1.76 . . . . 0.0 112.015 -170.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.37 150.49 76.01 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.598 2.865 . . . . 0.0 112.144 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.88 172.87 16.2 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.721 1.608 . . . . 0.0 112.275 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.17 159.69 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.523 1.529 . . . . 0.0 108.797 167.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.78 136.17 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.179 0.991 . . . . 0.0 110.421 -172.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.897 1.679 . . . . 0.0 111.667 -173.156 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.882 0 CA-C-O 118.997 -0.89 . . . . 0.0 114.491 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -148.06 150.2 33.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.402 1.601 . . . . 0.0 114.634 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -154.81 173.32 16.62 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.979 1.312 . . . . 0.0 112.171 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -118.33 122.01 41.81 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.226 1.811 . . . . 0.0 110.302 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.34 141.5 31.74 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.375 1.47 . . . . 0.0 108.511 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 64.4 mt -125.73 103.67 7.95 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.951 1.701 . . . . 0.0 108.191 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -83.47 157.51 22.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.339 0.656 . . . . 0.0 112.126 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -75.28 -25.33 57.89 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.463 0.705 . . . . 0.0 112.658 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -138.14 144.41 40.77 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.175 1.39 . . . . 0.0 111.032 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.32 -32.43 72.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.448 0.699 . . . . 0.0 111.222 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.3 m -57.12 -27.88 62.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.705 1.202 . . . . 0.0 112.996 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.4 m -72.33 -28.92 63.36 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.961 -1.087 . . . . 0.0 111.994 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.76 -39.13 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 121.697 -0.627 . . . . 0.0 109.781 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -66.24 -39.02 89.23 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.614 -0.679 . . . . 0.0 111.949 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.86 86.93 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.542 0.61 . . . . 0.0 112.306 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 26.8 tp -64.25 -48.63 75.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.478 0.711 . . . . 0.0 111.042 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.67 -41.44 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.022 0.929 . . . . 0.0 111.408 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.18 -17.71 63.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.725 1.21 . . . . 0.0 113.66 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.18 -13.46 18.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.071 1.348 . . . . 0.0 113.455 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.7 m -75.6 147.59 39.48 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.876 0.87 . . . . 0.0 113.266 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.43 173.08 12.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.529 1.532 . . . . 0.0 108.215 165.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.471 0.609 0 C-N-CA 123.217 0.607 . . . . 0.0 112.575 -170.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 89.6 mt . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -140.93 141.43 34.51 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -125.41 -169.75 2.05 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.183 1.793 . . . . 0.0 108.332 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.2 p -141.73 150.2 41.48 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.645 1.111 . . . . 0.0 113.607 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 27.6 m -151.95 177.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.567 1.947 . . . . 0.0 111.486 -171.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 79.7 p -160.55 170.49 20.79 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.031 1.332 . . . . 0.0 112.933 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.4 p -153.78 -179.35 1.04 Allowed Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.73 2.012 . . . . 0.0 110.425 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.65 -19.93 55.5 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.845 2.363 . . . . 0.0 114.337 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 52.7 p -114.97 -19.28 11.0 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.05 1.34 . . . . 0.0 114.285 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.81 137.03 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.43 1.492 . . . . 0.0 110.391 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -131.64 137.75 48.49 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.711 1.204 . . . . 0.0 112.092 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.1 t70 57.54 28.4 15.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.396 1.478 . . . . 0.0 113.283 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -72.11 127.13 90.85 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.837 -1.078 . . . . 0.0 111.466 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.6 142.91 18.6 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.317 2.678 . . . . 0.0 109.381 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.5 m -137.65 133.22 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.55 1.14 . . . . 0.0 110.627 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -81.52 131.23 35.27 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.654 1.182 . . . . 0.0 110.057 -172.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.1 mm -114.05 128.61 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 108.986 -171.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -136.22 89.15 20.16 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.909 1.283 . . . . 0.0 110.092 -175.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.95 134.8 64.7 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.658 2.905 . . . . 0.0 110.851 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 . . . . . 0 CA--C 1.537 0.442 0 CA-C-O 121.172 0.51 . . . . 0.0 112.024 -174.84 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -82.12 135.72 35.26 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.592 0.633 . . . . 0.0 110.601 171.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.82 117.77 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.195 0.998 . . . . 0.0 110.146 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -71.21 139.74 50.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.147 0.979 . . . . 0.0 110.715 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 64.1 t -133.64 118.16 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.399 1.48 . . . . 0.0 109.292 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.09 143.44 18.07 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 124.803 1.192 . . . . 0.0 113.478 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.49 15.49 32.04 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.109 1.338 . . . . 0.0 114.4 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.64 139.47 85.84 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.957 1.303 . . . . 0.0 110.933 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -55.12 156.46 16.18 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.578 2.852 . . . . 0.0 113.703 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.91 5.4 4.95 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.054 3.169 . . . . 0.0 113.715 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -140.3 29.54 2.0 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.393 1.477 . . . . 0.0 112.043 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -110.7 128.32 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.464 1.106 . . . . 0.0 111.179 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -97.73 167.49 10.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.667 1.187 . . . . 0.0 113.334 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -43.6 -46.53 7.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.261 1.825 . . . . 0.0 113.994 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -79.01 -25.44 43.31 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.846 0.858 . . . . 0.0 112.523 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -77.51 -36.41 52.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.589 0.756 . . . . 0.0 111.933 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 44.0 mt -65.54 -36.39 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.153 0.888 . . . . 0.0 109.569 170.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 60.4 m -64.23 -52.19 59.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.831 0.852 . . . . 0.0 110.54 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.16 -30.64 70.52 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.605 1.093 . . . . 0.0 112.992 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.1 m -66.86 -15.5 63.67 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -130.19 -2.78 4.48 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -61.12 -22.09 64.34 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.987 1.315 . . . . 0.0 113.096 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -56.91 -13.12 2.37 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.736 2.014 . . . . 0.0 114.956 169.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -104.56 -5.73 21.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.497 1.519 . . . . 0.0 113.961 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.8 170.97 13.66 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.878 1.704 . . . . 0.0 112.104 -170.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.56 151.35 70.18 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.793 2.995 . . . . 0.0 112.429 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.06 172.92 15.11 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.63 1.572 . . . . 0.0 112.486 -170.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.52 159.44 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.742 1.617 . . . . 0.0 109.33 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.98 136.36 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.489 1.115 . . . . 0.0 110.817 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.3 t70 . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 126.375 1.87 . . . . 0.0 111.659 -174.727 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.247 0 CA-C-O 119.618 -0.545 . . . . 0.0 114.13 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -151.44 158.0 43.1 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.622 1.211 . . . . 0.0 112.773 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -151.81 168.79 23.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.662 1.185 . . . . 0.0 111.904 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.57 118.69 33.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.51 1.924 . . . . 0.0 109.521 175.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 23.7 mt -82.34 142.33 32.11 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.306 1.442 . . . . 0.0 109.053 169.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 53.7 mt -125.97 106.79 9.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.018 1.727 . . . . 0.0 108.05 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.03 156.43 21.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.519 0.728 . . . . 0.0 112.161 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -69.01 -34.56 75.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.701 0.801 . . . . 0.0 112.41 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -140.57 141.62 35.21 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.991 1.716 . . . . 0.0 109.999 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -60.59 -32.41 71.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.052 0.941 . . . . 0.0 111.808 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 19.2 m -56.81 -27.05 59.3 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.616 1.166 . . . . 0.0 112.954 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 22.5 m -70.06 -28.73 65.69 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.089 -1.007 . . . . 0.0 112.283 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 57.9 t -77.18 -36.5 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.643 -0.66 . . . . 0.0 110.043 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -68.74 -37.15 79.22 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.515 -0.741 . . . . 0.0 111.871 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.43 -37.84 87.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.298 0.639 . . . . 0.0 112.294 172.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.0 tp -64.68 -48.55 74.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.435 0.694 . . . . 0.0 111.032 171.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.1 mt -55.89 -41.51 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.086 0.954 . . . . 0.0 111.261 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.45 -17.53 63.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.767 1.227 . . . . 0.0 113.636 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.83 -13.64 19.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.082 1.353 . . . . 0.0 113.27 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 56.8 m -71.93 141.17 49.47 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.029 0.919 . . . . 0.0 113.077 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 90.6 mt -80.94 176.28 9.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.541 1.536 . . . . 0.0 108.052 165.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 . . . . . 0 CA--C 1.536 0.421 0 C-N-CA 123.402 0.681 . . . . 0.0 110.956 178.773 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 120.713 0.292 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -141.22 152.13 44.33 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.873 1.269 . . . . 0.0 113.787 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.0 tp -140.17 161.62 37.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.767 1.627 . . . . 0.0 109.916 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 24.2 p -97.88 139.0 34.38 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.92 1.288 . . . . 0.0 112.769 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.1 m -148.21 175.61 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 126.627 1.971 . . . . 0.0 110.667 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 82.9 p -161.38 170.9 19.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.3 p -139.61 -177.82 0.74 Allowed Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 127.009 2.123 . . . . 0.0 110.885 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -65.6 -11.72 31.82 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.322 2.681 . . . . 0.0 114.273 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 43.7 p -122.7 -24.71 4.82 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.025 1.33 . . . . 0.0 113.857 -174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 31.0 mm -129.77 125.86 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.325 1.45 . . . . 0.0 109.648 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.06 143.74 48.91 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.576 1.15 . . . . 0.0 112.347 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 61.08 30.67 19.6 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.451 1.501 . . . . 0.0 112.701 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -69.18 127.95 92.76 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 121.128 -0.982 . . . . 0.0 111.529 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.25 131.8 5.05 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.397 2.732 . . . . 0.0 108.941 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.35 133.91 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.026 1.33 . . . . 0.0 110.915 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -77.34 127.98 33.5 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.411 1.085 . . . . 0.0 109.638 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.4 mm -109.21 132.77 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.91 1.284 . . . . 0.0 109.211 -174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -139.87 93.88 9.28 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.477 1.111 . . . . 0.0 110.295 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.04 135.56 69.38 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.252 2.635 . . . . 0.0 109.687 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -169.249 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.5 mtm-85 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -82.24 134.26 35.28 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.254 1.422 . . . . 0.0 111.128 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.6 t -141.0 121.05 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.297 1.039 . . . . 0.0 110.246 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -75.11 140.33 43.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.683 0.793 . . . . 0.0 110.49 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.73 120.6 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.24 1.416 . . . . 0.0 109.294 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.37 146.71 18.55 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 124.836 1.208 . . . . 0.0 113.917 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 91.32 23.75 28.38 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.958 1.266 . . . . 0.0 113.931 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.22 145.91 64.26 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.826 1.651 . . . . 0.0 111.717 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -52.34 155.56 9.38 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.13 3.22 . . . . 0.0 113.907 174.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.57 1.12 9.34 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.878 3.052 . . . . 0.0 113.576 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -140.4 45.79 1.83 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.672 1.589 . . . . 0.0 111.469 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.8 tt -127.57 147.67 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.437 1.495 . . . . 0.0 110.834 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -123.92 170.98 10.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.461 1.504 . . . . 0.0 113.08 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -50.28 -40.82 49.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.177 1.391 . . . . 0.0 113.994 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -81.1 -29.8 34.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.993 0.917 . . . . 0.0 112.361 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.22 -38.75 71.99 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.329 0.652 . . . . 0.0 111.882 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 46.8 mt -66.05 -38.23 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.52 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 88.8 m -61.26 -51.18 70.03 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.316 0.647 . . . . 0.0 110.634 172.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.84 -31.07 71.29 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.245 0.929 . . . . 0.0 112.866 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.5 m -69.09 -14.29 62.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -128.23 -3.08 5.65 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.34 0.973 . . . . 0.0 113.539 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -60.61 -22.1 63.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.905 1.282 . . . . 0.0 113.38 174.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -56.81 -14.17 3.19 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.663 1.985 . . . . 0.0 115.016 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -102.82 -4.4 24.95 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.36 1.464 . . . . 0.0 113.903 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 120.89 171.68 14.38 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.864 1.697 . . . . 0.0 111.981 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.18 151.87 72.35 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.589 2.859 . . . . 0.0 112.271 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.66 173.45 13.87 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.913 1.685 . . . . 0.0 112.312 -171.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.04 157.8 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.658 1.583 . . . . 0.0 108.707 166.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.18 136.25 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.514 1.126 . . . . 0.0 110.158 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 21.7 t0 . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.48 1.112 . . . . 0.0 112.751 -178.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.18 0 CA-C-O 119.369 -0.684 . . . . 0.0 114.354 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -148.16 160.76 42.58 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.775 1.288 . . . . 0.0 113.188 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.42 165.07 36.17 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.992 1.317 . . . . 0.0 111.879 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.28 121.52 45.48 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.832 1.653 . . . . 0.0 109.941 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 22.5 mt -84.85 139.91 31.56 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.433 1.493 . . . . 0.0 108.682 169.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 45.5 mt -127.06 103.13 7.28 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.922 1.689 . . . . 0.0 107.874 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -82.03 160.74 23.17 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.391 0.677 . . . . 0.0 111.813 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -82.84 -16.24 48.46 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -141.29 141.47 33.92 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.405 1.482 . . . . 0.0 110.51 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.77 -30.03 69.77 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.709 -0.62 . . . . 0.0 111.508 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.5 m -55.27 -28.46 53.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.666 1.187 . . . . 0.0 112.964 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.6 m -73.48 -28.74 62.09 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.01 -1.056 . . . . 0.0 112.213 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 86.1 t -75.21 -37.79 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.561 -0.712 . . . . 0.0 109.848 174.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -67.28 -38.2 84.69 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.552 -0.718 . . . . 0.0 111.967 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.83 -37.75 88.03 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.615 0.643 . . . . 0.0 112.322 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.1 tp -63.52 -49.12 74.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.386 0.675 . . . . 0.0 110.92 171.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.7 mt -55.85 -41.51 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.155 0.982 . . . . 0.0 111.351 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.4 -18.25 63.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.737 1.215 . . . . 0.0 113.672 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.48 -14.28 20.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.044 1.337 . . . . 0.0 113.433 174.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.0 m -75.03 146.72 41.34 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.064 0.935 . . . . 0.0 113.475 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -85.17 176.24 8.48 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.545 1.538 . . . . 0.0 107.844 165.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 123.375 0.67 . . . . 0.0 111.715 -175.863 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 120.82 0.343 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -144.98 150.55 37.13 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.504 1.122 . . . . 0.0 113.271 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.35 153.18 42.46 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.045 1.338 . . . . 0.0 110.617 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 21.5 p -83.72 136.45 34.17 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.627 1.171 . . . . 0.0 112.607 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.8 165.4 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 126.021 1.728 . . . . 0.0 111.264 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 50.4 m -146.59 168.06 22.19 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.262 1.025 . . . . 0.0 113.217 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.0 p -147.65 -173.79 0.38 Allowed Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 127.804 2.442 . . . . 0.0 109.942 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -64.63 -16.09 53.41 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.051 2.501 . . . . 0.0 114.341 171.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 57.4 p -126.99 -15.37 5.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.932 1.293 . . . . 0.0 114.312 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.0 mm -129.63 135.0 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.173 1.789 . . . . 0.0 109.27 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -133.14 132.4 41.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.039 0.936 . . . . 0.0 112.338 -169.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.7 t70 59.36 26.95 15.92 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.674 1.59 . . . . 0.0 113.032 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -75.15 129.86 81.81 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.401 1.48 . . . . 0.0 111.901 -169.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -76.35 117.75 4.71 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.407 2.738 . . . . 0.0 110.916 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.89 141.25 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.347 1.459 . . . . 0.0 110.436 173.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -79.03 129.47 34.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.045 0.938 . . . . 0.0 109.861 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.5 131.69 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.487 1.515 . . . . 0.0 108.77 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 29.2 mtp85 -139.25 86.86 14.21 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.681 1.193 . . . . 0.0 110.107 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.89 138.69 80.65 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.638 2.892 . . . . 0.0 111.372 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 123.478 0.711 . . . . 0.0 112.405 -173.202 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -71.19 138.63 49.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.928 0.891 . . . . 0.0 110.816 169.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.6 t -140.07 119.49 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.537 1.135 . . . . 0.0 109.717 175.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -71.77 139.53 49.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.867 0.867 . . . . 0.0 110.544 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.9 119.11 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.311 1.445 . . . . 0.0 109.407 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -117.03 147.67 18.88 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.113 1.339 . . . . 0.0 113.45 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 92.02 19.07 40.93 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 124.702 1.144 . . . . 0.0 114.142 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 98.3 mt -55.2 141.56 60.66 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.561 1.544 . . . . 0.0 111.189 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.94 148.86 28.17 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.625 2.884 . . . . 0.0 112.806 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.62 6.65 3.1 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.207 3.271 . . . . 0.0 114.461 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -140.05 16.57 2.45 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.48 1.512 . . . . 0.0 112.676 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.6 tt -93.39 137.73 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.039 0.936 . . . . 0.0 111.408 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -109.92 170.26 8.19 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.721 1.208 . . . . 0.0 113.161 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -47.66 -44.11 26.89 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.647 1.579 . . . . 0.0 113.746 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -79.65 -25.49 41.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.839 0.855 . . . . 0.0 112.316 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -77.99 -36.64 48.64 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.773 0.829 . . . . 0.0 111.496 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.0 mt -64.89 -38.64 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 118.932 0.787 . . . . 0.0 109.529 170.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 61.6 m -62.74 -52.01 64.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.533 0.733 . . . . 0.0 110.517 173.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.7 70.89 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.5 1.045 . . . . 0.0 112.998 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.6 m -67.66 -15.04 63.44 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -129.62 -2.97 4.8 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -60.98 -22.63 64.66 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.878 1.271 . . . . 0.0 113.142 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -56.42 -13.99 2.67 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.806 2.042 . . . . 0.0 115.009 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -103.67 -6.29 21.74 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.432 1.493 . . . . 0.0 113.946 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 123.44 172.33 13.77 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.961 1.743 . . . . 0.0 112.14 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.79 151.45 68.87 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.544 2.829 . . . . 0.0 112.358 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.27 172.88 15.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.746 1.618 . . . . 0.0 112.527 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -134.02 159.19 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.706 1.603 . . . . 0.0 109.28 167.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 56.1 t -129.26 135.11 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.308 1.043 . . . . 0.0 110.77 -171.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 CA--C 1.545 0.761 0 C-N-CA 126.257 1.823 . . . . 0.0 111.845 -172.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 CA-C-O 119.678 -0.512 . . . . 0.0 114.284 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -149.88 156.79 42.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.641 1.176 . . . . 0.0 112.651 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.58 169.67 22.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.905 1.282 . . . . 0.0 111.697 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -116.32 118.06 31.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.39 1.876 . . . . 0.0 109.531 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 25.4 mt -80.95 141.09 34.83 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.921 1.288 . . . . 0.0 108.682 169.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.8 mt -123.85 103.42 8.34 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.747 1.619 . . . . 0.0 107.871 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -81.02 156.52 25.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.116 0.566 . . . . 0.0 111.403 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -82.81 -15.75 50.45 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -141.87 141.85 33.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.4 1.48 . . . . 0.0 110.658 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.57 -31.86 70.97 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.228 0.611 . . . . 0.0 111.533 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -56.03 -28.04 55.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.65 1.18 . . . . 0.0 112.941 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.3 m -73.92 -29.64 62.15 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.955 -1.091 . . . . 0.0 112.168 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.95 -38.81 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.667 -0.646 . . . . 0.0 109.66 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -66.96 -38.51 86.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.636 -0.665 . . . . 0.0 111.985 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.92 88.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.627 0.649 . . . . 0.0 112.304 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.95 -48.85 74.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.45 0.7 . . . . 0.0 110.918 171.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 74.2 mt -55.67 -42.43 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.091 0.957 . . . . 0.0 111.345 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.98 -17.97 64.0 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.668 1.187 . . . . 0.0 113.671 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.09 -13.88 19.63 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.113 1.365 . . . . 0.0 113.431 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.9 m -77.51 150.46 34.86 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -86.83 176.23 7.81 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.79 1.636 . . . . 0.0 107.778 164.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.471 0.589 0 C-N-CA 123.463 0.705 . . . . 0.0 111.729 -174.783 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 120.68 0.276 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -144.18 148.97 35.7 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.224 1.01 . . . . 0.0 113.096 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -140.7 162.1 36.2 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.733 1.613 . . . . 0.0 110.017 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 24.8 p -97.79 141.17 31.11 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.082 1.353 . . . . 0.0 112.628 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.4 m -146.66 169.98 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 126.7 2.0 . . . . 0.0 110.644 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.7 m -148.9 169.05 21.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.553 1.141 . . . . 0.0 112.786 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.28 175.98 2.57 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 127.916 2.487 . . . . 0.0 109.493 -176.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -57.19 -31.97 92.13 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.162 2.575 . . . . 0.0 115.016 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 42.2 p -119.07 0.12 11.21 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.556 1.542 . . . . 0.0 114.03 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.6 mm -135.68 121.65 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.84 1.656 . . . . 0.0 109.061 -171.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -125.05 134.33 52.58 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.204 1.002 . . . . 0.0 111.984 -168.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.2 t70 60.3 30.81 20.14 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.298 1.439 . . . . 0.0 112.653 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -62.71 129.88 93.27 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.782 1.233 . . . . 0.0 110.962 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.87 137.61 11.19 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.214 2.61 . . . . 0.0 109.193 169.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.23 138.16 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.244 1.418 . . . . 0.0 110.201 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -79.05 127.74 32.38 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.012 1.325 . . . . 0.0 109.532 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.0 mm -112.22 132.8 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.581 1.552 . . . . 0.0 108.673 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -141.21 92.54 8.36 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.476 1.11 . . . . 0.0 110.074 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.79 133.37 55.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.53 2.82 . . . . 0.0 110.829 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 . . . . . 0 CA--C 1.54 0.559 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -169.875 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.26 133.86 35.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.686 1.195 . . . . 0.0 110.811 171.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.9 123.0 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.425 1.09 . . . . 0.0 110.524 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.37 143.44 44.85 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.313 1.045 . . . . 0.0 111.344 171.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.61 127.2 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.236 1.414 . . . . 0.0 109.586 172.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -127.78 146.44 16.62 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.938 1.256 . . . . 0.0 113.622 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 96.73 15.98 38.01 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.142 1.353 . . . . 0.0 114.451 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.31 141.99 86.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.238 1.415 . . . . 0.0 111.507 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.25 155.82 14.95 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.027 3.151 . . . . 0.0 114.283 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.75 2.71 7.58 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 124.117 3.212 . . . . 0.0 113.673 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -138.19 34.76 2.32 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.643 1.577 . . . . 0.0 111.815 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 10.4 tt -114.1 162.57 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.525 1.53 . . . . 0.0 110.234 172.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -146.22 170.36 16.9 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.049 1.34 . . . . 0.0 112.539 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -42.74 -47.66 5.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.132 1.773 . . . . 0.0 114.264 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.25 -29.2 42.53 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.388 -0.82 . . . . 0.0 112.34 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -74.15 -37.25 64.08 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.634 0.774 . . . . 0.0 111.45 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 64.6 mt -65.77 -39.52 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.454 -0.778 . . . . 0.0 109.569 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 62.0 m -60.63 -52.5 64.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.254 173.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.15 71.41 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.332 0.969 . . . . 0.0 112.942 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.2 m -69.42 -14.59 62.98 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -128.2 -4.1 5.59 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.347 0.976 . . . . 0.0 113.508 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -60.61 -22.44 63.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.952 1.301 . . . . 0.0 113.284 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -56.44 -13.7 2.47 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.716 2.006 . . . . 0.0 115.045 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -104.86 -4.38 22.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.236 1.414 . . . . 0.0 113.988 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.72 172.73 14.34 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.818 1.675 . . . . 0.0 112.228 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.68 151.59 69.55 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.722 2.948 . . . . 0.0 112.172 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.09 172.66 16.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.538 1.535 . . . . 0.0 112.553 -169.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.37 151.45 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.876 1.67 . . . . 0.0 109.389 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.98 134.77 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.338 1.455 . . . . 0.0 109.719 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 CA--C 1.544 0.724 0 C-N-CA 125.95 1.7 . . . . 0.0 112.05 -169.79 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 CA-C-O 118.813 -0.993 . . . . 0.0 114.315 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -137.15 158.05 45.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.495 1.648 . . . . 0.0 113.752 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.36 167.8 29.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.502 1.521 . . . . 0.0 111.763 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -118.71 135.07 54.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.023 1.729 . . . . 0.0 109.913 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.2 mt -103.41 139.26 39.03 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.064 1.746 . . . . 0.0 108.697 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 14.2 mt -121.27 113.0 19.31 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.86 156.19 19.08 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.761 0.824 . . . . 0.0 111.338 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -64.59 -35.64 81.64 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.746 -0.596 . . . . 0.0 112.359 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -141.0 144.99 35.35 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.641 1.576 . . . . 0.0 110.507 -171.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.02 -30.88 70.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.508 1.123 . . . . 0.0 112.203 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 24.0 p -61.25 -25.83 67.35 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.088 1.355 . . . . 0.0 113.147 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 25.9 m -70.36 -30.75 67.76 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.931 -1.105 . . . . 0.0 111.686 172.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.75 -34.53 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.539 -0.726 . . . . 0.0 110.249 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -66.44 -37.59 85.5 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.436 -0.79 . . . . 0.0 111.861 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.87 89.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.652 0.66 . . . . 0.0 112.408 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.7 tp -62.99 -48.83 77.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.252 0.621 . . . . 0.0 110.824 171.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 70.8 mt -55.82 -42.29 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.334 1.054 . . . . 0.0 111.289 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.27 -19.67 63.92 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.601 1.16 . . . . 0.0 113.63 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -96.63 -14.14 22.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.952 1.301 . . . . 0.0 113.312 174.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 29.7 m -75.55 146.69 40.27 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 88.7 mt -85.33 -179.06 6.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.998 1.719 . . . . 0.0 107.702 164.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 CA--C 1.537 0.469 0 O-C-N 121.465 -0.772 . . . . 0.0 111.843 -177.789 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 120.878 0.37 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -145.51 149.94 35.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.776 1.23 . . . . 0.0 112.711 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -144.27 153.17 41.76 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.891 1.276 . . . . 0.0 110.936 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 20.5 p -85.63 134.4 33.99 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.656 1.182 . . . . 0.0 112.804 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.87 167.48 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 126.335 1.854 . . . . 0.0 110.708 172.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.2 m -149.69 166.67 28.64 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.493 1.117 . . . . 0.0 112.814 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.5 p -138.51 -175.72 0.51 Allowed Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 127.209 2.204 . . . . 0.0 110.494 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.57 -15.39 49.7 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.064 2.509 . . . . 0.0 114.233 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 47.1 p -123.1 -23.7 4.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.898 1.279 . . . . 0.0 114.172 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.3 mm -126.23 132.28 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.601 1.56 . . . . 0.0 109.534 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -125.0 134.83 52.43 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.41 1.084 . . . . 0.0 111.773 -170.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 62.36 27.61 16.45 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.589 1.555 . . . . 0.0 112.928 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -60.32 127.27 86.11 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.607 1.163 . . . . 0.0 111.511 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.51 110.82 1.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.401 2.734 . . . . 0.0 108.287 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.27 136.22 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.115 0.966 . . . . 0.0 110.05 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -74.67 134.49 41.98 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.168 0.987 . . . . 0.0 109.486 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.73 133.92 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 126.14 1.776 . . . . 0.0 108.097 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 39.7 mtt180 -138.85 98.57 8.6 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.995 0.918 . . . . 0.0 110.343 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.31 134.4 61.29 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.434 2.756 . . . . 0.0 110.38 169.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 123.433 0.693 . . . . 0.0 112.455 -175.13 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -68.83 139.13 55.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.041 0.936 . . . . 0.0 111.222 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.5 t -139.04 118.53 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.595 1.158 . . . . 0.0 109.996 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -68.54 138.85 55.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.07 0.948 . . . . 0.0 110.838 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.5 t -132.55 116.91 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.255 1.422 . . . . 0.0 109.277 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.04 143.91 17.9 Favored Glycine 0 N--CA 1.47 0.913 0 C-N-CA 124.905 1.24 . . . . 0.0 113.637 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.1 23.71 21.68 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.669 1.128 . . . . 0.0 113.882 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.72 141.57 84.68 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.042 1.337 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.22 155.18 20.46 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.503 2.802 . . . . 0.0 113.538 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.23 3.29 6.36 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.803 3.002 . . . . 0.0 114.524 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -140.55 27.14 2.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.865 1.266 . . . . 0.0 112.819 -177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.2 tt -101.07 144.75 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.466 1.106 . . . . 0.0 110.817 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -122.38 170.93 9.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.609 1.163 . . . . 0.0 113.022 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -46.36 -43.71 16.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.109 1.764 . . . . 0.0 114.21 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -76.77 -27.86 55.47 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.447 -0.783 . . . . 0.0 112.401 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -78.67 -36.14 44.13 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.944 0.898 . . . . 0.0 111.499 172.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.0 mt -65.47 -36.77 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.968 0.803 . . . . 0.0 109.559 171.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 48.7 m -64.8 -52.39 57.11 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.461 0.704 . . . . 0.0 110.563 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.22 71.03 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.422 1.01 . . . . 0.0 113.019 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.2 m -67.84 -14.67 63.15 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.656 1.182 . . . . 0.0 114.094 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -129.65 -3.01 4.78 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.457 1.026 . . . . 0.0 113.651 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -60.5 -22.62 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.867 1.267 . . . . 0.0 113.143 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -56.81 -14.0 3.04 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.675 1.99 . . . . 0.0 115.001 170.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -103.78 -6.86 21.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.281 1.433 . . . . 0.0 113.97 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.98 172.18 13.44 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.072 1.796 . . . . 0.0 112.114 -171.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.09 151.21 72.9 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.512 2.808 . . . . 0.0 112.133 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.34 172.33 16.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.598 1.559 . . . . 0.0 112.367 -170.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.79 157.9 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.719 1.608 . . . . 0.0 109.411 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 80.4 t -126.74 135.0 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.61 1.164 . . . . 0.0 110.472 -171.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.0 t70 . . . . . 0 CA--C 1.544 0.72 0 C-N-CA 126.499 1.92 . . . . 0.0 111.689 -172.974 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.312 0 CA-C-O 119.59 -0.561 . . . . 0.0 114.468 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -149.04 161.5 41.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.681 1.192 . . . . 0.0 112.871 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -148.69 164.66 33.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.177 1.391 . . . . 0.0 111.549 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -115.33 115.43 26.61 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.186 1.794 . . . . 0.0 109.155 171.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.4 mt -80.82 142.31 33.83 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.739 1.215 . . . . 0.0 108.911 169.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 48.8 mt -123.37 108.77 13.1 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.603 1.561 . . . . 0.0 107.544 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -85.43 156.4 20.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.245 0.618 . . . . 0.0 111.953 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -75.18 -27.22 59.58 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -142.42 146.6 35.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.238 1.415 . . . . 0.0 111.018 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -63.97 -28.96 70.17 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.047 0.939 . . . . 0.0 111.742 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 22.2 p -61.79 -26.26 67.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 112.948 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.4 m -73.93 -34.34 64.28 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.863 -1.148 . . . . 0.0 111.75 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.77 -40.26 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.773 -0.579 . . . . 0.0 109.871 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -67.66 -40.35 84.51 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.615 -0.678 . . . . 0.0 111.957 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.67 76.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.318 0.963 . . . . 0.0 112.553 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.3 tp -64.92 -48.2 75.0 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.171 0.589 . . . . 0.0 111.012 170.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 85.6 mt -56.38 -42.86 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 118.895 0.771 . . . . 0.0 111.335 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.0 -14.97 63.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.245 1.418 . . . . 0.0 114.154 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.7 -14.51 18.06 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.907 1.283 . . . . 0.0 113.417 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 56.2 m -73.46 145.25 45.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.156 0.979 . . . . 0.0 113.448 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.5 mt -82.36 175.05 10.56 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.591 1.556 . . . . 0.0 107.823 165.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.468 0.462 0 C-N-CA 123.537 0.735 . . . . 0.0 111.253 -177.435 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 120.747 0.308 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -142.24 152.36 42.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.291 1.037 . . . . 0.0 113.161 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.9 tp -139.52 168.36 20.0 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.797 1.639 . . . . 0.0 109.507 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 25.3 p -105.2 142.22 35.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.207 1.403 . . . . 0.0 112.518 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -144.83 171.59 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.628 1.971 . . . . 0.0 110.462 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 64.0 m -147.8 161.49 41.15 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.169 -0.957 . . . . 0.0 113.402 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 53.8 p -148.36 179.1 1.25 Allowed Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.764 2.025 . . . . 0.0 110.998 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -65.13 -13.83 41.91 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.295 2.663 . . . . 0.0 114.06 170.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 34.0 p -107.59 -31.38 8.13 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.01 1.324 . . . . 0.0 113.12 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 8.7 mm -134.69 126.62 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.515 1.126 . . . . 0.0 110.973 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -96.03 133.08 40.69 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.277 1.031 . . . . 0.0 111.535 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 61.8 34.64 17.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.132 1.373 . . . . 0.0 112.811 172.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -55.92 129.06 71.9 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.331 1.052 . . . . 0.0 110.817 171.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.37 137.62 11.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.273 2.648 . . . . 0.0 109.108 169.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.06 136.0 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.063 1.345 . . . . 0.0 110.433 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -73.77 131.22 41.34 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.143 0.977 . . . . 0.0 109.301 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.9 mm -113.35 129.57 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.97 1.308 . . . . 0.0 108.33 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 44.8 mtm105 -137.66 91.97 13.43 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.952 0.901 . . . . 0.0 110.725 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.57 145.66 98.4 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.774 2.983 . . . . 0.0 111.5 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 122.205 1.003 . . . . 0.0 111.878 -176.678 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -83.07 137.64 34.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.473 1.509 . . . . 0.0 110.801 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.1 t -142.98 120.34 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.555 1.142 . . . . 0.0 110.207 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -74.35 142.31 45.12 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.604 0.762 . . . . 0.0 110.851 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.65 125.35 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.487 1.515 . . . . 0.0 109.163 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -123.16 148.17 16.75 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.815 1.198 . . . . 0.0 113.33 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 93.57 19.52 34.73 Favored Glycine 0 N--CA 1.474 1.182 0 C-N-CA 124.797 1.189 . . . . 0.0 114.316 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.22 143.59 78.85 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 125.477 1.511 . . . . 0.0 111.514 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.61 154.07 26.84 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.628 2.885 . . . . 0.0 113.457 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.5 3.01 6.74 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.881 3.054 . . . . 0.0 114.422 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -140.46 25.1 2.24 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.759 1.224 . . . . 0.0 112.764 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 10.7 tt -92.82 162.43 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.169 0.988 . . . . 0.0 110.741 170.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -142.9 169.42 17.6 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.163 1.385 . . . . 0.0 112.437 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.87 -42.54 26.95 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.302 1.841 . . . . 0.0 114.106 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.38 -27.62 41.89 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.402 -0.811 . . . . 0.0 112.357 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -77.31 -35.17 55.15 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.794 0.837 . . . . 0.0 111.572 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 59.6 mt -65.9 -37.45 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.431 -0.793 . . . . 0.0 109.54 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 63.3 m -63.11 -52.18 63.63 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.342 0.657 . . . . 0.0 110.422 172.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -59.88 -31.67 70.01 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.166 0.894 . . . . 0.0 112.995 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 74.5 m -69.55 -14.16 62.71 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -131.64 -2.0 3.81 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.513 1.051 . . . . 0.0 113.743 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.16 -23.17 61.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.859 1.264 . . . . 0.0 112.993 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -57.55 -11.16 1.83 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.487 1.915 . . . . 0.0 115.17 170.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -107.75 -2.02 20.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.586 1.554 . . . . 0.0 113.945 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 119.34 176.53 16.24 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.194 1.854 . . . . 0.0 112.613 -174.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -63.31 148.54 92.81 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.582 2.854 . . . . 0.0 112.865 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.9 170.47 20.57 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.373 1.469 . . . . 0.0 112.639 -176.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -131.44 157.9 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.911 1.685 . . . . 0.0 109.017 167.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 93.3 t -125.29 134.68 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.836 1.254 . . . . 0.0 109.93 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 125.975 1.71 . . . . 0.0 111.578 -170.776 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 CA-C-O 118.665 -1.075 . . . . 0.0 114.512 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -136.84 158.95 43.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.571 1.686 . . . . 0.0 114.051 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.31 165.82 35.45 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.388 1.475 . . . . 0.0 111.784 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.37 122.85 47.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.739 1.616 . . . . 0.0 110.01 170.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.0 mt -86.08 140.99 29.74 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.581 1.552 . . . . 0.0 108.917 169.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 52.2 mt -124.86 107.51 10.97 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.755 1.622 . . . . 0.0 107.811 171.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -85.54 159.47 19.89 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.622 0.769 . . . . 0.0 112.282 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -66.76 -36.08 81.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.941 0.896 . . . . 0.0 112.105 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -141.95 145.48 34.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.681 1.592 . . . . 0.0 110.109 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -63.77 -28.36 69.82 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.741 -0.6 . . . . 0.0 111.907 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 29.3 p -59.84 -24.53 64.27 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.912 -1.117 . . . . 0.0 113.181 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 27.5 m -70.7 -28.36 64.69 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.811 -1.181 . . . . 0.0 112.11 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.16 -37.14 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.696 -0.627 . . . . 0.0 109.929 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -64.13 -40.7 96.75 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.587 -0.696 . . . . 0.0 111.529 169.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.53 -37.93 85.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.763 0.711 . . . . 0.0 112.371 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.68 -47.85 76.88 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.432 0.693 . . . . 0.0 111.123 171.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.9 mt -56.02 -41.91 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.181 0.992 . . . . 0.0 111.421 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.24 -17.74 63.8 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.8 1.24 . . . . 0.0 113.485 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.04 -13.99 18.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.122 1.369 . . . . 0.0 113.518 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.4 m -74.3 146.57 43.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.001 0.905 . . . . 0.0 113.356 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.73 172.33 13.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.54 1.536 . . . . 0.0 108.097 165.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 N--CA 1.469 0.479 0 C-N-CA 123.532 0.733 . . . . 0.0 111.73 -175.529 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -143.34 147.26 34.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.225 1.01 . . . . 0.0 113.134 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.6 tp -130.68 -169.62 2.19 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.399 1.88 . . . . 0.0 108.5 170.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 29.3 p -141.3 149.96 41.93 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.069 0.947 . . . . 0.0 113.095 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -150.81 168.9 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 126.875 2.07 . . . . 0.0 110.478 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 56.4 m -144.24 161.85 37.85 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 54.0 p -147.81 179.05 1.25 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 126.926 2.09 . . . . 0.0 110.994 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -64.67 -13.76 40.84 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.389 2.726 . . . . 0.0 114.265 170.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 35.0 p -107.5 -32.36 7.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.924 1.29 . . . . 0.0 113.108 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 7.1 mm -134.4 126.88 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.451 1.1 . . . . 0.0 110.933 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -96.57 130.58 43.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 111.53 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 60.88 36.7 18.86 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.537 1.535 . . . . 0.0 112.691 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -56.53 125.64 67.42 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.431 1.092 . . . . 0.0 110.278 169.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.93 144.36 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.169 2.579 . . . . 0.0 109.4 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.65 135.39 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.973 1.309 . . . . 0.0 110.517 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -78.0 133.22 38.03 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.22 1.008 . . . . 0.0 109.717 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.5 mm -116.05 131.08 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.354 1.462 . . . . 0.0 108.538 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -137.42 90.31 15.17 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.665 1.186 . . . . 0.0 109.979 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.39 133.1 54.91 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.635 2.89 . . . . 0.0 110.881 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 121.568 0.699 . . . . 0.0 112.432 -173.403 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 56.5 mtm-85 . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -75.95 133.8 40.38 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.389 0.676 . . . . 0.0 110.783 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 52.7 t -138.22 117.27 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.424 1.09 . . . . 0.0 109.637 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -72.97 141.12 47.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.884 0.874 . . . . 0.0 110.468 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 81.2 t -133.05 119.37 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.477 1.511 . . . . 0.0 109.344 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -115.53 145.02 18.63 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 124.709 1.147 . . . . 0.0 113.718 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.32 17.75 28.31 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.123 1.344 . . . . 0.0 114.239 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.79 140.69 95.41 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.599 1.16 . . . . 0.0 111.121 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.24 156.37 13.62 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.958 3.106 . . . . 0.0 113.983 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.58 2.85 7.37 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.987 3.125 . . . . 0.0 113.448 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -140.29 41.92 1.92 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.8 1.64 . . . . 0.0 111.497 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -124.65 142.62 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.341 1.457 . . . . 0.0 110.529 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -119.65 172.62 7.54 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.098 1.359 . . . . 0.0 113.075 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -45.68 -46.67 14.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.713 1.605 . . . . 0.0 113.729 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.76 -26.04 49.55 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.542 0.737 . . . . 0.0 112.446 -173.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -79.06 -37.83 37.92 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.997 0.919 . . . . 0.0 111.524 172.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 48.3 mt -65.51 -36.32 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.403 -0.811 . . . . 0.0 109.589 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 71.4 m -64.62 -52.84 55.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.922 0.889 . . . . 0.0 110.414 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.16 70.23 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.579 1.081 . . . . 0.0 112.954 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.7 m -67.2 -15.57 63.78 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -130.7 -2.73 4.2 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -61.05 -22.29 64.45 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.165 1.386 . . . . 0.0 113.127 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -56.58 -13.71 2.6 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.809 2.044 . . . . 0.0 114.941 169.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -103.69 -7.19 20.86 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.47 1.508 . . . . 0.0 113.936 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.45 175.18 14.25 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.209 1.861 . . . . 0.0 112.269 -173.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.7 149.33 91.56 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.613 2.876 . . . . 0.0 112.796 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.15 171.88 17.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.216 1.406 . . . . 0.0 112.588 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -134.37 157.94 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.731 1.612 . . . . 0.0 109.431 167.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.94 137.74 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.643 1.177 . . . . 0.0 110.992 -171.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 CA--C 1.545 0.781 0 C-N-CA 126.603 1.961 . . . . 0.0 111.456 -176.874 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.233 0 CA-C-O 119.814 -0.437 . . . . 0.0 113.951 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -151.5 158.76 44.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.842 1.257 . . . . 0.0 112.654 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.14 167.48 26.72 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.671 1.188 . . . . 0.0 111.617 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.85 118.27 33.75 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.593 1.957 . . . . 0.0 109.599 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.5 mt -82.83 141.26 32.42 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.983 1.313 . . . . 0.0 108.688 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.5 mt -122.67 105.87 10.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.711 1.604 . . . . 0.0 107.768 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -81.14 156.61 25.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.218 0.607 . . . . 0.0 112.106 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -80.74 -24.62 38.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.152 0.981 . . . . 0.0 113.174 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.19 140.9 32.5 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.493 1.517 . . . . 0.0 110.357 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.77 -35.04 70.22 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.819 0.847 . . . . 0.0 111.96 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.9 m -56.95 -25.53 58.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.792 1.237 . . . . 0.0 113.212 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.3 m -69.23 -28.13 66.07 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.867 -1.146 . . . . 0.0 112.175 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.09 -37.42 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.602 -0.686 . . . . 0.0 109.775 175.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -70.26 -37.51 74.91 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.536 -0.728 . . . . 0.0 111.765 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.24 86.48 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.553 0.615 . . . . 0.0 112.079 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.6 tp -64.44 -49.81 70.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.463 0.705 . . . . 0.0 110.995 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.62 -41.66 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.094 0.958 . . . . 0.0 111.478 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.56 -18.24 63.63 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.799 1.24 . . . . 0.0 113.507 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.88 -13.64 19.96 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.21 1.404 . . . . 0.0 113.377 174.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.6 m -72.84 143.17 47.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.05 0.929 . . . . 0.0 113.37 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.27 175.9 9.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.779 1.632 . . . . 0.0 107.955 165.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 CA--C 1.537 0.45 0 C-N-CA 123.176 0.591 . . . . 0.0 111.712 -177.233 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.861 0.362 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -142.23 154.09 44.51 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.88 1.272 . . . . 0.0 113.097 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -141.8 158.29 43.98 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.627 1.571 . . . . 0.0 109.719 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 72.2 m -99.45 137.23 38.24 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.951 0.9 . . . . 0.0 112.105 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.9 m -144.78 177.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 126.762 2.025 . . . . 0.0 110.662 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 89.4 p -159.49 171.4 19.77 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.946 -1.096 . . . . 0.0 113.496 -175.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 91.6 p -155.16 179.91 1.23 Allowed Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 126.311 1.844 . . . . 0.0 110.586 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.51 -26.06 70.1 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.847 2.365 . . . . 0.0 113.933 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 40.3 p -116.35 -32.93 5.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.7 1.2 . . . . 0.0 113.793 -174.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 21.3 mm -112.18 127.78 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.932 1.293 . . . . 0.0 109.904 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -119.7 142.16 48.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.283 1.433 . . . . 0.0 112.075 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.46 32.92 19.89 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.042 1.337 . . . . 0.0 112.94 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -70.38 128.56 91.17 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.529 1.132 . . . . 0.0 111.428 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.48 131.31 5.53 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.279 2.653 . . . . 0.0 108.845 169.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.71 135.19 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.269 1.428 . . . . 0.0 110.294 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -79.15 131.25 36.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.095 0.958 . . . . 0.0 109.83 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.38 131.81 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.042 1.337 . . . . 0.0 109.319 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -137.78 90.25 14.53 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.953 1.301 . . . . 0.0 110.287 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -61.06 132.2 40.69 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.157 2.571 . . . . 0.0 110.695 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 123.448 0.699 . . . . 0.0 112.745 -174.062 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -86.47 139.8 30.55 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.009 0.924 . . . . 0.0 111.533 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.1 t -140.74 120.76 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.537 1.135 . . . . 0.0 110.378 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -71.65 140.2 49.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.195 0.998 . . . . 0.0 110.945 171.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.19 115.62 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.368 1.467 . . . . 0.0 109.217 173.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -114.91 144.27 18.37 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 124.942 1.258 . . . . 0.0 113.509 -177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.85 17.64 29.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.956 1.265 . . . . 0.0 114.163 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.21 141.48 93.97 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.713 1.205 . . . . 0.0 111.017 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.75 154.3 12.82 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.915 3.077 . . . . 0.0 113.746 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.43 3.78 6.5 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.93 3.087 . . . . 0.0 113.508 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -140.41 23.37 2.34 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.178 1.391 . . . . 0.0 112.227 -173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.4 tt -100.25 127.68 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.285 1.034 . . . . 0.0 111.029 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -92.99 165.71 12.73 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.497 1.119 . . . . 0.0 113.214 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -45.78 -45.51 14.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.918 1.687 . . . . 0.0 113.7 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.19 -29.24 54.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.777 0.831 . . . . 0.0 112.514 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -72.47 -38.71 68.15 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.416 0.686 . . . . 0.0 112.018 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.16 -39.6 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 119.193 0.906 . . . . 0.0 109.585 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 53.4 m -63.24 -51.62 65.46 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.438 0.695 . . . . 0.0 110.613 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.42 -29.08 70.25 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.38 0.991 . . . . 0.0 113.156 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.2 m -66.56 -22.83 66.15 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -123.46 -3.88 8.33 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.3 tpt85 -60.55 -22.36 63.57 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.275 1.43 . . . . 0.0 113.396 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -55.76 -18.71 8.96 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.384 1.874 . . . . 0.0 114.724 171.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.71 -3.4 35.96 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.508 1.523 . . . . 0.0 113.561 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.16 170.41 14.0 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.905 1.717 . . . . 0.0 111.982 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.9 151.0 78.62 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.667 2.912 . . . . 0.0 111.979 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.58 171.82 18.26 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.528 1.531 . . . . 0.0 112.498 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -132.66 157.34 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.494 1.518 . . . . 0.0 109.287 167.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.34 135.68 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.662 1.185 . . . . 0.0 110.351 -172.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.543 0.694 0 C-N-CA 126.264 1.826 . . . . 0.0 111.699 -173.819 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.365 0 N-CA-C 114.316 0.486 . . . . 0.0 114.316 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -153.82 158.81 41.41 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.777 1.231 . . . . 0.0 112.591 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -151.03 167.45 27.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.735 1.214 . . . . 0.0 111.641 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.45 118.22 33.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.312 1.845 . . . . 0.0 109.365 173.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 34.8 mt -81.34 138.98 35.62 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.032 1.333 . . . . 0.0 108.778 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 55.2 mt -122.71 104.42 9.3 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.913 1.685 . . . . 0.0 107.863 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -81.6 157.52 24.69 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.59 0.756 . . . . 0.0 111.764 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -73.15 -27.4 61.64 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.647 -0.658 . . . . 0.0 112.485 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.85 145.29 39.83 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.851 1.261 . . . . 0.0 110.731 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -62.73 -32.11 73.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.255 0.622 . . . . 0.0 111.535 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.3 m -56.73 -27.13 58.69 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.65 1.18 . . . . 0.0 113.289 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.7 m -68.96 -25.89 64.77 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.863 -1.148 . . . . 0.0 112.29 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.68 -38.3 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.707 -0.621 . . . . 0.0 109.985 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -66.34 -39.36 89.15 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.645 -0.659 . . . . 0.0 111.463 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.75 83.51 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.62 0.646 . . . . 0.0 112.498 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 26.8 tp -65.4 -48.42 72.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.517 0.727 . . . . 0.0 111.213 171.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 71.8 mt -55.27 -40.13 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.968 0.907 . . . . 0.0 111.528 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.37 -17.77 63.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.874 1.27 . . . . 0.0 113.683 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.09 -13.56 18.95 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.956 1.302 . . . . 0.0 113.248 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.1 m -74.59 146.43 42.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.14 0.971 . . . . 0.0 113.499 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.74 173.93 12.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.686 1.594 . . . . 0.0 107.777 164.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 123.477 0.711 . . . . 0.0 111.062 -178.203 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.037 0.446 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.16 142.78 32.75 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.089 0.956 . . . . 0.0 113.054 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -127.02 -179.36 4.8 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.605 1.562 . . . . 0.0 108.91 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 71.7 m -128.38 142.3 51.16 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.274 1.03 . . . . 0.0 112.176 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 29.8 m -148.91 173.13 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 126.08 1.752 . . . . 0.0 111.761 -174.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 79.9 p -160.42 171.41 19.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.103 1.361 . . . . 0.0 112.906 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.5 p -153.06 -176.18 0.57 Allowed Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.563 1.945 . . . . 0.0 110.565 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -63.91 -14.27 42.21 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.069 2.513 . . . . 0.0 114.38 170.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 60.7 p -122.3 -18.12 6.89 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.116 1.367 . . . . 0.0 114.114 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.4 mm -132.79 135.09 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.693 1.597 . . . . 0.0 110.363 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -128.38 136.18 50.56 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.849 1.26 . . . . 0.0 111.668 -171.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 58.76 28.68 17.66 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.305 1.442 . . . . 0.0 113.61 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -73.92 129.52 84.74 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.761 -1.212 . . . . 0.0 111.313 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.93 143.37 16.29 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.296 2.664 . . . . 0.0 109.758 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 2.4 m -129.43 135.72 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.309 1.444 . . . . 0.0 110.711 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -79.1 119.13 21.78 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.666 1.586 . . . . 0.0 109.565 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 31.3 mm -105.62 124.93 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.822 1.249 . . . . 0.0 108.477 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -133.11 92.22 25.94 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.243 1.017 . . . . 0.0 110.366 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.56 140.69 95.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.59 2.86 . . . . 0.0 111.569 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 . . . . . 0 CA--C 1.549 0.932 0 C-N-CA 123.872 0.869 . . . . 0.0 112.781 -178.825 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 76.3 mtm-85 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -77.4 134.32 38.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.529 1.132 . . . . 0.0 110.485 169.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.26 118.24 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.159 0.984 . . . . 0.0 110.039 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.47 139.23 45.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.618 0.767 . . . . 0.0 110.273 171.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 67.2 t -130.99 118.47 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.349 1.459 . . . . 0.0 109.156 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -115.29 151.27 18.51 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.789 1.185 . . . . 0.0 113.814 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 89.97 20.88 41.2 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.594 1.092 . . . . 0.0 113.802 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.61 144.61 72.31 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.885 1.274 . . . . 0.0 111.64 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.72 145.39 71.64 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.035 2.49 . . . . 0.0 112.02 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.07 0.52 7.12 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.921 3.081 . . . . 0.0 113.51 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -128.49 19.4 6.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.199 2.199 . . . . 0.0 112.291 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.5 tt -100.47 156.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.092 1.357 . . . . 0.0 111.96 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -135.25 170.57 15.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.186 1.395 . . . . 0.0 112.624 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -50.55 -42.27 55.09 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.386 1.475 . . . . 0.0 113.71 -172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.84 -27.65 44.27 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.561 0.744 . . . . 0.0 112.171 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -74.68 -39.15 62.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.811 0.845 . . . . 0.0 111.409 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.1 mt -64.43 -39.04 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.893 0.77 . . . . 0.0 109.564 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 59.1 m -63.1 -52.08 64.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.478 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.09 71.38 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.569 1.077 . . . . 0.0 112.944 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.4 m -68.51 -14.81 63.26 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -129.31 -3.16 4.97 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.312 0.96 . . . . 0.0 113.546 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -60.76 -22.45 64.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.98 1.312 . . . . 0.0 113.133 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -56.98 -12.01 1.79 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.794 2.037 . . . . 0.0 115.009 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -106.28 -4.15 20.43 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.527 1.531 . . . . 0.0 113.986 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.82 171.49 14.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.792 1.663 . . . . 0.0 112.204 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.37 150.2 58.04 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.659 2.906 . . . . 0.0 112.242 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.6 172.41 17.2 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.587 1.555 . . . . 0.0 112.632 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.85 159.43 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.747 1.619 . . . . 0.0 109.368 167.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.17 137.57 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.61 1.164 . . . . 0.0 110.729 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 CA--C 1.547 0.85 0 C-N-CA 126.407 1.883 . . . . 0.0 111.552 -174.333 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 CA-C-O 119.931 -0.372 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -152.95 160.85 43.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.314 1.445 . . . . 0.0 112.293 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.89 164.89 35.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.787 1.235 . . . . 0.0 111.808 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -110.84 117.79 34.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.158 1.783 . . . . 0.0 109.672 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.7 mt -82.59 140.94 32.95 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.99 1.316 . . . . 0.0 108.535 168.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 53.8 mt -125.1 104.85 8.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.622 1.569 . . . . 0.0 107.879 172.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -83.19 157.61 22.66 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.557 0.743 . . . . 0.0 111.505 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -83.26 -13.99 54.09 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.28 141.59 33.94 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.439 1.496 . . . . 0.0 110.617 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.68 -33.58 74.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.233 0.613 . . . . 0.0 111.359 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 12.4 m -59.51 -24.03 63.3 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.313 1.045 . . . . 0.0 113.057 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 22.9 m -70.67 -30.22 66.76 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.902 -1.124 . . . . 0.0 111.896 172.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.36 -34.91 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.502 -0.749 . . . . 0.0 109.902 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -69.64 -37.2 76.69 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.572 -0.705 . . . . 0.0 111.974 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.38 -37.39 85.53 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.961 0.8 . . . . 0.0 112.207 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.2 tp -63.66 -49.2 74.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.487 0.715 . . . . 0.0 110.894 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.23 -41.83 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.122 0.969 . . . . 0.0 111.557 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.51 -18.34 64.36 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.784 1.234 . . . . 0.0 113.63 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.99 -14.25 18.74 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.086 1.354 . . . . 0.0 113.487 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 53.3 m -72.55 144.56 47.89 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.019 0.914 . . . . 0.0 113.235 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.12 172.42 13.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.386 1.475 . . . . 0.0 107.782 165.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 123.384 0.674 . . . . 0.0 110.939 -179.281 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 120.99 0.424 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -141.84 148.81 39.42 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.565 1.146 . . . . 0.0 112.732 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.6 tp -131.9 171.06 14.03 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.03 1.732 . . . . 0.0 109.07 171.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 87.3 m -117.42 142.96 46.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.171 0.988 . . . . 0.0 112.351 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.21 172.94 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.848 2.059 . . . . 0.0 110.919 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 47.1 m -150.2 167.0 28.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.077 1.351 . . . . 0.0 112.344 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.9 m -161.54 167.44 13.05 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 127.755 2.422 . . . . 0.0 110.653 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.3 -22.03 14.78 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 124.407 3.405 . . . . 0.0 117.917 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 62.8 p -123.15 2.1 9.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.855 1.262 . . . . 0.0 113.908 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 30.3 mm -138.66 117.61 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.884 1.674 . . . . 0.0 110.536 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -118.35 137.73 52.9 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.375 1.07 . . . . 0.0 113.043 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 60.8 30.98 20.02 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.359 1.464 . . . . 0.0 112.423 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -63.89 126.25 89.56 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.739 1.216 . . . . 0.0 111.025 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.91 138.14 11.43 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.253 2.636 . . . . 0.0 109.067 171.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.7 m -130.98 132.26 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.061 1.344 . . . . 0.0 109.896 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -81.08 130.4 35.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.32 1.048 . . . . 0.0 109.876 -173.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 31.9 mm -111.01 132.03 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.905 1.282 . . . . 0.0 109.333 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -137.89 91.94 13.07 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.976 1.31 . . . . 0.0 110.192 -175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.66 132.62 49.14 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.406 2.737 . . . . 0.0 110.678 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -171.622 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.99 135.73 37.85 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.839 1.256 . . . . 0.0 110.654 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.52 121.63 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.274 1.03 . . . . 0.0 110.426 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.44 140.25 55.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.337 1.055 . . . . 0.0 111.385 172.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 56.9 t -133.53 123.18 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 109.422 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -122.11 149.37 17.08 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.452 1.501 . . . . 0.0 113.191 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.31 14.05 52.23 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.958 1.266 . . . . 0.0 114.366 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.96 141.59 85.93 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.031 1.332 . . . . 0.0 111.012 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.42 153.56 17.37 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.874 3.049 . . . . 0.0 113.638 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.73 6.1 4.77 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.002 3.135 . . . . 0.0 113.353 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -140.27 28.56 2.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.476 1.51 . . . . 0.0 111.9 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.8 tt -107.75 150.19 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.293 1.437 . . . . 0.0 110.075 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -124.77 170.29 11.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.81 1.244 . . . . 0.0 112.706 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -44.78 -46.23 10.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.409 1.884 . . . . 0.0 113.913 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -78.94 -26.31 43.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.65 0.78 . . . . 0.0 112.295 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -77.11 -36.53 55.49 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.684 0.794 . . . . 0.0 111.462 171.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.17 -38.73 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.322 0.965 . . . . 0.0 109.566 171.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 57.8 m -62.64 -52.03 64.92 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.367 0.667 . . . . 0.0 110.471 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.49 -30.95 70.94 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.401 1.001 . . . . 0.0 112.978 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.2 m -67.97 -14.67 63.15 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -129.82 -2.82 4.69 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.457 1.026 . . . . 0.0 113.604 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -60.31 -22.5 63.25 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.943 1.297 . . . . 0.0 113.104 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -56.83 -12.53 1.98 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.791 2.036 . . . . 0.0 115.103 170.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -105.65 -4.93 20.49 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.396 1.478 . . . . 0.0 113.974 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.48 172.96 14.14 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.801 1.667 . . . . 0.0 112.288 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.87 149.94 54.56 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.736 2.957 . . . . 0.0 112.29 -174.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.27 172.7 16.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.485 1.514 . . . . 0.0 112.668 -170.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.03 161.09 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.868 1.667 . . . . 0.0 108.728 167.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.49 135.25 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.273 1.029 . . . . 0.0 110.246 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 126.405 1.882 . . . . 0.0 111.538 -169.936 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.056 0 CA-C-O 118.917 -0.935 . . . . 0.0 114.315 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -140.33 157.95 44.78 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.469 1.635 . . . . 0.0 113.914 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.8 170.64 21.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.522 1.529 . . . . 0.0 111.625 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.53 120.49 36.9 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.952 1.701 . . . . 0.0 109.944 173.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.1 mt -80.99 140.83 34.97 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.848 1.259 . . . . 0.0 108.739 169.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 58.3 mt -124.34 101.98 7.45 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.696 1.598 . . . . 0.0 107.702 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -80.21 154.33 28.0 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.307 0.643 . . . . 0.0 110.978 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -76.89 -19.39 57.5 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.461 -0.774 . . . . 0.0 112.91 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.94 142.4 34.38 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.945 1.298 . . . . 0.0 110.799 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.71 -31.38 71.53 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.526 0.731 . . . . 0.0 111.649 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.4 m -56.39 -28.34 58.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.625 1.17 . . . . 0.0 112.899 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -28.4 62.45 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.964 -1.085 . . . . 0.0 112.118 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.3 t -76.32 -37.76 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.668 -0.645 . . . . 0.0 109.839 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -66.3 -38.14 87.03 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.578 -0.701 . . . . 0.0 111.85 172.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.5 91.21 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.557 0.617 . . . . 0.0 112.367 173.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.6 tp -63.53 -48.37 77.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.429 0.692 . . . . 0.0 110.926 171.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 69.9 mt -56.23 -43.25 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.249 1.02 . . . . 0.0 111.33 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.33 -18.88 64.6 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.682 1.193 . . . . 0.0 113.542 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.11 -13.65 19.72 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.185 1.394 . . . . 0.0 113.605 175.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.06 150.05 37.37 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.164 0.983 . . . . 0.0 113.617 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.3 mt -86.25 177.79 7.38 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.035 1.734 . . . . 0.0 107.843 165.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 N--CA 1.47 0.563 0 C-N-CA 123.437 0.695 . . . . 0.0 111.623 -175.099 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.615 0.245 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -141.04 145.47 35.92 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.977 0.911 . . . . 0.0 113.116 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.06 -173.95 3.19 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.142 1.777 . . . . 0.0 108.949 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.3 p -134.61 147.29 50.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.311 1.044 . . . . 0.0 113.276 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.2 m -152.05 -178.87 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 127.181 2.193 . . . . 0.0 110.753 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 80.5 p -161.7 170.56 19.45 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.503 1.121 . . . . 0.0 113.135 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 16.2 p -142.5 -177.01 0.61 Allowed Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 126.528 1.931 . . . . 0.0 110.682 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.17 -21.97 68.22 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.881 2.387 . . . . 0.0 114.145 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 46.3 p -123.09 -23.05 5.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.6 mm -115.24 127.63 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.075 1.35 . . . . 0.0 109.79 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -122.65 139.0 54.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.601 1.16 . . . . 0.0 111.974 -168.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.89 33.49 23.26 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.171 1.388 . . . . 0.0 112.963 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -69.45 126.56 92.72 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.201 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -80.48 142.9 14.96 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.286 2.657 . . . . 0.0 109.307 169.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.15 134.61 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.732 1.213 . . . . 0.0 110.585 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -79.14 126.41 30.71 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.902 1.681 . . . . 0.0 109.639 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 29.5 mm -114.87 132.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.545 1.538 . . . . 0.0 108.342 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -140.96 100.05 6.57 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.788 0.835 . . . . 0.0 110.678 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -55.88 134.95 67.16 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.472 2.781 . . . . 0.0 110.977 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -169.435 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -80.84 133.15 35.55 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.366 0.666 . . . . 0.0 110.765 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.2 115.44 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.383 1.073 . . . . 0.0 109.882 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -71.94 140.5 49.21 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.802 0.841 . . . . 0.0 110.384 171.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.73 118.59 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.08 1.352 . . . . 0.0 109.23 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.91 143.71 18.15 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.916 1.245 . . . . 0.0 113.381 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.88 11.0 47.95 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.451 1.501 . . . . 0.0 114.157 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.09 142.13 80.65 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.113 1.365 . . . . 0.0 111.482 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.41 154.79 18.22 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.769 2.98 . . . . 0.0 113.576 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -79.21 4.47 6.55 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.835 3.023 . . . . 0.0 113.421 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -135.97 20.24 3.25 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.691 1.597 . . . . 0.0 112.301 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 14.1 tt -104.02 123.38 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.696 1.199 . . . . 0.0 111.958 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.02 161.17 25.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.515 1.126 . . . . 0.0 112.806 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -48.1 -44.44 31.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.108 1.363 . . . . 0.0 112.543 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -74.74 -24.25 58.69 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.86 0.864 . . . . 0.0 112.891 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -78.21 -40.55 37.15 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.818 0.847 . . . . 0.0 111.118 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.2 mt -62.52 -41.84 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 170.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 60.7 m -61.0 -52.28 65.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.496 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.45 -29.36 70.46 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.552 1.069 . . . . 0.0 113.223 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 64.8 m -67.34 -23.26 65.6 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.58 -5.62 9.75 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.145 0.978 . . . . 0.0 113.552 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -61.52 -22.98 65.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.169 1.387 . . . . 0.0 113.139 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -53.04 -20.72 3.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.587 1.955 . . . . 0.0 114.73 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -97.74 -9.32 26.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.502 1.521 . . . . 0.0 113.915 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 126.12 170.55 13.0 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.976 1.75 . . . . 0.0 112.034 -169.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.88 150.82 56.0 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.682 2.922 . . . . 0.0 112.601 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.06 172.92 15.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.664 1.586 . . . . 0.0 112.664 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.62 158.69 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.851 1.66 . . . . 0.0 109.488 167.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 77.5 t -130.91 137.55 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.586 1.154 . . . . 0.0 110.89 -171.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 126.164 1.786 . . . . 0.0 111.628 -175.449 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 CA-C-O 119.504 -0.609 . . . . 0.0 114.259 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -152.45 158.1 42.12 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.797 1.298 . . . . 0.0 113.418 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.74 170.67 19.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.107 1.363 . . . . 0.0 111.645 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.29 121.65 41.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.32 1.848 . . . . 0.0 109.722 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.17 140.47 30.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.448 1.499 . . . . 0.0 108.916 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 55.0 mt -124.52 105.43 9.38 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.74 1.616 . . . . 0.0 107.96 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -83.41 159.12 21.87 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.523 0.729 . . . . 0.0 111.353 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.73 -22.04 24.83 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -130.12 144.53 51.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.125 1.77 . . . . 0.0 110.279 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 37.6 mp0 -66.01 -30.51 71.07 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.416 -0.803 . . . . 0.0 111.286 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.6 m -55.15 -27.76 47.85 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.832 1.253 . . . . 0.0 112.798 173.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.7 m -71.85 -29.56 64.51 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.109 -0.995 . . . . 0.0 112.048 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.99 -37.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.522 -0.736 . . . . 0.0 109.888 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -66.3 -38.16 87.09 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.533 -0.73 . . . . 0.0 111.86 172.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.81 -37.94 88.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.317 0.647 . . . . 0.0 112.38 173.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.2 tp -64.01 -48.78 75.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.333 0.653 . . . . 0.0 110.943 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 75.5 mt -55.54 -40.9 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.231 1.012 . . . . 0.0 111.35 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.45 -17.82 63.67 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.719 1.208 . . . . 0.0 113.818 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.02 -13.66 18.97 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.067 1.347 . . . . 0.0 113.351 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 54.6 m -75.89 149.29 37.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.052 0.941 . . . . 0.0 113.464 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.6 mt -83.84 173.28 11.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.431 1.492 . . . . 0.0 107.785 164.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 N--CA 1.469 0.51 0 C-N-CA 123.528 0.731 . . . . 0.0 111.733 -174.521 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.662 0.268 . . . . 0.0 111.525 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -144.81 145.87 31.84 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.993 0.917 . . . . 0.0 112.977 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.0 tp -131.62 -176.51 4.06 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.494 1.918 . . . . 0.0 108.614 172.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 89.6 m -129.63 146.12 51.45 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.508 1.049 . . . . 0.0 112.729 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 29.2 m -148.93 177.46 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 126.501 1.92 . . . . 0.0 111.531 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 80.2 p -161.13 170.79 19.71 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.096 1.358 . . . . 0.0 112.965 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.3 p -153.88 -179.78 1.13 Allowed Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 126.894 2.078 . . . . 0.0 110.567 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.61 -20.04 55.77 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.897 2.398 . . . . 0.0 114.403 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 57.6 p -113.88 -19.9 11.29 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.026 1.33 . . . . 0.0 114.325 -175.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.1 mm -132.31 135.99 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.489 1.516 . . . . 0.0 110.304 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -130.49 138.41 50.24 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.594 1.158 . . . . 0.0 112.179 -171.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.5 t70 57.54 29.88 17.83 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.336 1.454 . . . . 0.0 113.093 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -75.1 126.2 88.33 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-O 117.829 -1.081 . . . . 0.0 111.584 -172.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.32 141.78 18.41 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.297 2.665 . . . . 0.0 109.457 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.7 m -135.87 134.39 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.015 1.326 . . . . 0.0 110.453 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -75.37 129.67 37.74 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.555 1.142 . . . . 0.0 109.535 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.92 131.21 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.384 1.474 . . . . 0.0 108.373 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 16.7 mtp85 -137.11 89.72 16.33 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.491 1.116 . . . . 0.0 110.106 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -59.05 135.67 68.01 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.839 2.359 . . . . 0.0 109.102 169.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -171.057 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -80.41 137.86 36.56 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.694 1.198 . . . . 0.0 111.281 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.5 t -141.48 120.66 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.681 1.192 . . . . 0.0 109.763 175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -77.77 143.54 37.88 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.569 0.748 . . . . 0.0 110.79 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.02 124.62 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.58 1.552 . . . . 0.0 109.232 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -120.5 150.26 17.43 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.807 1.194 . . . . 0.0 113.409 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 90.49 20.1 42.46 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.543 1.068 . . . . 0.0 114.05 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.8 146.34 75.72 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.085 1.354 . . . . 0.0 111.562 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -54.04 152.79 22.88 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.586 2.858 . . . . 0.0 112.974 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.07 0.18 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.71 2.94 . . . . 0.0 114.667 -170.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -140.7 17.1 2.34 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.389 1.075 . . . . 0.0 113.128 -175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.1 tt -80.19 131.76 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.78 0.832 . . . . 0.0 111.527 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.22 170.48 9.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.92 -45.57 51.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.479 1.512 . . . . 0.0 113.044 176.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -74.88 -32.83 61.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.004 0.921 . . . . 0.0 112.609 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.2 -42.32 84.36 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.554 0.742 . . . . 0.0 112.201 170.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 51.3 mt -64.15 -38.36 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 119.197 0.908 . . . . 0.0 109.83 174.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 57.5 m -63.77 -52.31 60.94 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.357 0.663 . . . . 0.0 110.639 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.6 -31.18 71.23 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.348 0.976 . . . . 0.0 112.738 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.6 m -67.83 -15.08 63.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -129.16 -2.99 5.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.457 1.026 . . . . 0.0 113.507 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -60.48 -22.79 63.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.048 1.339 . . . . 0.0 113.268 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -57.48 -13.0 3.05 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.594 1.958 . . . . 0.0 114.99 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -104.11 -4.1 23.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.42 1.488 . . . . 0.0 113.823 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.69 170.26 13.82 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 126.07 1.795 . . . . 0.0 112.062 -170.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.09 153.03 75.9 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.495 2.796 . . . . 0.0 112.129 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.02 171.98 16.69 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.654 1.582 . . . . 0.0 112.424 -170.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.84 156.66 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.655 1.582 . . . . 0.0 109.248 167.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 65.9 t -128.64 137.42 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.705 1.202 . . . . 0.0 110.283 -171.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 27.5 t0 . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 126.025 1.73 . . . . 0.0 111.608 -175.345 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.269 0 N-CA-C 114.686 0.634 . . . . 0.0 114.686 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -151.25 155.27 38.44 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.513 1.156 . . . . 0.0 113.08 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.29 167.78 29.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.696 1.198 . . . . 0.0 112.362 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -112.65 127.16 56.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.632 1.973 . . . . 0.0 110.098 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.9 mt -92.95 139.24 30.73 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.184 1.794 . . . . 0.0 108.55 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 44.9 mt -123.93 107.56 11.48 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.458 1.503 . . . . 0.0 107.85 171.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -84.16 160.38 20.87 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.332 0.653 . . . . 0.0 112.292 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -75.65 -26.32 57.59 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.796 0.838 . . . . 0.0 112.856 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -140.09 144.79 36.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.29 1.436 . . . . 0.0 110.663 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.17 -30.88 69.62 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.711 -0.618 . . . . 0.0 111.564 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.4 m -55.55 -27.39 48.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.576 1.15 . . . . 0.0 113.139 172.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.1 m -73.84 -29.94 62.41 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.034 -1.041 . . . . 0.0 112.071 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.84 -38.54 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 121.744 -0.598 . . . . 0.0 109.584 173.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -68.63 -37.42 79.71 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.755 -0.591 . . . . 0.0 111.92 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.03 85.57 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.981 0.81 . . . . 0.0 112.287 173.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.71 -48.5 76.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.378 0.671 . . . . 0.0 110.87 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 80.8 mt -56.11 -43.04 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.986 0.914 . . . . 0.0 111.392 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.01 -18.62 64.76 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.738 1.215 . . . . 0.0 113.688 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.12 -13.42 18.98 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.06 1.344 . . . . 0.0 113.533 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 34.6 m -73.46 144.73 46.14 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.003 0.906 . . . . 0.0 113.33 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.2 172.69 13.34 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.311 1.444 . . . . 0.0 107.808 165.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 123.469 0.708 . . . . 0.0 111.363 -175.602 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -142.38 149.35 39.25 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.383 1.073 . . . . 0.0 113.144 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.3 tp -133.8 -170.44 2.5 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.475 1.91 . . . . 0.0 108.895 172.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 26.5 p -140.73 144.56 35.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.807 1.243 . . . . 0.0 112.593 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 25.3 m -147.99 171.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 126.255 1.822 . . . . 0.0 111.667 -169.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 40.1 m -147.65 153.66 39.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.601 1.16 . . . . 0.0 112.817 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.9 p -140.89 -173.9 0.38 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 126.383 1.873 . . . . 0.0 111.689 -174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -69.62 -10.89 29.81 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.34 2.693 . . . . 0.0 113.639 171.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 37.3 p -120.99 -32.27 3.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.076 1.35 . . . . 0.0 113.621 -171.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.0 mm -133.35 137.94 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.956 1.302 . . . . 0.0 110.005 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -119.75 135.16 54.96 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.98 1.312 . . . . 0.0 110.729 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 24.9 t70 64.53 27.3 13.41 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.344 1.457 . . . . 0.0 112.911 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -58.74 125.58 77.5 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.493 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.09 146.58 25.65 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.976 2.451 . . . . 0.0 109.776 171.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.8 m -139.3 140.56 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.16 1.384 . . . . 0.0 110.916 -174.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -83.03 132.33 35.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.912 1.285 . . . . 0.0 109.858 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.1 mm -114.95 131.23 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.831 1.252 . . . . 0.0 109.274 -174.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -135.76 90.2 19.93 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.401 1.481 . . . . 0.0 110.351 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.01 136.36 72.81 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.417 2.745 . . . . 0.0 111.041 172.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.189 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -64.31 136.54 57.25 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.08 0.952 . . . . 0.0 110.547 168.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 43.3 t -137.6 116.9 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.767 0.827 . . . . 0.0 109.375 169.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -73.37 137.17 44.53 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.587 0.755 . . . . 0.0 110.327 172.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 77.5 t -131.31 112.68 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.445 1.498 . . . . 0.0 108.991 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -110.45 151.29 17.58 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.117 1.342 . . . . 0.0 113.41 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 89.87 25.99 25.68 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.32 0.962 . . . . 0.0 113.891 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.77 143.21 91.33 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.787 1.235 . . . . 0.0 111.451 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.84 154.65 31.07 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.366 2.71 . . . . 0.0 113.052 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.04 3.15 6.88 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.901 3.068 . . . . 0.0 114.516 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -140.34 25.27 2.25 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.774 1.229 . . . . 0.0 112.835 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.2 tt -93.48 161.59 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.308 1.043 . . . . 0.0 110.85 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -140.79 169.29 17.92 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.212 1.405 . . . . 0.0 112.536 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.61 -43.07 25.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.581 1.952 . . . . 0.0 113.764 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.5 -27.25 41.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.632 0.773 . . . . 0.0 112.317 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -77.23 -35.94 55.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.834 0.854 . . . . 0.0 111.466 171.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.02 -37.0 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.425 -0.797 . . . . 0.0 109.562 171.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 61.4 m -64.0 -51.78 62.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.506 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.21 -31.28 70.01 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.252 0.933 . . . . 0.0 112.979 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 73.4 m -68.68 -14.59 63.11 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.85 -2.09 3.31 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.586 1.085 . . . . 0.0 113.797 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -60.73 -22.63 64.2 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.745 1.218 . . . . 0.0 112.868 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -56.93 -12.29 1.91 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.603 1.961 . . . . 0.0 114.976 170.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.05 -6.75 18.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.404 1.482 . . . . 0.0 113.924 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.56 179.81 15.87 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.258 1.885 . . . . 0.0 112.491 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.9 145.3 90.13 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.473 2.782 . . . . 0.0 112.54 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.75 170.76 20.83 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.262 1.425 . . . . 0.0 112.423 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -135.03 158.85 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.583 1.553 . . . . 0.0 109.148 167.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 72.6 t -125.05 136.56 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.706 1.202 . . . . 0.0 110.542 -170.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 126.182 1.793 . . . . 0.0 111.698 -173.471 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.275 0 CA-C-O 119.66 -0.522 . . . . 0.0 114.283 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -150.08 162.82 39.66 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.889 1.276 . . . . 0.0 113.05 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -149.24 161.91 41.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.058 1.343 . . . . 0.0 111.759 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -109.03 118.34 36.53 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.224 1.81 . . . . 0.0 109.211 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 38.5 mt -82.19 136.93 35.04 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.72 1.208 . . . . 0.0 108.579 169.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 63.7 mt -117.03 102.76 9.61 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.755 1.622 . . . . 0.0 107.74 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -81.79 156.05 25.12 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.206 0.526 . . . . 0.0 111.736 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -76.41 -26.26 55.35 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.753 0.821 . . . . 0.0 112.848 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -142.21 146.31 35.08 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.254 1.422 . . . . 0.0 110.99 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.85 -28.89 70.34 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.528 0.731 . . . . 0.0 111.995 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 25.1 p -60.53 -25.98 66.54 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.025 -1.047 . . . . 0.0 112.984 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.9 m -73.14 -30.9 63.93 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.852 -1.155 . . . . 0.0 111.942 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.47 -39.53 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 121.765 -0.584 . . . . 0.0 109.713 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -66.77 -38.13 85.98 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.61 -0.681 . . . . 0.0 112.16 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.7 87.54 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.703 0.683 . . . . 0.0 112.368 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.63 -49.19 74.24 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.289 0.636 . . . . 0.0 110.8 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 78.6 mt -55.76 -42.2 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.951 0.9 . . . . 0.0 111.335 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.53 -17.94 63.62 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.775 1.23 . . . . 0.0 113.625 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.97 -12.9 19.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.06 1.344 . . . . 0.0 113.419 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 35.6 m -75.13 147.29 40.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 122.114 0.959 . . . . 0.0 113.547 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.31 177.88 8.31 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.523 1.529 . . . . 0.0 107.73 164.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 CA--C 1.538 0.487 0 O-C-N 121.63 -0.669 . . . . 0.0 111.382 -177.316 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 120.774 0.321 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -140.72 148.22 40.4 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.984 0.914 . . . . 0.0 113.167 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.9 tp -134.87 173.13 12.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.786 1.634 . . . . 0.0 109.478 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 26.7 p -116.17 140.45 49.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.049 1.34 . . . . 0.0 112.58 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.38 178.48 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 126.761 2.024 . . . . 0.0 110.532 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 85.0 p -160.76 171.2 19.25 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 57.6 p -148.42 -179.34 0.94 Allowed Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 126.939 2.096 . . . . 0.0 110.957 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.67 -12.2 34.07 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.296 2.664 . . . . 0.0 114.124 170.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 37.2 p -109.86 -33.19 6.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.95 1.3 . . . . 0.0 113.255 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 6.7 mm -132.82 131.13 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.475 1.11 . . . . 0.0 110.948 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -111.73 141.2 45.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.227 1.411 . . . . 0.0 111.193 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 59.26 36.04 23.56 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.135 1.374 . . . . 0.0 112.906 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -67.41 127.7 93.5 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 120.943 -1.098 . . . . 0.0 110.899 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.35 140.91 12.39 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.34 2.693 . . . . 0.0 109.354 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.46 138.13 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.076 1.35 . . . . 0.0 110.697 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -85.13 120.59 26.8 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.171 1.788 . . . . 0.0 109.683 -172.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.27 129.49 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.998 1.319 . . . . 0.0 109.495 -171.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -135.6 94.03 15.53 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.282 1.433 . . . . 0.0 110.121 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.1 127.23 24.89 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.639 2.893 . . . . 0.0 109.522 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -168.117 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -81.54 140.0 34.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.76 0.824 . . . . 0.0 111.263 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.7 t -139.16 118.82 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.548 1.139 . . . . 0.0 109.758 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -73.78 140.05 45.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.314 0.646 . . . . 0.0 110.168 170.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.2 123.18 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.015 1.326 . . . . 0.0 109.175 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -117.67 146.17 18.64 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.724 1.154 . . . . 0.0 113.079 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 96.03 13.97 47.48 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.041 1.305 . . . . 0.0 114.241 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.4 mt -58.73 139.31 86.31 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.99 1.316 . . . . 0.0 110.632 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -55.1 152.42 30.44 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.433 2.755 . . . . 0.0 113.206 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.67 5.33 4.89 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.709 2.939 . . . . 0.0 114.189 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -133.78 18.07 3.87 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.765 1.626 . . . . 0.0 112.427 -174.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.7 tt -100.14 130.54 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 121.118 -0.988 . . . . 0.0 111.596 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -98.86 169.49 9.42 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 0.0 113.452 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -51.78 -41.55 61.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.096 1.359 . . . . 0.0 113.624 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.68 -25.3 44.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.677 0.791 . . . . 0.0 112.352 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -79.58 -36.23 38.47 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.6 0.76 . . . . 0.0 111.984 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 40.3 mt -65.53 -36.44 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.349 0.977 . . . . 0.0 109.418 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 89.3 m -63.53 -51.85 63.67 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.538 0.735 . . . . 0.0 110.636 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.39 -30.58 69.68 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.585 1.084 . . . . 0.0 112.944 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 69.9 m -67.51 -14.25 62.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -133.02 -2.01 3.25 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -60.37 -22.52 63.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.075 1.35 . . . . 0.0 112.899 173.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -57.2 -10.55 1.29 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.706 2.003 . . . . 0.0 115.133 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -108.67 -3.69 17.68 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.508 1.523 . . . . 0.0 114.127 175.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.76 178.55 15.78 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.164 1.84 . . . . 0.0 112.741 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -63.46 145.51 92.31 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.582 2.855 . . . . 0.0 112.996 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.41 170.41 21.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.634 1.574 . . . . 0.0 112.324 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.4 160.7 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.842 1.657 . . . . 0.0 108.635 166.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 93.5 t -135.7 138.52 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.158 0.983 . . . . 0.0 110.658 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 CA--C 1.544 0.743 0 C-N-CA 124.797 1.239 . . . . 0.0 112.232 179.845 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.129 0 CA-C-O 119.293 -0.726 . . . . 0.0 114.485 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -149.53 154.98 39.59 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.83 1.315 . . . . 0.0 113.512 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.32 170.5 21.73 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.835 1.254 . . . . 0.0 112.174 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -113.42 123.78 50.88 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.891 1.676 . . . . 0.0 110.67 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 22.5 mt -87.04 142.57 27.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.542 1.537 . . . . 0.0 108.74 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 65.7 mt -127.95 102.57 6.82 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.052 1.741 . . . . 0.0 108.175 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -85.1 154.99 21.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.361 0.664 . . . . 0.0 112.031 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -70.88 -27.58 63.92 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.655 0.782 . . . . 0.0 112.732 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -142.92 147.31 35.06 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.411 1.485 . . . . 0.0 110.635 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -63.58 -29.08 70.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.202 0.601 . . . . 0.0 111.952 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 23.0 p -60.24 -25.8 65.94 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.931 -1.105 . . . . 0.0 113.093 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 25.3 m -71.84 -30.8 65.84 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.815 -1.178 . . . . 0.0 111.996 171.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 49.8 t -74.84 -37.43 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.617 -0.677 . . . . 0.0 109.988 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -68.36 -35.31 77.54 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.576 -0.702 . . . . 0.0 111.742 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.17 86.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.074 0.852 . . . . 0.0 112.493 171.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.3 tp -63.4 -48.33 78.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.189 0.596 . . . . 0.0 110.741 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.81 -42.09 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.008 0.923 . . . . 0.0 111.267 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.28 -18.46 64.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.701 1.2 . . . . 0.0 113.887 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.11 -13.12 19.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.99 1.316 . . . . 0.0 113.362 175.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.4 m -72.23 143.07 48.94 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.902 0.858 . . . . 0.0 113.186 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.1 mt -78.87 170.04 17.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.061 1.344 . . . . 0.0 107.956 165.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 N--CA 1.468 0.45 0 C-N-CA 123.579 0.752 . . . . 0.0 111.3 -176.065 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 111.616 0.228 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -142.83 149.59 38.8 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.0 tp -135.0 -177.47 4.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.651 1.98 . . . . 0.0 108.734 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 97.3 m -131.49 145.6 51.84 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.599 1.09 . . . . 0.0 112.777 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 31.7 m -149.23 172.79 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 126.899 2.079 . . . . 0.0 111.598 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 58.6 m -149.38 161.58 41.8 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.833 1.253 . . . . 0.0 112.682 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 19.7 p -139.3 -172.37 0.31 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.611 1.964 . . . . 0.0 111.249 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.94 -13.79 37.39 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.112 2.541 . . . . 0.0 113.478 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 40.9 p -126.82 -25.43 3.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.046 1.339 . . . . 0.0 113.859 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 16.9 mm -127.08 134.47 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.512 1.525 . . . . 0.0 109.591 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -123.83 132.97 53.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.544 1.138 . . . . 0.0 111.26 -172.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.0 t70 62.27 30.89 17.63 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.236 1.414 . . . . 0.0 112.507 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -61.83 125.36 84.76 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.787 1.235 . . . . 0.0 110.871 176.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.75 143.98 24.27 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.206 2.604 . . . . 0.0 109.551 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.36 134.83 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.363 1.465 . . . . 0.0 110.417 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -78.37 131.6 37.04 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.652 0.781 . . . . 0.0 109.436 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.46 128.01 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.133 1.373 . . . . 0.0 108.618 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -135.97 84.99 29.86 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.654 1.182 . . . . 0.0 110.071 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.17 133.89 55.87 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.598 2.865 . . . . 0.0 110.984 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -172.509 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 70.8 mtm-85 . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -72.53 135.8 45.72 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.464 0.706 . . . . 0.0 110.506 169.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.41 117.75 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.384 1.074 . . . . 0.0 109.8 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -69.44 138.93 53.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.538 1.135 . . . . 0.0 110.885 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.62 115.38 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.428 1.491 . . . . 0.0 109.04 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.56 143.49 18.07 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 125.061 1.315 . . . . 0.0 113.8 -175.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.42 23.12 22.62 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.77 1.176 . . . . 0.0 114.196 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.77 141.91 88.67 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.957 1.303 . . . . 0.0 110.98 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.39 154.28 19.79 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.382 2.722 . . . . 0.0 113.106 172.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.49 3.76 6.09 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.733 2.955 . . . . 0.0 114.096 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -140.82 25.86 2.11 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.727 1.211 . . . . 0.0 112.599 -175.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.1 tt -99.27 137.3 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.311 1.045 . . . . 0.0 110.747 174.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -112.02 169.25 8.98 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.383 1.073 . . . . 0.0 113.437 -174.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -43.11 -46.54 5.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.146 1.779 . . . . 0.0 114.251 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -77.5 -26.47 51.26 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.647 -0.658 . . . . 0.0 112.414 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -79.38 -38.34 35.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.856 0.862 . . . . 0.0 111.533 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 46.2 mt -63.73 -35.84 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.794 0.724 . . . . 0.0 109.68 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 50.5 m -68.34 -53.32 24.92 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.644 0.778 . . . . 0.0 110.863 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.73 -29.69 70.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.515 1.052 . . . . 0.0 113.146 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.7 m -64.8 -25.39 67.89 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -120.49 -5.07 9.82 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.0 tpt85 -60.13 -22.49 62.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.05 1.34 . . . . 0.0 113.195 174.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -53.69 -21.41 6.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.732 2.013 . . . . 0.0 114.81 170.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -97.41 -7.56 31.44 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.311 1.444 . . . . 0.0 113.631 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 125.38 171.61 13.28 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.108 1.813 . . . . 0.0 112.102 -170.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.82 149.88 73.17 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.673 2.915 . . . . 0.0 112.292 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.08 171.69 18.84 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.622 1.569 . . . . 0.0 112.403 -171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.0 159.78 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.671 1.588 . . . . 0.0 109.223 167.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.84 135.88 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.224 1.009 . . . . 0.0 110.884 -170.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 126.169 1.788 . . . . 0.0 111.53 -175.647 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.326 0 CA-C-O 119.9 -0.389 . . . . 0.0 113.826 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -154.52 159.4 40.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.248 1.419 . . . . 0.0 112.167 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.08 170.93 18.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.769 1.227 . . . . 0.0 111.792 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -119.48 117.37 28.24 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.312 1.845 . . . . 0.0 109.705 177.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.85 142.01 34.08 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.162 1.385 . . . . 0.0 108.757 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 64.4 mt -124.07 106.17 10.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.672 1.589 . . . . 0.0 107.928 171.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.99 156.1 22.46 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.37 0.668 . . . . 0.0 111.946 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -78.61 -24.65 45.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -143.16 141.95 31.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.308 1.443 . . . . 0.0 110.675 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.47 -33.0 69.28 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.032 0.933 . . . . 0.0 111.935 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -55.52 -28.24 53.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.771 1.228 . . . . 0.0 113.111 174.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.5 m -73.37 -28.85 62.26 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.941 -1.099 . . . . 0.0 112.283 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.88 -39.55 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.685 -0.634 . . . . 0.0 109.624 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -66.18 -38.39 87.91 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.708 -0.62 . . . . 0.0 111.951 173.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.39 86.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.379 0.671 . . . . 0.0 112.409 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.25 -48.1 74.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.206 0.602 . . . . 0.0 111.049 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 78.4 mt -55.54 -41.95 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.93 0.892 . . . . 0.0 111.221 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.28 -17.15 63.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.814 1.246 . . . . 0.0 113.72 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.0 -13.65 18.99 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.167 1.387 . . . . 0.0 113.404 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 57.8 m -76.3 149.06 37.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 93.2 mt -85.94 177.46 7.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.666 1.586 . . . . 0.0 107.934 165.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 123.518 0.727 . . . . 0.0 111.337 -178.325 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 120.307 0.099 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.55 144.43 32.91 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 3.7 tp -129.68 -167.05 1.74 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.673 1.989 . . . . 0.0 108.375 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.7 p -144.3 152.31 40.59 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.912 -1.118 . . . . 0.0 113.38 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.37 169.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.85 2.06 . . . . 0.0 110.761 -171.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 71.1 m -148.12 163.86 35.66 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.453 1.101 . . . . 0.0 113.018 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 52.4 p -145.32 -178.33 0.77 Allowed Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 126.905 2.082 . . . . 0.0 110.886 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.28 -10.96 30.43 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.298 2.665 . . . . 0.0 113.98 170.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 42.4 p -113.28 -31.33 6.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.016 1.326 . . . . 0.0 113.329 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.9 mm -133.62 134.23 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.159 1.384 . . . . 0.0 110.412 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -115.95 135.47 53.94 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.866 1.266 . . . . 0.0 111.119 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 61.84 32.95 17.91 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.468 1.507 . . . . 0.0 112.761 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -62.97 124.36 83.38 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.935 -1.103 . . . . 0.0 110.225 174.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.48 145.88 27.0 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.983 2.455 . . . . 0.0 109.149 170.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.38 133.22 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.711 1.205 . . . . 0.0 110.719 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -76.41 130.59 38.25 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.497 1.119 . . . . 0.0 109.72 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.21 133.35 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.303 1.441 . . . . 0.0 108.54 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 51.8 mtp85 -138.65 98.19 8.92 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 124.306 1.042 . . . . 0.0 110.483 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.79 131.28 43.02 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.358 2.705 . . . . 0.0 110.01 169.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -169.472 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 82.9 mtm-85 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -79.61 136.78 36.93 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.884 1.274 . . . . 0.0 110.674 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.6 t -141.42 121.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.497 1.119 . . . . 0.0 110.104 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -74.54 142.17 44.77 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.72 0.808 . . . . 0.0 111.158 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.88 124.12 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.402 1.481 . . . . 0.0 109.251 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -122.49 149.64 16.95 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.011 1.291 . . . . 0.0 113.615 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 92.48 17.41 45.84 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.864 1.221 . . . . 0.0 114.366 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.92 141.74 89.39 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.295 1.438 . . . . 0.0 111.381 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.31 154.98 17.21 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.906 3.07 . . . . 0.0 113.818 175.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.43 2.6 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.984 3.122 . . . . 0.0 114.105 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -140.29 23.17 2.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.964 1.306 . . . . 0.0 112.413 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.1 tt -95.32 160.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.681 1.193 . . . . 0.0 109.744 169.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -142.33 171.15 14.45 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.294 1.037 . . . . 0.0 113.107 -173.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -41.67 -47.16 3.91 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.082 1.753 . . . . 0.0 114.241 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.4 -26.97 46.62 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.486 -0.759 . . . . 0.0 112.635 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -80.56 -35.23 34.65 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.016 0.927 . . . . 0.0 111.669 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 65.3 mt -64.7 -36.52 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.614 -0.679 . . . . 0.0 109.465 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 53.7 m -65.4 -53.5 42.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.559 171.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.26 -31.34 70.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.27 0.941 . . . . 0.0 113.275 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.1 m -67.68 -23.6 65.32 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -122.49 -4.3 8.81 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -59.5 -23.04 62.46 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.027 1.331 . . . . 0.0 112.909 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -53.54 -20.55 5.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.678 1.991 . . . . 0.0 114.921 170.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -99.51 -5.66 28.87 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.381 1.472 . . . . 0.0 113.718 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.89 177.47 15.2 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 126.294 1.902 . . . . 0.0 112.406 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.99 147.66 91.77 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.393 2.729 . . . . 0.0 112.65 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.5 169.82 23.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.359 1.464 . . . . 0.0 112.551 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.5 156.93 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.624 1.569 . . . . 0.0 109.158 167.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 94.3 t -119.67 136.38 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.904 1.282 . . . . 0.0 110.068 -173.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 126.288 1.835 . . . . 0.0 111.455 -171.227 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 CA-C-O 118.917 -0.935 . . . . 0.0 114.181 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -144.91 158.71 43.71 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.423 1.611 . . . . 0.0 114.741 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.99 170.04 23.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.607 1.563 . . . . 0.0 112.019 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -117.24 129.56 56.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.146 1.778 . . . . 0.0 110.243 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 35.8 mt -92.79 140.92 29.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.733 1.613 . . . . 0.0 108.699 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.8 mt -124.96 107.34 10.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.784 1.634 . . . . 0.0 108.077 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -88.21 161.55 17.16 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.822 0.849 . . . . 0.0 112.736 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -76.16 -27.2 56.88 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.294 1.038 . . . . 0.0 113.028 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.36 145.98 36.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.314 1.445 . . . . 0.0 110.515 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.98 -29.73 68.64 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.627 -0.67 . . . . 0.0 111.351 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.7 m -55.24 -28.15 51.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.358 1.063 . . . . 0.0 113.099 171.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 16.9 m -74.54 -28.59 61.03 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.928 -1.108 . . . . 0.0 112.046 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.59 -37.29 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.301 0.641 . . . . 0.0 109.83 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -63.33 -41.1 98.88 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.762 0.71 . . . . 0.0 111.552 170.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.21 84.61 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.655 0.661 . . . . 0.0 112.361 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.82 -48.22 75.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.413 0.685 . . . . 0.0 111.149 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 68.7 mt -55.56 -42.25 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.429 1.092 . . . . 0.0 111.16 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.2 -17.51 63.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.892 1.277 . . . . 0.0 113.589 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.11 -13.96 18.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.126 1.37 . . . . 0.0 113.317 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 59.0 m -74.75 146.8 41.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.944 0.878 . . . . 0.0 113.266 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.36 173.32 11.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.288 1.435 . . . . 0.0 108.001 165.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 N--CA 1.47 0.548 0 C-N-CA 123.646 0.778 . . . . 0.0 111.435 -175.236 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.36 0.124 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -143.19 149.1 37.52 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.1 tp -132.03 -179.67 5.55 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.614 1.966 . . . . 0.0 108.729 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 71.8 m -130.61 140.42 50.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.269 1.028 . . . . 0.0 112.04 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.9 m -148.43 171.39 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 126.159 1.783 . . . . 0.0 111.623 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 68.7 m -147.29 163.36 36.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.783 1.233 . . . . 0.0 112.516 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 28.4 p -140.19 -175.73 0.5 Allowed Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.84 2.056 . . . . 0.0 110.631 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -66.9 -13.07 38.54 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.0 2.467 . . . . 0.0 113.894 171.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 44.0 p -120.91 -28.18 4.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.906 1.282 . . . . 0.0 113.836 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 16.3 mm -126.5 135.28 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.206 1.402 . . . . 0.0 110.117 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -121.41 131.0 53.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.689 1.196 . . . . 0.0 111.158 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 24.5 t70 62.67 32.32 16.29 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.305 1.442 . . . . 0.0 112.666 176.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -60.55 128.33 88.1 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.348 1.059 . . . . 0.0 110.528 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.21 139.5 14.93 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.207 2.604 . . . . 0.0 109.095 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 5.2 m -131.38 132.17 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.271 1.428 . . . . 0.0 109.769 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.71 133.77 35.39 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.291 1.036 . . . . 0.0 109.815 -174.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.98 134.9 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.292 1.437 . . . . 0.0 108.901 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -141.11 95.5 7.48 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.53 1.132 . . . . 0.0 110.641 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.14 130.23 35.31 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.664 2.909 . . . . 0.0 111.241 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 123.74 0.816 . . . . 0.0 112.042 -175.606 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 46.7 mtm105 . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -79.92 136.99 36.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.146 0.978 . . . . 0.0 111.42 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.15 118.82 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.691 1.197 . . . . 0.0 109.709 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -75.23 142.31 43.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.394 0.678 . . . . 0.0 110.59 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.36 121.92 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.521 1.529 . . . . 0.0 109.189 176.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.78 148.23 18.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.796 1.189 . . . . 0.0 113.065 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 93.17 14.99 53.36 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.67 1.128 . . . . 0.0 114.268 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 92.9 mt -57.83 139.26 82.49 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.687 1.195 . . . . 0.0 110.375 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.32 150.56 19.8 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.602 2.868 . . . . 0.0 113.161 173.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.95 3.0 6.47 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.943 3.095 . . . . 0.0 113.579 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -137.57 16.07 2.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.728 2.011 . . . . 0.0 112.596 -169.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.4 tt -96.05 133.91 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.658 1.183 . . . . 0.0 111.781 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -94.8 162.16 13.87 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.472 1.109 . . . . 0.0 113.399 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -47.64 -44.49 26.96 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.107 1.763 . . . . 0.0 113.751 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.11 -27.91 57.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.825 0.85 . . . . 0.0 112.389 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -77.27 -34.47 55.68 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.528 0.731 . . . . 0.0 112.651 169.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.4 mt -64.99 -36.64 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.93 1.241 . . . . 0.0 109.609 169.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 54.0 m -64.99 -52.38 56.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.646 0.779 . . . . 0.0 110.54 172.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.49 -30.37 70.57 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.582 1.083 . . . . 0.0 112.924 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 75.6 m -65.61 -15.83 63.12 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -130.76 -3.24 4.14 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -61.03 -22.21 64.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.083 1.353 . . . . 0.0 113.009 173.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -57.58 -11.9 2.39 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.645 1.978 . . . . 0.0 114.931 169.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -105.92 -5.86 19.33 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.466 1.506 . . . . 0.0 114.047 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 123.91 173.98 14.04 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 126.073 1.797 . . . . 0.0 112.53 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.27 149.98 88.68 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.795 2.997 . . . . 0.0 113.016 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.75 171.98 16.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.255 1.422 . . . . 0.0 112.806 -176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.72 158.46 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.918 1.687 . . . . 0.0 109.298 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.37 135.63 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.578 1.151 . . . . 0.0 110.719 -170.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 125.893 1.677 . . . . 0.0 111.662 -175.277 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.186 0 N-CA-C 114.464 0.546 . . . . 0.0 114.464 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -152.22 157.53 41.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.463 1.131 . . . . 0.0 112.652 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.34 168.77 25.98 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.718 1.207 . . . . 0.0 112.257 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -113.37 121.14 43.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.307 1.843 . . . . 0.0 109.727 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.3 mt -86.02 140.73 30.03 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.422 1.489 . . . . 0.0 108.76 169.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.53 107.65 12.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.788 1.635 . . . . 0.0 107.734 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.97 154.17 22.32 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.417 0.687 . . . . 0.0 111.936 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -71.65 -26.29 62.48 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.76 0.824 . . . . 0.0 112.822 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -142.25 146.05 34.71 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.389 1.475 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.53 -31.44 71.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.308 0.643 . . . . 0.0 111.659 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -56.24 -28.41 58.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.75 1.22 . . . . 0.0 112.876 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.0 m -73.19 -29.13 62.61 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.964 -1.085 . . . . 0.0 112.147 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.04 -38.51 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.646 -0.659 . . . . 0.0 109.784 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -66.78 -38.35 86.39 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.547 -0.721 . . . . 0.0 111.897 172.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.84 88.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.579 0.627 . . . . 0.0 112.372 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.76 -49.13 74.18 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.306 0.642 . . . . 0.0 110.929 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.62 -42.18 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.1 0.96 . . . . 0.0 111.428 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.07 -17.84 63.92 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.76 1.224 . . . . 0.0 113.581 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.1 -13.59 18.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.165 1.386 . . . . 0.0 113.351 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 54.7 m -75.49 148.14 39.24 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.6 172.93 11.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.045 165.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.471 0.585 0 C-N-CA 123.487 0.715 . . . . 0.0 112.15 -175.08 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 110.83 -0.063 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -143.03 148.43 36.72 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.6 tp -135.75 177.93 7.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.474 1.91 . . . . 0.0 108.904 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 86.7 m -126.51 144.66 50.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.242 1.017 . . . . 0.0 112.761 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.0 m -149.85 170.06 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 126.855 2.062 . . . . 0.0 111.038 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 70.6 m -148.69 163.47 37.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.761 1.224 . . . . 0.0 112.406 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 25.7 p -140.89 -173.44 0.36 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 126.745 2.018 . . . . 0.0 111.278 -174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.79 -36.09 97.6 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.955 2.437 . . . . 0.0 113.863 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 44.8 p -119.29 -16.15 9.05 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 23.6 mm -113.69 128.79 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.693 1.133 . . . . 0.0 109.945 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -124.79 135.33 52.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.484 1.114 . . . . 0.0 111.69 -168.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 61.26 30.94 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.421 1.488 . . . . 0.0 112.631 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -66.85 128.32 93.82 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.52 1.128 . . . . 0.0 111.213 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.07 141.73 13.24 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.342 2.695 . . . . 0.0 109.119 169.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.18 135.08 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.396 1.479 . . . . 0.0 110.015 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -81.08 129.57 34.62 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.362 1.065 . . . . 0.0 109.561 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 35.7 mm -110.81 136.8 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.337 1.455 . . . . 0.0 109.08 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -142.14 87.01 9.89 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.904 1.282 . . . . 0.0 110.051 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.61 128.12 27.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.327 2.684 . . . . 0.0 109.763 172.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -169.417 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 86.3 mtm-85 . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -86.5 138.25 31.88 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.131 0.973 . . . . 0.0 111.132 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.0 t -140.6 120.63 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.293 1.037 . . . . 0.0 110.208 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -71.63 139.93 49.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.851 0.86 . . . . 0.0 110.644 171.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.4 t -132.6 119.35 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.32 1.448 . . . . 0.0 109.408 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.66 146.51 18.45 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.069 1.319 . . . . 0.0 113.435 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.13 17.87 30.75 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.883 1.23 . . . . 0.0 114.275 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.77 141.54 92.68 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.994 1.318 . . . . 0.0 111.441 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.11 156.77 15.22 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.877 3.052 . . . . 0.0 113.972 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.05 3.95 6.59 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.061 3.174 . . . . 0.0 113.815 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -137.45 23.22 2.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.377 1.471 . . . . 0.0 112.323 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.8 tt -104.81 142.66 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.556 1.142 . . . . 0.0 110.897 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -116.2 169.0 9.61 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.929 1.292 . . . . 0.0 113.068 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -48.64 -41.28 30.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.725 1.61 . . . . 0.0 113.921 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.13 -29.44 34.8 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.891 0.877 . . . . 0.0 112.388 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.93 -38.19 69.9 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.328 0.651 . . . . 0.0 111.822 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.1 mt -65.85 -38.71 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.301 -0.875 . . . . 0.0 109.449 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 85.2 m -60.93 -51.51 68.95 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.334 0.653 . . . . 0.0 110.539 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.93 -30.59 71.01 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.419 1.009 . . . . 0.0 112.914 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 65.9 m -68.93 -13.95 62.75 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -129.43 -2.89 4.91 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -60.96 -21.74 63.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.966 1.307 . . . . 0.0 113.228 174.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -56.74 -13.13 2.27 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.736 2.014 . . . . 0.0 114.976 169.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -104.47 -4.89 22.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.514 1.526 . . . . 0.0 113.999 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.07 175.1 15.08 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.983 1.754 . . . . 0.0 112.604 -174.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.26 145.54 98.38 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 123.923 3.082 . . . . 0.0 113.421 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.25 172.53 17.2 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.403 1.481 . . . . 0.0 112.698 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.58 159.85 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.835 1.654 . . . . 0.0 108.553 166.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 82.8 t -132.56 135.97 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.249 1.02 . . . . 0.0 110.421 -172.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 124.806 1.242 . . . . 0.0 112.437 -177.058 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.228 0 N-CA-C 114.724 0.649 . . . . 0.0 114.724 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -148.16 157.17 43.35 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.557 1.178 . . . . 0.0 112.973 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.91 167.54 27.25 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.051 1.341 . . . . 0.0 111.831 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -115.12 121.19 42.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.856 1.662 . . . . 0.0 109.845 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 21.0 mt -82.24 140.32 33.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.176 1.39 . . . . 0.0 108.731 169.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.9 mt -125.22 101.18 6.87 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.013 1.725 . . . . 0.0 108.11 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.34 159.13 27.3 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.165 0.586 . . . . 0.0 111.497 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -88.49 -13.51 40.09 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.68 142.23 34.92 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.695 1.598 . . . . 0.0 110.367 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.14 -29.78 71.07 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.556 -0.715 . . . . 0.0 112.04 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 26.7 p -59.58 -24.8 64.06 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.939 -1.1 . . . . 0.0 112.999 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.7 m -71.18 -28.79 64.48 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.888 -1.133 . . . . 0.0 112.314 172.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 70.4 t -73.88 -36.98 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.524 -0.735 . . . . 0.0 109.797 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -71.64 -35.74 70.49 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.736 -0.602 . . . . 0.0 112.137 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.37 85.87 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.673 0.67 . . . . 0.0 112.255 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.87 -49.17 73.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.543 0.737 . . . . 0.0 110.951 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.99 -41.64 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.094 0.958 . . . . 0.0 111.619 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.11 -18.48 63.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.844 1.258 . . . . 0.0 113.67 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.57 -13.5 20.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.049 1.339 . . . . 0.0 113.289 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 40.9 m -75.92 147.19 39.15 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.73 176.46 8.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.722 1.609 . . . . 0.0 107.798 165.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 CA--C 1.537 0.456 0 O-C-N 121.649 -0.657 . . . . 0.0 111.382 -179.381 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.94 0.4 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -143.65 148.84 36.38 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.513 1.125 . . . . 0.0 113.002 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.8 tp -140.39 157.91 44.82 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.365 1.466 . . . . 0.0 110.134 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 76.6 m -95.96 136.91 35.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.15 0.98 . . . . 0.0 112.424 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 31.5 m -146.11 177.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 126.846 2.058 . . . . 0.0 110.44 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 82.0 p -162.76 168.52 21.36 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.054 -1.029 . . . . 0.0 113.481 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 51.9 p -138.75 -175.54 0.49 Allowed Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.454 1.902 . . . . 0.0 110.617 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.55 -12.42 35.72 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.172 2.581 . . . . 0.0 114.154 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 46.9 p -119.11 -29.39 5.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.964 1.306 . . . . 0.0 113.689 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 27.2 mm -128.77 127.07 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.285 1.434 . . . . 0.0 109.592 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -117.26 141.79 47.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.661 1.184 . . . . 0.0 111.774 -169.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 57.69 31.92 21.12 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.123 1.369 . . . . 0.0 113.096 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -70.51 128.17 91.37 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.314 1.045 . . . . 0.0 111.712 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.62 128.38 4.62 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.309 2.673 . . . . 0.0 108.578 169.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.51 137.91 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.187 1.395 . . . . 0.0 110.47 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -76.71 125.95 30.13 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.104 1.362 . . . . 0.0 109.568 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.3 mm -110.96 128.78 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.54 1.536 . . . . 0.0 108.548 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -136.36 91.5 16.43 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.633 1.173 . . . . 0.0 109.85 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.9 132.48 51.95 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.765 2.977 . . . . 0.0 110.312 172.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -168.923 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 66.4 mtm-85 . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.48 136.0 49.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.566 1.147 . . . . 0.0 111.026 172.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 61.3 t -140.86 120.69 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.579 1.151 . . . . 0.0 110.111 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -68.64 141.25 55.44 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.221 1.008 . . . . 0.0 111.258 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.74 125.8 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.992 1.317 . . . . 0.0 109.161 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -127.28 148.6 17.51 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 125.218 1.39 . . . . 0.0 113.461 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 90.52 15.68 56.47 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.714 1.149 . . . . 0.0 114.009 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.68 142.5 62.25 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.485 1.514 . . . . 0.0 111.408 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.47 151.48 23.71 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.774 2.983 . . . . 0.0 113.145 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.96 0.62 8.66 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.776 2.984 . . . . 0.0 114.795 -169.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -140.71 16.92 2.34 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.38 1.072 . . . . 0.0 113.0 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.9 tt -79.75 131.61 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.632 0.773 . . . . 0.0 111.506 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -92.65 167.89 11.6 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.96 -39.99 69.53 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.491 1.117 . . . . 0.0 113.195 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.93 -30.24 58.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.969 0.907 . . . . 0.0 112.087 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.09 -42.54 80.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.948 0.899 . . . . 0.0 111.517 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 63.3 mt -63.15 -40.7 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.162 0.892 . . . . 0.0 109.795 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 56.9 m -62.21 -51.56 67.31 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.655 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.65 -31.08 71.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.275 0.943 . . . . 0.0 112.567 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.3 m -68.97 -13.14 62.27 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -129.02 -3.62 5.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.618 1.099 . . . . 0.0 113.572 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -61.02 -22.77 64.86 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.867 1.267 . . . . 0.0 113.165 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -57.11 -13.39 2.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.624 1.97 . . . . 0.0 114.951 170.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -103.34 -7.34 21.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.427 1.491 . . . . 0.0 113.901 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.07 172.14 13.61 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.1 1.81 . . . . 0.0 112.075 -170.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.1 150.8 60.69 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.501 2.801 . . . . 0.0 112.237 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.16 174.96 12.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.604 1.562 . . . . 0.0 112.603 -169.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.78 157.23 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.852 1.661 . . . . 0.0 109.144 167.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 59.3 t -124.04 134.02 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.856 1.262 . . . . 0.0 109.79 -174.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.2 t70 . . . . . 0 CA--C 1.545 0.775 0 C-N-CA 125.851 1.66 . . . . 0.0 111.817 -170.819 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 CA-C-O 118.752 -1.027 . . . . 0.0 114.481 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -137.51 156.74 47.79 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.591 1.696 . . . . 0.0 114.175 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -154.44 168.57 26.22 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.665 1.586 . . . . 0.0 111.647 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -120.22 120.71 36.92 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.947 1.699 . . . . 0.0 109.987 172.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.7 mt -83.27 141.12 32.08 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.909 1.284 . . . . 0.0 108.571 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 43.6 mt -123.5 105.49 9.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.395 1.478 . . . . 0.0 107.54 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.92 157.75 26.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.011 0.524 . . . . 0.0 111.274 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -90.48 -12.78 36.27 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -142.21 137.2 30.59 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.562 1.545 . . . . 0.0 110.098 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.48 -34.11 70.53 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.797 0.839 . . . . 0.0 111.964 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.6 m -55.97 -26.42 48.17 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.742 1.217 . . . . 0.0 113.197 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.4 m -71.84 -27.83 63.15 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.947 -1.096 . . . . 0.0 112.384 174.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 57.0 t -73.87 -39.9 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.657 -0.652 . . . . 0.0 109.513 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -67.94 -37.75 82.0 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.694 -0.629 . . . . 0.0 111.941 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.28 -38.36 89.05 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.554 0.616 . . . . 0.0 112.342 173.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.2 tp -63.85 -48.83 75.2 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.288 0.635 . . . . 0.0 110.888 171.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 76.4 mt -56.0 -42.68 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.958 0.903 . . . . 0.0 111.42 176.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.21 -19.02 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.729 1.212 . . . . 0.0 113.514 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.33 -14.07 20.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.052 1.341 . . . . 0.0 113.5 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 42.3 m -75.46 147.94 39.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.079 0.942 . . . . 0.0 113.41 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.54 172.85 11.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.505 1.522 . . . . 0.0 107.803 165.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 123.402 0.681 . . . . 0.0 111.501 -176.441 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 CA--C 1.534 0.355 0 CA-C-O 120.619 0.247 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -140.17 146.75 39.17 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.005 0.922 . . . . 0.0 112.707 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.4 tp -129.87 -174.75 3.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.418 1.887 . . . . 0.0 108.561 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 30.0 p -133.94 149.49 51.27 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.058 0.943 . . . . 0.0 113.173 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 26.0 m -148.15 170.23 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 126.279 1.832 . . . . 0.0 111.588 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 50.8 m -145.33 154.23 42.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.536 1.134 . . . . 0.0 112.755 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 24.6 p -144.4 -175.04 0.44 Allowed Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 126.207 1.803 . . . . 0.0 111.502 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.31 -13.99 41.32 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.122 2.548 . . . . 0.0 113.659 171.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 29.3 p -117.51 -32.0 5.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.148 1.379 . . . . 0.0 113.77 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.5 mm -133.64 142.45 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.96 1.304 . . . . 0.0 110.137 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -120.94 133.63 55.28 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.081 1.352 . . . . 0.0 110.577 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.2 t70 63.08 28.34 16.08 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.152 1.381 . . . . 0.0 112.926 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -57.18 126.52 74.05 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-O 117.34 -1.314 . . . . 0.0 110.662 174.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.8 140.56 23.47 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.215 2.61 . . . . 0.0 109.652 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.05 134.78 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.829 1.252 . . . . 0.0 110.657 -174.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -73.14 134.73 44.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.001 1.321 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.8 mm -119.9 131.43 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.65 1.58 . . . . 0.0 108.105 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -139.99 95.36 8.59 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 123.848 0.859 . . . . 0.0 110.862 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.64 139.96 91.41 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.602 2.868 . . . . 0.0 111.889 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 124.185 0.994 . . . . 0.0 112.568 -179.724 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.477 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 53.1 m -147.87 153.87 39.68 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.1 1.36 . . . . 0.0 111.378 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 28.4 p -78.71 -18.25 54.6 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 61.54 -122.37 28.91 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.296 0.95 . . . . 0.0 112.548 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 57.6 p -91.27 -1.5 57.65 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.107 1.363 . . . . 0.0 114.224 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 68.6 m -69.57 138.78 53.48 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.681 -1.262 . . . . 0.0 113.294 -174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 131.0 -117.66 2.24 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.209 1.385 . . . . 0.0 110.775 -172.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 23.2 t -145.68 167.57 22.79 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.146 1.378 . . . . 0.0 111.959 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 86.5 mtm-85 -75.11 -5.86 46.5 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.396 1.078 . . . . 0.0 113.506 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -76.52 137.49 39.63 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.002 0.921 . . . . 0.0 111.174 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.5 t -138.27 116.82 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.475 1.11 . . . . 0.0 109.77 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.2 141.75 49.03 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.536 0.734 . . . . 0.0 110.727 172.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 61.1 t -133.37 124.64 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.239 1.416 . . . . 0.0 109.509 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -119.57 144.88 17.78 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.789 1.185 . . . . 0.0 113.319 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 100.24 9.16 48.68 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.585 1.565 . . . . 0.0 114.502 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.05 141.77 75.66 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.38 1.472 . . . . 0.0 111.328 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -53.93 155.71 14.12 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.851 3.034 . . . . 0.0 114.084 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.45 3.75 7.22 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.956 3.104 . . . . 0.0 113.527 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -137.93 19.94 2.83 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.623 1.569 . . . . 0.0 112.159 -170.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -103.05 136.39 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.317 1.447 . . . . 0.0 110.547 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -109.03 171.79 7.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.177 0.991 . . . . 0.0 113.02 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -44.35 -46.25 9.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.863 1.665 . . . . 0.0 113.602 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -76.35 -26.96 56.24 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.449 0.699 . . . . 0.0 112.591 -173.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -78.7 -38.17 39.77 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.819 0.848 . . . . 0.0 111.425 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 34.6 mt -65.06 -39.89 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 121.601 -0.687 . . . . 0.0 109.415 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 90.2 m -61.29 -52.51 64.41 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.756 0.823 . . . . 0.0 110.345 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.3 69.88 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.453 1.024 . . . . 0.0 113.213 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.1 m -68.46 -23.99 64.66 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -120.42 -4.12 9.9 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.256 1.022 . . . . 0.0 113.435 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -60.39 -22.07 62.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.313 1.445 . . . . 0.0 113.439 176.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -54.87 -19.29 6.25 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.425 1.89 . . . . 0.0 114.888 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -98.85 -4.81 32.24 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.467 1.507 . . . . 0.0 113.688 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.66 170.65 13.63 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.996 1.76 . . . . 0.0 112.015 -170.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.37 150.49 76.01 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.598 2.865 . . . . 0.0 112.144 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.88 172.87 16.2 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.721 1.608 . . . . 0.0 112.275 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.17 159.69 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.523 1.529 . . . . 0.0 108.797 167.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.78 136.17 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.179 0.991 . . . . 0.0 110.421 -172.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.99 158.96 44.33 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.897 1.679 . . . . 0.0 111.667 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 32.0 p90 -158.03 159.72 30.15 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.454 1.101 . . . . 0.0 112.569 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -58.73 147.69 86.72 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 123.684 2.923 . . . . 0.0 113.167 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 66.76 5.71 4.11 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 125.506 1.523 . . . . 0.0 114.716 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -62.69 -33.51 75.23 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.542 -1.349 . . . . 0.0 112.105 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -62.34 -15.89 51.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.21 2.204 . . . . 0.0 115.018 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -128.47 7.44 5.83 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.583 1.553 . . . . 0.0 112.831 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 26.5 t -82.02 147.19 29.3 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.897 -1.127 . . . . 0.0 112.907 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -92.41 0.99 57.49 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.889 1.276 . . . . 0.0 113.171 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 62.2 m -141.4 148.19 39.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.977 1.311 . . . . 0.0 112.2 -173.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.24 14.96 6.85 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -170.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -107.49 153.44 41.31 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.572 1.549 . . . . 0.0 111.406 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.54 131.71 19.24 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.183 2.589 . . . . 0.0 110.958 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -72.9 140.86 32.46 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.345 2.696 . . . . 0.0 110.394 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt 61.3 9.81 2.74 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.408 1.483 . . . . 0.0 114.435 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 81.01 35.44 24.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.079 1.323 . . . . 0.0 114.491 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -148.06 150.2 33.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.402 1.601 . . . . 0.0 114.634 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -154.81 173.32 16.62 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.979 1.312 . . . . 0.0 112.171 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -118.33 122.01 41.81 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.226 1.811 . . . . 0.0 110.302 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.4 mt -83.34 141.5 31.74 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.375 1.47 . . . . 0.0 108.511 168.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 64.4 mt -125.73 103.67 7.95 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.951 1.701 . . . . 0.0 108.191 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -83.47 157.51 22.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.339 0.656 . . . . 0.0 112.126 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -75.28 -25.33 57.89 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.463 0.705 . . . . 0.0 112.658 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -138.14 144.41 40.77 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.175 1.39 . . . . 0.0 111.032 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.32 -32.43 72.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.448 0.699 . . . . 0.0 111.222 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.3 m -57.12 -27.88 62.21 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.705 1.202 . . . . 0.0 112.996 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.4 m -72.33 -28.92 63.36 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.961 -1.087 . . . . 0.0 111.994 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.76 -39.13 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 121.697 -0.627 . . . . 0.0 109.781 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -66.24 -39.02 89.23 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.614 -0.679 . . . . 0.0 111.949 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.86 86.93 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.542 0.61 . . . . 0.0 112.306 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 26.8 tp -64.25 -48.63 75.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.478 0.711 . . . . 0.0 111.042 171.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 76.7 mt -55.67 -41.44 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.022 0.929 . . . . 0.0 111.408 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.18 -17.71 63.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.725 1.21 . . . . 0.0 113.66 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.18 -13.46 18.92 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.071 1.348 . . . . 0.0 113.455 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.7 m -75.6 147.59 39.48 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.876 0.87 . . . . 0.0 113.266 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.43 173.08 12.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.529 1.532 . . . . 0.0 108.215 165.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -145.71 140.89 27.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.217 0.607 . . . . 0.0 112.575 -170.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -155.67 116.62 3.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.529 1.532 . . . . 0.0 110.019 176.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 61.01 15.84 6.5 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.732 1.613 . . . . 0.0 114.632 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 98.23 -6.83 61.81 Favored Glycine 0 N--CA 1.473 1.123 0 C-N-CA 125.782 1.658 . . . . 0.0 114.068 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -78.3 147.25 34.34 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.653 1.181 . . . . 0.0 109.124 168.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.18 151.97 26.64 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.042 0.937 . . . . 0.0 110.013 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -140.93 141.43 34.51 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -125.41 -169.75 2.05 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.183 1.793 . . . . 0.0 108.332 169.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.2 p -141.73 150.2 41.48 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.645 1.111 . . . . 0.0 113.607 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 27.6 m -151.95 177.02 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.567 1.947 . . . . 0.0 111.486 -171.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 79.7 p -160.55 170.49 20.79 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.031 1.332 . . . . 0.0 112.933 -174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.4 p -153.78 -179.35 1.04 Allowed Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.73 2.012 . . . . 0.0 110.425 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.65 -19.93 55.5 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.845 2.363 . . . . 0.0 114.337 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 52.7 p -114.97 -19.28 11.0 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.05 1.34 . . . . 0.0 114.285 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.81 137.03 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.43 1.492 . . . . 0.0 110.391 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -131.64 137.75 48.49 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.711 1.204 . . . . 0.0 112.092 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.1 t70 57.54 28.4 15.52 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.396 1.478 . . . . 0.0 113.283 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -72.11 127.13 90.85 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 117.837 -1.078 . . . . 0.0 111.466 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.6 142.91 18.6 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.317 2.678 . . . . 0.0 109.381 171.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.5 m -137.65 133.22 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.55 1.14 . . . . 0.0 110.627 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -81.52 131.23 35.27 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.654 1.182 . . . . 0.0 110.057 -172.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.1 mm -114.05 128.61 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.388 1.475 . . . . 0.0 108.986 -171.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -136.22 89.15 20.16 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.909 1.283 . . . . 0.0 110.092 -175.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.95 134.8 64.7 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.658 2.905 . . . . 0.0 110.851 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -73.75 122.69 22.79 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.172 0.51 . . . . 0.0 112.024 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -162.33 134.26 5.45 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.528 1.931 . . . . 0.0 109.087 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 80.2 mt -95.58 -2.51 48.21 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -170.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 70.0 m -76.39 147.43 38.03 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.147 -0.97 . . . . 0.0 113.027 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -76.16 152.29 36.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.854 1.262 . . . . 0.0 112.523 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 25.6 m -158.68 155.84 28.85 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.003 1.721 . . . . 0.0 111.581 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -80.17 1.14 29.39 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.103 1.361 . . . . 0.0 114.353 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -75.7 94.39 3.24 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.517 1.127 . . . . 0.0 111.436 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 12.2 p -154.87 138.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.852 1.661 . . . . 0.0 110.002 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -147.46 10.54 0.97 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.325 1.45 . . . . 0.0 113.803 -169.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.03 133.38 56.04 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.099 1.359 . . . . 0.0 112.268 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 42.4 m 67.94 -0.89 1.89 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 126.538 1.935 . . . . 0.0 114.7 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 77.71 178.9 49.08 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 125.233 1.397 . . . . 0.0 114.392 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.58 160.29 35.03 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 124.244 3.296 . . . . 0.0 111.763 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 55.9 p -161.12 140.91 10.7 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.85 1.26 . . . . 0.0 111.835 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 14.8 m -84.55 -7.26 59.32 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -174.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.359 1.457 . . . . 0.0 113.127 -178.093 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 57.6 p -169.09 -48.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.736 1.214 . . . . 0.0 112.106 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 24.1 m 70.09 4.28 4.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.928 2.091 . . . . 0.0 115.077 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -85.79 12.3 59.87 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.498 1.523 . . . . 0.0 115.054 -176.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 31.6 p -87.24 5.12 39.8 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.569 1.548 . . . . 0.0 114.565 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 87.5 p -155.64 178.93 9.69 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.157 1.383 . . . . 0.0 112.854 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 104.93 -123.38 7.62 Favored Glycine 0 N--CA 1.471 1.012 0 C-N-CA 125.248 1.404 . . . . 0.0 111.258 -174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 22.2 t -146.62 152.06 38.28 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.969 1.308 . . . . 0.0 111.461 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -95.2 -5.2 44.43 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -82.12 135.72 35.26 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.592 0.633 . . . . 0.0 110.601 171.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.7 t -138.82 117.77 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.195 0.998 . . . . 0.0 110.146 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -71.21 139.74 50.22 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.147 0.979 . . . . 0.0 110.715 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 64.1 t -133.64 118.16 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.399 1.48 . . . . 0.0 109.292 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.09 143.44 18.07 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 124.803 1.192 . . . . 0.0 113.478 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 99.49 15.49 32.04 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.109 1.338 . . . . 0.0 114.4 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.64 139.47 85.84 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.957 1.303 . . . . 0.0 110.933 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -55.12 156.46 16.18 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.578 2.852 . . . . 0.0 113.703 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.91 5.4 4.95 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.054 3.169 . . . . 0.0 113.715 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -140.3 29.54 2.0 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.393 1.477 . . . . 0.0 112.043 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -110.7 128.32 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.464 1.106 . . . . 0.0 111.179 177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -97.73 167.49 10.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.667 1.187 . . . . 0.0 113.334 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -43.6 -46.53 7.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.261 1.825 . . . . 0.0 113.994 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -79.01 -25.44 43.31 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.846 0.858 . . . . 0.0 112.523 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -77.51 -36.41 52.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.589 0.756 . . . . 0.0 111.933 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 44.0 mt -65.54 -36.39 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.153 0.888 . . . . 0.0 109.569 170.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 60.4 m -64.23 -52.19 59.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.831 0.852 . . . . 0.0 110.54 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.16 -30.64 70.52 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.605 1.093 . . . . 0.0 112.992 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.1 m -66.86 -15.5 63.67 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 175.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -130.19 -2.78 4.48 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -61.12 -22.09 64.34 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.987 1.315 . . . . 0.0 113.096 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -56.91 -13.12 2.37 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.736 2.014 . . . . 0.0 114.956 169.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -104.56 -5.73 21.22 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.497 1.519 . . . . 0.0 113.961 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.8 170.97 13.66 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.878 1.704 . . . . 0.0 112.104 -170.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.56 151.35 70.18 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.793 2.995 . . . . 0.0 112.429 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.06 172.92 15.11 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.63 1.572 . . . . 0.0 112.486 -170.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.52 159.44 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.742 1.617 . . . . 0.0 109.33 167.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 61.6 t -129.98 136.36 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.489 1.115 . . . . 0.0 110.817 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -146.2 163.21 36.13 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.375 1.87 . . . . 0.0 111.659 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -158.61 158.51 29.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.738 1.215 . . . . 0.0 112.277 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.24 147.8 93.57 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.03 2.486 . . . . 0.0 112.775 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 45.8 m170 65.78 14.95 9.83 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.572 1.549 . . . . 0.0 113.974 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -65.94 -19.01 65.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.305 1.442 . . . . 0.0 112.786 177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -71.37 -22.66 61.86 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.394 1.878 . . . . 0.0 113.961 171.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -116.53 -31.18 5.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.011 1.324 . . . . 0.0 112.798 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 75.8 m -82.87 101.69 11.16 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.066 0.946 . . . . 0.0 109.228 169.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -78.79 55.65 1.75 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.107 1.363 . . . . 0.0 113.491 -169.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 84.9 p -155.78 159.24 39.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.635 1.174 . . . . 0.0 113.117 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -94.06 24.71 4.13 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.666 1.586 . . . . 0.0 113.926 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -116.72 141.98 28.98 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 126.434 1.893 . . . . 0.0 109.846 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.56 119.94 6.82 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.105 2.536 . . . . 0.0 109.883 174.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.15 17.42 1.77 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.547 2.831 . . . . 0.0 113.382 -172.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -136.58 -3.91 2.08 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.225 1.41 . . . . 0.0 114.366 -171.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.51 15.27 81.59 Favored Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.207 0.908 . . . . 0.0 114.13 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -151.44 158.0 43.1 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.622 1.211 . . . . 0.0 112.773 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -151.81 168.79 23.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.662 1.185 . . . . 0.0 111.904 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.57 118.69 33.84 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.51 1.924 . . . . 0.0 109.521 175.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 23.7 mt -82.34 142.33 32.11 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.306 1.442 . . . . 0.0 109.053 169.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 53.7 mt -125.97 106.79 9.88 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.018 1.727 . . . . 0.0 108.05 172.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.03 156.43 21.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.519 0.728 . . . . 0.0 112.161 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -69.01 -34.56 75.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.701 0.801 . . . . 0.0 112.41 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -140.57 141.62 35.21 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.991 1.716 . . . . 0.0 109.999 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -60.59 -32.41 71.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.052 0.941 . . . . 0.0 111.808 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 19.2 m -56.81 -27.05 59.3 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.616 1.166 . . . . 0.0 112.954 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 22.5 m -70.06 -28.73 65.69 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.089 -1.007 . . . . 0.0 112.283 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 57.9 t -77.18 -36.5 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.643 -0.66 . . . . 0.0 110.043 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -68.74 -37.15 79.22 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.515 -0.741 . . . . 0.0 111.871 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.43 -37.84 87.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.298 0.639 . . . . 0.0 112.294 172.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.0 tp -64.68 -48.55 74.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.435 0.694 . . . . 0.0 111.032 171.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.1 mt -55.89 -41.51 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.086 0.954 . . . . 0.0 111.261 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.45 -17.53 63.64 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.767 1.227 . . . . 0.0 113.636 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.83 -13.64 19.13 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.082 1.353 . . . . 0.0 113.27 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 56.8 m -71.93 141.17 49.47 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.029 0.919 . . . . 0.0 113.077 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 90.6 mt -80.94 176.28 9.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.541 1.536 . . . . 0.0 108.052 165.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -142.24 129.63 21.2 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.402 0.681 . . . . 0.0 110.956 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -144.2 122.02 11.96 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.033 1.733 . . . . 0.0 109.32 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 58.2 26.35 13.7 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.431 1.492 . . . . 0.0 113.721 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 89.65 -0.84 80.68 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.616 1.579 . . . . 0.0 114.363 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -109.67 143.27 39.68 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.979 1.711 . . . . 0.0 110.144 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 82.7 mt -84.06 148.33 26.89 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.707 -0.621 . . . . 0.0 111.568 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -141.22 152.13 44.33 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.873 1.269 . . . . 0.0 113.787 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.0 tp -140.17 161.62 37.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.767 1.627 . . . . 0.0 109.916 175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 24.2 p -97.88 139.0 34.38 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.92 1.288 . . . . 0.0 112.769 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.1 m -148.21 175.61 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 126.627 1.971 . . . . 0.0 110.667 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 82.9 p -161.38 170.9 19.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.3 p -139.61 -177.82 0.74 Allowed Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 127.009 2.123 . . . . 0.0 110.885 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -65.6 -11.72 31.82 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.322 2.681 . . . . 0.0 114.273 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 43.7 p -122.7 -24.71 4.82 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.025 1.33 . . . . 0.0 113.857 -174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 31.0 mm -129.77 125.86 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.325 1.45 . . . . 0.0 109.648 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -121.06 143.74 48.91 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.576 1.15 . . . . 0.0 112.347 -172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 61.08 30.67 19.6 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.451 1.501 . . . . 0.0 112.701 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -69.18 127.95 92.76 Favored Pre-proline 0 CA--C 1.546 0.814 0 O-C-N 121.128 -0.982 . . . . 0.0 111.529 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.25 131.8 5.05 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.397 2.732 . . . . 0.0 108.941 169.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.35 133.91 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.026 1.33 . . . . 0.0 110.915 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -77.34 127.98 33.5 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.411 1.085 . . . . 0.0 109.638 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.4 mm -109.21 132.77 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.91 1.284 . . . . 0.0 109.211 -174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -139.87 93.88 9.28 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.477 1.111 . . . . 0.0 110.295 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.04 135.56 69.38 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.252 2.635 . . . . 0.0 109.687 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 54.6 t-105 -66.91 -14.76 63.11 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -169.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -83.79 -13.66 53.3 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.263 1.025 . . . . 0.0 113.384 172.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -124.38 -1.6 8.09 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.795 2.038 . . . . 0.0 113.337 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 65.3 p -72.49 -14.79 61.75 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -168.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -106.16 -0.96 24.2 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.037 1.735 . . . . 0.0 115.45 -168.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 7.2 t -159.99 165.42 32.03 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.127 0.876 . . . . 0.0 113.05 -176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 21.1 t70 69.51 -4.09 1.46 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.091 2.556 . . . . 0.0 115.311 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -79.26 12.18 2.49 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.561 1.545 . . . . 0.0 114.9 -174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 6.8 p -160.16 143.08 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 126.174 1.79 . . . . 0.0 110.323 -169.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.34 10.4 1.12 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.51 1.524 . . . . 0.0 113.785 -170.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.41 -3.15 28.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.592 1.557 . . . . 0.0 114.36 -170.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 13.2 m -67.64 -9.04 39.63 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.626 1.57 . . . . 0.0 114.865 -178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -169.24 168.77 41.49 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.932 1.253 . . . . 0.0 114.135 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.05 159.2 37.73 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.141 3.227 . . . . 0.0 111.67 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.3 m -74.58 -6.71 50.07 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 9.3 t -165.16 164.02 20.26 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.412 1.885 . . . . 0.0 111.003 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.218 0 C-N-CA 125.229 1.395 . . . . 0.0 112.863 -178.422 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.442 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 49.2 p -159.96 -60.46 0.06 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.053 0.941 . . . . 0.0 112.476 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 53.4 p -90.73 -11.45 39.57 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 86.43 155.34 26.55 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.652 1.596 . . . . 0.0 113.716 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 34.3 p -166.98 -66.97 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.971 1.308 . . . . 0.0 111.49 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 47.2 p -167.57 153.61 7.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.843 1.657 . . . . 0.0 112.042 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -155.76 -90.05 0.07 OUTLIER Glycine 0 N--CA 1.468 0.807 0 C-N-CA 125.737 1.636 . . . . 0.0 110.798 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 12.5 t -155.55 160.12 40.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.287 1.435 . . . . 0.0 111.748 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.5 mtm-85 -88.08 -3.76 58.85 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.333 1.053 . . . . 0.0 112.794 170.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -82.24 134.26 35.28 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.254 1.422 . . . . 0.0 111.128 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.6 t -141.0 121.05 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.297 1.039 . . . . 0.0 110.246 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -75.11 140.33 43.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.683 0.793 . . . . 0.0 110.49 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.73 120.6 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.24 1.416 . . . . 0.0 109.294 174.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.37 146.71 18.55 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 124.836 1.208 . . . . 0.0 113.917 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 91.32 23.75 28.38 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.958 1.266 . . . . 0.0 113.931 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.22 145.91 64.26 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.826 1.651 . . . . 0.0 111.717 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -52.34 155.56 9.38 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.13 3.22 . . . . 0.0 113.907 174.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.57 1.12 9.34 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.878 3.052 . . . . 0.0 113.576 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -140.4 45.79 1.83 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.672 1.589 . . . . 0.0 111.469 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.8 tt -127.57 147.67 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.437 1.495 . . . . 0.0 110.834 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -123.92 170.98 10.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.461 1.504 . . . . 0.0 113.08 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -50.28 -40.82 49.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.177 1.391 . . . . 0.0 113.994 -176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -81.1 -29.8 34.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.993 0.917 . . . . 0.0 112.361 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.22 -38.75 71.99 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.329 0.652 . . . . 0.0 111.882 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 46.8 mt -66.05 -38.23 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.354 -0.841 . . . . 0.0 109.52 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 88.8 m -61.26 -51.18 70.03 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.316 0.647 . . . . 0.0 110.634 172.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.84 -31.07 71.29 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.245 0.929 . . . . 0.0 112.866 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.5 m -69.09 -14.29 62.93 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -128.23 -3.08 5.65 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.34 0.973 . . . . 0.0 113.539 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -60.61 -22.1 63.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.905 1.282 . . . . 0.0 113.38 174.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -56.81 -14.17 3.19 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.663 1.985 . . . . 0.0 115.016 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -102.82 -4.4 24.95 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.36 1.464 . . . . 0.0 113.903 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 120.89 171.68 14.38 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.864 1.697 . . . . 0.0 111.981 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.18 151.87 72.35 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.589 2.859 . . . . 0.0 112.271 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.66 173.45 13.87 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.913 1.685 . . . . 0.0 112.312 -171.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.04 157.8 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.658 1.583 . . . . 0.0 108.707 166.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.18 136.25 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.514 1.126 . . . . 0.0 110.158 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -154.41 169.39 23.85 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.48 1.112 . . . . 0.0 112.751 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -156.88 157.21 30.65 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.827 1.251 . . . . 0.0 112.654 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.13 149.71 83.35 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.727 2.951 . . . . 0.0 113.963 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 32.5 m170 70.65 3.54 4.59 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.318 1.847 . . . . 0.0 115.067 170.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -58.42 -28.47 65.26 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.731 -1.231 . . . . 0.0 111.979 174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -59.31 -24.52 63.37 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.027 2.131 . . . . 0.0 114.666 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.09 -38.52 2.16 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.594 1.157 . . . . 0.0 112.304 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 74.9 m -89.65 79.53 6.79 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.465 1.106 . . . . 0.0 109.077 169.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -59.34 115.77 3.47 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.423 1.089 . . . . 0.0 111.509 -174.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 14.7 t -166.74 147.51 5.97 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.014 0.925 . . . . 0.0 112.215 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -101.72 6.62 41.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.416 1.487 . . . . 0.0 112.98 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -112.45 142.91 27.87 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.746 2.019 . . . . 0.0 109.134 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.89 117.78 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.955 2.437 . . . . 0.0 110.254 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.46 16.86 1.88 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.458 2.772 . . . . 0.0 113.14 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -135.33 -5.59 2.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.493 1.517 . . . . 0.0 114.144 -172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.87 13.11 83.77 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.45 1.024 . . . . 0.0 114.354 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -148.16 160.76 42.58 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.775 1.288 . . . . 0.0 113.188 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.42 165.07 36.17 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.992 1.317 . . . . 0.0 111.879 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.28 121.52 45.48 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.832 1.653 . . . . 0.0 109.941 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 22.5 mt -84.85 139.91 31.56 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.433 1.493 . . . . 0.0 108.682 169.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 45.5 mt -127.06 103.13 7.28 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.922 1.689 . . . . 0.0 107.874 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -82.03 160.74 23.17 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.391 0.677 . . . . 0.0 111.813 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -82.84 -16.24 48.46 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -141.29 141.47 33.92 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.405 1.482 . . . . 0.0 110.51 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.77 -30.03 69.77 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.709 -0.62 . . . . 0.0 111.508 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.5 m -55.27 -28.46 53.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.666 1.187 . . . . 0.0 112.964 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.6 m -73.48 -28.74 62.09 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.01 -1.056 . . . . 0.0 112.213 174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 86.1 t -75.21 -37.79 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.561 -0.712 . . . . 0.0 109.848 174.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -67.28 -38.2 84.69 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.552 -0.718 . . . . 0.0 111.967 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.83 -37.75 88.03 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.615 0.643 . . . . 0.0 112.322 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.1 tp -63.52 -49.12 74.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.386 0.675 . . . . 0.0 110.92 171.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.7 mt -55.85 -41.51 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.155 0.982 . . . . 0.0 111.351 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.4 -18.25 63.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.737 1.215 . . . . 0.0 113.672 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.48 -14.28 20.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.044 1.337 . . . . 0.0 113.433 174.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.0 m -75.03 146.72 41.34 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.064 0.935 . . . . 0.0 113.475 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -85.17 176.24 8.48 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.545 1.538 . . . . 0.0 107.844 165.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -146.04 138.23 25.28 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.375 0.67 . . . . 0.0 111.715 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -154.75 121.16 5.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.983 1.313 . . . . 0.0 110.233 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 65.42 6.19 3.57 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.339 2.256 . . . . 0.0 113.932 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 97.98 -8.52 63.24 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.835 1.683 . . . . 0.0 113.636 -170.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -79.33 142.82 35.73 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.495 1.147 . . . . 0.0 109.762 170.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.4 mt -93.41 156.04 17.01 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.35 0.66 . . . . 0.0 111.342 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -144.98 150.55 37.13 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.504 1.122 . . . . 0.0 113.271 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 7.8 tp -143.35 153.18 42.46 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.045 1.338 . . . . 0.0 110.617 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 21.5 p -83.72 136.45 34.17 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.627 1.171 . . . . 0.0 112.607 175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.8 165.4 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 126.021 1.728 . . . . 0.0 111.264 172.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 50.4 m -146.59 168.06 22.19 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.262 1.025 . . . . 0.0 113.217 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.0 p -147.65 -173.79 0.38 Allowed Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 127.804 2.442 . . . . 0.0 109.942 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -64.63 -16.09 53.41 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.051 2.501 . . . . 0.0 114.341 171.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 57.4 p -126.99 -15.37 5.35 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.932 1.293 . . . . 0.0 114.312 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.0 mm -129.63 135.0 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.173 1.789 . . . . 0.0 109.27 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -133.14 132.4 41.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.039 0.936 . . . . 0.0 112.338 -169.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.7 t70 59.36 26.95 15.92 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.674 1.59 . . . . 0.0 113.032 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -75.15 129.86 81.81 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 125.401 1.48 . . . . 0.0 111.901 -169.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -76.35 117.75 4.71 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.407 2.738 . . . . 0.0 110.916 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 5.4 m -106.89 141.25 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.347 1.459 . . . . 0.0 110.436 173.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -79.03 129.47 34.49 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.045 0.938 . . . . 0.0 109.861 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.5 131.69 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.487 1.515 . . . . 0.0 108.77 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 29.2 mtp85 -139.25 86.86 14.21 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.681 1.193 . . . . 0.0 110.107 -173.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.89 138.69 80.65 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.638 2.892 . . . . 0.0 111.372 175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -81.52 120.28 24.83 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.478 0.711 . . . . 0.0 112.405 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -162.63 156.1 20.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.529 1.532 . . . . 0.0 111.347 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.24 148.65 25.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.572 1.149 . . . . 0.0 111.738 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 14.7 m -70.83 -5.11 27.93 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -71.63 -14.11 61.96 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.679 1.191 . . . . 0.0 112.264 169.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 70.2 m -122.67 -3.23 8.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.271 1.428 . . . . 0.0 114.457 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -159.5 139.26 11.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.58 1.952 . . . . 0.0 110.651 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -68.37 161.69 26.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.557 0.743 . . . . 0.0 111.912 172.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 13.7 p -154.34 141.8 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.527 1.131 . . . . 0.0 111.242 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.17 7.77 10.84 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.976 2.11 . . . . 0.0 113.554 -170.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -148.54 123.68 10.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.991 1.716 . . . . 0.0 110.447 -169.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 48.3 m 67.62 -6.42 0.67 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.055 2.142 . . . . 0.0 114.994 -173.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 82.21 169.72 43.84 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 125.903 1.716 . . . . 0.0 114.43 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.34 145.74 97.99 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 124.201 3.267 . . . . 0.0 113.848 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 94.7 p -71.33 -9.0 57.43 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.055 0.942 . . . . 0.0 113.202 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 8.9 m -76.44 -9.27 58.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.107 1.763 . . . . 0.0 114.604 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.226 -1.319 . . . . 0.0 113.197 -179.342 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 8.4 t -164.64 -177.97 5.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.782 1.633 . . . . 0.0 110.998 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 73.9 m -139.83 130.5 25.81 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.917 1.687 . . . . 0.0 110.781 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -89.61 161.09 29.48 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.628 1.109 . . . . 0.0 113.672 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 45.2 p -85.91 2.89 44.27 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.459 1.504 . . . . 0.0 113.496 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 7.8 p -81.47 2.24 29.66 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.873 2.069 . . . . 0.0 114.934 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -68.88 169.44 42.33 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.56 1.076 . . . . 0.0 113.611 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 39.5 t -145.01 160.09 41.92 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.445 1.098 . . . . 0.0 112.794 -173.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -76.14 -7.1 54.02 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.25 1.02 . . . . 0.0 113.08 170.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -71.19 138.63 49.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.928 0.891 . . . . 0.0 110.816 169.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.6 t -140.07 119.49 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.537 1.135 . . . . 0.0 109.717 175.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -71.77 139.53 49.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.867 0.867 . . . . 0.0 110.544 172.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.9 119.11 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.311 1.445 . . . . 0.0 109.407 174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -117.03 147.67 18.88 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.113 1.339 . . . . 0.0 113.45 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 92.02 19.07 40.93 Favored Glycine 0 N--CA 1.473 1.133 0 C-N-CA 124.702 1.144 . . . . 0.0 114.142 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 98.3 mt -55.2 141.56 60.66 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.561 1.544 . . . . 0.0 111.189 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.94 148.86 28.17 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.625 2.884 . . . . 0.0 112.806 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.62 6.65 3.1 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.207 3.271 . . . . 0.0 114.461 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -140.05 16.57 2.45 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.48 1.512 . . . . 0.0 112.676 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.6 tt -93.39 137.73 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.039 0.936 . . . . 0.0 111.408 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -109.92 170.26 8.19 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.721 1.208 . . . . 0.0 113.161 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -47.66 -44.11 26.89 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.647 1.579 . . . . 0.0 113.746 -175.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -79.65 -25.49 41.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.839 0.855 . . . . 0.0 112.316 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -77.99 -36.64 48.64 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.773 0.829 . . . . 0.0 111.496 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.0 mt -64.89 -38.64 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 118.932 0.787 . . . . 0.0 109.529 170.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 61.6 m -62.74 -52.01 64.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.533 0.733 . . . . 0.0 110.517 173.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.66 -30.7 70.89 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.5 1.045 . . . . 0.0 112.998 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.6 m -67.66 -15.04 63.44 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 175.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -129.62 -2.97 4.8 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -60.98 -22.63 64.66 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.878 1.271 . . . . 0.0 113.142 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -56.42 -13.99 2.67 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.806 2.042 . . . . 0.0 115.009 169.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -103.67 -6.29 21.74 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.432 1.493 . . . . 0.0 113.946 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 123.44 172.33 13.77 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.961 1.743 . . . . 0.0 112.14 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.79 151.45 68.87 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.544 2.829 . . . . 0.0 112.358 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.27 172.88 15.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.746 1.618 . . . . 0.0 112.527 -170.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -134.02 159.19 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.706 1.603 . . . . 0.0 109.28 167.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 56.1 t -129.26 135.11 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.308 1.043 . . . . 0.0 110.77 -171.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -145.11 164.15 32.14 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.257 1.823 . . . . 0.0 111.845 -172.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -157.36 158.93 31.1 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.874 1.27 . . . . 0.0 112.083 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -62.98 150.79 87.57 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.139 2.559 . . . . 0.0 112.849 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 48.3 m170 64.85 12.64 7.92 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.435 1.494 . . . . 0.0 114.044 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -67.52 -15.32 63.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.551 1.541 . . . . 0.0 112.867 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -63.33 -22.93 67.18 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.612 1.965 . . . . 0.0 113.944 169.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.85 -40.68 2.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.138 1.375 . . . . 0.0 111.561 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 68.7 m -83.83 62.4 6.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.792 1.237 . . . . 0.0 109.931 169.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -74.77 -0.66 18.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.787 1.635 . . . . 0.0 114.53 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.6 m -56.79 159.95 3.7 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.797 1.639 . . . . 0.0 113.35 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.32 5.38 7.15 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -171.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -128.83 139.73 36.5 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.28 1.832 . . . . 0.0 110.008 -169.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.95 121.79 8.84 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.977 2.451 . . . . 0.0 110.173 173.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -85.58 16.97 1.85 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.322 2.681 . . . . 0.0 113.726 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -136.04 -3.04 2.27 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.83 15.44 81.23 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.121 0.867 . . . . 0.0 114.284 -176.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -149.88 156.79 42.38 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.641 1.176 . . . . 0.0 112.651 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.58 169.67 22.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.905 1.282 . . . . 0.0 111.697 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -116.32 118.06 31.71 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.39 1.876 . . . . 0.0 109.531 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 25.4 mt -80.95 141.09 34.83 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.921 1.288 . . . . 0.0 108.682 169.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.8 mt -123.85 103.42 8.34 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.747 1.619 . . . . 0.0 107.871 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -81.02 156.52 25.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.116 0.566 . . . . 0.0 111.403 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -82.81 -15.75 50.45 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -141.87 141.85 33.08 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.4 1.48 . . . . 0.0 110.658 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -60.57 -31.86 70.97 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.228 0.611 . . . . 0.0 111.533 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -56.03 -28.04 55.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.65 1.18 . . . . 0.0 112.941 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.3 m -73.92 -29.64 62.15 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.955 -1.091 . . . . 0.0 112.168 174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.3 t -73.95 -38.81 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 O-C-N 121.667 -0.646 . . . . 0.0 109.66 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -66.96 -38.51 86.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.636 -0.665 . . . . 0.0 111.985 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.92 88.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.627 0.649 . . . . 0.0 112.304 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.95 -48.85 74.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.45 0.7 . . . . 0.0 110.918 171.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 74.2 mt -55.67 -42.43 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.091 0.957 . . . . 0.0 111.345 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.98 -17.97 64.0 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.668 1.187 . . . . 0.0 113.671 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.09 -13.88 19.63 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.113 1.365 . . . . 0.0 113.431 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.9 m -77.51 150.46 34.86 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -86.83 176.23 7.81 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.79 1.636 . . . . 0.0 107.778 164.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -147.07 137.44 23.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.463 0.705 . . . . 0.0 111.729 -174.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -157.47 126.1 5.67 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.244 1.418 . . . . 0.0 110.202 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 58.77 24.3 12.14 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.22 1.808 . . . . 0.0 113.79 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 85.99 -4.52 85.81 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.711 1.625 . . . . 0.0 114.424 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -94.87 147.57 23.23 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.95 1.3 . . . . 0.0 110.341 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 95.8 mt -94.8 158.21 15.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.77 0.828 . . . . 0.0 111.163 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -144.18 148.97 35.7 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.224 1.01 . . . . 0.0 113.096 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -140.7 162.1 36.2 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.733 1.613 . . . . 0.0 110.017 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 24.8 p -97.79 141.17 31.11 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.082 1.353 . . . . 0.0 112.628 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.4 m -146.66 169.98 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 126.7 2.0 . . . . 0.0 110.644 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.7 m -148.9 169.05 21.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.553 1.141 . . . . 0.0 112.786 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.28 175.98 2.57 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 127.916 2.487 . . . . 0.0 109.493 -176.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -57.19 -31.97 92.13 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.162 2.575 . . . . 0.0 115.016 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 42.2 p -119.07 0.12 11.21 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.556 1.542 . . . . 0.0 114.03 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.6 mm -135.68 121.65 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.84 1.656 . . . . 0.0 109.061 -171.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -125.05 134.33 52.58 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.204 1.002 . . . . 0.0 111.984 -168.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.2 t70 60.3 30.81 20.14 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.298 1.439 . . . . 0.0 112.653 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -62.71 129.88 93.27 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.782 1.233 . . . . 0.0 110.962 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.87 137.61 11.19 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.214 2.61 . . . . 0.0 109.193 169.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.23 138.16 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.244 1.418 . . . . 0.0 110.201 176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -79.05 127.74 32.38 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.012 1.325 . . . . 0.0 109.532 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.0 mm -112.22 132.8 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.581 1.552 . . . . 0.0 108.673 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -141.21 92.54 8.36 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.476 1.11 . . . . 0.0 110.074 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.79 133.37 55.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.53 2.82 . . . . 0.0 110.829 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 45.4 t-105 -84.26 157.79 21.45 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -169.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -150.08 134.64 17.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.569 1.548 . . . . 0.0 110.821 -177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 73.3 mt -85.35 101.18 12.36 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.408 1.483 . . . . 0.0 110.094 -176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 10.6 t -163.87 -178.81 5.89 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.359 1.464 . . . . 0.0 110.996 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -75.61 -3.8 36.48 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.652 1.581 . . . . 0.0 113.802 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 25.3 t -158.09 140.75 14.65 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.707 1.603 . . . . 0.0 111.278 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -97.55 0.6 47.72 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.707 2.003 . . . . 0.0 113.704 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -61.6 149.34 39.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.764 1.626 . . . . 0.0 113.098 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 3.4 p -162.94 120.11 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.688 1.595 . . . . 0.0 110.462 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 70.6 mtp -159.0 157.55 31.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.986 2.514 . . . . 0.0 110.668 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -146.63 136.54 23.34 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.148 1.779 . . . . 0.0 110.58 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 9.5 t -165.54 166.55 18.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.289 1.436 . . . . 0.0 111.34 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 86.59 175.28 49.51 Favored Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.268 1.413 . . . . 0.0 113.961 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.5 152.76 34.25 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.059 3.173 . . . . 0.0 111.725 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.5 m -71.35 -5.71 34.56 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 17.5 m -77.22 -8.33 57.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.436 1.494 . . . . 0.0 114.346 -177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.194 0 CA-C-O 118.224 -1.32 . . . . 0.0 113.183 179.59 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 19.8 m -90.54 -1.54 57.89 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -173.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 87.3 p -163.5 172.73 14.03 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.507 1.523 . . . . 0.0 112.153 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 94.75 -25.8 21.54 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.499 1.524 . . . . 0.0 114.449 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 90.8 p -166.65 163.89 16.78 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.622 1.569 . . . . 0.0 112.011 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 17.0 p -97.34 11.13 37.66 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.806 1.643 . . . . 0.0 113.37 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 84.2 -59.98 4.88 Favored Glycine 0 N--CA 1.472 1.044 0 C-N-CA 125.761 1.648 . . . . 0.0 112.772 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 19.8 t -159.17 160.25 35.27 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.216 1.407 . . . . 0.0 112.263 -175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 -79.0 -13.28 59.89 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.2 1.0 . . . . 0.0 112.942 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.26 133.86 35.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.686 1.195 . . . . 0.0 110.811 171.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.9 123.0 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.425 1.09 . . . . 0.0 110.524 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -74.37 143.44 44.85 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.313 1.045 . . . . 0.0 111.344 171.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.61 127.2 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.236 1.414 . . . . 0.0 109.586 172.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -127.78 146.44 16.62 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.938 1.256 . . . . 0.0 113.622 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 96.73 15.98 38.01 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.142 1.353 . . . . 0.0 114.451 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.31 141.99 86.88 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.238 1.415 . . . . 0.0 111.507 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -54.25 155.82 14.95 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 124.027 3.151 . . . . 0.0 114.283 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.75 2.71 7.58 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 124.117 3.212 . . . . 0.0 113.673 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -138.19 34.76 2.32 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.643 1.577 . . . . 0.0 111.815 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 10.4 tt -114.1 162.57 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.525 1.53 . . . . 0.0 110.234 172.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -146.22 170.36 16.9 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.049 1.34 . . . . 0.0 112.539 -171.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -42.74 -47.66 5.46 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.132 1.773 . . . . 0.0 114.264 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.25 -29.2 42.53 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.388 -0.82 . . . . 0.0 112.34 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -74.15 -37.25 64.08 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.634 0.774 . . . . 0.0 111.45 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 64.6 mt -65.77 -39.52 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.454 -0.778 . . . . 0.0 109.569 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 62.0 m -60.63 -52.5 64.86 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.254 173.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.15 71.41 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.332 0.969 . . . . 0.0 112.942 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.2 m -69.42 -14.59 62.98 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -128.2 -4.1 5.59 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.347 0.976 . . . . 0.0 113.508 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -60.61 -22.44 63.76 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.952 1.301 . . . . 0.0 113.284 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -56.44 -13.7 2.47 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.716 2.006 . . . . 0.0 115.045 170.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -104.86 -4.38 22.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.236 1.414 . . . . 0.0 113.988 177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.72 172.73 14.34 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.818 1.675 . . . . 0.0 112.228 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.68 151.59 69.55 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.722 2.948 . . . . 0.0 112.172 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.09 172.66 16.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.538 1.535 . . . . 0.0 112.553 -169.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 8.2 p -130.37 151.45 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.876 1.67 . . . . 0.0 109.389 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.98 134.77 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.338 1.455 . . . . 0.0 109.719 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.88 161.71 40.74 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.95 1.7 . . . . 0.0 112.05 -169.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.5 p90 -165.23 163.57 13.32 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.657 1.583 . . . . 0.0 111.846 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -55.7 143.0 81.75 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.656 2.904 . . . . 0.0 112.9 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 69.99 3.65 4.44 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 126.098 1.759 . . . . 0.0 114.742 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -68.49 -21.13 64.62 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.31 -1.494 . . . . 0.0 112.639 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -78.47 -8.54 58.64 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.806 2.042 . . . . 0.0 114.142 172.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -135.9 13.04 3.38 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.62 1.568 . . . . 0.0 112.943 -170.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 42.6 t -153.25 147.94 26.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.695 1.598 . . . . 0.0 111.644 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -83.53 -4.08 58.22 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.52 1.128 . . . . 0.0 113.616 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 68.2 m -65.28 116.63 6.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.068 0.947 . . . . 0.0 112.97 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -98.08 13.7 30.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.919 1.688 . . . . 0.0 113.414 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -106.94 147.52 35.23 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 127.332 2.253 . . . . 0.0 110.224 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.52 126.46 14.18 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.108 2.538 . . . . 0.0 110.593 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.6 129.62 18.1 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.293 2.662 . . . . 0.0 110.238 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 58.32 13.07 2.22 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.562 1.545 . . . . 0.0 114.565 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 85.41 27.87 31.75 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.97 1.272 . . . . 0.0 114.315 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -137.15 158.05 45.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.495 1.648 . . . . 0.0 113.752 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.36 167.8 29.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.502 1.521 . . . . 0.0 111.763 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -118.71 135.07 54.68 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.023 1.729 . . . . 0.0 109.913 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.2 mt -103.41 139.26 39.03 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.064 1.746 . . . . 0.0 108.697 173.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 14.2 mt -121.27 113.0 19.31 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 168.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.86 156.19 19.08 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.761 0.824 . . . . 0.0 111.338 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -64.59 -35.64 81.64 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.746 -0.596 . . . . 0.0 112.359 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -141.0 144.99 35.35 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.641 1.576 . . . . 0.0 110.507 -171.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.02 -30.88 70.56 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.508 1.123 . . . . 0.0 112.203 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 24.0 p -61.25 -25.83 67.35 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.088 1.355 . . . . 0.0 113.147 174.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 25.9 m -70.36 -30.75 67.76 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.931 -1.105 . . . . 0.0 111.686 172.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.75 -34.53 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.539 -0.726 . . . . 0.0 110.249 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -66.44 -37.59 85.5 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.436 -0.79 . . . . 0.0 111.861 170.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.87 89.01 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.652 0.66 . . . . 0.0 112.408 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.7 tp -62.99 -48.83 77.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.252 0.621 . . . . 0.0 110.824 171.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 70.8 mt -55.82 -42.29 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.334 1.054 . . . . 0.0 111.289 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.27 -19.67 63.92 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.601 1.16 . . . . 0.0 113.63 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -96.63 -14.14 22.36 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.952 1.301 . . . . 0.0 113.312 174.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 29.7 m -75.55 146.69 40.27 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 88.7 mt -85.33 -179.06 6.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.998 1.719 . . . . 0.0 107.702 164.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -147.0 138.24 24.02 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.465 -0.772 . . . . 0.0 111.843 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.56 130.14 8.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.802 1.641 . . . . 0.0 109.442 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 59.09 17.43 5.54 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.728 1.611 . . . . 0.0 113.408 -171.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 83.1 -5.25 77.45 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.077 1.323 . . . . 0.0 113.85 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -89.27 147.28 24.21 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.759 1.623 . . . . 0.0 109.807 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.3 mt -86.41 157.49 19.82 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.848 -0.532 . . . . 0.0 111.431 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -145.51 149.94 35.54 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.776 1.23 . . . . 0.0 112.711 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -144.27 153.17 41.76 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.891 1.276 . . . . 0.0 110.936 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 20.5 p -85.63 134.4 33.99 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.656 1.182 . . . . 0.0 112.804 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.87 167.48 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 126.335 1.854 . . . . 0.0 110.708 172.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.2 m -149.69 166.67 28.64 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.493 1.117 . . . . 0.0 112.814 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.5 p -138.51 -175.72 0.51 Allowed Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 127.209 2.204 . . . . 0.0 110.494 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -64.57 -15.39 49.7 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.064 2.509 . . . . 0.0 114.233 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 47.1 p -123.1 -23.7 4.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.898 1.279 . . . . 0.0 114.172 -172.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.3 mm -126.23 132.28 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.601 1.56 . . . . 0.0 109.534 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -125.0 134.83 52.43 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.41 1.084 . . . . 0.0 111.773 -170.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 62.36 27.61 16.45 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.589 1.555 . . . . 0.0 112.928 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -60.32 127.27 86.11 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.607 1.163 . . . . 0.0 111.511 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.51 110.82 1.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.401 2.734 . . . . 0.0 108.287 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.27 136.22 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.115 0.966 . . . . 0.0 110.05 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -74.67 134.49 41.98 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.168 0.987 . . . . 0.0 109.486 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.1 mm -118.73 133.92 64.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 126.14 1.776 . . . . 0.0 108.097 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 39.7 mtt180 -138.85 98.57 8.6 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.995 0.918 . . . . 0.0 110.343 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.31 134.4 61.29 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.434 2.756 . . . . 0.0 110.38 169.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -74.51 149.24 40.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.433 0.693 . . . . 0.0 112.455 -175.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -78.89 -80.08 0.12 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.421 0.688 . . . . 0.0 111.832 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 68.5 mt -151.24 171.1 17.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.691 1.996 . . . . 0.0 110.82 -176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 29.9 p -69.52 -13.74 62.5 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 170.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -161.04 128.38 4.18 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.404 2.282 . . . . 0.0 109.575 173.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 17.8 p -165.63 154.42 11.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.615 1.166 . . . . 0.0 112.54 -173.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -84.94 -1.53 56.8 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.771 1.228 . . . . 0.0 113.907 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -152.78 155.74 37.75 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.606 1.562 . . . . 0.0 111.925 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.31 136.09 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 127.557 2.343 . . . . 0.0 107.687 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.14 125.65 28.82 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.209 0.604 . . . . 0.0 111.193 -172.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -161.51 -33.8 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.691 1.596 . . . . 0.0 113.313 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 12.0 m -71.84 -3.13 20.53 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -170.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 89.68 -159.48 28.18 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 124.604 1.097 . . . . 0.0 113.26 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.76 151.82 25.03 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.531 2.821 . . . . 0.0 111.646 -171.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 8.6 t -164.87 170.09 15.79 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.399 1.48 . . . . 0.0 111.36 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 10.1 t -164.33 159.96 20.38 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.92 1.688 . . . . 0.0 111.357 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.226 0 C-N-CA 125.298 1.428 . . . . 0.0 112.972 -178.209 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.443 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 58.8 m -147.31 152.55 38.43 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.02 1.328 . . . . 0.0 111.455 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 17.4 m -81.68 -3.5 53.75 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -80.66 165.03 47.48 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.979 1.276 . . . . 0.0 113.733 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 78.1 p -164.73 165.87 20.4 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.522 1.529 . . . . 0.0 111.868 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.8 m -108.06 137.06 46.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.321 1.449 . . . . 0.0 111.294 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 153.83 -162.36 30.38 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.61 1.1 . . . . 0.0 113.766 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 23.2 t -148.78 164.41 34.49 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.425 1.49 . . . . 0.0 111.967 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -76.53 1.55 16.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.692 1.197 . . . . 0.0 113.96 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -68.83 139.13 55.21 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.041 0.936 . . . . 0.0 111.222 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.5 t -139.04 118.53 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.595 1.158 . . . . 0.0 109.996 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -68.54 138.85 55.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.07 0.948 . . . . 0.0 110.838 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.5 t -132.55 116.91 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.255 1.422 . . . . 0.0 109.277 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.04 143.91 17.9 Favored Glycine 0 N--CA 1.47 0.913 0 C-N-CA 124.905 1.24 . . . . 0.0 113.637 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.1 23.71 21.68 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.669 1.128 . . . . 0.0 113.882 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.72 141.57 84.68 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.042 1.337 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.22 155.18 20.46 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 123.503 2.802 . . . . 0.0 113.538 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.23 3.29 6.36 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.803 3.002 . . . . 0.0 114.524 -173.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -140.55 27.14 2.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.865 1.266 . . . . 0.0 112.819 -177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.2 tt -101.07 144.75 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.466 1.106 . . . . 0.0 110.817 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -122.38 170.93 9.45 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.609 1.163 . . . . 0.0 113.022 -177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -46.36 -43.71 16.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.109 1.764 . . . . 0.0 114.21 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -76.77 -27.86 55.47 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.447 -0.783 . . . . 0.0 112.401 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -78.67 -36.14 44.13 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.944 0.898 . . . . 0.0 111.499 172.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.0 mt -65.47 -36.77 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.968 0.803 . . . . 0.0 109.559 171.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 48.7 m -64.8 -52.39 57.11 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.461 0.704 . . . . 0.0 110.563 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.26 -31.22 71.03 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.422 1.01 . . . . 0.0 113.019 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 70.2 m -67.84 -14.67 63.15 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.656 1.182 . . . . 0.0 114.094 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -129.65 -3.01 4.78 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.457 1.026 . . . . 0.0 113.651 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -60.5 -22.62 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.867 1.267 . . . . 0.0 113.143 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -56.81 -14.0 3.04 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.675 1.99 . . . . 0.0 115.001 170.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -103.78 -6.86 21.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.281 1.433 . . . . 0.0 113.97 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.98 172.18 13.44 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.072 1.796 . . . . 0.0 112.114 -171.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.09 151.21 72.9 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.512 2.808 . . . . 0.0 112.133 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.34 172.33 16.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.598 1.559 . . . . 0.0 112.367 -170.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.79 157.9 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.719 1.608 . . . . 0.0 109.411 167.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 80.4 t -126.74 135.0 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.61 1.164 . . . . 0.0 110.472 -171.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -141.36 162.23 35.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.499 1.92 . . . . 0.0 111.689 -172.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -161.19 156.79 21.28 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.105 1.362 . . . . 0.0 111.785 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.85 132.1 49.99 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.384 2.723 . . . . 0.0 112.328 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 22.9 m170 81.08 4.35 1.51 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 127.578 2.351 . . . . 0.0 114.279 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -62.55 -27.69 69.34 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.275 -1.516 . . . . 0.0 111.896 171.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -68.38 -8.67 42.35 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.362 1.865 . . . . 0.0 114.747 171.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.75 11.72 3.41 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.681 1.592 . . . . 0.0 113.145 -170.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 43.4 t -152.1 146.0 25.18 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.95 1.3 . . . . 0.0 112.518 -173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -81.75 -9.86 59.52 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.871 1.268 . . . . 0.0 113.223 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 71.2 m -66.25 118.15 9.54 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.948 -1.095 . . . . 0.0 112.886 -176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -94.77 15.4 18.49 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.251 1.42 . . . . 0.0 113.343 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -112.57 139.98 23.32 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.566 2.346 . . . . 0.0 107.865 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.6 117.51 5.04 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.387 2.725 . . . . 0.0 110.229 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -85.17 16.04 2.07 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.468 2.779 . . . . 0.0 113.533 -172.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -137.34 -3.12 1.95 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.675 1.59 . . . . 0.0 114.279 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.62 12.1 84.58 Favored Glycine 0 N--CA 1.476 1.312 0 C-N-CA 124.579 1.085 . . . . 0.0 114.468 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -149.04 161.5 41.8 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.681 1.192 . . . . 0.0 112.871 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -148.69 164.66 33.67 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.177 1.391 . . . . 0.0 111.549 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -115.33 115.43 26.61 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.186 1.794 . . . . 0.0 109.155 171.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.4 mt -80.82 142.31 33.83 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.739 1.215 . . . . 0.0 108.911 169.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 48.8 mt -123.37 108.77 13.1 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.603 1.561 . . . . 0.0 107.544 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -85.43 156.4 20.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.245 0.618 . . . . 0.0 111.953 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -75.18 -27.22 59.58 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -142.42 146.6 35.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.238 1.415 . . . . 0.0 111.018 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -63.97 -28.96 70.17 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.047 0.939 . . . . 0.0 111.742 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 22.2 p -61.79 -26.26 67.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 112.948 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.4 m -73.93 -34.34 64.28 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.863 -1.148 . . . . 0.0 111.75 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.77 -40.26 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.773 -0.579 . . . . 0.0 109.871 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -67.66 -40.35 84.51 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.615 -0.678 . . . . 0.0 111.957 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.67 76.01 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.318 0.963 . . . . 0.0 112.553 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.3 tp -64.92 -48.2 75.0 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.171 0.589 . . . . 0.0 111.012 170.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 85.6 mt -56.38 -42.86 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 118.895 0.771 . . . . 0.0 111.335 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.0 -14.97 63.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.245 1.418 . . . . 0.0 114.154 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.7 -14.51 18.06 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.907 1.283 . . . . 0.0 113.417 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 56.2 m -73.46 145.25 45.85 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.156 0.979 . . . . 0.0 113.448 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.5 mt -82.36 175.05 10.56 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.591 1.556 . . . . 0.0 107.823 165.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -144.05 139.81 29.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.537 0.735 . . . . 0.0 111.253 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -156.65 123.74 5.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.988 1.315 . . . . 0.0 110.074 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.42 21.46 12.59 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.072 1.749 . . . . 0.0 113.642 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 90.62 -2.61 80.59 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.485 1.516 . . . . 0.0 114.329 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -99.15 149.94 22.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.893 1.347 . . . . 0.0 111.167 173.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 93.5 mt -95.3 152.66 18.19 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.192 0.997 . . . . 0.0 111.374 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -142.24 152.36 42.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.291 1.037 . . . . 0.0 113.161 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.9 tp -139.52 168.36 20.0 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.797 1.639 . . . . 0.0 109.507 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 25.3 p -105.2 142.22 35.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.207 1.403 . . . . 0.0 112.518 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -144.83 171.59 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.628 1.971 . . . . 0.0 110.462 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 64.0 m -147.8 161.49 41.15 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.169 -0.957 . . . . 0.0 113.402 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 53.8 p -148.36 179.1 1.25 Allowed Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.764 2.025 . . . . 0.0 110.998 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -65.13 -13.83 41.91 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.295 2.663 . . . . 0.0 114.06 170.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 34.0 p -107.59 -31.38 8.13 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.01 1.324 . . . . 0.0 113.12 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 8.7 mm -134.69 126.62 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.515 1.126 . . . . 0.0 110.973 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -96.03 133.08 40.69 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.277 1.031 . . . . 0.0 111.535 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 61.8 34.64 17.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.132 1.373 . . . . 0.0 112.811 172.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -55.92 129.06 71.9 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.331 1.052 . . . . 0.0 110.817 171.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.37 137.62 11.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.273 2.648 . . . . 0.0 109.108 169.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.7 m -129.06 136.0 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.063 1.345 . . . . 0.0 110.433 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -73.77 131.22 41.34 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.143 0.977 . . . . 0.0 109.301 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.9 mm -113.35 129.57 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.97 1.308 . . . . 0.0 108.33 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 44.8 mtm105 -137.66 91.97 13.43 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 123.952 0.901 . . . . 0.0 110.725 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -60.57 145.66 98.4 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.774 2.983 . . . . 0.0 111.5 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -83.29 53.67 2.56 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.205 1.003 . . . . 0.0 111.878 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -76.85 136.5 38.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.083 1.353 . . . . 0.0 110.352 172.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 95.0 mt -124.08 17.83 9.22 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.058 1.743 . . . . 0.0 112.144 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.1 m -87.52 165.06 15.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.155 1.382 . . . . 0.0 112.356 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -156.98 113.89 3.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.123 1.369 . . . . 0.0 110.748 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 70.0 m -153.26 -54.3 0.11 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.828 1.251 . . . . 0.0 112.149 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -168.31 140.82 2.96 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.293 1.837 . . . . 0.0 110.198 -174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -141.42 155.68 45.86 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.543 1.537 . . . . 0.0 111.817 -175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 13.3 p -160.42 155.29 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 126.12 1.768 . . . . 0.0 110.105 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 22.1 ptm -147.23 140.89 25.63 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.482 1.513 . . . . 0.0 111.287 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.97 -28.42 29.76 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -171.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 80.6 p -165.27 147.87 7.95 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.502 1.121 . . . . 0.0 113.258 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -108.54 -142.75 10.12 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.998 1.761 . . . . 0.0 111.785 172.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -70.76 157.64 57.86 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.258 2.638 . . . . 0.0 111.409 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 14.1 m -74.13 -3.77 31.62 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 9.1 t -163.64 163.01 24.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.208 1.803 . . . . 0.0 111.276 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.208 0 C-N-CA 125.385 1.469 . . . . 0.0 112.855 -178.192 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.415 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 37.1 m -60.5 113.8 2.62 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.149 0.98 . . . . 0.0 111.788 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 72.9 p -168.01 167.15 12.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.86 1.264 . . . . 0.0 112.131 -169.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 179.23 174.24 45.16 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.048 1.309 . . . . 0.0 113.234 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 6.1 t 70.48 -160.3 0.15 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.397 1.879 . . . . 0.0 111.792 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 67.7 m -159.25 141.23 13.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.962 1.705 . . . . 0.0 110.905 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -81.88 -15.71 74.48 Favored Glycine 0 N--CA 1.475 1.299 0 C-N-CA 123.856 0.741 . . . . 0.0 114.461 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 12.3 t -168.68 172.77 7.74 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.301 1.84 . . . . 0.0 111.611 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -90.6 -9.26 47.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.061 1.344 . . . . 0.0 111.856 167.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -83.07 137.64 34.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.473 1.509 . . . . 0.0 110.801 174.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.1 t -142.98 120.34 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.555 1.142 . . . . 0.0 110.207 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -74.35 142.31 45.12 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.604 0.762 . . . . 0.0 110.851 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 57.8 t -131.65 125.35 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.487 1.515 . . . . 0.0 109.163 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -123.16 148.17 16.75 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.815 1.198 . . . . 0.0 113.33 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 93.57 19.52 34.73 Favored Glycine 0 N--CA 1.474 1.182 0 C-N-CA 124.797 1.189 . . . . 0.0 114.316 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.1 mt -58.22 143.59 78.85 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 125.477 1.511 . . . . 0.0 111.514 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.61 154.07 26.84 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.628 2.885 . . . . 0.0 113.457 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.5 3.01 6.74 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.881 3.054 . . . . 0.0 114.422 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -140.46 25.1 2.24 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.759 1.224 . . . . 0.0 112.764 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 10.7 tt -92.82 162.43 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.169 0.988 . . . . 0.0 110.741 170.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -142.9 169.42 17.6 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.163 1.385 . . . . 0.0 112.437 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.87 -42.54 26.95 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.302 1.841 . . . . 0.0 114.106 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.38 -27.62 41.89 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.402 -0.811 . . . . 0.0 112.357 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -77.31 -35.17 55.15 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.794 0.837 . . . . 0.0 111.572 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 59.6 mt -65.9 -37.45 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.431 -0.793 . . . . 0.0 109.54 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 63.3 m -63.11 -52.18 63.63 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.342 0.657 . . . . 0.0 110.422 172.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -59.88 -31.67 70.01 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.166 0.894 . . . . 0.0 112.995 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 74.5 m -69.55 -14.16 62.71 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -131.64 -2.0 3.81 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.513 1.051 . . . . 0.0 113.743 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.16 -23.17 61.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.859 1.264 . . . . 0.0 112.993 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -57.55 -11.16 1.83 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.487 1.915 . . . . 0.0 115.17 170.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -107.75 -2.02 20.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.586 1.554 . . . . 0.0 113.945 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 119.34 176.53 16.24 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.194 1.854 . . . . 0.0 112.613 -174.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -63.31 148.54 92.81 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.582 2.854 . . . . 0.0 112.865 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.9 170.47 20.57 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.373 1.469 . . . . 0.0 112.639 -176.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -131.44 157.9 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.911 1.685 . . . . 0.0 109.017 167.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 93.3 t -125.29 134.68 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.836 1.254 . . . . 0.0 109.93 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -151.38 165.45 34.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.975 1.71 . . . . 0.0 111.578 -170.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . 0.464 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 6.9 p90 -165.09 162.87 14.06 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 125.377 1.471 . . . . 0.0 112.185 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -57.88 149.38 70.11 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.745 2.963 . . . . 0.0 112.987 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 8.2 m170 73.07 -5.37 1.95 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 126.13 1.772 . . . . 0.0 114.338 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.464 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 41.4 tttm -67.64 -22.29 65.33 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.325 1.45 . . . . 0.0 112.361 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -86.82 -11.38 51.07 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.3 2.24 . . . . 0.0 113.964 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -111.62 -19.02 12.65 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.553 1.541 . . . . 0.0 112.479 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 22.9 t -149.73 125.1 10.2 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.801 1.64 . . . . 0.0 109.459 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.85 127.34 32.47 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.373 0.669 . . . . 0.0 111.782 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 22.9 t -162.01 157.89 24.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.916 1.286 . . . . 0.0 111.203 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -134.94 17.19 3.51 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.45 1.9 . . . . 0.0 112.258 176.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.27 138.67 23.1 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.212 1.805 . . . . 0.0 110.25 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.38 129.82 18.69 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.381 2.72 . . . . 0.0 111.419 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.48 131.05 16.91 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.502 2.801 . . . . 0.0 110.165 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 37.3 tttp 58.76 13.23 2.58 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 125.304 1.442 . . . . 0.0 114.428 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.2 35.88 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.053 1.311 . . . . 0.0 114.512 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -136.84 158.95 43.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.571 1.686 . . . . 0.0 114.051 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.31 165.82 35.45 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.388 1.475 . . . . 0.0 111.784 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -115.37 122.85 47.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.739 1.616 . . . . 0.0 110.01 170.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.0 mt -86.08 140.99 29.74 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.581 1.552 . . . . 0.0 108.917 169.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 52.2 mt -124.86 107.51 10.97 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.755 1.622 . . . . 0.0 107.811 171.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -85.54 159.47 19.89 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.622 0.769 . . . . 0.0 112.282 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -66.76 -36.08 81.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.941 0.896 . . . . 0.0 112.105 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -141.95 145.48 34.56 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.681 1.592 . . . . 0.0 110.109 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -63.77 -28.36 69.82 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.741 -0.6 . . . . 0.0 111.907 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 29.3 p -59.84 -24.53 64.27 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.912 -1.117 . . . . 0.0 113.181 172.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 27.5 m -70.7 -28.36 64.69 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.811 -1.181 . . . . 0.0 112.11 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.16 -37.14 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.696 -0.627 . . . . 0.0 109.929 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -64.13 -40.7 96.75 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.587 -0.696 . . . . 0.0 111.529 169.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.53 -37.93 85.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.763 0.711 . . . . 0.0 112.371 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.68 -47.85 76.88 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.432 0.693 . . . . 0.0 111.123 171.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 73.9 mt -56.02 -41.91 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.181 0.992 . . . . 0.0 111.421 176.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.24 -17.74 63.8 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.8 1.24 . . . . 0.0 113.485 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.04 -13.99 18.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.122 1.369 . . . . 0.0 113.518 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.4 m -74.3 146.57 43.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.001 0.905 . . . . 0.0 113.356 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.73 172.33 13.01 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.54 1.536 . . . . 0.0 108.097 165.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -143.55 132.35 22.64 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.532 0.733 . . . . 0.0 111.73 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -146.04 118.69 8.58 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.894 1.678 . . . . 0.0 109.313 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 64.37 11.46 6.48 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.628 1.971 . . . . 0.0 113.859 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 93.49 -8.52 74.69 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.577 1.56 . . . . 0.0 113.795 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -79.74 143.15 34.76 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.514 1.126 . . . . 0.0 109.847 170.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 91.4 mt -97.8 152.37 19.23 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.537 0.735 . . . . 0.0 111.915 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -143.34 147.26 34.43 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.225 1.01 . . . . 0.0 113.134 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.6 tp -130.68 -169.62 2.19 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.399 1.88 . . . . 0.0 108.5 170.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 29.3 p -141.3 149.96 41.93 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.069 0.947 . . . . 0.0 113.095 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -150.81 168.9 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 126.875 2.07 . . . . 0.0 110.478 -170.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 56.4 m -144.24 161.85 37.85 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 54.0 p -147.81 179.05 1.25 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 126.926 2.09 . . . . 0.0 110.994 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -64.67 -13.76 40.84 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.389 2.726 . . . . 0.0 114.265 170.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 35.0 p -107.5 -32.36 7.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.924 1.29 . . . . 0.0 113.108 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 7.1 mm -134.4 126.88 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.451 1.1 . . . . 0.0 110.933 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -96.57 130.58 43.72 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.351 1.06 . . . . 0.0 111.53 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 60.88 36.7 18.86 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.537 1.535 . . . . 0.0 112.691 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -56.53 125.64 67.42 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.431 1.092 . . . . 0.0 110.278 169.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.93 144.36 27.21 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.169 2.579 . . . . 0.0 109.4 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 m -136.65 135.39 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.973 1.309 . . . . 0.0 110.517 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -78.0 133.22 38.03 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.22 1.008 . . . . 0.0 109.717 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.5 mm -116.05 131.08 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.354 1.462 . . . . 0.0 108.538 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -137.42 90.31 15.17 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.665 1.186 . . . . 0.0 109.979 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.39 133.1 54.91 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.635 2.89 . . . . 0.0 110.881 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -73.62 135.34 43.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.568 0.699 . . . . 0.0 112.432 -173.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -164.65 148.95 9.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.397 1.879 . . . . 0.0 110.015 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.29 134.58 44.07 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.415 1.486 . . . . 0.0 110.129 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 9.3 t -165.4 173.94 10.57 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.251 1.421 . . . . 0.0 111.326 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.94 -3.45 57.97 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.714 1.606 . . . . 0.0 113.433 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 81.1 p -158.32 165.49 34.63 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.612 1.565 . . . . 0.0 112.521 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -163.08 149.37 12.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.948 2.099 . . . . 0.0 109.499 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -65.17 147.88 52.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.236 1.014 . . . . 0.0 112.986 -174.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.4 p -164.1 145.17 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.051 1.74 . . . . 0.0 109.996 -174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -160.08 157.4 28.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.501 1.52 . . . . 0.0 111.836 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -161.79 -38.69 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.133 1.373 . . . . 0.0 112.637 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 14.9 m -74.53 -3.83 33.22 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 89.58 -174.66 41.58 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.166 1.365 . . . . 0.0 113.494 -176.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.41 -10.64 12.13 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.985 3.123 . . . . 0.0 114.154 -173.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 85.0 p -163.5 164.98 24.18 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.123 1.369 . . . . 0.0 111.969 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 19.1 m -163.99 155.06 15.89 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.343 1.857 . . . . 0.0 110.912 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 CA-C-O 118.342 -1.254 . . . . 0.0 112.959 -179.423 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 14.9 m -81.0 -9.56 59.83 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 8.1 t -163.63 169.55 18.43 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.084 1.753 . . . . 0.0 111.008 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -97.46 -163.13 31.67 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.486 1.517 . . . . 0.0 113.449 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 3.4 p -72.98 140.79 47.6 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.012 1.325 . . . . 0.0 112.153 175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.3 p -125.15 -2.99 7.58 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -92.52 -158.85 34.72 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.227 1.394 . . . . 0.0 113.262 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 45.3 t -80.97 161.79 24.14 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.628 1.171 . . . . 0.0 112.12 173.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 56.5 mtm-85 -75.0 -6.73 50.97 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 169.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -75.95 133.8 40.38 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.389 0.676 . . . . 0.0 110.783 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 52.7 t -138.22 117.27 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.424 1.09 . . . . 0.0 109.637 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -72.97 141.12 47.77 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.884 0.874 . . . . 0.0 110.468 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 81.2 t -133.05 119.37 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.477 1.511 . . . . 0.0 109.344 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -115.53 145.02 18.63 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 124.709 1.147 . . . . 0.0 113.718 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.32 17.75 28.31 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.123 1.344 . . . . 0.0 114.239 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.79 140.69 95.41 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.599 1.16 . . . . 0.0 111.121 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -54.24 156.37 13.62 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.958 3.106 . . . . 0.0 113.983 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.58 2.85 7.37 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.987 3.125 . . . . 0.0 113.448 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -140.29 41.92 1.92 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.8 1.64 . . . . 0.0 111.497 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.9 tt -124.65 142.62 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.341 1.457 . . . . 0.0 110.529 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -119.65 172.62 7.54 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.098 1.359 . . . . 0.0 113.075 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -45.68 -46.67 14.94 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.713 1.605 . . . . 0.0 113.729 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.76 -26.04 49.55 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.542 0.737 . . . . 0.0 112.446 -173.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -79.06 -37.83 37.92 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.997 0.919 . . . . 0.0 111.524 172.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 48.3 mt -65.51 -36.32 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.403 -0.811 . . . . 0.0 109.589 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 71.4 m -64.62 -52.84 55.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.922 0.889 . . . . 0.0 110.414 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.16 70.23 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.579 1.081 . . . . 0.0 112.954 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.7 m -67.2 -15.57 63.78 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -130.7 -2.73 4.2 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -61.05 -22.29 64.45 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.165 1.386 . . . . 0.0 113.127 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -56.58 -13.71 2.6 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.809 2.044 . . . . 0.0 114.941 169.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -103.69 -7.19 20.86 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.47 1.508 . . . . 0.0 113.936 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.45 175.18 14.25 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.209 1.861 . . . . 0.0 112.269 -173.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.7 149.33 91.56 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.613 2.876 . . . . 0.0 112.796 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.15 171.88 17.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.216 1.406 . . . . 0.0 112.588 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -134.37 157.94 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.731 1.612 . . . . 0.0 109.431 167.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 98.6 t -125.94 137.74 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.643 1.177 . . . . 0.0 110.992 -171.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.57 159.08 43.09 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.603 1.961 . . . . 0.0 111.456 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -160.13 163.99 20.9 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.847 1.259 . . . . 0.0 112.304 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -59.1 136.51 73.46 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.459 2.772 . . . . 0.0 112.765 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 67.44 12.66 9.02 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.547 1.539 . . . . 0.0 114.46 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -62.66 -24.1 67.44 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.326 -1.484 . . . . 0.0 112.741 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -85.96 -8.37 58.04 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.929 2.092 . . . . 0.0 114.538 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -138.39 -21.19 1.05 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.5 t -85.31 140.87 30.47 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.748 -1.22 . . . . 0.0 112.008 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -81.01 56.94 2.93 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.995 1.318 . . . . 0.0 112.453 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 92.7 p -159.9 175.72 12.72 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.424 1.49 . . . . 0.0 112.569 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -135.13 27.97 3.48 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.413 1.485 . . . . 0.0 112.773 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -126.66 150.83 72.15 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 127.23 2.212 . . . . 0.0 109.471 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.66 117.86 5.18 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.05 2.5 . . . . 0.0 110.406 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -86.18 10.77 3.53 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.256 2.637 . . . . 0.0 113.863 -171.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -124.09 -5.33 7.89 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.85 1.66 . . . . 0.0 113.867 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.73 13.1 83.82 Favored Glycine 0 N--CA 1.474 1.233 0 C-N-CA 124.581 1.086 . . . . 0.0 113.951 -172.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -151.5 158.76 44.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.842 1.257 . . . . 0.0 112.654 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.14 167.48 26.72 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.671 1.188 . . . . 0.0 111.617 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.85 118.27 33.75 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.593 1.957 . . . . 0.0 109.599 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.5 mt -82.83 141.26 32.42 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.983 1.313 . . . . 0.0 108.688 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.5 mt -122.67 105.87 10.46 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.711 1.604 . . . . 0.0 107.768 170.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -81.14 156.61 25.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.218 0.607 . . . . 0.0 112.106 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -80.74 -24.62 38.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.152 0.981 . . . . 0.0 113.174 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -142.19 140.9 32.5 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.493 1.517 . . . . 0.0 110.357 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.77 -35.04 70.22 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.819 0.847 . . . . 0.0 111.96 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.9 m -56.95 -25.53 58.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.792 1.237 . . . . 0.0 113.212 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.3 m -69.23 -28.13 66.07 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.867 -1.146 . . . . 0.0 112.175 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.09 -37.42 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 121.602 -0.686 . . . . 0.0 109.775 175.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -70.26 -37.51 74.91 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.536 -0.728 . . . . 0.0 111.765 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.24 86.48 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.553 0.615 . . . . 0.0 112.079 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.6 tp -64.44 -49.81 70.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.463 0.705 . . . . 0.0 110.995 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.62 -41.66 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.094 0.958 . . . . 0.0 111.478 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.56 -18.24 63.63 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.799 1.24 . . . . 0.0 113.507 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.88 -13.64 19.96 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.21 1.404 . . . . 0.0 113.377 174.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.6 m -72.84 143.17 47.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.05 0.929 . . . . 0.0 113.37 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.27 175.9 9.9 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.779 1.632 . . . . 0.0 107.955 165.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -145.92 133.91 21.41 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.176 0.591 . . . . 0.0 111.712 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -142.01 112.18 6.96 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.995 1.718 . . . . 0.0 109.774 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 64.77 10.73 6.29 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.047 2.139 . . . . 0.0 113.833 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 99.79 -6.56 58.77 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.802 1.668 . . . . 0.0 113.834 -171.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -84.91 136.58 33.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.83 1.252 . . . . 0.0 109.671 173.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.9 mt -87.02 151.53 23.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.859 0.754 . . . . 0.0 111.904 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -142.23 154.09 44.51 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.88 1.272 . . . . 0.0 113.097 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.7 tp -141.8 158.29 43.98 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.627 1.571 . . . . 0.0 109.719 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 72.2 m -99.45 137.23 38.24 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.951 0.9 . . . . 0.0 112.105 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.9 m -144.78 177.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 126.762 2.025 . . . . 0.0 110.662 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 89.4 p -159.49 171.4 19.77 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.946 -1.096 . . . . 0.0 113.496 -175.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 91.6 p -155.16 179.91 1.23 Allowed Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 126.311 1.844 . . . . 0.0 110.586 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.51 -26.06 70.1 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.847 2.365 . . . . 0.0 113.933 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 40.3 p -116.35 -32.93 5.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.7 1.2 . . . . 0.0 113.793 -174.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 21.3 mm -112.18 127.78 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.932 1.293 . . . . 0.0 109.904 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -119.7 142.16 48.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.283 1.433 . . . . 0.0 112.075 -168.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.46 32.92 19.89 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.042 1.337 . . . . 0.0 112.94 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -70.38 128.56 91.17 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.529 1.132 . . . . 0.0 111.428 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -83.48 131.31 5.53 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.279 2.653 . . . . 0.0 108.845 169.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.71 135.19 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.269 1.428 . . . . 0.0 110.294 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -79.15 131.25 36.16 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.095 0.958 . . . . 0.0 109.83 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.38 131.81 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.042 1.337 . . . . 0.0 109.319 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -137.78 90.25 14.53 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.953 1.301 . . . . 0.0 110.287 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -61.06 132.2 40.69 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.157 2.571 . . . . 0.0 110.695 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 53.3 t-105 -82.06 148.57 28.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.448 0.699 . . . . 0.0 112.745 -174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -157.06 157.4 34.53 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.989 1.316 . . . . 0.0 111.749 175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 78.6 mt -71.69 172.32 9.95 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.666 1.186 . . . . 0.0 111.666 172.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 14.7 m -67.37 1.59 2.15 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -175.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -73.85 -19.2 60.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.473 1.509 . . . . 0.0 113.639 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 11.1 t -163.11 138.93 6.9 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.746 1.218 . . . . 0.0 112.024 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -165.27 168.4 17.0 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.402 2.281 . . . . 0.0 110.182 -173.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.26 145.52 51.02 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.948 1.699 . . . . 0.0 111.526 -175.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 7.7 p -161.02 137.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.789 1.635 . . . . 0.0 109.947 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -111.34 -0.23 16.43 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.061 1.344 . . . . 0.0 113.358 -174.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.25 -9.88 59.05 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.585 1.554 . . . . 0.0 113.624 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 32.8 p -74.08 -10.09 59.28 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.385 1.474 . . . . 0.0 114.193 175.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 78.84 -158.33 44.6 Favored Glycine 0 CA--C 1.543 1.805 0 C-N-CA 124.46 1.029 . . . . 0.0 113.912 174.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.86 161.23 39.46 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.916 3.077 . . . . 0.0 111.97 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 48.1 p -80.22 1.25 29.14 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.914 1.286 . . . . 0.0 114.46 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 19.1 m -163.55 152.1 13.8 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.08 2.152 . . . . 0.0 110.883 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.344 -1.253 . . . . 0.0 112.841 179.742 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 112.086 -0.406 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 7.9 t -163.35 -179.6 6.67 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.423 1.489 . . . . 0.0 111.295 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 49.5 m -67.75 146.33 53.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.25 1.42 . . . . 0.0 113.156 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -80.57 56.29 4.72 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.864 1.697 . . . . 0.0 111.564 175.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 22.7 m -73.04 -6.16 43.68 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.225 1.41 . . . . 0.0 114.594 -171.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 80.2 p -158.54 157.75 32.66 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.841 1.257 . . . . 0.0 113.027 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 154.14 -68.5 0.3 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.505 2.002 . . . . 0.0 110.55 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 18.4 t -153.04 162.6 41.13 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.702 1.601 . . . . 0.0 112.23 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -100.01 -3.72 31.52 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.355 1.462 . . . . 0.0 112.683 171.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -86.47 139.8 30.55 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.009 0.924 . . . . 0.0 111.533 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.1 t -140.74 120.76 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.537 1.135 . . . . 0.0 110.378 176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -71.65 140.2 49.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.195 0.998 . . . . 0.0 110.945 171.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.19 115.62 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.368 1.467 . . . . 0.0 109.217 173.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -114.91 144.27 18.37 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 124.942 1.258 . . . . 0.0 113.509 -177.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.85 17.64 29.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.956 1.265 . . . . 0.0 114.163 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 94.2 mt -61.21 141.48 93.97 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.713 1.205 . . . . 0.0 111.017 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.75 154.3 12.82 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.915 3.077 . . . . 0.0 113.746 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.43 3.78 6.5 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.93 3.087 . . . . 0.0 113.508 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -140.41 23.37 2.34 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.178 1.391 . . . . 0.0 112.227 -173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.4 tt -100.25 127.68 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.285 1.034 . . . . 0.0 111.029 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -92.99 165.71 12.73 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.497 1.119 . . . . 0.0 113.214 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -45.78 -45.51 14.71 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.918 1.687 . . . . 0.0 113.7 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -77.19 -29.24 54.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.777 0.831 . . . . 0.0 112.514 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -72.47 -38.71 68.15 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.416 0.686 . . . . 0.0 112.018 169.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.16 -39.6 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 119.193 0.906 . . . . 0.0 109.585 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 53.4 m -63.24 -51.62 65.46 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.438 0.695 . . . . 0.0 110.613 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.42 -29.08 70.25 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.38 0.991 . . . . 0.0 113.156 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.2 m -66.56 -22.83 66.15 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -123.46 -3.88 8.33 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.3 tpt85 -60.55 -22.36 63.57 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.275 1.43 . . . . 0.0 113.396 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -55.76 -18.71 8.96 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.384 1.874 . . . . 0.0 114.724 171.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -98.71 -3.4 35.96 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.508 1.523 . . . . 0.0 113.561 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.16 170.41 14.0 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.905 1.717 . . . . 0.0 111.982 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.9 151.0 78.62 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.667 2.912 . . . . 0.0 111.979 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.58 171.82 18.26 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.528 1.531 . . . . 0.0 112.498 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.9 p -132.66 157.34 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.494 1.518 . . . . 0.0 109.287 167.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 48.9 t -125.34 135.68 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.662 1.185 . . . . 0.0 110.351 -172.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -143.22 161.54 37.98 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.264 1.826 . . . . 0.0 111.699 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -156.85 158.46 31.28 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 124.92 1.288 . . . . 0.0 111.929 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -59.08 137.44 79.43 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.184 2.589 . . . . 0.0 113.219 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 66.75 16.41 10.37 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 126.098 1.759 . . . . 0.0 114.433 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -65.34 -20.16 66.28 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.632 -1.293 . . . . 0.0 112.678 174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -64.98 -33.69 76.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.745 1.618 . . . . 0.0 112.824 169.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -95.46 -51.7 4.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.961 1.304 . . . . 0.0 111.212 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.6 m -80.9 114.18 19.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.495 1.118 . . . . 0.0 111.336 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 1.55 16.8 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.2 p -68.14 131.98 46.38 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.097 1.359 . . . . 0.0 112.358 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -89.24 24.01 2.31 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.142 1.377 . . . . 0.0 113.422 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -126.74 141.09 39.32 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 128.43 2.692 . . . . 0.0 108.11 173.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.43 118.08 5.4 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.962 2.442 . . . . 0.0 110.064 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -86.12 18.62 1.54 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.511 2.807 . . . . 0.0 113.097 -173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -132.78 -4.7 3.21 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.601 1.56 . . . . 0.0 114.27 -171.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.61 13.9 82.68 Favored Glycine 0 N--CA 1.476 1.365 0 C-N-CA 124.5 1.047 . . . . 0.0 114.316 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -153.82 158.81 41.41 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.777 1.231 . . . . 0.0 112.591 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -151.03 167.45 27.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.735 1.214 . . . . 0.0 111.641 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.45 118.22 33.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.312 1.845 . . . . 0.0 109.365 173.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 34.8 mt -81.34 138.98 35.62 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.032 1.333 . . . . 0.0 108.778 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 55.2 mt -122.71 104.42 9.3 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.913 1.685 . . . . 0.0 107.863 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -81.6 157.52 24.69 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.59 0.756 . . . . 0.0 111.764 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -73.15 -27.4 61.64 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.647 -0.658 . . . . 0.0 112.485 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.85 145.29 39.83 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.851 1.261 . . . . 0.0 110.731 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -62.73 -32.11 73.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.255 0.622 . . . . 0.0 111.535 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.3 m -56.73 -27.13 58.69 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.65 1.18 . . . . 0.0 113.289 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.7 m -68.96 -25.89 64.77 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.863 -1.148 . . . . 0.0 112.29 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.68 -38.3 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.707 -0.621 . . . . 0.0 109.985 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 15.1 tp60 -66.34 -39.36 89.15 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.645 -0.659 . . . . 0.0 111.463 170.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.0 -38.75 83.51 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.62 0.646 . . . . 0.0 112.498 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 26.8 tp -65.4 -48.42 72.92 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.517 0.727 . . . . 0.0 111.213 171.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 71.8 mt -55.27 -40.13 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.968 0.907 . . . . 0.0 111.528 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.37 -17.77 63.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.874 1.27 . . . . 0.0 113.683 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.09 -13.56 18.95 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.956 1.302 . . . . 0.0 113.248 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 55.1 m -74.59 146.43 42.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.14 0.971 . . . . 0.0 113.499 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.74 173.93 12.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.686 1.594 . . . . 0.0 107.777 164.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -141.44 130.81 23.68 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.477 0.711 . . . . 0.0 111.062 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -146.15 122.35 10.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.724 1.609 . . . . 0.0 109.652 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 62.78 9.63 3.74 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.663 1.985 . . . . 0.0 114.61 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 105.17 -11.75 48.26 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 126.336 1.922 . . . . 0.0 114.051 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -91.64 155.6 18.22 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.916 1.286 . . . . 0.0 112.311 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.12 151.04 20.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.705 1.202 . . . . 0.0 111.633 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -142.16 142.78 32.75 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.089 0.956 . . . . 0.0 113.054 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -127.02 -179.36 4.8 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.605 1.562 . . . . 0.0 108.91 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 71.7 m -128.38 142.3 51.16 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.274 1.03 . . . . 0.0 112.176 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 29.8 m -148.91 173.13 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 126.08 1.752 . . . . 0.0 111.761 -174.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 79.9 p -160.42 171.41 19.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.103 1.361 . . . . 0.0 112.906 -173.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.5 p -153.06 -176.18 0.57 Allowed Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 126.563 1.945 . . . . 0.0 110.565 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -63.91 -14.27 42.21 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.069 2.513 . . . . 0.0 114.38 170.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 60.7 p -122.3 -18.12 6.89 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.116 1.367 . . . . 0.0 114.114 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.4 mm -132.79 135.09 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.693 1.597 . . . . 0.0 110.363 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -128.38 136.18 50.56 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.849 1.26 . . . . 0.0 111.668 -171.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 58.76 28.68 17.66 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.305 1.442 . . . . 0.0 113.61 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -73.92 129.52 84.74 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.761 -1.212 . . . . 0.0 111.313 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.93 143.37 16.29 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.296 2.664 . . . . 0.0 109.758 171.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 2.4 m -129.43 135.72 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.309 1.444 . . . . 0.0 110.711 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -79.1 119.13 21.78 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.666 1.586 . . . . 0.0 109.565 -175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 31.3 mm -105.62 124.93 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.822 1.249 . . . . 0.0 108.477 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -133.11 92.22 25.94 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.243 1.017 . . . . 0.0 110.366 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -58.56 140.69 95.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.59 2.86 . . . . 0.0 111.569 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -80.9 20.77 0.74 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.872 0.869 . . . . 0.0 112.781 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -68.17 -18.33 64.57 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.839 1.255 . . . . 0.0 112.836 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 56.5 tp -88.06 123.11 32.41 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.569 1.548 . . . . 0.0 109.353 170.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 34.5 m -128.52 4.31 5.61 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -141.01 8.64 2.09 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.184 1.394 . . . . 0.0 114.166 -169.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 10.3 t -164.91 174.39 10.61 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.536 1.535 . . . . 0.0 111.408 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -126.35 -2.92 6.85 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.258 1.823 . . . . 0.0 112.408 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -85.98 123.43 31.3 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.566 1.146 . . . . 0.0 110.322 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.3 p -151.98 36.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.384 1.473 . . . . 0.0 110.979 -171.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 99.1 mtp -141.05 140.3 34.22 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.628 1.571 . . . . 0.0 110.89 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -166.36 152.5 8.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.807 1.643 . . . . 0.0 111.839 -175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 67.5 m -141.57 4.01 1.72 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.148 1.779 . . . . 0.0 113.441 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -78.34 152.36 37.76 Favored Glycine 0 CA--C 1.542 1.719 0 O-C-N 120.916 -1.115 . . . . 0.0 113.575 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.6 160.25 31.65 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.955 3.103 . . . . 0.0 111.668 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.8 m -75.42 -5.8 46.79 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 16.4 m -167.58 155.3 8.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.617 2.367 . . . . 0.0 110.78 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.256 -1.302 . . . . 0.0 112.891 179.268 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 35.8 p -165.58 158.89 16.07 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.112 1.365 . . . . 0.0 111.81 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 28.3 m -69.61 142.41 53.51 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.094 0.958 . . . . 0.0 113.086 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 173.66 -169.09 42.14 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.068 1.318 . . . . 0.0 113.202 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 72.7 m -134.79 125.8 27.64 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.637 1.175 . . . . 0.0 110.861 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 71.7 m -94.04 139.47 30.92 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.3 1.04 . . . . 0.0 112.948 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 84.02 165.55 39.09 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.851 1.215 . . . . 0.0 113.71 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 23.8 t -72.8 168.12 19.49 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.833 0.853 . . . . 0.0 111.84 170.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 76.3 mtm-85 -67.72 -14.96 63.39 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -77.4 134.32 38.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.529 1.132 . . . . 0.0 110.485 169.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.9 t -140.26 118.24 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.159 0.984 . . . . 0.0 110.039 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.47 139.23 45.63 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.618 0.767 . . . . 0.0 110.273 171.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 67.2 t -130.99 118.47 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.349 1.459 . . . . 0.0 109.156 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -115.29 151.27 18.51 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 124.789 1.185 . . . . 0.0 113.814 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 89.97 20.88 41.2 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.594 1.092 . . . . 0.0 113.802 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.61 144.61 72.31 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 124.885 1.274 . . . . 0.0 111.64 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.72 145.39 71.64 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.035 2.49 . . . . 0.0 112.02 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.07 0.52 7.12 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.921 3.081 . . . . 0.0 113.51 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -128.49 19.4 6.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 127.199 2.199 . . . . 0.0 112.291 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.5 tt -100.47 156.39 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.092 1.357 . . . . 0.0 111.96 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -135.25 170.57 15.71 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.186 1.395 . . . . 0.0 112.624 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -50.55 -42.27 55.09 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.386 1.475 . . . . 0.0 113.71 -172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.84 -27.65 44.27 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.561 0.744 . . . . 0.0 112.171 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -74.68 -39.15 62.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.811 0.845 . . . . 0.0 111.409 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.1 mt -64.43 -39.04 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.893 0.77 . . . . 0.0 109.564 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 59.1 m -63.1 -52.08 64.06 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.478 174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.09 71.38 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.569 1.077 . . . . 0.0 112.944 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.4 m -68.51 -14.81 63.26 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -129.31 -3.16 4.97 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.312 0.96 . . . . 0.0 113.546 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -60.76 -22.45 64.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.98 1.312 . . . . 0.0 113.133 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -56.98 -12.01 1.79 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.794 2.037 . . . . 0.0 115.009 170.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -106.28 -4.15 20.43 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.527 1.531 . . . . 0.0 113.986 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.82 171.49 14.05 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.792 1.663 . . . . 0.0 112.204 -170.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.37 150.2 58.04 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.659 2.906 . . . . 0.0 112.242 -175.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.6 172.41 17.2 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.587 1.555 . . . . 0.0 112.632 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.85 159.43 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.747 1.619 . . . . 0.0 109.368 167.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.17 137.57 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.61 1.164 . . . . 0.0 110.729 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -147.52 163.53 36.27 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.407 1.883 . . . . 0.0 111.552 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . 0.401 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 14.1 p90 -160.59 162.97 22.34 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.027 1.331 . . . . 0.0 112.373 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -58.15 146.65 87.35 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.566 2.844 . . . . 0.0 113.428 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 68.6 4.31 4.28 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.903 1.681 . . . . 0.0 114.623 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.401 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 59.9 tttm -66.21 -21.48 66.31 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.166 1.387 . . . . 0.0 113.005 -173.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -76.78 -14.36 59.93 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.261 2.224 . . . . 0.0 114.384 175.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -124.87 -54.15 1.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.157 1.383 . . . . 0.0 110.577 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 21.2 m -77.81 54.23 1.23 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.64 1.976 . . . . 0.0 110.667 169.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -58.12 113.94 2.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.629 1.972 . . . . 0.0 111.836 -172.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 29.9 t -167.89 158.33 10.61 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.109 1.364 . . . . 0.0 110.996 -171.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.69 -4.56 58.71 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.003 1.321 . . . . 0.0 113.83 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -119.64 139.82 28.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.644 1.577 . . . . 0.0 110.158 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.57 121.36 7.63 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.385 2.724 . . . . 0.0 110.988 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -88.2 19.31 1.35 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.001 3.134 . . . . 0.0 113.006 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.03 -9.42 2.31 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.138 1.375 . . . . 0.0 114.633 -169.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 75.53 12.1 83.93 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 124.206 0.907 . . . . 0.0 113.988 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -152.95 160.85 43.07 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.314 1.445 . . . . 0.0 112.293 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.89 164.89 35.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.787 1.235 . . . . 0.0 111.808 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -110.84 117.79 34.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.158 1.783 . . . . 0.0 109.672 173.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.7 mt -82.59 140.94 32.95 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.99 1.316 . . . . 0.0 108.535 168.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 53.8 mt -125.1 104.85 8.76 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.622 1.569 . . . . 0.0 107.879 172.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -83.19 157.61 22.66 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.557 0.743 . . . . 0.0 111.505 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -83.26 -13.99 54.09 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.28 141.59 33.94 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.439 1.496 . . . . 0.0 110.617 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.68 -33.58 74.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.233 0.613 . . . . 0.0 111.359 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 12.4 m -59.51 -24.03 63.3 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.313 1.045 . . . . 0.0 113.057 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 22.9 m -70.67 -30.22 66.76 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.902 -1.124 . . . . 0.0 111.896 172.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.36 -34.91 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.502 -0.749 . . . . 0.0 109.902 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -69.64 -37.2 76.69 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.572 -0.705 . . . . 0.0 111.974 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.38 -37.39 85.53 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.961 0.8 . . . . 0.0 112.207 172.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.2 tp -63.66 -49.2 74.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.487 0.715 . . . . 0.0 110.894 171.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 74.2 mt -56.23 -41.83 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.122 0.969 . . . . 0.0 111.557 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.51 -18.34 64.36 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.784 1.234 . . . . 0.0 113.63 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.99 -14.25 18.74 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.086 1.354 . . . . 0.0 113.487 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 53.3 m -72.55 144.56 47.89 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.019 0.914 . . . . 0.0 113.235 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.12 172.42 13.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.386 1.475 . . . . 0.0 107.782 165.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.19 127.14 18.31 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.384 0.674 . . . . 0.0 110.939 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -148.91 129.03 13.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.97 1.708 . . . . 0.0 109.646 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 55.82 31.53 17.81 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.556 1.543 . . . . 0.0 113.767 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 85.25 5.1 85.79 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.517 1.532 . . . . 0.0 114.347 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -123.74 147.7 47.26 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.745 1.618 . . . . 0.0 110.917 -170.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.64 150.83 23.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.324 0.65 . . . . 0.0 111.766 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -141.84 148.81 39.42 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.565 1.146 . . . . 0.0 112.732 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.6 tp -131.9 171.06 14.03 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.03 1.732 . . . . 0.0 109.07 171.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 87.3 m -117.42 142.96 46.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.171 0.988 . . . . 0.0 112.351 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.5 m -146.21 172.94 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 126.848 2.059 . . . . 0.0 110.919 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 47.1 m -150.2 167.0 28.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.077 1.351 . . . . 0.0 112.344 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.9 m -161.54 167.44 13.05 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 127.755 2.422 . . . . 0.0 110.653 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.3 -22.03 14.78 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 124.407 3.405 . . . . 0.0 117.917 -169.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 62.8 p -123.15 2.1 9.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.855 1.262 . . . . 0.0 113.908 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 30.3 mm -138.66 117.61 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.884 1.674 . . . . 0.0 110.536 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -118.35 137.73 52.9 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.375 1.07 . . . . 0.0 113.043 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 60.8 30.98 20.02 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.359 1.464 . . . . 0.0 112.423 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -63.89 126.25 89.56 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 124.739 1.216 . . . . 0.0 111.025 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.91 138.14 11.43 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.253 2.636 . . . . 0.0 109.067 171.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 9.7 m -130.98 132.26 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.061 1.344 . . . . 0.0 109.896 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -81.08 130.4 35.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.32 1.048 . . . . 0.0 109.876 -173.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 31.9 mm -111.01 132.03 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.905 1.282 . . . . 0.0 109.333 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -137.89 91.94 13.07 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 124.976 1.31 . . . . 0.0 110.192 -175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.66 132.62 49.14 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.406 2.737 . . . . 0.0 110.678 172.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -76.52 146.01 38.73 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -171.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -156.02 125.71 6.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.87 1.668 . . . . 0.0 109.659 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 31.3 tp -100.74 -11.74 19.68 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.365 1.466 . . . . 0.0 112.935 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 30.8 m -101.48 -11.51 19.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.906 1.282 . . . . 0.0 113.632 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -160.09 155.22 24.85 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.48 1.912 . . . . 0.0 111.03 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 79.9 p -156.83 10.44 0.22 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.057 1.743 . . . . 0.0 113.564 -172.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.39 105.94 3.72 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.204 1.401 . . . . 0.0 111.886 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.87 165.28 23.59 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.419 1.888 . . . . 0.0 113.184 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.9 p -154.61 142.57 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.724 1.61 . . . . 0.0 110.791 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 11.5 tpt -159.29 144.41 15.76 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.41 1.884 . . . . 0.0 110.297 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -77.15 140.05 40.1 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.221 1.408 . . . . 0.0 112.525 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.0 t -164.74 148.74 9.07 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.392 1.477 . . . . 0.0 111.115 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 81.15 -177.73 54.21 Favored Glycine 0 CA--C 1.542 1.736 0 C-N-CA 124.687 1.137 . . . . 0.0 114.317 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.61 162.08 33.33 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 124.233 3.289 . . . . 0.0 111.956 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 23.9 t -161.65 154.79 20.89 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.186 1.394 . . . . 0.0 111.403 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 56.2 p -89.71 -6.31 56.2 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.07 1.348 . . . . 0.0 113.914 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.084 1.326 . . . . 0.0 113.244 179.535 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.545 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 8.6 t -162.53 177.29 9.59 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.497 1.519 . . . . 0.0 110.996 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 10.0 t -153.71 156.84 38.57 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.808 1.243 . . . . 0.0 112.433 -170.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 169.53 -149.34 13.19 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 126.174 1.845 . . . . 0.0 111.672 -169.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 8.7 t -160.49 174.73 13.65 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.251 1.024 . . . . 0.0 113.452 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 78.4 p -151.65 11.39 0.59 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.732 2.013 . . . . 0.0 112.912 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -75.35 159.27 51.37 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.661 1.124 . . . . 0.0 114.129 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 17.0 t -76.93 178.53 6.84 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.274 1.43 . . . . 0.0 113.076 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -67.37 -15.51 63.72 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.821 1.249 . . . . 0.0 113.191 170.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -77.99 135.73 37.85 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.839 1.256 . . . . 0.0 110.654 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.52 121.63 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.274 1.03 . . . . 0.0 110.426 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.44 140.25 55.76 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.337 1.055 . . . . 0.0 111.385 172.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 56.9 t -133.53 123.18 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 109.422 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -122.11 149.37 17.08 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.452 1.501 . . . . 0.0 113.191 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.31 14.05 52.23 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.958 1.266 . . . . 0.0 114.366 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.96 141.59 85.93 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.031 1.332 . . . . 0.0 111.012 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.42 153.56 17.37 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.874 3.049 . . . . 0.0 113.638 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.73 6.1 4.77 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.002 3.135 . . . . 0.0 113.353 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -140.27 28.56 2.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.476 1.51 . . . . 0.0 111.9 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.8 tt -107.75 150.19 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.293 1.437 . . . . 0.0 110.075 172.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -124.77 170.29 11.16 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.81 1.244 . . . . 0.0 112.706 -176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -44.78 -46.23 10.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.409 1.884 . . . . 0.0 113.913 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -78.94 -26.31 43.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.65 0.78 . . . . 0.0 112.295 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -77.11 -36.53 55.49 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.684 0.794 . . . . 0.0 111.462 171.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.17 -38.73 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.322 0.965 . . . . 0.0 109.566 171.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 57.8 m -62.64 -52.03 64.92 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.367 0.667 . . . . 0.0 110.471 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.49 -30.95 70.94 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.401 1.001 . . . . 0.0 112.978 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.2 m -67.97 -14.67 63.15 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -129.82 -2.82 4.69 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.457 1.026 . . . . 0.0 113.604 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -60.31 -22.5 63.25 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.943 1.297 . . . . 0.0 113.104 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -56.83 -12.53 1.98 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.791 2.036 . . . . 0.0 115.103 170.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -105.65 -4.93 20.49 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.396 1.478 . . . . 0.0 113.974 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.48 172.96 14.14 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.801 1.667 . . . . 0.0 112.288 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -71.87 149.94 54.56 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.736 2.957 . . . . 0.0 112.29 -174.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.27 172.7 16.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.485 1.514 . . . . 0.0 112.668 -170.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.03 161.09 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.868 1.667 . . . . 0.0 108.728 167.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.49 135.25 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.273 1.029 . . . . 0.0 110.246 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -145.09 164.16 32.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.405 1.882 . . . . 0.0 111.538 -169.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -162.69 160.97 19.83 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.168 1.387 . . . . 0.0 112.015 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -57.5 148.88 69.92 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.49 2.793 . . . . 0.0 112.672 177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 8.0 m170 72.98 -4.85 2.06 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 126.072 1.749 . . . . 0.0 114.098 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -67.34 -22.48 65.59 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.899 1.28 . . . . 0.0 112.471 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -82.89 -8.81 59.54 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.174 2.19 . . . . 0.0 114.19 173.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -120.71 -23.02 6.11 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.411 1.484 . . . . 0.0 112.838 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 49.7 m -143.25 126.86 16.95 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.13 1.772 . . . . 0.0 109.816 172.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.72 132.78 52.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.598 0.759 . . . . 0.0 111.662 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 35.6 p -160.35 153.91 22.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.718 1.207 . . . . 0.0 111.605 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -138.83 20.15 2.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.092 1.357 . . . . 0.0 112.787 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -126.61 146.47 57.0 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 127.233 2.213 . . . . 0.0 109.682 175.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.71 124.46 9.77 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.199 2.6 . . . . 0.0 110.632 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.62 130.52 19.67 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.089 2.526 . . . . 0.0 110.067 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 58.68 12.84 2.35 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.49 1.516 . . . . 0.0 114.548 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 85.64 28.81 28.47 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.903 1.24 . . . . 0.0 114.315 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -140.33 157.95 44.78 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.469 1.635 . . . . 0.0 113.914 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.8 170.64 21.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.522 1.529 . . . . 0.0 111.625 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.53 120.49 36.9 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.952 1.701 . . . . 0.0 109.944 173.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.1 mt -80.99 140.83 34.97 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.848 1.259 . . . . 0.0 108.739 169.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 58.3 mt -124.34 101.98 7.45 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.696 1.598 . . . . 0.0 107.702 171.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -80.21 154.33 28.0 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.307 0.643 . . . . 0.0 110.978 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -76.89 -19.39 57.5 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.461 -0.774 . . . . 0.0 112.91 177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -140.94 142.4 34.38 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.945 1.298 . . . . 0.0 110.799 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.71 -31.38 71.53 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.526 0.731 . . . . 0.0 111.649 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.4 m -56.39 -28.34 58.96 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.625 1.17 . . . . 0.0 112.899 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -28.4 62.45 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.964 -1.085 . . . . 0.0 112.118 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 59.3 t -76.32 -37.76 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 121.668 -0.645 . . . . 0.0 109.839 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -66.3 -38.14 87.03 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.578 -0.701 . . . . 0.0 111.85 172.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.5 91.21 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.557 0.617 . . . . 0.0 112.367 173.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 30.6 tp -63.53 -48.37 77.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.429 0.692 . . . . 0.0 110.926 171.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 69.9 mt -56.23 -43.25 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.249 1.02 . . . . 0.0 111.33 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -68.33 -18.88 64.6 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.682 1.193 . . . . 0.0 113.542 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.11 -13.65 19.72 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.185 1.394 . . . . 0.0 113.605 175.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.06 150.05 37.37 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.164 0.983 . . . . 0.0 113.617 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.3 mt -86.25 177.79 7.38 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.035 1.734 . . . . 0.0 107.843 165.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -145.66 133.64 21.39 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.437 0.695 . . . . 0.0 111.623 -175.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -164.51 139.97 5.8 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.66 1.584 . . . . 0.0 110.219 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 27.1 t70 60.28 28.62 18.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.813 1.245 . . . . 0.0 113.517 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 82.74 3.5 90.47 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.117 1.341 . . . . 0.0 114.175 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -123.52 162.44 22.9 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.719 2.008 . . . . 0.0 111.343 -170.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.8 mt -98.38 157.02 16.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.025 0.93 . . . . 0.0 111.103 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -141.04 145.47 35.92 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.977 0.911 . . . . 0.0 113.116 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.06 -173.95 3.19 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.142 1.777 . . . . 0.0 108.949 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.3 p -134.61 147.29 50.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.311 1.044 . . . . 0.0 113.276 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.2 m -152.05 -178.87 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 127.181 2.193 . . . . 0.0 110.753 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 80.5 p -161.7 170.56 19.45 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.503 1.121 . . . . 0.0 113.135 -176.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 16.2 p -142.5 -177.01 0.61 Allowed Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 126.528 1.931 . . . . 0.0 110.682 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.17 -21.97 68.22 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.881 2.387 . . . . 0.0 114.145 173.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 46.3 p -123.09 -23.05 5.03 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.6 mm -115.24 127.63 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.075 1.35 . . . . 0.0 109.79 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -122.65 139.0 54.43 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.601 1.16 . . . . 0.0 111.974 -168.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.9 t70 56.89 33.49 23.26 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.171 1.388 . . . . 0.0 112.963 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -69.45 126.56 92.72 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 117.781 -1.104 . . . . 0.0 111.201 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -80.48 142.9 14.96 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.286 2.657 . . . . 0.0 109.307 169.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.15 134.61 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.732 1.213 . . . . 0.0 110.585 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -79.14 126.41 30.71 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.902 1.681 . . . . 0.0 109.639 -175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 29.5 mm -114.87 132.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.545 1.538 . . . . 0.0 108.342 -174.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -140.96 100.05 6.57 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 123.788 0.835 . . . . 0.0 110.678 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -55.88 134.95 67.16 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.472 2.781 . . . . 0.0 110.977 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -74.37 124.37 26.37 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -169.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -76.87 114.03 15.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.605 0.762 . . . . 0.0 110.637 170.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 25.7 tp -85.0 59.75 5.82 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.753 1.221 . . . . 0.0 110.93 -178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 8.5 t -165.59 176.79 7.82 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.048 1.739 . . . . 0.0 110.889 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -80.77 51.7 1.57 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.146 1.778 . . . . 0.0 112.745 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 11.6 t -162.11 162.56 28.62 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.673 1.589 . . . . 0.0 111.764 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -154.2 39.12 0.46 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.182 1.793 . . . . 0.0 111.121 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -72.23 176.27 5.36 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.67 1.588 . . . . 0.0 113.936 -172.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.8 p -163.11 156.6 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.046 2.138 . . . . 0.0 109.626 -170.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 24.8 tpp 76.24 21.34 1.46 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.057 1.743 . . . . 0.0 113.082 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -154.12 143.11 21.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.991 1.716 . . . . 0.0 110.964 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 88.7 p -165.02 167.94 17.91 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.138 1.375 . . . . 0.0 112.494 -172.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -164.81 -177.67 37.56 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.253 1.406 . . . . 0.0 112.981 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.84 157.7 60.8 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.971 3.114 . . . . 0.0 112.392 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 13.4 m -72.49 -6.45 43.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 80.3 p -166.13 165.35 17.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.504 1.922 . . . . 0.0 111.702 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.176 0 CA-C-O 118.434 -1.203 . . . . 0.0 113.014 179.43 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.479 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 57.6 m -147.73 154.72 40.91 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.091 1.357 . . . . 0.0 111.411 -173.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 19.3 m -161.97 150.24 14.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.884 1.674 . . . . 0.0 111.129 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -93.14 172.49 33.57 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.926 1.25 . . . . 0.0 113.515 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 67.8 m 68.79 14.04 8.92 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.929 1.691 . . . . 0.0 115.27 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 23.2 m -76.8 -13.99 59.96 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -97.79 174.44 29.14 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 125.397 1.475 . . . . 0.0 113.937 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 34.4 t -85.52 153.29 22.54 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.649 0.78 . . . . 0.0 111.999 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -95.49 -3.27 47.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.453 1.101 . . . . 0.0 113.792 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -80.84 133.15 35.55 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.366 0.666 . . . . 0.0 110.765 172.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.2 115.44 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.383 1.073 . . . . 0.0 109.882 177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -71.94 140.5 49.21 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.802 0.841 . . . . 0.0 110.384 171.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.0 t -131.73 118.59 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.08 1.352 . . . . 0.0 109.23 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.91 143.71 18.15 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 124.916 1.245 . . . . 0.0 113.381 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 98.88 11.0 47.95 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.451 1.501 . . . . 0.0 114.157 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.09 142.13 80.65 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 125.113 1.365 . . . . 0.0 111.482 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.41 154.79 18.22 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.769 2.98 . . . . 0.0 113.576 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -79.21 4.47 6.55 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.835 3.023 . . . . 0.0 113.421 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -135.97 20.24 3.25 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.691 1.597 . . . . 0.0 112.301 -169.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 14.1 tt -104.02 123.38 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.696 1.199 . . . . 0.0 111.958 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -80.02 161.17 25.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.515 1.126 . . . . 0.0 112.806 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -48.1 -44.44 31.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.108 1.363 . . . . 0.0 112.543 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -74.74 -24.25 58.69 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.86 0.864 . . . . 0.0 112.891 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -78.21 -40.55 37.15 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.818 0.847 . . . . 0.0 111.118 173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 53.2 mt -62.52 -41.84 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 170.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 60.7 m -61.0 -52.28 65.69 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.496 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.45 -29.36 70.46 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.552 1.069 . . . . 0.0 113.223 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 64.8 m -67.34 -23.26 65.6 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -120.58 -5.62 9.75 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.145 0.978 . . . . 0.0 113.552 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -61.52 -22.98 65.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.169 1.387 . . . . 0.0 113.139 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -53.04 -20.72 3.77 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.587 1.955 . . . . 0.0 114.73 169.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -97.74 -9.32 26.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.502 1.521 . . . . 0.0 113.915 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 126.12 170.55 13.0 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.976 1.75 . . . . 0.0 112.034 -169.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.88 150.82 56.0 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.682 2.922 . . . . 0.0 112.601 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.06 172.92 15.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.664 1.586 . . . . 0.0 112.664 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.62 158.69 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.851 1.66 . . . . 0.0 109.488 167.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 77.5 t -130.91 137.55 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.586 1.154 . . . . 0.0 110.89 -171.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -148.1 157.54 43.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.164 1.786 . . . . 0.0 111.628 -175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -157.02 162.39 27.73 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.621 1.168 . . . . 0.0 112.428 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -59.24 139.52 90.52 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.465 2.777 . . . . 0.0 113.01 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 65.91 11.26 7.56 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.497 1.519 . . . . 0.0 114.56 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -63.35 -23.69 67.52 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 120.417 -1.427 . . . . 0.0 112.54 176.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -101.23 0.39 37.38 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.648 2.379 . . . . 0.0 113.863 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -136.07 2.52 2.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.952 1.301 . . . . 0.0 113.741 -169.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 14.0 t -151.37 147.51 27.0 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.364 1.466 . . . . 0.0 111.164 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -79.93 54.16 1.82 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.408 1.483 . . . . 0.0 112.789 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 70.5 m -132.55 111.66 11.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.805 1.242 . . . . 0.0 111.731 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -87.37 6.64 32.67 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.022 1.329 . . . . 0.0 113.388 173.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -112.0 152.98 44.69 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.115 2.166 . . . . 0.0 109.106 168.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -64.64 116.61 3.89 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.948 2.432 . . . . 0.0 110.069 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -84.32 12.01 3.16 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.719 2.946 . . . . 0.0 114.213 -169.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -135.74 1.17 2.78 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.029 1.732 . . . . 0.0 113.524 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.08 17.87 77.57 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.424 1.012 . . . . 0.0 114.259 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -152.45 158.1 42.12 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.797 1.298 . . . . 0.0 113.418 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.74 170.67 19.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.107 1.363 . . . . 0.0 111.645 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.29 121.65 41.75 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.32 1.848 . . . . 0.0 109.722 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.17 140.47 30.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.448 1.499 . . . . 0.0 108.916 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 55.0 mt -124.52 105.43 9.38 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.74 1.616 . . . . 0.0 107.96 172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -83.41 159.12 21.87 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.523 0.729 . . . . 0.0 111.353 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -87.73 -22.04 24.83 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -130.12 144.53 51.4 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.125 1.77 . . . . 0.0 110.279 173.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 37.6 mp0 -66.01 -30.51 71.07 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.416 -0.803 . . . . 0.0 111.286 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.6 m -55.15 -27.76 47.85 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.832 1.253 . . . . 0.0 112.798 173.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.7 m -71.85 -29.56 64.51 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.109 -0.995 . . . . 0.0 112.048 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.99 -37.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.522 -0.736 . . . . 0.0 109.888 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -66.3 -38.16 87.09 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.533 -0.73 . . . . 0.0 111.86 172.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.81 -37.94 88.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.317 0.647 . . . . 0.0 112.38 173.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.2 tp -64.01 -48.78 75.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.333 0.653 . . . . 0.0 110.943 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 75.5 mt -55.54 -40.9 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.231 1.012 . . . . 0.0 111.35 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.45 -17.82 63.67 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.719 1.208 . . . . 0.0 113.818 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.02 -13.66 18.97 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.067 1.347 . . . . 0.0 113.351 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 54.6 m -75.89 149.29 37.8 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.052 0.941 . . . . 0.0 113.464 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.6 mt -83.84 173.28 11.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.431 1.492 . . . . 0.0 107.785 164.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -145.36 138.24 26.17 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.528 0.731 . . . . 0.0 111.733 -174.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.1 121.51 5.79 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.893 1.277 . . . . 0.0 109.928 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 63.33 9.28 3.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.847 2.059 . . . . 0.0 113.945 -172.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 95.1 -13.19 67.43 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.842 1.687 . . . . 0.0 113.6 -170.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -72.17 141.88 49.07 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.393 1.096 . . . . 0.0 109.494 169.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.24 156.48 16.95 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.458 0.703 . . . . 0.0 111.525 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -144.81 145.87 31.84 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.993 0.917 . . . . 0.0 112.977 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.0 tp -131.62 -176.51 4.06 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.494 1.918 . . . . 0.0 108.614 172.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 89.6 m -129.63 146.12 51.45 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.508 1.049 . . . . 0.0 112.729 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 29.2 m -148.93 177.46 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 126.501 1.92 . . . . 0.0 111.531 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 80.2 p -161.13 170.79 19.71 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.096 1.358 . . . . 0.0 112.965 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 32.3 p -153.88 -179.78 1.13 Allowed Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 126.894 2.078 . . . . 0.0 110.567 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.61 -20.04 55.77 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.897 2.398 . . . . 0.0 114.403 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 57.6 p -113.88 -19.9 11.29 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.026 1.33 . . . . 0.0 114.325 -175.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.1 mm -132.31 135.99 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.489 1.516 . . . . 0.0 110.304 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -130.49 138.41 50.24 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.594 1.158 . . . . 0.0 112.179 -171.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.5 t70 57.54 29.88 17.83 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.336 1.454 . . . . 0.0 113.093 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -75.1 126.2 88.33 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-O 117.829 -1.081 . . . . 0.0 111.584 -172.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.32 141.78 18.41 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.297 2.665 . . . . 0.0 109.457 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.7 m -135.87 134.39 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.015 1.326 . . . . 0.0 110.453 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -75.37 129.67 37.74 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.555 1.142 . . . . 0.0 109.535 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.7 mm -110.92 131.21 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 125.384 1.474 . . . . 0.0 108.373 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 16.7 mtp85 -137.11 89.72 16.33 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.491 1.116 . . . . 0.0 110.106 -176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -59.05 135.67 68.01 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.839 2.359 . . . . 0.0 109.102 169.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -65.27 138.04 57.95 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -171.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -132.36 160.99 34.7 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.898 1.679 . . . . 0.0 112.28 -174.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 84.2 mt -76.8 163.95 26.31 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.521 1.128 . . . . 0.0 111.583 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 14.8 m -69.34 -8.07 43.03 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -169.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -83.98 -17.61 39.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -177.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 20.6 t -169.63 124.04 0.79 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.295 1.438 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -159.03 130.53 6.33 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.442 1.097 . . . . 0.0 111.511 -172.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -82.29 89.54 6.56 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.435 1.094 . . . . 0.0 112.058 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.59 139.92 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.466 1.906 . . . . 0.0 109.162 175.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 59.3 mtt -145.64 167.55 22.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.168 1.387 . . . . 0.0 111.946 -169.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -153.11 163.34 40.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.105 1.762 . . . . 0.0 110.999 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 22.7 m -71.15 -4.71 26.86 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -171.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -155.23 165.06 32.19 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.312 1.435 . . . . 0.0 113.551 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.83 163.93 30.68 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.087 3.191 . . . . 0.0 111.698 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 50.7 p -80.42 -4.96 55.67 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 15.5 m -167.01 153.62 8.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 127.463 2.305 . . . . 0.0 110.847 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.894 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.515 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 55.6 m -148.11 155.1 41.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.898 1.279 . . . . 0.0 111.602 -173.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 16.3 m -80.07 -0.48 35.82 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -80.69 144.23 25.15 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.961 1.267 . . . . 0.0 112.902 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 10.7 t -141.85 140.56 32.96 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.719 1.208 . . . . 0.0 111.929 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 52.0 m -152.89 160.48 43.06 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.874 1.67 . . . . 0.0 111.287 -169.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 127.05 -16.66 6.38 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.807 1.67 . . . . 0.0 114.598 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 10.2 t -161.15 154.48 21.56 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.278 1.431 . . . . 0.0 112.755 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -100.37 0.24 39.55 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.215 1.406 . . . . 0.0 112.886 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -80.41 137.86 36.56 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.694 1.198 . . . . 0.0 111.281 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.5 t -141.48 120.66 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.681 1.192 . . . . 0.0 109.763 175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -77.77 143.54 37.88 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.569 0.748 . . . . 0.0 110.79 172.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.0 t -132.02 124.62 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.58 1.552 . . . . 0.0 109.232 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -120.5 150.26 17.43 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.807 1.194 . . . . 0.0 113.409 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 90.49 20.1 42.46 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.543 1.068 . . . . 0.0 114.05 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.7 mt -58.8 146.34 75.72 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.085 1.354 . . . . 0.0 111.562 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -54.04 152.79 22.88 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.586 2.858 . . . . 0.0 112.974 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.07 0.18 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.71 2.94 . . . . 0.0 114.667 -170.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -140.7 17.1 2.34 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.389 1.075 . . . . 0.0 113.128 -175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.1 tt -80.19 131.76 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.78 0.832 . . . . 0.0 111.527 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.22 170.48 9.48 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.92 -45.57 51.15 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.479 1.512 . . . . 0.0 113.044 176.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -74.88 -32.83 61.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.004 0.921 . . . . 0.0 112.609 -178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.2 -42.32 84.36 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.554 0.742 . . . . 0.0 112.201 170.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 51.3 mt -64.15 -38.36 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 119.197 0.908 . . . . 0.0 109.83 174.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 57.5 m -63.77 -52.31 60.94 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.357 0.663 . . . . 0.0 110.639 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.6 -31.18 71.23 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.348 0.976 . . . . 0.0 112.738 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 71.6 m -67.83 -15.08 63.46 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -129.16 -2.99 5.06 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.457 1.026 . . . . 0.0 113.507 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -60.48 -22.79 63.9 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.048 1.339 . . . . 0.0 113.268 174.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -57.48 -13.0 3.05 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.594 1.958 . . . . 0.0 114.99 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -104.11 -4.1 23.63 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.42 1.488 . . . . 0.0 113.823 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.69 170.26 13.82 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 126.07 1.795 . . . . 0.0 112.062 -170.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.09 153.03 75.9 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.495 2.796 . . . . 0.0 112.129 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -162.02 171.98 16.69 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.654 1.582 . . . . 0.0 112.424 -170.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.0 p -130.84 156.66 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.655 1.582 . . . . 0.0 109.248 167.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 65.9 t -128.64 137.42 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.705 1.202 . . . . 0.0 110.283 -171.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -149.91 165.96 31.01 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.025 1.73 . . . . 0.0 111.608 -175.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . 0.449 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 26.7 p90 -157.08 155.51 28.22 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.419 1.088 . . . . 0.0 112.024 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -65.32 12.61 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 125.063 3.842 . . . . 0.0 118.102 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -132.71 -4.82 3.24 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.92 1.688 . . . . 0.0 112.794 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.449 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 37.7 ttmt -70.64 -20.45 62.72 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.557 1.143 . . . . 0.0 112.397 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -76.3 -9.76 58.89 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.054 1.741 . . . . 0.0 114.193 171.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -133.78 11.47 4.01 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.305 1.442 . . . . 0.0 113.251 -172.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 46.3 t -153.22 143.39 22.32 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.248 1.419 . . . . 0.0 111.825 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -7.46 55.55 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 66.8 m -82.76 126.38 32.33 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.173 -0.955 . . . . 0.0 112.382 -169.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -84.24 34.68 0.52 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.464 1.506 . . . . 0.0 112.936 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -136.12 135.29 21.02 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 128.143 2.577 . . . . 0.0 107.949 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.55 120.13 7.15 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.86 2.373 . . . . 0.0 109.92 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.28 11.33 3.32 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.126 2.55 . . . . 0.0 114.771 -169.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -136.79 0.57 2.45 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.616 1.566 . . . . 0.0 114.421 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 80.94 22.34 61.52 Favored Glycine 0 N--CA 1.475 1.269 0 O-C-N 121.381 -0.825 . . . . 0.0 114.686 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -151.25 155.27 38.44 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.513 1.156 . . . . 0.0 113.08 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.29 167.78 29.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.696 1.198 . . . . 0.0 112.362 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -112.65 127.16 56.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.632 1.973 . . . . 0.0 110.098 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.9 mt -92.95 139.24 30.73 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.184 1.794 . . . . 0.0 108.55 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 44.9 mt -123.93 107.56 11.48 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.458 1.503 . . . . 0.0 107.85 171.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -84.16 160.38 20.87 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.332 0.653 . . . . 0.0 112.292 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -75.65 -26.32 57.59 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.796 0.838 . . . . 0.0 112.856 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -140.09 144.79 36.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.29 1.436 . . . . 0.0 110.663 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.17 -30.88 69.62 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.711 -0.618 . . . . 0.0 111.564 174.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.4 m -55.55 -27.39 48.72 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.576 1.15 . . . . 0.0 113.139 172.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 17.1 m -73.84 -29.94 62.41 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.034 -1.041 . . . . 0.0 112.071 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.84 -38.54 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 121.744 -0.598 . . . . 0.0 109.584 173.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -68.63 -37.42 79.71 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.755 -0.591 . . . . 0.0 111.92 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.03 85.57 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.981 0.81 . . . . 0.0 112.287 173.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 31.6 tp -63.71 -48.5 76.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.378 0.671 . . . . 0.0 110.87 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 80.8 mt -56.11 -43.04 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.986 0.914 . . . . 0.0 111.392 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.01 -18.62 64.76 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.738 1.215 . . . . 0.0 113.688 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.12 -13.42 18.98 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.06 1.344 . . . . 0.0 113.533 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 34.6 m -73.46 144.73 46.14 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 122.003 0.906 . . . . 0.0 113.33 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.7 mt -81.2 172.69 13.34 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.311 1.444 . . . . 0.0 107.808 165.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -142.95 135.03 27.12 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.469 0.708 . . . . 0.0 111.363 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -159.36 135.62 9.01 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.075 1.35 . . . . 0.0 110.922 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 16.1 t70 55.82 22.02 5.24 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.78 2.032 . . . . 0.0 114.643 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 92.34 0.78 69.93 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.548 1.547 . . . . 0.0 114.525 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -114.73 161.7 17.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.704 1.602 . . . . 0.0 112.76 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.7 mt -101.2 152.32 20.79 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.708 1.203 . . . . 0.0 112.075 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -142.38 149.35 39.25 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.383 1.073 . . . . 0.0 113.144 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.3 tp -133.8 -170.44 2.5 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.475 1.91 . . . . 0.0 108.895 172.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 26.5 p -140.73 144.56 35.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.807 1.243 . . . . 0.0 112.593 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 25.3 m -147.99 171.26 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 126.255 1.822 . . . . 0.0 111.667 -169.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 40.1 m -147.65 153.66 39.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.601 1.16 . . . . 0.0 112.817 -173.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.9 p -140.89 -173.9 0.38 Allowed Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 126.383 1.873 . . . . 0.0 111.689 -174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -69.62 -10.89 29.81 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.34 2.693 . . . . 0.0 113.639 171.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 37.3 p -120.99 -32.27 3.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.076 1.35 . . . . 0.0 113.621 -171.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.0 mm -133.35 137.94 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.956 1.302 . . . . 0.0 110.005 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -119.75 135.16 54.96 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.98 1.312 . . . . 0.0 110.729 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 24.9 t70 64.53 27.3 13.41 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.344 1.457 . . . . 0.0 112.911 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -58.74 125.58 77.5 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.493 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.09 146.58 25.65 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.976 2.451 . . . . 0.0 109.776 171.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.8 m -139.3 140.56 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.16 1.384 . . . . 0.0 110.916 -174.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -83.03 132.33 35.14 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.912 1.285 . . . . 0.0 109.858 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 34.1 mm -114.95 131.23 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.831 1.252 . . . . 0.0 109.274 -174.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -135.76 90.2 19.93 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.401 1.481 . . . . 0.0 110.351 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.01 136.36 72.81 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.417 2.745 . . . . 0.0 111.041 172.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -69.93 134.88 48.86 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -147.23 150.52 35.02 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.017 1.727 . . . . 0.0 110.82 -175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 95.6 mt -136.03 156.19 49.1 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.268 1.827 . . . . 0.0 110.391 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 3.5 t 68.06 16.54 9.5 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.379 1.472 . . . . 0.0 113.271 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -157.59 162.32 38.74 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.996 2.119 . . . . 0.0 110.818 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 6.1 t -98.62 -178.51 4.02 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 125.208 1.403 . . . . 0.0 113.221 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -158.49 136.84 10.86 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.658 1.983 . . . . 0.0 110.738 -176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -63.08 151.87 38.73 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.989 1.315 . . . . 0.0 113.034 -173.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 10.9 p -157.01 138.84 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.883 1.273 . . . . 0.0 110.711 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -93.41 17.64 11.07 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.693 1.597 . . . . 0.0 113.639 -173.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -150.2 152.16 34.19 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.89 1.676 . . . . 0.0 111.824 -173.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 6.9 t -110.76 11.67 22.54 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.989 1.316 . . . . 0.0 113.661 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -78.23 -177.98 48.8 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.778 1.18 . . . . 0.0 114.1 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.36 133.26 57.09 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.462 3.442 . . . . 0.0 112.776 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 57.1 m -131.24 12.15 5.04 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.65 1.18 . . . . 0.0 113.108 -174.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 70.6 m -145.59 150.57 36.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.883 1.673 . . . . 0.0 111.435 -173.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.341 -1.255 . . . . 0.0 112.955 -179.82 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 24.7 m -66.58 144.9 56.15 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.458 1.103 . . . . 0.0 112.919 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 7.7 t -163.01 170.83 17.42 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.997 1.319 . . . . 0.0 111.683 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -78.1 83.05 1.2 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.07 1.319 . . . . 0.0 111.106 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 29.9 m -130.91 17.83 5.11 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.682 1.193 . . . . 0.0 113.531 -169.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 81.6 p -158.07 163.4 37.71 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.83 1.252 . . . . 0.0 113.072 -177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 94.38 -148.22 18.91 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.28 1.419 . . . . 0.0 112.659 -177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 33.4 t -152.66 164.04 38.49 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.438 1.095 . . . . 0.0 113.253 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -76.54 -5.23 46.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.337 1.055 . . . . 0.0 112.921 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt -64.31 136.54 57.25 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.08 0.952 . . . . 0.0 110.547 168.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 43.3 t -137.6 116.9 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.767 0.827 . . . . 0.0 109.375 169.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -73.37 137.17 44.53 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.587 0.755 . . . . 0.0 110.327 172.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 77.5 t -131.31 112.68 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.445 1.498 . . . . 0.0 108.991 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -110.45 151.29 17.58 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.117 1.342 . . . . 0.0 113.41 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 89.87 25.99 25.68 Favored Glycine 0 N--CA 1.471 1.002 0 C-N-CA 124.32 0.962 . . . . 0.0 113.891 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.77 143.21 91.33 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.787 1.235 . . . . 0.0 111.451 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.84 154.65 31.07 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.366 2.71 . . . . 0.0 113.052 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.04 3.15 6.88 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.901 3.068 . . . . 0.0 114.516 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -140.34 25.27 2.25 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.774 1.229 . . . . 0.0 112.835 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.2 tt -93.48 161.59 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.308 1.043 . . . . 0.0 110.85 171.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -140.79 169.29 17.92 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.212 1.405 . . . . 0.0 112.536 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -47.61 -43.07 25.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.581 1.952 . . . . 0.0 113.764 -173.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.5 -27.25 41.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.632 0.773 . . . . 0.0 112.317 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -77.23 -35.94 55.09 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.834 0.854 . . . . 0.0 111.466 171.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.02 -37.0 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.425 -0.797 . . . . 0.0 109.562 171.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 61.4 m -64.0 -51.78 62.64 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.506 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.21 -31.28 70.01 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.252 0.933 . . . . 0.0 112.979 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 73.4 m -68.68 -14.59 63.11 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.85 -2.09 3.31 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.586 1.085 . . . . 0.0 113.797 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -60.73 -22.63 64.2 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.745 1.218 . . . . 0.0 112.868 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -56.93 -12.29 1.91 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.603 1.961 . . . . 0.0 114.976 170.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -106.05 -6.75 18.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.404 1.482 . . . . 0.0 113.924 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.56 179.81 15.87 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.258 1.885 . . . . 0.0 112.491 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.9 145.3 90.13 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.473 2.782 . . . . 0.0 112.54 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.75 170.76 20.83 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.262 1.425 . . . . 0.0 112.423 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -135.03 158.85 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.583 1.553 . . . . 0.0 109.148 167.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 72.6 t -125.05 136.56 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.706 1.202 . . . . 0.0 110.542 -170.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -148.07 165.9 29.41 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.182 1.793 . . . . 0.0 111.698 -173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . 0.505 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 13.7 p90 -161.02 160.56 24.75 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.357 1.463 . . . . 0.0 111.906 176.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -57.68 138.11 84.5 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.345 2.696 . . . . 0.0 112.902 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 11.9 m170 76.17 0.01 3.19 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 127.289 2.236 . . . . 0.0 114.407 177.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.505 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 48.4 tttm -64.08 -24.67 67.79 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.6 -1.313 . . . . 0.0 112.427 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -86.5 -11.71 50.93 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.379 2.272 . . . . 0.0 114.246 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -112.03 -21.66 11.42 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.547 1.539 . . . . 0.0 112.37 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 22.8 t -141.35 110.41 6.22 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.959 1.704 . . . . 0.0 108.312 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.75 129.49 39.24 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.41 0.684 . . . . 0.0 112.123 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 23.0 t -164.76 161.38 20.51 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.462 1.505 . . . . 0.0 110.72 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -124.63 14.54 8.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.727 1.611 . . . . 0.0 112.566 172.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -114.5 132.96 22.58 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.88 1.672 . . . . 0.0 109.161 169.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.76 116.94 4.88 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.39 2.727 . . . . 0.0 110.512 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -89.48 15.84 1.89 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.371 2.714 . . . . 0.0 113.472 -172.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.9 mttp -137.19 -3.81 1.94 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.357 1.463 . . . . 0.0 114.42 -171.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.72 13.28 83.63 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 124.284 0.945 . . . . 0.0 114.283 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -150.08 162.82 39.66 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.889 1.276 . . . . 0.0 113.05 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -149.24 161.91 41.07 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.058 1.343 . . . . 0.0 111.759 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -109.03 118.34 36.53 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.224 1.81 . . . . 0.0 109.211 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 38.5 mt -82.19 136.93 35.04 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.72 1.208 . . . . 0.0 108.579 169.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 63.7 mt -117.03 102.76 9.61 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.755 1.622 . . . . 0.0 107.74 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -81.79 156.05 25.12 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.206 0.526 . . . . 0.0 111.736 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -76.41 -26.26 55.35 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.753 0.821 . . . . 0.0 112.848 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -142.21 146.31 35.08 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.254 1.422 . . . . 0.0 110.99 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.85 -28.89 70.34 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.528 0.731 . . . . 0.0 111.995 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 25.1 p -60.53 -25.98 66.54 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.025 -1.047 . . . . 0.0 112.984 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.9 m -73.14 -30.9 63.93 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.852 -1.155 . . . . 0.0 111.942 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.47 -39.53 62.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 O-C-N 121.765 -0.584 . . . . 0.0 109.713 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -66.77 -38.13 85.98 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.61 -0.681 . . . . 0.0 112.16 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.7 87.54 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.703 0.683 . . . . 0.0 112.368 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.63 -49.19 74.24 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.289 0.636 . . . . 0.0 110.8 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 78.6 mt -55.76 -42.2 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.951 0.9 . . . . 0.0 111.335 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.53 -17.94 63.62 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.775 1.23 . . . . 0.0 113.625 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -99.97 -12.9 19.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.06 1.344 . . . . 0.0 113.419 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 35.6 m -75.13 147.29 40.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 122.114 0.959 . . . . 0.0 113.547 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.0 mt -83.31 177.88 8.31 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.523 1.529 . . . . 0.0 107.73 164.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -145.43 134.7 22.94 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.63 -0.669 . . . . 0.0 111.382 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -160.32 132.28 6.1 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.231 1.412 . . . . 0.0 110.485 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 52.68 37.41 23.52 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.482 1.513 . . . . 0.0 113.437 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 81.22 3.27 90.69 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.738 1.161 . . . . 0.0 114.736 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -119.88 158.1 27.36 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.387 1.475 . . . . 0.0 112.175 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 88.2 mt -92.35 153.55 19.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.256 1.022 . . . . 0.0 110.971 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -140.72 148.22 40.4 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.984 0.914 . . . . 0.0 113.167 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.9 tp -134.87 173.13 12.04 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.786 1.634 . . . . 0.0 109.478 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 26.7 p -116.17 140.45 49.29 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.049 1.34 . . . . 0.0 112.58 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.38 178.48 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 126.761 2.024 . . . . 0.0 110.532 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 85.0 p -160.76 171.2 19.25 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 57.6 p -148.42 -179.34 0.94 Allowed Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 126.939 2.096 . . . . 0.0 110.957 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.67 -12.2 34.07 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.296 2.664 . . . . 0.0 114.124 170.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 37.2 p -109.86 -33.19 6.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.95 1.3 . . . . 0.0 113.255 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 6.7 mm -132.82 131.13 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.475 1.11 . . . . 0.0 110.948 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -111.73 141.2 45.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.227 1.411 . . . . 0.0 111.193 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 59.26 36.04 23.56 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.135 1.374 . . . . 0.0 112.906 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -67.41 127.7 93.5 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 120.943 -1.098 . . . . 0.0 110.899 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.35 140.91 12.39 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.34 2.693 . . . . 0.0 109.354 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.46 138.13 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.076 1.35 . . . . 0.0 110.697 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -85.13 120.59 26.8 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.171 1.788 . . . . 0.0 109.683 -172.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.27 129.49 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.998 1.319 . . . . 0.0 109.495 -171.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -135.6 94.03 15.53 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.282 1.433 . . . . 0.0 110.121 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.1 127.23 24.89 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.639 2.893 . . . . 0.0 109.522 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -75.74 148.66 38.39 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -168.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -144.06 137.8 27.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.818 1.647 . . . . 0.0 111.01 -171.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.22 -165.23 1.12 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.79 2.036 . . . . 0.0 109.714 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 15.8 m -64.61 -6.14 7.06 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.09 -2.95 56.34 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.663 1.985 . . . . 0.0 113.525 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 6.2 p -151.31 -173.67 4.58 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.096 1.759 . . . . 0.0 111.802 -168.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -163.1 143.95 9.45 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.474 -1.391 . . . . 0.0 112.163 -169.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -147.41 143.19 27.76 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.841 2.056 . . . . 0.0 109.006 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 8.3 p -164.29 149.02 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.251 1.42 . . . . 0.0 110.613 -169.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 13.4 tpt -158.11 158.62 35.06 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.181 1.793 . . . . 0.0 110.72 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 20.0 t70 82.24 -3.1 1.46 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.87 2.868 . . . . 0.0 114.394 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 22.8 m -71.07 -11.48 60.98 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.506 1.122 . . . . 0.0 113.949 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 161.21 166.94 20.93 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 126.136 1.827 . . . . 0.0 113.279 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.4 153.33 35.21 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.803 3.002 . . . . 0.0 111.419 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.2 m -67.68 -9.0 39.61 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 54.1 p -92.05 -4.74 54.04 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.052 1.741 . . . . 0.0 114.084 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.255 -1.303 . . . . 0.0 113.641 179.959 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 33.7 p -89.79 -7.59 54.06 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 83.8 p -162.8 159.88 24.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.676 1.59 . . . . 0.0 112.006 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -116.91 143.37 18.02 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 125.401 1.477 . . . . 0.0 112.193 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 70.8 m -150.67 153.69 36.07 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.941 1.296 . . . . 0.0 112.009 -175.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 16.2 p -77.81 153.6 32.65 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.799 1.24 . . . . 0.0 113.687 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -96.35 -3.64 59.93 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.641 1.115 . . . . 0.0 114.642 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 22.9 t -162.93 165.06 25.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.866 1.666 . . . . 0.0 112.23 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -79.93 -9.14 59.65 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.709 1.204 . . . . 0.0 113.108 169.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -81.54 140.0 34.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.76 0.824 . . . . 0.0 111.263 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 54.7 t -139.16 118.82 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.548 1.139 . . . . 0.0 109.758 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -73.78 140.05 45.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.314 0.646 . . . . 0.0 110.168 170.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.2 t -130.2 123.18 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.015 1.326 . . . . 0.0 109.175 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -117.67 146.17 18.64 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.724 1.154 . . . . 0.0 113.079 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 96.03 13.97 47.48 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.041 1.305 . . . . 0.0 114.241 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 93.4 mt -58.73 139.31 86.31 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.99 1.316 . . . . 0.0 110.632 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -55.1 152.42 30.44 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.433 2.755 . . . . 0.0 113.206 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.67 5.33 4.89 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.709 2.939 . . . . 0.0 114.189 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -133.78 18.07 3.87 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.765 1.626 . . . . 0.0 112.427 -174.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.7 tt -100.14 130.54 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 121.118 -0.988 . . . . 0.0 111.596 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -98.86 169.49 9.42 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 0.0 113.452 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -51.78 -41.55 61.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.096 1.359 . . . . 0.0 113.624 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -78.68 -25.3 44.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.677 0.791 . . . . 0.0 112.352 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -79.58 -36.23 38.47 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.6 0.76 . . . . 0.0 111.984 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 40.3 mt -65.53 -36.44 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.349 0.977 . . . . 0.0 109.418 169.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 89.3 m -63.53 -51.85 63.67 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.538 0.735 . . . . 0.0 110.636 172.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.39 -30.58 69.68 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.585 1.084 . . . . 0.0 112.944 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 69.9 m -67.51 -14.25 62.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -133.02 -2.01 3.25 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -60.37 -22.52 63.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.075 1.35 . . . . 0.0 112.899 173.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -57.2 -10.55 1.29 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.706 2.003 . . . . 0.0 115.133 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -108.67 -3.69 17.68 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.508 1.523 . . . . 0.0 114.127 175.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.76 178.55 15.78 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.164 1.84 . . . . 0.0 112.741 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -63.46 145.51 92.31 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.582 2.855 . . . . 0.0 112.996 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.41 170.41 21.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.634 1.574 . . . . 0.0 112.324 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.1 p -132.4 160.7 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.842 1.657 . . . . 0.0 108.635 166.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 93.5 t -135.7 138.52 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.158 0.983 . . . . 0.0 110.658 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -155.16 165.98 34.98 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.797 1.239 . . . . 0.0 112.232 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -155.75 155.24 29.26 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -62.95 157.61 47.69 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 123.812 3.008 . . . . 0.0 113.254 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 11.8 m170 68.66 3.63 3.97 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.438 1.495 . . . . 0.0 113.84 173.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -67.96 -22.2 65.04 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.391 1.876 . . . . 0.0 112.595 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -74.88 -15.59 60.71 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.904 2.081 . . . . 0.0 114.386 173.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.45 -15.31 6.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.042 1.337 . . . . 0.0 113.534 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 39.7 t -66.49 147.37 53.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.169 1.388 . . . . 0.0 112.823 172.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -95.88 6.41 48.95 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.116 1.366 . . . . 0.0 112.131 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 67.4 m -133.28 148.72 51.95 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.484 1.513 . . . . 0.0 111.927 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -88.85 26.23 1.59 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.51 1.524 . . . . 0.0 113.573 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -117.04 159.92 39.14 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 127.72 2.408 . . . . 0.0 110.035 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.26 118.63 5.57 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.7 2.267 . . . . 0.0 109.298 170.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.79 5.52 5.86 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.481 2.787 . . . . 0.0 115.157 -168.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -141.22 6.88 1.96 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.517 1.927 . . . . 0.0 113.376 -177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.66 24.28 62.92 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.229 0.918 . . . . 0.0 114.485 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -149.53 154.98 39.59 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.83 1.315 . . . . 0.0 113.512 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.32 170.5 21.73 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.835 1.254 . . . . 0.0 112.174 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -113.42 123.78 50.88 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.891 1.676 . . . . 0.0 110.67 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 22.5 mt -87.04 142.57 27.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.542 1.537 . . . . 0.0 108.74 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 65.7 mt -127.95 102.57 6.82 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.052 1.741 . . . . 0.0 108.175 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -85.1 154.99 21.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.361 0.664 . . . . 0.0 112.031 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -70.88 -27.58 63.92 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.655 0.782 . . . . 0.0 112.732 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -142.92 147.31 35.06 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.411 1.485 . . . . 0.0 110.635 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -63.58 -29.08 70.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.202 0.601 . . . . 0.0 111.952 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 23.0 p -60.24 -25.8 65.94 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.931 -1.105 . . . . 0.0 113.093 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 25.3 m -71.84 -30.8 65.84 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.815 -1.178 . . . . 0.0 111.996 171.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 49.8 t -74.84 -37.43 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.617 -0.677 . . . . 0.0 109.988 174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -68.36 -35.31 77.54 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.576 -0.702 . . . . 0.0 111.742 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.17 86.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.074 0.852 . . . . 0.0 112.493 171.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 27.3 tp -63.4 -48.33 78.29 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.189 0.596 . . . . 0.0 110.741 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.81 -42.09 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.008 0.923 . . . . 0.0 111.267 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.28 -18.46 64.53 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.701 1.2 . . . . 0.0 113.887 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.11 -13.12 19.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.99 1.316 . . . . 0.0 113.362 175.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 50.4 m -72.23 143.07 48.94 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.902 0.858 . . . . 0.0 113.186 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 92.1 mt -78.87 170.04 17.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.061 1.344 . . . . 0.0 107.956 165.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -141.88 133.01 26.2 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.579 0.752 . . . . 0.0 111.3 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -160.81 133.11 6.06 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.509 1.524 . . . . 0.0 109.928 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 27.1 t70 58.22 31.97 21.45 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.793 1.237 . . . . 0.0 113.105 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 78.77 3.69 87.53 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.056 1.312 . . . . 0.0 114.421 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -117.36 151.69 36.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.381 1.872 . . . . 0.0 110.956 -172.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 85.5 mt -99.04 151.12 21.29 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.056 0.942 . . . . 0.0 111.616 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -142.83 149.59 38.8 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.0 tp -135.0 -177.47 4.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.651 1.98 . . . . 0.0 108.734 171.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 97.3 m -131.49 145.6 51.84 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.599 1.09 . . . . 0.0 112.777 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 31.7 m -149.23 172.79 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 126.899 2.079 . . . . 0.0 111.598 -172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 58.6 m -149.38 161.58 41.8 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.833 1.253 . . . . 0.0 112.682 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 19.7 p -139.3 -172.37 0.31 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 126.611 1.964 . . . . 0.0 111.249 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -68.94 -13.79 37.39 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.112 2.541 . . . . 0.0 113.478 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 40.9 p -126.82 -25.43 3.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.046 1.339 . . . . 0.0 113.859 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 16.9 mm -127.08 134.47 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.512 1.525 . . . . 0.0 109.591 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -123.83 132.97 53.87 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.544 1.138 . . . . 0.0 111.26 -172.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.0 t70 62.27 30.89 17.63 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.236 1.414 . . . . 0.0 112.507 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -61.83 125.36 84.76 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.787 1.235 . . . . 0.0 110.871 176.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.75 143.98 24.27 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.206 2.604 . . . . 0.0 109.551 169.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.36 134.83 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.363 1.465 . . . . 0.0 110.417 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -78.37 131.6 37.04 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.652 0.781 . . . . 0.0 109.436 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.46 128.01 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.133 1.373 . . . . 0.0 108.618 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -135.97 84.99 29.86 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.654 1.182 . . . . 0.0 110.071 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.17 133.89 55.87 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.598 2.865 . . . . 0.0 110.984 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -78.98 153.8 30.04 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -172.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -165.44 174.19 10.27 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.99 2.116 . . . . 0.0 111.244 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 61.1 tp -145.5 121.08 10.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.269 1.427 . . . . 0.0 109.391 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 6.7 t -169.88 -165.34 0.48 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.967 1.707 . . . . 0.0 110.456 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -150.91 135.61 17.24 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.454 1.902 . . . . 0.0 110.648 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 45.6 p -166.56 158.93 13.82 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.772 1.229 . . . . 0.0 112.62 -170.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -89.41 -2.29 58.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.56 1.544 . . . . 0.0 114.785 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -63.65 139.39 58.76 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.774 1.229 . . . . 0.0 112.177 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 12.5 p -161.3 145.09 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.638 1.575 . . . . 0.0 110.479 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 91.3 mtp -136.22 114.0 11.14 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.272 1.429 . . . . 0.0 109.397 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -167.15 156.16 10.25 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.347 1.859 . . . . 0.0 110.458 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 57.2 p -77.58 -10.05 59.28 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -72.17 -62.48 3.3 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.448 1.499 . . . . 0.0 113.532 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.01 124.75 10.34 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.156 2.571 . . . . 0.0 110.871 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 69.5 p -96.88 -9.23 28.98 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 27.6 m 65.64 6.74 4.01 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.86 2.064 . . . . 0.0 114.906 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.037 1.304 . . . . 0.0 113.316 179.632 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.554 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 25.1 m -128.08 9.61 6.28 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -170.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 25.0 m 68.67 8.93 7.04 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.349 1.86 . . . . 0.0 115.267 172.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 85.25 -128.8 8.92 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.798 1.19 . . . . 0.0 112.64 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 41.8 m -148.74 165.93 29.93 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.527 1.531 . . . . 0.0 111.669 -172.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 26.2 m -157.83 160.76 38.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.015 1.726 . . . . 0.0 111.089 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 113.18 -147.65 18.55 Favored Glycine 0 N--CA 1.47 0.961 0 C-N-CA 125.212 1.387 . . . . 0.0 112.561 -175.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 35.5 t -148.55 164.54 33.91 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.038 1.335 . . . . 0.0 112.375 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 70.8 mtm-85 -75.48 -3.8 36.05 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.09 0.956 . . . . 0.0 113.45 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -72.53 135.8 45.72 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.464 0.706 . . . . 0.0 110.506 169.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.41 117.75 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.384 1.074 . . . . 0.0 109.8 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -69.44 138.93 53.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.538 1.135 . . . . 0.0 110.885 172.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.62 115.38 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.428 1.491 . . . . 0.0 109.04 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.56 143.49 18.07 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 125.061 1.315 . . . . 0.0 113.8 -175.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.42 23.12 22.62 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.77 1.176 . . . . 0.0 114.196 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.77 141.91 88.67 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.957 1.303 . . . . 0.0 110.98 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.39 154.28 19.79 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.382 2.722 . . . . 0.0 113.106 172.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.49 3.76 6.09 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.733 2.955 . . . . 0.0 114.096 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -140.82 25.86 2.11 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.727 1.211 . . . . 0.0 112.599 -175.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 12.1 tt -99.27 137.3 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.311 1.045 . . . . 0.0 110.747 174.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -112.02 169.25 8.98 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.383 1.073 . . . . 0.0 113.437 -174.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -43.11 -46.54 5.82 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.146 1.779 . . . . 0.0 114.251 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -77.5 -26.47 51.26 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.647 -0.658 . . . . 0.0 112.414 -173.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -79.38 -38.34 35.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.856 0.862 . . . . 0.0 111.533 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 46.2 mt -63.73 -35.84 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.794 0.724 . . . . 0.0 109.68 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 50.5 m -68.34 -53.32 24.92 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.644 0.778 . . . . 0.0 110.863 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.73 -29.69 70.28 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.515 1.052 . . . . 0.0 113.146 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 68.7 m -64.8 -25.39 67.89 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -120.49 -5.07 9.82 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 50.0 tpt85 -60.13 -22.49 62.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.05 1.34 . . . . 0.0 113.195 174.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -53.69 -21.41 6.97 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.732 2.013 . . . . 0.0 114.81 170.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -97.41 -7.56 31.44 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.311 1.444 . . . . 0.0 113.631 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 125.38 171.61 13.28 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.108 1.813 . . . . 0.0 112.102 -170.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.82 149.88 73.17 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.673 2.915 . . . . 0.0 112.292 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.08 171.69 18.84 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.622 1.569 . . . . 0.0 112.403 -171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.0 159.78 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.671 1.588 . . . . 0.0 109.223 167.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 58.4 t -131.84 135.88 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.224 1.009 . . . . 0.0 110.884 -170.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -148.12 162.76 38.76 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.169 1.788 . . . . 0.0 111.53 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 21.4 p90 -159.54 159.15 28.18 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.617 1.167 . . . . 0.0 112.601 -177.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -61.01 146.02 98.32 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.388 2.725 . . . . 0.0 112.752 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 63.59 18.39 11.06 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.93 1.292 . . . . 0.0 114.083 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -64.14 -33.73 76.45 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.286 -1.509 . . . . 0.0 112.082 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -76.92 -22.12 53.84 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.824 2.049 . . . . 0.0 114.08 174.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -94.14 -43.46 8.46 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.81 1.244 . . . . 0.0 111.608 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 67.6 m -83.2 -13.89 54.48 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.459 1.104 . . . . 0.0 113.089 174.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 50.1 mttp 55.91 49.38 16.05 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.321 1.448 . . . . 0.0 112.081 169.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 25.1 t -143.47 151.26 40.1 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.372 1.069 . . . . 0.0 112.737 -169.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -93.93 16.1 15.15 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.372 1.869 . . . . 0.0 113.174 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -117.23 142.46 30.17 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 127.26 2.224 . . . . 0.0 109.213 169.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.95 121.22 7.13 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.402 2.735 . . . . 0.0 110.832 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.49 13.9 2.63 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.729 2.952 . . . . 0.0 113.41 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -124.59 -10.23 7.36 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.599 1.56 . . . . 0.0 114.198 -171.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 75.56 13.27 83.11 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 124.348 0.975 . . . . 0.0 113.826 -172.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -154.52 159.4 40.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.248 1.419 . . . . 0.0 112.167 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -152.08 170.93 18.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.769 1.227 . . . . 0.0 111.792 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -119.48 117.37 28.24 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.312 1.845 . . . . 0.0 109.705 177.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.85 142.01 34.08 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.162 1.385 . . . . 0.0 108.757 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 64.4 mt -124.07 106.17 10.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.672 1.589 . . . . 0.0 107.928 171.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.99 156.1 22.46 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.37 0.668 . . . . 0.0 111.946 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -78.61 -24.65 45.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -143.16 141.95 31.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.308 1.443 . . . . 0.0 110.675 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.47 -33.0 69.28 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.032 0.933 . . . . 0.0 111.935 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -55.52 -28.24 53.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.771 1.228 . . . . 0.0 113.111 174.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.5 m -73.37 -28.85 62.26 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 120.941 -1.099 . . . . 0.0 112.283 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.2 t -74.88 -39.55 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.685 -0.634 . . . . 0.0 109.624 174.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -66.18 -38.39 87.91 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.708 -0.62 . . . . 0.0 111.951 173.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.39 86.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.379 0.671 . . . . 0.0 112.409 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.25 -48.1 74.44 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.206 0.602 . . . . 0.0 111.049 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 78.4 mt -55.54 -41.95 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.93 0.892 . . . . 0.0 111.221 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.28 -17.15 63.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.814 1.246 . . . . 0.0 113.72 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.0 -13.65 18.99 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.167 1.387 . . . . 0.0 113.404 175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 57.8 m -76.3 149.06 37.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 93.2 mt -85.94 177.46 7.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.666 1.586 . . . . 0.0 107.934 165.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.37 130.16 18.14 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.518 0.727 . . . . 0.0 111.337 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -150.6 128.48 11.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.044 1.737 . . . . 0.0 110.385 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 22.2 t70 59.42 22.74 11.23 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.772 1.629 . . . . 0.0 113.96 175.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 92.27 -1.46 73.25 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.662 1.601 . . . . 0.0 114.602 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -110.39 151.75 27.09 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.242 1.817 . . . . 0.0 111.466 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.4 mt -90.85 155.76 18.53 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.846 0.859 . . . . 0.0 111.137 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -142.55 144.43 32.91 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 3.7 tp -129.68 -167.05 1.74 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.673 1.989 . . . . 0.0 108.375 169.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 28.7 p -144.3 152.31 40.59 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.912 -1.118 . . . . 0.0 113.38 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.37 169.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.85 2.06 . . . . 0.0 110.761 -171.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 71.1 m -148.12 163.86 35.66 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.453 1.101 . . . . 0.0 113.018 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 52.4 p -145.32 -178.33 0.77 Allowed Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 126.905 2.082 . . . . 0.0 110.886 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -67.28 -10.96 30.43 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.298 2.665 . . . . 0.0 113.98 170.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 42.4 p -113.28 -31.33 6.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.016 1.326 . . . . 0.0 113.329 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.9 mm -133.62 134.23 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.159 1.384 . . . . 0.0 110.412 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -115.95 135.47 53.94 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.866 1.266 . . . . 0.0 111.119 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 25.1 t70 61.84 32.95 17.91 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.468 1.507 . . . . 0.0 112.761 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -62.97 124.36 83.38 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.935 -1.103 . . . . 0.0 110.225 174.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -76.48 145.88 27.0 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.983 2.455 . . . . 0.0 109.149 170.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 2.6 m -136.38 133.22 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.711 1.205 . . . . 0.0 110.719 -175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -76.41 130.59 38.25 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.497 1.119 . . . . 0.0 109.72 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 28.7 mm -113.21 133.35 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.303 1.441 . . . . 0.0 108.54 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 51.8 mtp85 -138.65 98.19 8.92 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 124.306 1.042 . . . . 0.0 110.483 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.79 131.28 43.02 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.358 2.705 . . . . 0.0 110.01 169.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -76.84 141.64 40.57 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -169.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -160.24 152.16 20.18 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.422 2.289 . . . . 0.0 109.227 172.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.22 64.16 4.95 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.427 1.091 . . . . 0.0 110.372 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.1 m -84.24 -0.98 54.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.341 1.457 . . . . 0.0 114.215 -173.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 20.3 t70 71.87 9.74 6.18 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 127.769 2.427 . . . . 0.0 114.007 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 89.1 p -157.53 154.18 28.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.982 1.713 . . . . 0.0 112.066 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.1 137.58 7.37 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.755 1.622 . . . . 0.0 110.523 -174.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -142.68 155.02 44.85 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.602 1.161 . . . . 0.0 112.818 -168.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.2 125.68 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.77 1.228 . . . . 0.0 110.513 171.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 16.0 ttt -90.78 -13.08 34.62 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.472 1.509 . . . . 0.0 113.577 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -80.07 141.24 36.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.335 1.454 . . . . 0.0 111.566 176.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 18.3 m -69.33 -14.79 63.12 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . 79.73 -169.19 53.15 Favored Glycine 0 CA--C 1.542 1.732 0 C-N-CA 124.893 1.235 . . . . 0.0 114.038 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -62.2 156.33 51.19 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 124.533 3.488 . . . . 0.0 113.319 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 11.1 t -162.12 169.91 20.07 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.231 1.412 . . . . 0.0 111.325 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 79.6 p -147.55 5.13 0.8 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.196 1.398 . . . . 0.0 114.364 -172.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.125 0 CA-C-O 118.34 -1.255 . . . . 0.0 113.077 -179.695 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.591 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 30.9 m -59.52 123.37 16.62 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.431 1.093 . . . . 0.0 112.255 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 51.7 p -166.86 164.48 16.33 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.868 1.267 . . . . 0.0 111.826 -171.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 79.95 -58.46 4.55 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.382 1.468 . . . . 0.0 111.571 -177.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 50.8 m -65.57 133.72 51.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.315 1.046 . . . . 0.0 110.627 169.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 57.5 m -133.24 15.59 4.14 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.817 1.247 . . . . 0.0 113.065 -169.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 82.65 -41.48 2.85 Favored Glycine 0 N--CA 1.473 1.118 0 C-N-CA 125.758 1.647 . . . . 0.0 112.724 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 13.3 t -162.89 166.89 23.46 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.606 1.962 . . . . 0.0 111.56 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 82.9 mtm-85 -86.68 -7.82 57.97 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.136 0.974 . . . . 0.0 112.275 168.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -79.61 136.78 36.93 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.884 1.274 . . . . 0.0 110.674 172.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.6 t -141.42 121.24 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.497 1.119 . . . . 0.0 110.104 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -74.54 142.17 44.77 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.72 0.808 . . . . 0.0 111.158 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.88 124.12 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.402 1.481 . . . . 0.0 109.251 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -122.49 149.64 16.95 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.011 1.291 . . . . 0.0 113.615 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 92.48 17.41 45.84 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.864 1.221 . . . . 0.0 114.366 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.92 141.74 89.39 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.295 1.438 . . . . 0.0 111.381 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.31 154.98 17.21 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.906 3.07 . . . . 0.0 113.818 175.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.43 2.6 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.984 3.122 . . . . 0.0 114.105 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -140.29 23.17 2.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.964 1.306 . . . . 0.0 112.413 -176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.1 tt -95.32 160.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.681 1.193 . . . . 0.0 109.744 169.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -142.33 171.15 14.45 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.294 1.037 . . . . 0.0 113.107 -173.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -41.67 -47.16 3.91 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.082 1.753 . . . . 0.0 114.241 -178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.4 -26.97 46.62 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.486 -0.759 . . . . 0.0 112.635 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -80.56 -35.23 34.65 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.016 0.927 . . . . 0.0 111.669 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 65.3 mt -64.7 -36.52 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.614 -0.679 . . . . 0.0 109.465 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 53.7 m -65.4 -53.5 42.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.559 171.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -60.26 -31.34 70.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.27 0.941 . . . . 0.0 113.275 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 66.1 m -67.68 -23.6 65.32 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 176.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -122.49 -4.3 8.81 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -59.5 -23.04 62.46 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.027 1.331 . . . . 0.0 112.909 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -53.54 -20.55 5.1 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.678 1.991 . . . . 0.0 114.921 170.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -99.51 -5.66 28.87 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.381 1.472 . . . . 0.0 113.718 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 122.89 177.47 15.2 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 126.294 1.902 . . . . 0.0 112.406 -173.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.99 147.66 91.77 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.393 2.729 . . . . 0.0 112.65 -177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.5 169.82 23.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.359 1.464 . . . . 0.0 112.551 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.8 p -131.5 156.93 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.624 1.569 . . . . 0.0 109.158 167.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 94.3 t -119.67 136.38 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.904 1.282 . . . . 0.0 110.068 -173.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -146.34 162.45 38.13 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.288 1.835 . . . . 0.0 111.455 -171.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -164.25 164.1 14.47 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.094 1.358 . . . . 0.0 112.315 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -57.39 139.96 91.67 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.36 2.707 . . . . 0.0 112.341 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 66.14 15.14 9.97 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 125.064 1.346 . . . . 0.0 114.421 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -64.41 -20.49 66.18 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.056 -1.653 . . . . 0.0 113.043 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -72.69 -18.2 61.57 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.057 2.143 . . . . 0.0 114.789 173.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -136.44 -11.58 1.86 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 17.5 t -66.93 152.73 45.17 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.813 1.245 . . . . 0.0 112.954 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -93.09 9.48 35.68 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -169.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 98.7 p -153.84 170.0 22.03 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.795 1.238 . . . . 0.0 113.029 -175.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -109.85 23.41 14.41 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.218 1.807 . . . . 0.0 112.771 -174.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -104.03 152.9 39.17 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 127.273 2.229 . . . . 0.0 110.901 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.01 126.55 13.95 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.179 2.586 . . . . 0.0 110.549 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.37 135.4 26.64 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.411 2.741 . . . . 0.0 110.46 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 60.2 11.35 2.74 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.18 1.392 . . . . 0.0 114.291 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 85.65 25.69 37.91 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.222 1.391 . . . . 0.0 114.181 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -144.91 158.71 43.71 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.423 1.611 . . . . 0.0 114.741 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -156.99 170.04 23.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.607 1.563 . . . . 0.0 112.019 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -117.24 129.56 56.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.146 1.778 . . . . 0.0 110.243 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 35.8 mt -92.79 140.92 29.01 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.733 1.613 . . . . 0.0 108.699 169.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.8 mt -124.96 107.34 10.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.784 1.634 . . . . 0.0 108.077 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -88.21 161.55 17.16 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.822 0.849 . . . . 0.0 112.736 -176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -76.16 -27.2 56.88 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.294 1.038 . . . . 0.0 113.028 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -141.36 145.98 36.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.314 1.445 . . . . 0.0 110.515 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.98 -29.73 68.64 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.627 -0.67 . . . . 0.0 111.351 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 16.7 m -55.24 -28.15 51.25 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.358 1.063 . . . . 0.0 113.099 171.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 16.9 m -74.54 -28.59 61.03 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.928 -1.108 . . . . 0.0 112.046 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.59 -37.29 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.301 0.641 . . . . 0.0 109.83 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -63.33 -41.1 98.88 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.762 0.71 . . . . 0.0 111.552 170.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.21 84.61 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.655 0.661 . . . . 0.0 112.361 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.82 -48.22 75.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.413 0.685 . . . . 0.0 111.149 171.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 68.7 mt -55.56 -42.25 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.429 1.092 . . . . 0.0 111.16 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.2 -17.51 63.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.892 1.277 . . . . 0.0 113.589 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.11 -13.96 18.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.126 1.37 . . . . 0.0 113.317 175.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 59.0 m -74.75 146.8 41.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.944 0.878 . . . . 0.0 113.266 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.36 173.32 11.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.288 1.435 . . . . 0.0 108.001 165.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -145.81 135.38 23.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.646 0.778 . . . . 0.0 111.435 -175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -158.06 122.25 4.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.574 1.15 . . . . 0.0 111.185 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 66.45 5.88 4.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.819 2.448 . . . . 0.0 114.903 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 103.02 -2.32 47.84 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.892 1.71 . . . . 0.0 113.908 -170.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -93.82 144.79 25.11 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.537 1.535 . . . . 0.0 110.473 173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.3 mt -97.22 154.33 17.46 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.929 0.891 . . . . 0.0 111.054 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -143.19 149.1 37.52 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.1 tp -132.03 -179.67 5.55 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.614 1.966 . . . . 0.0 108.729 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 71.8 m -130.61 140.42 50.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.269 1.028 . . . . 0.0 112.04 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.9 m -148.43 171.39 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 126.159 1.783 . . . . 0.0 111.623 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 68.7 m -147.29 163.36 36.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.783 1.233 . . . . 0.0 112.516 -174.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 28.4 p -140.19 -175.73 0.5 Allowed Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.84 2.056 . . . . 0.0 110.631 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -66.9 -13.07 38.54 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.0 2.467 . . . . 0.0 113.894 171.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 44.0 p -120.91 -28.18 4.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.906 1.282 . . . . 0.0 113.836 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 16.3 mm -126.5 135.28 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.206 1.402 . . . . 0.0 110.117 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -121.41 131.0 53.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.689 1.196 . . . . 0.0 111.158 -174.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 24.5 t70 62.67 32.32 16.29 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.305 1.442 . . . . 0.0 112.666 176.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -60.55 128.33 88.1 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.348 1.059 . . . . 0.0 110.528 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.21 139.5 14.93 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.207 2.604 . . . . 0.0 109.095 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 5.2 m -131.38 132.17 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.271 1.428 . . . . 0.0 109.769 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.71 133.77 35.39 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.291 1.036 . . . . 0.0 109.815 -174.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 30.0 mm -115.98 134.9 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.292 1.437 . . . . 0.0 108.901 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -141.11 95.5 7.48 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.53 1.132 . . . . 0.0 110.641 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.14 130.23 35.31 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.664 2.909 . . . . 0.0 111.241 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -74.23 143.31 45.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.74 0.816 . . . . 0.0 112.042 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -161.83 157.65 24.39 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.985 1.314 . . . . 0.0 111.897 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.89 154.34 48.37 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.58 1.552 . . . . 0.0 110.763 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 25.8 m 65.96 17.96 10.94 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.452 1.501 . . . . 0.0 114.427 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -158.18 163.17 37.8 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.664 1.986 . . . . 0.0 110.846 -174.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 8.3 t -161.29 162.33 30.94 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.728 1.211 . . . . 0.0 112.395 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -160.77 142.19 12.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.309 2.244 . . . . 0.0 109.511 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -63.98 145.64 55.52 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 3.7 p -166.96 131.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 128.022 2.529 . . . . 0.0 106.955 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -16.24 63.64 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -169.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -84.34 -2.24 56.75 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.328 1.451 . . . . 0.0 113.444 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 3.1 t -70.28 3.57 2.8 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.252 1.421 . . . . 0.0 114.578 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -78.61 -147.49 3.58 Favored Glycine 0 CA--C 1.544 1.848 0 C-N-CA 125.651 1.596 . . . . 0.0 112.688 171.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -53.8 -26.48 39.2 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.113 3.209 . . . . 0.0 115.28 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 24.2 m -66.27 -14.37 61.88 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 67.7 m -119.96 5.27 10.89 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.592 1.557 . . . . 0.0 113.353 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.25 -1.306 . . . . 0.0 113.773 -179.113 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 36.1 p -73.49 -12.83 60.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.084 0.953 . . . . 0.0 113.166 171.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 9.3 t -153.62 -175.76 5.51 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.57 2.348 . . . . 0.0 109.473 170.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 92.87 0.43 68.74 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.27 1.415 . . . . 0.0 115.022 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 66.9 m -145.57 132.78 20.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.743 1.617 . . . . 0.0 110.174 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 69.7 p -154.41 4.91 0.26 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -169.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.11 -143.7 22.21 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.324 0.964 . . . . 0.0 113.104 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 24.0 t -158.76 166.09 32.78 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.309 1.443 . . . . 0.0 112.222 -170.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 46.7 mtm105 -75.25 -9.35 58.48 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.324 1.05 . . . . 0.0 112.931 169.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -79.92 136.99 36.78 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.146 0.978 . . . . 0.0 111.42 171.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 48.8 t -139.15 118.82 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.691 1.197 . . . . 0.0 109.709 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -75.23 142.31 43.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.394 0.678 . . . . 0.0 110.59 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.36 121.92 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.521 1.529 . . . . 0.0 109.189 176.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -116.78 148.23 18.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.796 1.189 . . . . 0.0 113.065 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 93.17 14.99 53.36 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.67 1.128 . . . . 0.0 114.268 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 92.9 mt -57.83 139.26 82.49 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.687 1.195 . . . . 0.0 110.375 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.32 150.56 19.8 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.602 2.868 . . . . 0.0 113.161 173.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.95 3.0 6.47 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.943 3.095 . . . . 0.0 113.579 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -137.57 16.07 2.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.728 2.011 . . . . 0.0 112.596 -169.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.4 tt -96.05 133.91 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.658 1.183 . . . . 0.0 111.781 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -94.8 162.16 13.87 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.472 1.109 . . . . 0.0 113.399 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -47.64 -44.49 26.96 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.107 1.763 . . . . 0.0 113.751 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -76.11 -27.91 57.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.825 0.85 . . . . 0.0 112.389 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -77.27 -34.47 55.68 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.528 0.731 . . . . 0.0 112.651 169.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.4 mt -64.99 -36.64 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.93 1.241 . . . . 0.0 109.609 169.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 54.0 m -64.99 -52.38 56.53 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.646 0.779 . . . . 0.0 110.54 172.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.49 -30.37 70.57 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.582 1.083 . . . . 0.0 112.924 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 75.6 m -65.61 -15.83 63.12 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -130.76 -3.24 4.14 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.6 tpt85 -61.03 -22.21 64.34 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.083 1.353 . . . . 0.0 113.009 173.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -57.58 -11.9 2.39 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.645 1.978 . . . . 0.0 114.931 169.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -105.92 -5.86 19.33 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.466 1.506 . . . . 0.0 114.047 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 123.91 173.98 14.04 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 126.073 1.797 . . . . 0.0 112.53 -173.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.27 149.98 88.68 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.795 2.997 . . . . 0.0 113.016 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -161.75 171.98 16.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.255 1.422 . . . . 0.0 112.806 -176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.72 158.46 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.918 1.687 . . . . 0.0 109.298 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.37 135.63 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.578 1.151 . . . . 0.0 110.719 -170.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -149.56 162.42 40.21 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.893 1.677 . . . . 0.0 111.662 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -157.79 157.03 29.41 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.369 1.067 . . . . 0.0 112.722 -178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -59.89 156.3 39.21 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.951 3.101 . . . . 0.0 113.847 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 69.02 -6.46 0.9 Allowed 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 126.842 2.057 . . . . 0.0 114.183 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -66.56 -23.74 66.25 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.299 1.44 . . . . 0.0 112.385 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -82.71 -14.3 54.83 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.183 2.193 . . . . 0.0 114.162 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -112.4 -21.19 11.49 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.459 1.503 . . . . 0.0 112.562 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 23.0 t -145.33 111.65 5.7 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.787 1.635 . . . . 0.0 108.806 170.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -74.04 132.64 42.54 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.421 0.688 . . . . 0.0 111.946 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 26.1 t -164.71 155.37 14.52 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.376 1.471 . . . . 0.0 110.51 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -108.59 15.9 23.38 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.362 1.465 . . . . 0.0 112.782 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.69 141.52 32.5 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.81 2.044 . . . . 0.0 109.594 169.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.64 120.22 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.226 2.617 . . . . 0.0 109.803 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -83.58 9.57 4.05 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.51 2.807 . . . . 0.0 114.611 -169.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -140.79 1.98 1.74 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.817 1.647 . . . . 0.0 114.239 -173.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 78.82 21.63 68.15 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.115 0.864 . . . . 0.0 114.464 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -152.22 157.53 41.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.463 1.131 . . . . 0.0 112.652 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -155.34 168.77 25.98 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.718 1.207 . . . . 0.0 112.257 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -113.37 121.14 43.47 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.307 1.843 . . . . 0.0 109.727 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 26.3 mt -86.02 140.73 30.03 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.422 1.489 . . . . 0.0 108.76 169.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.53 107.65 12.25 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.788 1.635 . . . . 0.0 107.734 171.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -84.97 154.17 22.32 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.417 0.687 . . . . 0.0 111.936 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -71.65 -26.29 62.48 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.76 0.824 . . . . 0.0 112.822 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -142.25 146.05 34.71 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.389 1.475 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.53 -31.44 71.46 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.308 0.643 . . . . 0.0 111.659 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.2 m -56.24 -28.41 58.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.75 1.22 . . . . 0.0 112.876 173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.0 m -73.19 -29.13 62.61 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.964 -1.085 . . . . 0.0 112.147 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.04 -38.51 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.646 -0.659 . . . . 0.0 109.784 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -66.78 -38.35 86.39 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.547 -0.721 . . . . 0.0 111.897 172.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.84 88.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.579 0.627 . . . . 0.0 112.372 173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.76 -49.13 74.18 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.306 0.642 . . . . 0.0 110.929 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.62 -42.18 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.1 0.96 . . . . 0.0 111.428 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.07 -17.84 63.92 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.76 1.224 . . . . 0.0 113.581 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -100.1 -13.59 18.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.165 1.386 . . . . 0.0 113.351 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 54.7 m -75.49 148.14 39.24 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 94.0 mt -83.6 172.93 11.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.045 165.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -146.91 139.06 24.62 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.487 0.715 . . . . 0.0 112.15 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -155.18 118.09 4.34 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.324 1.45 . . . . 0.0 109.275 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 18.6 t70 65.51 5.75 3.39 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.891 2.076 . . . . 0.0 114.973 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 103.09 -6.3 50.9 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.768 1.651 . . . . 0.0 113.575 -171.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -82.27 138.16 34.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.881 1.273 . . . . 0.0 109.348 169.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 92.8 mt -97.61 155.91 16.76 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.674 0.79 . . . . 0.0 110.83 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -143.03 148.43 36.72 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 4.6 tp -135.75 177.93 7.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.474 1.91 . . . . 0.0 108.904 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 86.7 m -126.51 144.66 50.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.242 1.017 . . . . 0.0 112.761 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.0 m -149.85 170.06 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 126.855 2.062 . . . . 0.0 111.038 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 70.6 m -148.69 163.47 37.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.761 1.224 . . . . 0.0 112.406 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 25.7 p -140.89 -173.44 0.36 Allowed Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 126.745 2.018 . . . . 0.0 111.278 -174.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -58.79 -36.09 97.6 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.955 2.437 . . . . 0.0 113.863 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 44.8 p -119.29 -16.15 9.05 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 23.6 mm -113.69 128.79 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.693 1.133 . . . . 0.0 109.945 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -124.79 135.33 52.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.484 1.114 . . . . 0.0 111.69 -168.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 61.26 30.94 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.421 1.488 . . . . 0.0 112.631 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -66.85 128.32 93.82 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.52 1.128 . . . . 0.0 111.213 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.07 141.73 13.24 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.342 2.695 . . . . 0.0 109.119 169.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.18 135.08 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.396 1.479 . . . . 0.0 110.015 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -81.08 129.57 34.62 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.362 1.065 . . . . 0.0 109.561 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 35.7 mm -110.81 136.8 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.337 1.455 . . . . 0.0 109.08 -173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -142.14 87.01 9.89 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.904 1.282 . . . . 0.0 110.051 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.61 128.12 27.09 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.327 2.684 . . . . 0.0 109.763 172.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -74.66 121.19 21.27 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -169.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -154.4 19.86 0.48 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.032 1.733 . . . . 0.0 111.764 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 54.0 tp -73.14 125.35 27.5 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.012 1.325 . . . . 0.0 111.533 -171.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 67.6 m -134.13 57.81 1.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.455 1.502 . . . . 0.0 109.394 176.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . 0.285 2.6 p30 56.6 16.07 2.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.558 2.343 . . . . 0.0 114.431 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 4.7 p -84.67 8.59 16.43 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.865 2.866 . . . . 0.0 114.547 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -63.39 -6.37 4.73 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -81.21 3.7 22.89 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.488 1.515 . . . . 0.0 114.708 172.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.91 132.97 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.011 1.724 . . . . 0.0 110.955 -171.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 65.0 ttp -168.78 141.22 2.75 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.924 2.09 . . . . 0.0 109.868 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -163.43 169.62 18.62 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.113 1.365 . . . . 0.0 112.897 -175.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 89.1 p -155.02 166.49 33.43 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.889 1.676 . . . . 0.0 111.984 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -167.71 172.48 42.54 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.571 1.081 . . . . 0.0 113.973 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.68 153.85 49.02 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.074 3.183 . . . . 0.0 111.823 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 33.6 p -84.29 -3.56 58.31 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.754 1.222 . . . . 0.0 114.159 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 3.3 t 70.7 -175.29 0.19 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.03 2.132 . . . . 0.0 113.854 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 C-N-CA 125.7 1.619 . . . . 0.0 112.831 -178.009 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 92.0 p -163.87 178.41 7.82 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.547 1.539 . . . . 0.0 111.496 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 37.5 p -80.94 -3.67 52.31 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -97.51 173.13 28.21 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.558 1.552 . . . . 0.0 114.024 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 8.2 t -163.0 157.36 20.82 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.361 1.465 . . . . 0.0 111.442 173.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 48.7 m -153.45 155.23 35.92 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.06 1.744 . . . . 0.0 111.274 -171.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 151.76 -32.21 0.9 Allowed Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.048 1.309 . . . . 0.0 114.469 172.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 8.2 t -165.9 156.21 12.82 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.555 1.542 . . . . 0.0 112.32 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 86.3 mtm-85 -100.33 -2.52 33.38 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.486 1.114 . . . . 0.0 112.457 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -86.5 138.25 31.88 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.131 0.973 . . . . 0.0 111.132 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.0 t -140.6 120.63 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.293 1.037 . . . . 0.0 110.208 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -71.63 139.93 49.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.851 0.86 . . . . 0.0 110.644 171.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 62.4 t -132.6 119.35 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.32 1.448 . . . . 0.0 109.408 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -118.66 146.51 18.45 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 125.069 1.319 . . . . 0.0 113.435 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 97.13 17.87 30.75 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.883 1.23 . . . . 0.0 114.275 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.77 141.54 92.68 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.994 1.318 . . . . 0.0 111.441 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.11 156.77 15.22 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.877 3.052 . . . . 0.0 113.972 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -78.05 3.95 6.59 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.061 3.174 . . . . 0.0 113.815 -177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -137.45 23.22 2.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.377 1.471 . . . . 0.0 112.323 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 11.8 tt -104.81 142.66 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.556 1.142 . . . . 0.0 110.897 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -116.2 169.0 9.61 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.929 1.292 . . . . 0.0 113.068 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -48.64 -41.28 30.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.725 1.61 . . . . 0.0 113.921 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -81.13 -29.44 34.8 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.891 0.877 . . . . 0.0 112.388 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.93 -38.19 69.9 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.328 0.651 . . . . 0.0 111.822 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 45.1 mt -65.85 -38.71 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.301 -0.875 . . . . 0.0 109.449 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 85.2 m -60.93 -51.51 68.95 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.334 0.653 . . . . 0.0 110.539 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -61.93 -30.59 71.01 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.419 1.009 . . . . 0.0 112.914 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 65.9 m -68.93 -13.95 62.75 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.077 1.139 . . . . 0.0 114.077 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -129.43 -2.89 4.91 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.5 tpt85 -60.96 -21.74 63.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.966 1.307 . . . . 0.0 113.228 174.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -56.74 -13.13 2.27 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.736 2.014 . . . . 0.0 114.976 169.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -104.47 -4.89 22.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.514 1.526 . . . . 0.0 113.999 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 121.07 175.1 15.08 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.983 1.754 . . . . 0.0 112.604 -174.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.26 145.54 98.38 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 123.923 3.082 . . . . 0.0 113.421 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.25 172.53 17.2 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.403 1.481 . . . . 0.0 112.698 -177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.58 159.85 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.835 1.654 . . . . 0.0 108.553 166.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 82.8 t -132.56 135.97 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.249 1.02 . . . . 0.0 110.421 -172.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -153.84 172.1 17.9 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.806 1.242 . . . . 0.0 112.437 -177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -152.6 150.88 25.83 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.928 0.891 . . . . 0.0 113.08 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -70.45 16.52 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 125.083 3.855 . . . . 0.0 117.666 -168.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -147.87 7.38 0.83 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.585 1.554 . . . . 0.0 113.674 -169.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -66.31 -21.33 66.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.237 1.015 . . . . 0.0 112.438 172.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -72.03 -33.17 67.82 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.612 1.565 . . . . 0.0 113.164 172.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.97 -21.54 17.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.659 1.184 . . . . 0.0 113.091 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 31.6 t -137.38 114.25 10.56 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.226 1.41 . . . . 0.0 108.587 169.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -72.36 0.95 8.74 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -167.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 49.0 m -60.96 139.06 58.12 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.157 1.383 . . . . 0.0 113.461 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -86.82 15.69 5.57 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.833 1.253 . . . . 0.0 113.44 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -118.22 133.92 23.42 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 128.515 2.726 . . . . 0.0 106.723 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.03 117.36 5.05 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.654 2.236 . . . . 0.0 110.638 -176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.04 13.58 2.32 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.562 2.841 . . . . 0.0 114.427 -172.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -132.56 -0.28 3.57 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.851 1.66 . . . . 0.0 113.998 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 77.61 18.35 77.68 Favored Glycine 0 N--CA 1.474 1.228 0 C-N-CA 124.276 0.941 . . . . 0.0 114.724 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -148.16 157.17 43.35 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.557 1.178 . . . . 0.0 112.973 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -150.91 167.54 27.25 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.051 1.341 . . . . 0.0 111.831 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -115.12 121.19 42.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.856 1.662 . . . . 0.0 109.845 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 21.0 mt -82.24 140.32 33.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.176 1.39 . . . . 0.0 108.731 169.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 60.9 mt -125.22 101.18 6.87 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.013 1.725 . . . . 0.0 108.11 173.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.34 159.13 27.3 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.165 0.586 . . . . 0.0 111.497 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -88.49 -13.51 40.09 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.68 142.23 34.92 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.695 1.598 . . . . 0.0 110.367 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.14 -29.78 71.07 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.556 -0.715 . . . . 0.0 112.04 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 26.7 p -59.58 -24.8 64.06 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.939 -1.1 . . . . 0.0 112.999 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 20.7 m -71.18 -28.79 64.48 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.888 -1.133 . . . . 0.0 112.314 172.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 70.4 t -73.88 -36.98 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.524 -0.735 . . . . 0.0 109.797 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -71.64 -35.74 70.49 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.736 -0.602 . . . . 0.0 112.137 174.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.37 85.87 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.673 0.67 . . . . 0.0 112.255 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 28.0 tp -63.87 -49.17 73.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.543 0.737 . . . . 0.0 110.951 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.99 -41.64 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.094 0.958 . . . . 0.0 111.619 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.11 -18.48 63.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.844 1.258 . . . . 0.0 113.67 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.57 -13.5 20.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.049 1.339 . . . . 0.0 113.289 174.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 40.9 m -75.92 147.19 39.15 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.73 176.46 8.94 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.722 1.609 . . . . 0.0 107.798 165.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -144.74 128.96 17.74 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.649 -0.657 . . . . 0.0 111.382 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -149.43 132.6 16.36 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.965 2.106 . . . . 0.0 108.981 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 57.3 31.8 20.72 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.867 1.267 . . . . 0.0 113.246 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 78.42 7.36 87.95 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.811 1.196 . . . . 0.0 114.419 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -123.71 152.32 42.21 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.17 1.788 . . . . 0.0 111.354 -175.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 89.5 mt -89.21 154.07 20.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.68 0.792 . . . . 0.0 111.671 -178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -143.65 148.84 36.38 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.513 1.125 . . . . 0.0 113.002 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 6.8 tp -140.39 157.91 44.82 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.365 1.466 . . . . 0.0 110.134 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 76.6 m -95.96 136.91 35.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.15 0.98 . . . . 0.0 112.424 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 31.5 m -146.11 177.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 126.846 2.058 . . . . 0.0 110.44 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 82.0 p -162.76 168.52 21.36 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.054 -1.029 . . . . 0.0 113.481 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 51.9 p -138.75 -175.54 0.49 Allowed Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 126.454 1.902 . . . . 0.0 110.617 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -66.55 -12.42 35.72 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.172 2.581 . . . . 0.0 114.154 169.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 46.9 p -119.11 -29.39 5.25 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.964 1.306 . . . . 0.0 113.689 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 27.2 mm -128.77 127.07 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.285 1.434 . . . . 0.0 109.592 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -117.26 141.79 47.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.661 1.184 . . . . 0.0 111.774 -169.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 57.69 31.92 21.12 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 125.123 1.369 . . . . 0.0 113.096 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -70.51 128.17 91.37 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.314 1.045 . . . . 0.0 111.712 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.62 128.38 4.62 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.309 2.673 . . . . 0.0 108.578 169.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.51 137.91 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.187 1.395 . . . . 0.0 110.47 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -76.71 125.95 30.13 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.104 1.362 . . . . 0.0 109.568 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 36.3 mm -110.96 128.78 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.54 1.536 . . . . 0.0 108.548 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -136.36 91.5 16.43 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.633 1.173 . . . . 0.0 109.85 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.9 132.48 51.95 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.765 2.977 . . . . 0.0 110.312 172.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -88.3 170.94 10.55 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -168.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -157.83 149.48 21.76 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.728 1.611 . . . . 0.0 111.414 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 532' ' ' LEU . 1.8 pt? -100.3 -14.87 18.24 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 79.9 p -97.17 -5.87 36.12 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -161.99 150.43 15.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.293 1.837 . . . . 0.0 111.406 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 78.3 p -156.5 15.56 0.31 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.631 1.973 . . . . 0.0 112.712 -176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -84.23 58.88 5.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.337 1.455 . . . . 0.0 112.623 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -63.1 115.93 4.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.306 1.442 . . . . 0.0 110.322 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 9.6 p -161.02 150.25 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.545 1.538 . . . . 0.0 110.883 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 27.0 ttt -157.44 146.38 19.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.503 1.521 . . . . 0.0 110.961 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -154.24 145.48 22.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.941 1.696 . . . . 0.0 110.777 177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 50.3 m -80.92 96.2 6.99 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.168 0.987 . . . . 0.0 112.282 -174.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -83.43 168.33 46.05 Favored Glycine 0 CA--C 1.541 1.714 0 C-N-CA 124.602 1.096 . . . . 0.0 113.409 174.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.12 158.63 45.29 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.964 3.109 . . . . 0.0 111.609 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 51.5 p -82.63 -2.98 55.46 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 16.0 m -166.01 155.32 11.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.292 2.237 . . . . 0.0 110.944 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 118.278 -1.29 . . . . 0.0 112.889 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.554 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' SER . . . . . . . . . . . . . 7.9 t -155.53 -168.11 2.72 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.035 1.334 . . . . 0.0 111.907 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' SER . . . . . . . . . . . . . 72.3 p -121.57 14.52 11.04 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.405 1.882 . . . . 0.0 113.828 -171.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -77.55 176.57 53.53 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.283 1.421 . . . . 0.0 114.127 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . . . . . . . . . 4.8 m -170.71 157.25 5.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.223 2.209 . . . . 0.0 110.127 -173.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 84.1 p -81.52 -20.02 40.94 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.008 -1.058 . . . . 0.0 112.769 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 82.55 3.64 90.44 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.305 1.431 . . . . 0.0 113.983 -175.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' SER . . . . . . . . . . . . . 22.6 t -68.41 135.31 51.53 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.01 1.405 . . . . 0.0 112.739 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' ARG . . . . . . . . . . . . . 66.4 mtm-85 -100.37 3.66 43.4 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.375 1.47 . . . . 0.0 113.599 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -70.48 136.0 49.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.566 1.147 . . . . 0.0 111.026 172.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 61.3 t -140.86 120.69 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.579 1.151 . . . . 0.0 110.111 176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -68.64 141.25 55.44 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.221 1.008 . . . . 0.0 111.258 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.74 125.8 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.992 1.317 . . . . 0.0 109.161 169.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . -127.28 148.6 17.51 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 125.218 1.39 . . . . 0.0 113.461 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 90.52 15.68 56.47 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.714 1.149 . . . . 0.0 114.009 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.68 142.5 62.25 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.485 1.514 . . . . 0.0 111.408 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.47 151.48 23.71 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.774 2.983 . . . . 0.0 113.145 176.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.96 0.62 8.66 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.776 2.984 . . . . 0.0 114.795 -169.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -140.71 16.92 2.34 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.38 1.072 . . . . 0.0 113.0 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 13.9 tt -79.75 131.61 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.632 0.773 . . . . 0.0 111.506 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -92.65 167.89 11.6 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.96 -39.99 69.53 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.491 1.117 . . . . 0.0 113.195 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.93 -30.24 58.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.969 0.907 . . . . 0.0 112.087 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.09 -42.54 80.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.948 0.899 . . . . 0.0 111.517 169.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' ILE . . . . . . . . . . . . . 63.3 mt -63.15 -40.7 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.162 0.892 . . . . 0.0 109.795 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' THR . . . . . . . . . . . . . 56.9 m -62.21 -51.56 67.31 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.655 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' ALA . . . . . . . . . . . . . . . -62.65 -31.08 71.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.275 0.943 . . . . 0.0 112.567 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' SER . . . . . . . . . . . . . 67.3 m -68.97 -13.14 62.27 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -129.02 -3.62 5.1 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.618 1.099 . . . . 0.0 113.572 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -61.02 -22.77 64.86 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.867 1.267 . . . . 0.0 113.165 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -57.11 -13.39 2.88 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.624 1.97 . . . . 0.0 114.951 170.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -103.34 -7.34 21.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.427 1.491 . . . . 0.0 113.901 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 124.07 172.14 13.61 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.1 1.81 . . . . 0.0 112.075 -170.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.1 150.8 60.69 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.501 2.801 . . . . 0.0 112.237 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -161.16 174.96 12.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.604 1.562 . . . . 0.0 112.603 -169.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.78 157.23 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.852 1.661 . . . . 0.0 109.144 167.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' VAL . . . . . . . . . . . . . 59.3 t -124.04 134.02 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.856 1.262 . . . . 0.0 109.79 -174.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -147.4 164.28 33.81 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.851 1.66 . . . . 0.0 111.817 -170.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . 0.498 ' CZ2' ' HE2' ' A' ' 474' ' ' LYS . 10.2 p90 -163.19 162.68 17.67 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.553 1.541 . . . . 0.0 111.724 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -55.03 140.85 80.17 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.645 2.897 . . . . 0.0 113.006 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 69.64 3.35 4.2 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 126.106 1.762 . . . . 0.0 114.901 177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.498 ' HE2' ' CZ2' ' A' ' 471' ' ' TRP . 42.8 tttm -65.35 -29.79 70.55 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 120.551 -1.343 . . . . 0.0 112.165 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' ALA . . . . . . . . . . . . . . . -67.29 -29.47 69.08 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.257 1.823 . . . . 0.0 113.628 175.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -101.53 -36.1 8.92 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.759 1.223 . . . . 0.0 112.558 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 66.7 m -91.68 -11.0 38.18 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 55.41 33.11 20.21 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 125.389 1.476 . . . . 0.0 112.206 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 27.6 p -81.29 164.5 22.17 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -168.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -134.51 3.51 3.32 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -168.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.25 144.96 54.72 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.61 1.964 . . . . 0.0 109.104 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.85 126.98 13.13 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.393 2.729 . . . . 0.0 111.242 -170.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.28 130.1 19.3 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.351 2.701 . . . . 0.0 109.964 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.0 mttm 58.53 12.66 2.19 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.399 1.48 . . . . 0.0 114.461 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' GLY . . . . . . . . . . . . . . . 85.46 27.87 31.62 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.974 1.273 . . . . 0.0 114.481 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -137.51 156.74 47.79 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.591 1.696 . . . . 0.0 114.175 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -154.44 168.57 26.22 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.665 1.586 . . . . 0.0 111.647 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -120.22 120.71 36.92 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.947 1.699 . . . . 0.0 109.987 172.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 24.7 mt -83.27 141.12 32.08 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.909 1.284 . . . . 0.0 108.571 169.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' LEU . . . . . . . . . . . . . 43.6 mt -123.5 105.49 9.82 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.395 1.478 . . . . 0.0 107.54 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.92 157.75 26.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.011 0.524 . . . . 0.0 111.274 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -90.48 -12.78 36.27 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -142.21 137.2 30.59 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.562 1.545 . . . . 0.0 110.098 175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -58.48 -34.11 70.53 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.797 0.839 . . . . 0.0 111.964 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' SER . . . . . . . . . . . . . 17.6 m -55.97 -26.42 48.17 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.742 1.217 . . . . 0.0 113.197 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.4 m -71.84 -27.83 63.15 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.947 -1.096 . . . . 0.0 112.384 174.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' VAL . . . . . . . . . . . . . 57.0 t -73.87 -39.9 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.657 -0.652 . . . . 0.0 109.513 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -67.94 -37.75 82.0 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.694 -0.629 . . . . 0.0 111.941 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.28 -38.36 89.05 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.554 0.616 . . . . 0.0 112.342 173.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' LEU . . . . . . . . . . . . . 29.2 tp -63.85 -48.83 75.2 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.288 0.635 . . . . 0.0 110.888 171.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' ILE . . . . . . . . . . . . . 76.4 mt -56.0 -42.68 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.958 0.903 . . . . 0.0 111.42 176.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.21 -19.02 63.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.729 1.212 . . . . 0.0 113.514 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -98.33 -14.07 20.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.052 1.341 . . . . 0.0 113.5 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' CYS . . . . . . . . . . . . . 42.3 m -75.46 147.94 39.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.079 0.942 . . . . 0.0 113.41 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.54 172.85 11.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.505 1.522 . . . . 0.0 107.803 165.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -142.8 132.48 23.89 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.402 0.681 . . . . 0.0 111.501 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -147.12 121.49 9.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.818 1.647 . . . . 0.0 109.499 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 63.71 6.16 2.54 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.71 2.004 . . . . 0.0 114.42 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 101.6 -10.56 57.68 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.938 1.733 . . . . 0.0 113.589 -172.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -79.27 147.95 32.34 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.511 1.155 . . . . 0.0 109.7 169.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 94.1 mt -95.92 153.57 17.69 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.181 0.592 . . . . 0.0 111.014 173.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -140.17 146.75 39.17 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.005 0.922 . . . . 0.0 112.707 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' LEU . . . . . . . . . . . . . 5.4 tp -129.87 -174.75 3.4 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.418 1.887 . . . . 0.0 108.561 171.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' CYS . . . . . . . . . . . . . 30.0 p -133.94 149.49 51.27 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.058 0.943 . . . . 0.0 113.173 175.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 26.0 m -148.15 170.23 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 126.279 1.832 . . . . 0.0 111.588 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 50.8 m -145.33 154.23 42.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.536 1.134 . . . . 0.0 112.755 -174.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 24.6 p -144.4 -175.04 0.44 Allowed Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 126.207 1.803 . . . . 0.0 111.502 -172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.31 -13.99 41.32 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.122 2.548 . . . . 0.0 113.659 171.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 29.3 p -117.51 -32.0 5.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.148 1.379 . . . . 0.0 113.77 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 10.5 mm -133.64 142.45 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.96 1.304 . . . . 0.0 110.137 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -120.94 133.63 55.28 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.081 1.352 . . . . 0.0 110.577 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 26.2 t70 63.08 28.34 16.08 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.152 1.381 . . . . 0.0 112.926 177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -57.18 126.52 74.05 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-O 117.34 -1.314 . . . . 0.0 110.662 174.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.8 140.56 23.47 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.215 2.61 . . . . 0.0 109.652 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.05 134.78 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.829 1.252 . . . . 0.0 110.657 -174.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -73.14 134.73 44.55 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.001 1.321 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 33.8 mm -119.9 131.43 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.65 1.58 . . . . 0.0 108.105 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -139.99 95.36 8.59 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 123.848 0.859 . . . . 0.0 110.862 178.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.64 139.96 91.41 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.602 2.868 . . . . 0.0 111.889 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -82.26 -3.45 55.2 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.185 0.994 . . . . 0.0 112.568 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -77.79 95.8 4.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.788 1.235 . . . . 0.0 111.707 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -119.73 157.91 27.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.112 1.765 . . . . 0.0 110.522 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 81.1 p -163.91 180.0 6.66 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.428 1.491 . . . . 0.0 111.441 176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.45 8.02 4.74 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.101 1.36 . . . . 0.0 113.245 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' SER . . . . . . . . . . . . . 31.0 m -75.95 -0.07 20.22 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -174.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 25.2 t0 81.29 150.19 0.1 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 129.118 2.967 . . . . 0.0 113.799 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -72.74 169.64 16.27 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.253 1.821 . . . . 0.0 113.045 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.6 p -152.92 139.28 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.806 1.642 . . . . 0.0 110.402 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' MET . . . . . . . . . . . . . 28.2 ttt -164.77 143.62 6.85 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.427 1.891 . . . . 0.0 110.036 -174.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' ASP . . . . . . . . . . . . . 25.5 t70 63.44 18.14 10.83 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.651 1.98 . . . . 0.0 113.814 173.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 70.0 m -98.96 11.37 39.15 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.294 1.437 . . . . 0.0 113.86 -170.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' GLY . . . . . . . . . . . . . . . -75.35 170.21 54.51 Favored Glycine 0 CA--C 1.543 1.782 0 C-N-CA 124.765 1.174 . . . . 0.0 113.812 177.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.67 152.72 53.7 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.047 3.165 . . . . 0.0 111.858 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 19.5 m -77.08 -3.41 39.11 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' SER . . . . . . . . . . . . . 80.5 p -164.49 165.37 21.41 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.025 1.73 . . . . 0.0 112.138 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.255 -1.303 . . . . 0.0 112.863 179.513 . . . . . . . . 0 0 . 1 stop_ save_